token,label,label_gpt
Joys,O,O
and,O,O
F,O,B
.,O,O
2,O,O
cases,O,O
of,O,O
type,O,O
II,O,O
tyrosinosis,O,B
(,O,O
Richner,O,B
-,O,I
Hanhart,O,I
syndrome,O,I
),O,O
Following,O,O
conditioning,O,O
",",O,O
a,O,O
single,O,O
coat,O,O
of,O,O
adhesive,O,O
was,O,O
applied,O,O
and,O,O
light,O,O
-,O,O
cured,O,O
.,O,O
The,O,O
East,O,O
African,O,O
dik,O,O
-,O,O
dik,O,O
antelope,O,O
represents,O,O
a,O,O
miniature,O,O
model,O,O
ruminant,O,O
for,O,O
comparative,O,O
studies,O,O
.,O,O
Evaluation,O,O
of,O,O
automatic,O,O
blood,O,O
cell,O,O
counters,O,O
.,O,O
Auditory,O,O
threshold,O,O
shifts,O,O
",",O,O
as,O,O
measured,O,O
by,O,O
the,O,O
auditory,O,O
evoked,O,O
brainstem,O,O
response,O,O
",",O,O
were,O,O
measured,O,O
at,O,O
2,O,O
",",O,O
4,O,O
",",O,O
8,O,O
",",O,O
12,O,O
",",O,O
16,O,O
",",O,O
20,O,O
and,O,O
24,O,O
kHz,O,O
.,O,O
A,O,O
portion,O,O
of,O,O
Region,O,O
II,O,O
also,O,O
resembles,O,O
part,O,O
of,O,O
the,O,O
human,O,B
c,B,I
-,I,I
jun,I,I
oncoprotein,O,I
',O,O
s,O,O
leucine,O,O
zipper,O,O
",",O,O
which,O,O
in,O,O
turn,O,O
",",O,O
has,O,O
been,O,O
demonstrated,O,O
to,O,O
be,O,O
the,O,O
heterodimerization,O,O
site,O,O
between,O,O
the,O,O
jun,B,O
and,O,O
fos,B,O
oncoproteins,I,O
.,O,O
Of,O,O
the,O,O
117,O,O
patients,O,O
(,O,O
out,O,O
of,O,O
the,O,O
136,O,O
),O,O
with,O,O
serologic,O,O
evidence,O,O
of,O,O
chronic,O,O
thyroiditis,O,O
who,O,O
could,O,O
be,O,O
studied,O,O
",",O,O
eight,O,O
(,O,O
7,O,O
%,O,O
),O,O
had,O,O
hyperthyroidism,O,O
and,O,O
45,O,O
(,O,O
38,O,O
%,O,O
),O,O
were,O,O
hypothyroid,O,O
.,O,O
All,O,O
other,O,O
normal,O,O
and,O,O
transformed,O,O
lymphoid,O,O
and,O,O
nonlymphoid,O,O
cell,O,O
lines,O,O
and,O,O
normal,O,O
tissues,O,O
were,O,O
negative,O,O
for,O,O
PANG,B,B
expression,O,O
except,O,O
for,O,O
the,O,O
brain,O,O
",",O,O
wherein,O,O
unique,O,O
4,O,O
.,O,O
0,O,O
.,O,O
1,O,O
-,O,O
kb,O,O
transcripts,O,O
were,O,O
detected,O,O
.,O,O
Type,O,O
I,O,O
position,O,O
-,O,O
vestibular,O,O
-,O,O
pause,O,O
(,O,O
PVP,O,O
I,O,O
),O,O
and,O,O
vestibular,O,O
-,O,O
only,O,O
(,O,O
V,O,B
I,O,I
),O,O
neurons,O,O
",",O,O
as,O,O
well,O,O
as,O,O
a,O,O
smaller,O,O
number,O,O
of,O,O
other,O,O
type,O,O
I,O,O
and,O,O
type,O,O
II,O,O
eye,O,O
-,O,O
plus,O,O
-,O,O
vestibular,O,O
neurons,O,O
were,O,O
studied,O,O
.,O,O
Risk,O,O
of,O,O
infection,O,O
in,O,O
the,O,O
treatment,O,O
of,O,O
fractures,O,O
Marine,O,O
oils,O,O
and,O,O
cardiovascular,O,O
reactivity,O,O
.,O,O
Influence,O,O
of,O,O
cyclo,B,B
-,I,I
oxygenase,I,I
inhibition,O,O
and,O,O
of,O,O
leukotriene,B,O
receptor,I,O
blockade,O,O
on,O,O
pulmonary,O,O
vascular,O,O
pressure,O,O
/,O,O
cardiac,O,O
index,O,O
relationships,O,O
in,O,O
hyperoxic,O,O
and,O,O
in,O,O
hypoxic,O,O
dogs,O,O
.,O,O
The,O,O
HMG,B,B
domain,I,O
of,O,O
both,O,O
HMG20,B,B
proteins,I,O
is,O,O
most,O,O
similar,O,O
to,O,O
that,O,O
of,O,O
yeast,B,O
NHP6A,I,B
(,O,O
38,O,O
%,O,O
to,O,O
42,O,O
%,O,O
),O,O
.,O,O
The,O,O
antigen,B,O
-,I,O
specific,I,O
IgG4,I,B
antibody,I,O
seems,O,O
to,O,O
be,O,O
an,O,O
index,O,O
in,O,O
evaluating,O,O
immunotherapy,O,O
objectively,O,O
.,O,O
This,O,O
strategy,O,O
was,O,O
used,O,O
to,O,O
place,O,O
both,O,O
the,O,O
Tn903,B,B
neo,I,I
gene,I,I
and,O,O
the,O,O
Rhodosporidium,B,B
toruloides,I,I
phenylalanine,I,I
ammonia,I,I
lyase,I,I
(,O,O
PAL,B,B
),O,O
-,O,O
encoding,O,O
gene,O,O
under,O,O
the,O,O
transcriptional,O,O
control,O,O
of,O,O
pPGK,B,O
:,O,O
:,O,O
REP2,B,O
.,O,O
Here,O,O
we,O,O
describe,O,O
the,O,O
cloning,O,O
",",O,O
tissue,O,O
-,O,O
specific,O,O
expression,O,O
pattern,O,O
",",O,O
and,O,O
functional,O,O
characterization,O,O
of,O,O
two,O,O
novel,O,O
TEF,B,B
-,I,I
1,I,I
isoforms,I,I
",",O,O
TEF,B,B
-,I,I
1beta,I,I
and,O,O
TEF,B,B
-,I,I
1gamma,I,I
.,O,O
The,O,O
experimental,O,O
group,O,O
consisted,O,O
of,O,O
61,O,O
examinees,O,O
class,O,O
II,O,O
/,O,O
2,O,O
orthodontic,O,O
anomalies,O,O
.,O,O
Phosphatidylinositol,B,O
3,I,O
-,I,O
kinase,I,O
requirement,O,O
in,O,O
activation,O,O
of,O,O
the,O,O
ras,B,B
/,O,O
C,B,B
-,I,I
raf,I,I
-,I,I
1,I,I
/,O,O
MEK,B,B
/,O,O
ERK,B,B
and,O,O
p70,B,B
(,O,I
s6k,B,I
),O,O
signaling,O,O
cascade,O,O
by,O,O
the,O,O
insulinomimetic,O,O
agent,O,O
vanadyl,O,O
sulfate,O,O
.,O,O
This,O,O
apparently,O,O
anomalous,O,O
structure,O,O
/,O,O
activity,O,O
relationship,O,O
raises,O,O
important,O,O
issues,O,O
for,O,O
understanding,O,O
the,O,O
evolution,O,O
of,O,O
regulatory,O,O
peptides,O,O
and,O,O
the,O,O
mechanisms,O,O
that,O,O
control,O,O
their,O,O
expression,O,O
.,O,O
In,O,O
the,O,O
same,O,O
period,O,O
we,O,O
pointed,O,O
out,O,O
an,O,O
increase,O,O
of,O,O
hematocrit,O,O
(,O,O
from,O,O
29,O,O
%,O,O
to,O,O
35,O,O
%,O,O
),O,O
and,O,O
of,O,O
the,O,O
Hb,B,B
(,O,O
from,O,O
9,O,O
.,O,O
3,O,O
to,O,O
11,O,O
.,O,O
2,O,O
g,O,O
/,O,O
dl,O,O
),O,O
.,O,O
The,O,O
C,O,O
-,O,O
LIP,O,O
also,O,O
was,O,O
compared,O,O
with,O,O
transcather,O,O
arterial,O,O
embolization,O,O
(,O,O
TAE,O,O
;,O,O
C,O,O
-,O,O
LIP,O,O
followed,O,O
by,O,O
gelatin,O,O
sponge,O,O
),O,O
and,O,O
percutaneous,O,O
ethanol,O,O
injection,O,O
therapy,O,O
(,O,O
PEIT,O,O
),O,O
.,O,O
The,O,O
ORF1,O,O
product,O,O
was,O,O
required,O,O
for,O,O
competence,O,O
",",O,O
while,O,O
ORF2,O,O
",",O,O
which,O,O
was,O,O
cotranscribed,O,O
with,O,O
ORF1,O,O
and,O,O
encoded,O,O
a,O,O
predicted,O,O
protein,O,O
of,O,O
126,O,O
amino,O,O
acids,O,O
",",O,O
was,O,O
not,O,O
.,O,O
2,O,O
.,O,O
Cotransfection,O,O
of,O,O
Ets,B,B
-,I,I
2,I,I
and,O,O
p44,B,B
mitogen,B,I
-,I,I
activated,I,I
protein,I,I
(,I,O
MAP,I,B
),I,O
kinase,I,O
expression,O,O
vectors,O,O
strongly,O,O
potentiated,O,O
HB,B,O
-,O,O
EGF,B,O
promoter,O,O
activation,O,O
in,O,O
response,O,O
to,O,O
deltaRaf,B,O
-,I,O
1,I,O
:,O,O
ER,B,O
.,O,O
Bitter,O,O
cassava,O,O
contains,O,O
cyanogenic,O,O
glycosides,O,O
;,O,O
processing,O,O
breaks,O,O
them,O,O
down,O,O
to,O,O
acetone,O,O
cyanohydrin,O,O
and,O,O
hydrogen,O,O
cyanide,O,O
.,O,O
Sequence,O,O
analysis,O,O
of,O,O
the,O,O
promoter,O,O
region,O,O
showed,O,O
no,O,O
TATA,O,O
box,O,O
but,O,O
identified,O,O
consensus,O,O
binding,O,O
motifs,O,O
for,O,O
Sp1,B,B
",",O,O
CREB,B,B
",",O,O
and,O,O
half,O,O
sites,O,O
of,O,O
the,O,O
estrogen,B,O
receptor,I,O
binding,I,O
site,I,O
.,O,O
Unique,O,O
to,O,O
this,O,O
system,O,O
",",O,O
the,O,O
activity,O,O
of,O,O
TraR,B,B
is,O,O
negatively,O,O
modulated,O,O
by,O,O
an,O,O
antiactivator,O,O
called,O,O
TraM,B,B
.,O,O
Thus,O,O
",",O,O
an,O,O
increase,O,O
in,O,O
plasma,B,O
TBG,I,B
and,O,O
a,O,O
shift,O,O
from,O,O
adrenal,O,O
and,O,O
steroid,O,O
secretion,O,O
towards,O,O
cortisol,O,O
secretion,O,O
may,O,O
be,O,O
endocrine,O,O
markers,O,O
for,O,O
progression,O,O
of,O,O
the,O,O
disease,O,O
in,O,O
patients,O,O
with,O,O
HIV,O,B
-,O,I
infection,O,I
.,O,O
Such,O,O
studied,O,O
acquired,O,O
with,O,O
low,O,O
energy,O,O
or,O,O
medium,O,O
energy,O,O
collimation,O,O
and,O,O
a,O,O
window,O,O
centered,O,O
on,O,O
the,O,O
159,O,O
keV,O,O
123I,O,B
photopeak,O,I
contain,O,O
appreciable,O,O
septal,O,O
breakthrough,O,O
signals,O,O
originating,O,O
from,O,O
Compton,O,O
scatter,O,O
of,O,O
high,O,O
energy,O,O
photons,O,O
primarily,O,O
from,O,O
124I,O,B
.,O,O
Dissolution,O,O
of,O,O
the,O,O
Pt,O,B
-,O,I
30,O,I
%,O,I
Ir,O,I
microelectrode,O,I
tip,O,I
was,O,O
observed,O,O
by,O,O
scanning,O,O
electron,O,O
microscopy,O,O
at,O,O
charge,O,O
densities,O,O
as,O,O
low,O,O
as,O,O
200,O,O
microC,O,O
/,O,O
cm2,O,O
X,O,O
ph,O,O
(,O,O
1,O,O
A,O,O
/,O,O
cm2,O,O
),O,O
",",O,O
whereas,O,O
erosion,O,O
of,O,O
activated,O,O
iridium,O,B
microelectrodes,O,I
occurred,O,O
only,O,O
at,O,O
the,O,O
highest,O,O
charge,O,O
and,O,O
current,O,O
densities,O,O
(,O,O
3200,O,O
microC,O,O
/,O,O
cm2,O,O
X,O,O
ph,O,O
",",O,O
16,O,O
A,O,O
/,O,O
cm2,O,O
),O,O
.,O,O
E1A,B,B
represses,O,O
apolipoprotein,B,B
AI,I,I
enhancer,I,O
activity,O,O
in,O,O
liver,O,O
cells,O,O
through,O,O
a,O,O
pRb,B,B
-,O,I
and,O,I
CBP,B,B
-,O,I
independent,O,O
pathway,O,O
.,O,O
Ganciclovir,O,O
and,O,O
foscarnet,O,O
efficacy,O,O
in,O,O
AIDS,O,O
-,O,O
related,O,O
CMV,O,O
polyradiculopathy,O,O
.,O,O
JCAHO,O,O
asks,O,O
for,O,O
hospitals,O,O
',O,O
patience,O,O
.,O,O
Conservative,O,O
treatment,O,O
of,O,O
bladder,O,O
carcinoma,O,O
by,O,O
partial,O,O
cystectomy,O,O
and,O,O
interstitial,O,O
iridium,O,O
192,O,O
.,O,O
The,O,O
spermicide,O,O
nonoxynol,O,B
-,O,I
9,O,I
is,O,O
a,O,O
member,O,O
of,O,O
a,O,O
homologous,O,O
series,O,O
of,O,O
alkylphenol,O,O
-,O,O
ethoxylates,O,O
(,O,O
polyethoxyethanols,O,O
),O,O
of,O,O
general,O,O
formula,O,O
C9H19,O,O
-,O,O
C6H6,O,O
-,O,O
O,O,O
-,O,O
(,O,O
CH2CH2O,O,O
),O,O
n,O,O
-,O,O
1,O,O
CH2CH2OH,O,O
.,O,O
A,O,O
raised,O,O
amplitude,O,O
of,O,O
the,O,O
aggregation,O,O
of,O,O
plates,O,O
and,O,O
a,O,O
decrease,O,O
in,O,O
the,O,O
threshold,O,O
of,O,O
their,O,O
sensitivity,O,O
to,O,O
ADP,O,B
were,O,O
established,O,O
in,O,O
the,O,O
persons,O,O
with,O,O
types,O,O
IIa,O,O
and,O,O
IIb,O,O
HLP,O,O
and,O,O
in,O,O
CHD,O,O
without,O,O
HLP,O,O
.,O,O
Dominant,O,O
negative,O,O
Sos,B,B
did,O,O
not,O,O
affect,O,O
carbachol,O,O
stimulation,O,O
of,O,O
HA,B,O
-,O,O
ERK2,B,B
but,O,O
inhibited,O,O
the,O,O
stimulatory,O,O
effect,O,O
of,O,O
EGF,B,O
by,O,O
60,O,O
%,O,O
.,O,O
[,O,O
Pulmonary,O,O
vascular,O,O
resistance,O,O
(,O,O
PVR,O,B
),O,O
during,O,O
10,O,O
%,O,O
O2,O,O
-,O,O
PVR,O,B
during,O,O
21,O,O
%,O,O
O2,O,O
/,O,O
PVR,O,B
during,O,O
21,O,O
%,O,O
O2,O,O
x,O,O
100,O,O
was,O,O
termed,O,O
as,O,O
hypoxic,O,O
pulmonary,O,O
vasoconstriction,O,O
(,O,O
HPV,O,B
),O,O
.,O,O
While,O,O
all,O,O
deletions,O,O
within,O,O
the,O,O
sequence,O,O
coding,O,O
for,O,O
the,O,O
mature,O,O
tRNA,O,B
led,O,O
to,O,O
inactivity,O,O
of,O,O
the,O,O
mutated,O,O
genes,O,O
",",O,O
substitution,O,O
of,O,O
the,O,O
central,O,O
portion,O,O
by,O,O
concatenated,B,O
Hind,I,B
III,I,I
linkers,I,I
produced,O,O
gene,O,O
units,O,O
active,O,O
in,O,O
transcription,O,O
.,O,O
Identification,O,O
and,O,O
characterization,O,O
of,O,O
two,O,O
putative,O,O
human,B,B
arginine,I,I
methyltransferases,I,I
(,O,O
HRMT1L1,B,B
and,O,O
HRMT1L2,B,B
),O,O
.,O,O
Remarkably,O,O
",",O,O
U21,B,O
contains,O,O
a,O,O
long,O,O
stretch,O,O
(,O,O
13,O,O
nt,O,O
.,O,O
),O,O
of,O,O
complementarity,O,O
to,O,O
a,O,O
highly,O,O
conserved,O,O
sequence,O,O
in,O,O
28S,B,O
rRNA,I,O
.,O,O
Immunohistochemically,O,O
",",O,O
anticytokeratin,B,O
19,I,O
antibody,I,O
revealed,O,O
strong,O,O
staining,O,O
in,O,O
both,O,O
epithelial,O,O
and,O,O
sarcomatous,O,O
MPM,O,O
tissues,O,O
.,O,O
Analysis,O,O
of,O,O
Standard,O,O
Reference,O,O
Material,O,O
1846,O,O
",",O,O
Infant,O,O
Formula,O,O
",",O,O
gave,O,O
a,O,O
mean,O,O
value,O,O
of,O,O
0,O,O
.,O,O
95,O,O
+,O,O
/,O,O
-,O,O
0,O,O
mg,O,O
vitamin,O,O
K,O,B
/,O,O
kg,O,O
(,O,O
K,O,B
or,O,O
K1,O,B
?,O,O
),O,O
(,O,O
n,O,O
=,O,O
31,O,O
),O,O
with,O,O
a,O,O
coefficient,O,O
of,O,O
variation,O,O
of,O,O
9,O,O
.,O,O
26,O,O
Data,O,O
from,O,O
in,O,O
vitro,O,O
splicing,O,O
assays,O,O
",",O,O
UV,O,O
crosslinking,O,O
and,O,O
RNA,O,O
-,O,O
binding,O,O
competition,O,O
experiments,O,O
indicates,O,O
a,O,O
strong,O,O
correlation,O,O
between,O,O
the,O,O
binding,O,O
affinities,O,O
of,O,O
PSI,B,B
for,O,O
the,O,O
SELEX,O,O
sequences,O,O
and,O,O
their,O,O
ability,O,O
to,O,O
modulate,O,O
splicing,O,O
of,O,O
P,B,B
element,I,I
IVS3,B,I
in,O,I
vitro,O,I
.,O,O
Factors,O,O
involved,O,O
in,O,O
specific,O,O
transcription,O,O
by,O,O
mammalian,O,B
RNA,B,I
polymerase,I,I
II,I,I
:,O,O
purification,O,O
",",O,O
genetic,O,O
specificity,O,O
",",O,O
and,O,O
TATA,O,B
box,O,I
-,O,I
promoter,O,I
interactions,O,I
of,O,O
TFIID,B,B
.,O,O
EsaR,B,B
can,O,O
repress,O,O
its,O,O
own,O,O
expression,O,O
but,O,O
seems,O,O
not,O,O
to,O,O
regulate,O,O
the,O,O
expression,O,O
of,O,O
esaI,B,B
.,O,O
Charcoal,O,O
-,O,O
facilitated,O,O
dialysis,O,O
.,O,O
The,O,O
structure,O,O
of,O,O
these,O,O
genes,O,O
suggests,O,O
a,O,O
common,O,O
ancestor,O,O
for,O,O
all,O,O
viperid,B,O
PLA2,I,B
genes,I,O
.,O,O
Quantitative,O,O
analysis,O,O
of,O,O
plasmid,O,O
loss,O,O
rates,O,O
in,O,O
cdc28,B,B
-,I,I
1N,I,I
strains,O,O
carrying,O,O
plasmids,O,O
with,O,O
multiple,O,O
replication,O,O
origins,O,O
suggests,O,O
that,O,O
a,O,O
defect,O,O
in,O,O
initiating,O,O
DNA,O,O
replication,O,O
probably,O,O
causes,O,O
this,O,O
plasmid,O,O
loss,O,O
phenotype,O,O
.,O,O
Bullous,O,O
angiolymphoid,O,O
hyperplasia,O,O
with,O,O
eosinophilia,O,O
Our,O,O
results,O,O
show,O,O
that,O,O
",",O,O
from,O,O
a,O,O
thermodynamical,O,O
standpoint,O,O
",",O,O
melatonin,O,O
may,O,O
directly,O,O
scavenge,O,O
hydroxyl,O,O
radicals,O,O
both,O,O
in,O,O
vacuum,O,O
and,O,O
in,O,O
aqueous,O,O
solution,O,O
.,O,O
Neither,O,O
ethanol,O,O
nor,O,O
estrogen,O,O
has,O,O
been,O,O
shown,O,O
to,O,O
cause,O,O
UROD,B,B
-,O,I
deficiency,O,I
in,O,O
animals,O,O
.,O,O
CONCLUSION,O,O
:,O,O
Treatment,O,O
of,O,O
sepsis,O,O
with,O,O
the,O,O
platelet,B,O
-,I,O
activating,I,O
factor,I,O
antagonist,O,O
BB,O,O
-,O,O
882,O,O
offers,O,O
no,O,O
advantage,O,O
over,O,O
placebo,O,O
on,O,O
survival,O,O
",",O,O
hemodynamic,O,O
status,O,O
",",O,O
respiratory,O,O
function,O,O
",",O,O
or,O,O
organ,O,O
failure,O,O
scores,O,O
.,O,O
Also,O,O
",",O,O
transient,O,O
overexpression,O,O
of,O,O
this,O,O
protein,O,O
in,O,O
C2C12,O,O
cells,O,O
reduced,O,O
the,O,O
transcription,O,O
of,O,O
a,O,O
CAT,B,O
-,O,O
reporter,O,O
regulated,O,O
by,O,O
an,O,O
E12,B,O
/,O,O
MyoD,B,O
driven,O,O
enhancer,O,O
.,O,O
She,O,O
drank,O,O
alcohol,O,O
once,O,O
or,O,O
twice,O,O
a,O,O
week,O,O
and,O,O
regularly,O,O
took,O,O
an,O,O
analgesic,O,O
preparation,O,O
",",O,O
containing,O,O
aspirin,O,B
and,O,O
acetaminophen,O,B
",",O,O
for,O,O
alleviation,O,O
of,O,O
headaches,O,O
.,O,O
Diffuse,O,O
myalgias,O,O
were,O,O
more,O,O
frequent,O,O
in,O,O
patients,O,O
with,O,O
than,O,O
without,O,O
an,O,O
MMF,O,B
lesion,O,I
at,O,O
deltoid,O,O
muscle,O,O
biopsy,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
0001,O,O
),O,O
.,O,O
There,O,O
was,O,O
no,O,O
difference,O,O
in,O,O
the,O,O
hormone,O,O
receptor,O,O
status,O,O
between,O,O
the,O,O
cases,O,O
without,O,O
lymph,O,O
node,O,O
metastases,O,O
and,O,O
with,O,O
lymph,O,O
node,O,O
metastases,O,O
",",O,O
',O,O
clandestine,O,O
',O,O
or,O,O
macrometastases,O,O
.,O,O
Infant,O,O
aged,O,O
3,O,O
.,O,O
5,O,O
years,O,O
presents,O,O
persistence,O,O
of,O,O
primordial,O,O
vitreous,O,O
body,O,O
with,O,O
crystalline,O,O
dislocation,O,O
in,O,O
the,O,O
camera,O,O
aquosa,O,O
and,O,O
secondary,O,O
buphthalmos,O,O
of,O,O
the,O,O
left,O,O
eye,O,O
and,O,O
microphthalmos,O,O
with,O,O
dislocation,O,O
of,O,O
the,O,O
crystalline,O,O
in,O,O
the,O,O
vitreous,O,O
body,O,O
of,O,O
the,O,O
right,O,O
eye,O,O
.,O,O
BACKGROUND,O,O
AND,O,O
DESIGN,O,O
:,O,O
Fifty,O,O
-,O,O
nine,O,O
melanocytic,O,O
nevi,O,O
with,O,O
eccentric,O,O
foci,O,O
of,O,O
hyperpigmentation,O,O
(,O,O
measured,O,O
primarily,O,O
1,O,O
to,O,O
2,O,O
mm,O,O
in,O,O
diameter,O,O
were,O,O
prospectively,O,O
examined,O,O
to,O,O
determine,O,O
the,O,O
histologic,O,O
correlates,O,O
of,O,O
the,O,O
dark,O,O
dots,O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
Using,O,O
icodextrin,O,O
-,O,O
based,O,O
instead,O,O
of,O,O
glucose,O,O
-,O,O
based,O,O
PD,O,O
fluids,O,O
can,O,O
largely,O,O
reduce,O,O
the,O,O
formation,O,O
of,O,O
Amadori,O,B
albumin,B,I
and,O,O
AGEs,O,B
.,O,O
The,O,O
Mauriceville,O,O
and,O,O
Varkud,O,O
mitochondrial,O,O
plasmids,O,O
are,O,O
closely,O,O
related,O,O
",",O,O
closed,O,O
-,O,O
circular,O,O
DNAs,O,O
(,O,O
3,O,O
.,O,O
6,O,O
and,O,O
3,O,O
.,O,O
7,O,O
kb,O,O
",",O,O
respectively,O,O
),O,O
that,O,O
have,O,O
characteristics,O,O
of,O,O
mtDNA,O,O
introns,O,O
and,O,O
retroid,O,O
elements,O,O
.,O,O
Biol,O,O
.,O,O
As,O,O
in,O,O
Tb,O,B
",",O,O
U6,B,B
is,O,O
a,O,O
single,O,O
-,O,O
copy,O,O
gene,O,O
and,O,O
two,O,O
tRNA,O,B
genes,O,O
",",O,O
tRNAGln,B,B
and,O,O
tRNAIle,B,B
",",O,O
are,O,O
found,O,O
upstream,O,O
to,O,O
the,O,O
gene,O,O
.,O,O
Association,O,O
of,O,O
stress,O,O
during,O,O
delivery,O,O
with,O,O
increased,O,O
numbers,O,O
of,O,O
nucleated,O,O
cells,O,O
and,O,O
hematopoietic,O,O
progenitor,O,O
cells,O,O
in,O,O
umbilical,O,O
cord,O,O
blood,O,O
.,O,O
An,O,O
aromatic,O,O
stacking,O,O
interaction,O,O
between,O,O
subunits,O,O
helps,O,O
mediate,O,O
DNA,O,B
sequence,O,I
specificity,O,O
:,O,O
operator,O,O
site,O,O
discrimination,O,O
by,O,O
phage,B,O
lambda,I,O
cI,I,B
repressor,I,O
.,O,O
Symptoms,O,O
",",O,O
however,O,O
",",O,O
appear,O,O
to,O,O
correlate,O,O
poorly,O,O
with,O,O
oesophagitis,O,O
;,O,O
hence,O,O
",",O,O
severe,O,O
symptoms,O,O
do,O,O
not,O,O
indicate,O,O
there,O,O
is,O,O
greater,O,O
oesophageal,O,O
damage,O,O
.,O,O
This,O,O
relatively,O,O
simple,O,O
and,O,O
easily,O,O
performed,O,O
technique,O,O
of,O,O
measuring,O,O
deep,O,O
muscle,O,O
temperature,O,O
appears,O,O
to,O,O
be,O,O
a,O,O
useful,O,O
adjunct,O,O
in,O,O
choosing,O,O
the,O,O
amputation,O,O
level,O,O
.,O,O
Multistep,O,O
transformation,O,O
by,O,O
defined,O,O
fragments,O,O
of,O,O
herpes,O,B
simplex,O,I
virus,O,I
type,O,I
2,O,I
DNA,O,I
:,O,O
oncogenic,O,O
region,O,O
and,O,O
its,O,O
gene,O,B
product,O,O
.,O,O
The,O,O
two,O,O
drugs,O,O
increase,O,O
the,O,O
rate,O,O
of,O,O
early,O,O
diastolic,O,O
filling,O,O
.,O,O
A,O,O
4,O,O
.,O,O
8,O,O
-,O,O
kilobase,O,O
BamHI,B,O
-,O,O
HindIII,B,O
fragment,O,O
encoding,O,O
the,O,O
entire,B,O
Neurospora,I,B
crassa,I,I
CuZn,I,I
superoxide,I,I
dismutase,I,I
gene,I,I
(,O,O
herein,O,O
designated,O,O
sod,B,B
-,I,I
1,I,I
),O,O
was,O,O
isolated,O,O
from,O,O
a,O,O
genomic,O,O
library,O,O
using,O,O
two,O,O
60,O,O
-,O,O
base,O,O
deoxyoligonucleotide,O,O
probes,O,O
corresponding,O,O
to,O,O
the,O,O
published,O,O
N,O,B
.,O,O
crassa,O,O
amino,O,B
acid,O,I
sequence,O,I
.,O,O
We,O,O
have,O,O
previously,O,O
shown,O,O
that,O,O
the,O,O
adenoviral,B,O
12S,I,O
E1A,I,O
protein,I,O
modulates,O,O
the,O,O
phosphorylation,O,O
status,O,O
of,O,O
p130,B,B
and,O,O
p107,B,B
without,O,O
apparent,O,O
changes,O,O
in,O,O
the,O,O
cell,O,O
cycle,O,O
dependent,O,O
phosphorylation,O,O
of,O,O
the,O,O
retinoblastoma,B,B
protein,I,I
.,O,O
Individual,O,O
mutations,O,O
in,O,O
motifs,O,O
III,O,O
",",O,O
IV,O,O
",",O,O
and,O,O
V,O,O
had,O,O
distinctive,O,O
effects,O,O
on,O,O
the,O,O
affinity,O,O
of,O,O
enzyme,O,O
for,O,O
GTP,O,B
",",O,O
the,O,O
rate,O,O
of,O,O
covalent,O,O
catalysis,O,O
(,O,O
EpG,O,O
formation,O,O
),O,O
",",O,O
or,O,O
the,O,O
transfer,O,O
of,O,O
GMP,O,B
from,O,O
enzyme,O,O
to,O,O
RNA,O,B
.,O,O
In,O,O
this,O,O
paper,O,O
we,O,O
report,O,O
that,O,O
ligand,O,O
binding,O,O
induced,O,O
tyrosine,O,O
phosphorylation,O,O
in,O,O
BaF3,O,O
cells,O,O
engineered,O,O
to,O,O
express,O,O
the,O,O
murine,B,B
Mpl,I,I
receptor,I,I
(,O,O
BaF3,O,O
/,O,O
mMpl,B,O
),O,O
.,O,O
Genome,O,O
plasticity,O,O
in,O,O
the,O,O
distal,O,O
tail,O,O
fiber,O,O
locus,O,O
of,O,O
the,O,O
T,O,O
-,O,O
even,O,O
bacteriophage,O,O
:,O,O
recombination,O,O
between,O,O
conserved,O,O
motifs,O,O
swaps,O,O
adhesin,B,O
specificity,O,O
.,O,O
Inactivity,O,O
of,O,O
the,O,O
human,B,B
cytomegalovirus,I,I
(,I,O
HCMV,I,B
),I,O
major,I,O
immediate,I,O
-,I,O
early,I,O
regulatory,I,O
region,I,O
(,O,O
MIERR,B,B
),O,O
",",O,O
which,O,O
is,O,O
composed,O,O
of,O,O
promoter,O,O
",",O,O
enhancer,O,O
",",O,O
unique,O,O
region,O,O
",",O,O
and,O,O
modulator,O,O
",",O,O
is,O,O
linked,O,O
to,O,O
lack,O,O
of,O,O
HCMV,O,B
replication,O,O
in,O,O
latently,O,O
infected,O,O
cells,O,O
and,O,O
in,O,O
other,O,O
nonpermissive,O,O
cell,O,O
types,O,O
",",O,O
including,O,O
human,O,B
embryonal,O,I
NTera2,O,I
carcinoma,O,I
(,O,O
NT2,O,B
),O,O
cells,O,O
.,O,O
In,O,O
some,O,O
early,O,O
B,O,B
cells,O,O
and,O,O
Abelson,O,B
murine,O,I
leukemia,O,I
virus,O,I
-,O,I
transformed,O,I
pre,O,I
-,O,I
B,O,I
-,O,I
cell,O,I
lines,O,I
",",O,O
LT,B,B
mRNA,I,I
is,O,O
constitutively,O,O
expressed,O,O
.,O,O
Female,O,O
Wistar,O,O
rats,O,O
were,O,O
fed,O,O
a,O,O
liquid,O,O
diet,O,O
",",O,O
Sustacal,O,O
",",O,O
which,O,O
contained,O,O
ethanol,O,O
(,O,O
40,O,O
%,O,O
of,O,O
calories,O,O
),O,O
or,O,O
isocaloric,O,O
sucrose,O,O
.,O,O
The,O,O
5,O,O
',O,O
flanking,O,O
region,O,O
contains,O,O
potential,O,O
binding,O,O
sites,O,O
for,O,O
TATA,B,B
-,I,I
binding,I,I
protein,I,I
",",O,O
Sp1,B,B
",",O,O
nuclear,B,O
factor,I,O
1,I,O
(,O,O
NF1,B,B
),O,O
",",O,O
CAAT,B,B
-,I,I
box,I,I
binding,I,I
protein,I,I
(,O,O
C,B,B
/,I,I
EBP,I,I
),O,O
",",O,O
hepatocyte,B,O
nuclear,I,O
factors,I,O
1,I,O
and,I,O
5,I,O
(,O,O
HNF1,B,B
",",O,O
HNF5,B,B
),O,O
and,O,O
activator,B,O
proteins,I,O
1,I,O
and,I,O
2,I,O
(,O,O
AP1,B,B
",",O,O
AP2,B,B
),O,O
.,O,O
The,O,O
median,O,O
post,O,O
-,O,O
treatment,O,O
",",O,O
pre,O,O
-,O,O
operative,O,O
serum,B,O
PSA,I,B
was,O,O
0,O,O
.,O,O
4,O,O
ng,O,O
/,O,O
ml,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
transiently,O,O
transfected,O,O
cells,O,O
expressing,O,O
EBNA,B,B
-,I,I
3,I,I
revealed,O,O
a,O,O
sixfold,O,O
increase,O,O
in,O,O
EBNA,B,B
-,I,I
3,I,I
protein,I,O
expression,O,O
from,O,O
the,O,O
genomic,O,O
EBNA,B,B
-,I,I
3,I,I
gene,I,O
compared,O,O
to,O,O
EBNA,B,B
-,I,I
3,I,I
cDNA,I,O
.,O,O
By,O,O
progressive,O,O
5,O,O
',O,O
-,O,O
deletion,O,O
studies,O,O
",",O,O
we,O,O
have,O,O
identified,O,O
a,O,O
248,O,O
-,O,O
bp,O,O
DNA,O,O
fragment,O,O
(,O,O
-,O,O
1018,O,O
to,O,O
-,O,O
771,O,O
",",O,O
relative,O,O
to,O,O
the,O,O
translation,O,O
start,O,O
site,O,O
),O,O
at,O,O
the,O,O
5,O,O
',O,O
-,O,O
flanking,O,O
region,O,O
of,O,O
the,O,O
human,B,B
GnRHR,I,I
gene,I,O
that,O,O
is,O,O
responsible,O,O
for,O,O
the,O,O
GnRHa,O,O
-,O,O
mediated,O,O
down,O,O
-,O,O
regulation,O,O
of,O,O
human,B,B
GnRHR,I,I
promoter,I,O
activity,O,O
.,O,O
This,O,O
finding,O,O
is,O,O
the,O,O
first,O,O
example,O,O
of,O,O
utilization,O,O
of,O,O
noncomplementary,O,O
dinucleotide,O,O
primer,O,O
by,O,O
an,O,O
RNA,B,B
polymerase,I,I
.,O,O
Mucin,B,B
gene,I,I
expression,O,I
has,O,O
been,O,O
shown,O,O
to,O,O
be,O,O
altered,O,O
in,O,O
many,O,O
intestinal,O,O
diseases,O,O
and,O,O
especially,O,O
cancers,O,O
of,O,O
the,O,O
gastrointestinal,O,O
tract,O,O
.,O,O
In,O,O
both,O,O
cases,O,O
",",O,O
at,O,O
the,O,O
end,O,O
of,O,O
exposure,O,O
the,O,O
same,O,O
level,O,O
of,O,O
blood,B,O
carboxyhemoglobin,I,O
(,O,O
COHb,B,B
),O,O
(,O,O
about,O,O
50,O,O
%,O,O
),O,O
was,O,O
reached,O,O
.,O,O
The,O,O
Delta6CCI,O,B
virus,O,O
was,O,O
extremely,O,O
attenuated,O,O
in,O,O
replication,O,O
capacity,O,O
yet,O,O
retained,O,O
infectiousness,O,O
for,O,O
CEMx174,O,B
and,O,O
MT4,O,B
cells,O,O
.,O,O
Weak,O,O
promoter,O,O
activity,O,O
was,O,O
observed,O,O
for,O,O
the,O,O
promoter,O,O
of,O,O
the,O,O
C1,B,B
and,O,O
C2,B,I
ORFs,O,I
(,O,O
C1,B,B
-,O,I
C2,B,I
gene,O,I
),O,O
and,O,O
for,O,O
the,O,O
promoter,O,O
of,O,O
the,O,O
V1,B,B
ORF,I,I
.,O,O
In,O,O
addition,O,O
",",O,O
the,O,O
calbindin,B,B
-,I,I
D28K,I,I
promoter,I,I
is,O,O
composed,O,O
of,O,O
a,O,O
variety,O,O
of,O,O
simple,O,O
repeated,O,O
sequences,O,O
",",O,O
some,O,O
of,O,O
which,O,O
are,O,O
components,O,O
of,O,O
putative,O,O
regulatory,O,O
signals,O,O
.,O,O
Acute,O,O
idiopathic,O,O
thrombocytopenic,O,O
purpura,O,O
presenting,O,O
a,O,O
high,O,O
serum,O,O
level,O,O
of,O,O
immunoglobulin,B,O
E,I,B
and,O,O
eosinophilia,O,O
in,O,O
an,O,O
elderly,O,O
patient,O,O
.,O,O
VDR,B,B
/,O,O
RXR,B,B
bound,O,O
well,O,O
to,O,O
the,O,O
VDREs,O,B
and,O,O
to,O,O
DR4,O,B
and,O,O
DR5,O,B
using,O,O
the,O,O
electrophoretic,O,O
mobility,O,O
shift,O,O
assay,O,O
.,O,O
Swim,O,O
-,O,O
over,O,O
:,O,O
an,O,O
alternative,O,O
method,O,O
for,O,O
harvesting,O,O
motile,O,O
spermatozoa,O,O
.,O,O
Significant,O,O
increases,O,O
in,O,O
mean,O,O
serum,O,O
E2,O,B
concentration,O,O
(,O,O
100,O,O
to,O,O
150,O,O
pg,O,O
/,O,O
ml,O,O
),O,O
were,O,O
noted,O,O
at,O,O
6,O,O
and,O,O
8,O,O
hours,O,O
after,O,O
administration,O,O
on,O,O
day,O,O
1,O,O
and,O,O
at,O,O
8,O,O
hours,O,O
on,O,O
day,O,O
4,O,O
.,O,O
OBJECTIVE,O,O
:,O,O
To,O,O
determine,O,O
whether,O,O
RSTD,O,O
predicts,O,O
coronary,O,O
anatomy,O,O
during,O,O
acute,O,O
coronary,O,O
occlusion,O,O
.,O,O
We,O,O
were,O,O
able,O,O
to,O,O
detect,O,O
significant,O,O
differences,O,O
in,O,O
functional,O,O
residual,O,O
capacity,O,O
adjusted,O,O
for,O,O
weight,O,O
or,O,O
height,O,O
",",O,O
and,O,O
compliance,O,O
of,O,O
the,O,O
respiratory,O,O
system,O,O
adjusted,O,O
for,O,O
weight,O,O
or,O,O
lung,O,O
volume,O,O
in,O,O
the,O,O
ILD,O,O
infants,O,O
compared,O,O
to,O,O
the,O,O
healthy,O,O
controls,O,O
or,O,O
infants,O,O
who,O,O
had,O,O
PPHN,O,O
",",O,O
indicating,O,O
that,O,O
these,O,O
PFTs,O,O
were,O,O
sensitive,O,O
enough,O,O
to,O,O
determine,O,O
abnormal,O,O
lung,O,O
function,O,O
in,O,O
this,O,O
age,O,O
group,O,O
.,O,O
In,O,O
Experiment,O,O
2,O,O
",",O,O
we,O,O
again,O,O
used,O,O
classification,O,O
",",O,O
but,O,O
the,O,O
fixed,O,O
standard,O,O
75,O,O
was,O,O
not,O,O
at,O,O
the,O,O
center,O,O
of,O,O
the,O,O
range,O,O
of,O,O
target,O,O
numbers,O,O
(,O,O
20,O,O
",",O,O
21,O,O
",",O,O
.,O,O
.,O,O
amino,O,O
acid,O,O
sequence,O,O
of,O,O
matrilysin,B,B
-,I,I
2,I,I
also,O,O
contains,O,O
a,O,O
threonine,O,O
residue,O,O
adjacent,O,O
to,O,O
the,O,O
Zn,O,O
-,O,O
binding,O,O
site,O,O
that,O,O
has,O,O
been,O,O
defined,O,O
as,O,O
a,O,O
specific,O,O
feature,O,O
of,O,O
matrilysin,B,O
.,O,O
Testosterone,O,B
",",O,O
free,O,O
testosterone,O,B
",",O,O
non,B,O
-,I,O
sex,I,O
hormone,I,O
-,I,O
binding,I,O
globulin,I,O
-,O,O
bound,O,O
testosterone,O,B
",",O,O
and,O,O
free,O,O
androgen,O,B
index,O,I
:,O,O
which,O,O
testosterone,O,B
measurement,O,O
is,O,O
most,O,O
relevant,O,O
to,O,O
reproductive,O,O
and,O,O
sexual,O,O
function,O,O
in,O,O
men,O,O
with,O,O
epilepsy,O,O
?,O,O
Thus,O,O
",",O,O
elongin,B,B
C,I,I
is,O,O
found,O,O
to,O,O
oligomerize,O,O
in,O,O
solution,O,O
and,O,O
to,O,O
undergo,O,O
significant,O,O
structural,O,O
rearrangements,O,O
upon,O,O
binding,O,O
of,O,O
two,O,O
different,O,O
partner,O,O
proteins,O,O
.,O,O
Targeted,O,O
disruption,O,O
of,O,O
the,O,O
OGG1,B,B
gene,I,O
in,O,O
yeast,O,O
revealed,O,O
a,O,O
second,O,O
OG,B,B
glycosylase,I,I
/,I,I
lyase,I,I
protein,I,O
",",O,O
tentatively,O,O
named,O,O
Ogg2,B,B
",",O,O
which,O,O
differs,O,O
from,O,O
Ogg1,B,B
in,O,O
that,O,O
it,O,O
preferentially,O,O
acts,O,O
on,O,O
OG,O,B
:,O,O
G,O,I
.,O,O
For,O,O
this,O,O
purpose,O,O
",",O,O
we,O,O
used,O,O
a,O,O
series,O,O
of,O,O
plasmid,O,O
constructs,O,O
encoding,O,O
different,O,O
forms,O,O
of,O,O
the,O,O
envelope,B,O
glycoprotein,I,O
E,I,O
of,I,O
the,I,O
flavivirus,I,O
tick,I,O
-,I,O
borne,I,O
encephalitis,I,O
virus,I,O
.,O,O
The,O,O
nucleotide,O,O
sequence,O,O
directly,O,O
upstream,O,O
of,O,O
fimA,B,B
contains,O,O
two,O,O
open,O,O
reading,O,O
frames,O,O
",",O,O
ORF5,O,B
and,O,O
ORF1,O,B
",",O,O
whose,O,O
deduced,O,O
protein,O,O
products,O,O
are,O,O
homologous,O,O
to,O,O
members,O,O
of,O,O
a,O,O
superfamily,O,O
of,O,O
ATP,B,B
-,I,I
binding,I,I
cassette,I,I
membrane,I,I
transport,I,I
proteins,I,O
",",O,O
including,O,O
both,O,O
prokaryotic,O,O
and,O,O
eukaryotic,O,O
uptake,O,O
and,O,O
export,O,O
systems,O,O
.,O,O
Optically,O,O
detected,O,O
librons,O,B
and,O,O
phonons,O,B
in,O,O
crystalline,O,O
C60,O,B
.,O,O
Classical,O,O
ligand,O,O
-,O,O
activated,O,O
nuclear,O,O
receptors,O,O
(,O,O
e,O,O
.,O,O
g,O,O
.,O,O
thyroid,B,B
hormone,I,I
receptor,I,I
",",O,O
retinoic,B,B
acid,I,I
receptor,I,I
),O,O
",",O,O
orphan,B,O
nuclear,I,O
receptors,I,O
(,O,O
e,O,O
.,O,O
g,O,O
.,O,O
Site,O,O
S,O,O
-,O,O
II,O,O
also,O,O
spans,O,O
a,O,O
23,O,O
bp,O,O
sequence,O,O
containing,O,O
two,O,O
tandem,O,O
consensus,O,O
binding,O,O
sites,O,O
with,O,O
three,O,O
base,O,O
pair,O,O
mismatches,O,O
in,O,O
each,O,O
and,O,O
a,O,O
one,O,O
base,O,O
pair,O,O
deletion,O,O
.,O,O
To,O,O
this,O,O
end,O,O
",",O,O
an,O,O
expression,O,O
cassette,O,O
consisting,O,O
of,O,O
the,O,O
gene,O,B
for,O,O
a,O,O
green,B,O
fluorescent,I,O
protein,I,O
(,O,O
GFP,B,B
),O,O
flanked,O,O
at,O,O
its,O,O
3,O,O
',O,O
end,O,O
by,O,O
EAV,O,O
-,O,O
specific,O,O
transcription,O,O
-,O,O
regulating,O,O
sequences,O,O
was,O,O
constructed,O,O
.,O,O
Toxicity,O,O
was,O,O
significant,O,O
in,O,O
selected,O,O
cases,O,O
;,O,O
three,O,O
patients,O,O
developed,O,O
WBC,O,O
counts,O,O
less,O,O
than,O,O
1,O,O
",",O,O
000,O,O
/,O,O
mm3,O,O
and,O,O
one,O,O
of,O,O
these,O,O
patients,O,O
died,O,O
with,O,O
sepsis,O,O
.,O,O
Indeed,O,O
",",O,O
it,O,O
is,O,O
shown,O,O
that,O,O
it,O,O
mediates,O,O
the,O,O
formation,O,O
of,O,O
disulfide,O,O
-,O,O
linked,O,O
homodimers,O,O
and,O,O
that,O,O
the,O,O
formation,O,O
of,O,O
homo,O,O
-,O,O
and,O,O
heterodimers,O,O
are,O,O
mutually,O,O
excluded,O,O
.,O,O
The,O,O
study,O,O
was,O,O
repeated,O,O
after,O,O
administration,O,O
of,O,O
oral,O,O
amiodarone,O,B
",",O,O
50,O,O
mg,O,O
/,O,O
kg,O,O
/,O,O
day,O,O
for,O,O
2,O,O
days,O,O
in,O,O
8,O,O
divided,O,O
doses,O,O
(,O,O
mean,O,O
dose,O,O
6,O,O
.,O,O
9,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
4,O,O
g,O,O
),O,O
.,O,O
These,O,O
data,O,O
are,O,O
consistent,O,O
with,O,O
the,O,O
idea,O,O
that,O,O
the,O,O
neuron,B,B
-,I,I
specific,I,I
SCG10,I,B
gene,I,O
evolved,O,O
by,O,O
duplication,O,O
and,O,O
modification,O,O
of,O,O
the,O,O
more,O,O
broadly,O,O
expressed,O,O
stathmin,B,O
/,O,O
Lap18,B,O
gene,O,O
.,O,O
Vibrio,O,O
fluvialis,O,O
(,O,O
group,O,O
F,O,O
vibrio,O,O
),O,O
in,O,O
Maharashtra,O,O
.,O,O
The,O,O
gene,O,O
encoding,O,O
TRP,B,B
-,I,I
2,I,I
maps,O,O
to,O,O
mouse,O,O
chromosome,O,O
14,O,O
",",O,O
in,O,O
the,O,O
region,O,O
of,O,O
the,O,O
coat,B,O
colour,I,O
mutation,I,O
slaty,I,O
.,O,O
Ketamine,O,O
in,O,O
the,O,O
treatment,O,O
of,O,O
bronchospasm,O,O
during,O,O
mechanical,O,O
ventilation,O,O
.,O,O
An,O,O
implant,O,O
may,O,O
release,O,O
a,O,O
drug,O,O
either,O,O
by,O,O
diffusion,O,O
concurrent,O,O
with,O,O
dissolution,O,O
of,O,O
the,O,O
polymeric,O,O
implant,O,O
material,O,O
without,O,O
depolymerization,O,O
(,O,O
Type,O,O
A,O,O
),O,O
or,O,O
by,O,O
bioerosion,O,O
involving,O,O
depolymerization,O,O
(,O,O
Type,O,O
B,O,O
),O,O
.,O,O
In,O,O
addition,O,O
a,O,O
greater,O,O
proportion,O,O
of,O,O
women,O,O
in,O,O
the,O,O
sweeping,O,O
group,O,O
had,O,O
a,O,O
cervical,O,O
dilatation,O,O
of,O,O
4,O,O
cm,O,O
or,O,O
more,O,O
at,O,O
the,O,O
first,O,O
vaginal,O,O
examination,O,O
in,O,O
the,O,O
labour,O,O
ward,O,O
(,O,O
16,O,O
/,O,O
33,O,O
(,O,O
49,O,O
%,O,O
),O,O
vs,O,O
5,O,O
/,O,O
32,O,O
(,O,O
16,O,O
%,O,O
),O,O
;,O,O
OR,O,O
4,O,O
.,O,O
39,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
1,O,O
.,O,O
56,O,O
to,O,O
12,O,O
.,O,O
32,O,O
;,O,O
P,O,O
=,O,O
0,O,O
.,O,O
005,O,O
.,O,O
Reliability,O,O
of,O,O
cervical,O,O
range,O,O
of,O,O
motion,O,O
using,O,O
the,O,O
OSI,O,O
CA,O,O
6000,O,O
spine,O,O
motion,O,O
analyser,O,O
on,O,O
asymptomatic,O,O
and,O,O
symptomatic,O,O
subjects,O,O
.,O,O
Expression,O,O
of,O,O
Bcl,B,B
-,I,I
XL,I,I
inhibited,O,O
the,O,O
association,O,O
of,O,O
Apaf,B,B
-,I,I
1,I,I
with,O,O
caspase,B,O
-,I,O
9,I,O
in,O,O
mammalian,O,O
cells,O,O
.,O,O
There,O,O
was,O,O
a,O,O
trend,O,O
toward,O,O
an,O,O
association,O,O
between,O,O
IENF,O,O
and,O,O
sural,O,O
nerve,O,O
unmyelinated,O,O
fiber,O,O
densities,O,O
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
32,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
054,O,O
),O,O
.,O,O
As,O,O
an,O,O
oral,O,O
",",O,O
nontoxic,O,O
compound,O,O
with,O,O
a,O,O
mechanism,O,O
of,O,O
action,O,O
distinct,O,O
from,O,O
that,O,O
of,O,O
ABL,B,B
tyrosine,I,I
kinase,I,I
inhibition,O,O
",",O,O
FTI,O,O
SCH66336,O,O
shows,O,O
promise,O,O
for,O,O
the,O,O
treatment,O,O
of,O,O
BCR,B,B
/,O,I
ABL,B,I
-,O,I
induced,O,I
leukemia,O,O
.,O,O
Here,O,O
we,O,O
have,O,O
examined,O,O
the,O,O
ability,O,O
of,O,O
the,O,O
cellular,O,O
protein,O,O
YB,B,B
-,I,I
1,I,I
to,O,O
modulate,O,O
transcription,O,O
of,O,O
the,O,O
HIV,B,B
-,I,I
1,I,I
promoter,I,O
in,O,O
a,O,O
human,O,B
astrocytic,O,I
cell,O,I
line,O,I
(,O,O
U,O,B
-,O,I
87MG,O,I
),O,O
",",O,O
a,O,O
neuronal,O,B
cell,O,I
line,O,I
(,O,O
SK,O,B
-,O,I
N,O,I
-,O,I
MC,O,I
),O,O
and,O,O
lymphoid,O,B
cells,O,I
(,O,O
Jurkat,O,B
),O,O
by,O,O
transfection,O,O
assay,O,O
.,O,O
The,O,O
distribution,O,O
phase,O,O
is,O,O
followed,O,O
by,O,O
an,O,O
elimination,O,O
phase,O,O
with,O,O
a,O,O
much,O,O
longer,O,O
half,O,O
-,O,O
life,O,O
(,O,O
mean,O,O
value,O,O
375,O,O
min,O,O
),O,O
and,O,O
a,O,O
volume,O,O
of,O,O
distribution,O,O
of,O,O
approximately,O,O
200,O,O
-,O,O
400,O,O
l,O,O
.,O,O
Potentiation,O,O
of,O,O
the,O,O
thrombolytic,O,O
efficacy,O,O
of,O,O
single,B,O
-,I,O
chain,I,O
urokinase,I,B
(,O,O
Pro,B,B
-,I,I
urokinase,I,I
),O,O
by,O,O
heparin,O,O
.,O,O
Using,O,O
mouse,O,O
-,O,O
human,O,B
somatic,O,I
hybrids,O,I
and,O,O
FISH,O,O
analysis,O,O
",",O,O
the,O,O
PE,B,B
-,I,I
2,I,I
gene,I,I
is,O,O
localized,O,O
to,O,O
human,O,B
chromosome,O,I
19q13,O,I
.,O,O
2,O,O
",",O,O
a,O,O
region,O,O
involved,O,O
in,O,O
translocations,O,O
and,O,O
deletions,O,O
in,O,O
leukemias,O,O
and,O,O
several,O,O
solid,O,O
tumors,O,O
",",O,O
suggesting,O,O
that,O,O
this,O,O
novel,O,O
ETS,B,B
factor,I,O
may,O,O
play,O,O
a,O,O
role,O,O
in,O,O
carcinogenesis,O,O
.,O,O
Within,O,O
the,O,O
span,O,O
of,O,O
attenuator,O,O
region,O,O
encoding,O,O
the,O,O
three,O,O
stem,O,O
-,O,O
loop,O,O
structures,O,O
of,O,O
mRNA,O,O
secondary,O,O
configuration,O,O
",",O,O
hot,O,O
spots,O,O
of,O,O
base,O,O
-,O,O
residue,O,O
divergence,O,O
were,O,O
localized,O,O
to,O,O
looped,O,O
-,O,O
out,O,O
regions,O,O
.,O,O
Heparin,O,O
had,O,O
no,O,O
effect,O,O
on,O,O
rAC,B,B
-,I,I
st,I,I
myosin,I,B
light,I,I
chain,I,I
phosphatase,I,I
activity,O,O
",",O,O
while,O,O
the,O,O
B,O,B
subunit,O,I
-,O,I
containing,O,I
forms,O,O
were,O,O
stimulated,O,O
2,O,O
-,O,O
3,O,O
-,O,O
fold,O,O
.,O,O
Neither,O,O
of,O,O
these,O,O
proteins,O,O
",",O,O
individually,O,O
or,O,O
as,O,O
a,O,O
pair,O,O
",",O,O
can,O,O
bind,O,O
the,O,O
alpha,B,B
-,I,I
globin,I,I
3,I,I
',I,I
UTR,I,I
unless,O,O
they,O,O
are,O,O
complexed,O,O
with,O,O
the,O,O
remaining,O,O
non,O,O
-,O,O
poly,O,O
(,O,O
C,O,O
),O,O
binding,O,O
proteins,O,O
of,O,O
the,O,O
alpha,B,B
-,I,I
complex,I,I
.,O,O
These,O,O
findings,O,O
suggest,O,O
that,O,O
the,O,O
increase,O,O
in,O,O
V,O,B
O2,O,I
may,O,O
have,O,O
been,O,O
a,O,O
consequence,O,O
of,O,O
the,O,O
increase,O,O
in,O,O
Q,O,B
O2,O,I
rather,O,O
than,O,O
a,O,O
response,O,O
to,O,O
the,O,O
procedure,O,O
itself,O,O
.,O,O
A,O,O
unified,O,O
approach,O,O
to,O,O
the,O,O
standardization,O,O
of,O,O
allergens,O,O
.,O,O
Although,O,O
the,O,O
N13,O,B
-,O,I
N20,O,I
interpeak,O,O
interval,O,O
remained,O,O
stable,O,O
because,O,O
of,O,O
the,O,O
parallel,O,O
shift,O,O
of,O,O
the,O,O
2,O,O
peaks,O,O
",",O,O
the,O,O
central,O,O
conduction,O,O
time,O,O
measured,O,O
from,O,O
onset,O,O
latencies,O,O
of,O,O
N11,O,B
and,O,O
N20,O,B
significantly,O,O
increased,O,O
.,O,O
Using,O,O
sequence,O,O
information,O,O
from,O,O
human,B,B
BMAL1,I,I
(,O,O
hBMAL1,B,B
),O,O
cDNAs,O,O
previously,O,O
reported,O,O
by,O,O
our,O,O
laboratory,O,O
",",O,O
we,O,O
have,O,O
isolated,O,O
and,O,O
characterized,O,O
cDNAs,O,O
encoding,O,O
three,O,O
splice,O,O
variants,O,O
of,O,O
the,O,O
mouse,B,B
BMAL1,I,I
(,O,O
mBMAL1,B,B
),O,O
gene,O,O
.,O,O
Biologically,O,O
significant,O,O
amounts,O,O
of,O,O
platelet,B,O
activating,I,O
factor,I,O
were,O,O
eluted,O,O
from,O,O
the,O,O
sorbent,O,O
during,O,O
the,O,O
entire,O,O
treatment,O,O
time,O,O
.,O,O
Because,O,O
a,O,O
close,O,O
correlation,O,O
between,O,O
regional,O,O
decreases,O,O
in,O,O
FMZ,O,B
binding,O,O
and,O,O
spiking,O,O
activity,O,O
was,O,O
recently,O,O
demonstrated,O,O
in,O,O
neocortical,O,O
epilepsies,O,O
",",O,O
abnormal,O,O
peri,O,O
-,O,O
lesional,O,O
FMZ,O,B
binding,O,O
may,O,O
bear,O,O
some,O,O
relation,O,O
to,O,O
the,O,O
mechanisms,O,O
of,O,O
epileptogenesis,O,O
in,O,O
symptomatic,O,O
epilepsies,O,O
.,O,O
These,O,O
observations,O,O
indicate,O,O
that,O,O
there,O,O
are,O,O
multiple,O,O
mechanisms,O,O
by,O,O
which,O,O
an,O,O
individual,O,O
transcript,O,O
can,O,O
be,O,O
degraded,O,O
following,O,O
deadenylation,O,O
.,O,O
Van,O,O
der,O,O
Ende,O,O
",",O,O
R,O,O
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
UBP41,B,B
may,O,O
play,O,O
an,O,O
important,O,O
role,O,O
in,O,O
the,O,O
recycling,O,O
of,O,O
ubiquitin,B,O
by,O,O
hydrolysis,O,O
of,O,O
branched,B,O
poly,I,O
-,I,O
ubiquitin,I,O
chains,I,O
generated,O,O
by,O,O
the,O,O
action,O,O
of,O,O
26,B,O
S,I,O
proteasome,I,O
on,O,O
poly,O,O
-,O,O
ubiquitinated,O,O
protein,O,O
substrates,O,O
",",O,O
as,O,O
well,O,O
as,O,O
in,O,O
the,O,O
production,O,O
of,O,O
free,O,O
ubiquitin,B,O
from,O,O
linear,B,O
poly,I,O
-,I,O
ubiquitin,I,O
chains,I,O
and,O,O
of,O,O
certain,O,O
ribosomal,O,O
proteins,O,O
from,O,O
ubiquitin,B,O
fusion,I,O
proteins,I,O
.,O,O
In,O,O
the,O,O
present,O,O
study,O,O
",",O,O
beta,O,B
-,O,I
funaltrexamine,O,I
(,O,O
beta,O,B
-,O,I
FNA,O,I
),O,O
and,O,O
naltrindole,O,B
(,O,O
NTI,O,B
),O,O
(,O,O
nonequilibrium,O,O
mu,O,O
-,O,O
and,O,O
delta,O,O
-,O,O
antagonist,O,O
",",O,O
respectively,O,O
),O,O
were,O,O
used,O,O
to,O,O
precipitate,O,O
withdrawal,O,O
in,O,O
butorphanol,O,O
-,O,O
dependent,O,O
rats,O,O
.,O,O
Both,O,O
Z,B,O
and,O,O
R,B,O
expression,O,O
resulted,O,O
in,O,O
PML,O,B
dispersion,O,O
in,O,O
EBV,O,O
-,O,O
positive,O,O
cells,O,O
.,O,O
Based,O,O
on,O,O
peptide,O,O
map,O,O
similarities,O,O
",",O,O
partial,O,O
amino,O,O
-,O,O
terminal,O,O
sequence,O,O
data,O,O
",",O,O
and,O,O
common,O,O
genetic,O,O
origin,O,O
",",O,O
it,O,O
is,O,O
suggested,O,O
that,O,O
p60,B,B
and,O,O
p62,B,B
have,O,O
identical,O,O
amino,O,O
sequences,O,O
carboxy,O,O
-,O,O
terminal,O,O
to,O,O
the,O,O
p60,B,O
initiator,O,O
methionine,O,O
(,O,O
residue,O,O
21,O,O
of,O,O
p62,B,O
),O,O
.,O,O
Two,O,O
other,O,O
patients,O,O
underwent,O,O
PRFR,O,O
.,O,O
From,O,O
February,O,O
1991,O,O
to,O,O
August,O,O
1997,O,O
",",O,O
124,O,O
patients,O,O
with,O,O
endometrial,O,O
carcinoma,O,O
were,O,O
treated,O,O
postoperatively,O,O
with,O,O
high,O,O
-,O,O
dose,O,O
-,O,O
rate,O,O
vaginal,O,O
vault,O,O
brachytherapy,O,O
as,O,O
the,O,O
only,O,O
adjuvant,O,O
treatment,O,O
.,O,O
In,O,O
order,O,O
to,O,O
examine,O,O
the,O,O
potential,O,O
role,O,O
of,O,O
transcriptional,O,O
silencing,O,O
during,O,O
productive,O,O
HSV,O,B
-,O,I
1,O,I
infection,O,O
",",O,O
recombinant,O,O
viruses,O,O
were,O,O
generated,O,O
in,O,O
which,O,O
wild,B,O
-,I,O
type,I,O
or,I,O
mutant,I,O
ICP34,I,B
.,I,O
5,I,O
promoters,I,O
controlling,O,O
the,O,O
expression,O,O
of,O,O
a,O,O
chloramphenicol,B,B
acetyltransferase,I,I
reporter,I,I
gene,I,I
were,O,O
inserted,O,O
into,O,O
the,O,O
thymidine,B,O
kinase,I,O
gene,I,O
of,O,O
the,O,O
viral,O,O
genome,O,O
.,O,O
The,O,O
syndrome,O,O
.,O,O
The,O,O
atp,B,B
1,I,I
and,O,O
atp,B,B
2,I,I
types,O,O
of,O,O
cDNA,O,O
sequences,O,O
were,O,O
the,O,O
most,O,O
redundant,O,O
among,O,O
the,O,O
28,O,O
different,O,O
isoperoxidases,B,O
identified,O,O
among,O,O
about,O,O
200,O,O
peroxidase,B,O
encoding,I,O
ESTs,I,O
.,O,O
In,O,O
patients,O,O
with,O,O
type,O,O
IA,O,O
maple,O,B
syrup,O,I
urine,O,I
disease,O,I
",",O,O
the,O,O
E1alpha,B,B
subunit,I,I
is,O,O
affected,O,O
",",O,O
resulting,O,O
in,O,O
the,O,O
loss,O,O
of,O,O
E1,B,B
and,O,O
branched,B,B
-,I,I
chain,I,I
ketoacid,I,I
dehydrogenase,I,I
catalytic,O,I
activities,O,I
.,O,O
Benign,O,O
intramural,O,O
tumors,O,O
of,O,O
the,O,O
esophagus,O,O
We,O,O
conclude,O,O
that,O,O
(,O,O
a,O,O
),O,O
the,O,O
likelihood,O,O
of,O,O
detecting,O,O
carcinoma,O,O
or,O,O
atypical,O,O
hyperplasia,O,O
exclusively,O,O
in,O,O
the,O,O
adipose,O,O
tissue,O,O
component,O,O
of,O,O
grossly,O,O
benign,O,O
breast,O,O
biopsies,O,O
is,O,O
extremely,O,O
low,O,O
",",O,O
and,O,O
(,O,O
b,O,O
),O,O
a,O,O
possible,O,O
cost,O,O
-,O,O
effective,O,O
method,O,O
of,O,O
sampling,O,O
grossly,O,O
benign,O,O
breast,O,O
biopsies,O,O
consists,O,O
of,O,O
initially,O,O
submitting,O,O
a,O,O
maximum,O,O
of,O,O
10,O,O
blocks,O,O
of,O,O
fibrous,O,O
parenchyma,O,O
for,O,O
each,O,O
case,O,O
",",O,O
then,O,O
examining,O,O
the,O,O
remaining,O,O
tissue,O,O
histologically,O,O
only,O,O
if,O,O
carcinoma,O,O
or,O,O
atypical,O,O
hyperplasia,O,O
is,O,O
found,O,O
among,O,O
these,O,O
blocks,O,O
.,O,O
Transcriptional,O,O
analysis,O,O
of,O,O
a,O,O
series,O,O
of,O,O
deletion,O,O
mutants,O,O
of,O,O
the,O,O
gene,O,B
in,O,O
the,O,O
nuclear,O,O
extracts,O,O
prepared,O,O
from,O,O
the,O,O
middle,O,O
silk,O,O
gland,O,O
of,O,O
2,O,O
-,O,O
day,O,O
-,O,O
old,O,O
fifth,O,O
instar,O,O
larvae,O,O
revealed,O,O
the,O,O
presence,O,O
of,O,O
multiple,O,O
cis,O,O
-,O,O
regulatory,O,O
elements,O,O
located,O,O
both,O,O
upstream,O,O
and,O,O
downstream,O,O
of,O,O
the,O,O
initiation,O,O
site,O,O
.,O,O
RNA,O,O
blot,O,O
hybridizations,O,O
identified,O,O
an,O,O
1,O,O
.,O,O
8,O,O
-,O,O
kb,O,O
mRNA,O,O
common,O,O
to,O,O
cytochrome,B,B
b6,I,I
and,O,O
subunit,O,B
IV,O,I
",",O,O
and,O,O
an,O,O
intensely,O,O
hybridizing,O,O
0,O,O
.,O,O
8,O,O
-,O,O
kb,O,O
mRNA,O,O
specific,O,O
to,O,O
the,O,O
subunit,O,B
IV,O,I
gene,O,I
probe,O,O
.,O,O
The,O,O
micturition,O,O
pressure,O,O
was,O,O
significantly,O,O
decreased,O,O
only,O,O
after,O,O
injection,O,O
with,O,O
BUP,O,O
-,O,O
4,O,O
in,O,O
both,O,O
normal,O,O
and,O,O
obstructed,O,O
rats,O,O
.,O,O
Over,O,O
a,O,O
period,O,O
of,O,O
15,O,O
days,O,O
16,O,O
%,O,O
of,O,O
the,O,O
dose,O,O
administered,O,O
was,O,O
excreted,O,O
with,O,O
faeces,O,O
and,O,O
0,O,O
.,O,O
9,O,O
%,O,O
in,O,O
the,O,O
urine,O,O
.,O,O
ME1a1,B,O
",",O,O
a,O,O
16,O,O
-,O,O
base,O,O
-,O,O
pair,O,O
nuclear,O,O
factor,O,O
binding,O,O
site,O,O
residing,O,O
between,O,O
the,O,O
c,B,O
-,I,O
MYC,I,B
P1,I,I
and,I,O
P2,I,I
transcription,I,O
initiation,I,O
sites,I,O
",",O,O
is,O,O
required,O,O
for,O,O
P2,O,I
activity,O,O
.,O,O
We,O,O
have,O,O
demonstrated,O,O
that,O,O
the,O,O
activity,O,O
of,O,O
ILK,B,B
is,O,O
constitutively,O,O
elevated,O,O
in,O,O
PTEN,B,B
mutant,I,I
cells,O,O
.,O,O
Respiratory,O,O
interaction,O,O
after,O,O
spinal,O,O
anesthesia,O,O
and,O,O
sedation,O,O
with,O,O
midazolam,O,O
.,O,O
Finally,O,O
a,O,O
10,O,O
-,O,O
nucleotide,O,O
region,O,O
flanking,O,O
the,O,O
exon,O,O
4,O,O
protein,O,O
-,O,O
binding,O,O
site,O,O
is,O,O
homologous,O,O
to,O,O
instability,O,O
elements,O,O
within,O,O
five,O,O
other,O,O
transcripts,O,O
",",O,O
suggesting,O,O
that,O,O
a,O,O
common,O,O
coding,O,O
region,O,O
determinant,O,O
may,O,O
exist,O,O
.,O,O
The,O,O
Van,O,O
der,O,O
Hoeve,O,O
',O,O
s,O,O
syndrome,O,O
lesions,O,O
as,O,O
poorly,O,O
mineralized,O,O
",",O,O
with,O,O
low,O,O
calcium,O,O
salt,O,O
and,O,O
apparent,O,O
increase,O,O
of,O,O
phosphates,O,O
.,O,O
The,O,O
galactose,B,B
transporter,I,O
shows,O,O
both,O,O
sequence,O,O
and,O,O
structural,O,O
homology,O,O
with,O,O
a,O,O
superfamily,O,O
of,O,O
sugar,B,O
transporters,I,O
which,O,O
includes,O,O
the,O,O
human,B,B
HepG2,I,I
-,I,I
erythrocyte,I,I
and,I,I
fetal,I,I
muscle,I,I
glucose,I,I
transporters,I,I
",",O,O
the,O,O
rat,B,B
brain,I,I
and,I,I
liver,I,I
glucose,I,I
transporters,I,I
",",O,O
the,O,O
Escherichia,B,B
coli,I,I
xylose,I,I
and,I,I
arabinose,I,I
permeases,I,I
",",O,O
and,O,O
the,O,O
S,B,B
.,I,O
cerevisiae,I,B
glucose,I,O
",",I,O
maltose,I,O
",",I,O
and,I,O
galactose,I,O
transporters,I,O
.,O,O
Members,O,O
of,O,O
the,O,O
myocyte,B,O
-,I,O
specific,I,O
enhancer,I,O
-,I,O
binding,I,O
factor,I,O
2,I,O
(,O,O
MEF2,B,B
),O,O
family,O,O
of,O,O
transcription,O,O
factors,O,O
bind,O,O
a,O,O
conserved,O,O
A,O,O
/,O,O
T,O,O
-,O,O
rich,O,O
sequence,O,O
in,O,O
the,O,O
control,O,O
regions,O,O
of,O,O
numerous,O,O
muscle,O,O
-,O,O
specific,O,O
genes,O,O
.,O,O
To,O,O
estimate,O,O
the,O,O
locations,O,O
of,O,O
sources,O,O
with,O,O
the,O,O
TF,O,B
-,O,I
MUSIC,O,I
algorithm,O,O
",",O,O
we,O,O
first,O,O
set,O,O
the,O,O
target,O,O
region,O,O
on,O,O
the,O,O
spectrogram,O,O
of,O,O
the,O,O
somatosensory,O,O
responses,O,O
.,O,O
Bacteriologic,O,O
culture,O,O
of,O,O
pancreatic,O,O
tissue,O,O
was,O,O
positive,O,O
in,O,O
6,O,O
/,O,O
8,O,O
IB,O,O
and,O,O
3,O,O
/,O,O
17,O,O
NIB,O,O
rats,O,O
(,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
01,O,O
),O,O
.,O,O
The,O,O
LA,O,O
50s,O,O
derived,O,O
from,O,O
this,O,O
combined,O,O
data,O,O
when,O,O
compared,O,O
with,O,O
our,O,O
earlier,O,O
series,O,O
from,O,O
1965,O,O
to,O,O
1970,O,O
also,O,O
did,O,O
not,O,O
show,O,O
a,O,O
significant,O,O
change,O,O
in,O,O
mortality,O,O
.,O,O
Two,O,O
-,O,O
dimensional,O,O
gel,O,O
electrophoresis,O,O
of,O,O
anti,B,O
-,I,O
p59fyn,I,B
immunoprecipitates,O,O
obtained,O,O
from,O,O
non,O,O
-,O,O
transformed,O,O
resting,O,O
human,O,B
T,O,I
lymphocytes,O,O
resulted,O,O
in,O,O
the,O,O
identification,O,O
of,O,O
an,O,O
oligomeric,O,O
protein,O,O
complex,O,O
which,O,O
is,O,O
constitutively,O,O
formed,O,O
between,O,O
Fyn,B,B
and,O,O
several,O,O
additional,O,O
phosphoproteins,O,O
(,O,O
pp43,B,B
",",O,O
pp72,B,B
",",O,O
pp85,B,B
",",O,O
the,O,O
protein,B,O
tyrosine,I,O
kinase,I,O
Pyk2,B,B
",",O,O
as,O,O
well,O,O
as,O,O
the,O,O
two,O,O
recently,O,O
cloned,O,O
adaptor,O,O
proteins,O,O
",",O,O
SKAP55,B,B
and,O,O
SLAP,B,B
-,I,I
130,I,I
),O,O
.,O,O
Although,O,O
the,O,O
OC,B,B
promoter,I,O
is,O,O
activated,O,O
in,O,O
a,O,O
C,O,O
terminus,O,O
dependent,O,O
manner,O,O
",",O,O
the,O,O
MDR,B,B
",",O,O
LTR,O,B
and,O,O
BSP,B,B
promoters,I,O
are,O,O
repressed,O,O
by,O,O
three,O,O
distinct,O,O
mechanisms,O,O
",",O,O
either,O,O
independent,O,O
of,O,O
or,O,O
involving,O,O
the,O,O
AML,B,B
C,I,I
terminus,I,I
",",O,O
or,O,O
requiring,O,O
only,O,O
the,O,O
conserved,O,O
C,O,O
-,O,O
terminal,O,O
pentapeptide,O,O
VWRPY,O,O
.,O,O
A,O,O
developmentally,O,O
modulated,O,O
chromatin,O,O
structure,O,O
at,O,O
the,O,O
mouse,B,O
immunoglobulin,I,O
kappa,I,O
3,I,O
',I,O
enhancer,I,O
.,O,O
The,O,O
COOH,O,O
-,O,O
terminal,O,O
region,O,O
of,O,O
the,O,O
transcripts,O,O
contained,O,O
fifteen,O,O
triplet,O,O
repeats,O,O
(,O,O
GCT,O,B
;,O,O
alanine,O,O
),O,O
at,O,O
nucleotide,O,O
465,O,O
to,O,O
509,O,O
",",O,O
which,O,O
is,O,O
significantly,O,O
expanded,O,O
compared,O,O
to,O,O
the,O,O
rat,B,O
RL14,I,O
.,O,O
E2F,B,B
-,I,I
1,I,I
is,O,O
a,O,O
transcription,O,O
factor,O,O
that,O,O
regulates,O,O
cell,O,O
cycle,O,O
progression,O,O
into,O,O
S,O,O
-,O,O
phase,O,O
.,O,O
Both,O,O
toxins,O,O
in,O,O
a,O,O
dose,O,O
10,O,O
-,O,O
fold,O,O
surpassing,O,O
the,O,O
maximum,O,O
permissible,O,O
concentration,O,O
increased,O,O
activity,O,O
of,O,O
glutathione,B,O
peroxidase,I,O
in,O,O
brain,O,O
tissue,O,O
;,O,O
moreover,O,O
",",O,O
toluene,O,O
increased,O,O
chemiluminescence,O,O
intensity,O,O
",",O,O
which,O,O
attested,O,O
to,O,O
activation,O,O
of,O,O
free,O,O
radical,O,O
processes,O,O
.,O,O
Several,O,O
7SL,B,B
RNA,I,I
-,I,I
encoding,I,I
sequences,I,I
and,O,O
various,O,O
intergenic,O,O
spacers,O,O
were,O,O
amplified,O,O
from,O,O
the,O,O
individual,O,O
HindIII,B,O
fragments,I,O
of,O,O
about,O,O
1,O,O
.,O,O
3,O,O
and,O,O
2,O,O
.,O,O
8,O,O
kb,O,O
.,O,O
Movement,O,O
time,O,O
and,O,O
kinematic,O,O
characteristics,O,O
were,O,O
analyzed,O,O
together,O,O
with,O,O
the,O,O
magnitude,O,O
of,O,O
cerebral,O,O
blood,O,O
flow,O,O
to,O,O
identify,O,O
areas,O,O
of,O,O
brain,O,O
activity,O,O
proportionate,O,O
to,O,O
task,O,O
and,O,O
movement,O,O
variables,O,O
.,O,O
In,O,O
resting,O,O
3T3,O,O
cells,O,O
",",O,O
jun,B,B
-,I,I
D,I,I
is,O,O
expressed,O,O
at,O,O
a,O,O
higher,O,O
level,O,O
compared,O,O
to,O,O
c,B,O
-,I,O
jun,I,B
and,O,O
jun,B,B
-,I,I
B,I,I
",",O,O
and,O,O
its,O,O
transcription,O,O
is,O,O
stimulated,O,O
only,O,O
slightly,O,O
by,O,O
serum,O,O
growth,O,O
factors,O,O
.,O,O
Diltiazem,O,O
decreased,O,O
the,O,O
total,O,O
body,O,O
clearance,O,O
from,O,O
34,O,O
.,O,O
0,O,O
+,O,O
/,O,O
-,O,O
8,O,O
.,O,O
0,O,O
to,O,O
28,O,O
.,O,O
6,O,O
+,O,O
/,O,O
-,O,O
6,O,O
.,O,O
1,O,O
mL,O,O
/,O,O
min,O,O
(,O,O
P,O,O
less,O,O
than,O,O
.,O,O
01,O,O
),O,O
",",O,O
and,O,O
prolonged,O,O
the,O,O
elimination,O,O
half,O,O
-,O,O
life,O,O
from,O,O
12,O,O
.,O,O
6,O,O
+,O,O
/,O,O
-,O,O
3,O,O
.,O,O
0,O,O
to,O,O
14,O,O
.,O,O
3,O,O
+,O,O
/,O,O
-,O,O
2,O,O
.,O,O
5,O,O
hours,O,O
(,O,O
P,O,O
less,O,O
than,O,O
.,O,O
01,O,O
),O,O
of,O,O
antipyrine,O,O
without,O,O
any,O,O
changes,O,O
in,O,O
volume,O,O
of,O,O
distribution,O,O
.,O,O
Their,O,O
conduction,O,O
velocity,O,O
ranged,O,O
from,O,O
0,O,O
.,O,O
23,O,O
to,O,O
0,O,O
.,O,O
98,O,O
m,O,O
/,O,O
sec,O,O
(,O,O
group,O,O
C,O,O
),O,O
.,O,O
Dilutions,O,O
of,O,O
H,B,B
-,I,I
2b,I,I
or,I,O
H,I,B
-,I,I
2d,I,I
NP,I,I
peptides,I,O
indicated,O,O
that,O,O
3,O,O
-,O,O
4,O,O
logs,O,O
less,O,O
H,B,B
-,I,I
2b,I,I
NP,I,I
peptide,I,O
was,O,O
required,O,O
to,O,O
sensitize,O,O
syngeneic,O,O
target,O,O
cells,O,O
for,O,O
CTL,O,O
-,O,O
specific,O,O
lysis,O,O
",",O,O
suggesting,O,O
that,O,O
the,O,O
differing,O,O
affinities,O,O
of,O,O
H,O,B
-,O,I
2b,O,I
and,O,O
H,O,B
-,O,I
2d,O,I
major,B,O
histocompatibility,I,O
complex,I,O
molecules,I,O
for,O,O
their,O,O
peptides,O,O
likely,O,O
account,O,O
for,O,O
the,O,O
total,O,O
removal,O,O
of,O,O
NP,O,I
CTL,O,O
in,O,O
the,O,O
H,O,B
-,O,I
2b,O,I
mice,O,O
but,O,O
only,O,O
partial,O,O
removal,O,O
in,O,O
H,O,B
-,O,I
2d,O,I
mice,O,O
made,O,O
to,O,O
express,O,O
thymic,O,O
NP,O,I
.,O,O
Differential,O,O
sensitivity,O,O
of,O,O
the,O,O
MMPI,O,B
-,O,I
2,O,I
depression,O,O
scales,O,O
and,O,O
subscales,O,O
.,O,O
However,O,O
",",O,O
such,O,O
a,O,O
mechanism,O,O
was,O,O
not,O,O
detected,O,O
in,O,O
preliminary,O,O
observations,O,O
on,O,O
M,O,B
.,O,O
synoviae,O,O
.,O,O
A,O,O
fine,O,O
-,O,O
structure,O,O
deletion,O,O
map,O,O
of,O,O
human,O,B
chromosome,O,O
11p,O,O
:,O,O
analysis,O,O
of,O,O
J1,O,O
series,O,O
hybrids,O,O
.,O,O
The,O,O
existence,O,O
of,O,O
these,O,O
two,O,O
categories,O,O
of,O,O
strains,O,O
offers,O,O
a,O,O
new,O,O
genetic,O,O
system,O,O
in,O,O
which,O,O
the,O,O
properties,O,O
of,O,O
a,O,O
potential,O,O
invertebrate,O,O
retrovirus,O,O
can,O,O
be,O,O
tested,O,O
.,O,O
N,O,O
-,O,O
Substituted,O,O
trimethylsilylcarbamates,O,O
were,O,O
tested,O,O
as,O,O
derivatizing,O,O
reagents,O,O
for,O,O
gas,O,O
chromatographic,O,O
analysis,O,O
.,O,O
A,O,O
region,O,O
approximately,O,O
100,O,O
bp,O,O
upstream,O,O
from,O,O
the,O,O
transcription,O,O
start,O,O
point,O,O
of,O,O
virB,B,B
was,O,O
identified,O,O
as,O,O
being,O,O
necessary,O,O
for,O,O
full,O,O
activation,O,O
of,O,O
this,O,O
promoter,O,O
by,O,O
VirF,B,B
.,O,O
PATIENTS,O,O
and,O,O
METHODS,O,O
:,O,O
Thallium,O,B
-,O,I
201,O,I
myocardial,O,I
scintigraphy,O,I
was,O,O
performed,O,O
at,O,O
rest,O,O
and,O,O
after,O,O
0,O,O
.,O,O
56,O,O
mg,O,O
/,O,O
kg,O,O
intravenous,O,O
dipyridamole,O,B
during,O,O
four,O,O
minutes,O,O
in,O,O
16,O,O
patients,O,O
with,O,O
sarcoidosis,O,O
.,O,O
The,O,O
electrocardiogram,O,O
.,O,O
The,O,O
two,O,O
IL6,B,B
mRNA,I,I
species,O,O
are,O,O
generated,O,O
by,O,O
alternative,O,O
polyadenylation,O,O
at,O,O
sites,O,O
separated,O,O
by,O,O
a,O,O
distance,O,O
of,O,O
1,O,O
.,O,O
2,O,O
kilobases,O,O
.,O,O
Biol,O,O
.,O,O
Analysis,O,O
of,O,O
this,O,O
sequence,O,O
combined,O,O
with,O,O
that,O,O
previously,O,O
reported,O,O
for,O,O
the,O,O
5,O,O
',O,O
-,O,O
flanking,O,O
region,O,O
directly,O,O
proximal,O,O
to,O,O
the,O,O
start,O,O
of,O,O
transcription,O,O
revealed,O,O
several,O,O
putative,O,O
regulatory,O,O
sequences,O,O
.,O,O
In,O,O
the,O,O
last,O,O
20,O,O
years,O,O
",",O,O
the,O,O
therapeutic,O,O
uses,O,O
of,O,O
botulinum,B,B
toxin,I,I
",",O,O
a,O,O
potent,O,O
neurotoxin,O,O
",",O,O
have,O,O
been,O,O
investigated,O,O
.,O,O
Arhythmacanthus,O,O
Yamaguti,O,O
",",O,O
1935,O,O
is,O,O
maintained,O,O
as,O,O
a,O,O
synonym,O,O
of,O,O
Heterosentis,O,O
because,O,O
the,O,O
distinction,O,O
between,O,O
two,O,O
and,O,O
three,O,O
hook,O,O
types,O,O
is,O,O
made,O,O
equivocal,O,O
when,O,O
the,O,O
transition,O,O
between,O,O
the,O,O
apical,O,O
and,O,O
subapical,O,O
hooks,O,O
is,O,O
gradual,O,O
.,O,O
Linear,O,O
eight,O,O
-,O,O
or,O,O
nine,O,O
-,O,O
D,O,B
-,O,I
peptides,O,O
derived,O,O
from,O,O
the,O,O
pocket,O,O
-,O,O
binding,O,O
domain,O,O
of,O,O
the,O,O
cyclic,O,O
molecules,O,O
also,O,O
bind,O,O
specifically,O,O
.,O,O
No,O,O
recombination,O,O
signal,O,O
sequences,O,O
have,O,O
been,O,O
found,O,O
contiguous,O,O
to,O,O
the,O,O
recombination,O,O
point,O,O
.,O,O
Development,O,O
of,O,O
a,O,O
yeast,O,O
system,O,O
to,O,O
assay,O,O
mutational,O,O
specificity,O,O
.,O,O
AgMNPV,O,B
and,O,O
Orgyia,O,B
pseudotsugata,O,I
MNPV,O,I
(,O,O
OpMNPV,O,B
),O,O
are,O,O
similar,O,O
in,O,O
terms,O,O
of,O,O
promoter,O,O
structure,O,O
and,O,O
polyhedrin,B,O
primary,I,O
sequence,I,O
",",O,O
and,O,O
the,O,O
polyhedrin,B,O
gene,I,O
of,O,O
both,O,O
viruses,O,O
is,O,O
transcribed,O,O
in,O,O
the,O,O
anti,O,O
-,O,O
clockwise,O,O
direction,O,O
in,O,O
relation,O,O
to,O,O
their,O,O
physical,O,O
maps,O,O
.,O,O
Efficacy,O,O
and,O,O
field,O,O
evaluation,O,O
of,O,O
Bacillus,O,B
thuringiensis,O,I
(,O,O
H,O,B
-,O,I
14,O,I
),O,O
and,O,O
B,O,B
.,O,O
sphaericus,O,I
against,O,O
floodwater,O,O
mosquitoes,O,O
in,O,O
California,O,O
.,O,O
Thus,O,O
E14,O,B
.,O,O
1TG3B1,O,O
is,O,O
a,O,O
useful,O,O
ES,O,B
cell,O,I
line,O,I
for,O,O
modifying,O,O
the,O,O
mouse,O,O
genome,O,O
using,O,O
the,O,O
HPRT,B,B
gene,I,I
as,O,O
a,O,O
selection,O,O
marker,O,O
and,O,O
for,O,O
transmission,O,O
at,O,O
a,O,O
high,O,O
frequency,O,O
into,O,O
the,O,O
mouse,O,O
germ,O,O
line,O,O
.,O,O
It,O,O
was,O,O
concluded,O,O
that,O,O
both,O,O
of,O,O
these,O,O
surgical,O,O
procedures,O,O
were,O,O
as,O,O
effective,O,O
as,O,O
pinealectomy,O,O
in,O,O
reversing,O,O
the,O,O
pineal,O,O
-,O,O
induced,O,O
alterations,O,O
in,O,O
the,O,O
reproductive,O,O
physiology,O,O
of,O,O
the,O,O
blind,O,O
-,O,O
anosmic,O,O
female,O,O
rat,O,O
.,O,O
However,O,O
",",O,O
an,O,O
intrinsic,O,O
DNA,O,B
-,O,I
binding,O,I
subunit,O,I
for,O,O
HiNF,B,B
-,I,I
D,I,I
was,O,O
not,O,O
identified,O,O
.,O,O
Expression,O,O
of,O,O
constitutively,O,O
active,O,O
MEK1,B,B
",",O,O
the,O,O
kinase,O,O
that,O,O
activates,O,O
ERKs,B,B
",",O,O
or,O,O
overexpression,O,O
of,O,O
ERK2,B,B
",",O,O
but,O,O
not,O,O
JNK1,B,B
",",O,O
inhibited,O,O
Stat3,B,B
activation,O,O
.,O,O
We,O,O
have,O,O
isolated,O,O
a,O,O
Drosophila,O,B
melanogaster,O,I
(,O,O
Dm,O,B
),O,O
cDNA,O,O
encoding,O,O
a,O,O
polypeptide,O,O
that,O,O
has,O,O
extensive,O,O
sequence,O,O
similarity,O,O
to,O,O
the,O,O
mammalian,B,O
MAPKAPK,I,B
-,I,I
2,I,I
.,O,O
The,O,O
sequence,O,O
data,O,O
now,O,O
permit,O,O
a,O,O
detailed,O,O
interpretation,O,O
of,O,O
the,O,O
X,O,O
-,O,O
ray,O,O
crystallographic,O,O
structure,O,O
of,O,O
the,O,O
enzyme,O,O
and,O,O
the,O,O
cloning,O,O
and,O,O
expression,O,O
of,O,O
the,O,O
clostridial,O,O
gene,O,O
will,O,O
facilitate,O,O
site,O,O
-,O,O
directed,O,O
mutagenesis,O,O
.,O,O
Recent,O,O
studies,O,O
have,O,O
revealed,O,O
unconventional,O,O
myosin,B,B
V,I,I
to,O,O
be,O,O
an,O,O
important,O,O
actin,B,O
-,O,O
based,O,O
molecular,O,O
motor,O,O
involved,O,O
in,O,O
vesicular,O,O
movement,O,O
.,O,O
EGFR,B,B
levels,O,O
were,O,O
found,O,O
to,O,O
be,O,O
elevated,O,O
5,O,O
-,O,O
",",O,O
3,O,O
.,O,O
It,O,O
bound,O,O
to,O,O
vitamin,B,O
D,I,O
receptor,I,O
(,O,O
VDR,B,B
),O,O
but,O,O
not,O,O
retinoic,B,O
acid,I,O
Xalpha,I,O
receptor,I,O
(,O,O
RXRalpha,B,B
),O,O
in,O,O
the,O,O
human,O,B
T,O,I
cell,O,I
line,O,I
MT2,O,I
cells,O,O
.,O,O
The,O,O
Functional,O,O
Independence,O,O
Measure,O,O
:,O,O
a,O,O
comparative,O,O
study,O,O
of,O,O
clinician,O,O
and,O,O
self,O,O
ratings,O,O
.,O,O
A,O,O
high,O,O
-,O,O
resolution,O,O
restriction,O,O
map,O,O
of,O,O
over,O,O
200,O,O
kb,O,O
of,O,O
contiguous,O,O
DNA,O,B
containing,O,O
N,B,B
-,I,I
myc,I,I
has,O,O
been,O,O
generated,O,O
by,O,O
subcloning,O,O
YACs,O,O
into,O,O
cosmids,O,O
.,O,O
Prevention,O,O
of,O,O
transfusion,O,O
reactions,O,O
by,O,O
the,O,O
use,O,O
of,O,O
saline,O,O
washed,O,O
red,O,O
blood,O,O
cells,O,O
.,O,O
Two,O,O
patients,O,O
had,O,O
immediate,O,O
adverse,O,O
effects,O,O
from,O,O
NMF,O,B
;,O,O
one,O,O
had,O,O
a,O,O
grand,O,O
mal,O,O
seizure,O,O
and,O,O
the,O,O
other,O,O
developed,O,O
severe,O,O
abdominal,O,O
pain,O,O
.,O,O
As,O,O
hypothesized,O,O
",",O,O
believers,O,O
showed,O,O
relatively,O,O
higher,O,O
right,O,O
hemispheric,O,O
activation,O,O
and,O,O
reduced,O,O
hemispheric,O,O
asymmetry,O,O
of,O,O
functional,O,O
complexity,O,O
.,O,O
Intensification,O,O
of,O,O
human,O,B
myocardial,O,I
contractile,O,I
activity,O,I
as,O,O
affected,O,O
by,O,O
blood,O,O
serum,O,O
Pregnancy,O,O
screening,O,O
by,O,O
uterine,O,O
artery,O,O
Doppler,O,O
velocimetry,O,O
-,O,O
-,O,O
which,O,O
criterion,O,O
performs,O,O
best,O,O
?,O,O
OBJECTIVE,O,O
:,O,O
To,O,O
test,O,O
whether,O,O
repeating,O,O
Doppler,O,O
studies,O,O
of,O,O
the,O,O
uteroplacental,O,O
circulation,O,O
late,O,O
in,O,O
gestation,O,O
will,O,O
improve,O,O
the,O,O
test,O,O
',O,O
s,O,O
power,O,O
for,O,O
predicting,O,O
pregnancy,O,O
-,O,O
induced,O,O
hypertension,O,O
and,O,O
fetal,O,O
growth,O,O
restriction,O,O
(,O,O
FGR,O,B
),O,O
",",O,O
and,O,O
whether,O,O
analysis,O,O
based,O,O
on,O,O
a,O,O
combination,O,O
of,O,O
quantitative,O,O
and,O,O
qualitative,O,O
assessments,O,O
of,O,O
the,O,O
uterine,O,O
arterial,O,O
waveforms,O,O
will,O,O
yield,O,O
better,O,O
results,O,O
than,O,O
analysis,O,O
based,O,O
on,O,O
either,O,O
alone,O,O
.,O,O
These,O,O
characteristics,O,O
of,O,O
N22,O,B
/,O,O
P22,O,B
indicate,O,O
that,O,O
it,O,O
is,O,O
a,O,O
localized,O,O
synaptically,O,O
dependent,O,O
event,O,O
conforming,O,O
to,O,O
a,O,O
transverse,O,O
dipole,O,O
with,O,O
dorsal,O,O
negativity,O,O
and,O,O
a,O,O
simultaneous,O,O
anterior,O,O
positivity,O,O
.,O,O
Effects,O,O
of,O,O
ionizing,O,O
radiation,O,O
in,O,O
the,O,O
human,O,B
oral,O,I
cavity,O,I
and,O,O
oropharynx,O,B
:,O,O
results,O,O
of,O,O
a,O,O
survey,O,O
.,O,O
FDA,O,O
regulations,O,O
for,O,O
growth,O,O
factors,O,O
and,O,O
related,O,O
products,O,O
.,O,O
Pulmonary,O,O
hypertension,O,O
",",O,O
with,O,O
or,O,O
without,O,O
coronary,O,O
arterial,O,O
narrowing,O,O
",",O,O
is,O,O
the,O,O
major,O,O
condition,O,O
leading,O,O
to,O,O
isolated,O,O
atrial,O,O
infarction,O,O
.,O,O
The,O,O
most,O,O
frequent,O,O
causes,O,O
of,O,O
the,O,O
meningitis,O,O
was,O,O
the,O,O
external,O,O
ventricular,O,O
drainage,O,O
(,O,O
14,O,O
.,O,O
8,O,O
%,O,O
),O,O
",",O,O
post,O,O
-,O,O
neurosurgical,O,O
(,O,O
0,O,O
.,O,O
8,O,O
%,O,O
),O,O
and,O,O
head,O,O
injury,O,O
(,O,O
0,O,O
.,O,O
0007,O,O
%,O,O
),O,O
.,O,O
Some,O,O
research,O,O
studies,O,O
have,O,O
related,O,O
this,O,O
kind,O,O
of,O,O
tumors,O,O
with,O,O
prolonged,O,O
ingestion,O,O
of,O,O
H2,O,B
inhibitors,O,O
and,O,O
others,O,O
antacid,O,O
.,O,O
The,O,O
aim,O,O
of,O,O
our,O,O
study,O,O
was,O,O
to,O,O
evaluate,O,O
the,O,O
level,O,O
of,O,O
oxidative,O,O
stress,O,O
in,O,O
healthy,O,O
controls,O,O
(,O,O
CTL,O,B
),O,O
compared,O,O
with,O,O
CRF,O,O
and,O,O
HD,O,O
patients,O,O
before,O,O
(,O,O
pre,O,O
-,O,O
HD,O,O
),O,O
and,O,O
after,O,O
(,O,O
post,O,O
-,O,O
HD,O,O
),O,O
the,O,O
dialysis,O,O
session,O,O
",",O,O
carried,O,O
out,O,O
on,O,O
a,O,O
high,O,O
biocompatible,O,O
polyacrylonitrile,O,O
membrane,O,O
AN69,O,O
.,O,O
Hrs,B,B
has,O,O
a,O,O
FYVE,O,B
double,O,I
zinc,O,I
finger,O,I
domain,O,I
",",O,O
which,O,O
specifically,O,O
binds,O,O
phosphatidylinositol,O,O
(,O,O
3,O,O
),O,O
-,O,O
phosphate,O,O
and,O,O
is,O,O
conserved,O,O
in,O,O
several,O,O
proteins,O,O
involved,O,O
in,O,O
vesicular,O,O
traffic,O,O
.,O,O
Only,O,O
nine,O,O
patients,O,O
were,O,O
offered,O,O
surgery,O,O
(,O,O
six,O,O
were,O,O
resected,O,O
and,O,O
three,O,O
were,O,O
found,O,O
inoperable,O,O
),O,O
.,O,O
Twelve,O,O
patients,O,O
had,O,O
stage,O,O
IBG3,O,O
",",O,O
14,O,O
had,O,O
ICG1,O,O
",",O,O
9,O,O
had,O,O
ICG2,O,O
",",O,O
and,O,O
3,O,O
had,O,O
ICG3,O,O
disease,O,O
.,O,O
IgM,B,B
and,O,O
IgG,B,B
anti,I,I
A,I,I
and,O,I
anti,B,I
B,I,I
antibody,I,I
status,O,I
of,O,I
100,O,I
antenatal,O,I
O,O,I
group,O,I
mothers,O,I
(,O,O
who,O,O
had,O,O
non,O,O
O,O,O
group,O,O
husbands,O,O
),O,O
were,O,O
studied,O,O
.,O,O
The,O,O
pheromone,O,O
response,O,O
pathway,O,O
activates,O,O
transcription,O,O
of,O,O
Ty5,B,B
retrotransposons,I,O
located,O,O
within,O,O
silent,O,O
chromatin,O,O
of,O,O
Saccharomyces,O,B
cerevisiae,O,I
.,O,O
EMSA,O,O
with,O,O
crude,O,O
nuclear,O,O
extracts,O,O
demonstrated,O,O
that,O,O
stimulation,O,O
with,O,O
CD40L,B,O
results,O,O
in,O,O
the,O,O
induction,O,O
of,O,O
NF,B,B
-,I,I
kappaB,I,I
complexes,I,O
that,O,O
bind,O,O
to,O,O
each,O,O
of,O,O
the,O,O
three,O,O
NF,B,B
-,I,I
kappaB,I,I
sites,I,O
and,O,O
are,O,O
composed,O,O
mainly,O,O
of,O,O
p50,B,B
and,O,O
RelB,B,B
",",O,O
but,O,O
also,O,O
include,O,O
c,B,B
-,I,I
Rel,I,I
and,O,O
p65,B,B
.,O,O
In,O,O
the,O,O
budding,O,O
yeast,O,O
",",O,O
Saccharomyces,O,B
cerevisiae,O,I
",",O,O
replicators,O,O
can,O,O
function,O,O
outside,O,O
the,O,O
chromosome,O,O
as,O,O
autonomously,O,O
replicating,O,O
sequence,O,O
(,O,O
ARS,O,B
),O,O
elements,O,O
;,O,O
however,O,O
",",O,O
within,O,O
chromosome,O,O
III,O,O
",",O,O
certain,O,O
ARSs,O,B
near,O,O
the,O,O
transcriptionally,O,O
silent,O,O
HML,B,B
locus,I,O
show,O,O
no,O,O
replication,O,O
origin,O,O
activity,O,O
.,O,O
Among,O,O
booked,O,O
patients,O,O
the,O,O
maternal,O,O
mortality,O,O
rate,O,O
was,O,O
0,O,O
.,O,O
32,O,O
and,O,O
among,O,O
unbooked,O,O
patients,O,O
11,O,O
.,O,O
13,O,O
per,O,O
1000,O,O
deliveries,O,O
.,O,O
RESULTS,O,O
:,O,O
The,O,O
binding,O,O
of,O,O
99mTc,O,B
d,O,I
",",O,O
1,O,O
-,O,O
HMPAO,O,B
to,O,O
human,O,B
placenta,O,I
ranged,O,O
from,O,O
2,O,O
.,O,O
95,O,O
%,O,O
+,O,O
/,O,O
-,O,O
1,O,O
.,O,O
5,O,O
%,O,O
to,O,O
5,O,O
.,O,O
82,O,O
%,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
3,O,O
%,O,O
per,O,O
1,O,O
ml,O,O
standard,O,O
solution,O,O
.,O,O
These,O,O
results,O,O
were,O,O
corroborated,O,O
in,O,O
a,O,O
subsequent,O,O
study,O,O
in,O,O
which,O,O
30,O,O
hypogonadal,O,O
men,O,O
were,O,O
supplemented,O,O
with,O,O
SLT,O,B
5,O,O
mg,O,O
three,O,O
times,O,O
daily,O,O
for,O,O
6,O,O
months,O,O
.,O,O
The,O,O
recombinant,O,O
contains,O,O
the,O,O
normal,O,O
beta,B,B
A,I,I
-,I,I
globin,I,I
gene,I,I
",",O,O
the,O,O
mutant,O,O
gene,O,O
and,O,O
Ylp,O,O
vector,O,O
sequences,O,O
between,O,O
the,O,O
two,O,O
copies,O,O
.,O,O
Although,O,O
metabolized,O,O
by,O,O
the,O,O
cytochrome,B,O
P,I,B
-,I,I
450,I,I
(,O,O
CYP,B,B
),O,O
system,O,O
",",O,O
venlafaxine,O,O
inhibits,O,O
CYP,B,B
2D6,I,I
and,I,O
3A4,I,B
to,O,O
a,O,O
far,O,O
lesser,O,O
extent,O,O
than,O,O
do,O,O
the,O,O
SSRIs,O,O
.,O,O
Reduction,O,O
in,O,O
dosage,O,O
restored,O,O
normal,O,O
taste,O,O
sense,O,O
in,O,O
all,O,O
three,O,O
",",O,O
but,O,O
in,O,O
two,O,O
the,O,O
drug,O,O
had,O,O
to,O,O
be,O,O
discontinued,O,O
because,O,O
of,O,O
persisting,O,O
high,O,O
transaminase,O,O
levels,O,O
.,O,O
Codon,O,O
usage,O,O
in,O,O
C,O,B
.,O,O
reinhardtii,O,O
mitochondria,O,O
is,O,O
highly,O,O
biased,O,O
",",O,O
with,O,O
eight,O,O
codons,O,O
entirely,O,O
absent,O,O
from,O,O
all,O,O
protein,O,O
-,O,O
coding,O,O
genes,O,O
;,O,O
however,O,O
",",O,O
even,O,O
though,O,O
codon,O,O
usage,O,O
is,O,O
restricted,O,O
",",O,O
it,O,O
appears,O,O
that,O,O
C,O,B
.,O,O
reinhardtii,O,O
mtDNA,O,O
cannot,O,O
encode,O,O
the,O,O
minimum,O,O
number,O,O
of,O,O
tRNAs,O,O
needed,O,O
to,O,O
support,O,O
mitochondrial,O,O
protein,O,O
synthesis,O,O
.,O,O
Amino,O,O
acid,O,O
sequence,O,O
comparison,O,O
revealed,O,O
significant,O,O
homology,O,O
between,O,O
the,O,O
yeast,B,O
and,I,O
Escherichia,I,B
coli,I,I
gamma,I,I
-,I,I
glutamyl,I,I
kinases,I,I
throughout,O,O
their,O,O
lengths,O,O
.,O,O
Transfection,O,O
experiments,O,O
using,O,O
preformed,O,O
triplexes,O,O
with,O,O
a,O,O
reporter,O,O
plasmid,O,O
containing,O,O
the,O,O
collagen,B,B
promoter,I,I
sequence,I,I
showed,O,O
significant,O,O
inhibition,O,O
of,O,O
transcription,O,O
when,O,O
compared,O,O
with,O,O
a,O,O
control,O,O
phosphorothioate,O,O
ODN,O,O
.,O,O
The,O,O
likelihood,O,O
that,O,O
a,O,O
common,O,O
region,O,O
of,O,O
deletions,O,O
would,O,O
contain,O,O
a,O,O
tumor,O,O
suppressor,O,O
is,O,O
strongly,O,O
enhanced,O,O
by,O,O
coincidence,O,O
of,O,O
that,O,O
region,O,O
with,O,O
a,O,O
chromosome,O,O
fragment,O,O
suppressing,O,O
tumorigenicity,O,O
upon,O,O
introduction,O,O
in,O,O
tumor,O,O
cells,O,O
.,O,O
Collectively,O,O
",",O,O
the,O,O
results,O,O
suggest,O,O
that,O,O
ARF,B,B
binding,O,O
to,O,O
Mdm2,B,B
induces,O,O
a,O,O
conformational,O,O
change,O,O
that,O,O
facilitates,O,O
nucleolar,O,O
import,O,O
of,O,O
the,O,O
ARF,B,B
-,O,I
Mdm2,B,I
complex,O,O
and,O,O
p53,B,B
-,O,I
dependent,O,I
cell,O,I
cycle,O,I
arrest,O,I
.,O,O
Effect,O,O
of,O,O
Azadirachta,O,B
indica,O,I
hydroalcoholic,O,O
leaf,O,O
extract,O,O
on,O,O
the,O,O
cardiovascular,O,O
system,O,O
.,O,O
The,O,O
210,O,O
kDa,O,O
precursor,O,O
is,O,O
converted,O,O
slowly,O,O
(,O,O
t,O,O
1,O,O
/,O,O
2,O,O
h,O,O
),O,O
by,O,O
proteolytic,O,O
processing,O,O
into,O,O
a,O,O
125,O,O
kDa,O,O
(,O,O
alpha,O,O
',O,O
),O,O
and,O,O
83,O,O
kDa,O,O
(,O,O
beta,O,O
',O,O
),O,O
species,O,O
.,O,O
The,O,O
leader,O,O
sequence,O,O
of,O,O
the,O,O
isolated,O,O
cDNA,O,O
clone,O,O
contains,O,O
several,O,O
small,O,O
open,O,O
reading,O,O
frames,O,O
upstream,O,O
of,O,O
the,O,O
initiation,O,O
codon,O,O
of,O,O
the,O,O
largest,O,O
open,O,O
reading,O,O
frame,O,O
coding,O,O
for,O,O
the,O,O
homeodomain,B,O
protein,I,O
.,O,O
Colorectal,O,B
carcinoma,O,I
:,O,O
therapeutic,O,O
approach,O,O
in,O,O
patients,O,O
already,O,O
treated,O,O
with,O,O
metastasis,O,O
resection,O,O
As,O,O
a,O,O
last,O,O
resort,O,O
",",O,O
it,O,O
may,O,O
be,O,O
possible,O,O
to,O,O
maintain,O,O
a,O,O
patient,O,O
on,O,O
dialysis,O,O
in,O,O
reasonable,O,O
health,O,O
with,O,O
a,O,O
DiaTAP,O,B
button,O,I
graft,O,I
complex,O,I
infected,O,O
with,O,O
Staphylococcus,O,B
epidermidis,O,I
and,O,O
intermittent,O,O
positive,O,O
blood,O,O
cultures,O,O
using,O,O
long,O,O
term,O,O
vancomycin,O,O
therapy,O,O
.,O,O
Twelve,O,O
genomic,O,O
fragments,O,O
containing,O,O
novel,O,O
response,O,O
elements,O,O
are,O,O
described,O,O
",",O,O
and,O,O
the,O,O
transcription,O,O
unit,O,O
associated,O,O
with,O,O
one,O,O
of,O,O
them,O,O
",",O,O
NN,B,B
-,I,I
84AG,I,I
",",O,O
was,O,O
characterized,O,O
in,O,O
detail,O,O
.,O,O
Foreigners,O,O
return,O,O
.,O,O
Nickel,O,O
is,O,O
the,O,O
most,O,O
common,O,O
cause,O,O
of,O,O
allergic,O,O
contact,O,O
dermatitis,O,O
in,O,O
Singapore,O,O
",",O,O
resulting,O,O
in,O,O
positive,O,O
reactions,O,O
in,O,O
patch,O,O
tests,O,O
between,O,O
7,O,O
and,O,O
14,O,O
%,O,O
.,O,O
The,O,O
first,O,O
symptoms,O,O
of,O,O
enzootic,O,O
calcinosis,O,O
were,O,O
noted,O,O
in,O,O
March,O,O
1998,O,O
",",O,O
when,O,O
some,O,O
of,O,O
the,O,O
cows,O,O
developed,O,O
locomotor,O,O
abnormalities,O,O
.,O,O
We,O,O
mapped,O,O
the,O,O
DGCR6,B,B
gene,I,O
to,O,O
chromosome,O,O
22q11,O,O
within,O,O
a,O,O
low,O,O
copy,O,O
repeat,O,O
",",O,O
termed,O,O
sc11,O,O
.,O,O
1a,O,O
",",O,O
and,O,O
identified,O,O
a,O,O
second,O,O
copy,O,O
of,O,O
the,O,O
gene,O,O
",",O,O
DGCR6L,B,B
",",O,O
within,O,O
the,O,O
duplicate,O,O
locus,O,O
",",O,O
termed,O,O
sc11,O,O
.,O,O
1b,O,O
.,O,O
Attenuation,O,O
from,O,O
the,O,O
vit,B,B
A2,I,I
consensus,O,I
ERE,O,I
is,O,O
not,O,O
necessarily,O,O
dependent,O,O
on,O,O
DNA,O,O
binding,O,O
as,O,O
the,O,O
TR,B,O
alpha,I,O
DNA,O,O
binding,O,O
mutant,O,O
was,O,O
still,O,O
able,O,O
to,O,O
inhibit,O,O
E,O,O
-,O,O
dependent,O,O
transactivation,O,O
.,O,O
The,O,O
recruitment,O,O
of,O,O
constitutively,O,O
phosphorylated,O,O
p185,B,B
(,O,O
neu,B,B
),O,O
and,O,O
the,O,O
activated,O,O
mitogenic,O,O
pathway,O,O
proteins,O,O
to,O,O
this,O,O
membrane,O,O
-,O,O
microfilament,O,O
interaction,O,O
site,O,O
provides,O,O
a,O,O
physical,O,O
model,O,O
for,O,O
integrating,O,O
the,O,O
assembly,O,O
of,O,O
the,O,O
mitogenic,O,O
pathway,O,O
with,O,O
the,O,O
transmission,O,O
of,O,O
growth,O,O
factor,O,O
signal,O,O
to,O,O
the,O,O
cytoskeleton,O,O
.,O,O
Two,O,O
mutants,O,O
",",O,O
each,O,O
representative,O,O
of,O,O
a,O,O
separate,O,O
pet,B,O
complementation,O,O
group,O,O
",",O,O
have,O,O
been,O,O
analyzed,O,O
.,O,O
Molecular,O,O
analysis,O,O
of,O,O
the,O,O
pRA2,O,O
partitioning,O,O
region,O,O
:,O,O
ParB,B,O
autoregulates,O,O
parAB,B,O
transcription,O,O
and,O,O
forms,O,O
a,O,O
nucleoprotein,O,O
complex,O,O
with,O,O
the,O,O
plasmid,O,O
partition,O,O
site,O,O
",",O,O
parS,B,O
.,O,O
The,O,O
purpose,O,O
of,O,O
the,O,O
study,O,O
reported,O,O
here,O,O
was,O,O
to,O,O
investigate,O,O
whether,O,O
differences,O,O
in,O,O
T1,O,O
and,O,O
T2,O,O
between,O,O
tumors,O,O
are,O,O
mainly,O,O
a,O,O
consequence,O,O
of,O,O
differences,O,O
in,O,O
the,O,O
fractional,O,O
volume,O,O
of,O,O
the,O,O
extracellular,O,O
compartment,O,O
.,O,O
The,O,O
levels,O,O
of,O,O
NPY,B,B
-,O,I
ir,O,I
in,O,O
the,O,O
rat,O,O
vas,O,O
deferens,O,O
were,O,O
not,O,O
affected,O,O
by,O,O
either,O,O
surgical,O,O
or,O,O
pharmacological,O,O
treatment,O,O
.,O,O
The,O,O
dichloromethane,O,O
is,O,O
removed,O,O
",",O,O
mobile,O,O
phase,O,O
solvent,O,O
is,O,O
added,O,O
",",O,O
and,O,O
aliquots,O,O
are,O,O
injected,O,O
onto,O,O
a,O,O
PRP,O,O
-,O,O
1,O,O
liquid,O,O
chromatographic,O,O
column,O,O
;,O,O
fluazifop,O,O
acid,O,O
is,O,O
separated,O,O
from,O,O
coextracted,O,O
compounds,O,O
and,O,O
detected,O,O
at,O,O
an,O,O
applied,O,O
potential,O,O
of,O,O
+,O,O
1,O,O
.,O,O
25,O,O
V,O,O
",",O,O
using,O,O
an,O,O
amperometric,O,O
electrochemical,O,O
detector,O,O
in,O,O
the,O,O
oxidation,O,O
mode,O,O
.,O,O
The,O,O
diagnostic,O,O
accuracy,O,O
of,O,O
serum,O,O
PE,B,O
-,I,O
1,I,O
was,O,O
0,O,O
.,O,O
80,O,O
",",O,O
and,O,O
that,O,O
of,O,O
amylase,B,O
0,O,O
.,O,O
97,O,O
.,O,O
Alternative,O,O
splicing,O,O
of,O,O
ClC,B,B
-,I,I
6,I,I
(,O,O
a,O,O
member,O,O
of,O,O
the,O,O
CIC,B,O
chloride,I,O
-,I,O
channel,I,O
family,I,O
),O,O
transcripts,O,O
generates,O,O
three,O,O
truncated,O,O
isoforms,O,O
one,O,O
of,O,O
which,O,O
",",O,O
ClC,B,B
-,I,I
6c,I,I
",",O,O
is,O,O
kidney,O,O
-,O,O
specific,O,O
.,O,O
Because,O,O
single,O,O
-,O,O
chamber,O,O
rate,O,O
-,O,O
adaptive,O,O
atrial,O,O
pacing,O,O
leaves,O,O
the,O,O
patient,O,O
exposed,O,O
to,O,O
the,O,O
risk,O,O
of,O,O
future,O,O
development,O,O
of,O,O
AV,O,B
block,O,I
and,O,O
DDD,O,B
pacing,O,O
does,O,O
not,O,O
provide,O,O
chronotropic,O,O
support,O,O
",",O,O
it,O,O
is,O,O
likely,O,O
that,O,O
the,O,O
new,O,O
rate,O,O
-,O,O
adaptive,O,O
dual,O,O
-,O,O
chamber,O,O
(,O,O
DDDR,O,B
),O,O
devices,O,O
will,O,O
be,O,O
used,O,O
in,O,O
a,O,O
significant,O,O
number,O,O
of,O,O
these,O,O
patients,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
250,O,O
WORDS,O,O
),O,O
The,O,O
JHRLSS,O,O
has,O,O
been,O,O
used,O,O
in,O,O
prior,O,O
studies,O,O
to,O,O
assess,O,O
RLS,O,O
severity,O,O
",",O,O
but,O,O
has,O,O
not,O,O
previously,O,O
been,O,O
validated,O,O
in,O,O
relation,O,O
to,O,O
direct,O,O
measures,O,O
of,O,O
the,O,O
morbidity,O,O
associated,O,O
with,O,O
RLS,O,O
.,O,O
These,O,O
observations,O,O
lead,O,O
to,O,O
the,O,O
proposal,O,O
that,O,O
the,O,O
RNAP,B,B
II,I,I
CTD,I,I
might,O,O
be,O,O
an,O,O
in,O,O
vivo,O,O
target,O,O
for,O,O
the,O,O
activated,O,O
p42mapk,B,B
and,O,O
p44mapk,B,B
MAP,I,I
kinases,I,I
.,O,O
The,O,O
various,O,O
available,O,O
data,O,O
strongly,O,O
suggesting,O,O
an,O,O
environmental,O,O
toxic,O,O
origin,O,O
for,O,O
the,O,O
will,O,O
be,O,O
presented,O,O
as,O,O
well,O,O
as,O,O
the,O,O
most,O,O
frequently,O,O
suspected,O,O
class,O,O
of,O,O
substances,O,O
",",O,O
the,O,O
xenoestrogens,O,B
.,O,O
We,O,O
have,O,O
separated,O,O
a,O,O
dermatan,O,B
sulfate,O,I
proteoglycan,O,I
",",O,O
epiphycan,O,B
",",O,O
from,O,O
decorin,B,B
and,O,O
biglycan,O,B
by,O,O
using,O,O
dissociative,O,O
extraction,O,O
of,O,O
bovine,O,O
fetal,O,O
epiphyseal,O,O
cartilage,O,O
",",O,O
followed,O,O
by,O,O
sequential,O,O
ion,O,O
-,O,O
exchange,O,O
",",O,O
gel,O,O
permeation,O,O
",",O,O
hydrophobic,O,O
",",O,O
and,O,O
Zn2,O,B
+,O,I
chelate,O,I
chromatographic,O,I
steps,O,O
.,O,O
Visual,O,O
response,O,O
properties,O,O
of,O,O
neurons,O,O
in,O,O
four,O,O
extrastriate,O,O
visual,O,O
areas,O,O
of,O,O
the,O,O
owl,O,O
monkey,O,O
(,O,O
Aotus,O,B
trivirgatus,O,I
),O,O
:,O,O
a,O,O
quantitative,O,O
comparison,O,O
of,O,O
medial,O,O
",",O,O
dorsomedial,O,O
",",O,O
dorsolateral,O,O
",",O,O
and,O,O
middle,O,O
temporal,O,O
areas,O,O
.,O,O
Glomerular,O,O
mesangial,O,O
cells,O,O
expressed,O,O
an,O,O
abundant,O,O
1,O,O
.,O,O
1,O,O
kb,O,O
mRNA,O,O
transcript,O,O
for,O,O
Id1,B,B
",",O,O
but,O,O
in,O,O
contrast,O,O
to,O,O
other,O,O
cell,O,O
types,O,O
Id1,B,B
mRNA,I,O
was,O,O
expressed,O,O
in,O,O
both,O,O
randomly,O,O
cycling,O,O
cells,O,O
and,O,O
in,O,O
serum,O,O
-,O,O
deprived,O,O
",",O,O
quiescent,O,O
cultures,O,O
.,O,O
There,O,O
was,O,O
no,O,O
apparent,O,O
effect,O,O
of,O,O
growth,O,O
temperature,O,O
on,O,O
the,O,O
steady,O,O
-,O,O
state,O,O
levels,O,O
of,O,O
fad7,B,B
mRNA,I,O
in,O,O
wild,O,O
type,O,O
plants,O,O
.,O,O
Difficulties,O,O
bound,O,O
to,O,O
measuring,O,O
of,O,O
sputum,O,O
viscosity,O,O
RESULTS,O,O
:,O,O
Significant,O,O
changes,O,O
from,O,O
pretreatment,O,O
to,O,O
posttreatment,O,O
were,O,O
observed,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
.,O,O
The,O,O
overall,O,O
results,O,O
of,O,O
this,O,O
paper,O,O
are,O,O
consistent,O,O
with,O,O
the,O,O
conclusion,O,O
that,O,O
the,O,O
carboxyl,O,O
-,O,O
terminal,O,O
LBD,O,O
is,O,O
not,O,O
sufficient,O,O
for,O,O
mediating,O,O
PR,B,B
dimerization,O,O
and,O,O
that,O,O
multiple,O,O
regions,O,O
",",O,O
including,O,O
the,O,O
hinge,O,O
and,O,O
amino,O,O
-,O,O
terminal,O,O
sequences,O,O
",",O,O
contribute,O,O
either,O,O
directly,O,O
or,O,O
indirectly,O,O
to,O,O
homodimerization,O,O
of,O,O
PR,B,B
.,O,O
The,O,O
equilibrium,O,O
dissociation,O,O
binding,O,O
constant,O,O
for,O,O
the,O,O
interaction,O,O
of,O,O
TnrA,B,B
with,O,O
the,O,O
nrgAB,B,B
promoter,I,I
fragment,I,I
was,O,O
7,O,O
.,O,O
7,O,O
nM,O,O
under,O,O
the,O,O
conditions,O,O
used,O,O
here,O,O
.,O,O
Effect,O,O
of,O,O
a,O,O
high,O,O
-,O,O
intensity,O,O
SHF,O,O
field,O,O
on,O,O
the,O,O
blood,O,O
coagulation,O,O
system,O,O
It,O,O
is,O,O
now,O,O
well,O,O
accepted,O,O
that,O,O
the,O,O
p53,B,B
C,I,I
-,I,I
terminus,I,I
plays,O,O
a,O,O
central,O,O
role,O,O
in,O,O
controlling,O,O
the,O,O
activity,O,O
of,O,O
the,O,O
wild,O,O
-,O,O
type,O,O
molecule,O,O
.,O,O
The,O,O
activity,O,O
of,O,O
the,O,O
minimal,O,O
promoter,O,O
was,O,O
found,O,O
to,O,O
be,O,O
controlled,O,O
by,O,O
a,O,O
combination,O,O
of,O,O
the,O,O
activities,O,O
of,O,O
the,O,O
transcription,O,O
factors,O,O
Sp1,B,B
",",O,O
Sp3,B,B
",",O,O
and,O,O
NF,B,B
-,I,I
Y,I,I
.,O,O
We,O,O
evaluated,O,O
the,O,O
likelihood,O,O
of,O,O
tissues,O,O
to,O,O
be,O,O
positive,O,O
for,O,O
carcinoembryonic,B,B
antigen,I,I
and,O,O
the,O,O
intensity,O,O
of,O,O
carcinoembryonic,B,B
antigen,I,I
staining,O,O
in,O,O
specimens,O,O
of,O,O
villous,O,O
adenomas,O,O
",",O,O
mixed,O,O
polypoid,O,O
villous,O,O
adenomas,O,O
",",O,O
polypoid,O,O
adenomas,O,O
",",O,O
and,O,O
diverticulitis,O,O
using,O,O
the,O,O
peroxidase,B,O
-,O,O
antiperoxidase,B,O
technique,O,O
.,O,O
Mapping,O,O
results,O,O
suggested,O,O
that,O,O
the,O,O
complementation,O,O
group,O,O
identified,O,O
by,O,O
these,O,O
mutants,O,O
is,O,O
allelic,O,O
to,O,O
the,O,O
ag,B,B
alpha,I,I
1,I,I
mutation,O,O
identified,O,O
previously,O,O
.,O,O
Comparison,O,O
with,O,O
the,O,O
sequence,O,O
databanks,O,O
show,O,O
that,O,O
Tactile,B,B
is,O,O
a,O,O
member,O,O
of,O,O
the,O,O
immunoglobulin,B,O
gene,I,O
superfamily,I,O
",",O,O
with,O,O
similarity,O,O
to,O,O
Drosophila,B,O
amalgam,I,O
",",O,O
the,O,O
melanoma,B,O
Ag,I,B
MUC,I,I
-,I,I
18,I,I
",",O,O
members,O,O
of,O,O
the,O,O
carcinoembryonic,B,O
Ag,I,B
family,I,I
",",O,O
the,O,O
poliovirus,B,O
receptor,I,O
",",O,O
and,O,O
the,O,O
neural,B,O
cell,I,O
adhesion,I,O
molecule,I,O
.,O,O
Liquid,O,O
chromatography,O,O
with,O,O
amperometric,O,O
detection,O,O
(,O,O
LC,O,O
/,O,O
AD,O,O
),O,O
is,O,O
used,O,O
to,O,O
determine,O,O
fluazifop,O,B
acid,O,I
produced,O,O
from,O,O
the,O,O
metabolism,O,O
or,O,O
base,O,O
hydrolysis,O,O
of,O,O
fluazifop,O,B
-,O,I
butyl,O,I
in,O,O
soybeans,O,O
and,O,O
soybean,O,O
oil,O,O
.,O,O
Saccharomyces,O,B
cerevisiae,O,I
has,O,O
been,O,O
used,O,O
widely,O,O
both,O,O
as,O,O
a,O,O
model,O,O
system,O,O
for,O,O
unraveling,O,O
the,O,O
biochemical,O,O
",",O,O
genetic,O,O
",",O,O
and,O,O
molecular,O,O
details,O,O
of,O,O
gene,O,B
expression,O,O
and,O,O
the,O,O
secretion,O,O
process,O,O
",",O,O
and,O,O
as,O,O
a,O,O
host,O,O
for,O,O
the,O,O
production,O,O
of,O,O
heterologous,O,O
proteins,O,O
of,O,O
biotechnological,O,O
interest,O,O
.,O,O
Neural,O,O
blockade,O,O
in,O,O
chronic,O,O
and,O,O
cancer,O,O
pain,O,O
.,O,O
Differential,O,O
regulation,O,O
of,O,O
the,O,O
pre,B,O
-,I,O
C,I,O
and,O,O
pregenomic,O,O
promoters,O,O
of,O,O
human,O,B
hepatitis,O,I
B,O,I
virus,O,I
by,O,O
members,O,O
of,O,O
the,O,O
nuclear,B,O
receptor,I,O
superfamily,I,O
.,O,O
Mutational,O,O
analysis,O,O
of,O,O
essential,O,O
IncP,O,B
alpha,O,I
plasmid,O,I
transfer,O,I
genes,O,I
traF,B,B
and,O,O
traG,B,B
and,O,O
involvement,O,O
of,O,O
traF,B,B
in,O,O
phage,O,O
sensitivity,O,O
.,O,O
A,O,O
cis,O,O
-,O,O
acting,O,O
DNA,O,O
element,O,O
located,O,O
between,O,O
TATA,O,O
box,O,O
and,O,O
transcription,O,O
initiation,O,O
site,O,O
is,O,O
critical,O,O
in,O,O
response,O,O
to,O,O
regulatory,O,O
sequences,O,O
in,O,O
human,O,B
angiotensinogen,B,I
gene,I,O
.,O,O
This,O,O
study,O,O
was,O,O
designed,O,O
to,O,O
compare,O,O
the,O,O
efficacy,O,O
of,O,O
efegatran,O,O
plus,O,O
streptokinase,B,O
versus,O,O
heparin,O,O
plus,O,O
accelerated,O,O
tissue,B,O
plasminogen,I,O
activator,I,O
(,O,O
TPA,B,O
),O,O
in,O,O
coronary,O,O
reperfusion,O,O
in,O,O
acute,O,O
MI,O,O
.,O,O
We,O,O
used,O,O
expression,O,O
cloning,O,O
to,O,O
identify,O,O
interleukin,B,B
-,I,I
6,I,I
(,O,O
IL,B,B
-,I,I
6,I,I
),O,O
as,O,O
one,O,O
factor,O,O
that,O,O
suppressed,O,O
growth,O,O
of,O,O
a,O,O
pre,O,O
-,O,O
B,O,O
-,O,O
cell,O,O
variant,O,O
line,O,O
",",O,O
1A9,O,O
-,O,O
M,O,O
.,O,O
Control,O,O
Tmuscle,O,O
was,O,O
35,O,O
.,O,O
8,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
7,O,O
degrees,O,O
C,O,O
",",O,O
with,O,O
control,O,O
Wi,O,O
",",O,O
max,O,O
being,O,O
51,O,O
.,O,O
6,O,O
(,O,O
SD,O,O
8,O,O
.,O,O
7,O,O
),O,O
W,O,O
.,O,O
kg,O,O
-,O,O
1,O,O
.,O,O
The,O,O
results,O,O
suggest,O,O
that,O,O
the,O,O
role,O,O
of,O,O
S,O,O
.,O,O
argyrostoma,O,O
in,O,O
the,O,O
dissemination,O,O
of,O,O
Trichinella,O,O
larvae,O,O
in,O,O
nature,O,O
is,O,O
limited,O,O
in,O,O
comparison,O,O
to,O,O
the,O,O
role,O,O
played,O,O
by,O,O
mammals,O,O
with,O,O
scavenger,O,O
and,O,O
cannibalistic,O,O
behavior,O,O
.,O,O
Experimental,O,O
adhesion,O,O
prophylaxis,O,O
with,O,O
recombinant,B,O
tissue,I,B
plasminogen,I,I
activator,I,I
.,O,O
Atcys1,B,O
",",O,O
Athyp1,B,O
",",O,O
AKin10,B,O
and,O,O
the,O,O
ORF,O,O
are,O,O
very,O,O
close,O,O
to,O,O
each,O,O
other,O,O
and,O,O
organized,O,O
in,O,O
the,O,O
same,O,O
polarity,O,O
;,O,O
hence,O,O
",",O,O
the,O,O
intergenic,O,O
regions,O,O
probably,O,O
contain,O,O
",",O,O
within,O,O
less,O,O
than,O,O
0,O,O
.,O,O
5,O,O
kb,O,O
",",O,O
all,O,O
the,O,O
regulatory,O,O
elements,O,O
necessary,O,O
to,O,O
govern,O,O
initiation,O,O
and,O,O
termination,O,O
of,O,O
transcription,O,O
.,O,O
Paracrine,O,O
activation,O,O
of,O,O
the,O,O
HIV,B,B
-,I,I
1,I,I
LTR,I,I
promoter,I,O
by,O,O
the,O,O
viral,B,O
Tat,I,B
protein,I,O
is,O,O
mechanistically,O,O
similar,O,O
to,O,O
trans,O,O
-,O,O
activation,O,O
within,O,O
a,O,O
cell,O,O
.,O,O
The,O,O
primary,O,O
structure,O,O
and,O,O
cotranscription,O,O
of,O,O
the,O,O
petCA,B,B
genes,I,O
encoding,O,O
the,O,O
Rieske,B,B
-,I,I
FeS,I,I
(,O,O
nuclear,B,O
encoded,I,O
in,I,O
plants,I,O
),O,O
and,O,O
apocytochrome,B,B
f,I,I
proteins,I,O
has,O,O
been,O,O
described,O,O
previously,O,O
(,O,O
Kallas,O,B
",",O,O
T,O,O
.,O,O
",",O,O
Spiller,O,O
",",O,O
S,O,B
.,O,O
",",O,O
and,O,O
Malkin,O,O
",",O,O
R,O,B
.,O,O
Southern,O,O
blot,O,O
analysis,O,O
of,O,O
endonuclease,O,O
-,O,O
digested,O,O
genomic,O,O
DNA,O,O
from,O,O
primary,O,O
chick,O,O
embryo,O,O
fibroblasts,O,O
(,O,O
CEF,O,O
),O,O
suggested,O,O
that,O,O
MEK2,B,B
is,O,O
a,O,O
single,O,O
-,O,O
copy,O,O
gene,O,O
in,O,O
this,O,O
vertebrate,O,O
species,O,O
.,O,O
One,O,O
complex,O,O
most,O,O
likely,O,O
contained,O,O
Sp1,B,B
",",O,O
and,O,O
another,O,O
complex,O,O
showed,O,O
S,O,B
-,O,I
phase,O,I
-,O,I
specific,O,I
binding,O,O
",",O,O
suggesting,O,O
a,O,O
direct,O,O
role,O,O
in,O,O
the,O,O
cell,O,O
-,O,O
cycle,O,O
-,O,O
dependent,O,O
R1,B,B
gene,I,I
expression,O,O
.,O,O
Induction,O,O
of,O,O
anaesthesia,O,O
was,O,O
standardised,O,O
:,O,O
fentanyl,O,B
(,O,O
3,O,O
micrograms,O,O
/,O,O
kg,O,O
),O,O
",",O,O
thiopentone,O,B
(,O,O
5,O,O
mg,O,O
/,O,O
kg,O,O
),O,O
",",O,O
atracurium,O,B
(,O,O
0,O,O
.,O,O
4,O,O
mg,O,O
/,O,O
kg,O,O
),O,O
.,O,O
Vasoactive,B,O
intestinal,I,O
peptide,I,O
and,O,O
pituitary,B,O
adenylate,I,O
cyclase,I,O
-,I,O
activating,I,O
polypeptide,I,O
inhibit,O,O
nuclear,B,O
factor,I,O
-,I,O
kappa,I,O
B,I,B
-,I,I
dependent,I,I
gene,I,I
activation,O,O
at,O,O
multiple,O,O
levels,O,O
in,O,O
the,O,O
human,O,B
monocytic,O,I
cell,O,I
line,O,I
THP,O,B
-,O,I
1,O,I
.,O,O
Iodine,O,O
-,O,O
123,O,O
was,O,O
satisfactorily,O,O
imaged,O,O
only,O,O
with,O,O
the,O,O
MEC,O,B
and,O,O
pinhole,O,O
collimators,O,O
",",O,O
which,O,O
in,O,O
turn,O,O
yielded,O,O
MTF,O,O
values,O,O
comparable,O,O
to,O,O
those,O,O
measured,O,O
for,O,O
99mTc,O,O
.,O,O
Taken,O,O
together,O,O
",",O,O
these,O,O
observations,O,O
indicate,O,O
that,O,O
the,O,O
C,O,O
-,O,O
terminal,O,O
24,O,O
amino,O,O
acids,O,O
are,O,O
sufficient,O,O
for,O,O
NodO,B,B
secretion,O,O
although,O,O
the,O,O
region,O,O
adjacent,O,O
to,O,O
this,O,O
domain,O,O
appears,O,O
to,O,O
affect,O,O
secretion,O,O
efficiency,O,O
.,O,O
We,O,O
found,O,O
that,O,O
120,O,O
bp,O,O
of,O,O
the,O,O
enhancer,O,O
',O,O
s,O,O
transcriptional,O,O
core,O,O
becomes,O,O
DNase,B,B
I,I,I
hypersensitive,O,I
early,O,O
in,O,O
B,O,O
-,O,O
cell,O,O
development,O,O
.,O,O
Pokeweed,B,B
antiviral,I,I
protein,I,I
(,O,O
PAP,B,B
),O,O
from,O,O
Phytolacca,O,B
americana,O,I
is,O,O
a,O,O
highly,O,O
specific,O,O
N,B,B
-,I,I
glycosidase,I,I
removing,O,O
adenine,O,O
residues,O,O
(,O,O
A4324,O,B
in,O,O
28S,B,B
rRNA,I,I
and,O,O
A2660,O,B
in,O,O
23S,B,B
rRNA,I,I
),O,O
from,O,O
intact,O,O
ribosomes,O,O
of,O,O
both,O,O
eukaryotes,O,O
and,O,O
prokaryotes,O,O
.,O,O
Conventionally,O,O
",",O,O
four,O,O
nominal,O,O
allotypic,O,O
variants,O,O
",",O,O
b4,O,B
",",O,O
b5,O,B
",",O,O
b6,O,B
and,O,O
b9,O,B
have,O,O
been,O,O
shown,O,O
to,O,O
be,O,O
co,O,O
-,O,O
dominantly,O,O
expressed,O,O
at,O,O
the,O,O
Ckappa1,B,B
gene,I,I
locus,I,I
.,O,O
Patients,O,O
with,O,O
an,O,O
enzymatic,O,O
activity,O,O
below,O,O
X,O,B
-,O,I
-,O,I
1,O,I
manifested,O,O
a,O,O
decrease,O,O
of,O,O
the,O,O
content,O,O
of,O,O
IgA,B,B
",",O,O
IgG,B,B
",",O,O
IgM,B,B
",",O,O
T,O,B
and,O,O
B,O,B
lymphocytes,O,I
",",O,O
and,O,O
of,O,O
phagocytic,O,O
activity,O,O
of,O,O
neutrophils,O,O
as,O,O
compared,O,O
to,O,O
patients,O,O
exhibiting,O,O
a,O,O
high,O,O
enzymatic,O,O
activity,O,O
.,O,O
Eight,O,O
patients,O,O
received,O,O
1,O,O
.,O,O
5,O,O
mg,O,O
of,O,O
adefovir,O,B
dipivoxil,O,I
per,O,O
kg,O,O
of,O,O
body,O,O
weight,O,O
",",O,O
and,O,O
six,O,O
patients,O,O
received,O,O
3,O,O
.,O,O
0,O,O
mg,O,O
of,O,O
adefovir,O,B
dipivoxil,O,I
per,O,O
kg,O,O
.,O,O
Pseudosubstrate,O,O
(,O,O
19,O,O
-,O,O
36,O,O
),O,O
",",O,O
derived,O,O
from,O,O
the,O,O
C,O,O
-,O,O
terminus,O,O
of,O,O
Ca,B,B
-,I,I
dependent,I,I
PKC,I,I
isotypes,I,I
",",O,O
inhibited,O,O
beta,B,B
-,I,I
PKC,I,I
but,O,O
not,O,O
nPKC,B,B
activity,O,O
using,O,O
either,O,O
Histone,B,O
IIIS,I,O
or,O,O
peptide,O,O
(,O,O
19,O,O
-,O,O
31,O,O
),O,O
as,O,O
substrate,O,O
.,O,O
The,O,O
alpha,O,B
-,O,I
subunit,O,I
by,O,O
itself,O,O
binds,O,O
to,O,O
telomeric,O,O
DNA,O,O
.,O,O
Thirty,O,O
-,O,O
one,O,O
age,O,O
-,O,O
matched,O,O
",",O,O
conscious,O,O
",",O,O
virgin,O,O
",",O,O
male,O,O
Sprague,O,O
-,O,O
Dawley,O,O
rats,O,O
and,O,O
spontaneously,O,O
hypertensive,O,O
rats,O,O
(,O,O
SHRs,O,O
),O,O
were,O,O
individually,O,O
injected,O,O
with,O,O
a,O,O
single,O,O
subcutaneous,O,O
dose,O,O
of,O,O
85,O,O
mg,O,O
/,O,O
kg,O,O
dl,O,O
-,O,O
isoproterenol,O,O
to,O,O
determine,O,O
the,O,O
degree,O,O
and,O,O
time,O,O
course,O,O
of,O,O
drug,O,O
-,O,O
induced,O,O
cardiac,O,O
failure,O,O
and,O,O
functional,O,O
recovery,O,O
.,O,O
From,O,O
all,O,O
clinically,O,O
important,O,O
yeasts,O,O
species,O,O
",",O,O
a,O,O
total,O,O
of,O,O
96,O,O
%,O,O
were,O,O
identified,O,O
by,O,O
ATB,O,O
method,O,O
according,O,O
to,O,O
conventional,O,O
methods,O,O
.,O,O
The,O,O
authors,O,O
report,O,O
the,O,O
clinicopathologic,O,O
findings,O,O
in,O,O
four,O,O
cases,O,O
of,O,O
adult,O,O
women,O,O
with,O,O
rhabdomyosarcomas,O,O
that,O,O
originated,O,O
in,O,O
the,O,O
endometrium,O,O
or,O,O
cervix,O,O
",",O,O
or,O,O
both,O,O
.,O,O
By,O,O
deletion,O,O
analysis,O,O
of,O,O
the,O,O
MLS1,B,O
control,O,O
region,O,O
",",O,O
we,O,O
identified,O,O
two,O,O
sites,O,O
",",O,O
UAS1,O,O
and,O,O
UAS2,O,O
",",O,O
as,O,O
important,O,O
for,O,O
efficient,O,O
derepression,O,O
of,O,O
the,O,O
gene,O,B
.,O,O
Improved,O,O
cosmesis,O,O
",",O,O
extension,O,O
of,O,O
the,O,O
scope,O,O
of,O,O
the,O,O
problems,O,O
that,O,O
can,O,O
be,O,O
addressed,O,O
with,O,O
this,O,O
repair,O,O
(,O,O
including,O,O
treatment,O,O
of,O,O
a,O,O
distal,O,O
urethrocutaneous,O,O
fistula,O,O
),O,O
and,O,O
the,O,O
ease,O,O
with,O,O
which,O,O
the,O,O
Arap,O,B
procedure,O,O
can,O,O
be,O,O
performed,O,O
are,O,O
the,O,O
advantages,O,O
that,O,O
this,O,O
operation,O,O
has,O,O
over,O,O
other,O,O
1,O,O
-,O,O
stage,O,O
distal,O,O
hypospadias,O,O
repairs,O,O
.,O,O
Occupational,O,O
exposure,O,O
to,O,O
hepatitis,O,B
B,O,I
virus,O,I
and,O,O
human,O,B
immunodeficiency,O,I
virus,O,I
:,O,O
a,O,O
comparative,O,O
risk,O,O
analysis,O,O
.,O,O
Dd,B,O
PK1,I,B
RNA,I,I
decreases,O,O
after,O,O
6,O,O
h,O,O
of,O,O
starvation,O,O
to,O,O
re,O,O
-,O,O
accumulate,O,O
once,O,O
the,O,O
cells,O,O
have,O,O
aggregated,O,O
.,O,O
Both,O,O
carbachol,O,O
(,O,O
100,O,O
microM,O,O
),O,O
and,O,O
EGF,B,B
(,O,O
10,O,O
nM,O,O
),O,O
induced,O,O
Ras,B,B
activation,O,O
.,O,O
Sural,O,O
nerve,O,O
biopsy,O,O
showed,O,O
mild,O,O
thickening,O,O
of,O,O
the,O,O
perineurium,O,O
",",O,O
vascular,O,O
alterations,O,O
with,O,O
inflammatory,O,O
cell,O,O
infiltration,O,O
in,O,O
the,O,O
perineurium,O,O
",",O,O
and,O,O
remarkable,O,O
loss,O,O
of,O,O
large,O,O
and,O,O
small,O,O
myelinated,O,O
fibers,O,O
.,O,O
Five,O,O
-,O,O
year,O,O
survivals,O,O
amounted,O,O
to,O,O
100,O,O
%,O,O
",",O,O
86,O,O
.,O,O
2,O,O
%,O,O
",",O,O
59,O,O
.,O,O
4,O,O
%,O,O
",",O,O
29,O,O
.,O,O
8,O,O
%,O,O
",",O,O
and,O,O
20,O,O
%,O,O
for,O,O
stages,O,O
I,O,O
",",O,O
II,O,O
",",O,O
III,O,O
",",O,O
IVA,O,O
and,O,O
IVB,O,O
respectively,O,O
.,O,O
Once,O,O
more,O,O
Hong,O,O
Kong,O,O
influenza,O,O
in,O,O
the,O,O
Netherlands,O,O
Conversely,O,O
",",O,O
when,O,O
VDR,B,O
is,O,O
overexpressed,O,O
",",O,O
vitamin,O,O
D3,O,O
attenuates,O,O
9,O,O
-,O,O
cis,O,O
RA,O,O
induction,O,O
from,O,O
an,O,O
RXR,B,O
-,O,O
responsive,O,O
element,O,O
.,O,O
HeLa,O,O
and,O,O
Jurkat,O,B
cell,O,I
lines,O,O
carrying,O,O
the,O,O
nef,B,B
gene,I,O
linked,O,O
to,O,O
the,O,O
CMV,O,B
promoter,O,O
or,O,O
the,O,O
HIV,B,B
-,I,I
1,I,I
LTR,I,I
were,O,O
isolated,O,O
by,O,O
coselection,O,O
for,O,O
neomycin,O,O
resistance,O,O
.,O,O
In,O,O
canrenoate,O,O
-,O,O
treated,O,O
rats,O,O
",",O,O
ANP,B,O
infusion,O,O
caused,O,O
greater,O,O
increases,O,O
in,O,O
sodium,O,O
excretion,O,O
(,O,O
FENA,O,O
from,O,O
3,O,O
.,O,O
05,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
71,O,O
to,O,O
7,O,O
.,O,O
21,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
45,O,O
%,O,O
;,O,O
P,O,O
<,O,O
0,O,O
.,O,O
05,O,O
;,O,O
n,O,O
=,O,O
8,O,O
),O,O
than,O,O
saline,O,O
infusion,O,O
(,O,O
FENA,O,O
from,O,O
4,O,O
.,O,O
16,O,O
+,O,O
/,O,O
-,O,O
1,O,O
5,O,O
.,O,O
47,O,O
+,O,O
/,O,O
-,O,O
0,O,O
%,O,O
;,O,O
n,O,O
=,O,O
6,O,O
),O,O
the,O,O
hypocapnia,O,O
.,O,O
Furthermore,O,O
",",O,O
we,O,O
have,O,O
identified,O,O
a,O,O
soluble,O,O
form,O,O
of,O,O
ERp57,B,B
/,O,I
GRP58,B,I
by,O,O
Western,O,O
blotting,O,O
and,O,O
biosynthetic,O,O
labeling,O,O
.,O,O
Our,O,O
results,O,O
suggest,O,O
that,O,O
proteasome,O,O
inhibition,O,O
leads,O,O
to,O,O
upregulation,O,O
of,O,O
specific,O,O
members,O,O
of,O,O
transcription,O,O
factor,O,O
families,O,O
controlling,O,O
cellular,O,O
stress,O,O
response,O,O
and,O,O
proliferation,O,O
.,O,O
Thus,O,O
",",O,O
prostacyclin,O,O
enhanced,O,O
the,O,O
autoregulative,O,O
property,O,O
of,O,O
the,O,O
inner,O,O
ear,O,O
vessels,O,O
.,O,O
Serotonin,B,B
receptors,I,O
in,O,O
suicide,O,O
victims,O,O
with,O,O
major,O,O
depression,O,O
.,O,O
Effects,O,O
of,O,O
methiothepin,O,O
and,O,O
lysergic,O,O
acid,O,O
diethylamide,O,O
on,O,O
serotonin,O,B
release,O,O
in,O,O
vitro,O,O
and,O,O
serotonin,O,B
synthesis,O,O
in,O,O
vivo,O,O
:,O,O
possible,O,O
relation,O,O
to,O,O
serotonin,B,B
autoreceptor,I,O
function,O,O
.,O,O
Nucleotide,O,O
sequences,O,O
between,O,O
the,O,O
env,B,B
gene,I,I
and,O,O
the,O,O
LTR,B,B
of,I,O
SFV,I,B
-,I,I
1,I,I
were,O,O
determined,O,O
.,O,O
Two,O,O
separate,O,O
NF1,B,B
-,I,I
binding,I,I
loci,I,I
were,O,O
also,O,O
found,O,O
in,O,O
the,O,O
equivalent,O,O
IE68,B,B
gene,I,I
of,O,O
HCMV,O,B
(,O,O
Towne,O,O
),O,O
DNA,O,O
",",O,O
but,O,O
in,O,O
this,O,O
case,O,O
the,O,O
DNA,O,O
sequence,O,O
and,O,O
competition,O,O
filter,O,O
binding,O,O
experiments,O,O
indicated,O,O
a,O,O
maximum,O,O
of,O,O
only,O,O
four,O,O
to,O,O
five,O,O
consensus,O,O
binding,O,O
sites,O,O
encompassing,O,O
the,O,O
promoter,O,O
-,O,O
enhancer,O,O
region,O,O
.,O,O
Area,O,O
under,O,O
the,O,O
drug,O,O
concentration,O,O
-,O,O
time,O,O
curves,O,O
(,O,O
AUC0,O,O
-,O,O
24,O,O
hr,O,O
),O,O
for,O,O
MTX,O,B
were,O,O
2379,O,O
and,O,O
3534,O,O
ng,O,O
*,O,O
hr,O,O
/,O,O
ml,O,O
from,O,O
PG,O,O
-,O,O
2,O,O
.,O,O
%,O,O
Azone,O,O
and,O,O
PG,O,O
-,O,O
7,O,O
.,O,O
%,O,O
Azone,O,O
systems,O,O
respectively,O,O
.,O,O
Expression,O,O
in,O,O
early,O,O
postnatal,O,O
pituitary,O,O
and,O,O
in,O,O
pre,O,O
-,O,O
somatotrophic,O,O
cells,O,O
suggests,O,O
that,O,O
Zn,B,O
-,I,O
16,I,O
could,O,O
play,O,O
a,O,O
role,O,O
in,O,O
pituitary,O,O
development,O,O
prior,O,O
to,O,O
somatotroph,O,O
differentiation,O,O
.,O,O
The,O,O
novel,O,O
hematopoietic,B,O
growth,I,O
factor,I,O
FLT3,I,B
ligand,I,O
(,O,O
FL,B,B
),O,O
is,O,O
the,O,O
cognate,O,O
ligand,O,O
for,O,O
the,O,O
FLT3,B,B
",",O,O
tyrosine,B,O
kinase,I,O
receptor,I,O
(,O,O
R,B,B
),O,O
",",O,O
also,O,O
referred,O,O
to,O,O
as,O,O
FLK,B,O
-,I,O
2,I,O
and,O,O
STK,B,O
-,I,O
1,I,O
.,O,O
Significant,O,O
clinical,O,O
differences,O,O
between,O,O
the,O,O
patients,O,O
treated,O,O
with,O,O
and,O,O
without,O,O
AMB,O,O
were,O,O
longer,O,O
survival,O,O
time,O,O
following,O,O
diagnosis,O,O
of,O,O
illness,O,O
(,O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
05,O,O
),O,O
and,O,O
more,O,O
frequent,O,O
cranial,O,O
nerve,O,O
signs,O,O
in,O,O
the,O,O
treated,O,O
patients,O,O
(,O,O
P,O,O
=,O,O
0,O,O
.,O,O
089,O,O
),O,O
.,O,O
RT,O,O
-,O,O
PCR,O,O
indicated,O,O
that,O,O
p21,B,B
mRNA,I,O
was,O,O
induced,O,O
1,O,O
.,O,O
4,O,O
-,O,O
",",O,O
2,O,O
.,O,O
0,O,O
-,O,O
",",O,O
and,O,O
3,O,O
.,O,O
1,O,O
-,O,O
in,O,O
the,O,O
2,O,O
-,O,O
day,O,O
neonatal,O,O
",",O,O
7,O,O
-,O,O
day,O,O
neonatal,O,O
",",O,O
and,O,O
adult,O,O
stages,O,O
",",O,O
respectively,O,O
",",O,O
compared,O,O
to,O,O
the,O,O
17,O,O
-,O,O
day,O,O
fetal,O,O
stage,O,O
.,O,O
This,O,O
report,O,O
describes,O,O
a,O,O
patient,O,O
with,O,O
a,O,O
previous,O,O
inferior,O,O
acute,O,O
myocardial,O,O
infarction,O,O
who,O,O
developed,O,O
right,O,O
ventricular,O,O
infarction,O,O
with,O,O
significant,O,O
anterior,O,O
lead,O,O
ST,O,O
segment,O,O
elevation,O,O
(,O,O
V1,O,O
-,O,O
V4,O,O
),O,O
caused,O,O
by,O,O
the,O,O
loss,O,O
of,O,O
two,O,O
large,O,O
right,O,O
ventricular,O,O
branches,O,O
during,O,O
a,O,O
coronary,O,O
angioplasty,O,O
of,O,O
the,O,O
right,O,O
coronary,O,O
artery,O,O
.,O,O
It,O,O
also,O,O
suggests,O,O
that,O,O
there,O,O
is,O,O
another,O,O
pathway,O,O
which,O,O
can,O,O
activate,O,O
SWI4,B,B
transcription,O,O
in,O,O
the,O,O
absence,O,O
of,O,O
SWI6,B,B
.,O,O
Some,O,O
reflexions,O,O
apropos,O,O
of,O,O
a,O,O
personal,O,O
statistical,O,O
study,O,O
of,O,O
513,O,O
arterial,O,O
embolisms,O,O
Energy,O,O
expenditure,O,O
was,O,O
obtained,O,O
using,O,O
a,O,O
primed,O,O
",",O,O
3,O,O
-,O,O
hour,O,O
infusion,O,O
of,O,O
NaH,O,B
(,O,O
13,O,O
),O,O
CO,O,B
(,O,O
3,O,O
',O,O
),O,O
",",O,O
breath,O,O
(,O,O
13,O,O
),O,O
CO,O,B
(,O,O
2,O,O
),O,O
enrichment,O,O
determination,O,O
by,O,O
isotope,O,O
ratio,O,O
mass,O,O
spectroscopy,O,O
",",O,O
and,O,O
the,O,O
application,O,O
of,O,O
a,O,O
standard,O,O
regression,O,O
equation,O,O
.,O,O
Oncogenic,O,O
activation,O,O
of,O,O
the,O,O
tyrosine,B,B
kinase,I,I
domain,I,I
of,O,I
the,O,I
human,B,B
trk,I,I
proto,I,I
-,I,I
oncogene,I,I
by,O,O
fusion,O,O
to,O,O
a,O,O
cell,O,O
adhesion,O,O
molecule,O,O
.,O,O
The,O,O
absolute,O,O
concentrations,O,O
of,O,O
alpha,B,B
2,I,I
-,I,I
plasmin,I,I
inhibitor,O,I
",",O,O
alpha,B,B
2,I,I
-,I,I
macroglobulin,I,I
",",O,O
and,O,O
antithrombin,B,B
III,I,I
increased,O,O
with,O,O
exercise,O,O
(,O,O
all,O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
005,O,O
),O,O
",",O,O
but,O,O
when,O,O
concentrations,O,O
were,O,O
corrected,O,O
for,O,O
acute,O,O
shifts,O,O
of,O,O
plasma,O,O
water,O,O
during,O,O
exercise,O,O
",",O,O
the,O,O
quantity,O,O
of,O,O
these,O,O
inhibitors,O,O
actually,O,O
decreased,O,O
(,O,O
all,O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
005,O,O
),O,O
.,O,O
Each,O,O
of,O,O
these,O,O
genes,O,B
contains,O,O
a,O,O
putative,O,O
upstream,O,O
ORF,O,O
",",O,O
while,O,O
STA2,B,B
has,O,O
two,O,O
additional,O,O
in,O,O
-,O,O
frame,O,O
AUG,O,O
codons,O,O
5,O,O
',O,O
to,O,O
the,O,O
major,O,O
cistron,O,O
.,O,O
Members,O,O
of,O,O
the,O,O
Ras,B,B
subfamily,I,O
of,O,O
small,B,O
GTP,I,O
-,I,O
binding,I,O
proteins,I,O
have,O,O
been,O,O
shown,O,O
to,O,O
be,O,O
promiscuous,O,O
towards,O,O
a,O,O
variety,O,O
of,O,O
putative,O,O
effector,O,O
molecules,O,O
such,O,O
as,O,O
the,O,O
protein,B,O
kinase,I,O
c,I,O
-,I,O
Raf,I,O
and,O,O
the,O,O
Ral,B,B
-,I,I
specific,I,I
guanine,I,I
nucleotide,I,I
exchange,I,I
factor,I,I
(,O,O
Ral,B,B
-,I,I
GEF,I,I
),O,O
.,O,O
Almost,O,O
complete,O,O
sequence,O,O
identity,O,O
was,O,O
found,O,O
between,O,O
the,O,O
3,O,O
',O,O
end,O,O
of,O,O
the,O,O
DXS6673E,B,B
gene,I,O
and,O,O
two,O,O
expressed,O,O
sequence,O,O
tags,O,O
(,O,O
ESTs,O,O
),O,O
and,O,O
between,O,O
the,O,O
5,O,O
',O,O
end,O,O
of,O,O
the,O,O
DXS6673E,B,B
gene,I,O
and,O,O
a,O,O
third,O,O
EST,O,O
.,O,O
Leukocyte,O,O
cultures,O,O
",",O,O
prepared,O,O
from,O,O
blood,O,O
drawn,O,O
from,O,O
these,O,O
18,O,O
children,O,O
at,O,O
6,O,O
months,O,O
of,O,O
age,O,O
",",O,O
produced,O,O
lower,O,O
yields,O,O
of,O,O
IFN,B,B
than,O,O
those,O,O
of,O,O
the,O,O
remaining,O,O
53,O,O
children,O,O
",",O,O
when,O,O
stimulated,O,O
with,O,O
adenovirus,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
",",O,O
coronavirus,O,B
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
or,O,O
rhinovirus,O,B
(,O,O
P,O,O
=,O,O
0,O,O
.,O,O
002,O,O
),O,O
.,O,O
Morphine,O,O
produced,O,O
a,O,O
dose,O,O
-,O,O
dependent,O,O
bradycardia,O,O
followed,O,O
by,O,O
tachycardia,O,O
.,O,O
To,O,O
identify,O,O
these,O,O
sites,O,O
",",O,O
the,O,O
deduced,O,O
amino,O,O
acid,O,O
sequence,O,O
of,O,O
the,O,O
3T3,O,O
-,O,O
L1,O,O
adipocyte,B,O
insulin,I,O
receptor,I,O
of,O,O
the,O,O
mouse,O,O
was,O,O
determined,O,O
.,O,O
We,O,O
present,O,O
a,O,O
case,O,O
of,O,O
carcinoma,O,O
of,O,O
the,O,O
breast,O,O
presenting,O,O
concurrently,O,O
with,O,O
SSc,O,O
that,O,O
subsequently,O,O
progressed,O,O
to,O,O
dialysis,O,O
-,O,O
dependent,O,O
renal,O,O
failure,O,O
in,O,O
just,O,O
1,O,O
month,O,O
.,O,O
For,O,O
example,O,O
",",O,O
introduction,O,O
of,O,O
immunogenic,O,O
and,O,O
purification,O,O
tag,O,O
sequences,O,O
into,O,O
the,O,O
C,O,O
-,O,O
terminal,O,O
coding,O,O
region,O,O
significantly,O,O
decreased,O,O
bop,B,B
gene,I,I
mRNA,I,I
and,O,O
protein,O,O
accumulation,O,O
.,O,O
The,O,O
uncomplicated,O,O
cases,O,O
of,O,O
typhoid,O,O
fever,O,O
were,O,O
found,O,O
to,O,O
have,O,O
an,O,O
intact,O,O
CMIR,O,B
as,O,O
compared,O,O
to,O,O
the,O,O
complicated,O,O
cases,O,O
.,O,O
Organ,O,O
transplantation,O,O
in,O,O
Denmark,O,O
.,O,O
327,O,O
and,O,O
736,O,O
protocols,O,O
of,O,O
postmortem,O,O
examinations,O,O
from,O,O
Moscow,O,O
hospitals,O,O
N,O,O
31,O,O
and,O,O
57,O,O
",",O,O
respectively,O,O
",",O,O
were,O,O
evaluated,O,O
statistically,O,O
.,O,O
Fibromuscular,O,O
intimal,O,O
thickening,O,O
was,O,O
seen,O,O
in,O,O
the,O,O
ascending,O,O
and,O,O
thoracic,O,O
aorta,O,O
of,O,O
the,O,O
swine,O,O
fed,O,O
62,O,O
",",O,O
500,O,O
IU,O,O
of,O,O
vitamin,O,O
D3,O,O
/,O,O
kg,O,O
of,O,O
diet,O,O
for,O,O
three,O,O
months,O,O
duration,O,O
;,O,O
and,O,O
after,O,O
3,O,O
months,O,O
of,O,O
vitamin,O,O
D3,O,O
withdrawal,O,O
",",O,O
atherosclerotic,O,O
lesions,O,O
were,O,O
found,O,O
.,O,O
Is,O,O
leishmaniasis,O,B
endemic,O,O
on,O,O
the,O,O
island,O,O
of,O,O
Minorca,O,O
(,O,O
Spain,O,O
),O,O
?,O,O
A,O,O
human,O,B
visceral,O,O
case,O,O
after,O,O
living,O,O
13,O,O
years,O,O
in,O,O
Minorca,O,O
.,O,O
The,O,O
susceptibility,O,O
of,O,O
the,O,O
PPNG,O,B
strains,O,O
to,O,O
clinically,O,O
relevant,O,O
antibiotics,O,O
varied,O,O
with,O,O
the,O,O
plasmid,O,O
pattern,O,O
;,O,O
this,O,O
stresses,O,O
the,O,O
necessity,O,O
of,O,O
permanent,O,O
surveillance,O,O
of,O,O
gonococcal,O,B
infections,O,O
and,O,O
of,O,O
regular,O,O
evaluation,O,O
of,O,O
the,O,O
recommendations,O,O
for,O,O
antimicrobial,O,O
treatment,O,O
.,O,O
Of,O,O
these,O,O
carriers,O,O
149,O,O
were,O,O
diagnosed,O,O
to,O,O
be,O,O
asymptomatic,O,O
clinically,O,O
",",O,O
biochemically,O,O
and,O,O
echographically,O,O
.,O,O
In,O,O
the,O,O
absence,O,O
of,O,O
E1A243,B,B
",",O,O
YY1,B,B
represses,O,O
CRE,O,O
-,O,O
dependent,O,O
transcription,O,O
of,O,O
c,B,O
-,I,O
fos,I,O
by,O,O
physically,O,O
interacting,O,O
with,O,O
ATF,B,B
/,O,O
CREB,B,B
proteins,O,O
bound,O,O
to,O,O
the,O,O
-,O,O
67,O,O
CRE,O,O
.,O,O
The,O,O
gene,O,O
sequence,O,O
also,O,O
identified,O,O
a,O,O
340,O,O
-,O,O
nucleotide,O,O
RNA,O,O
in,O,O
total,O,O
yeast,O,O
RNA,O,O
and,O,O
in,O,O
purified,O,O
RNase,B,B
MRP,I,I
enzyme,I,I
preparations,O,O
.,O,O
Mechanisms,O,O
of,O,O
tachyphylaxis,O,O
in,O,O
regional,O,O
anesthesia,O,O
of,O,O
long,O,O
duration,O,O
Transcriptional,O,O
regulation,O,O
of,O,O
the,O,O
GluR2,B,B
gene,I,O
:,O,O
neural,O,O
-,O,O
specific,O,O
expression,O,O
",",O,O
multiple,O,O
promoters,O,O
",",O,O
and,O,O
regulatory,O,O
elements,O,O
.,O,O
The,O,O
bactericidal,O,O
activity,O,O
of,O,O
six,O,O
new,O,O
rifamycin,O,B
derivatives,O,O
-,O,O
-,O,O
rifabutin,O,B
(,O,O
RBU,O,B
),O,O
",",O,O
FCE,O,B
22250,O,I
(,O,O
F22,O,B
),O,O
",",O,O
rifapentine,O,B
(,O,O
RPE,O,B
),O,O
",",O,O
CGP,O,B
29861,O,I
(,O,O
C29,O,B
),O,O
",",O,O
CGP,O,B
7040,O,I
(,O,O
C70,O,B
),O,O
and,O,O
CGP,O,B
27557,O,I
(,O,O
C27,O,B
),O,O
and,O,O
rifampicin,O,B
(,O,O
RMP,O,B
),O,O
-,O,O
-,O,O
have,O,O
been,O,O
measured,O,O
against,O,O
log,O,O
phase,O,O
and,O,O
",",O,O
as,O,O
a,O,O
better,O,O
test,O,O
of,O,O
sterilising,O,O
activity,O,O
",",O,O
against,O,O
stationary,O,O
phase,O,O
cultures,O,O
of,O,O
Mycobacterium,O,B
tuberculosis,O,I
",",O,O
H37Rv,O,B
.,O,O
This,O,O
establishes,O,O
Rad3,B,B
/,O,O
Mec1,B,B
as,O,O
the,O,O
only,O,O
conserved,O,O
protein,O,O
which,O,O
is,O,O
required,O,O
for,O,O
all,O,O
the,O,O
DNA,O,O
structure,O,O
checkpoints,O,O
in,O,O
both,O,O
yeast,O,O
model,O,O
systems,O,O
.,O,O
A,O,O
36,O,O
year,O,O
-,O,O
old,O,O
woman,O,O
was,O,O
given,O,O
Ergotamine,O,B
Tartrate,O,I
4,O,I
.,O,O
5,O,O
mg,O,O
p,O,O
.,O,O
d,O,O
.,O,O
during,O,O
seven,O,O
days,O,O
",",O,O
after,O,O
an,O,O
abortion,O,O
(,O,O
a,O,O
still,O,O
birth,O,O
),O,O
.,O,O
The,O,O
effects,O,O
of,O,O
these,O,O
mutations,O,O
on,O,O
protein,O,O
function,O,O
require,O,O
further,O,O
examination,O,O
.,O,O
Hailey,O,B
-,O,I
Hailey,O,I
disease,O,O
is,O,O
caused,O,O
by,O,O
mutations,O,O
in,O,O
ATP2C1,B,B
encoding,O,O
a,O,O
novel,O,O
Ca,O,B
(,O,O
2,O,I
+,O,I
),O,O
pump,O,O
.,O,O
Moreover,O,O
",",O,O
the,O,O
same,O,O
mutations,O,O
alter,O,O
the,O,O
structure,O,O
of,O,O
junB,B,B
5,O,I
',O,I
flanking,O,I
DNA,O,I
within,O,O
chromatin,O,O
.,O,O
Serum,B,O
TNF,I,B
concentrations,O,O
were,O,O
elevated,O,O
at,O,O
diagnosis,O,O
and,O,O
gradually,O,O
decreased,O,O
toward,O,O
the,O,O
reference,O,O
limits,O,O
by,O,O
week,O,O
16,O,O
.,O,O
A,O,O
0,O,O
.,O,O
5,O,O
rating,O,O
was,O,O
intended,O,O
to,O,O
characterize,O,O
subjects,O,O
in,O,O
whom,O,O
mild,O,O
cognitive,O,O
impairment,O,O
due,O,O
to,O,O
senile,O,O
dementia,O,O
of,O,O
the,O,O
Alzheimer,O,B
type,O,I
was,O,O
suspected,O,O
but,O,O
was,O,O
insufficient,O,O
in,O,O
degree,O,O
to,O,O
warrant,O,O
a,O,O
diagnosis,O,O
of,O,O
definite,O,O
dementia,O,O
.,O,O
Thromboelastography,O,O
is,O,O
a,O,O
test,O,O
that,O,O
could,O,O
potentially,O,O
correlate,O,O
with,O,O
the,O,O
degree,O,O
of,O,O
anticoagulation,O,O
produced,O,O
by,O,O
low,O,O
molecular,O,O
weight,O,O
heparin,O,O
.,O,O
Calcification,O,O
of,O,O
a,O,O
cariogenic,O,O
Streptococcus,O,B
and,O,O
of,O,O
Corynebacterium,O,B
(,O,O
Bacterionema,O,B
),O,O
matruchotii,O,O
.,O,O
Sequence,O,O
divergence,O,O
is,O,O
observed,O,O
in,O,O
untranslated,O,O
regions,O,O
which,O,O
allows,O,O
the,O,O
definition,O,O
of,O,O
gene,O,B
-,O,I
specific,O,I
probes,O,O
.,O,O
Appropriate,O,O
restriction,O,O
sites,O,O
allow,O,O
one,O,O
to,O,O
insert,O,O
virtually,O,O
any,O,O
desired,O,O
cDNA,O,O
fragment,O,O
directly,O,O
behind,O,O
the,O,O
epitope,O,O
-,O,O
specific,O,O
sequence,O,O
and,O,O
before,O,O
a,O,O
long,O,O
poly,O,O
(,O,O
A,O,O
),O,O
tail,O,O
.,O,O
Serial,O,O
followup,O,O
strength,O,O
data,O,O
for,O,O
2,O,O
patients,O,O
were,O,O
compared,O,O
to,O,O
change,O,O
in,O,O
creatinine,B,O
kinase,I,O
(,O,O
CK,B,B
),O,O
levels,O,O
.,O,O
Recently,O,O
",",O,O
a,O,O
mutation,O,O
in,O,O
the,O,O
amino,O,O
-,O,O
terminus,O,O
of,O,O
IB1,B,B
was,O,O
associated,O,O
with,O,O
diabetes,O,O
.,O,O
Nevertheless,O,O
cryopreservation,O,O
of,O,O
spermatozoa,O,O
in,O,O
a,O,O
medium,O,O
containing,O,O
neither,O,O
SP,O,B
nor,O,O
biological,O,O
substances,O,O
could,O,O
offer,O,O
an,O,O
acceptable,O,O
cryoprotection,O,O
of,O,O
spermatozoa,O,O
to,O,O
be,O,O
used,O,O
in,O,O
assisted,O,O
fertilization,O,O
procedures,O,O
",",O,O
especially,O,O
for,O,O
intracytoplasmic,O,O
sperm,O,O
injection,O,O
.,O,O
Depending,O,O
on,O,O
the,O,O
location,O,O
and,O,O
size,O,O
of,O,O
the,O,O
mass,O,O
",",O,O
a,O,O
wide,O,O
range,O,O
of,O,O
clinical,O,O
presentations,O,O
is,O,O
associated,O,O
with,O,O
the,O,O
lesion,O,O
.,O,O
Histopathological,O,O
features,O,O
of,O,O
relapsed,O,O
leprosy,O,O
.,O,O
Differential,O,O
expression,O,O
was,O,O
confirmed,O,O
by,O,O
Northern,O,O
blot,O,O
analysis,O,O
employing,O,O
multiple,O,O
normal,O,O
and,O,O
tumor,O,O
cell,O,O
lines,O,O
.,O,O
Intra,O,O
-,O,O
operative,O,O
ultrasound,O,O
(,O,O
IOUS,O,O
),O,O
has,O,O
been,O,O
widely,O,O
used,O,O
in,O,O
an,O,O
attempt,O,O
to,O,O
overcome,O,O
these,O,O
difficulties,O,O
",",O,O
but,O,O
is,O,O
limited,O,O
by,O,O
its,O,O
two,O,O
-,O,O
dimensional,O,O
nature,O,O
",",O,O
inter,O,O
-,O,O
user,O,O
variability,O,O
",",O,O
and,O,O
image,O,O
obliteration,O,O
with,O,O
ablative,O,O
or,O,O
resectional,O,O
techniques,O,O
.,O,O
These,O,O
results,O,O
were,O,O
compared,O,O
with,O,O
those,O,O
obtained,O,O
in,O,O
-,O,O
D,O,O
mothers,O,O
and,O,O
pups,O,O
",",O,O
after,O,O
giving,O,O
the,O,O
mothers,O,O
an,O,O
oral,O,O
supplement,O,O
(,O,O
10,O,O
i,O,O
.,O,O
u,O,O
.,O,O
vitamin,O,B
D3,O,I
/,O,O
day,O,O
),O,O
during,O,O
the,O,O
period,O,O
of,O,O
lactation,O,O
(,O,O
20,O,O
days,O,O
),O,O
.,O,O
There,O,O
are,O,O
four,O,O
polyglutamine,O,O
motifs,O,O
interspersed,O,O
with,O,O
histidine,O,O
-,O,O
rich,O,O
regions,O,O
.,O,O
Basal,O,O
components,O,O
of,O,O
the,O,O
transcription,O,O
apparatus,O,O
(,O,O
RNA,B,B
polymerase,I,I
II,I,I
",",O,O
TATA,B,B
-,I,I
binding,I,I
protein,I,I
),O,O
contain,O,O
activation,O,O
domains,O,O
:,O,O
is,O,O
the,O,O
repetitive,O,O
C,O,B
-,O,I
terminal,O,I
domain,O,I
(,O,O
CTD,O,B
),O,O
of,O,O
RNA,B,B
polymerase,I,I
II,I,I
a,O,O
?,O,O
Regions,O,O
rich,O,O
in,O,O
serine,O,O
",",O,O
threonine,O,O
",",O,O
and,O,O
proline,O,O
residues,O,O
can,O,O
be,O,O
found,O,O
in,O,O
transcriptional,O,O
activation,O,O
domains,O,O
",",O,O
as,O,O
well,O,O
as,O,O
in,O,O
the,O,O
N,O,B
-,O,I
terminal,O,I
parts,O,O
of,O,O
mammalian,B,O
TATA,I,B
-,I,I
binding,I,I
proteins,I,I
",",O,O
where,O,O
they,O,O
are,O,O
interrupted,O,O
by,O,O
polyglutamine,O,O
stretches,O,O
.,O,O
The,O,O
contraceptive,O,O
pattern,O,O
of,O,O
157,O,O
women,O,O
was,O,O
analysed,O,O
and,O,O
13,O,O
.,O,O
8,O,O
percent,O,O
were,O,O
using,O,O
inefficient,O,O
methods,O,O
.,O,O
No,O,O
drop,O,O
in,O,O
oxygen,O,O
saturation,O,O
(,O,O
SaO2,O,O
),O,O
or,O,O
visual,O,O
evidence,O,O
of,O,O
transient,O,O
electroencephalographic,O,O
(,O,O
EEG,O,O
),O,O
arousals,O,O
can,O,O
be,O,O
found,O,O
at,O,O
repeat,O,O
polysomnography,O,O
.,O,O
To,O,O
determine,O,O
the,O,O
signal,B,O
recognition,I,O
particle,I,O
(,O,O
SRP,B,B
),O,O
-,O,O
SRP,B,B
receptor,I,O
(,O,O
Srb,B,B
),O,O
system,O,O
in,O,O
Bacillus,O,O
subtilis,O,O
(,O,O
Bs,O,O
),O,O
",",O,O
we,O,O
cloned,O,O
the,O,O
Bs,B,O
srb,I,B
gene,I,O
",",O,O
which,O,O
encodes,O,O
a,O,O
homologue,O,O
of,O,O
the,O,O
mammalian,B,O
SRP,I,B
receptor,I,O
alpha,I,O
-,I,O
subunit,I,O
[,O,O
Oguro,O,O
et,O,O
al,O,O
.,O,O
",",O,O
DNA,O,B
Res,O,O
.,O,O
Refugees,O,O
living,O,O
in,O,O
Lund,O,O
and,O,O
repatriated,O,O
to,O,O
Chile,O,O
considered,O,O
their,O,O
health,O,O
as,O,O
bad,O,O
in,O,O
a,O,O
higher,O,O
proportion,O,O
than,O,O
their,O,O
Swedish,O,O
counterparts,O,O
",",O,O
with,O,O
an,O,O
odds,O,O
ratio,O,O
of,O,O
3,O,O
.,O,O
48,O,O
(,O,O
2,O,O
.,O,O
03,O,O
-,O,O
5,O,O
.,O,O
66,O,O
),O,O
and,O,O
4,O,O
.,O,O
78,O,O
(,O,O
2,O,O
.,O,O
1,O,O
-,O,O
10,O,O
.,O,O
25,O,O
),O,O
respectively,O,O
.,O,O
The,O,O
results,O,O
indicate,O,O
that,O,O
increased,O,O
pulmonary,O,O
blood,O,O
flow,O,O
and,O,O
decreased,O,O
pulmonary,O,O
vascular,O,O
resistance,O,O
with,O,O
advancing,O,O
gestation,O,O
are,O,O
due,O,O
to,O,O
an,O,O
increase,O,O
in,O,O
the,O,O
total,O,O
number,O,O
of,O,O
vessels,O,O
and,O,O
increased,O,O
vasomotor,O,O
reactivity,O,O
is,O,O
related,O,O
to,O,O
an,O,O
increase,O,O
in,O,O
the,O,O
total,O,O
amount,O,O
of,O,O
smooth,O,O
muscle,O,O
while,O,O
the,O,O
thickness,O,O
of,O,O
muscle,O,O
in,O,O
individual,O,O
vessels,O,O
remains,O,O
constant,O,O
.,O,O
Its,O,O
hydropathy,O,O
profile,O,O
predicts,O,O
seven,O,O
transmembrane,O,O
spans,O,O
and,O,O
a,O,O
hydrophilic,O,O
amino,O,O
terminus,O,O
of,O,O
approximately,O,O
100,O,O
residues,O,O
",",O,O
and,O,O
it,O,O
suggests,O,O
the,O,O
presence,O,O
of,O,O
an,O,O
amphiphilic,O,O
alpha,O,O
-,O,O
helix,O,O
(,O,O
L,O,B
-,O,I
61,O,I
to,O,O
F,O,B
-,O,I
97,O,I
),O,O
in,O,O
close,O,O
proximity,O,O
to,O,O
the,O,O
first,O,O
strongly,O,O
hydrophobic,O,O
segment,O,O
of,O,O
ProW,B,B
.,O,O
Between,O,O
the,O,O
subgroups,O,O
of,O,O
dementia,O,O
disorders,O,O
there,O,O
were,O,O
no,O,O
significant,O,O
differences,O,O
in,O,O
basal,O,O
cortisol,O,O
levels,O,O
.,O,O
We,O,O
have,O,O
previously,O,O
demonstrated,O,O
that,O,O
expression,O,O
of,O,O
the,O,O
gene,O,B
for,O,O
the,O,O
reproductive,O,O
neuropeptide,O,O
",",O,O
GnRH,B,B
",",O,O
is,O,O
repressed,O,O
by,O,O
the,O,O
glutamate,O,O
/,O,O
NO,O,O
/,O,O
cyclic,O,O
GMP,O,O
(,O,O
cGMP,O,O
),O,O
signal,O,O
transduction,O,O
pathway,O,O
through,O,O
cGMP,B,O
-,I,O
dependent,I,O
protein,I,O
kinase,I,O
in,O,O
the,O,O
hypothalamic,O,O
GnRH,B,B
-,O,O
secreting,O,O
neuronal,O,O
cell,O,O
line,O,O
GT1,O,O
-,O,O
7,O,O
.,O,O
A,O,O
comparison,O,O
of,O,O
the,O,O
promoters,O,O
for,O,O
muMIP,B,B
-,I,I
1,I,I
beta,I,I
and,O,O
muMIP,B,B
-,I,I
1,I,I
alpha,I,I
reveals,O,O
a,O,O
conserved,O,O
CK,O,B
-,O,I
1,O,I
element,O,I
",",O,O
but,O,O
transient,O,O
expression,O,O
studies,O,O
in,O,O
RAW,O,O
264,O,O
.,O,O
7,O,O
macrophages,O,O
with,O,O
proximal,O,O
fragments,O,O
of,O,O
either,O,O
the,O,O
muMIP,B,B
-,I,I
1,I,I
beta,I,I
or,O,O
the,O,O
muMIP,B,B
-,I,I
1,I,I
alpha,I,I
5,I,I
',I,O
promoter,I,O
fused,O,O
to,O,O
a,O,O
human,B,B
growth,I,I
hormone,I,I
reporter,I,I
gene,I,I
link,O,O
LPS,O,O
-,O,O
inducibility,O,O
in,O,O
both,O,O
to,O,O
promoter,O,O
segments,O,O
near,O,O
to,O,O
",",O,O
but,O,O
not,O,O
identical,O,O
with,O,O
",",O,O
the,O,O
consensus,O,O
CK,O,B
-,O,I
1,O,I
sequence,O,I
.,O,O
This,O,O
may,O,O
explain,O,O
in,O,O
part,O,O
a,O,O
secular,O,O
trend,O,O
towards,O,O
reduced,O,O
birthweight,O,O
for,O,O
gestation,O,O
in,O,O
preterm,O,O
infants,O,O
.,O,O
Arterial,O,O
blood,O,O
gas,O,O
tensions,O,O
were,O,O
similar,O,O
across,O,O
all,O,O
ventilation,O,O
modes,O,O
.,O,O
Disability,O,O
insurance,O,O
under,O,O
social,O,O
security,O,O
.,O,O
It,O,O
contains,O,O
25,O,O
exons,O,O
coding,O,O
for,O,O
a,O,O
4,O,O
.,O,O
7kb,O,O
transcript,O,O
including,O,O
large,O,O
5,O,O
',O,O
-,O,O
and,O,O
3,O,O
',O,O
-,O,O
(,O,O
1218bp,O,O
and,O,O
701bp,O,O
",",O,O
respectively,O,O
),O,O
untranslated,O,O
regions,O,O
(,O,O
UTRs,O,O
.,O,O
The,O,O
number,O,O
of,O,O
polymerases,O,O
active,O,O
in,O,O
vitro,O,O
at,O,O
the,O,O
E,O,B
strand,O,I
promoter,O,I
was,O,O
similar,O,O
to,O,O
the,O,O
number,O,O
of,O,O
polymerases,O,O
at,O,O
the,O,O
L,O,B
strand,O,I
promoter,O,I
.,O,O
Moreover,O,O
",",O,O
the,O,O
ability,O,O
to,O,O
selectivity,O,O
arrest,O,O
elongation,O,O
by,O,O
polIII,B,B
at,O,O
defined,O,O
positions,O,O
within,O,O
the,O,O
tRNA,O,B
gene,O,I
transcription,O,I
unit,O,I
has,O,O
permitted,O,O
the,O,O
identification,O,O
of,O,O
discrete,O,O
functional,O,O
properties,O,O
of,O,O
paused,O,O
mammalian,B,O
polIII,I,B
ternary,I,I
complexes,I,I
.,O,O
Molecular,O,O
cloning,O,O
and,O,O
characterization,O,O
of,O,O
a,O,O
new,O,O
member,O,O
of,O,O
the,O,O
rat,B,O
placental,I,O
prolactin,I,B
(,O,O
PRL,B,B
),O,O
family,O,O
",",O,O
PRL,B,B
-,O,I
like,O,I
protein,B,I
H,I,I
.,O,O
The,O,O
prescription,O,O
for,O,O
apoplexy,O,O
includes,O,O
C1,O,B
-,O,I
7,O,I
",",O,O
T1,O,B
-,O,I
9,O,I
and,O,O
L2,O,B
-,O,I
4,O,I
.,O,O
Grade,O,O
3,O,O
mucositis,O,O
was,O,O
reported,O,O
in,O,O
1,O,O
patient,O,O
.,O,O
However,O,O
",",O,O
it,O,O
remains,O,O
an,O,O
open,O,O
question,O,O
whether,O,O
vertebrate,B,O
Hox,I,B
genes,I,O
expressed,O,O
under,O,O
the,O,O
control,O,O
of,O,O
Drosophila,O,O
regulatory,O,O
sequences,O,O
can,O,O
substitute,O,O
the,O,O
function,O,O
of,O,O
Drosophila,B,O
Hox,I,B
genes,I,O
.,O,O
The,O,O
molecular,O,O
basis,O,O
for,O,O
commitment,O,O
of,O,O
progenitors,O,O
to,O,O
the,O,O
eosinophil,O,B
lineage,O,O
and,O,O
mechanisms,O,O
by,O,O
which,O,O
eosinophil,O,B
-,O,I
specific,O,I
genes,O,O
are,O,O
expressed,O,O
and,O,O
regulated,O,O
during,O,O
differentiation,O,O
is,O,O
unknown,O,O
.,O,O
Cloning,O,O
and,O,O
primary,O,O
structure,O,O
of,O,O
neurocan,O,B
",",O,O
a,O,O
developmentally,O,O
regulated,O,O
",",O,O
aggregating,O,O
chondroitin,O,O
sulfate,O,O
proteoglycan,O,O
of,O,O
brain,O,O
.,O,O
The,O,O
newly,O,O
recognised,O,O
skeletogenital,O,O
syndrome,O,O
.,O,O
VII,O,O
.,O,O
The,O,O
development,O,O
and,O,O
distribution,O,O
of,O,O
Trypanosoma,O,B
congolense,O,I
",",O,O
T,O,B
vivax,O,I
and,O,O
T,O,B
brucei,O,I
in,O,O
the,O,O
skin,O,O
of,O,O
goats,O,O
was,O,O
examined,O,O
after,O,O
the,O,O
animals,O,O
were,O,O
bitten,O,O
by,O,O
infected,O,O
Glossina,O,B
morsitans,O,I
centralis,O,I
.,O,O
The,O,O
variations,O,O
were,O,O
caused,O,O
by,O,O
opposite,O,O
shifts,O,O
in,O,O
TSH,B,B
frequency,O,O
distribution,O,O
in,O,O
mothers,O,O
and,O,O
neonates,O,O
.,O,O
Cells,O,O
containing,O,O
alpha,O,B
subunits,O,O
that,O,O
lacked,O,O
a,O,O
distal,O,O
domain,O,O
(,O,O
term,O,O
-,O,O
3,O,O
),O,O
or,O,O
had,O,O
the,O,O
alternatively,O,O
spliced,O,O
alpha,O,B
-,O,I
2,O,I
distal,O,I
domain,O,I
showed,O,O
markedly,O,O
decreased,O,O
ability,O,O
to,O,O
support,O,O
tyrosine,O,O
phosphorylation,O,O
of,O,O
Jak,B,B
-,I,I
2,I,I
and,O,O
its,O,O
substrates,O,O
or,O,O
to,O,O
up,O,O
-,O,O
regulate,O,O
CD86,B,B
.,O,O
Clinical,O,O
and,O,O
biological,O,O
correlates,O,O
of,O,O
panic,O,O
states,O,O
.,O,O
Finally,O,O
",",O,O
the,O,O
mechanism,O,O
of,O,O
ASK1,B,B
activation,O,O
involves,O,O
",",O,O
in,O,O
part,O,O
",",O,O
homo,O,O
-,O,O
oligomerization,O,O
.,O,O
Also,O,O
",",O,O
the,O,O
human,B,B
glycoprotein,I,I
alpha,I,I
-,I,I
subunit,I,I
promoter,I,O
was,O,O
induced,O,O
10,O,O
-,O,O
fold,O,O
by,O,O
FSK,B,O
in,O,O
GH4,O,O
rat,O,O
pituitary,O,O
cells,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
400,O,O
WORDS,O,O
),O,O
The,O,O
differential,O,O
investigation,O,O
of,O,O
lipoproteins,O,O
",",O,O
however,O,O
",",O,O
showed,O,O
that,O,O
the,O,O
high,B,O
-,I,O
density,I,O
lipoprotein,I,O
(,O,O
HDL,B,B
),O,O
fractions,O,O
are,O,O
absolutely,O,O
or,O,O
relatively,O,O
decreased,O,O
with,O,O
respect,O,O
to,O,O
low,B,O
-,I,O
density,I,O
lipoproteins,I,O
(,O,O
LDL,B,B
),O,O
in,O,O
cerebral,O,O
infarcts,O,O
and,O,O
in,O,O
transient,O,O
ischaemic,O,O
attacks,O,O
.,O,O
The,O,O
mean,O,O
weight,O,O
and,O,O
height,O,O
velocities,O,O
were,O,O
148,O,O
%,O,O
and,O,O
122,O,O
%,O,O
of,O,O
the,O,O
standard,O,O
",",O,O
respectively,O,O
.,O,O
Using,O,O
autoantibodies,O,O
from,O,O
a,O,O
Sjogren,O,B
',O,I
s,O,I
syndrome,O,I
patient,O,O
",",O,O
we,O,O
have,O,O
previously,O,O
identified,O,O
a,O,O
230,O,O
-,O,O
kDa,O,O
peripheral,O,O
membrane,O,O
protein,O,O
associated,O,O
with,O,O
the,O,O
cytosolic,O,O
face,O,O
of,O,O
the,O,O
trans,O,O
-,O,O
Golgi,O,O
(,O,O
Kooy,O,B
",",O,O
J,O,O
.,O,O
",",O,O
Toh,O,B
",",O,O
B,O,O
.,O,O
The,O,O
need,O,O
in,O,O
the,O,O
small,O,O
hospital,O,O
.,O,O
3,O,O
.,O,O
The,O,O
used,O,O
expression,O,O
system,O,O
could,O,O
allow,O,O
to,O,O
produce,O,O
mutated,O,O
forms,O,O
of,O,O
SsEF,B,B
-,I,I
2,I,I
obtained,O,O
by,O,O
mutagenesis,O,O
of,O,O
the,O,O
corresponding,O,O
gene,O,O
.,O,O
Statistics,O,O
of,O,O
the,O,O
past,O,O
5,O,O
years,O,O
Mucosal,O,O
application,O,O
of,O,O
NCX,O,B
-,O,I
4016,O,I
",",O,O
however,O,O
",",O,O
did,O,O
not,O,O
cause,O,O
PD,O,B
reduction,O,O
and,O,O
luminal,O,O
H,O,O
+,O,O
loss,O,O
",",O,O
but,O,O
produced,O,O
a,O,O
marked,O,O
hyperemia,O,O
",",O,O
resulting,O,O
in,O,O
no,O,O
damage,O,O
in,O,O
the,O,O
stomach,O,O
of,O,O
both,O,O
normal,O,O
and,O,O
STZ,O,O
-,O,O
diabetic,O,O
rats,O,O
.,O,O
The,O,O
RNA,O,B
-,O,I
binding,O,I
and,O,O
RNA,B,B
-,I,I
DNA,I,I
helicase,I,I
activities,O,O
of,O,O
the,O,O
Escherichia,B,B
coli,I,I
transcription,I,I
termination,I,I
factor,I,I
rho,I,I
have,O,O
been,O,O
investigated,O,O
using,O,O
natural,O,O
RNA,O,B
molecules,O,O
that,O,O
are,O,O
255,O,O
and,O,O
391,O,O
nucleotide,O,O
residues,O,O
in,O,O
length,O,O
and,O,O
that,O,O
contain,O,O
the,O,O
trp,B,O
t,I,O
',I,O
rho,I,I
-,I,I
dependent,I,I
termination,I,I
sequence,I,I
of,O,O
E,O,O
.,O,O
coli,O,I
resulting,O,O
integrated,O,O
physical,O,O
",",O,O
genetic,O,O
",",O,O
and,O,O
cytogenetic,O,O
map,O,O
constitutes,O,O
a,O,O
resource,O,O
for,O,O
the,O,O
characterization,O,O
of,O,O
genes,O,O
that,O,O
may,O,O
be,O,O
involved,O,O
in,O,O
the,O,O
WAGR,O,O
syndrome,O,O
.,O,O
L,O,O
.,O,O
",",O,O
Greer,O,B
",",O,O
J,O,B
.,O,O
&,O,O
Carter,O,B
",",O,O
G,O,B
.,O,O
Lithium,O,B
phthalocyanine,O,I
(,O,O
LiPc,O,B
),O,O
is,O,O
a,O,O
prototype,O,O
of,O,O
another,O,O
generation,O,O
of,O,O
synthetic,O,O
",",O,O
metallic,O,O
-,O,O
organic,O,O
",",O,O
paramagnetic,O,O
crystallites,O,O
that,O,O
appear,O,O
very,O,O
useful,O,O
for,O,O
in,O,O
vitro,O,O
and,O,O
in,O,O
vivo,O,O
electron,O,O
paramagnetic,O,O
resonance,O,O
oximetry,O,O
.,O,O
Rats,O,O
with,O,O
one,O,O
olfactory,O,O
bulb,O,O
removed,O,O
and,O,O
the,O,O
contralateral,O,O
naris,O,O
closed,O,O
can,O,O
detect,O,O
odors,O,O
.,O,O
The,O,O
H,O,B
-,O,I
reflex,O,I
recovery,O,O
curve,O,O
was,O,O
obtained,O,O
after,O,O
stimulation,O,O
of,O,O
the,O,O
median,O,B
nerve,O,I
at,O,O
the,O,O
elbow,O,O
and,O,O
recording,O,O
from,O,O
the,O,O
flexor,O,O
carpi,O,O
radialis,O,O
.,O,O
Recruitment,O,O
of,O,O
an,O,O
RNA,B,B
polymerase,I,I
II,I,I
complex,I,I
is,O,O
mediated,O,O
by,O,O
the,O,O
constitutive,O,O
activation,O,O
domain,O,O
in,O,O
CREB,B,B
",",O,O
independently,O,O
of,O,O
CREB,B,B
phosphorylation,O,O
.,O,O
Promoter,O,O
activity,O,O
was,O,O
high,O,O
in,O,O
cell,O,O
lines,O,O
that,O,O
expressed,O,O
high,O,O
levels,O,O
of,O,O
endogenous,O,O
D3,B,B
mRNA,I,I
",",O,O
as,O,O
indicated,O,O
by,O,O
Northern,O,O
blot,O,O
analyses,O,O
",",O,O
and,O,O
was,O,O
significantly,O,O
reduced,O,O
when,O,O
the,O,O
promoter,O,O
was,O,O
truncated,O,O
to,O,O
-,O,O
122,O,O
bp,O,O
.,O,O
Antimicrobial,O,O
substance,O,O
isolated,O,O
from,O,O
an,O,O
acorn,O,O
extract,O,O
.,O,O
Caries,O,O
and,O,O
parodontitis,O,O
have,O,O
been,O,O
one,O,O
of,O,O
the,O,O
most,O,O
spread,O,O
diseases,O,O
of,O,O
mankind,O,O
.,O,O
The,O,O
mean,O,O
values,O,O
of,O,O
the,O,O
first,O,O
three,O,O
components,O,O
were,O,O
not,O,O
significantly,O,O
different,O,O
in,O,O
ARVD,O,O
patients,O,O
and,O,O
control,O,O
subjects,O,O
.,O,O
WRN,B,B
helicase,I,I
resolves,O,O
alternate,O,O
DNA,O,O
structures,O,O
including,O,O
tetraplex,O,O
and,O,O
triplex,O,O
DNA,O,O
",",O,O
and,O,O
Holliday,O,B
junctions,O,I
.,O,O
BCL,B,B
-,I,I
2,I,I
",",O,O
an,O,O
inhibitor,O,O
of,O,O
apoptosis,O,O
in,O,O
a,O,O
wide,O,O
variety,O,O
of,O,O
cell,O,O
types,O,O
",",O,O
has,O,O
been,O,O
reported,O,O
to,O,O
prevent,O,O
oxidative,O,O
stress,O,O
-,O,O
induced,O,O
cell,O,O
death,O,O
.,O,O
Selective,O,O
translation,O,O
initiation,O,O
by,O,O
ribosome,O,O
jumping,O,O
in,O,O
adenovirus,O,O
-,O,O
infected,O,O
and,O,O
heat,O,O
-,O,O
shocked,O,O
cells,O,O
.,O,O
Biol,O,O
.,O,O
One,O,O
RNA,O,O
construct,O,O
which,O,O
consisted,O,O
of,O,O
112,O,O
nucleotides,O,O
(,O,O
nt,O,O
),O,O
from,O,O
nt,O,O
639,O,O
to,O,O
nt,O,O
750,O,O
formed,O,O
a,O,O
heterodimeric,O,O
complex,O,O
with,O,O
the,O,O
RNA,O,O
which,O,O
consisted,O,O
of,O,O
200,O,O
nucleotides,O,O
from,O,O
nt,O,O
551,O,O
to,O,O
nt,O,O
750,O,O
.,O,O
These,O,O
RZR,B,B
subtypes,O,O
represent,O,O
members,O,O
of,O,O
a,O,O
new,O,O
family,O,O
of,O,O
orphan,B,O
nuclear,I,O
receptors,I,O
that,O,O
most,O,O
likely,O,O
regulate,O,O
specific,O,O
gene,O,B
expression,O,O
.,O,O
Primary,O,O
adrenal,O,O
hypersensitivity,O,O
to,O,O
ACTH,B,O
drive,O,O
in,O,O
obesity,O,O
has,O,O
also,O,O
been,O,O
suggested,O,O
.,O,O
Downregulation,O,O
of,O,O
FUS,B,B
expression,O,O
in,O,O
BCR,B,O
/,O,O
ABL,B,O
-,O,O
expressing,O,O
32Dcl3,O,O
cells,O,O
was,O,O
associated,O,O
with,O,O
suppression,O,O
of,O,O
growth,O,O
factor,O,O
-,O,O
independent,O,O
colony,O,O
formation,O,O
",",O,O
restoration,O,O
of,O,O
G,B,B
-,I,I
CSF,I,I
-,O,I
induced,O,I
granulocytic,O,I
differentiation,O,I
and,O,O
reduced,O,O
tumorigenic,O,O
potential,O,O
in,O,O
vivo,O,O
.,O,O
We,O,O
have,O,O
overexpressed,O,O
",",O,O
purified,O,O
",",O,O
characterized,O,O
",",O,O
and,O,O
crystallized,O,O
the,O,O
BTB,B,B
/,O,I
POZ,O,I
domain,O,I
from,O,O
PLZF,B,B
(,O,O
PLZF,B,B
-,O,I
BTB,B,I
/,O,I
POZ,O,I
),O,O
.,O,O
As,O,O
such,O,O
the,O,O
findings,O,O
support,O,O
existing,O,O
studies,O,O
that,O,O
have,O,O
identified,O,O
given,O,O
social,O,O
characteristics,O,O
of,O,O
drink,O,O
drivers,O,O
.,O,O
Increase,O,O
in,O,O
urinary,O,O
calcium,O,O
and,O,O
oxalate,O,O
after,O,O
fructose,O,O
infusion,O,O
.,O,O
Wherever,O,O
the,O,O
site,O,O
of,O,O
the,O,O
conditioning,O,O
stimulation,O,O
",",O,O
these,O,O
modifications,O,O
disappeared,O,O
after,O,O
ischaemia,O,O
of,O,O
the,O,O
leg,O,O
.,O,O
The,O,O
roxithromycin,O,O
doses,O,O
that,O,O
were,O,O
chosen,O,O
for,O,O
these,O,O
studies,O,O
were,O,O
less,O,O
than,O,O
achievable,O,O
blood,O,O
levels,O,O
.,O,O
Transformation,O,O
of,O,O
the,O,O
sconC3,B,O
mutant,I,O
with,O,O
sconB,B,O
+,I,O
restores,O,O
the,O,O
wild,O,O
-,O,O
type,O,O
phenotype,O,O
.,O,O
The,O,O
muscles,O,O
from,O,O
the,O,O
ischemic,O,O
group,O,O
had,O,O
significantly,O,O
lower,O,O
(,O,O
P,O,O
less,O,O
than,O,O
.,O,O
05,O,O
),O,O
values,O,O
for,O,O
capillary,O,O
density,O,O
and,O,O
capillary,O,O
to,O,O
fiber,O,O
ratio,O,O
and,O,O
significantly,O,O
higher,O,O
intercapillary,O,O
distance,O,O
than,O,O
those,O,O
from,O,O
the,O,O
normal,O,O
group,O,O
.,O,O
Discrimination,O,O
between,O,O
HIV,O,B
-,O,I
1,O,I
and,O,O
HIV,O,B
-,O,I
2,O,I
showed,O,O
evidence,O,O
for,O,O
the,O,O
presence,O,O
of,O,O
HIV,O,B
-,O,I
1,O,I
only,O,O
.,O,O
Molecular,O,O
cloning,O,O
and,O,O
sequencing,O,O
of,O,O
a,O,O
cDNA,O,O
encoding,O,O
SR,B,B
beta,I,I
revealed,O,O
that,O,O
SR,B,B
beta,I,I
is,O,O
a,O,O
transmembrane,O,O
protein,O,O
and,O,O
",",O,O
like,O,O
SR,B,B
alpha,I,I
and,O,O
SRP54,B,O
",",O,O
is,O,O
a,O,O
member,O,O
of,O,O
the,O,O
GTPase,B,O
superfamily,I,O
.,O,O
The,O,O
bearing,O,O
of,O,O
season,O,O
and,O,O
sequence,O,O
of,O,O
calving,O,O
on,O,O
frequency,O,O
of,O,O
male,O,B
",",O,O
female,O,B
and,O,O
total,O,O
calvings,O,O
in,O,O
Hariana,O,O
cows,O,O
.,O,O
On,O,O
the,O,O
other,O,O
hand,O,O
",",O,O
hepatic,O,O
arterial,O,O
infusion,O,O
therapy,O,O
prolongs,O,O
the,O,O
survival,O,O
of,O,O
H3,O,O
patients,O,O
only,O,O
.,O,O
5,O,O
micrograms,O,O
/,O,O
l,O,O
was,O,O
detected,O,O
in,O,O
urine,O,O
from,O,O
some,O,O
non,O,O
-,O,O
occupationally,O,O
exposed,O,O
persons,O,O
.,O,O
The,O,O
Babcock,O,O
Surgical,O,O
Clinic,O,O
.,O,O
The,O,O
plant,O,O
hormone,O,O
auxin,O,B
transcriptionally,O,O
activates,O,O
early,B,O
genes,I,O
.,O,O
This,O,O
sequence,O,O
",",O,O
Thr,O,B
-,O,I
Gly,O,I
-,O,I
X,O,I
-,O,I
X,O,I
-,O,I
Gly,O,I
-,O,I
Asp,O,I
-,O,I
Gly,O,I
-,O,I
Lys,O,I
-,O,I
Ile,O,I
-,O,I
Phe,O,I
",",O,O
forms,O,O
part,O,O
of,O,O
the,O,O
B,O,B
-,O,I
loop,O,I
and,O,O
is,O,O
conserved,O,O
in,O,O
a,O,O
wide,O,O
variety,O,O
of,O,O
organisms,O,O
that,O,O
include,O,O
bacteria,O,O
",",O,O
algae,O,O
and,O,O
archeabacteria,O,O
.,O,O
Study,O,O
of,O,O
antinuclear,O,O
autoantibodies,O,O
by,O,O
immunofluorescence,O,O
technic,O,O
in,O,O
collagen,B,O
diseases,O,O
Interestingly,O,O
",",O,O
continuation,O,O
of,O,O
the,O,O
interferon,B,O
therapy,O,O
in,O,O
the,O,O
presence,O,O
of,O,O
a,O,O
mild,O,O
-,O,O
to,O,O
-,O,O
moderate,O,O
exacerbation,O,O
of,O,O
sarcoidosis,O,O
may,O,O
be,O,O
safe,O,O
in,O,O
a,O,O
minority,O,O
of,O,O
patients,O,O
with,O,O
noncritical,O,O
organ,O,O
involvement,O,O
.,O,O
Resistance,O,O
to,O,O
the,O,O
simulated,O,O
physiologic,O,O
environment,O,O
was,O,O
tested,O,O
by,O,O
measured,O,O
retention,O,O
of,O,O
mechanical,O,O
properties,O,O
after,O,O
immersion,O,O
times,O,O
in,O,O
pseudo,O,O
-,O,O
extracellular,O,O
fluid,O,O
(,O,O
PECF,O,B
),O,O
at,O,O
37,O,O
degrees,O,O
C,O,O
for,O,O
as,O,O
long,O,O
as,O,O
three,O,O
years,O,O
.,O,O
The,O,O
recombinant,O,O
protein,O,O
was,O,O
purified,O,O
to,O,O
homogeneity,O,O
by,O,O
(,O,O
NH4,O,B
),O,O
2SO4,O,I
-,O,I
precipitation,O,I
and,O,O
affinity,O,O
chromatography,O,O
on,O,O
5,O,O
',O,O
AMP,O,B
-,O,I
Sepharose,O,I
.,O,O
Three,O,O
of,O,O
the,O,O
short,O,O
ORFs,O,O
in,O,O
the,O,O
central,O,O
region,O,O
of,O,O
BIV,O,B
have,O,O
been,O,O
identified,O,O
by,O,O
location,O,O
and,O,O
structural,O,O
similarity,O,O
to,O,O
the,O,O
nonstructural,O,O
/,O,O
regulatory,O,O
genes,O,O
(,O,O
vif,B,B
",",O,O
tat,B,B
",",O,O
and,O,O
rev,B,B
),O,O
of,O,O
other,O,O
lentiviruses,O,O
;,O,O
we,O,O
also,O,O
discovered,O,O
two,O,O
unique,O,O
ORFs,O,O
",",O,O
termed,O,O
W,O,B
and,O,O
Y,O,B
",",O,O
which,O,O
may,O,O
serve,O,O
as,O,O
exons,O,O
for,O,O
novel,O,O
genes,O,O
.,O,O
Oseltamivir,O,B
(,O,O
GS4104,O,I
),O,O
",",O,O
which,O,O
can,O,O
be,O,O
administered,O,O
orally,O,O
",",O,O
is,O,O
the,O,O
prodrug,O,O
of,O,O
GS4071,O,B
",",O,O
a,O,O
potent,O,O
and,O,O
selective,O,O
inhibitor,O,O
of,O,O
influenzavirus,B,O
neuraminidases,I,O
.,O,O
(,O,O
2,O,O
),O,O
Erythroid,O,O
32D,O,O
Epo1,B,O
cells,O,O
showed,O,O
a,O,O
lower,O,O
level,O,O
of,O,O
bulk,O,O
PKC,B,B
catalytic,O,I
activity,O,I
",",O,O
lacked,O,O
the,O,O
expression,O,O
of,O,O
epsilon,B,B
and,I,O
eta,I,B
PKC,I,B
isoforms,I,I
",",O,O
and,O,O
showed,O,O
a,O,O
weak,O,O
or,O,O
absent,O,O
upregulation,O,O
of,O,O
the,O,O
remaining,O,O
isoforms,O,I
",",O,O
except,O,O
betaI,B,B
",",O,O
upon,O,O
readdition,O,O
of,O,O
Epo,B,O
to,O,O
growth,O,O
factor,O,O
-,O,O
starved,O,O
cells,O,O
.,O,O
However,O,O
",",O,O
as,O,O
determined,O,O
by,O,O
PCR,O,O
with,O,O
primers,O,O
specific,O,O
for,O,O
the,O,O
26,O,O
-,O,O
kDa,O,O
product,O,O
",",O,O
the,O,O
majority,O,O
of,O,O
cats,O,O
at,O,O
2,O,O
and,O,O
4,O,O
weeks,O,O
p,O,O
.,O,O
t,O,O
.,O,O
had,O,O
gastric,O,O
fluid,O,O
samples,O,O
which,O,O
were,O,O
positive,O,O
for,O,O
H,O,B
.,O,O
pylori,O,I
and,O,O
three,O,O
of,O,O
three,O,O
cats,O,O
at,O,O
2,O,O
weeks,O,O
p,O,O
.,O,O
t,O,O
dental,O,O
plaque,O,O
which,O,O
was,O,O
positive,O,O
for,O,O
H,O,B
.,O,O
pylori,O,I
.,O,O
SNAC,O,O
or,O,O
PBS,O,O
was,O,O
infused,O,O
for,O,O
6,O,O
.,O,O
5,O,O
h,O,O
",",O,O
beginning,O,O
30,O,O
min,O,O
before,O,O
ischemia,O,O
and,O,O
continuing,O,O
throughout,O,O
the,O,O
duration,O,O
of,O,O
reperfusion,O,O
.,O,O
Removal,O,O
of,O,O
the,O,O
GST,B,O
domain,I,O
from,O,O
GST,B,O
-,O,O
Tax,B,O
by,O,O
thrombin,B,O
restores,O,O
Tax,B,O
',O,O
s,O,O
ability,O,O
to,O,O
assemble,O,O
a,O,O
ternary,O,O
Tax,B,O
-,O,O
CREB,B,O
-,O,O
21,O,O
-,O,O
bp,O,O
-,O,O
repeat,O,O
complex,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
400,O,O
WORDS,O,O
),O,O
Previous,O,O
work,O,O
has,O,O
shown,O,O
that,O,O
spleen,B,O
necrosis,I,O
virus,I,O
(,I,O
SNV,I,B
),I,O
long,I,O
terminal,I,O
repeats,I,O
(,O,O
LTRs,O,O
),O,O
are,O,O
associated,O,O
with,O,O
Rex,B,O
/,O,O
Rex,B,O
-,O,O
responsive,O,O
element,O,O
-,O,O
independent,O,O
expression,O,O
of,O,O
bovine,O,O
leukemia,O,O
virus,O,O
RNA,O,O
and,O,O
supports,O,O
the,O,O
hypothesis,O,O
that,O,O
SNV,O,B
RNA,O,O
contains,O,O
a,O,O
cis,O,O
-,O,O
acting,O,O
element,O,O
that,O,O
interacts,O,O
with,O,O
cellular,B,O
Rex,I,O
-,I,O
like,I,O
proteins,I,O
.,O,O
Early,O,O
disagnosis,O,O
of,O,O
cancer,O,O
-,O,O
-,O,O
50,O,O
per,O,O
cent,O,O
of,O,O
all,O,O
patients,O,O
could,O,O
be,O,O
cured,O,O
In,O,O
the,O,O
normal,O,O
",",O,O
basal,O,O
(,O,O
unstimulated,O,O
),O,O
condition,O,O
there,O,O
were,O,O
no,O,O
significant,O,O
correlations,O,O
(,O,O
p,O,O
greater,O,O
than,O,O
0,O,O
.,O,O
05,O,O
),O,O
between,O,O
the,O,O
systolic,O,O
blood,O,O
pressure,O,O
and,O,O
dopamine,O,B
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
09,O,O
),O,O
",",O,O
norepinephrine,O,B
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
26,O,O
),O,O
",",O,O
or,O,O
epinephrine,O,B
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
27,O,O
),O,O
",",O,O
nor,O,O
were,O,O
there,O,O
significant,O,O
correlations,O,O
between,O,O
melatonin,O,B
and,O,O
dopamine,O,B
(,O,O
r,O,O
=,O,O
-,O,O
0,O,O
.,O,O
01,O,O
),O,O
",",O,O
norepinephrine,O,B
(,O,O
r,O,O
=,O,O
-,O,O
0,O,O
.,O,O
26,O,O
),O,O
",",O,O
or,O,O
growth,B,O
hormone,I,B
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
17,O,O
),O,O
.,O,O
We,O,O
propose,O,O
that,O,O
the,O,O
technique,O,O
of,O,O
low,O,O
-,O,O
frequency,O,O
kindling,O,O
is,O,O
a,O,O
useful,O,O
experimental,O,O
model,O,O
in,O,O
assessing,O,O
the,O,O
effects,O,O
of,O,O
antipsychotic,O,O
or,O,O
antiepileptic,O,O
drugs,O,O
on,O,O
the,O,O
excitability,O,O
of,O,O
the,O,O
limbic,O,O
regions,O,O
.,O,O
desmethyltrimebutine,O,O
was,O,O
inactive,O,O
.,O,O
RANTES,B,B
(,O,O
regulated,B,O
upon,I,O
activation,I,O
",",I,O
normally,I,O
T,I,O
-,I,O
cell,I,O
expressed,I,O
and,I,O
presumably,I,O
secreted,I,O
),O,O
is,O,O
a,O,O
CC,O,O
chemokine,O,O
which,O,O
recruits,O,O
and,O,O
activates,O,O
monocytes,O,B
",",O,O
lymphocytes,O,B
",",O,O
and,O,O
eosinophils,O,B
",",O,O
all,O,O
cell,O,O
types,O,O
present,O,O
in,O,O
the,O,O
lung,O,O
inflammatory,O,O
infiltrate,O,O
induced,O,O
by,O,O
RSV,O,O
infection,O,O
.,O,O
We,O,O
describe,O,O
a,O,O
case,O,O
of,O,O
acetaminophen,O,B
overdose,O,O
that,O,O
was,O,O
treated,O,O
with,O,O
both,O,O
hemodialysis,O,O
(,O,O
HD,O,B
),O,O
and,O,O
NAC,O,B
due,O,O
to,O,O
severe,O,O
intoxication,O,O
and,O,O
slow,O,O
drug,O,O
clearance,O,O
.,O,O
A,O,O
method,O,O
for,O,O
the,O,O
simultaneous,O,O
determination,O,O
of,O,O
de,O,O
(,O,O
N,O,B
-,O,I
methyl,O,I
),O,O
-,O,O
N,O,B
-,O,I
ethyl,O,I
-,O,I
8,O,I
",",O,O
9,O,I
-,O,I
A,O,I
6,O,I
",",O,O
9,O,I
-,O,I
hemiacetal,O,I
(,O,O
EM523,O,B
",",O,O
I,O,O
),O,O
and,O,O
its,O,O
three,O,O
metabolites,O,O
in,O,O
human,O,B
plasma,O,O
and,O,O
urine,O,O
has,O,O
been,O,O
developed,O,O
using,O,O
high,O,O
-,O,O
performance,O,O
liquid,O,O
chromatography,O,O
(,O,O
HPLC,O,B
),O,O
with,O,O
chemiluminescence,O,O
(,O,O
CL,O,B
),O,O
detection,O,O
.,O,O
The,O,O
major,O,O
promoter,O,O
responds,O,O
strongly,O,O
to,O,O
virus,O,B
-,O,I
encoded,O,I
trans,O,I
activators,O,I
EIA,B,B
and,O,O
EIV,B,B
and,O,O
contains,O,O
four,O,O
elements,O,O
:,O,O
a,O,O
TAGA,O,O
motif,O,O
analogous,O,O
to,O,O
the,O,O
TATA,O,O
box,O,O
",",O,O
two,O,O
EIIF,B,B
sites,I,O
present,O,O
in,O,O
an,O,O
inverted,O,O
orientation,O,O
",",O,O
and,O,O
an,O,O
ATF,B,B
/,O,I
CREB,B,I
site,O,O
.,O,O
However,O,O
",",O,O
reoperation,O,O
for,O,O
bulky,O,O
cervical,O,O
disease,O,O
(,O,O
group,O,O
3,O,O
),O,O
rarely,O,O
results,O,O
in,O,O
normal,O,O
calcitonin,B,O
levels,O,O
and,O,O
is,O,O
associated,O,O
with,O,O
a,O,O
high,O,O
incidence,O,O
of,O,O
permanent,O,O
hypoparathyroidism,O,O
.,O,O
To,O,O
confirm,O,O
the,O,O
GapIII,B,B
protein,I,I
activity,O,O
",",O,O
constructs,O,O
containing,O,O
different,O,O
GapIII,B,B
-,O,I
GRD,B,I
domains,O,I
were,O,O
transformed,O,O
into,O,O
iral,B,O
mutant,O,O
yeast,O,O
to,O,O
determine,O,O
their,O,O
relative,O,O
ability,O,O
to,O,O
replace,O,O
IRA1,B,O
functionally,O,O
.,O,O
Modification,O,O
of,O,O
the,O,O
growth,O,O
of,O,O
Tetrahymena,O,O
by,O,O
compounds,O,O
which,O,O
affect,O,O
the,O,O
adrenergic,O,O
mechanism,O,O
.,O,O
The,O,O
gene,O,O
is,O,O
essential,O,O
for,O,O
yeast,O,O
vegetative,O,O
growth,O,O
.,O,O
These,O,O
cell,O,O
lines,O,O
",",O,O
selected,O,O
for,O,O
the,O,O
ability,O,O
to,O,O
support,O,O
the,O,O
replication,O,O
of,O,O
a,O,O
temperature,O,O
-,O,O
sensitive,O,O
VP5,B,B
mutant,I,O
",",O,O
were,O,O
used,O,O
to,O,O
isolate,O,O
VP5,B,B
and,O,O
VP23,B,B
mutants,O,O
.,O,O
NF,B,B
-,I,I
kappaB,I,I
",",O,O
which,O,O
is,O,O
probably,O,O
important,O,O
for,O,O
basal,O,O
activity,O,O
of,O,O
the,O,O
human,B,O
NOS,I,B
II,I,I
promoter,I,O
",",O,O
is,O,O
unlikely,O,O
to,O,O
function,O,O
as,O,O
a,O,O
major,O,O
effector,O,O
of,O,O
CM,O,O
in,O,O
DLD,O,O
-,O,O
1,O,O
cells,O,O
.,O,O
Canalith,O,O
repositioning,O,O
is,O,O
the,O,O
mainstay,O,O
of,O,O
treatment,O,O
.,O,O
Because,O,O
the,O,O
Pit,B,B
-,I,I
1,I,I
sites,I,O
in,O,O
the,O,O
hGH,B,B
-,I,I
N,I,I
gene,I,I
promoter,I,O
are,O,O
insufficient,O,O
for,O,O
such,O,O
gene,O,O
activation,O,O
in,O,O
vivo,O,O
",",O,O
these,O,O
data,O,O
suggested,O,O
a,O,O
unique,O,O
chromatin,O,O
-,O,O
mediated,O,O
developmental,O,O
role,O,O
for,O,O
Pit,B,B
-,I,I
1,I,I
in,O,O
the,O,O
hGH,B,B
LCR,I,I
.,O,O
In,O,O
patients,O,O
who,O,O
respond,O,O
to,O,O
quetiapine,O,O
",",O,O
therapy,O,O
should,O,O
be,O,O
continued,O,O
at,O,O
the,O,O
optimal,O,O
dose,O,O
that,O,O
maintains,O,O
remission,O,O
",",O,O
within,O,O
the,O,O
range,O,O
of,O,O
150,O,O
to,O,O
750,O,O
mg,O,O
/,O,O
d,O,O
.,O,O
Behaviorally,O,O
",",O,O
a,O,O
pain,O,O
-,O,O
tolerant,O,O
group,O,O
(,O,O
PT,O,O
=,O,O
29,O,O
Ss,O,O
),O,O
tolerated,O,O
the,O,O
entire,O,O
3,O,O
-,O,O
min,O,O
test,O,O
(,O,O
means,O,O
=,O,O
180,O,O
+,O,O
/,O,O
-,O,O
0,O,O
sec,O,O
),O,O
",",O,O
while,O,O
a,O,O
pain,O,O
-,O,O
sensitive,O,O
group,O,O
(,O,O
PS,O,O
=,O,O
13,O,O
Ss,O,O
),O,O
averaged,O,O
only,O,O
50,O,O
.,O,O
31,O,O
+,O,O
/,O,O
-,O,O
20,O,O
.,O,O
81,O,O
sec,O,O
of,O,O
the,O,O
cold,O,O
-,O,O
pressor,O,O
test,O,O
(,O,O
t,O,O
=,O,O
16,O,O
.,O,O
75,O,O
",",O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
0001,O,O
),O,O
",",O,O
replicating,O,O
our,O,O
earlier,O,O
studies,O,O
.,O,O
V,O,O
.,O,O
A,O,O
triple,O,O
Ser,O,B
-,O,I
-,O,I
>,O,I
Ala,O,I
mutant,O,O
form,O,O
of,O,O
yeast,O,B
eIF,B,I
-,I,I
2,I,I
alpha,I,I
was,O,O
found,O,O
to,O,O
be,O,O
no,O,O
longer,O,O
phosphorylated,O,O
by,O,O
either,O,O
of,O,O
the,O,O
yeast,O,B
(,O,O
or,O,O
mammalian,O,O
),O,O
casein,B,O
kinase,I,O
activities,O,O
in,O,O
vitro,O,O
.,O,O
Similar,O,O
observations,O,O
were,O,O
made,O,O
with,O,O
unilateral,O,O
pneumothorax,O,O
of,O,O
15,O,O
cmH2O,O,O
for,O,O
30,O,O
min,O,O
.,O,O
In,O,O
293,O,O
cells,O,O
",",O,O
expression,O,O
of,O,O
the,O,O
NF,B,B
-,I,I
kappa,I,I
B,I,I
inhibitor,O,O
",",O,O
I,B,B
kappa,I,I
B,I,I
-,I,I
alpha,I,I
",",O,O
reduced,O,O
the,O,O
stimulatory,O,O
activity,O,O
of,O,O
LMP,B,O
.,O,O
The,O,O
E1,B,B
nuclear,I,I
transport,I,I
motif,I,I
is,O,O
highly,O,O
conserved,O,O
in,O,O
the,O,O
animal,O,O
and,O,O
human,O,B
papillomaviruses,O,I
and,O,O
is,O,O
encoded,O,O
in,O,O
a,O,O
similar,O,O
region,O,O
in,O,O
the,O,O
related,O,O
E1,B,B
genes,I,O
.,O,O
The,O,O
studied,O,O
protein,O,O
fragments,O,O
consist,O,O
of,O,O
residues,O,O
Arg183,O,B
-,O,I
His267,O,I
of,O,O
the,O,O
human,B,B
ER,I,I
and,O,O
residues,O,O
Lys438,O,B
-,O,I
Gln520,O,I
of,O,O
the,O,O
rat,O,O
GR,B,B
.,O,O
The,O,O
revertant,O,O
TATA,O,B
boxes,O,I
accelerated,O,O
the,O,O
kinetics,O,O
of,O,O
HIV,O,B
replication,O,O
when,O,O
present,O,O
in,O,O
the,O,O
context,O,O
of,O,O
an,O,O
LTR,O,B
containing,O,O
a,O,O
Sp1,B,B
mutation,O,O
(,O,O
deletion,O,O
or,O,O
site,O,O
specific,O,O
),O,O
;,O,O
no,O,O
effect,O,O
was,O,O
observed,O,O
on,O,O
the,O,O
infectivity,O,O
of,O,O
wild,O,O
-,O,O
type,O,O
HIV,O,B
.,O,O
Basing,O,O
on,O,O
experimental,O,O
toxicity,O,O
research,O,O
it,O,O
was,O,O
established,O,O
that,O,O
",",O,O
out,O,O
of,O,O
50,O,O
atmosphere,O,O
metal,O,O
corrosion,O,O
inhibitors,O,O
",",O,O
some,O,O
14,O,O
per,O,O
cent,O,O
were,O,O
found,O,O
extremely,O,O
hazardous,O,O
",",O,O
42,O,O
per,O,O
cent,O,O
-,O,O
-,O,O
of,O,O
high,O,O
level,O,O
hazardous,O,O
",",O,O
33,O,O
percent,O,O
-,O,O
-,O,O
of,O,O
moderate,O,O
and,O,O
11,O,O
per,O,O
cent,O,O
-,O,O
-,O,O
of,O,O
low,O,O
hazardous,O,O
.,O,O
In,O,O
conclusion,O,O
",",O,O
we,O,O
observed,O,O
a,O,O
great,O,O
regeneration,O,O
ability,O,O
following,O,O
mechanical,O,O
injury,O,O
in,O,O
the,O,O
nasal,O,O
mucosa,O,O
.,O,O
In,O,O
11,O,O
patients,O,O
with,O,O
Horton,O,B
',O,I
s,O,O
headache,O,O
morphological,O,O
investigations,O,O
(,O,O
differential,O,O
white,O,O
blood,O,O
cell,O,O
count,O,O
),O,O
",",O,O
cytoenzymatic,O,O
determinations,O,O
(,O,O
alkaline,B,O
and,I,O
acid,I,O
phosphatase,I,O
",",O,O
non,B,O
-,I,O
specific,I,O
esterase,I,O
),O,O
and,O,O
cytoimmunological,O,O
tests,O,O
(,O,O
IgM,B,B
and,O,O
IgG,B,B
binding,O,O
),O,O
were,O,O
carried,O,O
out,O,O
on,O,O
capillary,O,O
blood,O,O
neutrophils,O,O
obtained,O,O
from,O,O
the,O,O
area,O,O
of,O,O
pain,O,O
",",O,O
non,O,O
-,O,O
painful,O,O
area,O,O
of,O,O
the,O,O
skin,O,O
on,O,O
the,O,O
head,O,O
on,O,O
the,O,O
contralateral,O,O
side,O,O
",",O,O
and,O,O
from,O,O
the,O,O
finger,O,O
.,O,O
A,O,O
vector,O,O
containing,O,O
a,O,O
transcriptionally,O,O
inactive,O,O
neomycin,B,B
phosphotransferase,I,I
II,I,I
gene,I,I
was,O,O
used,O,O
to,O,O
select,O,O
promoter,O,O
sequences,O,O
from,O,O
a,O,O
pool,O,O
of,O,O
random,O,O
genomic,O,O
DNA,O,O
fragments,O,O
.,O,O
In,O,O
co,O,O
-,O,O
transfection,O,O
studies,O,O
",",O,O
an,O,O
AP,B,O
-,I,O
2,I,O
but,O,O
not,O,O
an,O,O
Egr,B,O
-,I,O
1,I,O
expression,O,O
vector,O,O
activated,O,O
VPF,B,O
/,O,O
VEGF,B,O
transcription,O,O
",",O,O
thus,O,O
indicating,O,O
that,O,O
AP,B,O
-,I,O
2,I,O
protein,I,O
is,O,O
functionally,O,O
important,O,O
in,O,O
TGF,B,O
alpha,I,O
-,O,O
induced,O,O
VPF,B,O
/,O,O
VEGF,B,O
gene,O,O
expression,O,O
.,O,O
The,O,O
original,O,O
technique,O,O
was,O,O
developed,O,O
in,O,O
the,O,O
1960,O,O
',O,O
s,O,O
to,O,O
analyze,O,O
the,O,O
inner,O,O
ear,O,O
fluid,O,O
as,O,O
a,O,O
diagnostic,O,O
procedure,O,O
(,O,O
i,O,O
.,O,O
e,O,O
.,O,O
",",O,O
diagnostic,O,O
labyrinthotomy,O,O
),O,O
in,O,O
acoustic,O,O
neuroma,O,O
suspects,O,O
.,O,O
However,O,O
",",O,O
there,O,O
has,O,O
not,O,O
been,O,O
any,O,O
evidence,O,O
of,O,O
A,O,B
.,O,O
salmonicida,O,I
infections,O,O
",",O,O
specifically,O,O
furunculosis,O,O
",",O,O
associated,O,O
with,O,O
the,O,O
fish,O,O
in,O,O
this,O,O
loch,O,O
.,O,O
Thus,O,O
",",O,O
YMIP,B,B
is,O,O
a,O,O
functional,O,O
homolog,O,O
of,O,O
RMIP,B,B
and,O,O
represents,O,O
a,O,O
new,O,O
component,O,O
of,O,O
the,O,O
yeast,O,O
mitochondrial,O,O
import,O,O
machinery,O,O
.,O,O
Reverse,B,O
transcriptase,I,O
and,O,O
protease,O,O
activities,O,O
of,O,O
avian,O,O
leukosis,O,O
virus,O,O
Gag,B,B
-,O,I
Pol,B,I
fusion,O,I
proteins,O,O
expressed,O,O
in,O,O
insect,O,O
cells,O,O
.,O,O
The,O,O
incidence,O,O
of,O,O
cryptosporidiosis,O,O
in,O,O
young,O,O
children,O,O
was,O,O
determined,O,O
by,O,O
staining,O,O
of,O,O
faecal,O,O
specimens,O,O
with,O,O
a,O,O
modified,O,O
Kinyoun,O,B
stain,O,O
.,O,O
Thus,O,O
",",O,O
multiple,O,O
myogenic,O,O
factors,O,O
that,O,O
vary,O,O
qualitatively,O,O
and,O,O
quantitatively,O,O
may,O,O
be,O,O
responsible,O,O
for,O,O
the,O,O
different,O,O
and,O,O
complex,O,O
modulatory,O,O
programs,O,O
of,O,O
actin,B,B
gene,I,I
expression,O,I
observed,O,O
during,O,O
in,O,O
vivo,O,O
muscle,O,O
differentiation,O,O
.,O,O
The,O,O
codon,O,O
usage,O,O
is,O,O
particularly,O,O
marked,O,O
for,O,O
the,O,O
gag,B,B
",",O,O
pol,B,B
",",O,O
and,O,O
env,B,B
genes,I,I
.,O,O
All,O,O
patients,O,O
diagnosed,O,O
of,O,O
H,O,B
.,O,O
influenza,O,B
type,O,I
b,O,I
meningitis,O,O
were,O,O
less,O,O
than,O,O
3,O,O
years,O,O
old,O,O
.,O,O
There,O,O
occurred,O,O
a,O,O
linear,O,O
relationship,O,O
between,O,O
the,O,O
drop,O,O
in,O,O
glucose,B,O
-,I,O
6,I,O
-,I,O
phosphatase,I,O
dehydrogenase,I,O
activity,O,O
and,O,O
in,O,O
vitamin,O,O
E,O,O
level,O,O
",",O,O
on,O,O
one,O,O
hand,O,O
",",O,O
and,O,O
the,O,O
duration,O,O
of,O,O
poisoning,O,O
with,O,O
sodium,O,O
nitrite,O,O
.,O,O
Residues,O,O
removed,O,O
from,O,O
transcripts,O,O
by,O,O
splicing,O,O
were,O,O
identified,O,O
.,O,O
The,O,O
M,O,B
-,O,I
3,O,I
subtype,O,O
was,O,O
an,O,O
adverse,O,O
prognostic,O,O
factor,O,O
.,O,O
These,O,O
data,O,O
define,O,O
a,O,O
conserved,O,O
pathway,O,O
wherein,O,O
sequential,O,O
histone,B,B
modifications,O,O
establish,O,O
a,O,O
essential,O,O
for,O,O
the,O,O
epigenetic,O,O
inheritance,O,O
of,O,O
heterochromatin,O,O
assembly,O,O
.,O,O
Five,O,O
-,O,O
year,O,O
prospective,O,O
study,O,O
of,O,O
peripheral,O,O
white,O,O
blood,O,O
cells,O,O
in,O,O
infectious,O,O
mononucleosis,O,O
.,O,O
Water,O,O
content,O,O
and,O,O
equilibrium,O,O
water,O,O
partition,O,O
in,O,O
immature,O,O
cartilage,O,O
.,O,O
Expression,O,O
of,O,O
a,O,O
dominant,B,O
-,I,O
negative,I,O
ras,I,B
gene,I,I
also,O,O
blocks,O,O
TIS10,B,B
/,O,I
PGS2,B,I
induction,O,O
by,O,O
v,B,O
-,I,O
src,I,O
.,O,O
(,O,O
1989,O,O
),O,O
",",O,O
which,O,O
is,O,O
identical,O,O
to,O,O
the,O,O
SSC1,B,B
gene,I,I
(,O,O
Smith,O,B
et,O,I
al,O,I
.,O,O
",",O,O
1988,O,O
),O,O
.,O,O
Previous,O,O
analysis,O,O
of,O,O
the,O,O
98,O,O
-,O,O
bp,O,O
sequence,O,O
has,O,O
delineated,O,O
several,O,O
protein,O,O
-,O,O
binding,O,O
domains,O,O
that,O,O
are,O,O
recognized,O,O
by,O,O
nuclear,O,O
factors,O,O
present,O,O
in,O,O
human,O,B
brain,O,I
cells,O,I
.,O,O
The,O,O
identified,O,O
isolates,O,O
of,O,O
CSF,O,B
(,O,O
20,O,O
of,O,O
29,O,O
),O,O
were,O,O
:,O,O
ECHO,O,B
30,O,O
(,O,O
9,O,O
),O,O
",",O,O
ECHO,O,B
11,O,O
(,O,O
7,O,O
),O,O
",",O,O
ECHO,O,B
9,O,O
(,O,O
3,O,O
),O,O
and,O,O
ECHO,O,B
7,O,O
(,O,O
1,O,O
),O,O
.,O,O
Full,B,O
-,I,O
length,I,O
AT,I,B
-,I,I
PHH1,I,I
",",O,O
and,O,O
both,O,O
AT,B,B
-,I,I
PHH1,I,I
and,O,O
AT,B,B
-,I,I
PHH1,I,I
delta,I,I
C,I,I
-,I,I
513,I,I
(,O,O
truncated,O,O
to,O,O
be,O,O
approximately,O,O
the,O,O
size,O,O
of,O,O
microbial,B,O
photolyase,I,O
genes,I,O
),O,O
cDNAs,O,O
",",O,O
were,O,O
overexpressed,O,O
",",O,O
respectively,O,O
",",O,O
in,O,O
yeast,O,O
and,O,O
Escherichia,O,B
coli,O,I
mutants,O,O
hypersensitive,O,O
to,O,O
ultraviolet,O,O
light,O,O
.,O,O
Naval,O,O
personnel,O,O
who,O,O
exceed,O,O
standards,O,O
for,O,O
%,O,O
BF,O,O
can,O,O
be,O,O
separated,O,O
from,O,O
active,O,O
duty,O,O
.,O,O
No,O,O
significant,O,O
differences,O,O
existed,O,O
between,O,O
the,O,O
two,O,O
age,O,O
groups,O,O
in,O,O
baseline,O,O
characteristics,O,O
",",O,O
including,O,O
treatment,O,O
protocol,O,O
",",O,O
performance,O,O
status,O,O
",",O,O
and,O,O
serum,B,O
lactate,I,O
dehydrogenase,I,O
(,O,O
LDH,B,B
),O,O
level,O,O
.,O,O
Hepatitis,B,O
B,I,B
surface,I,I
antigen,I,I
was,O,O
detected,O,O
in,O,O
2,O,O
patients,O,O
",",O,O
with,O,O
negative,O,O
hepatitis,B,O
C,I,B
virus,I,I
antibody,I,I
.,O,O
The,O,O
presence,O,O
of,O,O
the,O,O
RV,O,B
5,O,I
',O,I
(,O,O
+,O,O
),O,O
SL,O,B
sequence,O,I
had,O,O
the,O,O
primary,O,O
enhancing,O,O
effect,O,O
on,O,O
translation,O,O
.,O,O
There,O,O
was,O,O
a,O,O
general,O,O
broadening,O,O
of,O,O
proton,O,O
resonances,O,O
for,O,O
a,O,O
three,O,O
-,O,O
nucleotide,O,O
segment,O,O
centered,O,O
about,O,O
the,O,O
lesion,O,O
site,O,O
which,O,O
resulted,O,O
in,O,O
a,O,O
tentative,O,O
assignment,O,O
for,O,O
the,O,O
sugar,O,O
protons,O,O
of,O,O
the,O,O
C7,O,O
residue,O,O
in,O,O
the,O,O
spectrum,O,O
of,O,O
the,O,O
adduct,O,O
duplex,O,O
.,O,O
No,O,O
difference,O,O
in,O,O
telomere,O,O
length,O,O
was,O,O
seen,O,O
in,O,O
mutants,O,O
affected,O,O
in,O,O
the,O,O
regulation,O,O
of,O,O
Cdc2,B,B
",",O,O
whereas,O,O
some,O,O
of,O,O
the,O,O
DNA,O,O
repair,O,O
mutants,O,O
examined,O,O
had,O,O
slightly,O,O
longer,O,O
telomeres,O,O
than,O,O
did,O,O
the,O,O
wild,O,O
type,O,O
.,O,O
Comparison,O,O
of,O,O
remnant,O,O
-,O,O
like,O,O
lipoprotein,O,O
particles,O,O
in,O,O
postmenopausal,O,O
women,O,O
with,O,O
and,O,O
without,O,O
coronary,O,O
artery,O,O
disease,O,O
and,O,O
in,O,O
men,O,O
with,O,O
coronary,O,O
artery,O,O
disease,O,O
.,O,O
Further,O,O
",",O,O
the,O,O
reduction,O,O
in,O,O
5,O,B
-,O,I
hydroxytryptophan,O,I
(,O,O
5,O,B
-,O,I
HTP,O,I
),O,O
accumulation,O,O
by,O,O
LSD,O,O
showed,O,O
regional,O,O
differences,O,O
in,O,O
inhibition,O,O
by,O,O
methiothepin,O,O
(,O,O
hypothalamus,O,O
greater,O,O
than,O,O
cortex,O,O
greater,O,O
than,O,O
striatum,O,O
),O,O
which,O,O
paralleled,O,O
the,O,O
autoreceptor,O,O
antagonist,O,O
activity,O,O
of,O,O
methiothepin,O,O
in,O,O
vitro,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
250,O,O
WORDS,O,O
),O,O
Internal,O,O
modes,O,O
of,O,O
a,O,O
soliton,O,O
.,O,O
They,O,O
also,O,O
discuss,O,O
the,O,O
existing,O,O
nomenclature,O,O
.,O,O
ACE,B,B
-,I,I
2,I,I
has,O,O
a,O,O
hydrophobic,O,O
C,O,O
terminus,O,O
of,O,O
H,O,B
type,O,I
.,O,O
Umweltchem,O,O
.,O,O
The,O,O
gene,O,O
structure,O,O
of,O,O
Elk1,B,B
spans,O,O
15,O,O
.,O,O
2,O,O
kb,O,O
and,O,O
consists,O,O
of,O,O
seven,O,O
exons,O,O
and,O,O
six,O,O
introns,O,O
.,O,O
Northern,O,O
blot,O,O
analysis,O,O
of,O,O
total,O,O
cellular,O,O
RNA,O,O
indicated,O,O
that,O,O
xylP,B,B
encodes,O,O
a,O,O
1,O,O
.,O,O
3,O,O
-,O,O
kb,O,O
transcript,O,O
which,O,O
is,O,O
induced,O,O
by,O,O
xylan,O,O
.,O,O
Although,O,O
there,O,O
are,O,O
no,O,O
octamer,O,O
elements,O,O
in,O,O
the,O,O
adenovirus,O,B
genome,O,I
that,O,O
are,O,O
known,O,O
to,O,O
be,O,O
important,O,O
for,O,O
transcription,O,O
",",O,O
there,O,O
are,O,O
octamer,O,O
elements,O,O
in,O,O
the,O,O
viral,O,O
terminal,O,O
repeat,O,O
sequences,O,O
.,O,O
Here,O,O
",",O,O
we,O,O
present,O,O
evidence,O,O
that,O,O
exposure,O,O
of,O,O
DT40,O,B
lymphoma,O,I
B,O,I
cells,O,I
to,O,O
low,O,O
energy,O,O
electromagnetic,O,O
field,O,O
(,O,O
EMF,O,B
),O,O
results,O,O
in,O,O
a,O,O
tyrosine,B,O
kinase,I,O
-,O,O
dependent,O,O
activation,O,O
of,O,O
phospholipase,B,O
Cgamma2,I,B
(,O,O
PLC,B,B
-,I,I
gamma2,I,I
),O,O
leading,O,O
to,O,O
increased,O,O
inositol,O,O
phospholipid,O,O
turnover,O,O
.,O,O
An,O,O
11,O,O
-,O,O
month,O,O
-,O,O
old,O,O
girl,O,O
suffering,O,O
from,O,O
Dandy,O,B
-,O,I
Walker,O,I
malformation,O,I
(,O,O
DWM,O,B
),O,O
associated,O,O
with,O,O
tetralogy,O,O
of,O,O
Fallot,O,B
(,O,O
TOF,O,B
),O,O
is,O,O
presented,O,O
.,O,O
This,O,O
generalization,O,O
of,O,O
MFP,O,B
involves,O,O
defining,O,O
an,O,O
appropriate,O,O
high,O,O
-,O,O
resolution,O,O
cost,O,O
function,O,O
",",O,O
parametrizing,O,O
the,O,O
search,O,O
space,O,O
of,O,O
the,O,O
environment,O,O
and,O,O
source,O,O
",",O,O
constructing,O,O
solutions,O,O
of,O,O
the,O,O
wave,O,O
equation,O,O
",",O,O
and,O,O
utilizing,O,O
a,O,O
nonlinear,O,O
optimization,O,O
method,O,O
to,O,O
search,O,O
the,O,O
parameter,O,O
landscape,O,O
for,O,O
the,O,O
global,O,O
minimum,O,O
of,O,O
the,O,O
cost,O,O
function,O,O
.,O,O
A,O,O
dose,O,O
-,O,O
dependent,O,O
fall,O,O
in,O,O
GABA,O,B
content,O,O
was,O,O
observed,O,O
;,O,O
GABA,O,B
decrease,O,O
was,O,O
evident,O,O
15,O,O
min,O,O
after,O,O
the,O,O
administration,O,O
",",O,O
reached,O,O
its,O,O
nadir,O,O
at,O,O
60,O,O
min,O,O
and,O,O
disappeared,O,O
at,O,O
120,O,O
minutes,O,O
.,O,O
Two,O,O
splice,O,O
variants,O,O
of,O,O
ALF1,B,B
cDNA,I,I
have,O,O
been,O,O
found,O,O
",",O,O
differing,O,O
by,O,O
a,O,O
72,O,O
-,O,O
bp,O,O
insertion,O,O
",",O,O
coding,O,O
for,O,O
putative,O,O
proteins,O,O
of,O,O
682,O,O
and,O,O
706,O,O
amino,O,O
acids,O,O
.,O,O
Efficacy,O,O
of,O,O
cervical,O,O
spine,O,O
immobilization,O,O
methods,O,O
.,O,O
The,O,O
class,B,O
II,I,O
Escherichia,I,B
coli,I,I
alanine,I,I
tRNA,I,I
synthetase,I,I
aminoacylates,I,O
RNA,I,B
miniduplexes,I,I
",",O,O
which,O,O
reconstruct,O,O
the,O,O
acceptor,O,O
end,O,O
of,O,O
alanine,B,I
tRNA,I,I
with,O,O
the,O,O
critical,O,O
G3,O,B
:,O,O
U70,O,B
base,O,I
pair,O,I
.,O,O
Twenty,O,O
eligible,O,O
patients,O,O
with,O,O
cirrhosis,O,O
were,O,O
randomized,O,O
into,O,O
two,O,O
groups,O,O
:,O,O
10,O,O
patients,O,O
treated,O,O
with,O,O
6,O,O
million,O,O
units,O,O
of,O,O
natural,O,O
IFN,B,B
-,I,I
beta,I,I
twice,O,O
a,O,O
week,O,O
for,O,O
36,O,O
months,O,O
and,O,O
10,O,O
patients,O,O
without,O,O
IFN,B,B
therapy,O,O
.,O,O
The,O,O
results,O,O
indicate,O,O
that,O,O
hrpRS,B,B
and,O,O
hrpL,B,B
are,O,O
part,O,O
of,O,O
a,O,O
regulatory,O,O
cascade,O,O
in,O,O
which,O,O
HrpR,B,B
and,O,O
HrpS,B,B
activate,O,O
expression,O,O
of,O,O
hrpL,B,B
and,O,O
HrpL,B,B
",",O,O
a,O,O
putative,O,O
sigma,B,O
factor,I,O
",",O,O
induces,O,O
expression,O,O
of,O,O
HrpL,B,B
-,I,I
responsive,I,I
genes,I,I
.,O,O
BACKGROUND,O,O
:,O,O
The,O,O
c,B,O
-,I,O
myc,I,B
proto,I,I
-,I,I
oncogene,I,I
has,O,O
been,O,O
suggested,O,O
to,O,O
play,O,O
key,O,O
roles,O,O
in,O,O
cell,O,O
proliferation,O,O
",",O,O
differentiation,O,O
",",O,O
transformation,O,O
and,O,O
apoptosis,O,O
.,O,O
These,O,O
findings,O,O
suggest,O,O
one,O,O
potential,O,O
mechanism,O,O
for,O,O
direct,O,O
recruitment,O,O
of,O,O
distal,O,O
regulatory,O,O
regions,O,O
of,O,O
the,O,O
globin,B,B
loci,I,I
to,O,O
the,O,O
individual,O,O
promoters,O,O
.,O,O
By,O,O
in,O,O
vitro,O,O
immunoprecipitations,O,O
and,O,O
gel,O,O
shift,O,O
assays,O,O
",",O,O
we,O,O
identified,O,O
two,O,O
classes,O,O
of,O,O
high,O,O
affinity,O,O
Engrailed,B,B
-,I,I
binding,I,I
sites,I,I
upstream,O,O
of,O,O
each,O,O
of,O,O
the,O,O
two,O,O
polyhomeotic,O,B
transcription,O,I
units,O,I
.,O,O
A,O,O
possible,O,O
role,O,O
for,O,O
the,O,O
mixed,O,O
function,O,O
oxidase,B,O
enzyme,O,O
system,O,O
in,O,O
the,O,O
requirement,O,O
for,O,O
selenium,O,O
in,O,O
the,O,O
rat,O,O
.,O,O
Moreover,O,O
",",O,O
the,O,O
hypoxia,O,O
-,O,O
induced,O,O
expression,O,O
of,O,O
the,O,O
endogenous,O,O
Epo,B,B
gene,I,I
was,O,O
significantly,O,O
inhibited,O,O
in,O,O
Hep3B,O,O
cells,O,O
stably,O,O
transfected,O,O
with,O,O
HNF,B,B
-,I,I
4,I,I
delta,I,I
C,I,I
.,O,O
The,O,O
general,O,O
transcription,B,O
factor,I,O
IIA,I,B
(,O,O
TFIIA,B,B
),O,O
interacts,O,O
with,O,O
the,O,O
TATA,B,B
binding,I,I
protein,I,I
(,O,O
TBP,B,B
),O,O
and,O,O
promoter,O,O
DNA,O,O
to,O,O
mediate,O,O
transcription,O,O
activation,O,O
in,O,O
vitro,O,O
.,O,O
Training,O,O
for,O,O
audit,O,O
.,O,O
The,O,O
content,O,O
of,O,O
glucosamine,O,B
and,O,O
galactosamine,O,B
in,O,O
tartar,O,O
ID,O,O
-,O,O
PaGIA,O,O
diphtheria,B,O
toxin,I,O
polymer,O,O
particle,O,O
diagnostic,O,O
agent,O,O
manufactured,O,O
by,O,O
DiaMed,O,O
AG,O,O
",",O,O
Switzerland,O,O
",",O,O
was,O,O
tried,O,O
at,O,O
bacteriological,O,O
laboratory,O,O
of,O,O
Institute,O,O
of,O,O
Childhood,O,O
Infections,O,O
in,O,O
St,O,O
.,O,O
CD4,B,B
lymphocyte,O,I
and,O,O
viral,O,O
load,O,O
levels,O,O
suggested,O,O
an,O,O
optimal,O,O
response,O,O
to,O,O
ARV,O,B
therapy,O,O
at,O,O
the,O,O
time,O,O
LD,O,O
developed,O,O
.,O,O
Homozygous,O,O
embryos,O,O
also,O,O
displayed,O,O
abnormalities,O,O
in,O,O
heart,O,O
development,O,O
",",O,O
consistent,O,O
with,O,O
the,O,O
conclusion,O,O
that,O,O
Tek,B,B
is,O,O
necessary,O,O
for,O,O
endocardial,O,O
/,O,O
myocardial,O,O
interactions,O,O
during,O,O
development,O,O
.,O,O
The,O,O
non,O,O
-,O,O
role,O,O
of,O,O
fluoride,O,O
in,O,O
the,O,O
control,O,O
of,O,O
plasma,O,O
calcium,O,O
in,O,O
the,O,O
parathyroidectomized,O,O
rat,O,O
.,O,O
Alternative,O,O
splicing,O,O
of,O,O
fibroblast,B,O
growth,I,O
factor,I,O
receptor,I,O
2,I,O
(,O,O
FGF,B,B
-,I,I
R2,I,I
),O,O
is,O,O
an,O,O
example,O,O
of,O,O
highly,O,O
regulated,O,O
alternative,O,O
splicing,O,O
in,O,O
which,O,O
exons,O,O
IIIb,O,O
and,O,O
IIIc,O,O
are,O,O
utilized,O,O
in,O,O
a,O,O
mutually,O,O
exclusive,O,O
manner,O,O
in,O,O
different,O,O
cell,O,O
types,O,O
.,O,O
ORF,O,O
2,O,O
potentially,O,O
encoded,O,O
a,O,O
hydrophobic,O,O
protein,O,O
of,O,O
29,O,O
",",O,O
705,O,O
Da,O,O
with,O,O
six,O,O
potential,O,O
membrane,O,O
-,O,O
spanning,O,O
regions,O,O
.,O,O
Effects,O,O
of,O,O
a,O,O
perfluorochemical,O,O
blood,O,O
substitute,O,O
on,O,O
diazepam,O,O
binding,O,O
by,O,O
human,B,B
albumin,I,I
.,O,O
Isolation,O,O
of,O,O
cDNAs,B,O
encoding,I,O
gibbon,I,O
and,I,O
monkey,I,O
platelet,I,O
and,I,O
T,I,O
cell,I,O
activation,I,O
antigen,I,O
1,I,O
(,O,O
PTA1,B,B
),O,O
.,O,O
Since,O,O
the,O,O
regulation,O,O
of,O,O
SWI4,B,B
is,O,O
required,O,O
for,O,O
normal,O,O
cell,O,O
cycle,O,O
progression,O,O
",",O,O
we,O,O
have,O,O
characterized,O,O
cis,O,O
-,O,O
and,O,O
trans,O,O
-,O,O
acting,O,O
regulators,O,O
of,O,O
SWI4,B,B
transcription,O,O
.,O,O
Liquid,O,O
chromatographic,O,O
method,O,O
for,O,O
determination,O,O
of,O,O
citreoviridin,O,B
in,O,O
corn,O,O
and,O,O
rice,O,O
.,O,O
Surprisingly,O,O
",",O,O
there,O,O
is,O,O
no,O,O
sequence,O,O
homology,O,O
between,O,O
this,O,O
region,O,O
of,O,O
Ly,B,O
-,I,O
6E,I,O
and,O,O
the,O,O
established,O,O
consensus,O,O
for,O,O
the,O,O
interferon,B,O
-,I,O
stimulated,I,O
response,I,O
element,I,O
",",O,O
which,O,O
has,O,O
been,O,O
shown,O,O
functionally,O,O
important,O,O
to,O,O
all,O,O
previously,O,O
characterized,O,O
alpha,B,O
/,I,O
beta,I,O
interferon,I,O
-,O,O
inducible,O,O
promoters,O,O
.,O,O
ICAM,B,B
-,I,I
1,I,O
has,O,O
been,O,O
suggested,O,O
a,O,O
predictor,O,O
of,O,O
the,O,O
onset,O,O
of,O,O
GO,O,O
.,O,O
Adjacent,O,O
to,O,O
those,O,O
lesions,O,O
",",O,O
and,O,O
in,O,O
homologous,O,O
contralateral,O,O
structures,O,O
",",O,O
FMZ,O,B
binding,O,O
was,O,O
analysed,O,O
in,O,O
four,O,O
pairs,O,O
of,O,O
cortical,O,O
9,O,O
x,O,O
9,O,O
-,O,O
mm,O,O
regions,O,O
of,O,O
interest,O,O
(,O,O
ROIs,O,O
),O,O
placed,O,O
on,O,O
transaxial,O,O
and,O,O
coronal,O,O
slices,O,O
",",O,O
respectively,O,O
",",O,O
as,O,O
well,O,O
as,O,O
in,O,O
the,O,O
lesion,O,O
volume,O,O
and,O,O
its,O,O
mirror,O,O
region,O,O
.,O,O
In,O,O
the,O,O
SPK,O,B
and,O,O
PTA,O,B
category,O,O
",",O,O
anti,O,O
-,O,O
T,O,B
-,O,I
cell,O,I
therapy,O,O
significantly,O,O
lowered,O,O
the,O,O
risk,O,O
of,O,O
graft,O,O
loss,O,O
.,O,O
These,O,O
changes,O,O
in,O,O
virus,O,O
entry,O,O
features,O,O
may,O,O
result,O,O
in,O,O
coronaviruses,O,O
with,O,O
novel,O,O
pathogenic,O,O
properties,O,O
.,O,O
In,O,O
the,O,O
present,O,O
article,O,O
",",O,O
the,O,O
causes,O,O
of,O,O
death,O,O
or,O,O
ill,O,O
-,O,O
being,O,O
as,O,O
found,O,O
in,O,O
10,O,O
consecutive,O,O
carcinogenicity,O,O
studies,O,O
-,O,O
-,O,O
5,O,O
studies,O,O
with,O,O
2400,O,O
OFA,O,B
(,O,O
Sprague,O,B
-,O,I
Dawley,O,I
-,O,I
derived,O,I
),O,O
and,O,O
Wistar,O,B
rats,O,O
and,O,O
5,O,O
studies,O,O
with,O,O
2400,O,O
OF1,O,B
and,O,O
NMRI,O,B
mice,O,O
-,O,O
-,O,O
were,O,O
re,O,O
-,O,O
examined,O,O
.,O,O
Analysis,O,O
of,O,O
lacZ,B,B
transcriptional,I,I
fusions,I,I
shows,O,O
that,O,O
the,O,O
KdgR,B,B
-,I,I
binding,I,I
sites,I,I
negatively,O,O
affect,O,O
the,O,O
expression,O,O
of,O,O
rsmB,B,B
.,O,O
Many,O,O
factors,O,O
do,O,O
influence,O,O
the,O,O
educational,O,O
outcome,O,O
in,O,O
students,O,O
and,O,O
large,O,O
statistical,O,O
power,O,O
(,O,O
such,O,O
as,O,O
meta,O,O
analysis,O,O
),O,O
should,O,O
be,O,O
helpful,O,O
to,O,O
eliminate,O,O
many,O,O
sources,O,O
of,O,O
error,O,O
.,O,O
The,O,O
relation,O,O
between,O,O
myocardial,B,O
beta,I,B
-,I,I
adrenergic,I,I
receptor,I,I
and,O,O
left,O,O
ventricular,O,O
(,O,O
LV,O,O
),O,O
function,O,O
was,O,O
studied,O,O
in,O,O
10,O,O
patients,O,O
",",O,O
aged,O,O
41,O,O
to,O,O
61,O,O
years,O,O
(,O,O
average,O,O
51,O,O
),O,O
",",O,O
with,O,O
LV,O,O
volume,O,O
overload,O,O
mainly,O,O
due,O,O
to,O,O
chronic,O,O
mitral,O,O
regurgitation,O,O
.,O,O
In,O,O
transient,O,O
cotransfection,O,O
assays,O,O
using,O,O
Chang,O,B
liver,O,I
cells,O,I
(,O,O
CCL,O,B
13,O,I
),O,O
",",O,O
pM1,O,B
DNA,O,I
exerts,O,O
a,O,O
6,O,O
-,O,O
to,O,O
10,O,O
-,O,O
fold,O,O
trans,O,O
-,O,O
activating,O,O
effect,O,O
on,O,O
the,O,O
expression,O,O
of,O,O
the,O,O
pSV2CAT,O,B
reporter,O,I
plasmid,O,I
.,O,O
As,O,O
expected,O,O
",",O,O
the,O,O
insulin,B,B
effect,O,O
to,O,O
increase,O,O
ras,B,B
GTP,I,I
formation,O,I
and,O,O
MAP,B,B
kinase,I,I
activity,O,I
was,O,O
negligible,O,O
in,O,O
A,O,O
/,O,O
K1018,O,O
cells,O,O
but,O,O
normal,O,O
",",O,O
or,O,O
supernormal,O,O
",",O,O
in,O,O
Y,O,O
/,O,O
F2,O,O
cells,O,O
.,O,O
Expression,O,O
of,O,O
the,O,O
human,O,B
T,B,B
cell,I,I
receptor,I,I
(,I,O
TCR,I,B
),I,O
alpha,I,B
gene,I,I
is,O,O
regulated,O,O
by,O,O
a,O,O
T,O,B
cell,O,I
-,O,I
specific,O,I
transcriptional,O,I
enhancer,O,I
that,O,O
is,O,O
located,O,O
4,O,O
.,O,O
5,O,O
kilobases,O,O
(,O,O
kb,O,O
),O,O
3,O,O
',O,O
to,O,O
the,O,O
C,B,B
alpha,I,I
gene,I,I
segment,I,I
.,O,O
I,O,O
report,O,O
here,O,O
that,O,O
induction,O,O
of,O,O
HSP82,B,B
is,O,O
regulated,O,O
by,O,O
the,O,O
early,O,O
meiotic,O,O
IME1,B,B
-,O,I
IME2,B,I
transcriptional,O,I
cascade,O,I
.,O,O
This,O,O
report,O,O
substantiates,O,O
that,O,O
at,O,O
least,O,O
two,O,O
of,O,O
the,O,O
18,O,O
kDa,O,O
hsps,B,O
in,O,O
maize,O,O
are,O,O
products,O,O
of,O,O
different,O,O
but,O,O
related,O,O
genes,O,O
.,O,O
Ga,O,B
-,O,I
67,O,I
and,O,O
Tl,O,B
-,O,I
201,O,I
scintigraphy,O,O
in,O,O
extramedullary,O,O
plasmacytoma,O,O
:,O,O
a,O,O
case,O,O
report,O,O
.,O,O
Oligonucleotide,O,O
competitors,O,O
were,O,O
used,O,O
to,O,O
evaluate,O,O
the,O,O
accessibility,O,O
of,O,O
the,O,O
TATA,O,B
-,O,I
binding,O,I
site,O,I
in,O,O
TIF,B,B
-,I,I
IB,I,I
",",O,O
TFIID,B,B
",",O,O
and,O,O
TFIIIB,B,B
.,O,O
The,O,O
findings,O,O
suggest,O,O
that,O,O
",",O,O
although,O,O
iodine,O,B
deficiency,O,I
is,O,O
the,O,O
most,O,O
probable,O,O
cause,O,O
of,O,O
goiter,O,O
among,O,O
immigrants,O,O
of,O,O
the,O,O
1928,O,O
cohort,O,O
",",O,O
where,O,O
the,O,O
native,O,O
population,O,O
is,O,O
concerned,O,O
(,O,O
both,O,O
men,O,O
and,O,O
women,O,O
),O,O
",",O,O
some,O,O
other,O,O
goitrogenic,O,O
factor,O,O
(,O,O
s,O,O
),O,O
must,O,O
be,O,O
involved,O,O
.,O,O
To,O,O
our,O,O
knowledge,O,O
this,O,O
is,O,O
the,O,O
first,O,O
case,O,O
in,O,O
which,O,O
a,O,O
probable,O,O
association,O,O
between,O,O
cholelithiasis,O,B
and,O,O
Wildervanck,O,B
',O,I
s,O,I
syndrome,O,I
has,O,O
been,O,O
recorded,O,O
.,O,O
Schistosoma,O,B
mansoni,O,I
schistosomiasis,O,O
],O,O
Schistosomosis,O,O
are,O,O
parasitic,O,O
diseases,O,O
caused,O,O
by,O,O
blood,O,O
flukes,O,O
of,O,O
the,O,O
Schistosoma,O,B
genus,O,O
.,O,O
Our,O,O
data,O,O
",",O,O
however,O,O
",",O,O
did,O,O
not,O,O
suggest,O,O
the,O,O
existence,O,O
of,O,O
a,O,O
conversion,O,O
factor,O,O
for,O,O
LDF,O,O
signal,O,O
to,O,O
absolute,O,O
flow,O,O
values,O,O
from,O,O
experiment,O,O
to,O,O
experiment,O,O
.,O,O
Insertion,O,O
of,O,O
short,O,O
oligonucleotides,O,O
encoding,O,O
the,O,O
basic,O,O
amino,O,O
acid,O,O
motifs,O,O
726,O,O
-,O,O
GRKRKSP,O,B
-,O,I
732,O,I
from,O,O
IE175,B,O
and,O,O
500,O,O
-,O,O
VRPRKRR,O,B
-,O,I
506,O,I
from,O,O
IE110,B,O
into,O,O
deleted,O,O
cytoplasmic,O,O
forms,O,O
of,O,O
the,O,O
two,O,O
proteins,O,O
restored,O,O
the,O,O
karyophilic,O,O
phenotype,O,O
and,O,O
confirmed,O,O
that,O,O
these,O,O
motifs,O,O
are,O,O
both,O,O
necessary,O,O
and,O,O
sufficient,O,O
for,O,O
proper,O,O
nuclear,O,O
localization,O,O
.,O,O
Control,O,O
examination,O,O
was,O,O
performed,O,O
at,O,O
the,O,O
end,O,O
of,O,O
each,O,O
period,O,O
.,O,O
Addition,O,O
of,O,O
phalloidin,O,B
-,O,I
stabilized,O,I
F,B,B
-,I,I
actin,I,I
nuclei,O,O
and,O,O
phalloidin,O,B
restored,O,O
L266D,O,B
actin,B,I
',O,O
s,O,O
ability,O,O
to,O,O
polymerize,O,O
at,O,O
4,O,O
degrees,O,O
C,O,O
.,O,O
The,O,O
protein,O,O
product,O,O
of,O,O
orfD,B,B
",",O,O
which,O,O
is,O,O
probably,O,O
a,O,O
new,O,O
tra,B,B
gene,I,O
(,O,O
named,O,O
traX,B,B
),O,O
",",O,O
contains,O,O
65,O,O
%,O,O
hydrophobic,O,O
amino,O,O
acids,O,O
",",O,O
especially,O,O
rich,O,O
in,O,O
alanine,O,B
and,O,O
leucine,O,B
.,O,O
Pure,O,O
T1,O,B
and,O,O
dual,O,O
-,O,O
T1,O,B
images,O,O
were,O,O
visually,O,O
evaluated,O,O
for,O,O
image,O,O
quality,O,O
(,O,O
IQ,O,O
),O,O
on,O,O
a,O,O
five,O,O
-,O,O
point,O,O
scale,O,O
(,O,O
0,O,O
=,O,O
unacceptable,O,O
to,O,O
4,O,O
=,O,O
excellent,O,O
),O,O
.,O,O
The,O,O
Thr161Val,O,B
mutation,O,O
causes,O,O
a,O,O
lethal,O,O
phenotype,O,O
in,O,O
the,O,O
fission,O,O
yeast,O,O
Schizosaccharomyces,O,B
pombe,O,I
",",O,O
while,O,O
replacement,O,O
of,O,O
Thr161,O,B
with,O,O
glutamic,O,O
acid,O,O
",",O,O
potentially,O,O
mimicking,O,O
phosphorylation,O,O
",",O,O
causes,O,O
uncoordination,O,O
of,O,O
mitosis,O,O
and,O,O
multiple,O,O
cytokinesis,O,O
.,O,O
The,O,O
effect,O,O
of,O,O
hydrostatic,O,O
pressure,O,O
on,O,O
the,O,O
swimming,O,O
activity,O,O
of,O,O
three,O,O
hyponeustonic,O,O
crustacea,O,O
",",O,O
Anomalocera,O,B
patersoni,O,I
",",O,O
Pontella,O,B
mediterranea,O,I
",",O,O
Labidocera,O,B
wollastoni,O,I
Animals,O,O
were,O,O
put,O,O
to,O,O
death,O,O
8,O,O
weeks,O,O
later,O,O
and,O,O
the,O,O
grafts,O,O
were,O,O
sterilely,O,O
explanted,O,O
and,O,O
analyzed,O,O
via,O,O
microbiologic,O,O
culture,O,O
and,O,O
standard,O,O
histologic,O,O
procedures,O,O
for,O,O
evidence,O,O
of,O,O
infection,O,O
.,O,O
Recently,O,O
",",O,O
roles,O,O
also,O,O
have,O,O
been,O,O
suggested,O,O
for,O,O
the,O,O
nuclear,O,O
trans,O,O
-,O,O
factor,O,O
GATA,B,B
-,I,I
1,I,I
in,O,O
regulating,O,O
progenitor,O,O
cell,O,O
proliferation,O,O
.,O,O
Six,O,O
distinct,O,O
Ets,B,B
mRNAs,I,O
were,O,O
identified,O,O
:,O,O
Ets2,B,B
",",O,O
Fli1,B,B
",",O,O
GABPalpha,B,B
",",O,O
SAP1,B,B
",",O,O
Elk1,B,B
",",O,O
and,O,O
PE1,B,B
.,O,O
During,O,O
the,O,O
observation,O,O
period,O,O
of,O,O
0,O,O
.,O,O
4,O,O
-,O,O
30,O,O
weeks,O,O
",",O,O
cardiac,O,O
white,O,O
spots,O,O
on,O,O
the,O,O
right,O,O
ventricle,O,O
of,O,O
BALB,O,O
/,O,O
c,O,O
mice,O,O
were,O,O
first,O,O
detected,O,O
at,O,O
three,O,O
weeks,O,O
(,O,O
6,O,O
of,O,O
20,O,O
mice,O,O
;,O,O
30,O,O
%,O,O
),O,O
",",O,O
and,O,O
the,O,O
maximal,O,O
incidence,O,O
of,O,O
cardiac,O,O
white,O,O
spots,O,O
was,O,O
obtained,O,O
at,O,O
nine,O,O
weeks,O,O
(,O,O
39,O,O
of,O,O
44,O,O
mice,O,O
;,O,O
88,O,O
%,O,O
),O,O
.,O,O
The,O,O
early,O,O
dg,O,O
.,O,O
of,O,O
rejection,O,O
and,O,O
especially,O,O
acute,O,O
rejection,O,O
",",O,O
it,O,O
',O,O
s,O,O
adequate,O,O
management,O,O
",",O,O
decreased,O,O
risk,O,O
for,O,O
the,O,O
future,O,O
chronic,O,O
rejection,O,O
nephropathy,O,O
.,O,O
These,O,O
two,O,O
repeat,O,O
motifs,O,O
are,O,O
organized,O,O
in,O,O
an,O,O
extremely,O,O
well,O,O
-,O,O
ordered,O,O
pattern,O,O
in,O,O
each,O,O
domain,O,O
",",O,O
which,O,O
suggests,O,O
that,O,O
SbHRGP3,B,B
belongs,O,O
to,O,O
a,O,O
new,O,O
group,O,O
of,O,O
proteins,O,O
having,O,O
the,O,O
repeat,O,O
motifs,O,O
of,O,O
two,O,O
distinct,O,O
groups,O,O
of,O,O
dicot,B,O
extensins,I,O
.,O,O
Allergic,O,O
reaction,O,O
to,O,O
Patent,O,B
Blue,O,I
Violet,O,I
during,O,O
lymphography,O,O
.,O,O
Naphthalene,O,O
and,O,O
paradichlorobenzene,O,O
in,O,O
clinical,O,O
toxicology,O,O
The,O,O
most,O,O
important,O,O
one,O,O
among,O,O
them,O,O
is,O,O
Cyclosporin,O,B
A,O,I
",",O,O
which,O,O
is,O,O
a,O,O
selective,O,O
immunosuppressive,O,O
drug,O,O
.,O,O
Both,O,O
NUP98,B,B
-,O,I
HOXA9,B,I
chimeras,O,O
transformed,O,O
NIH,O,O
3T3,O,O
fibroblasts,O,O
",",O,O
and,O,O
this,O,O
transformation,O,O
required,O,O
the,O,O
HOXA9,B,B
domains,I,O
for,O,O
DNA,O,O
binding,O,O
and,O,O
PBX,B,O
interaction,O,O
.,O,O
RESULTS,O,O
:,O,O
Patients,O,O
in,O,O
Group,O,O
A,O,O
had,O,O
a,O,O
higher,O,O
incidence,O,O
of,O,O
posterolateral,O,O
wall,O,O
motion,O,O
abnormalities,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
on,O,O
radionuclide,O,O
ventriculography,O,O
",",O,O
a,O,O
larger,O,O
infarct,O,O
area,O,O
(,O,O
as,O,O
evidenced,O,O
by,O,O
higher,O,O
peak,O,O
creatine,B,O
kinase,I,O
levels,O,O
),O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
02,O,O
),O,O
and,O,O
a,O,O
lower,O,O
left,O,O
ventricular,O,O
ejection,O,O
fraction,O,O
(,O,O
LVEF,O,O
),O,O
at,O,O
hospital,O,O
discharge,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
008,O,O
),O,O
than,O,O
those,O,O
in,O,O
Group,O,O
B,O,O
.,O,O
The,O,O
MSL,B,B
complex,I,O
is,O,O
specifically,O,O
localized,O,O
on,O,O
the,O,O
male,O,O
X,O,O
chromosome,O,O
to,O,O
increase,O,O
its,O,O
expression,O,O
approximately,O,O
2,O,O
-,O,O
fold,O,O
.,O,O
The,O,O
Pro,O,O
-,O,O
258,O,O
-,O,O
-,O,O
>,O,O
Leu,O,O
(,O,O
P258L,O,B
),O,O
mutation,O,O
caused,O,O
constitutive,O,O
receptor,O,O
signaling,O,O
that,O,O
was,O,O
equivalent,O,O
to,O,O
about,O,O
45,O,O
%,O,O
of,O,O
the,O,O
maximum,O,O
level,O,O
observed,O,O
in,O,O
wild,O,O
-,O,O
type,O,O
cells,O,O
stimulated,O,O
with,O,O
alpha,B,O
-,I,O
factor,I,O
.,O,O
However,O,O
",",O,O
cotransfection,O,O
studies,O,O
indicate,O,O
that,O,O
RVR,B,B
does,O,O
not,O,O
activate,O,O
transcription,O,O
when,O,O
this,O,O
hormone,O,O
response,O,O
element,O,O
is,O,O
linked,O,O
to,O,O
a,O,O
reporter,O,O
gene,O,O
but,O,O
rather,O,O
acts,O,O
as,O,O
a,O,O
potent,O,O
competitive,O,O
repressor,O,O
of,O,O
ROR,B,B
alpha,I,I
function,O,O
.,O,O
An,O,O
infectious,O,O
origin,O,O
should,O,O
always,O,O
be,O,O
excluded,O,O
since,O,O
specific,O,O
etiologic,O,O
therapy,O,O
may,O,O
be,O,O
implemented,O,O
.,O,O
SETTING,O,O
-,O,O
-,O,O
Delhi,O,O
",",O,O
urban,O,O
India,O,O
",",O,O
1985,O,O
-,O,O
6,O,O
.,O,O
(,O,O
ii,O,O
),O,O
opening,O,O
of,O,O
KATP,O,B
attenuates,O,O
",",O,O
inhibition,O,O
of,O,O
the,O,O
channel,O,O
exacerbates,O,O
functional,O,O
consequences,O,O
of,O,O
coronary,O,O
occlusion,O,O
",",O,O
and,O,O
(,O,O
iii,O,O
),O,O
KATP,O,B
opening,O,O
attenuates,O,O
reperfusion,O,O
-,O,O
induced,O,O
VF,O,O
",",O,O
but,O,O
it,O,O
triggers,O,O
ischemia,O,O
-,O,O
induced,O,O
VF,O,O
.,O,O
ATP,O,B
gamma,O,I
S,O,I
inhibition,O,O
can,O,O
be,O,O
overcome,O,O
by,O,O
high,O,O
concentrations,O,O
of,O,O
ATP,O,B
",",O,O
dATP,O,B
",",O,O
araATP,O,B
",",O,O
or,O,O
ddATP,O,B
.,O,O
The,O,O
selenium,O,B
level,O,O
and,O,O
glutathione,B,B
peroxidase,I,I
activity,O,O
in,O,O
the,O,O
blood,O,O
",",O,O
liver,O,O
",",O,O
and,O,O
stomach,O,O
mucosa,O,O
were,O,O
significantly,O,O
higher,O,O
in,O,O
the,O,O
high,O,O
-,O,O
selenium,O,O
diet,O,O
group,O,O
than,O,O
in,O,O
the,O,O
low,O,O
-,O,O
selenium,O,O
diet,O,O
group,O,O
.,O,O
Increasing,O,O
the,O,O
RH,O,O
beyond,O,O
32,O,O
%,O,O
resulted,O,O
in,O,O
solvation,O,O
of,O,O
the,O,O
peroxy,O,O
radical,O,O
",",O,O
sterically,O,O
hindering,O,O
the,O,O
radical,O,O
from,O,O
entering,O,O
the,O,O
propagation,O,O
transition,O,O
state,O,O
.,O,O
Previous,O,O
genetic,O,O
studies,O,O
led,O,O
to,O,O
the,O,O
conclusion,O,O
that,O,O
nitrate,O,B
and,O,O
nitrite,O,B
induction,O,O
of,O,O
nasF,B,B
operon,I,I
expression,O,O
is,O,O
determined,O,O
by,O,O
a,O,O
transcriptional,O,O
antitermination,O,O
mechanism,O,O
.,O,O
The,O,O
effect,O,O
of,O,O
acute,O,O
",",O,O
mid,O,O
-,O,O
cervical,O,O
spinal,O,O
cord,O,O
lesions,O,O
on,O,O
neuronal,O,O
and,O,O
reflex,O,O
activity,O,O
evoked,O,O
by,O,O
the,O,O
noxious,O,O
visceral,O,O
stimulus,O,O
",",O,O
colorectal,O,O
distension,O,O
(,O,O
CRD,O,B
;,O,O
80,O,O
mmHg,O,O
",",O,O
20,O,O
s,O,O
),O,O
",",O,O
was,O,O
determined,O,O
in,O,O
halothane,O,O
-,O,O
anesthetized,O,O
rats,O,O
.,O,O
A,O,O
mutant,B,O
areA,I,B
product,I,O
truncated,O,O
immediately,O,O
after,O,O
the,O,O
last,O,O
residue,O,O
of,O,O
the,O,O
highly,O,O
conserved,O,O
GATA,B,B
(,I,I
DNA,I,I
-,I,I
binding,I,I
),I,O
domain,I,O
retains,O,O
partial,O,O
function,O,O
.,O,O
Thromboplastic,O,O
and,O,O
fibrynolytic,O,O
activity,O,O
of,O,O
the,O,O
blood,O,O
after,O,O
administration,O,O
of,O,O
intralipid,O,O
in,O,O
men,O,O
with,O,O
history,O,O
of,O,O
myocardial,O,O
infarction,O,O
up,O,O
to,O,O
45,O,O
year,O,O
of,O,O
life,O,O
We,O,O
have,O,O
characterized,O,O
a,O,O
panel,O,O
of,O,O
6,O,O
monoclonal,O,O
antibodies,O,O
raised,O,O
against,O,O
human,B,B
platelet,I,I
talin,I,I
by,O,O
Western,O,O
blotting,O,O
",",O,O
immune,O,O
precipitation,O,O
",",O,O
and,O,O
immunofluorescence,O,O
",",O,O
and,O,O
shown,O,O
that,O,O
antibodies,B,O
TA205,I,O
and,O,O
TD77,B,O
disrupt,O,O
actin,B,O
stress,O,O
fibers,O,O
and,O,O
focal,O,O
adhesions,O,O
",",O,O
and,O,O
inhibit,O,O
cell,O,O
motility,O,O
when,O,O
microinjected,O,O
into,O,O
human,O,B
fibroblasts,O,I
.,O,O
This,O,O
paper,O,O
summarises,O,O
the,O,O
experimental,O,O
evidence,O,O
upon,O,O
which,O,O
the,O,O
clinical,O,O
trials,O,O
of,O,O
aldose,B,B
reductase,I,I
inhibitors,O,I
in,O,O
diabetic,O,O
patients,O,O
have,O,O
been,O,O
initiated,O,O
and,O,O
the,O,O
results,O,O
of,O,O
published,O,O
drug,O,O
trials,O,O
in,O,O
these,O,O
patients,O,O
.,O,O
Diffuse,O,O
white,O,O
matter,O,O
injury,O,O
can,O,O
be,O,O
attributed,O,O
to,O,O
radiation,O,O
and,O,O
associated,O,O
with,O,O
neurological,O,O
deficits,O,O
",",O,O
but,O,O
leukoencephalopathy,O,O
is,O,O
rarely,O,O
observed,O,O
in,O,O
the,O,O
absence,O,O
of,O,O
chemotherapy,O,O
.,O,O
However,O,O
",",O,O
artificially,O,O
ventilated,O,O
rats,O,O
",",O,O
pretreated,O,O
with,O,O
MK,O,B
-,O,I
801,O,I
",",O,O
were,O,O
more,O,O
sensitive,O,O
(,O,O
lethal,O,O
cocaine,O,O
dose,O,O
",",O,O
76,O,O
.,O,O
6,O,O
+,O,O
/,O,O
-,O,O
8,O,O
),O,O
than,O,O
vehicle,O,O
pretreated,O,O
rats,O,O
(,O,O
129,O,O
.,O,O
4,O,O
+,O,O
/,O,O
-,O,O
15,O,O
.,O,O
8,O,O
mg,O,O
/,O,O
kg,O,O
",",O,O
n,O,O
=,O,O
6,O,O
),O,O
",",O,O
indicating,O,O
that,O,O
MK,O,B
-,O,I
801,O,I
may,O,O
increase,O,O
both,O,O
the,O,O
respiratory,O,O
and,O,O
the,O,O
cardiac,O,O
toxicity,O,O
of,O,O
cocaine,O,O
in,O,O
urethane,O,O
anesthetized,O,O
rats,O,O
.,O,O
This,O,O
region,O,O
also,O,O
contains,O,O
a,O,O
gene,O,B
specifying,O,O
a,O,O
Leu,B,B
-,I,I
tRNA,I,I
precursor,I,I
and,O,O
a,O,O
remnant,O,O
of,O,O
a,O,O
tau,O,B
element,O,I
.,O,O
Splenectomized,O,O
patients,O,O
are,O,O
predisposed,O,O
toward,O,O
developing,O,O
overwhelming,O,O
bacterial,O,O
infections,O,O
.,O,O
The,O,O
recently,O,O
developed,O,O
gamma,B,B
-,I,I
interferon,I,I
(,O,O
IFN,B,B
-,I,I
gamma,I,I
),O,O
assay,O,O
system,O,O
for,O,O
the,O,O
diagnosis,O,O
of,O,O
bovine,O,O
tuberculosis,O,O
in,O,O
cattle,O,O
has,O,O
been,O,O
accredited,O,O
by,O,O
the,O,O
Standing,O,O
Committee,O,O
on,O,O
Agriculture,O,O
for,O,O
use,O,O
in,O,O
Australia,O,O
.,O,O
This,O,O
.,O,O
74,O,O
kb,O,O
cDNA,O,O
contains,O,O
an,O,O
open,O,O
reading,O,O
frame,O,O
(,O,O
ORF,O,O
),O,O
of,O,O
477,O,O
bp,O,O
encoding,O,O
a,O,O
polypeptide,O,O
of,O,O
159,O,O
amino,O,O
acids,O,O
(,O,O
aa,O,O
),O,O
which,O,O
differs,O,O
at,O,O
only,O,O
one,O,O
position,O,O
(,O,O
position,O,O
65,O,O
),O,O
from,O,O
the,O,O
human,B,B
U1,I,I
-,I,I
C,I,I
protein,I,I
.,O,O
Mycoplasma,O,O
hominis,O,O
infections,O,O
are,O,O
easily,O,O
missed,O,O
because,O,O
conventional,O,O
methods,O,O
for,O,O
bacterial,O,O
detection,O,O
may,O,O
fail,O,O
.,O,O
METHODS,O,O
:,O,O
302,O,O
consecutive,O,O
patients,O,O
with,O,O
BS,O,B
and,O,O
438,O,O
patients,O,O
with,O,O
other,O,O
rheumatological,O,O
conditions,O,O
were,O,O
surveyed,O,O
for,O,O
the,O,O
presence,O,O
or,O,O
absence,O,O
of,O,O
the,O,O
features,O,O
of,O,O
BS,O,B
by,O,O
means,O,O
of,O,O
a,O,O
standard,O,O
form,O,O
which,O,O
had,O,O
been,O,O
prepared,O,O
according,O,O
to,O,O
ISG,O,O
criteria,O,O
.,O,O
We,O,O
have,O,O
now,O,O
identified,O,O
",",O,O
after,O,O
21,O,O
serial,O,O
undiluted,O,O
passages,O,O
of,O,O
MHV,O,B
",",O,O
a,O,O
small,B,O
DI,I,B
RNA,I,I
",",O,O
DIssF,B,B
",",O,O
which,O,O
is,O,O
efficiently,O,O
packaged,O,O
into,O,O
virions,O,O
.,O,O
In,O,O
a,O,O
recent,O,O
measles,O,B
epidemic,O,I
in,O,O
El,O,B
Paso,O,I
",",O,O
TX,O,O
",",O,O
120,O,O
",",O,O
000,O,O
records,O,O
were,O,O
screened,O,O
using,O,O
these,O,O
criteria,O,O
",",O,O
and,O,O
as,O,O
a,O,O
result,O,O
13,O,O
",",O,O
000,O,O
students,O,O
were,O,O
vaccinated,O,O
.,O,O
In,O,O
these,O,O
constructs,O,O
",",O,O
GUS,B,B
expression,O,O
was,O,O
driven,O,O
by,O,O
promoter,O,O
regions,O,O
derived,O,O
from,O,O
the,O,O
Arabidopsis,B,B
alcohol,I,I
dehydrogenase,I,I
(,O,I
Adh1,B,I
),O,O
",",O,O
maize,B,B
ubiquitin,I,I
(,O,I
Ubi1,B,I
),O,O
",",O,O
rice,B,B
actin,I,I
(,O,I
Act1,B,I
),O,O
and,O,O
CaMV,B,B
35S,I,I
genes,I,I
.,O,O
Both,O,O
Rep78,B,B
and,O,O
Rep68,B,B
cut,O,O
the,O,O
terminal,O,O
AAV,O,B
sequence,O,O
at,O,O
the,O,O
same,O,O
site,O,O
(,O,O
nucleotide,O,O
124,O,O
),O,O
.,O,O
In,O,O
this,O,O
regard,O,O
",",O,O
it,O,O
differs,O,O
from,O,O
a,O,O
recently,O,O
reported,O,O
BFA,O,B
-,O,I
sensitive,O,I
ARF,B,B
-,O,I
GEP,B,I
that,O,O
contains,O,O
a,O,O
Sec7,B,B
domain,I,O
.,O,O
Circulating,O,O
platelets,O,O
may,O,O
be,O,O
activated,O,O
by,O,O
exposed,O,O
triple,O,O
-,O,O
helical,O,O
collagen,B,O
in,O,O
atherosclerotic,O,O
lesions,O,O
in,O,O
Mg,O,B
-,O,I
deficient,O,I
ruminants,O,I
.,O,O
The,O,O
potency,O,O
of,O,O
the,O,O
effect,O,O
of,O,O
Nim,O,B
(,O,O
0,O,O
.,O,O
5,O,O
mg,O,O
.,O,O
kg,O,O
-,O,O
1,O,O
i,O,O
.,O,O
p,O,O
.,O,O
),O,O
was,O,O
similar,O,O
to,O,O
that,O,O
of,O,O
NBP,O,B
(,O,O
10,O,O
mg,O,O
.,O,O
kg,O,O
-,O,O
1,O,O
i,O,O
.,O,O
p,O,O
.,O,O
),O,O
.,O,O
Inhibition,O,O
of,O,O
histalog,O,O
-,O,O
stimulated,O,O
gastric,O,O
secretion,O,O
by,O,O
40,O,O
749,O,O
RP,O,O
",",O,O
a,O,O
new,O,O
long,O,O
-,O,O
acting,O,O
gastric,O,O
antisecretory,O,O
agent,O,O
.,O,O
The,O,O
Spo0F,B,O
residues,I,O
making,O,O
up,O,O
the,O,O
hydrophobic,O,O
patch,O,O
are,O,O
very,O,O
similar,O,O
in,O,O
all,O,O
response,O,O
regulators,O,O
suggesting,O,O
that,O,O
the,O,O
binding,O,O
is,O,O
initiated,O,O
through,O,O
the,O,O
same,O,O
residues,O,O
in,O,O
all,O,O
interacting,O,O
response,O,O
regulator,O,O
-,O,O
kinase,O,O
pairs,O,O
.,O,O
Me,O,O
(,O,O
2,O,O
),O,O
SO,O,O
-,O,O
induced,O,O
neuronal,O,O
differentiation,O,O
of,O,O
N1E,O,O
-,O,O
115,O,O
neuroblastoma,O,O
cells,O,O
increased,O,O
both,O,O
the,O,O
expression,O,O
of,O,O
the,O,O
endogenous,B,O
Ntr,I,B
-,I,I
1,I,I
gene,I,O
and,O,O
reporter,O,O
genes,O,O
driven,O,O
by,O,O
NTR,B,B
-,I,I
1,I,I
promoter,I,O
sequences,I,O
by,O,O
3,O,O
-,O,O
4,O,O
-,O,O
.,O,O
3,O,O
.,O,O
04,O,O
+,O,O
/,O,O
-,O,O
1,O,O
.,O,O
2,O,O
",",O,O
P,O,O
<,O,O
0,O,O
.,O,O
0001,O,O
),O,O
",",O,O
large,O,O
accelerations,O,O
/,O,O
30,O,O
min,O,O
(,O,O
1,O,O
.,O,O
46,O,O
+,O,O
/,O,O
-,O,O
1,O,O
.,O,O
96,O,O
vs,O,O
.,O,O
Resistance,O,O
ratios,O,O
for,O,O
the,O,O
other,O,O
field,O,O
strains,O,O
obtained,O,O
by,O,O
comparison,O,O
with,O,O
the,O,O
R5,O,B
strain,O,O
ranged,O,O
from,O,O
24,O,O
.,O,O
5,O,O
to,O,O
239,O,O
for,O,O
topical,O,O
application,O,O
and,O,O
from,O,O
1,O,O
.,O,O
2,O,O
to,O,O
9,O,O
.,O,O
8,O,O
for,O,O
the,O,O
glass,O,O
jar,O,O
method,O,O
.,O,O
A,O,O
water,O,O
-,O,O
vapour,O,O
giga,O,O
-,O,O
maser,O,O
in,O,O
the,O,O
active,O,O
galaxy,O,O
TXFS2226,O,B
-,O,I
184,O,I
.,O,O
In,O,O
the,O,O
United,O,O
States,O,O
high,O,O
-,O,O
MW,O,O
HES,O,B
480,O,I
which,O,O
is,O,O
difficult,O,O
to,O,O
degrade,O,O
is,O,O
most,O,O
frequently,O,O
used,O,O
and,O,O
results,O,O
in,O,O
a,O,O
larger,O,O
in,O,O
vivo,O,O
MW,O,O
and,O,O
subsequent,O,O
decrease,O,O
in,O,O
factor,B,O
VIII,I,B
/,O,I
von,B,I
Willebrand,I,I
factor,I,I
levels,O,O
.,O,O
Among,O,O
six,O,O
different,O,O
library,O,O
isolates,O,O
containing,O,O
6,B,O
.,I,O
5,I,O
-,I,O
to,I,O
7,I,O
-,I,O
kb,I,O
IAP,I,B
units,I,O
",",O,O
some,O,O
restriction,O,O
sites,O,O
were,O,O
highly,O,O
conserved,O,O
whereas,O,O
others,O,O
varied,O,O
in,O,O
both,O,O
occurrence,O,O
and,O,O
position,O,O
.,O,O
Cytokine,O,O
-,O,O
induced,O,O
NF,B,B
-,I,I
kappa,I,I
B,I,I
DNA,O,I
binding,O,I
activity,O,I
",",O,O
RelA,B,B
nuclear,O,I
translocation,O,I
",",O,O
I,B,B
kappa,I,I
B,I,I
alpha,I,I
degradation,O,I
",",O,O
I,B,B
kappa,I,I
B,I,I
serine,O,I
32,O,I
phosphorylation,O,I
",",O,O
and,O,O
I,B,B
kappa,I,I
B,I,I
kinase,I,I
(,O,I
IKK,B,I
),O,I
activity,O,I
were,O,O
blocked,O,O
by,O,O
curcumin,O,O
treatment,O,O
.,O,O
1,O,O
.,O,O
Actins,B,B
show,O,O
two,O,O
different,O,O
forms,O,O
of,O,O
N,O,B
-,O,I
terminal,O,I
processing,O,O
dependent,O,O
on,O,O
their,O,O
N,O,B
-,O,I
terminal,O,I
sequence,O,I
.,O,O
A,O,O
comparison,O,O
of,O,O
the,O,O
amino,O,O
acid,O,O
sequence,O,O
of,O,O
the,O,O
T,O,O
.,O,O
thermophilus,O,O
enzyme,O,O
with,O,O
that,O,O
of,O,O
the,O,O
Escherichia,O,B
coli,O,I
enzyme,O,O
showed,O,O
(,O,O
i,O,O
),O,O
a,O,O
37,O,O
%,O,O
overall,O,O
similarity,O,O
;,O,O
(,O,O
ii,O,O
),O,O
the,O,O
conservation,O,O
of,O,O
the,O,O
Ser,O,B
residue,O,O
",",O,O
which,O,O
is,O,O
known,O,O
to,O,O
be,O,O
phosphorylated,O,O
in,O,O
the,O,O
E,O,B
enzyme,O,O
",",O,O
and,O,O
of,O,O
the,O,O
surrounding,O,O
sequence,O,O
;,O,O
and,O,O
(,O,O
iii,O,O
),O,O
the,O,O
presence,O,O
of,O,O
141,O,O
extra,O,O
residues,O,O
at,O,O
the,O,O
C,O,O
terminus,O,O
of,O,O
the,O,O
T,O,B
.,O,O
thermophilus,O,O
enzyme,O,O
.,O,O
However,O,O
",",O,O
alterations,O,O
in,O,O
electrostatic,O,O
and,O,O
hydrophobic,O,O
interactions,O,O
created,O,O
by,O,O
the,O,O
three,O,O
amino,O,O
acid,O,O
substitutions,O,O
prevent,O,O
the,O,O
conformational,O,O
change,O,O
in,O,O
the,O,O
enzyme,O,O
usually,O,O
produced,O,O
by,O,O
calmodulin,B,B
binding,O,O
.,O,O
We,O,O
found,O,O
that,O,O
T3,O,B
(,O,O
10,O,O
(,O,O
-,O,O
8,O,O
),O,O
M,O,O
),O,O
selectively,O,O
stimulates,O,O
transcription,O,O
from,O,O
rGH,B,B
-,O,I
TRE,O,I
-,O,I
and,O,O
TREpal,O,B
-,O,I
",",O,O
but,O,O
not,O,O
ME,O,O
-,O,O
TRE,O,O
-,O,O
and,O,O
F2,O,O
-,O,O
TRE,O,O
-,O,O
",",O,O
containing,O,O
templates,O,O
in,O,O
which,O,O
these,O,O
TREs,O,O
are,O,O
linked,O,O
in,O,O
front,O,O
of,O,O
the,O,O
rGH,B,B
minimal,I,I
promoter,I,I
containing,O,I
only,O,I
the,O,I
TATA,B,I
box,I,I
binding,I,I
protein,I,I
",",O,O
but,O,O
not,O,O
any,O,O
other,O,O
proximal,O,O
binding,O,O
protein,O,O
",",O,O
sequence,O,O
.,O,O
All,O,O
ribosomal,B,B
protein,I,I
(,O,O
rp,B,B
),O,O
gene,O,O
promoters,O,O
from,O,O
Saccharomyces,O,B
cerevisiae,O,I
studied,O,O
so,O,O
far,O,O
contain,O,O
either,O,O
(,O,O
usually,O,O
two,O,O
),O,O
binding,O,O
sites,O,O
for,O,O
the,O,O
global,O,O
gene,O,O
regulator,O,O
Rap1p,B,B
or,O,O
one,O,O
binding,O,O
site,O,O
for,O,O
another,O,O
global,O,O
factor,O,O
",",O,O
Abf1p,B,B
.,O,O
All,O,O
three,O,O
NR,B,B
isoforms,O,O
are,O,O
expressed,O,O
in,O,O
cv,O,O
.,O,O
All,O,O
three,O,O
NR,B,B
isoforms,I,O
are,O,O
expressed,O,O
in,O,O
cv,O,O
.,O,O
Heme,B,B
oxygenase,I,I
1,I,O
is,O,O
an,O,O
essential,O,O
enzyme,O,O
in,O,O
heme,O,B
catabolism,O,O
that,O,O
cleaves,O,O
heme,O,B
to,O,O
form,O,O
biliverdin,O,O
",",O,O
iron,O,O
",",O,O
and,O,O
carbon,O,O
monoxide,O,O
.,O,O
The,O,O
results,O,O
are,O,O
discussed,O,O
in,O,O
relation,O,O
to,O,O
acoustical,O,O
models,O,O
of,O,O
sound,O,O
propagation,O,O
and,O,O
physiology,O,O
",",O,O
and,O,O
it,O,O
is,O,O
suggested,O,O
that,O,O
height,O,O
-,O,O
dependent,O,O
degradation,O,O
within,O,O
a,O,O
forest,O,O
is,O,O
an,O,O
important,O,O
selection,O,O
pressure,O,O
for,O,O
transmissibility,O,O
in,O,O
avian,O,O
communication,O,O
.,O,O
The,O,O
suppression,O,O
was,O,O
also,O,O
demonstrated,O,O
in,O,O
a,O,O
transient,O,O
expression,O,O
assay,O,O
in,O,O
vivo,O,O
using,O,O
isolated,O,O
barley,O,O
endosperms,O,O
.,O,O
We,O,O
have,O,O
cloned,O,O
cDNA,O,O
and,O,O
genomic,O,O
DNA,O,O
for,O,O
a,O,O
mouse,O,B
gene,O,O
encoding,O,O
a,O,O
protein,O,O
with,O,O
significant,O,O
sequence,O,O
similarity,O,O
to,O,O
conserved,O,O
domains,O,O
found,O,O
in,O,O
proteins,O,O
of,O,O
the,O,O
Spo11p,B,B
family,I,O
.,O,O
While,O,O
determination,O,O
of,O,O
the,O,O
protein,O,O
content,O,O
of,O,O
the,O,O
formulae,O,O
gave,O,O
no,O,O
valid,O,O
information,O,O
",",O,O
RAST,O,O
/,O,O
EAST,O,O
inhibition,O,O
was,O,O
highest,O,O
for,O,O
cow,O,O
',O,O
s,O,O
milk,O,O
",",O,O
followed,O,O
by,O,O
the,O,O
partially,O,O
hydrolysed,O,O
whey,O,O
formula,O,O
",",O,O
partially,O,O
hydrolysed,O,O
whey,O,O
/,O,O
casein,B,O
formula,O,O
",",O,O
soy,B,O
/,I,O
pork,I,O
collagen,I,O
formula,O,O
",",O,O
and,O,O
the,O,O
amino,O,O
acid,O,O
formula,O,O
.,O,O
To,O,O
determine,O,O
which,O,O
sequences,O,O
in,O,O
the,O,O
rat,B,B
P450c17,I,I
promoter,I,O
may,O,O
be,O,O
responsible,O,O
for,O,O
basal,O,O
and,O,O
cAMP,O,O
-,O,O
stimulated,O,O
gene,O,O
transcription,O,O
",",O,O
deletion,O,O
constructs,O,O
containing,O,O
between,O,O
-,O,O
1,O,O
",",O,O
560,O,O
and,O,O
-,O,O
53,O,O
base,O,O
pairs,O,O
of,O,O
5,O,O
',O,O
-,O,O
flanking,O,O
DNA,O,O
from,O,O
the,O,O
rat,B,B
P450c17,I,I
gene,I,I
were,O,O
ligated,O,O
to,O,O
plasmids,O,O
expressing,O,O
the,O,O
reporter,O,O
gene,O,O
luciferase,B,B
and,O,O
transfected,O,O
into,O,O
two,O,O
mouse,O,O
cell,O,O
lines,O,O
",",O,O
adrenal,O,O
Y,O,O
-,O,O
1,O,O
cells,O,O
",",O,O
and,O,O
testicular,O,O
Leydig,O,B
MA,O,I
-,O,I
10,O,I
cells,O,O
.,O,O
The,O,O
transcription,O,O
initiation,O,O
site,O,O
was,O,O
determined,O,O
by,O,O
S1,B,B
nuclease,I,I
mapping,O,O
.,O,O
Certain,O,O
transcript,O,O
patterns,O,O
in,O,O
Epifagus,O,B
plastids,O,O
are,O,O
highly,O,O
complex,O,O
and,O,O
similar,O,O
to,O,O
those,O,O
of,O,O
tobacco,O,O
operons,O,O
.,O,O
The,O,O
ensembles,O,O
are,O,O
considered,O,O
to,O,O
be,O,O
one,O,O
of,O,O
the,O,O
forms,O,O
of,O,O
activity,O,O
of,O,O
the,O,O
structured,O,O
morphofunctional,O,O
cortical,O,O
units,O,O
",",O,O
i,O,O
.,O,O
the,O,O
columns,O,O
.,O,O
Autonomic,O,O
dysfunctions,O,O
were,O,O
restricted,O,O
to,O,O
tonic,O,O
pupils,O,O
.,O,O
This,O,O
region,O,O
contains,O,O
a,O,O
motif,O,O
with,O,O
partial,O,O
identity,O,O
with,O,O
the,O,O
binding,O,O
site,O,O
for,O,O
the,O,O
ubiquitous,O,O
transcription,O,O
factor,O,O
upstream,B,O
stimulatory,I,O
factor,I,O
(,O,O
USF,B,B
),O,O
",",O,O
which,O,O
binds,O,O
to,O,O
the,O,O
human,B,B
insulin,I,I
promoter,I,O
.,O,O
The,O,O
RAS,B,B
-,O,I
cyclic,B,I
AMP,I,I
-,I,I
dependent,I,I
protein,I,I
kinase,I,I
cAPK,B,B
pathway,O,O
prevents,O,O
the,O,O
UAS,O,O
activity,O,O
of,O,O
IREu,B,O
in,O,O
the,O,O
presence,O,O
of,O,O
glucose,O,O
as,O,O
the,O,O
sole,O,O
carbon,O,O
source,O,O
",",O,O
while,O,O
the,O,O
transcriptional,O,O
activators,O,O
Msn2p,B,B
and,O,O
Msn4p,B,B
promote,O,O
the,O,O
UAS,O,O
activity,O,O
of,O,O
this,O,O
repeat,O,O
in,O,O
the,O,O
presence,O,O
of,O,O
acetate,O,O
.,O,O
Polymyxin,O,B
B,O,I
was,O,O
given,O,O
intravenously,O,O
for,O,O
1,O,O
week,O,O
postburn,O,O
in,O,O
doses,O,O
designed,O,O
to,O,O
neutralize,O,O
circulating,O,O
endotoxemia,O,O
.,O,O
Internal,O,O
biliary,O,O
drainage,O,O
",",O,O
unlike,O,O
external,O,O
drainage,O,O
",",O,O
does,O,O
not,O,O
suppress,O,O
the,O,O
regeneration,O,O
of,O,O
cholestatic,O,O
rat,O,O
liver,O,O
after,O,O
partial,O,O
hepatectomy,O,O
.,O,O
RT,O,O
-,O,O
PCR,O,O
and,O,O
in,O,O
situ,O,O
hybridization,O,O
analyses,O,O
of,O,O
a,O,O
time,O,O
course,O,O
of,O,O
juvenile,O,O
testis,O,O
development,O,O
indicate,O,O
that,O,O
Spo11,B,B
expression,O,O
begins,O,O
in,O,O
early,O,O
meiotic,O,O
Prophase,O,O
I,O,O
",",O,O
prior,O,O
to,O,O
the,O,O
pachytene,O,O
stage,O,O
",",O,O
with,O,O
increasing,O,O
accumulation,O,O
of,O,O
mRNA,O,O
through,O,O
the,O,O
pachytene,O,O
stage,O,O
.,O,O
The,O,O
number,O,O
of,O,O
lactotropes,O,B
",",O,O
somatotropes,O,B
",",O,O
thyrotropes,O,B
",",O,O
and,O,O
gonadotropes,O,B
was,O,O
not,O,O
altered,O,O
compared,O,O
with,O,O
controls,O,O
",",O,O
indicating,O,O
that,O,O
in,O,O
the,O,O
adult,O,O
pituitary,O,O
",",O,O
POMC,B,B
products,I,I
are,O,O
not,O,O
required,O,O
to,O,O
maintain,O,O
the,O,O
distribution,O,O
of,O,O
cell,O,O
types,O,O
.,O,O
As,O,O
assessed,O,O
by,O,O
a,O,O
genetic,O,O
assay,O,O
that,O,O
measures,O,O
AAI,O,B
-,O,I
dependent,O,I
DNA,O,I
binding,O,I
",",O,O
TraM,B,B
inhibited,O,O
TraR,B,B
function,O,O
before,O,O
and,O,O
after,O,O
the,O,O
transcription,O,O
factor,O,O
had,O,O
bound,O,O
to,O,O
its,O,O
DNA,O,B
recognition,O,I
site,O,I
.,O,O
Limits,O,O
of,O,O
energy,O,O
turnover,O,O
in,O,O
relation,O,O
to,O,O
physical,O,O
performance,O,O
were,O,O
addressed,O,O
in,O,O
terms,O,O
of,O,O
upper,O,O
and,O,O
lower,O,O
limit,O,O
",",O,O
changes,O,O
during,O,O
a,O,O
training,O,O
programme,O,O
and,O,O
how,O,O
to,O,O
regulate,O,O
energy,O,O
balance,O,O
at,O,O
a,O,O
changing,O,O
energy,O,O
turnover,O,O
.,O,O
Phorbol,O,O
esters,O,O
stimulated,O,O
phosphorylation,O,O
of,O,O
CSK,B,B
35H,I,I
proteins,I,O
",",O,O
thus,O,O
emphasizing,O,O
that,O,O
sequences,O,O
isolated,O,O
according,O,O
to,O,O
PKC,B,B
binding,O,O
activity,O,O
in,O,O
vitro,O,O
are,O,O
also,O,O
PKC,B,B
substrates,O,O
in,O,O
vivo,O,O
.,O,O
Catch,O,O
-,O,O
up,O,O
growth,O,O
was,O,O
observed,O,O
only,O,O
for,O,O
a,O,O
12,O,O
-,O,O
month,O,O
period,O,O
in,O,O
4,O,O
children,O,O
with,O,O
a,O,O
bone,O,O
age,O,O
of,O,O
7,O,O
to,O,O
8,O,O
years,O,O
.,O,O
Recombinant,B,O
prenylcysteine,I,B
lyase,I,I
was,O,O
produced,O,O
in,O,O
a,O,O
baculovirus,O,O
-,O,O
Sf9,O,O
expression,O,O
system,O,O
.,O,O
These,O,O
results,O,O
support,O,O
the,O,O
diagnostic,O,O
validity,O,O
of,O,O
NFPD,O,B
in,O,O
CP,O,O
/,O,O
NCA,O,O
patients,O,O
",",O,O
because,O,O
such,O,O
patients,O,O
had,O,O
a,O,O
family,O,O
history,O,O
of,O,O
panic,O,O
disorder,O,O
similar,O,O
to,O,O
patients,O,O
with,O,O
a,O,O
more,O,O
classical,O,O
panic,O,O
disorder,O,O
presentation,O,O
.,O,O
In,O,O
a,O,O
previous,O,O
study,O,O
(,O,O
Brandl,O,B
",",O,O
C,O,O
.,O,O
In,O,O
vivo,O,O
dimethyl,O,O
sulfate,O,O
footprinting,O,O
of,O,O
the,O,O
cyclin,B,B
E,I,I
promoter,I,O
revealed,O,O
several,O,O
regions,O,O
of,O,O
protection,O,O
and,O,O
hypersensitivity,O,O
that,O,O
were,O,O
unique,O,O
to,O,O
infected,O,O
cells,O,O
.,O,O
Structure,O,O
and,O,O
regulation,O,O
of,O,O
the,O,O
gene,O,O
encoding,O,O
the,O,O
neuron,O,B
-,O,I
specific,O,I
protein,B,I
kinase,I,I
C,I,I
substrate,O,I
neurogranin,B,I
(,O,O
RC3,B,B
protein,I,I
),O,O
.,O,O
Mutations,O,O
of,O,O
the,O,O
RET,B,B
gene,I,O
",",O,O
encoding,O,O
a,O,O
receptor,B,O
tyrosine,I,O
kinase,I,O
",",O,O
have,O,O
been,O,O
associated,O,O
with,O,O
the,O,O
inherited,O,O
cancer,O,O
syndromes,O,O
MEN,O,B
2A,O,I
and,O,O
MEN,O,B
2B,O,I
.,O,O
The,O,O
promoter,O,O
region,O,O
showed,O,O
no,O,O
consensus,O,O
TATA,O,O
box,O,O
but,O,O
it,O,O
contains,O,O
CCAAT,O,O
and,O,O
CreA,B,O
boxes,O,O
known,O,O
to,O,O
be,O,O
involved,O,O
in,O,O
both,O,O
stress,O,O
and,O,O
carbon,O,O
-,O,O
catabolite,O,O
regulation,O,O
of,O,O
fungal,O,O
promoters,O,O
.,O,O
Diabetes,O,O
care,O,O
:,O,O
a,O,O
guideline,O,O
to,O,O
the,O,O
facilities,O,O
needed,O,O
to,O,O
support,O,O
internationally,O,O
endorsed,O,O
standards,O,O
.,O,O
We,O,O
also,O,O
provide,O,O
evidence,O,O
that,O,O
gar2,B,B
is,O,O
phosphorylated,O,O
in,O,O
vitro,O,O
by,O,O
a,O,O
p13,B,O
(,O,O
suc1,B,O
),O,O
-,O,O
bound,O,O
kinase,O,O
from,O,O
Schizosaccharomyces,O,O
pombe,O,O
extracts,O,O
that,O,O
displays,O,O
cell,O,O
cycle,O,O
-,O,O
regulated,O,O
activity,O,O
similar,O,O
to,O,O
that,O,O
of,O,O
the,O,O
p34,B,O
(,O,O
cdc2,B,B
(,O,I
kinase,O,O
.,O,O
A,O,O
control,O,O
group,O,O
of,O,O
nine,O,O
women,O,O
(,O,O
age,O,O
23,O,O
-,O,O
40,O,O
years,O,O
),O,O
on,O,O
oral,O,O
contraceptives,O,O
(,O,O
Nordette,O,B
-,O,I
28,O,I
),O,O
was,O,O
also,O,O
studied,O,O
four,O,O
times,O,O
during,O,O
a,O,O
pill,O,O
cycle,O,O
.,O,O
TPBF,B,B
has,O,O
two,O,O
potential,O,O
coiled,O,O
-,O,O
coil,O,O
regions,O,O
",",O,O
a,O,O
basic,O,O
region,O,O
",",O,O
a,O,O
proline,O,O
-,O,O
rich,O,O
region,O,O
",",O,O
a,O,O
histidine,O,O
-,O,O
rich,O,O
N,O,O
terminus,O,O
",",O,O
and,O,O
a,O,O
nuclear,O,O
targeting,O,O
sequence,O,O
.,O,O
Biol,O,O
.,O,O
However,O,O
",",O,O
a,O,O
10,O,O
-,O,O
-,O,O
15,O,O
%,O,O
lengthening,O,O
of,O,O
the,O,O
partial,O,O
thromboplastin,B,O
time,O,O
is,O,O
evident,O,O
after,O,O
24,O,O
hours,O,O
of,O,O
storage,O,O
.,O,O
40,O,O
",",O,O
000,O,O
),O,O
.,O,O
These,O,O
two,O,O
contigs,O,O
contain,O,O
a,O,O
total,O,O
of,O,O
163,O,O
open,O,O
reading,O,O
frames,O,O
(,O,O
ORFs,O,O
),O,O
in,O,O
26,O,O
-,O,O
29,O,O
putative,O,O
operons,O,O
;,O,O
56,O,O
ORFs,O,O
could,O,O
be,O,O
identified,O,O
with,O,O
reasonable,O,O
certainty,O,O
.,O,O
Members,O,O
of,O,O
the,O,O
meis1,B,B
and,O,O
pbx,B,B
homeodomain,I,I
protein,I,I
families,I,O
cooperatively,O,O
bind,O,O
a,O,O
cAMP,O,O
-,O,O
responsive,O,O
sequence,O,O
(,O,O
CRS1,O,O
),O,O
from,O,O
bovine,B,O
CYP17,I,B
.,O,O
As,O,O
regards,O,O
lipid,O,O
metabolism,O,O
",",O,O
the,O,O
mean,O,O
values,O,O
for,O,O
total,O,O
triglycerides,O,O
",",O,O
cholesterol,O,O
",",O,O
LDL,B,B
-,I,I
cholesterol,I,I
and,O,O
HDL,B,B
-,I,I
cholesterol,I,I
seen,O,O
at,O,O
the,O,O
end,O,O
of,O,O
five,O,O
years,O,O
of,O,O
Norplant,O,B
-,O,I
2,O,I
rod,O,I
use,O,O
and,O,O
six,O,O
months,O,O
postremoval,O,O
were,O,O
similar,O,O
to,O,O
the,O,O
preinsertion,O,O
mean,O,O
.,O,O
The,O,O
novel,O,O
Notch,B,B
homologue,I,O
mouse,B,O
Notch,I,B
3,I,I
lacks,O,O
specific,O,O
epidermal,B,O
growth,I,O
factor,I,O
-,I,O
repeats,I,O
and,O,O
is,O,O
expressed,O,O
in,O,O
proliferating,O,O
neuroepithelium,O,O
.,O,O
Gene,O,B
and,O,O
pseudogene,O,O
of,O,O
the,O,O
mouse,O,B
cation,O,I
-,O,I
dependent,O,I
mannose,B,I
6,I,I
-,I,I
phosphate,I,I
receptor,I,I
.,O,O
Approximately,O,O
20,O,O
%,O,O
of,O,O
ALCLs,O,B
that,O,O
express,O,O
ALK,B,B
do,O,O
not,O,O
contain,O,O
the,O,O
t,O,O
(,O,O
2,O,O
;,O,O
5,O,O
),O,O
",",O,O
suggesting,O,O
that,O,O
other,O,O
genetic,O,O
abnormalities,O,O
can,O,O
result,O,O
in,O,O
aberrant,O,O
ALK,B,B
expression,O,O
.,O,O
The,O,O
primary,O,O
CT,O,O
findings,O,O
were,O,O
misinterpreted,O,O
as,O,O
a,O,O
brain,O,O
infarct,O,O
or,O,O
possibly,O,O
a,O,O
tumour,O,O
.,O,O
A,O,O
case,O,O
of,O,O
M,O,B
hemoglobinosis,O,I
The,O,O
fatigue,O,O
exercise,O,O
showed,O,O
relatively,O,O
high,O,O
blood,O,O
lactate,O,O
concentration,O,O
[,O,O
12,O,O
.,O,O
5,O,O
(,O,O
SD,O,O
2,O,O
.,O,O
6,O,O
),O,O
mmol,O,O
x,O,O
l,O,O
(,O,O
-,O,O
1,O,O
),O,O
and,O,O
an,O,O
increase,O,O
of,O,O
serum,B,O
creatine,I,O
kinase,I,O
(,O,O
CK,B,B
),O,O
activity,O,O
delayed,O,O
by,O,O
2,O,O
days,O,O
[,O,O
540,O,O
(,O,O
SD,O,O
407,O,O
),O,O
U,O,O
x,O,O
l,O,O
(,O,O
-,O,O
1,O,O
),O,O
.,O,O
A,O,O
patient,O,O
is,O,O
described,O,O
with,O,O
skin,O,O
lesions,O,O
resembling,O,O
Kaposi,O,B
',O,I
s,O,I
sarcoma,O,I
(,O,O
KS,O,B
),O,O
.,O,O
Novel,O,O
multigene,O,O
families,O,O
encoding,O,O
highly,O,O
repetitive,O,O
peptide,O,O
sequences,O,O
.,O,O
Seven,O,O
clones,O,O
encoding,O,O
interferon,B,B
response,I,I
element,I,I
binding,I,I
factors,I,I
have,O,O
been,O,O
isolated,O,O
from,O,O
a,O,O
mouse,O,B
fibroblast,O,I
lambda,O,I
gt11,O,I
cDNA,O,I
library,O,I
by,O,O
using,O,O
a,O,O
32P,O,O
end,O,O
-,O,O
labeled,O,O
tandem,O,O
trimer,O,O
of,O,O
the,O,O
mouse,B,B
(,I,O
2,I,O
',I,O
-,I,O
5,I,O
',I,O
),I,O
oligoadenylate,I,O
synthetase,I,O
gene,I,O
interferon,O,B
response,O,I
element,O,I
as,O,O
a,O,O
probe,O,O
.,O,O
However,O,O
",",O,O
L,B,B
-,I,I
plastin,I,I
has,O,O
been,O,O
found,O,O
in,O,O
many,O,O
types,O,O
of,O,O
malignant,O,O
human,O,B
cells,O,O
of,O,O
non,O,O
-,O,O
hemopoietic,O,O
origin,O,O
suggesting,O,O
that,O,O
its,O,O
expression,O,O
is,O,O
induced,O,O
accompanying,O,O
tumorigenesis,O,O
in,O,O
solid,O,O
tissues,O,O
.,O,O
The,O,O
second,O,O
complex,O,O
",",O,O
when,O,O
purified,O,O
",",O,O
contained,O,O
four,O,O
protein,O,O
components,O,O
including,O,O
the,O,O
36,O,O
-,O,O
kDa,O,O
protein,O,O
.,O,O
The,O,O
role,O,O
of,O,O
HIV,B,B
tat,I,I
",",O,O
which,O,O
is,O,O
the,O,O
main,O,O
enhancing,O,O
factor,O,O
for,O,O
viral,B,O
LTR,I,O
",",O,O
in,O,O
the,O,O
regulation,O,O
of,O,O
IL,B,B
-,I,I
2,I,I
gene,I,O
transcription,O,O
has,O,O
been,O,O
studied,O,O
following,O,O
transient,O,O
expression,O,O
of,O,O
the,O,O
tat,B,B
gene,I,O
in,O,O
phorbol,O,O
ester,O,O
and,O,O
calcium,O,O
ionophore,O,O
-,O,O
activated,O,O
Jurkat,O,O
cells,O,O
transfected,O,O
with,O,O
IL,B,B
-,I,I
2,I,I
promoter,O,O
-,O,O
chloramphenicol,B,O
acetyltransferase,I,O
reporter,O,O
constructs,O,O
.,O,O
Comparison,O,O
of,O,O
the,O,O
amino,O,O
acid,O,O
sequence,O,O
of,O,O
the,O,O
M,B,B
RNA,I,I
product,I,I
of,I,I
Uukuniemi,I,B
virus,I,I
with,O,O
that,O,O
of,O,O
Punta,O,B
Toro,O,I
and,O,O
Rift,O,B
Valley,O,I
fever,O,I
viruses,O,I
showed,O,O
in,O,O
both,O,O
cases,O,O
a,O,O
weak,O,O
homology,O,O
that,O,O
was,O,O
more,O,O
pronounced,O,O
for,O,O
the,O,O
proteins,O,O
located,O,O
at,O,O
the,O,O
COOH,O,B
-,O,I
terminal,O,I
end,O,I
of,O,I
the,O,I
precursor,O,I
.,O,O
Contraction,O,O
of,O,O
the,O,O
tracheal,O,O
muscle,O,O
and,O,O
the,O,O
activity,O,O
of,O,O
stretch,O,O
receptors,O,O
in,O,O
the,O,O
trachea,O,O
Due,O,O
to,O,O
its,O,O
relatively,O,O
soluble,O,O
chemical,O,O
form,O,O
",",O,O
90Sr,O,B
was,O,O
rapidly,O,O
translocated,O,O
from,O,O
lung,O,O
to,O,O
bone,O,O
where,O,O
a,O,O
substantial,O,O
portion,O,O
was,O,O
retained,O,O
for,O,O
a,O,O
long,O,O
period,O,O
of,O,O
time,O,O
.,O,O
To,O,O
evaluate,O,O
the,O,O
relative,O,O
accuracy,O,O
of,O,O
continuous,O,O
wave,O,O
(,O,O
CW,O,O
),O,O
and,O,O
high,O,O
pulse,O,O
repetition,O,O
frequency,O,O
(,O,O
HPRF,O,O
),O,O
Doppler,O,O
for,O,O
estimating,O,O
aortic,O,O
transvalvular,O,O
pressure,O,O
gradients,O,O
",",O,O
Doppler,O,O
examinations,O,O
with,O,O
both,O,O
devices,O,O
were,O,O
obtained,O,O
in,O,O
87,O,O
consecutive,O,O
patients,O,O
with,O,O
aortic,O,O
valve,O,O
disease,O,O
.,O,O
Histamine,O,O
-,O,O
2,O,O
blockade,O,O
in,O,O
psoriasis,O,O
Estimation,O,O
of,O,O
L,O,B
-,O,I
alanine,O,I
in,O,O
serum,O,O
or,O,O
plasma,O,O
using,O,O
the,O,O
LKB,O,B
reaction,O,I
rate,O,I
analyser,O,I
.,O,O
Analysis,O,O
of,O,O
its,O,O
genomic,O,O
region,O,O
revealed,O,O
that,O,O
the,O,O
13,O,O
-,O,O
kb,O,O
Cdc6,B,B
gene,I,O
is,O,O
divided,O,O
into,O,O
12,O,O
exons,O,O
by,O,O
11,O,O
introns,O,O
.,O,O
We,O,O
have,O,O
performed,O,O
toeprinting,O,O
analyses,O,O
on,O,O
repA,B,O
mRNA,I,O
of,O,O
plasmid,O,O
R1,O,O
",",O,O
both,O,O
free,O,O
and,O,O
in,O,O
duplex,O,O
with,O,O
the,O,O
antisense,O,O
RNA,O,O
",",O,O
CopA,B,B
.,O,O
Type,O,O
II,O,O
could,O,O
be,O,O
divided,O,O
further,O,O
into,O,O
two,O,O
forms,O,O
(,O,O
IIA,O,O
and,O,O
IIB,O,O
),O,O
that,O,O
may,O,O
represent,O,O
two,O,O
underscribed,O,O
species,O,O
or,O,O
developmental,O,O
stages,O,O
of,O,O
the,O,O
same,O,O
species,O,O
.,O,O
Each,O,O
recombinant,O,O
product,O,O
was,O,O
a,O,O
fusion,O,O
protein,O,O
with,O,O
a,O,O
B,O,B
domain,O,O
of,O,O
Staphylococcal,B,B
protein,I,I
A,I,I
(,O,O
SPA,B,B
),O,O
.,O,O
An,O,O
FP,B,O
mutant,I,O
",",O,O
AcFP875,B,O
-,I,O
2,I,O
",",O,O
had,O,O
a,O,O
1,O,O
.,O,O
6,O,O
-,O,O
kbp,O,O
insertion,O,O
of,O,O
S,O,B
.,O,I
frugiperda,O,I
DNA,O,I
near,O,O
the,O,O
5,O,O
',O,O
end,O,O
of,O,O
these,O,O
transcripts,O,O
which,O,O
by,O,O
S1,B,O
analysis,O,O
were,O,O
shown,O,O
to,O,O
initiate,O,O
within,O,O
the,O,O
host,O,O
cell,O,O
sequence,O,O
.,O,O
These,O,O
data,O,O
suggest,O,O
that,O,O
other,O,O
Ras,B,B
effectors,I,O
can,O,O
collaborate,O,O
with,O,O
PI,B,B
3,I,I
-,I,I
kinase,I,I
and,O,O
with,O,O
each,O,O
other,O,O
to,O,O
activate,O,O
Pak,B,B
.,O,O
MSSPs,B,O
are,O,O
believed,O,O
to,O,O
regulate,O,O
DNA,O,O
replication,O,O
",",O,O
transcription,O,O
",",O,O
apopotosis,O,O
and,O,O
cell,O,O
cycle,O,O
progression,O,O
by,O,O
interacting,O,O
with,O,O
the,O,O
C,B,O
-,I,O
MYC,I,B
protein,I,O
.,O,O
Mutations,O,O
at,O,O
the,O,O
extreme,O,O
C,O,O
-,O,O
terminus,O,O
of,O,O
EIAV,B,O
Tat,I,O
impaired,O,O
both,O,O
RNA,O,O
binding,O,O
and,O,O
activation,O,O
domain,O,O
functions,O,O
",",O,O
suggesting,O,O
effects,O,O
on,O,O
secondary,O,O
or,O,O
tertiary,O,O
structure,O,O
.,O,O
A,O,O
114,O,O
-,O,O
base,O,O
pair,O,O
sequence,O,O
of,O,O
predominantly,O,O
repeating,O,O
purine,O,B
-,O,I
pyrimidine,O,I
nucleotides,O,I
separates,O,O
these,O,O
two,O,O
d,O,O
(,O,O
AC,O,B
),O,O
repeats,O,O
.,O,O
We,O,O
have,O,O
shown,O,O
previously,O,O
that,O,O
in,O,O
contrast,O,O
to,O,O
other,O,O
extracellular,O,O
matrix,O,O
molecules,O,O
pepsin,B,O
-,O,O
solubilized,O,O
collagen,B,O
VI,I,B
(,O,O
CVI,B,B
),O,O
can,O,O
stimulate,O,O
DNA,O,O
synthesis,O,O
of,O,O
various,O,O
mesenchymal,O,O
cell,O,O
types,O,O
",",O,O
apparently,O,O
independent,O,O
of,O,O
integrin,B,O
-,O,O
mediated,O,O
signal,O,O
transduction,O,O
.,O,O
Experimental,O,O
data,O,O
showed,O,O
that,O,O
these,O,O
abnormal,O,O
proteins,O,O
are,O,O
constitutively,O,O
localized,O,O
in,O,O
the,O,O
nucleus,O,O
",",O,O
have,O,O
lost,O,O
the,O,O
transcriptional,O,O
repressor,O,O
functions,O,O
typical,O,O
of,O,O
normal,O,O
NF,B,B
-,I,I
kappa,I,I
B2p52,I,I
and,O,O
may,O,O
be,O,O
capable,O,O
of,O,O
transactivation,O,O
activity,O,O
.,O,O
The,O,O
human,B,B
cytomegalovirus,I,I
(,I,O
HCMV,I,B
),I,O
major,I,O
immediate,I,O
-,I,O
early,I,O
protein,I,O
IE2,I,O
is,O,O
a,O,O
nuclear,O,O
phosphoprotein,O,O
that,O,O
is,O,O
believed,O,O
to,O,O
be,O,O
a,O,O
key,O,O
regulator,O,O
in,O,O
both,O,O
lytic,O,O
and,O,O
latent,O,O
infections,O,O
.,O,O
Evidence,O,O
for,O,O
a,O,O
role,O,O
of,O,O
endogenous,B,O
corticotropin,I,B
-,I,I
releasing,I,I
factor,I,I
in,O,O
cold,O,O
",",O,O
ether,O,O
",",O,O
immobilization,O,O
",",O,O
and,O,O
traumatic,O,O
stress,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
severe,O,O
vision,O,O
loss,O,O
can,O,O
be,O,O
seen,O,O
with,O,O
interferon,B,B
alfa,I,I
-,I,I
2b,I,I
-,O,I
associated,O,I
retinopathy,O,I
.,O,O
Proteins,O,O
known,O,O
to,O,O
bind,O,O
the,O,O
PEPCK,B,O
CRE,O,O
include,O,O
the,O,O
CRE,B,O
-,I,O
binding,I,O
protein,I,O
(,O,O
CREB,B,B
),O,O
and,O,O
members,O,O
of,O,O
the,O,O
CCAAT,B,O
/,I,O
enhancer,I,O
-,I,O
binding,I,O
protein,I,O
(,O,O
C,B,B
/,I,I
EBP,I,I
),O,O
family,O,O
.,O,O
Although,O,O
IL,B,B
-,I,I
2,I,I
and,O,O
IFN,B,B
-,I,I
alpha,I,I
activated,O,O
STAT1,B,B
alpha,I,I
and,O,O
STAT5,B,B
",",O,O
IL,B,B
-,I,I
2,I,I
predominantly,O,O
activated,O,O
STAT5,B,B
",",O,O
while,O,O
IFN,B,B
-,I,I
alpha,I,I
predominantly,O,O
activated,O,O
STAT1,B,B
alpha,I,I
.,O,O
Copyright,O,O
2000,O,O
Academic,O,O
Press,O,O
.,O,O
Ten,O,O
volunteers,O,O
were,O,O
tested,O,O
at,O,O
18,O,O
",",O,O
000,O,O
ft,O,O
(,O,O
5,O,O
",",O,O
486,O,O
m,O,O
),O,O
",",O,O
and,O,O
through,O,O
12,O,O
",",O,O
000,O,O
",",O,O
8,O,O
",",O,O
000,O,O
",",O,O
and,O,O
5,O,O
",",O,O
000,O,O
ft,O,O
(,O,O
3,O,O
",",O,O
657,O,O
",",O,O
2,O,O
",",O,O
438,O,O
",",O,O
and,O,O
1,O,O
",",O,O
524,O,O
m,O,O
),O,O
with,O,O
directional,O,O
sounds,O,O
recorded,O,O
via,O,O
a,O,O
dummy,O,O
head,O,O
microphone,O,O
and,O,O
presented,O,O
binaurally,O,O
.,O,O
Nodular,O,O
involvement,O,O
of,O,O
the,O,O
left,O,O
lung,O,O
and,O,O
infiltration,O,O
of,O,O
the,O,O
mucosa,O,O
of,O,O
the,O,O
left,O,O
lower,O,O
lobe,O,O
bronchus,O,O
followed,O,O
very,O,O
gradually,O,O
and,O,O
a,O,O
monoclonal,O,O
gammopathy,O,O
(,O,O
IgA,B,B
-,I,I
-,I,I
Type,I,I
Kappa,I,I
),O,O
was,O,O
demonstrated,O,O
.,O,O
The,O,O
aim,O,O
of,O,O
this,O,O
study,O,O
was,O,O
to,O,O
investigate,O,O
the,O,O
spontaneous,O,O
reports,O,O
of,O,O
suspected,O,O
adverse,O,O
drug,O,O
reactions,O,O
",",O,O
observed,O,O
in,O,O
elderly,O,O
patients,O,O
(,O,O
over,O,O
65,O,O
years,O,O
of,O,O
age,O,O
),O,O
in,O,O
Sicily,O,O
(,O,O
Italy,O,O
),O,O
during,O,O
the,O,O
period,O,O
from,O,O
1,O,O
January,O,O
1995,O,O
to,O,O
31,O,O
December,O,O
1997,O,O
.,O,O
I,O,O
.,O,O
We,O,O
demonstrate,O,O
that,O,O
Ddc1p,B,B
interacts,O,O
physically,O,O
in,O,O
vivo,O,O
with,O,O
Mec3p,B,B
",",O,O
and,O,O
this,O,O
interaction,O,O
requires,O,O
Rad17p,B,B
.,O,O
The,O,O
presence,O,O
in,O,O
such,O,O
patients,O,O
of,O,O
antibodies,O,O
to,O,O
adrenaline,O,B
and,O,O
noradrenaline,O,B
is,O,O
indicative,O,O
of,O,O
considerable,O,O
disruption,O,O
of,O,O
catecholamine,O,O
biotransformation,O,O
.,O,O
However,O,O
",",O,O
for,O,O
the,O,O
evaluable,O,O
cases,O,O
",",O,O
the,O,O
performances,O,O
of,O,O
the,O,O
CD3500,O,B
and,O,O
the,O,O
STKS,O,B
were,O,O
broadly,O,O
similar,O,O
and,O,O
generally,O,O
correlated,O,O
well,O,O
with,O,O
the,O,O
manual,O,O
reference,O,O
procedure,O,O
.,O,O
Either,O,O
a,O,O
UV,O,O
detector,O,O
set,O,O
at,O,O
268,O,O
nm,O,O
or,O,O
an,O,O
electrochemical,O,O
(,O,O
EC,O,O
),O,O
detector,O,O
set,O,O
at,O,O
a,O,O
potential,O,O
of,O,O
+,O,O
0,O,O
.,O,O
9,O,O
V,O,O
(,O,O
versus,O,O
Ag,O,O
/,O,O
AgCl,O,O
/,O,O
3,O,O
M,O,O
NaCl,O,O
),O,O
was,O,O
used,O,O
to,O,O
monitor,O,O
the,O,O
drug,O,O
.,O,O
Muscle,B,O
GSH,I,B
-,I,I
Px,I,I
activity,O,O
after,O,O
prolonged,O,O
exercise,O,O
",",O,O
training,O,O
",",O,O
and,O,O
selenium,O,O
supplementation,O,O
.,O,O
The,O,O
Authors,O,O
have,O,O
proposed,O,O
to,O,O
develop,O,O
this,O,O
research,O,O
employing,O,O
a,O,O
preparation,O,O
containing,O,O
exclusively,O,O
a,O,O
cortisonic,O,O
",",O,O
the,O,O
desametazone,O,O
",",O,O
in,O,O
order,O,O
to,O,O
evaluate,O,O
the,O,O
alterations,O,O
of,O,O
the,O,O
dentinogenesis,O,O
to,O,O
be,O,O
attributed,O,O
to,O,O
such,O,O
component,O,O
.,O,O
Previous,O,O
studies,O,O
showed,O,O
that,O,O
mutations,O,O
in,O,O
the,O,O
6K,O,B
protein,O,O
led,O,O
to,O,O
the,O,O
slow,O,O
release,O,O
of,O,O
aberrant,O,O
",",O,O
multi,O,O
-,O,O
cored,O,O
infectious,O,O
virions,O,O
.,O,O
M,B,O
-,I,O
66,I,O
identified,O,O
the,O,O
14,O,O
-,O,O
kDa,O,B
protein,O,O
in,O,O
another,O,O
MMTV,O,O
bearing,O,O
T,O,O
-,O,O
cell,O,O
lymphoma,O,O
",",O,O
EL,O,O
-,O,O
4,O,O
.,O,O
ECG,O,O
-,O,O
gated,O,O
myocardial,O,O
Technetium,O,O
-,O,O
99m,O,O
sestamibi,O,O
SPECT,O,O
is,O,O
a,O,O
useful,O,O
technique,O,O
to,O,O
measure,O,O
myocardial,O,O
perfusion,O,O
and,O,O
function,O,O
simultaneously,O,O
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
G,B,B
beta,I,I
gamma,I,I
-,O,I
stimulated,O,O
Shc,B,B
phosphorylation,O,O
represents,O,O
an,O,O
early,O,O
step,O,O
in,O,O
the,O,O
pathway,O,O
leading,O,O
to,O,O
p21ras,B,B
activation,O,O
",",O,O
similar,O,O
to,O,O
the,O,O
mechanism,O,O
utilized,O,O
by,O,O
growth,B,O
factor,I,O
tyrosine,I,O
kinase,I,O
receptors,I,O
.,O,O
We,O,O
recommend,O,O
that,O,O
paracervical,O,O
block,O,O
with,O,O
lignocaine,O,O
should,O,O
be,O,O
used,O,O
in,O,O
conjunction,O,O
with,O,O
i,O,O
.,O,O
v,O,O
.,O,O
sedation,O,O
/,O,O
analgesia,O,O
during,O,O
egg,O,O
collection,O,O
performed,O,O
through,O,O
the,O,O
transvaginal,O,O
route,O,O
under,O,O
ultrasound,O,O
guidance,O,O
(,O,O
TUGOR,O,O
),O,O
to,O,O
reduce,O,O
the,O,O
pain,O,O
of,O,O
the,O,O
procedure,O,O
.,O,O
To,O,O
understand,O,O
the,O,O
function,O,O
of,O,O
receptor,B,O
-,I,O
linked,I,O
tyrosine,I,O
phosphatases,I,O
in,O,O
neural,O,O
development,O,O
",",O,O
we,O,O
sought,O,O
to,O,O
identify,O,O
LAR,B,B
isoforms,I,O
preferentially,O,O
expressed,O,O
in,O,O
the,O,O
nervous,O,O
system,O,O
and,O,O
cellular,O,O
processes,O,O
regulating,O,O
LAR,B,B
alternative,O,I
splicing,O,I
.,O,O
Transitory,O,O
subclinical,O,O
and,O,O
permanent,O,O
hypothyroidism,O,O
in,O,O
the,O,O
course,O,O
of,O,O
subacute,O,O
thyroiditis,O,O
(,O,O
de,O,O
Quervain,O,O
),O,O
.,O,O
Thrombotic,O,O
thrombocytopenic,O,O
purpura,O,O
in,O,O
systemic,O,O
lupus,O,O
erythematosus,O,O
.,O,O
Rifabutin,O,O
has,O,O
substantial,O,O
efficacy,O,O
when,O,O
combined,O,O
with,O,O
other,O,O
agents,O,O
.,O,O
In,O,O
experiments,O,O
with,O,O
the,O,O
D1,O,B
antagonist,O,O
SCH,O,B
23390,O,I
",",O,O
buprenorphine,O,O
-,O,O
induced,O,O
depression,O,O
was,O,O
consistently,O,O
blocked,O,O
",",O,O
but,O,O
facilitation,O,O
was,O,O
unaffected,O,O
.,O,O
(,O,O
1992,O,O
),O,O
J,O,O
.,O,O
Sp1,B,B
can,O,O
activate,O,O
transcription,O,O
through,O,O
immunoglobulin,B,O
kappa,I,B
-,I,I
chain,I,I
enhancer,I,I
or,O,O
P,B,B
-,I,I
selectin,I,I
promoter,I,I
NF,B,O
-,I,O
kappaB,I,B
sites,I,O
.,O,O
p50,B,B
homodimers,I,O
replace,O,O
Sp1,B,B
from,O,O
the,O,O
P,B,B
-,I,I
selectin,I,I
promoter,I,I
by,O,O
binding,O,O
site,O,O
competition,O,O
and,O,O
thereby,O,O
either,O,O
inhibit,O,O
basal,O,O
Sp1,B,B
-,O,I
driven,O,I
expression,O,O
or,O,O
",",O,O
in,O,O
concert,O,O
with,O,O
Bcl,B,B
-,I,I
3,I,I
",",O,O
stimulate,O,O
expression,O,O
.,O,O
A,O,O
yeast,O,B
DNA,O,I
fragment,O,O
carrying,O,O
the,O,O
gene,B,O
CP,I,B
A1,I,I
encoding,O,O
the,O,O
small,O,O
subunit,O,O
of,O,O
the,O,O
arginine,O,O
pathway,O,O
carbamoyl,B,O
-,I,O
phosphate,I,O
synthetase,I,O
has,O,O
been,O,O
sequenced,O,O
.,O,O
Interestingly,O,O
",",O,O
these,O,O
response,O,O
elements,O,O
display,O,O
dramatically,O,O
reduced,O,O
affinity,O,O
for,O,O
retinoic,B,O
acid,I,O
receptor,I,O
-,O,O
retinoid,B,O
-,I,O
X,I,O
receptor,I,O
heterodimers,O,O
.,O,O
The,O,O
delta,B,O
srb10,I,O
mutation,I,O
also,O,O
influenced,O,O
on,O,O
the,O,O
transcript,O,O
levels,O,O
of,O,O
meiosis,O,O
-,O,O
inducing,O,O
genes,O,O
called,O,O
IME1,B,B
and,O,O
IME2,B,B
:,O,O
the,O,O
mutation,O,O
elevated,O,O
the,O,O
transcript,O,O
level,O,O
of,O,O
IME1,B,B
but,O,O
reduced,O,O
that,O,O
of,O,O
IME2,B,B
",",O,O
resulting,O,O
in,O,O
partial,O,O
defects,O,O
in,O,O
premeiotic,O,O
DNA,O,O
synthesis,O,O
and,O,O
meiosis,O,O
.,O,O
Upstream,O,O
activation,O,O
sites,O,O
of,O,O
the,O,O
CYC1,B,B
gene,I,O
of,O,O
Saccharomyces,O,B
cerevisiae,O,I
are,O,O
active,O,O
when,O,O
inverted,O,O
but,O,O
not,O,O
when,O,O
placed,O,O
downstream,O,O
of,O,O
the,O,O
.,O,O
The,O,O
most,O,O
important,O,O
risk,O,O
factors,O,O
are,O,O
:,O,O
1,O,O
),O,O
genetic,O,O
;,O,O
2,O,O
),O,O
Epstein,O,B
-,O,I
Barr,O,I
virus,O,I
(,O,O
infectious,O,O
mononucleosis,O,O
),O,O
;,O,O
3,O,O
),O,O
congenital,O,O
and,O,O
acquired,O,O
immunodeficiency,O,O
;,O,O
4,O,O
),O,O
occupational,O,O
exposure,O,O
(,O,O
the,O,O
wood,O,O
industry,O,O
),O,O
.,O,O
The,O,O
gene,O,B
product,O,O
of,O,O
cotS,B,B
was,O,O
confirmed,O,O
to,O,O
be,O,O
identical,O,O
to,O,O
Cot40,B,B
-,I,I
2,I,I
by,O,O
SDS,O,O
-,O,O
PAGE,O,O
and,O,O
immunoblotting,O,O
from,O,O
Escherichia,O,O
coli,O,O
transformed,O,O
with,O,O
a,O,O
plasmid,O,O
containing,O,O
the,O,O
cotS,B,B
region,I,O
.,O,O
A,O,O
2,B,B
.,I,I
4,I,I
-,I,I
kb,I,I
MAPKAPK,I,B
-,I,I
2,I,I
message,I,O
is,O,O
expressed,O,O
throughout,O,O
development,O,O
",",O,O
while,O,O
two,O,O
shorter,O,O
transcripts,O,O
of,O,O
2,O,B
.,O,I
3,O,I
and,O,O
1,O,B
.,O,I
8,O,I
kb,O,I
appear,O,O
to,O,O
be,O,O
specifically,O,O
expressed,O,O
in,O,O
the,O,O
germline,O,O
.,O,O
Apart,O,O
from,O,O
iron,O,O
regulation,O,O
",",O,O
sodA,B,B
expression,O,O
was,O,O
affected,O,O
by,O,O
changes,O,O
in,O,O
DNA,O,O
topology,O,O
induced,O,O
by,O,O
coumermycin,O,O
A,O,O
but,O,O
not,O,O
by,O,O
the,O,O
global,O,O
virulence,O,O
regulatory,O,O
Bvg,B,O
system,I,O
.,O,O
Lithium,O,O
delays,O,O
the,O,O
circadian,O,O
rhythm,O,O
of,O,O
wheel,O,O
-,O,O
running,O,O
in,O,O
Syrian,O,O
hamsters,O,O
at,O,O
plasma,O,O
concentrations,O,O
(,O,O
0,O,O
.,O,O
59,O,O
-,O,O
0,O,O
.,O,O
74,O,O
mM,O,O
),O,O
that,O,O
also,O,O
cause,O,O
toxic,O,O
weight,O,O
loss,O,O
.,O,O
The,O,O
significance,O,O
of,O,O
the,O,O
phenolphthalein,B,O
sulphatase,I,O
test,O,O
for,O,O
the,O,O
differentiation,O,O
and,O,O
identification,O,O
of,O,O
Nocardia,O,B
species,O,O
.,O,O
We,O,O
conclude,O,O
that,O,O
Hansel,O,O
',O,O
s,O,O
stain,O,O
substantially,O,O
improves,O,O
the,O,O
recognition,O,O
of,O,O
eosinophiluria,O,O
as,O,O
compared,O,O
with,O,O
Wright,O,O
',O,O
s,O,O
stain,O,O
.,O,O
c,B,O
-,I,O
Fos,I,B
transcriptional,O,O
activity,O,O
stimulated,O,O
by,O,O
H,B,B
-,I,I
Ras,I,I
-,I,I
activated,I,I
protein,I,I
kinase,I,I
distinct,O,O
from,O,O
JNK,B,B
and,O,O
ERK,B,B
.,O,O
Quantitative,O,O
evaluation,O,O
of,O,O
the,O,O
steady,O,O
state,O,O
kinetics,O,O
of,O,O
MEK,B,B
inhibition,O,O
by,O,O
these,O,O
compounds,O,O
reveals,O,O
that,O,O
U0126,O,O
has,O,O
approximately,O,O
100,O,O
-,O,O
fold,O,O
higher,O,O
affinity,O,O
for,O,O
deltaN3,B,O
-,I,O
S218E,I,O
/,I,O
S222D,I,O
MEK,I,O
than,O,O
does,O,O
PD098059,O,O
.,O,O
She,O,O
has,O,O
since,O,O
developed,O,O
a,O,O
positive,O,O
anti,B,O
-,I,O
cardiolipin,I,O
antibody,I,O
but,O,O
does,O,O
not,O,O
meet,O,O
diagnostic,O,O
criteria,O,O
for,O,O
systemic,O,O
lupus,O,O
erythematosis,O,O
.,O,O
CONCLUSION,O,O
:,O,O
The,O,O
presence,O,O
of,O,O
known,O,O
autoimmune,O,O
disease,O,O
in,O,O
a,O,O
woman,O,O
with,O,O
POF,O,O
should,O,O
not,O,O
dissuade,O,O
the,O,O
clinician,O,O
from,O,O
evaluating,O,O
for,O,O
a,O,O
potential,O,O
genetic,O,O
cause,O,O
.,O,O
Both,O,O
parents,O,O
are,O,O
clinically,O,O
normal,O,O
and,O,O
unrelated,O,O
.,O,O
The,O,O
DNA,O,O
sequences,O,O
predict,O,O
proteins,O,O
for,O,O
SRP54sc,B,B
and,O,O
SRP54sp,B,B
that,O,O
are,O,O
47,O,O
%,O,O
and,O,O
52,O,O
%,O,O
identical,O,O
to,O,O
SRP54mam,B,B
",",O,O
respectively,O,O
.,O,O
Another,O,O
cis,O,O
-,O,O
acting,O,O
element,O,O
",",O,O
exonic,O,O
splicing,O,O
suppressor,O,O
1,O,O
(,O,O
ESS1,O,B
),O,O
",",O,O
represses,O,O
use,O,O
of,O,O
the,O,O
nt,O,O
3225,O,O
3,O,O
',O,O
splice,O,O
site,O,O
.,O,O
Although,O,O
methods,O,O
to,O,O
align,O,O
the,O,O
control,O,O
and,O,O
activation,O,O
fMR,O,O
images,O,O
may,O,O
correct,O,O
for,O,O
some,O,O
of,O,O
this,O,O
motional,O,O
error,O,O
",",O,O
they,O,O
will,O,O
be,O,O
incomplete,O,O
in,O,O
correcting,O,O
for,O,O
those,O,O
that,O,O
depend,O,O
on,O,O
spatial,O,O
orientation,O,O
.,O,O
In,O,O
the,O,O
ultramarathon,O,O
runner,O,O
the,O,O
testosterone,O,B
levels,O,O
sharply,O,O
rose,O,O
at,O,O
the,O,O
beginning,O,O
of,O,O
the,O,O
training,O,O
session,O,O
(,O,O
from,O,O
the,O,O
7,O,O
",",O,O
20,O,O
ng,O,O
/,O,O
ml,O,O
to,O,O
11,O,O
",",O,O
50,O,O
ng,O,O
/,O,O
ml,O,O
after,O,O
20,O,O
',O,O
training,O,O
),O,O
",",O,O
and,O,O
subsequently,O,O
decrease,O,O
after,O,O
3,O,O
hours,O,O
(,O,O
9,O,O
",",O,O
20,O,O
ng,O,O
/,O,O
ml,O,O
),O,O
and,O,O
at,O,O
the,O,O
end,O,O
of,O,O
the,O,O
6,O,O
hours,O,O
training,O,O
(,O,O
4,O,O
",",O,O
60,O,O
ng,O,O
/,O,O
ml,O,O
),O,O
.,O,O
The,O,O
predicted,O,O
amino,O,O
acid,O,O
sequence,O,O
of,O,O
m,B,O
-,I,O
Staf,I,B
is,O,O
highly,O,O
homologous,O,O
to,O,O
that,O,O
of,O,O
Staf,B,B
",",O,O
another,O,O
selenocysteine,B,O
tRNA,I,O
gene,I,O
transcription,I,O
activating,I,O
factor,I,O
of,O,O
Xenopus,O,O
laevis,O,O
.,O,O
However,O,O
",",O,O
laparoscopy,O,O
failed,O,O
to,O,O
establish,O,O
inoperability,O,O
in,O,O
any,O,O
cases,O,O
of,O,O
carcinoma,O,O
spread,O,O
to,O,O
areas,O,O
not,O,O
accessible,O,O
to,O,O
laparoscopic,O,O
visualization,O,O
.,O,O
Limited,O,O
role,O,O
for,O,O
PCR,O,O
-,O,O
based,O,O
diagnosis,O,O
of,O,O
Whipple,O,O
',O,O
s,O,O
disease,O,O
from,O,O
peripheral,O,O
blood,O,O
mononuclear,O,O
cells,O,O
.,O,O
In,O,O
ischemic,O,O
and,O,O
hypoxic,O,O
hypoxia,O,O
",",O,O
a,O,O
strong,O,O
correlation,O,O
was,O,O
found,O,O
between,O,O
cyt,O,B
a,O,I
",",O,O
a3,O,B
oxidation,O,O
level,O,O
and,O,O
VO2,O,O
in,O,O
both,O,O
ischemic,O,O
and,O,O
hypoxic,O,O
hypoxia,O,O
(,O,O
r2,O,O
=,O,O
.,O,O
90,O,O
and,O,O
.,O,O
87,O,O
",",O,O
respectively,O,O
),O,O
.,O,O
The,O,O
sequence,O,O
similarity,O,O
has,O,O
suggested,O,O
that,O,O
SCG10,B,B
and,O,O
stathmin,B,B
have,O,O
been,O,O
derived,O,O
from,O,O
structurally,O,O
and,O,O
evolutionarily,O,O
related,O,O
genes,O,O
.,O,O
When,O,O
considered,O,O
with,O,O
the,O,O
known,O,O
neurotoxic,O,O
effects,O,O
on,O,O
children,O,O
of,O,O
of,O,O
exposure,O,O
to,O,O
lead,O,O
",",O,O
these,O,O
results,O,O
also,O,O
suggest,O,O
that,O,O
either,O,O
an,O,O
excessively,O,O
narrow,O,O
margin,O,O
of,O,O
safety,O,O
or,O,O
insufficient,O,O
safety,O,O
is,O,O
provided,O,O
by,O,O
present,O,O
U,O,B
.,O,O
S,O,O
.,O,O
guidelines,O,O
",",O,O
which,O,O
classify,O,O
an,O,O
elevated,O,O
blood,O,O
lead,O,O
concentration,O,O
as,O,O
25,O,O
micrograms,O,O
/,O,O
dl,O,O
or,O,O
greater,O,O
.,O,O
Whereas,O,O
",",O,O
in,O,O
the,O,O
single,O,O
-,O,O
chambered,O,O
body,O,O
box,O,O
",",O,O
PenH,O,O
units,O,O
(,O,O
Enhanced,O,O
Pause,O,O
),O,O
reflect,O,O
measured,O,O
as,O,O
the,O,O
pause,O,O
between,O,O
inspiration,O,O
and,O,O
expiration,O,O
.,O,O
The,O,O
cwg2,B,B
-,I,I
1,I,I
mutation,I,O
was,O,O
identified,O,O
as,O,O
a,O,O
guanine,O,O
to,O,O
adenine,O,O
substitution,O,O
at,O,O
nucleotide,O,O
604,O,O
of,O,O
the,O,O
coding,O,O
region,O,O
",",O,O
originating,O,O
the,O,O
change,O,O
A202T,O,O
in,O,O
the,O,O
cwg2p,B,O
.,O,O
Abnormal,O,O
calcium,O,B
metabolism,O,O
in,O,O
normocalcaemic,O,O
sarcoidosis,O,O
.,O,O
These,O,O
genes,O,O
are,O,O
expressed,O,O
within,O,O
a,O,O
few,O,O
hours,O,O
of,O,O
the,O,O
initiation,O,O
of,O,O
development,O,O
;,O,O
their,O,O
mRNAs,O,O
accumulate,O,O
to,O,O
a,O,O
peak,O,O
at,O,O
12,O,O
hr,O,O
and,O,O
persist,O,O
until,O,O
culmination,O,O
.,O,O
First,O,O
",",O,O
two,O,O
MCTs,O,O
using,O,O
a,O,O
long,O,O
electrode,O,O
",",O,O
3,O,O
cm,O,O
in,O,O
size,O,O
",",O,O
were,O,O
performed,O,O
in,O,O
the,O,O
central,O,O
area,O,O
of,O,O
the,O,O
tumor,O,O
",",O,O
and,O,O
eight,O,O
MCTs,O,O
by,O,O
a,O,O
short,O,O
electrode,O,O
",",O,O
2,O,O
cm,O,O
in,O,O
size,O,O
",",O,O
were,O,O
done,O,O
in,O,O
the,O,O
peripheral,O,O
and,O,O
surrounding,O,O
area,O,O
of,O,O
the,O,O
tumor,O,O
.,O,O
The,O,O
bovine,B,B
PGHS,I,B
-,I,I
2,I,I
cDNA,I,I
was,O,O
cloned,O,O
by,O,O
a,O,O
combination,O,O
of,O,O
reverse,O,O
transcription,O,O
-,O,O
polymerase,O,O
chain,O,O
reaction,O,O
and,O,O
cDNA,O,O
library,O,O
screening,O,O
.,O,O
Functional,O,O
flow,O,O
was,O,O
evaluated,O,O
using,O,O
laser,O,O
Doppler,O,O
flowmetry,O,O
(,O,O
LDF,O,O
),O,O
",",O,O
for,O,O
which,O,O
the,O,O
output,O,O
signal,O,O
",",O,O
blood,O,O
cell,O,O
flux,O,O
(,O,O
BCF,O,O
),O,O
",",O,O
is,O,O
expressed,O,O
in,O,O
terms,O,O
of,O,O
volts,O,O
.,O,O
66,O,O
:,O,O
469,O,O
-,O,O
479,O,O
",",O,O
1992,O,O
),O,O
.,O,O
These,O,O
results,O,O
provide,O,O
evidence,O,O
of,O,O
a,O,O
bypass,O,O
of,O,O
p53,B,B
-,O,I
induced,O,I
Waf1,B,I
/,O,I
Cip1,B,I
-,O,I
mediated,O,I
cell,O,O
cycle,O,O
regulatory,O,O
pathways,O,O
by,O,O
a,O,O
member,O,O
of,O,O
the,O,O
myb,B,B
oncogene,I,I
family,I,O
.,O,O
Extracellular,B,O
-,I,O
regulated,I,O
kinase,I,O
(,O,O
ERK,B,B
),O,O
activation,O,O
and,O,O
molecular,O,O
coupling,O,O
of,O,O
the,O,O
adaptor,O,O
proteins,O,O
p130,B,O
Crk,B,O
-,I,O
associated,I,O
substrate,I,O
(,O,O
CAS,B,O
),O,O
and,O,O
c,B,O
-,I,O
CrkII,I,O
(,O,O
Crk,B,O
),O,O
represent,O,O
two,O,O
distinct,O,O
pathways,O,O
that,O,O
induce,O,O
cell,O,O
invasion,O,O
and,O,O
protect,O,O
cells,O,O
from,O,O
apoptosis,O,O
in,O,O
a,O,O
three,O,O
-,O,O
dimensional,O,O
collagen,B,O
matrix,O,O
.,O,O
DNA,O,B
hybridization,O,O
analysis,O,O
revealed,O,O
that,O,O
both,O,O
pigmented,O,O
and,O,O
nonpigmented,O,O
cells,O,O
of,O,O
Y,O,O
.,O,O
pestis,O,O
possess,O,O
a,O,O
DNA,O,B
locus,O,O
homologous,O,O
to,O,O
the,O,O
Escherichia,B,B
coli,I,I
fur,I,I
gene,I,I
.,O,O
The,O,O
genetic,O,O
basis,O,O
for,O,O
the,O,O
expression,O,O
of,O,O
a,O,O
latent,O,O
VH,B,B
allotype,I,I
in,O,O
the,O,O
rabbit,O,O
was,O,O
investigated,O,O
.,O,O
NF,B,B
-,I,I
kappa,I,I
B,I,I
p65,B,I
",",O,O
p50,B,B
",",O,O
and,O,O
Rel,B,B
functionally,O,O
synergize,O,O
with,O,O
C,B,B
/,I,I
EBP,I,I
alpha,I,I
",",O,O
C,B,B
/,I,I
EBP,I,I
beta,I,I
",",O,O
and,O,O
C,B,B
/,I,I
EBP,I,I
delta,I,I
.,O,O
A,O,O
5,O,O
.,O,O
0,O,O
-,O,O
kb,O,O
transcript,O,O
detected,O,O
by,O,O
the,O,O
differential,O,O
display,O,O
amplicon,O,O
3G1,O,O
was,O,O
found,O,O
to,O,O
correlate,O,O
strongly,O,O
with,O,O
RAG1,B,B
mRNA,I,I
expression,O,O
in,O,O
various,O,O
human,O,B
cell,O,I
lines,O,I
.,O,O
Because,O,O
L,B,B
-,I,I
plastin,I,I
expression,O,O
in,O,O
tissue,O,O
-,O,O
specifically,O,O
regulated,O,O
in,O,O
both,O,O
humans,O,B
and,O,O
rodents,O,O
",",O,O
it,O,O
is,O,O
likely,O,O
that,O,O
similar,O,O
mechanisms,O,O
regulate,O,O
L,B,B
-,I,I
plastin,I,I
gene,I,I
expression,O,O
in,O,O
human,O,B
and,O,O
rodent,O,O
cells,O,O
and,O,O
that,O,O
they,O,O
could,O,O
be,O,O
identified,O,O
by,O,O
comparing,O,O
the,O,O
function,O,O
and,O,O
nucleotide,O,O
sequences,O,O
of,O,O
the,O,O
human,O,B
and,O,O
murine,O,O
L,B,B
-,I,I
plastin,I,I
gene,O,I
promoters,O,O
.,O,O
It,O,O
is,O,O
transparent,O,O
",",O,O
cheap,O,O
to,O,O
be,O,O
made,O,O
",",O,O
and,O,O
easy,O,O
to,O,O
empty,O,O
and,O,O
was,O,O
tested,O,O
in,O,O
118,O,O
animals,O,O
for,O,O
two,O,O
and,O,O
four,O,O
weeks,O,O
.,O,O
All,O,O
clones,O,O
and,O,O
strains,O,O
produced,O,O
have,O,O
been,O,O
deposited,O,O
in,O,O
the,O,O
EUROFAN,O,O
genetic,O,O
stock,O,O
centre,O,O
(,O,O
EUROSCARF,O,O
",",O,O
Frankfurt,O,O
),O,O
.,O,O
This,O,O
approach,O,O
places,O,O
gHoxb,B,B
-,I,I
1,I,I
into,O,O
the,O,O
normal,O,O
embryonic,O,O
spatiotemporal,O,O
context,O,O
in,O,O
which,O,O
lab,O,O
acts,O,O
.,O,O
Here,O,O
we,O,O
describe,O,O
the,O,O
identification,O,O
and,O,O
characterization,O,O
of,O,O
several,O,O
Sp100,B,B
splice,I,I
variant,I,I
proteins,I,I
and,O,O
support,O,O
their,O,O
existence,O,O
by,O,O
elucidation,O,O
of,O,O
the,O,O
3,O,O
',O,O
-,O,O
end,O,O
of,O,O
the,O,O
Sp100,B,B
gene,I,I
.,O,O
During,O,O
the,O,O
following,O,O
9,O,O
1,O,O
/,O,O
2,O,O
years,O,O
three,O,O
sequential,O,O
liver,O,O
biopsies,O,O
were,O,O
performed,O,O
.,O,O
A,O,O
motif,O,O
(,O,O
TGATGTCA,O,O
),O,O
which,O,O
matches,O,O
a,O,O
CREB,B,B
site,I,I
and,O,O
is,O,O
similar,O,O
to,O,O
an,O,O
AP,B,B
-,I,I
1,I,I
site,I,I
is,O,O
embedded,O,O
within,O,O
ER2,B,O
.,O,O
The,O,O
effects,O,O
of,O,O
the,O,O
transfected,O,O
receptors,O,O
were,O,O
associated,O,O
with,O,O
antagonism,O,O
of,O,O
activator,B,O
protein,I,O
1,I,O
(,O,O
AP,B,B
-,I,I
1,I,I
),O,O
activity,O,O
.,O,O
Evolution,O,O
of,O,O
lesions,O,O
did,O,O
not,O,O
necessarily,O,O
follow,O,O
a,O,O
regular,O,O
progression,O,O
through,O,O
the,O,O
later,O,O
stages,O,O
of,O,O
the,O,O
vitelliform,O,O
classification,O,O
.,O,O
The,O,O
utility,O,O
of,O,O
such,O,O
analyses,O,O
in,O,O
the,O,O
design,O,O
of,O,O
ceramic,O,O
/,O,O
substrate,O,O
bilayer,O,O
systems,O,O
for,O,O
optimal,O,O
resistance,O,O
to,O,O
lifetime,O,O
-,O,O
threatening,O,O
damage,O,O
is,O,O
discussed,O,O
.,O,O
Thus,O,O
",",O,O
dpp,B,B
and,O,O
omb,B,B
promote,O,O
both,O,O
dorsal,O,O
leg,O,O
cell,O,O
fate,O,O
as,O,O
well,O,O
as,O,O
transdetermination,O,O
-,O,O
competent,O,O
leg,O,O
disc,O,O
cells,O,O
.,O,O
The,O,O
present,O,O
study,O,O
examined,O,O
the,O,O
dependence,O,O
of,O,O
difference,O,O
tone,O,O
level,O,O
[,O,O
L,O,O
(,O,O
f2,O,O
-,O,O
f1,O,O
),O,O
],O,O
on,O,O
the,O,O
following,O,O
parameters,O,O
of,O,O
the,O,O
two,O,O
-,O,O
tone,O,O
input,O,O
:,O,O
f1,O,O
",",O,O
f2,O,O
/,O,O
f1,O,O
(,O,O
f2,O,O
greater,O,O
than,O,O
f1,O,O
),O,O
",",O,O
L1,O,O
",",O,O
L2,O,O
",",O,O
and,O,O
L1,O,O
=,O,O
L2,O,O
.,O,O
In,O,O
the,O,O
case,O,O
of,O,O
congenital,O,O
protein,B,O
C,I,B
deficiency,O,O
",",O,O
vitamin,O,O
K,O,B
antagonists,O,O
must,O,O
be,O,O
started,O,O
cautiously,O,O
due,O,O
to,O,O
the,O,O
risk,O,O
of,O,O
skin,O,O
necrosis,O,O
.,O,O
Y15170,B,B
(,O,O
Surf,B,B
-,I,I
2,I,I
",",O,O
Surf,B,B
-,I,I
4,I,I
),O,O
",",O,O
Y15171,B,B
(,O,O
Surf,B,B
-,I,I
3,I,I
",",O,O
Surf,B,B
-,I,I
1,I,I
",",O,O
Surf,B,B
-,I,I
6,I,I
),O,O
",",O,O
and,O,O
Y15172,B,B
(,O,O
Surf,B,B
-,I,I
5,I,I
.,O,O
),O,O
],O,O
Formalin,O,O
activated,O,O
both,O,O
SNO,O,B
NS,O,I
and,O,O
NnS,O,B
neurones,O,O
",",O,O
but,O,O
",",O,O
when,O,O
they,O,O
responded,O,O
",",O,O
NS,O,B
neurones,O,O
(,O,O
n,O,O
=,O,O
5,O,O
),O,O
showed,O,O
only,O,O
the,O,O
first,O,O
phase,O,O
of,O,O
activity,O,O
while,O,O
NnS,O,B
neurones,O,O
showed,O,O
either,O,O
one,O,O
(,O,O
n,O,O
=,O,O
13,O,O
),O,O
or,O,O
two,O,O
phases,O,O
(,O,O
n,O,O
=,O,O
6,O,O
),O,O
.,O,O
The,O,O
-,O,O
64,O,O
/,O,O
-,O,O
37,O,O
region,O,O
interacted,O,O
with,O,O
purified,O,O
Sp1,B,B
and,O,O
an,O,O
unidentified,O,O
protein,O,O
(,O,O
s,O,O
),O,O
",",O,O
proximal,B,O
regulatory,I,O
factor,I,O
(,I,O
s,I,O
),I,O
I,I,O
(,O,O
PRF,B,B
-,I,I
I,I,I
),O,O
.,O,O
The,O,O
mean,O,O
transfer,O,O
ratios,O,O
of,O,O
the,O,O
drug,O,O
into,O,O
the,O,O
genital,O,O
tissues,O,O
to,O,O
the,O,O
concentration,O,O
in,O,O
the,O,O
uterine,O,O
arterial,O,O
blood,O,O
were,O,O
such,O,O
that,O,O
the,O,O
transfer,O,O
ratio,O,O
into,O,O
the,O,O
portio,O,O
vaginalis,O,O
was,O,O
the,O,O
highest,O,O
",",O,O
followed,O,O
by,O,O
the,O,O
uterine,O,O
cervix,O,O
and,O,O
the,O,O
myometrium,O,O
",",O,O
and,O,O
that,O,O
into,O,O
the,O,O
oviduct,O,O
was,O,O
the,O,O
lowest,O,O
with,O,O
about,O,O
1,O,O
/,O,O
2,O,O
that,O,O
into,O,O
the,O,O
portio,O,O
vaginalis,O,O
.,O,O
Pentazocine,O,O
analgesia,O,O
:,O,O
is,O,O
there,O,O
a,O,O
niche,O,O
for,O,O
Talwin,O,B
Nx,O,I
?,O,O
Pentazocine,O,O
can,O,O
be,O,O
a,O,O
useful,O,O
analgesic,O,O
agent,O,O
for,O,O
the,O,O
management,O,O
of,O,O
acute,O,O
dental,O,O
pain,O,O
.,O,O
A,O,O
series,O,O
of,O,O
5,O,O
',O,O
-,O,O
deletions,O,O
revealed,O,O
that,O,O
the,O,O
fragment,O,O
-,O,O
218,O,O
to,O,O
+,O,O
4,O,O
from,O,O
the,O,O
TSS,O,O
had,O,O
the,O,O
highest,O,O
promoter,O,O
activity,O,O
",",O,O
nearly,O,O
1000,O,O
-,O,O
fold,O,O
greater,O,O
than,O,O
the,O,O
promoterless,O,O
chloramphenicol,B,O
acetyltransferase,I,O
construct,I,O
.,O,O
In,O,O
44,O,O
evaluable,O,O
patients,O,O
the,O,O
response,O,O
rate,O,O
was,O,O
50,O,O
%,O,O
",",O,O
with,O,O
one,O,O
complete,O,O
response,O,O
.,O,O
Metastasis,O,O
of,O,O
colon,O,O
carcinoma,O,O
to,O,O
the,O,O
lip,O,O
.,O,O
one,O,O
acromegalic,O,O
patient,O,O
visual,O,O
improvement,O,O
was,O,O
obtained,O,O
while,O,O
the,O,O
abnormal,O,O
GH,B,B
secretion,O,O
remained,O,O
unaltered,O,O
.,O,O
affinities,O,O
of,O,O
different,O,O
nucleotide,O,O
mono,O,O
-,O,O
",",O,O
di,O,O
-,O,O
and,O,O
triphosphates,O,O
and,O,O
non,O,O
-,O,O
hydrolyzable,O,O
analogs,O,O
indicate,O,O
that,O,O
the,O,O
beta,O,O
-,O,O
phosphate,O,O
moiety,O,O
is,O,O
required,O,O
for,O,O
substrate,O,O
binding,O,O
.,O,O
The,O,O
central,O,O
(,O,O
R,O,B
),O,O
domain,O,O
is,O,O
responsible,O,O
for,O,O
receptor,O,O
-,O,O
binding,O,O
activity,O,O
whereas,O,O
the,O,O
N,O,B
-,O,I
terminal,O,I
(,O,O
T,O,B
),O,O
domain,O,O
mediates,O,O
translocation,O,O
",",O,O
the,O,O
process,O,O
by,O,O
which,O,O
the,O,O
C,O,B
-,O,I
terminal,O,I
cytotoxic,O,I
domain,O,I
is,O,O
transported,O,O
from,O,O
the,O,O
receptor,O,O
to,O,O
the,O,O
site,O,O
of,O,O
its,O,O
cytotoxicity,O,O
.,O,O
Localization,O,O
of,O,O
the,O,O
brachial,O,O
plexus,O,O
with,O,O
the,O,O
nerve,O,O
stimulator,O,O
is,O,O
equally,O,O
effective,O,O
at,O,O
the,O,O
interscalene,O,O
",",O,O
supraclavicular,O,O
",",O,O
and,O,O
axillary,O,O
sites,O,O
.,O,O
Additionally,O,O
",",O,O
a,O,O
CaCO3,O,O
-,O,O
CO2,O,O
/,O,O
N2,O,O
buffered,O,O
solution,O,O
was,O,O
necessary,O,O
to,O,O
maintain,O,O
a,O,O
pH,O,O
of,O,O
8,O,O
.,O,O
Nitrogen,O,O
-,O,O
hydrogen,O,O
tautomerism,O,O
in,O,O
porphyrins,O,O
and,O,O
chlorins,O,O
.,O,O
Using,O,O
anchored,O,O
PCR,O,O
",",O,O
a,O,O
VL,B,O
element,I,O
rearranged,O,O
to,O,O
CL2,B,O
was,O,O
isolated,O,O
.,O,O
Eight,O,O
recombinant,O,O
DNA,O,O
clones,O,O
of,O,O
endogenous,O,O
murine,O,B
leukemia,O,I
virus,O,I
(,O,O
MuLV,O,B
),O,O
-,O,O
related,O,O
DNA,O,O
sequences,O,O
have,O,O
been,O,O
isolated,O,O
from,O,O
a,O,O
lambdaphage,O,O
genomic,O,O
library,O,O
of,O,O
Balb,O,O
/,O,O
c,O,O
mouse,O,O
DNA,O,O
.,O,O
In,O,O
this,O,O
article,O,O
we,O,O
propose,O,O
to,O,O
find,O,O
out,O,O
the,O,O
percentage,O,O
of,O,O
normal,O,O
occlusion,O,O
and,O,O
the,O,O
distribution,O,O
of,O,O
maloclusions,O,O
",",O,O
according,O,O
to,O,O
the,O,O
anteroposterior,O,O
relationship,O,O
between,O,O
the,O,O
dental,O,O
archs,O,O
(,O,O
following,O,O
the,O,O
ANGLE3,O,O
classification,O,O
),O,O
.,O,O
Sequence,O,O
analysis,O,O
suggests,O,O
that,O,O
TtrA,B,B
contains,O,O
a,O,O
molybdopterin,O,O
guanine,O,O
dinucleotide,O,O
cofactor,O,O
and,O,O
a,O,O
[,O,O
4Fe,O,O
-,O,O
4S,O,O
],O,O
cluster,O,O
",",O,O
that,O,O
TtrB,B,B
binds,O,O
four,O,O
[,O,O
4Fe,O,O
-,O,O
4S,O,O
],O,O
clusters,O,O
",",O,O
and,O,O
that,O,O
TtrC,B,B
is,O,O
an,O,O
integral,O,O
membrane,O,O
protein,O,O
containing,O,O
a,O,O
quinol,O,O
oxidation,O,O
site,O,O
.,O,O
The,O,O
bioavailability,O,O
of,O,O
etodolac,O,B
from,O,O
capsules,O,O
exposed,O,O
to,O,O
stressed,O,O
conditions,O,O
was,O,O
compared,O,O
in,O,O
both,O,O
dogs,O,O
and,O,O
humans,O,B
to,O,O
capsules,O,O
stored,O,O
at,O,O
RT,O,O
conditions,O,O
.,O,O
The,O,O
results,O,O
confirm,O,O
that,O,O
a,O,O
single,O,O
base,O,O
change,O,O
in,O,O
the,O,O
branchpoint,O,O
consensus,O,O
sequence,O,O
of,O,O
an,O,O
intron,O,O
can,O,O
cause,O,O
human,O,B
disease,O,O
although,O,O
this,O,O
sequence,O,O
is,O,O
poorly,O,O
conserved,O,O
in,O,O
mammals,O,O
.,O,O
Re,O,O
:,O,O
no,O,O
differences,O,O
in,O,O
the,O,O
measurement,O,O
data,O,O
derived,O,O
from,O,O
this,O,O
method,O,O
and,O,O
actual,O,O
measurement,O,O
data,O,O
from,O,O
an,O,O
object,O,O
created,O,O
by,O,O
the,O,O
computer,O,O
-,O,O
aided,O,O
dental,O,O
design,O,O
program,O,O
.,O,O
Clinical,O,O
findings,O,O
were,O,O
:,O,O
height,O,O
183,O,O
cm,O,O
",",O,O
weight,O,O
62,O,O
kg,O,O
",",O,O
increased,O,O
length,O,O
of,O,O
lower,O,O
limbs,O,O
",",O,O
P2,O,O
-,O,O
A2,O,O
pilosity,O,O
and,O,O
micropenis,O,O
.,O,O
Both,O,O
strains,O,O
grew,O,O
very,O,O
poorly,O,O
",",O,O
or,O,O
not,O,O
at,O,O
all,O,O
",",O,O
on,O,O
nonfermentable,O,O
carbon,O,O
sources,O,O
and,O,O
exhibited,O,O
",",O,O
at,O,O
most,O,O
",",O,O
only,O,O
5,O,O
%,O,O
of,O,O
wild,B,O
-,I,O
type,I,O
ubiquinol,I,B
-,I,I
cytochrome,I,I
c,I,I
oxidoreductase,I,I
activity,O,O
.,O,O
Exposure,O,O
of,O,O
peripheral,O,O
blood,O,O
T,O,O
cells,O,O
from,O,O
young,O,O
subjects,O,O
to,O,O
PHA,B,B
or,O,O
cross,O,O
-,O,O
linked,O,O
anti,B,O
-,I,O
CD3,I,B
monoclonal,I,I
antibodies,I,I
stimulated,O,O
rapid,O,O
increases,O,O
in,O,O
MAPK,B,B
and,O,O
MEK,B,B
enzymatic,O,I
activity,O,O
.,O,O
Re,O,O
-,O,O
examining,O,O
methylbenzene,O,O
(,O,O
toluene,O,O
),O,O
as,O,O
a,O,O
treatment,O,O
for,O,O
Ancylostomum,O,O
caninum,O,O
.,O,O
In,O,O
the,O,O
point,O,O
mutant,O,O
we,O,O
observed,O,O
normal,O,O
repair,O,O
of,O,O
endonuclease,B,O
III,I,O
site,I,O
(,O,O
i,O,O
.,O,O
e,O,O
.,O,O
as,O,O
wild,O,O
type,O,O
),O,O
",",O,O
but,O,O
no,O,O
removal,O,O
of,O,O
CPDs,O,O
at,O,O
the,O,O
MAT,B,O
alpha,I,O
and,O,O
HML,B,O
alpha,I,O
loci,I,O
.,O,O
Ischemic,O,O
heart,O,O
disease,O,O
",",O,O
age,O,O
of,O,O
more,O,O
than,O,O
75,O,O
years,O,O
",",O,O
and,O,O
the,O,O
fact,O,O
that,O,O
the,O,O
patient,O,O
was,O,O
a,O,O
woman,O,O
were,O,O
independent,O,O
predictors,O,O
of,O,O
poor,O,O
cardiac,O,O
function,O,O
.,O,O
Felodipine,O,O
did,O,O
not,O,O
alter,O,O
the,O,O
baseline,O,O
FEV1,O,O
",",O,O
but,O,O
showed,O,O
a,O,O
small,O,O
significant,O,O
inhibitory,O,O
effect,O,O
upon,O,O
histamine,O,B
and,O,O
AMP,O,B
induced,O,O
bronchoconstriction,O,O
.,O,O
The,O,O
mutant,O,O
allele,O,O
of,O,O
the,O,O
alpha,B,B
1,I,I
-,I,I
tubulin,I,I
gene,I,I
was,O,O
designated,O,O
tua1,B,B
-,I,I
1,I,I
.,O,O
Effects,O,O
of,O,O
dopamine,O,B
and,O,O
of,O,O
a,O,O
dopaminergic,O,O
blocker,O,O
",",O,O
haloperidol,O,B
",",O,O
on,O,O
the,O,O
responses,O,O
of,O,O
carotid,O,O
body,O,O
chemoreceptors,O,O
to,O,O
hypoxia,O,O
and,O,O
hypercapnia,O,O
were,O,O
investigated,O,O
in,O,O
16,O,O
anesthetized,O,O
cats,O,O
.,O,O
Marked,O,O
thrombocytopenia,O,O
",",O,O
depletion,O,O
of,O,O
serum,B,O
fibrinogen,I,O
and,O,O
prolonged,O,O
prothrombin,B,O
and,O,O
activated,O,O
partial,O,O
thromboplastin,B,O
time,O,O
",",O,O
were,O,O
recorded,O,O
at,O,O
5,O,O
to,O,O
10,O,O
and,O,O
30,O,O
to,O,O
40,O,O
minutes,O,O
after,O,O
intravenous,O,O
envenomation,O,O
.,O,O
Serum,O,O
induction,O,O
of,O,O
a,O,O
MEF2,B,B
reporter,I,I
gene,I,I
was,O,O
not,O,O
observed,O,O
in,O,O
a,O,O
line,O,O
of,O,O
NIH,O,B
3T3,O,I
cells,O,I
which,O,O
contain,O,O
low,O,O
MEF2,B,B
site,I,I
binding,O,I
activity,O,I
.,O,O
Competitive,O,O
mobility,O,O
shift,O,O
assays,O,O
using,O,O
either,O,O
alphaT3,O,B
-,O,I
1,O,I
nuclear,O,O
extract,O,O
or,O,O
recombinant,B,O
SF,I,B
-,I,I
1,I,I
protein,I,O
clearly,O,O
indicated,O,O
that,O,O
SF,B,B
-,I,I
1,I,I
is,O,O
able,O,O
to,O,O
interact,O,O
specifically,O,O
with,O,O
this,O,O
GSE,B,B
element,I,O
positioned,O,O
at,O,O
-,O,O
134,O,O
.,O,O
Restriction,O,O
maps,O,O
of,O,O
the,O,O
cloned,O,O
plasmids,O,O
revealed,O,O
that,O,O
their,O,O
chromosomal,O,O
inserts,O,O
consisted,O,O
of,O,O
overlapping,O,O
fragments,O,O
.,O,O
Schwab,O,O
and,O,O
England,O,O
ADL,O,O
scores,O,O
in,O,O
the,O,O
state,O,O
were,O,O
improved,O,O
by,O,O
18,O,O
%,O,O
and,O,O
in,O,O
the,O,O
state,O,O
the,O,O
scores,O,O
declined,O,O
by,O,O
2,O,O
%,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
marked,O,O
hypertension,O,O
accompanied,O,O
this,O,O
disorder,O,O
and,O,O
all,O,O
abnormalities,O,O
",",O,O
including,O,O
the,O,O
hypertension,O,O
",",O,O
responded,O,O
to,O,O
1,B,O
-,I,O
desamino,I,O
-,I,O
8,I,O
-,I,O
D,I,O
-,I,O
arginine,I,O
vasopressin,I,O
therapy,O,O
.,O,O
Localization,O,O
of,O,O
67,O,B
exons,O,O
on,O,O
a,O,O
YAC,O,O
contig,O,O
spanning,O,O
1,O,O
.,O,O
5,O,O
Mb,O,O
around,O,O
the,O,O
multidrug,B,O
resistance,I,O
gene,I,O
region,I,O
of,O,O
human,O,B
chromosome,O,I
7q21,O,I
.,O,O
1,O,O
.,O,O
In,O,O
both,O,O
settings,O,O
",",O,O
it,O,O
can,O,O
be,O,O
phosphorylated,O,O
by,O,O
cyclin,B,O
D,I,O
-,I,O
dependent,I,O
kinases,I,O
",",O,O
suggesting,O,O
that,O,O
its,O,O
transcriptional,O,O
activity,O,O
may,O,O
normally,O,O
be,O,O
regulated,O,O
through,O,O
such,O,O
mechanisms,O,O
.,O,O
It,O,O
is,O,O
now,O,O
estimated,O,O
that,O,O
inactivation,O,O
mutants,O,O
of,O,O
PTEN,B,B
exist,O,O
in,O,O
60,O,O
%,O,O
of,O,O
all,O,O
forms,O,O
of,O,O
solid,O,O
tumors,O,O
.,O,O
Based,O,O
on,O,O
a,O,O
type,O,O
I,O,O
error,O,O
of,O,O
0,O,O
.,O,O
05,O,O
",",O,O
our,O,O
study,O,O
had,O,O
a,O,O
power,O,O
greater,O,O
than,O,O
or,O,O
equal,O,O
to,O,O
75,O,O
%,O,O
to,O,O
detect,O,O
group,O,O
differences,O,O
in,O,O
treatment,O,O
effect,O,O
of,O,O
greater,O,O
than,O,O
or,O,O
equal,O,O
to,O,O
15,O,O
%,O,O
to,O,O
20,O,O
%,O,O
.,O,O
The,O,O
aim,O,O
of,O,O
this,O,O
study,O,O
was,O,O
to,O,O
determine,O,O
the,O,O
risk,O,O
factors,O,O
for,O,O
background,O,O
diabetic,O,O
retinopathy,O,O
(,O,O
BDR,O,B
),O,O
and,O,O
PDR,O,B
by,O,O
following,O,O
394,O,O
Japanese,O,O
patients,O,O
with,O,O
early,O,O
-,O,O
onset,O,O
type,O,O
2,O,O
diabetes,O,O
diagnosed,O,O
before,O,O
30,O,O
years,O,O
of,O,O
age,O,O
(,O,O
mean,O,O
age,O,O
27,O,O
",",O,O
mean,O,O
blood,O,O
pressure,O,O
at,O,O
entry,O,O
116,O,O
/,O,O
73,O,O
mm,O,O
Hg,O,O
),O,O
.,O,O
Also,O,O
",",O,O
samples,O,O
of,O,O
serum,O,O
were,O,O
absorbed,O,O
with,O,O
the,O,O
various,O,O
solid,O,O
-,O,O
phase,O,O
allergens,O,O
and,O,O
the,O,O
reactivity,O,O
of,O,O
the,O,O
remaining,O,O
IgE,B,B
antibodies,I,O
was,O,O
determined,O,O
.,O,O
Computer,O,O
-,O,O
aided,O,O
analysis,O,O
revealed,O,O
four,O,O
possible,O,O
open,O,O
reading,O,O
frames,O,O
(,O,O
ORFs,O,O
),O,O
",",O,O
three,O,O
in,O,O
one,O,O
direction,O,O
and,O,O
one,O,O
in,O,O
the,O,O
opposite,O,O
direction,O,O
.,O,O
Southern,O,O
blot,O,O
analysis,O,O
using,O,O
probes,O,O
from,O,O
the,O,O
3,O,O
',O,O
portions,O,O
of,O,O
the,O,O
genomic,O,O
and,O,O
B,B,B
MB,B,B
cDNA,I,O
clones,O,O
showed,O,O
that,O,O
MA,B,B
type,I,O
myrosinases,B,O
are,O,O
encoded,O,O
by,O,O
approximately,O,O
4,O,O
genes,O,O
",",O,O
while,O,O
MB,B,B
type,I,O
myrosinases,B,O
are,O,O
encoded,O,O
by,O,O
more,O,O
than,O,O
10,O,O
genes,O,O
in,O,O
B,O,O
.,O,O
napus,O,O
.,O,O
In,O,O
general,O,O
",",O,O
the,O,O
filtration,O,O
rate,O,O
in,O,O
relevant,O,O
areas,O,O
appears,O,O
to,O,O
be,O,O
an,O,O
integrative,O,O
and,O,O
easily,O,O
determined,O,O
parameter,O,O
",",O,O
reflecting,O,O
hormonal,O,O
and,O,O
neurogenic,O,O
vascular,O,O
as,O,O
well,O,O
as,O,O
local,O,O
interstitial,O,O
control,O,O
of,O,O
the,O,O
Starling,O,O
forces,O,O
.,O,O
Translation,O,O
of,O,O
specific,O,O
cellular,O,O
genes,O,B
from,O,O
the,O,O
chimeric,O,O
viral,O,O
-,O,O
cellular,O,O
transcripts,O,O
seems,O,O
to,O,O
be,O,O
unlikely,O,O
.,O,O
Possible,O,O
relationship,O,O
between,O,O
hyperinsulinemia,O,O
and,O,O
glomerular,O,O
hypertrophy,O,O
in,O,O
nephrosclerosis,O,O
.,O,O
These,O,O
data,O,O
suggest,O,O
that,O,O
ADAM,B,B
-,I,I
TS12,I,I
may,O,O
play,O,O
roles,O,O
in,O,O
pulmonary,O,O
cells,O,O
during,O,O
fetal,O,O
development,O,O
or,O,O
in,O,O
tumor,O,O
processes,O,O
through,O,O
its,O,O
proteolytic,O,O
activity,O,O
or,O,O
as,O,O
a,O,O
molecule,O,O
potentially,O,O
involved,O,O
in,O,O
regulation,O,O
of,O,O
cell,O,O
adhesion,O,O
.,O,O
A,O,O
polypeptide,O,O
encoded,O,O
by,O,O
the,O,O
NTS,O,B
16,O,I
open,O,O
reading,O,O
frame,O,O
has,O,O
sequence,O,O
similarity,O,O
to,O,O
the,O,O
catalytic,O,O
domain,O,O
of,O,O
several,O,O
receptor,B,O
protein,I,O
kinases,I,O
from,I,O
plants,I,O
including,O,O
the,O,O
S,B,B
-,I,I
receptor,I,I
kinases,I,I
implicated,O,O
in,O,O
the,O,O
rejection,O,O
of,O,O
self,O,O
-,O,O
pollen,O,O
in,O,O
Brassica,O,O
species,O,O
and,O,O
the,O,O
Pto,B,B
gene,I,I
product,I,I
of,I,I
tomato,I,I
which,O,O
confers,O,O
resistance,O,O
to,O,O
a,O,O
bacterial,O,O
pathogen,O,O
.,O,O
A,O,O
Dictyostelium,O,B
transformant,O,O
overexpressing,O,O
DdPTPa,B,B
does,O,O
not,O,O
develop,O,O
normally,O,O
.,O,O
100,O,O
more,O,O
than,O,O
in,O,O
the,O,O
summer,O,O
coat,O,O
),O,O
.,O,O
However,O,O
",",O,O
the,O,O
relative,O,O
binding,O,O
affinity,O,O
for,O,O
the,O,O
motifs,O,O
is,O,O
different,O,O
.,O,O
These,O,O
differences,O,O
are,O,O
smaller,O,O
than,O,O
those,O,O
described,O,O
in,O,O
standard,O,O
textbooks,O,O
.,O,O
This,O,O
c,B,O
-,I,O
Jun,I,B
activity,O,O
is,O,O
inhibited,O,O
by,O,O
c,B,O
-,I,O
Fos,I,B
",",O,O
another,O,O
protooncoprotein,O,O
that,O,O
can,O,O
dimerize,O,O
with,O,O
c,B,O
-,I,O
Jun,I,B
to,O,O
form,O,O
the,O,O
transcription,O,O
factor,O,O
AP,B,B
-,I,I
1,I,I
.,O,O
The,O,O
XS2,B,B
gene,I,O
down,O,O
-,O,O
regulates,O,O
but,O,O
does,O,O
not,O,O
abolish,O,O
expression,O,O
of,O,O
LU,B,B
genes,I,O
and,O,O
does,O,O
not,O,O
affect,O,O
expression,O,O
of,O,O
CD44,B,B
.,O,O
Northern,O,O
analysis,O,O
of,O,O
RNA,O,O
samples,O,O
isolated,O,O
from,O,O
ammonium,O,O
-,O,O
grown,O,O
cultures,O,O
of,O,O
the,O,O
ntcA,B,O
mutant,I,O
showed,O,O
reduced,O,O
amounts,O,O
of,O,O
glnA,B,B
message,I,O
and,O,O
the,O,O
absence,O,O
of,O,O
a,O,O
1,O,O
.,O,O
7,O,O
-,O,O
kb,O,O
transcript,O,O
.,O,O
Upstream,O,O
of,O,O
-,O,O
37,O,O
",",O,O
the,O,O
5,O,O
',O,O
untranslated,O,O
sequences,O,O
of,O,O
the,O,O
isolates,O,O
differ,O,O
in,O,O
both,O,O
length,O,O
and,O,O
sequence,O,O
.,O,O
Null,O,O
alleles,O,O
of,O,O
SAS4,B,B
and,O,O
SAS5,B,B
bypassed,O,O
the,O,O
role,O,O
of,O,O
the,O,O
Abf1p,B,B
binding,I,O
site,I,O
of,O,O
the,O,O
HMR,B,B
-,I,I
E,I,I
silencer,I,I
but,O,O
not,O,O
the,O,O
role,O,O
of,O,O
the,O,O
ACS,B,B
or,O,O
Rap1p,B,B
binding,I,O
site,I,O
.,O,O
Surprisingly,O,O
",",O,O
the,O,O
RXR,B,B
-,O,I
specific,O,I
ligand,O,O
9,O,O
-,O,O
cis,O,O
-,O,O
retinoic,O,O
acid,O,O
induced,O,O
binding,O,O
of,O,O
SRC,B,B
-,I,I
1,I,I
to,O,O
the,O,O
RXR,B,B
component,I,O
of,O,O
the,O,O
TRE,O,B
-,O,I
bound,O,I
heterodimer,O,I
.,O,O
Anecdotal,O,O
observations,O,O
scattered,O,O
throughout,O,O
the,O,O
literature,O,O
have,O,O
often,O,O
provided,O,O
clues,O,O
to,O,O
underlying,O,O
variations,O,O
in,O,O
humans,O,O
',O,O
ability,O,O
to,O,O
handle,O,O
dietary,O,O
chemicals,O,O
.,O,O
As,O,O
expected,O,O
",",O,O
homologous,B,O
loxP,I,B
sequences,I,O
efficiently,O,O
underwent,O,O
Cre,B,B
-,O,I
mediated,O,I
recombination,O,O
.,O,O
Effects,O,O
of,O,O
repeated,O,O
exposures,O,O
of,O,O
hydrogen,O,B
sulphide,O,I
on,O,O
rat,O,O
hippocampal,O,O
EEG,O,O
.,O,O
The,O,O
ORF3,O,B
probe,O,O
also,O,O
hybridized,O,O
to,O,O
a,O,O
540,O,O
bp,O,O
transcript,O,O
consistent,O,O
with,O,O
the,O,O
size,O,O
of,O,O
ORF3,O,B
alone,O,O
and,O,O
supportive,O,O
of,O,O
the,O,O
mutagenesis,O,O
data,O,O
of,O,O
non,O,O
-,O,O
linkage,O,O
.,O,O
Studies,O,O
on,O,O
the,O,O
organic,O,O
matrix,O,O
of,O,O
human,O,B
ear,O,O
ossicles,O,O
However,O,O
",",O,O
kidneys,O,O
perfused,O,O
for,O,O
72,O,O
hr,O,O
demonstrated,O,O
more,O,O
similar,O,O
renal,O,O
functions,O,O
when,O,O
tested,O,O
by,O,O
either,O,O
IMPK,O,O
or,O,O
IBPK,O,O
.,O,O
The,O,O
ectopic,O,O
expression,O,O
of,O,O
Oct,B,B
-,I,I
3,I,I
/,I,I
4,I,I
in,O,O
hybrid,O,O
cells,O,O
under,O,O
a,O,O
constitutive,O,O
promoter,O,O
is,O,O
sufficient,O,O
for,O,O
transcriptional,O,O
activation,O,O
of,O,O
an,O,O
octamer,O,O
-,O,O
dependent,O,O
promoter,O,O
.,O,O
RESULTS,O,O
:,O,O
The,O,O
age,O,O
distribution,O,O
was,O,O
28,O,O
to,O,O
83,O,O
years,O,O
old,O,O
(,O,O
mean,O,O
was,O,O
54,O,O
.,O,O
1,O,O
years,O,O
),O,O
.,O,O
DNA,O,B
-,O,I
protein,O,O
UV,O,O
cross,O,O
-,O,O
linking,O,O
studies,O,O
indicated,O,O
that,O,O
UHF,B,B
-,I,I
1,I,I
has,O,O
an,O,O
electrophoretic,O,O
mobility,O,O
on,O,O
sodium,O,O
dodecyl,O,O
sulfate,O,O
-,O,O
acrylamide,O,O
gels,O,O
of,O,O
approximately,O,O
85,O,O
kDa,O,O
and,O,O
suggested,O,O
that,O,O
additional,O,O
proteins,O,O
",",O,O
specific,O,O
to,O,O
each,O,O
promoter,O,O
",",O,O
bind,O,O
to,O,O
each,O,O
site,O,O
.,O,O
In,O,O
cases,O,O
of,O,O
1,O,O
degrees,O,O
HPT,O,O
",",O,O
the,O,O
plasma,O,O
1,O,O
",",O,O
25,O,O
-,O,O
(,O,O
OH,O,B
),O,O
2D,O,O
level,O,O
rose,O,O
significantly,O,O
in,O,O
all,O,O
cases,O,O
(,O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
05,O,O
),O,O
",",O,O
although,O,O
the,O,O
pattern,O,O
of,O,O
the,O,O
increase,O,O
was,O,O
not,O,O
uniform,O,O
.,O,O
4,O,O
.,O,O
26,O,O
+,O,O
/,O,O
-,O,O
1,O,O
.,O,O
54,O,O
mmol,O,O
/,O,O
l,O,O
",",O,O
P,O,O
<,O,O
0,O,O
.,O,O
01,O,O
BP,O,O
responses,O,O
to,O,O
intravenous,O,O
norepinephrine,O,O
and,O,O
angiotensin,B,O
II,I,O
were,O,O
significantly,O,O
higher,O,O
on,O,O
glibenclamide,O,O
than,O,O
on,O,O
metformin,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
02,O,O
and,O,O
P,O,O
<,O,O
0,O,O
.,O,O
05,O,O
",",O,O
respectively,O,O
),O,O
of,O,O
fatty,O,O
liver,O,O
syndrome,O,O
in,O,O
a,O,O
Jersey,O,O
herd,O,O
by,O,O
a,O,O
change,O,O
of,O,O
diet,O,O
and,O,O
the,O,O
use,O,O
of,O,O
recombinant,O,O
bovine,O,B
somatotrophin,B,I
.,O,O
Precipitation,O,O
using,O,O
GST,B,O
fusion,I,O
proteins,I,O
containing,O,O
Fyn,B,B
SH2,B,I
",",O,O
SH3,B,I
",",O,O
and,O,O
SH2,B,B
/,O,I
SH3,B,I
domains,O,O
revealed,O,O
that,O,O
PI,B,O
3,I,O
-,I,O
kinase,I,O
bound,O,O
principally,O,O
to,O,O
the,O,O
SH3,B,B
domain,I,I
of,O,I
Fyn,B,I
.,O,O
Fluorimetric,O,O
determination,O,O
of,O,O
methylmercury,O,O
as,O,O
an,O,O
ion,O,O
-,O,O
association,O,O
complex,O,O
with,O,O
rhodamine,O,O
B,O,O
in,O,O
the,O,O
presence,O,O
of,O,O
iodide,O,O
.,O,O
Unlike,O,O
the,O,O
mammalian,O,O
proteins,O,O
",",O,O
XFGF3,B,B
is,O,O
efficiently,O,O
secreted,O,O
as,O,O
a,O,O
Mr,O,O
31,O,O
",",O,O
000,O,O
glycoprotein,O,O
",",O,O
gp31,B,B
",",O,O
which,O,O
undergoes,O,O
proteolytic,O,O
cleavage,O,O
to,O,O
produce,O,O
an,O,O
NH2,O,O
-,O,O
terminally,O,O
truncated,O,O
product,O,O
",",O,O
gp27,B,B
.,O,O
Tristetraprolin,B,B
(,O,O
TTP,B,B
),O,O
is,O,O
the,O,O
prototype,O,O
of,O,O
a,O,O
group,O,O
of,O,O
potential,O,O
transcription,O,O
factors,O,O
that,O,O
contain,O,O
two,O,O
or,O,O
more,O,O
unusual,O,O
CCCH,O,B
zinc,O,I
fingers,O,I
.,O,O
Unusual,O,O
course,O,O
of,O,O
plasmocytosis,O,O
.,O,O
Binding,O,O
of,O,O
U2,B,B
small,I,I
nuclear,I,I
ribonucleoprotein,I,I
(,O,O
snRNP,O,B
),O,O
to,O,O
the,O,O
pre,O,O
-,O,O
mRNA,O,O
is,O,O
an,O,O
early,O,O
and,O,O
important,O,O
step,O,O
in,O,O
spliceosome,O,O
assembly,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
we,O,O
observe,O,O
that,O,O
the,O,O
hUBF,B,B
-,I,I
promoter,I,I
interaction,O,O
is,O,O
highly,O,O
sensitive,O,O
to,O,O
the,O,O
antagonistic,O,O
effects,O,O
of,O,O
cisplatin,O,O
-,O,O
DNA,O,O
adducts,O,O
.,O,O
Mss4,B,O
also,O,O
acts,O,O
as,O,O
a,O,O
relatively,O,O
inefficient,O,O
guanine,B,B
nucleotide,I,I
exchange,I,I
factor,I,I
(,O,O
GEF,B,B
),O,O
.,O,O
Prolonged,O,O
heavy,O,O
work,O,O
effected,O,O
an,O,O
increase,O,O
of,O,O
10,O,O
.,O,O
3,O,O
plus,O,O
or,O,O
minus,O,O
0,O,O
.,O,O
9,O,O
mmHg,O,O
in,O,O
in,O,O
vivo,O,O
P50,O,O
(,O,O
7,O,O
.,O,O
30,O,O
PH,O,O
-,O,O
v,O,O
",",O,O
41,O,O
degrees,O,O
C,O,O
-,O,O
v,O,O
",",O,O
and,O,O
45,O,O
Pv,O,O
-,O,O
CO2,O,O
),O,O
;,O,O
due,O,O
entirely,O,O
to,O,O
the,O,O
additive,O,O
effects,O,O
of,O,O
increased,O,O
venous,O,O
temperature,O,O
and,O,O
[,O,O
H,O,B
+,O,I
],O,O
.,O,O
The,O,O
RFLP,O,O
patterns,O,O
of,O,O
the,O,O
isolates,O,O
from,O,O
six,O,O
of,O,O
these,O,O
patients,O,O
remained,O,O
essentially,O,O
unchanged,O,O
(,O,O
two,O,O
strains,O,O
showed,O,O
one,O,O
additional,O,O
band,O,O
),O,O
despite,O,O
the,O,O
development,O,O
of,O,O
drug,O,O
resistance,O,O
.,O,O
Plasma,O,O
and,O,O
erthrocyte,O,O
lipid,O,O
profile,O,O
and,O,O
lipoprotein,B,O
lipase,I,O
activity,O,O
in,O,O
postheparin,O,O
plasma,O,O
on,O,O
vasectomized,O,O
rabbits,O,O
were,O,O
studied,O,O
and,O,O
also,O,O
the,O,O
incidence,O,O
of,O,O
atherosclerosis,O,O
in,O,O
different,O,O
arterial,O,O
beds,O,O
.,O,O
TEMTU,O,O
and,O,O
DPTU,O,O
were,O,O
the,O,O
most,O,O
potent,O,O
teratogens,O,O
.,O,O
We,O,O
have,O,O
shown,O,O
that,O,O
the,O,O
epidural,O,O
(,O,O
EPI,O,B
),O,O
delivery,O,O
of,O,O
morphine,O,O
encapsulated,O,O
in,O,O
multivesicular,O,O
liposomes,O,O
(,O,O
DepoFoam,O,O
drug,O,O
delivery,O,O
system,O,O
),O,O
produces,O,O
a,O,O
sustained,O,O
clearance,O,O
of,O,O
morphine,O,O
and,O,O
a,O,O
prolonged,O,O
analgesia,O,O
.,O,O
A,O,O
case,O,O
of,O,O
AIDS,O,B
-,O,I
related,O,I
complex,O,I
(,O,O
ARC,O,B
/,O,I
LAS,O,I
),O,O
in,O,O
a,O,O
health,O,O
worker,O,O
The,O,O
mechanism,O,O
of,O,O
the,O,O
induction,O,O
of,O,O
3beta,B,B
-,I,I
HSD,I,I
type,I,I
1,I,I
gene,I,I
expression,O,O
was,O,O
further,O,O
characterized,O,O
in,O,O
ZR,O,O
-,O,O
75,O,O
-,O,O
1,O,O
human,O,B
breast,O,I
cancer,O,I
cells,O,O
.,O,O
From,O,O
this,O,O
library,O,O
",",O,O
LEU2,B,B
and,O,O
HIS3,B,B
cDNAs,O,O
were,O,O
recovered,O,O
at,O,O
a,O,O
frequency,O,O
of,O,O
about,O,O
1,O,O
in,O,O
10,O,O
(,O,O
4,O,O
),O,O
and,O,O
in,O,O
12,O,O
out,O,O
of,O,O
13,O,O
cases,O,O
these,O,O
were,O,O
expressed,O,O
in,O,O
a,O,O
galactose,O,O
-,O,O
dependent,O,O
manner,O,O
.,O,O
Here,O,O
",",O,O
we,O,O
identify,O,O
Rsc3,B,B
and,O,O
Rsc30,B,B
as,O,O
novel,O,O
components,O,O
of,O,O
the,O,O
essential,O,O
yeast,B,O
remodeler,I,O
RSC,I,O
complex,I,O
.,O,O
We,O,O
also,O,O
observed,O,O
that,O,O
the,O,O
predictive,O,O
ability,O,O
of,O,O
the,O,O
selected,O,O
attitudes,O,O
and,O,O
orientations,O,O
increased,O,O
considerably,O,O
from,O,O
1975,O,O
to,O,O
1982,O,O
.,O,O
Electromobility,O,O
shift,O,O
and,O,O
cotransfection,O,O
assays,O,O
demonstrated,O,O
that,O,O
HNF1alpha,B,B
",",O,O
but,O,O
not,O,O
HNF4,B,B
",",O,O
bound,O,O
to,O,O
its,O,O
cognate,O,O
site,O,O
and,O,O
transactivated,O,O
G6Pase,B,B
gene,I,I
expression,O,O
.,O,O
Comparison,O,O
with,O,O
the,O,O
bHLH,B,B
/,O,I
PAS,B,I
family,O,I
genes,O,I
revealed,O,O
that,O,O
the,O,O
intron,O,O
/,O,O
exon,O,O
splice,O,O
pattern,O,O
of,O,O
mBMAL1,B,B
most,O,O
closely,O,O
matches,O,O
that,O,O
of,O,O
the,O,O
mAhr,B,B
",",O,O
which,O,O
suggests,O,O
that,O,O
BMAL1,B,B
and,O,O
Ahr,B,B
belong,O,O
to,O,O
the,O,O
same,O,O
subclass,O,O
and,O,O
may,O,O
be,O,O
derived,O,O
from,O,O
a,O,O
common,O,O
primordial,O,O
gene,O,O
.,O,O
In,O,O
three,O,O
of,O,O
the,O,O
seven,O,O
",",O,O
inhalation,O,O
of,O,O
2,O,O
ml,O,O
normal,O,O
saline,O,O
produced,O,O
FEV1,O,B
falls,O,O
of,O,O
25,O,O
%,O,O
to,O,O
30,O,O
%,O,O
",",O,O
but,O,O
these,O,O
falls,O,O
were,O,O
not,O,O
as,O,O
great,O,O
as,O,O
each,O,O
subject,O,O
',O,O
s,O,O
to,O,O
the,O,O
test,O,O
solutions,O,O
.,O,O
Stable,O,O
transfection,O,O
of,O,O
the,O,O
BL,O,B
cell,O,I
line,O,I
Raji,O,B
with,O,O
constructs,O,O
containing,O,O
core,O,O
promoter,O,O
mutations,O,O
confirmed,O,O
that,O,O
the,O,O
proximal,O,O
Sp1,B,B
site,I,I
and,O,O
the,O,O
TATA,O,B
box,O,I
are,O,O
essential,O,O
for,O,O
the,O,O
activation,O,O
of,O,O
promoter,O,O
P1,O,B
by,O,O
the,O,O
Ig,B,B
kappa,I,I
enhancers,I,I
.,O,O
Is,O,O
clopidogrel,O,B
superior,O,O
to,O,O
aspirin,O,B
in,O,O
secondary,O,O
prevention,O,O
of,O,O
vascular,O,O
disease,O,O
?,O,O
The,O,O
cornerstone,O,O
in,O,O
clinical,O,O
evidence,O,O
of,O,O
the,O,O
relative,O,O
efficacy,O,O
of,O,O
thienopyridines,O,B
(,O,O
clopidogrel,O,B
",",O,O
ticlopidine,O,B
),O,O
versus,O,O
aspirin,O,B
in,O,O
the,O,O
secondary,O,O
prevention,O,O
of,O,O
vascular,O,O
disease,O,O
is,O,O
the,O,O
Clopidogrel,O,B
versus,O,O
Aspirin,O,B
in,O,O
Patients,O,O
at,O,O
Risk,O,O
of,O,O
Ischaemic,O,O
Events,O,O
trial,O,O
.,O,O
These,O,O
results,O,O
indicate,O,O
that,O,O
the,O,O
total,O,O
number,O,O
of,O,O
subunit,O,O
c,O,B
in,O,O
F0,B,O
should,O,O
be,O,O
a,O,O
multiple,O,O
of,O,O
2,O,O
and,O,O
3,O,O
.,O,O
UF,O,O
-,O,O
021,O,O
ophthalmic,O,O
solution,O,O
(,O,O
0,O,O
.,O,O
03,O,O
to,O,O
0,O,O
.,O,O
24,O,O
%,O,O
),O,O
",",O,O
when,O,O
topically,O,O
applied,O,O
to,O,O
the,O,O
eyes,O,O
of,O,O
rabbits,O,O
",",O,O
caused,O,O
dose,O,O
-,O,O
dependent,O,O
IOP,O,O
reduction,O,O
(,O,O
2,O,O
.,O,O
8,O,O
to,O,O
5,O,O
.,O,O
2,O,O
mmHg,O,O
),O,O
",",O,O
without,O,O
transient,O,O
IOP,O,O
rise,O,O
.,O,O
The,O,O
continuing,O,O
development,O,O
of,O,O
ligands,O,O
that,O,O
function,O,O
as,O,O
selective,O,O
estrogens,O,O
or,O,O
antiestrogens,O,O
for,O,O
ERalpha,B,B
or,O,O
ERbeta,B,B
should,O,O
allow,O,O
optimized,O,O
tissue,O,O
selectivity,O,O
of,O,O
these,O,O
agents,O,O
for,O,O
menopausal,O,O
hormone,O,O
replacement,O,O
therapy,O,O
and,O,O
the,O,O
treatment,O,O
and,O,O
prevention,O,O
of,O,O
breast,O,O
cancer,O,O
.,O,O
From,O,O
two,O,O
inhibitor,O,O
scaffolds,O,O
",",O,O
we,O,O
have,O,O
identified,O,O
potent,O,O
and,O,O
selective,O,O
inhibitors,O,O
for,O,O
sensitized,O,O
kinases,O,O
from,O,O
five,O,O
distinct,O,O
subfamilies,O,O
.,O,O
RESULTS,O,O
:,O,O
Average,O,O
age,O,O
at,O,O
symptom,O,O
onset,O,O
was,O,O
41,O,O
.,O,O
2,O,O
years,O,O
.,O,O
A,O,O
role,O,O
for,O,O
glycogen,B,B
synthase,I,I
kinase,I,I
-,I,I
3,I,I
in,O,O
the,O,O
control,O,O
of,O,O
gene,O,O
expression,O,O
.,O,O
Tolerance,O,O
test,O,O
of,O,O
HB,O,O
419,O,O
in,O,O
animal,O,O
experiments,O,O
Possibly,O,O
",",O,O
the,O,O
scr1,B,O
-,I,O
1,I,O
mutation,I,O
does,O,O
not,O,O
affect,O,O
signal,O,O
recognition,O,O
or,O,O
translational,O,O
arrest,O,O
but,O,O
instead,O,O
results,O,O
in,O,O
maintenance,O,O
of,O,O
translational,O,O
arrest,O,O
of,O,O
AEP,B,O
synthesis,O,O
.,O,O
A,O,O
total,O,O
of,O,O
194,O,O
STSs,O,B
map,O,O
to,O,O
this,O,O
interval,O,O
of,O,O
3,O,O
Mb,O,O
",",O,O
giving,O,O
an,O,O
average,O,O
marker,O,O
resolution,O,O
of,O,O
approximately,O,O
one,O,O
per,O,O
15,O,O
kb,O,O
.,O,O
Brainstem,O,B
auditory,O,I
evoked,O,I
responses,O,I
(,O,O
BAERs,O,B
),O,O
and,O,O
quantitative,O,O
saccadic,O,O
eye,O,O
movement,O,O
studies,O,O
provide,O,O
information,O,O
on,O,O
the,O,O
integrity,O,O
of,O,O
pathways,O,O
traversing,O,O
the,O,O
brainstem,O,O
.,O,O
Latanoprost,O,B
produces,O,O
an,O,O
additional,O,O
reduction,O,O
of,O,O
intraocular,O,B
pressure,O,I
(,O,I
IOP,O,I
),O,O
when,O,O
used,O,O
in,O,O
combination,O,O
with,O,O
timolol,O,B
",",O,O
pilocarpine,O,B
",",O,O
acetazolamide,O,B
and,O,O
dipivefrin,O,B
.,O,O
In,O,O
patients,O,O
with,O,O
type,O,O
II,O,O
tumors,O,O
",",O,O
the,O,O
pattern,O,O
of,O,O
lymphatic,O,O
spread,O,O
was,O,O
primarily,O,O
directed,O,O
toward,O,O
the,O,O
paracardial,O,O
",",O,O
lesser,O,O
curvature,O,O
",",O,O
and,O,O
left,O,O
gastric,O,O
artery,O,O
nodes,O,O
;,O,O
esophagectomy,O,O
offered,O,O
no,O,O
survival,O,O
benefit,O,O
over,O,O
extended,O,O
gastrectomy,O,O
in,O,O
these,O,O
patients,O,O
.,O,O
In,O,O
contrast,O,O
to,O,O
the,O,O
wild,O,O
-,O,O
type,O,O
protein,O,O
",",O,O
expression,O,O
of,O,O
p45,B,B
NF,B,I
-,I,I
E2,I,I
lacking,O,O
this,O,O
activation,O,O
domain,O,O
in,O,O
an,O,O
NF,B,B
-,I,I
E2,I,I
cell,O,I
line,O,I
fails,O,O
to,O,O
support,O,O
enhancer,O,O
-,O,O
dependent,O,O
transcription,O,O
in,O,O
transient,O,O
assays,O,O
.,O,O
Levels,O,O
of,O,O
the,O,O
MEK,B,B
inhibitor,O,O
PD98059,O,O
that,O,O
block,O,O
EGF,B,O
-,O,O
induced,O,O
mitogenesis,O,O
and,O,O
MAP,B,O
kinase,I,O
phosphorylation,O,O
also,O,O
abrogate,O,O
EGF,B,O
-,O,O
induced,O,O
focal,O,O
adhesion,O,O
disassembly,O,O
and,O,O
cell,O,O
motility,O,O
.,O,O
Finally,O,O
",",O,O
there,O,O
are,O,O
a,O,O
growing,O,O
number,O,O
of,O,O
arguments,O,O
favouring,O,O
the,O,O
use,O,O
of,O,O
ACE,B,O
inhibitors,O,O
very,O,O
early,O,O
in,O,O
patients,O,O
with,O,O
diabetes,O,O
mellitus,O,O
.,O,O
These,O,O
corrections,O,O
do,O,O
not,O,O
involve,O,O
sequences,O,O
predicted,O,O
to,O,O
function,O,O
as,O,O
transcription,O,O
factor,O,O
binding,O,O
sites,O,O
.,O,O
Because,O,O
of,O,O
the,O,O
small,O,O
number,O,O
of,O,O
visceral,O,O
angiography,O,O
procedures,O,O
performed,O,O
(,O,O
38,O,O
),O,O
",",O,O
no,O,O
definitive,O,O
conclusions,O,O
could,O,O
be,O,O
drawn,O,O
as,O,O
to,O,O
the,O,O
differences,O,O
between,O,O
ionic,O,O
and,O,O
nonionic,O,O
agents,O,O
regarding,O,O
grade,O,O
-,O,O
2,O,O
and,O,O
grade,O,O
-,O,O
3,O,O
adverse,O,O
events,O,O
.,O,O
The,O,O
predicted,O,O
L,B,B
mRNA,I,O
was,O,O
6398,O,O
nucleotides,O,O
long,O,O
and,O,O
contained,O,O
a,O,O
single,O,O
open,O,O
reading,O,O
frame,O,O
corresponding,O,O
to,O,O
an,O,O
L,B,B
protein,I,O
encompassing,I,O
2109,I,O
amino,I,O
acids,I,O
with,O,O
a,O,O
MW,O,O
of,O,O
241,O,O
",",O,O
546,O,O
.,O,O
Like,O,O
scrotal,O,O
testes,O,O
",",O,O
undescended,O,O
testes,O,O
were,O,O
hypointense,O,O
to,O,O
fat,O,O
on,O,O
sequences,O,O
with,O,O
a,O,O
short,O,O
repetition,O,O
time,O,O
(,O,O
TR,O,O
),O,O
and,O,O
echo,O,O
time,O,O
(,O,O
TE,O,O
),O,O
in,O,O
all,O,O
cases,O,O
",",O,O
and,O,O
hyperintense,O,O
or,O,O
isointense,O,O
to,O,O
fat,O,O
on,O,O
long,O,O
TR,O,O
/,O,O
TE,O,O
sequences,O,O
in,O,O
all,O,O
but,O,O
two,O,O
cases,O,O
.,O,O
We,O,O
found,O,O
that,O,O
both,O,O
the,O,O
E26,O,B
virus,O,I
-,O,I
encoded,O,I
v,B,I
-,I,I
ets,I,I
and,O,O
the,O,O
myeloid,B,B
/,I,I
B,I,I
-,I,I
cell,I,I
-,I,I
specific,I,I
factor,I,I
PU,I,B
.,I,O
1,I,O
bind,O,O
efficiently,O,O
to,O,O
this,O,O
site,O,O
in,O,O
vitro,O,O
.,O,O
MS,O,O
characteristics,O,O
of,O,O
coumarins,O,O
",",O,O
psoralens,O,O
and,O,O
polymethoxylated,O,O
flavones,O,O
with,O,O
different,O,O
substitution,O,O
patterns,O,O
were,O,O
determined,O,O
on,O,O
the,O,O
basis,O,O
of,O,O
the,O,O
response,O,O
obtained,O,O
with,O,O
the,O,O
APcI,O,O
interface,O,O
.,O,O
Macroscopic,O,O
researches,O,O
on,O,O
heart,O,O
vascularization,O,O
have,O,O
indicated,O,O
that,O,O
the,O,O
angioarchitecture,O,O
of,O,O
the,O,O
conducting,O,O
system,O,O
differs,O,O
from,O,O
that,O,O
of,O,O
the,O,O
normal,O,O
myocardium,O,O
.,O,O
Deleting,O,O
SNF1,B,B
repressed,O,O
meiosis,O,O
at,O,O
the,O,O
same,O,O
three,O,O
steps,O,O
that,O,O
were,O,O
inhibited,O,O
by,O,O
glucose,O,O
",",O,O
suggesting,O,O
that,O,O
glucose,O,O
blocks,O,O
meiosis,O,O
by,O,O
inhibiting,O,O
Snf1,B,B
.,O,O
The,O,O
images,O,O
showed,O,O
rapid,O,O
",",O,O
predominantly,O,O
urinary,O,O
excretion,O,O
of,O,O
99mTc,O,O
ciprofloxacin,O,O
",",O,O
with,O,O
low,O,O
to,O,O
absent,O,O
brain,O,O
",",O,O
lung,O,O
and,O,O
bone,O,O
marrow,O,O
uptake,O,O
and,O,O
low,O,O
liver,O,O
uptake,O,O
and,O,O
excretion,O,O
.,O,O
Relations,O,O
between,O,O
adrenergic,O,O
mechanisms,O,O
and,O,O
analgesic,O,O
effects,O,O
Self,O,O
or,O,O
foreign,O,O
cellular,O,O
proteins,O,O
provide,O,O
peptides,O,O
for,O,O
presentation,O,O
by,O,O
major,B,O
histocompatibility,I,O
complex,I,O
(,I,O
MHC,I,B
),I,O
class,I,O
I,I,O
molecules,I,O
on,O,O
the,O,O
surface,O,O
of,O,O
antigen,O,O
presenting,O,O
cells,O,O
(,O,O
APC,O,B
),O,O
.,O,O
By,O,O
an,O,O
induced,O,O
-,O,O
fit,O,O
mechanism,O,O
",",O,O
contacts,O,O
with,O,O
the,O,O
anticodon,O,O
can,O,O
activate,O,O
formation,O,O
of,O,O
a,O,O
robust,O,O
transition,O,O
state,O,O
at,O,O
a,O,O
site,O,O
over,O,O
70,O,O
A,O,O
away,O,O
.,O,O
In,O,O
Experiment,O,O
1,O,O
",",O,O
pups,O,O
that,O,O
had,O,O
received,O,O
an,O,O
injection,O,O
of,O,O
the,O,O
noncompetitive,O,O
N,B,B
-,I,I
methyl,I,I
-,I,I
D,I,I
-,I,I
aspartate,I,I
receptor,I,I
antagonist,O,I
MK,O,B
-,O,I
801,O,I
(,O,O
0,O,O
.,O,O
1,O,O
mg,O,O
/,O,O
kg,O,O
",",O,O
i,O,O
.,O,O
p,O,O
.,O,O
),O,O
either,O,O
30,O,O
min,O,O
before,O,O
or,O,O
immediately,O,O
after,O,O
conditioning,O,O
spent,O,O
less,O,O
time,O,O
over,O,O
the,O,O
conditioned,O,O
odor,O,O
than,O,O
saline,O,O
-,O,O
treated,O,O
controls,O,O
.,O,O
Evaluation,O,O
of,O,O
the,O,O
Du,O,B
Pont,O,I
aca,O,I
ammonia,O,I
procedure,O,O
.,O,O
A,O,O
new,O,O
non,O,O
-,O,O
LTR,O,O
retrotransposon,O,O
provides,O,O
evidence,O,O
for,O,O
multiple,O,O
distinct,O,O
site,O,O
-,O,O
specific,O,O
elements,O,O
in,O,O
Crithidia,O,B
fasciculata,O,I
miniexon,O,I
arrays,O,I
.,O,O
The,O,O
seco,O,O
-,O,O
steroid,O,O
hormone,O,O
1,O,O
",",O,O
25,O,O
-,O,O
dihydroxyvitamin,O,O
D3,O,O
is,O,O
known,O,O
to,O,O
induce,O,O
the,O,O
expression,O,O
of,O,O
a,O,O
calcium,O,O
binding,O,O
protein,O,O
termed,O,O
calbindin,B,B
-,I,I
D28K,I,I
in,O,O
a,O,O
variety,O,O
of,O,O
target,O,O
tissues,O,O
.,O,O
Entry,O,O
of,O,O
yeast,O,B
cells,O,I
into,O,O
the,O,O
mitotic,O,O
cell,O,O
cycle,O,O
(,O,O
Start,O,O
),O,O
involves,O,O
a,O,O
form,O,O
of,O,O
the,O,O
CDC28,B,B
kinase,I,O
that,O,O
associates,O,O
with,O,O
G1,O,O
-,O,O
specific,O,O
cyclins,B,O
encoded,O,O
by,O,O
CLN1,B,B
and,O,O
CLN2,B,B
(,O,O
ref,O,O
.,O,O
A,O,O
third,O,O
is,O,O
a,O,O
partial,O,O
element,O,O
terminating,O,O
at,O,O
a,O,O
probable,O,O
internal,O,O
restriction,O,O
site,O,O
used,O,O
for,O,O
cloning,O,O
.,O,O
In,O,O
76,O,O
%,O,O
of,O,O
59,O,O
lead,O,O
-,O,O
toxic,O,O
children,O,O
",",O,O
bone,O,O
lead,O,O
values,O,O
measured,O,O
by,O,O
LXRF,O,O
were,O,O
equal,O,O
to,O,O
or,O,O
greater,O,O
than,O,O
those,O,O
measured,O,O
in,O,O
normal,O,O
and,O,O
industrially,O,O
exposed,O,O
adults,O,O
.,O,O
Sequence,O,O
analysis,O,O
of,O,O
the,O,O
sMtCK,B,B
genomic,I,O
upstream,I,O
sequences,I,O
reveals,O,O
a,O,O
typical,O,O
TATAA,O,O
box,O,O
within,O,O
the,O,O
80,O,O
base,O,O
pairs,O,O
(,O,O
bp,O,O
),O,O
that,O,O
",",O,O
by,O,O
transfection,O,O
experiments,O,O
",",O,O
are,O,O
sufficient,O,O
to,O,O
promote,O,O
expression,O,O
of,O,O
chimeric,O,O
plasmids,O,O
with,O,O
the,O,O
chloramphenicol,B,O
acetyltransferase,I,O
reporter,I,O
.,O,O
Sequence,O,O
analysis,O,O
of,O,O
the,O,O
sMtCK,B,B
genomic,I,O
upstream,I,O
sequences,I,O
reveals,O,O
a,O,O
typical,O,O
TATAA,O,O
box,O,O
within,O,O
the,O,O
80,O,O
base,O,O
pairs,O,O
(,O,O
bp,O,O
),O,O
that,O,O
",",O,O
by,O,O
transfection,O,O
experiments,O,O
",",O,O
are,O,O
sufficient,O,O
to,O,O
promote,O,O
expression,O,O
of,O,O
chimeric,O,O
plasmids,O,O
with,O,O
the,O,O
chloramphenicol,B,O
acetyltransferase,I,O
reporter,I,O
.,O,O
CONCLUSION,O,O
:,O,O
Patients,O,O
wit,O,O
clinically,O,O
palpable,O,O
neck,O,O
disease,O,O
(,O,O
N1,O,O
-,O,O
3,O,O
),O,O
",",O,O
histological,O,O
evidence,O,O
of,O,O
metastatic,O,O
nodal,O,O
disease,O,O
",",O,O
extracapsular,O,O
spread,O,O
",",O,O
and,O,O
three,O,O
or,O,O
more,O,O
positive,O,O
lymph,O,O
nodes,O,O
are,O,O
at,O,O
greater,O,O
risk,O,O
of,O,O
developing,O,O
failure,O,O
at,O,O
distant,O,O
sites,O,O
.,O,O
The,O,O
fast,O,O
real,O,O
-,O,O
time,O,O
digital,O,O
processing,O,O
of,O,O
the,O,O
N2,O,O
and,O,O
flow,O,O
signals,O,O
incorporated,O,O
filtering,O,O
",",O,O
delay,O,O
compensation,O,O
",",O,O
and,O,O
corrections,O,O
for,O,O
the,O,O
effects,O,O
of,O,O
changes,O,O
in,O,O
gas,O,O
composition,O,O
and,O,O
temperature,O,O
.,O,O
They,O,O
were,O,O
found,O,O
to,O,O
stimulate,O,O
at,O,O
nanomolar,O,O
concentrations,O,O
the,O,O
turnover,O,O
of,O,O
biosynthetically,O,O
labeled,O,O
ceramide,O,B
",",O,O
glucosylceramide,O,B
",",O,O
and,O,O
lactosylceramide,O,B
.,O,O
Petrous,O,O
meningioma,O,O
en,O,O
plaque,O,O
presenting,O,O
as,O,O
a,O,O
right,O,O
middle,O,O
ear,O,O
tumor,O,O
.,O,O
In,O,O
order,O,O
to,O,O
study,O,O
the,O,O
influence,O,O
of,O,O
iron,O,O
overload,O,O
on,O,O
the,O,O
polymorphonuclear,O,O
leucocyte,O,O
(,O,O
PMN,O,O
),O,O
metabolism,O,O
of,O,O
patients,O,O
on,O,O
chronic,O,O
hemodialysis,O,O
",",O,O
generation,O,O
of,O,O
superoxide,O,O
anion,O,O
(,O,O
O2,O,B
-,O,I
),O,O
by,O,O
PMN,O,O
in,O,O
whole,O,O
blood,O,O
was,O,O
compared,O,O
in,O,O
two,O,O
groups,O,O
of,O,O
hemodialyzed,O,O
patients,O,O
:,O,O
group,O,O
A,O,O
consisted,O,O
of,O,O
twenty,O,O
-,O,O
one,O,O
individuals,O,O
with,O,O
serum,O,O
ferritin,B,O
levels,O,O
above,O,O
1000,O,O
ng,O,O
/,O,O
ml,O,O
and,O,O
group,O,O
B,O,O
of,O,O
nineteen,O,O
individuals,O,O
with,O,O
serum,O,O
ferritin,B,O
levels,O,O
below,O,O
1000,O,O
ng,O,O
/,O,O
ml,O,O
.,O,O
Mo,O,B
+,O,I
SV,O,I
M,O,I
-,O,I
MuLV,O,I
-,O,I
inoculated,O,O
animals,O,O
became,O,O
moribund,O,O
at,O,O
3,O,O
to,O,O
13,O,O
months,O,O
postinoculation,O,O
",",O,O
whereas,O,O
delta,O,O
Mo,O,B
+,O,I
SV,O,I
M,O,I
-,O,I
MuLV,O,I
-,O,I
inoculated,O,O
animals,O,O
became,O,O
moribund,O,O
at,O,O
6,O,O
to,O,O
24,O,O
months,O,O
postinoculation,O,O
.,O,O
Crosstalk,O,O
among,O,O
the,O,O
pathways,O,O
may,O,O
explain,O,O
how,O,O
some,O,O
forms,O,O
of,O,O
stress,O,O
can,O,O
contribute,O,O
to,O,O
the,O,O
development,O,O
of,O,O
a,O,O
malignancy,O,O
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
VP1,B,B
was,O,O
efficiently,O,O
transported,O,O
to,O,O
the,O,O
nucleus,O,O
and,O,O
localized,O,O
in,O,O
the,O,O
discrete,O,O
subnuclear,O,O
regions,O,O
",",O,O
possibly,O,O
with,O,O
VP2,B,B
and,O,O
VP3,B,B
.,O,O
It,O,O
is,O,O
concluded,O,O
that,O,O
axillo,O,O
-,O,O
axillary,O,O
by,O,O
-,O,O
pass,O,O
is,O,O
a,O,O
simple,O,O
solution,O,O
for,O,O
a,O,O
complex,O,O
haemodynamic,O,O
",",O,O
clinical,O,O
and,O,O
therapeutic,O,O
problem,O,O
.,O,O
Combination,O,O
of,O,O
a,O,O
Shwachman,O,B
syndrome,O,I
and,O,O
a,O,O
complex,O,O
granulocyte,O,O
function,O,O
disorder,O,O
in,O,O
a,O,O
girl,O,O
Moreover,O,O
",",O,O
it,O,O
is,O,O
the,O,O
assumptions,O,O
behind,O,O
steady,O,O
-,O,O
state,O,O
O2,O,B
uptake,O,O
that,O,O
do,O,O
not,O,O
permit,O,O
proper,O,O
interpretation,O,O
of,O,O
energy,O,O
expenditure,O,O
during,O,O
EPOC,O,O
;,O,O
1,O,O
l,O,O
O2,O,B
not,O,O
=,O,O
20,O,O
.,O,O
9,O,O
kJ,O,O
.,O,O
Experiments,O,O
showed,O,O
that,O,O
temporary,O,O
arrest,O,O
of,O,O
pulmonary,O,O
circulation,O,O
under,O,O
conditions,O,O
of,O,O
extracorporeal,O,O
circulation,O,O
is,O,O
attended,O,O
by,O,O
the,O,O
development,O,O
of,O,O
ischemia,O,O
of,O,O
the,O,O
respiratory,O,O
pulmonary,O,O
tissue,O,O
.,O,O
The,O,O
Arabidopsis,B,B
FAD7,I,I
gene,I,O
encodes,O,O
a,O,O
chloroplast,B,O
omega,I,O
-,I,O
3,I,O
fatty,I,O
acid,I,O
desaturase,I,O
that,O,O
catalyzes,O,O
the,O,O
desaturation,O,O
of,O,O
lipid,O,O
-,O,O
linked,O,O
dienoic,O,O
fatty,O,O
acids,O,O
(,O,O
18,O,O
:,O,O
2,O,O
and,O,O
16,O,O
:,O,O
2,O,O
),O,O
.,O,O
Near,O,O
term,O,O
",",O,O
under,O,O
experimental,O,O
conditions,O,O
",",O,O
maternal,O,O
and,O,O
fetal,O,O
blood,O,O
gases,O,O
",",O,O
pH,O,O
",",O,O
uterine,O,O
and,O,O
umbilical,O,O
blood,O,O
flows,O,O
were,O,O
measured,O,O
or,O,O
calculated,O,O
.,O,O
The,O,O
regurgitation,O,O
of,O,O
large,O,O
vitreous,O,O
injections,O,O
.,O,O
Zebrafish,O,O
cyclops,B,B
(,O,O
cyc,B,B
),O,O
encodes,O,O
a,O,O
Transforming,B,O
Growth,I,O
Factor,I,O
beta,I,B
(,O,O
TGFbeta,B,B
),O,O
signaling,O,O
factor,O,O
closely,O,O
related,O,O
to,O,O
mouse,O,O
Nodal,B,O
.,O,O
UDP,B,O
-,I,O
Gal,I,B
:,I,O
Gal,I,B
beta,I,I
1,I,I
-,I,I
-,I,I
-,I,I
-,I,I
4GlcNAc,I,O
alpha,I,O
1,I,O
-,I,O
-,I,O
-,I,O
-,I,O
galactosyltransferase,I,O
is,O,O
a,O,O
terminal,B,O
glycosyltransferase,I,O
that,O,O
is,O,O
widely,O,O
expressed,O,O
in,O,O
a,O,O
variety,O,O
of,O,O
mammalian,O,O
species,O,O
",",O,O
with,O,O
the,O,O
notable,O,O
exception,O,O
of,O,O
man,O,O
",",O,O
apes,O,O
",",O,O
and,O,O
Old,O,O
World,O,O
monkeys,O,O
.,O,O
The,O,O
first,O,O
group,O,O
of,O,O
sequential,O,O
BMB,O,O
showed,O,O
a,O,O
significant,O,O
progress,O,O
to,O,O
myelofibrosis,O,O
in,O,O
so,O,O
-,O,O
called,O,O
-,O,O
-,O,O
to,O,O
Agnogenic,O,O
Myeloid,O,O
Metaplasia,O,O
-,O,O
AMM,O,O
-,O,O
in,O,O
72,O,O
.,O,O
4,O,O
%,O,O
(,O,O
21,O,O
/,O,O
29,O,O
patients,O,O
),O,O
",",O,O
as,O,O
well,O,O
as,O,O
in,O,O
CML,O,B
with,O,O
megakaryocytic,O,O
increase,O,O
-,O,O
CML,O,B
.,O,O
MI,O,O
-,O,O
in,O,O
39,O,O
.,O,O
2,O,O
%,O,O
(,O,O
20,O,O
/,O,O
51,O,O
),O,O
.,O,O
T,O,O
.,O,O
",",O,O
Mahasneh,O,B
",",O,O
A,O,O
.,O,O
",",O,O
and,O,O
Cote,O,B
",",O,O
G,O,O
.,O,O
If,O,O
delay,O,O
has,O,O
occurred,O,O
between,O,O
centrifugation,O,O
and,O,O
the,O,O
measurement,O,O
",",O,O
causing,O,O
substantial,O,O
loss,O,O
of,O,O
CO2,O,B
",",O,O
equilibration,O,O
of,O,O
the,O,O
sample,O,O
with,O,O
a,O,O
gas,O,O
mixture,O,O
corresponding,O,O
to,O,O
PCO2,O,B
=,O,O
5,O,O
.,O,O
3,O,O
kPa,O,O
prior,O,O
to,O,O
the,O,O
measurement,O,O
is,O,O
recommended,O,O
.,O,O
This,O,O
domain,O,O
",",O,O
although,O,O
adjacent,O,O
to,O,O
the,O,O
5,O,O
',O,O
edge,O,O
of,O,O
the,O,O
SD,O,O
sequence,O,O
",",O,O
does,O,O
not,O,O
inhibit,O,O
ribosome,O,O
binding,O,O
as,O,O
long,O,O
as,O,O
the,O,O
single,O,O
-,O,O
stranded,O,O
region,O,O
of,O,O
domain,O,O
3,O,O
is,O,O
present,O,O
.,O,O
Combined,O,O
expression,O,O
of,O,O
c,B,O
-,I,O
Jun,I,B
and,O,O
p65,B,B
induced,O,O
vigorous,O,O
transcription,O,O
of,O,O
IL,B,B
-,I,I
2,I,I
promoter,O,O
-,O,O
and,O,O
CD28RE,B,B
-,I,I
driven,I,I
reporter,I,I
constructs,I,I
in,O,O
both,O,O
LFA,B,O
-,I,O
3,I,O
-,O,O
and,O,O
B7,B,O
-,I,O
1,I,O
-,O,O
costimulated,O,O
Jurkat,O,O
cells,O,O
.,O,O
Unlike,O,O
ARF,B,B
",",O,O
the,O,O
ARP,B,B
immunoreactivity,O,O
was,O,O
detected,O,O
in,O,O
plasma,O,O
membranes,O,O
but,O,O
not,O,O
in,O,O
cytosol,O,O
of,O,O
fractionated,O,O
3T3,O,O
-,O,O
L1,O,O
cells,O,O
.,O,O
USF,B,B
synthesized,O,O
in,O,O
an,O,O
in,O,O
vitro,O,O
transcription,O,O
and,O,O
translation,O,O
system,O,O
also,O,O
binds,O,O
to,O,O
the,O,O
ADH,B,B
promoter,I,O
as,O,O
well,O,O
as,O,O
to,O,O
the,O,O
MLP,O,B
.,O,O
The,O,O
tyrosine,B,O
hydroxylase,I,O
gene,I,O
(,O,O
TH,B,B
),O,O
contains,O,O
a,O,O
single,O,O
copy,O,O
of,O,O
a,O,O
consensus,O,O
CRE,O,B
at,O,O
-,O,O
45,O,O
to,O,O
-,O,O
38,O,O
base,O,O
pair,O,O
(,O,O
bp,O,O
),O,O
upstream,O,O
of,O,O
the,O,O
transcription,O,O
initiation,O,O
site,O,O
.,O,O
Restriction,O,O
analysis,O,O
and,O,O
Southern,O,O
hybridization,O,O
revealed,O,O
the,O,O
presence,O,O
of,O,O
Tn5422,B,B
in,O,O
all,O,O
the,O,O
plasmid,O,O
-,O,O
mediated,O,O
cadmium,O,O
-,O,O
resistant,O,O
L,O,O
.,O,O
monocytogenes,O,O
strains,O,O
tested,O,O
but,O,O
not,O,O
in,O,O
strains,O,O
encoding,O,O
cadmium,O,O
resistance,O,O
on,O,O
the,O,O
chromosome,O,O
.,O,O
Wild,B,O
-,I,O
type,I,O
AT1A,I,B
receptors,I,O
",",O,O
expressed,O,O
in,O,O
Chinese,O,B
hamster,O,I
ovary,O,I
cells,O,O
",",O,O
rapidly,O,O
internalized,O,O
after,O,O
Ang,B,B
II,I,I
stimulation,O,O
[,O,O
t1,O,O
/,O,O
2,O,O
level,O,O
of,O,O
internalization,O,O
(,O,O
Ymax,O,O
),O,O
78,O,O
.,O,O
2,O,O
%,O,O
],O,O
did,O,O
mutant,O,O
receptors,O,O
carrying,O,O
single,O,O
acidic,O,O
substitutions,O,O
(,O,O
T332E,O,O
",",O,O
t1,O,O
/,O,O
2,O,O
%,O,O
;,O,O
S335D,O,O
",",O,O
t1,O,O
/,O,O
2,O,O
.,O,O
7,O,O
%,O,O
;,O,O
T336E,O,O
",",O,O
t1,O,O
/,O,O
2,O,O
min,O,O
",",O,O
Ymax,O,O
78,O,O
.,O,O
2,O,O
%,O,O
;,O,O
S338D,O,O
",",O,O
t1,O,O
/,O,O
2,O,O
.,O,O
6,O,O
min,O,O
",",O,O
Ymax,O,O
78,O,O
.,O,O
4,O,O
%,O,O
),O,O
.,O,O
Feline,O,B
leukemia,O,I
viruses,O,I
(,O,O
FeLVs,O,B
),O,O
",",O,O
which,O,O
are,O,O
replication,O,O
-,O,O
competent,O,O
oncoretroviruses,O,O
of,O,O
the,O,O
domestic,O,O
cat,O,O
species,O,O
",",O,O
are,O,O
contagiously,O,O
transmitted,O,O
in,O,O
natural,O,O
environments,O,O
.,O,O
Neuromyelitis,O,B
optica,O,I
(,O,O
Devic,O,B
',O,I
s,O,I
syndrome,O,I
),O,O
:,O,O
not,O,O
always,O,O
multiple,O,O
sclerosis,O,O
.,O,O
Arterial,O,O
radioactivity,O,O
content,O,O
after,O,O
the,O,O
intravenous,O,O
administration,O,O
of,O,O
HMPAO,O,B
in,O,O
seven,O,O
human,O,B
subjects,O,O
was,O,O
analyzed,O,O
.,O,O
In,O,O
the,O,O
brain,O,O
",",O,O
muscarinic,B,O
receptors,I,O
mediate,O,O
motor,O,O
and,O,O
memory,O,O
function,O,O
by,O,O
interaction,O,O
with,O,O
their,O,O
ligand,O,O
acetylcholine,O,B
.,O,O
Quantitation,O,O
of,O,O
exocrine,B,O
IgA,I,B
in,O,O
human,O,B
serum,O,O
in,O,O
health,O,O
and,O,O
disease,O,O
.,O,O
This,O,O
phenomenon,O,O
did,O,O
not,O,O
require,O,O
DNA,O,O
binding,O,O
by,O,O
the,O,O
receptor,O,O
but,O,O
required,O,O
it,O,O
to,O,O
be,O,O
hormone,O,O
-,O,O
bound,O,O
",",O,O
indicating,O,O
that,O,O
a,O,O
transcriptionally,O,O
active,O,O
form,O,O
of,O,O
the,O,O
interfering,O,O
receptor,O,O
is,O,O
essential,O,O
for,O,O
the,O,O
interfering,O,O
effect,O,O
.,O,O
We,O,O
use,O,O
the,O,O
term,O,O
corticosteroid,O,B
-,O,I
dependent,O,I
IA,O,I
to,O,O
refer,O,O
to,O,O
the,O,O
serious,O,O
problem,O,O
of,O,O
chronic,O,O
IA,O,O
requiring,O,O
maintenance,O,O
prednisone,O,O
therapy,O,O
.,O,O
Insulin,B,B
-,I,I
like,I,I
growth,I,I
factor,I,I
-,I,I
binding,I,I
protein,I,I
-,I,I
2,I,I
(,O,O
IGF,B,B
-,I,I
BP,I,I
-,I,I
2,I,I
),O,O
transcription,O,O
in,O,O
rat,O,O
liver,O,O
varies,O,O
with,O,O
developmental,O,O
age,O,O
and,O,O
fasting,O,O
.,O,O
The,O,O
dnaQ,B,B
-,O,I
lacZ,B,I
and,O,O
the,O,O
rnh,B,B
-,O,I
lacZ,B,I
fused,O,O
genes,O,O
were,O,O
constructed,O,O
and,O,O
hybrid,O,O
proteins,O,O
with,O,O
beta,B,O
-,I,O
galactosidase,I,O
activity,O,O
were,O,O
produced,O,O
.,O,O
Moreover,O,O
",",O,O
this,O,O
enhancement,O,O
of,O,O
transcriptional,O,O
activation,O,O
by,O,O
COUP,B,B
-,I,I
TFI,I,I
requires,O,O
specifically,O,O
the,O,O
AF,O,B
-,O,I
1,O,I
transactivation,O,O
function,O,O
of,O,O
ER,B,B
and,O,O
can,O,O
be,O,O
observed,O,O
in,O,O
the,O,O
presence,O,O
of,O,O
E2,O,O
or,O,O
4,O,O
-,O,O
hydroxytamoxifen,O,O
but,O,O
not,O,O
ICI,O,O
164384,O,O
.,O,O
Furthermore,O,O
",",O,O
we,O,O
have,O,O
identified,O,O
a,O,O
43,O,O
-,O,O
bp,O,O
region,O,O
of,O,O
the,O,O
24p3,B,B
promoter,I,O
required,O,O
for,O,O
the,O,O
Dex,O,B
responsiveness,O,O
.,O,O
The,O,O
novel,O,O
approach,O,O
to,O,O
insulin,B,B
administration,O,O
known,O,O
as,O,O
chronic,O,O
intermittent,O,O
intravenous,O,O
insulin,B,B
therapy,O,O
(,O,O
CIIIT,O,B
),O,O
delivers,O,O
insulin,B,B
in,O,O
a,O,O
pulsatile,O,O
fashion,O,O
and,O,O
achieves,O,O
physiological,O,O
insulin,B,B
concentration,O,O
in,O,O
the,O,O
portal,O,O
vein,O,O
.,O,O
We,O,O
found,O,O
three,O,O
out,O,O
of,O,O
four,O,O
original,O,O
(,O,O
Volkan,O,O
',O,O
s,O,O
),O,O
groups,O,O
of,O,O
linking,O,O
objects,O,O
",",O,O
but,O,O
also,O,O
an,O,O
additional,O,O
one,O,O
",",O,O
hitherto,O,O
undescribed,O,O
",",O,O
comprising,O,O
objects,O,O
used,O,O
for,O,O
designing,O,O
a,O,O
memorial,O,O
shrine,O,O
to,O,O
the,O,O
deceased,O,O
.,O,O
The,O,O
immuno,O,O
-,O,O
purified,O,O
mRNA,O,O
in,O,O
the,O,O
polysome,O,O
complex,O,O
was,O,O
used,O,O
to,O,O
prepare,O,O
cDNA,O,O
with,O,O
which,O,O
to,O,O
probe,O,O
a,O,O
D,O,B
.,O,O
melanogaster,O,I
genomic,O,O
library,O,O
.,O,O
A,O,O
gene,O,O
in,O,O
Drosophila,O,B
melanogaster,O,I
that,O,O
maps,O,O
cytologically,O,O
to,O,O
2C1,O,O
-,O,O
3,O,O
on,O,O
the,O,O
distal,O,O
portion,O,O
of,O,O
the,O,O
X,O,O
-,O,O
chromosome,O,O
encodes,O,O
a,O,O
member,O,O
of,O,O
the,O,O
steroid,B,O
/,I,O
thyroid,I,O
hormone,I,O
receptor,I,O
superfamily,I,O
.,O,O
Endocrine,O,O
cells,O,O
were,O,O
studied,O,O
by,O,O
means,O,O
of,O,O
Grimelius,O,O
',O,O
silver,O,O
staining,O,O
and,O,O
immunostaining,O,O
for,O,O
chromogranin,B,B
",",O,O
a,O,O
general,O,O
marker,O,O
of,O,O
endocrine,O,O
cells,O,O
.,O,O
We,O,O
also,O,O
demonstrate,O,O
that,O,O
preformed,O,O
triplexes,O,O
are,O,O
quite,O,O
stable,O,O
when,O,O
precipitated,O,O
with,O,O
ethanol,O,O
and,O,O
resuspended,O,O
in,O,O
water,O,O
.,O,O
The,O,O
Twentieth,O,O
Anniversary,O,O
of,O,O
the,O,O
Pomeranian,O,O
Medical,O,O
Academy,O,O
.,O,O
Plastic,O,O
solution,O,O
of,O,O
elbow,O,O
joint,O,O
ankylosis,O,O
with,O,O
a,O,O
decorticated,O,O
cylindrical,O,O
flap,O,O
National,O,O
Institutes,O,O
of,O,O
Health,O,O
Consensus,O,O
Development,O,O
Conference,O,O
Statement,O,O
.,O,O
We,O,O
have,O,O
identified,O,O
in,O,O
the,O,O
5,O,O
',O,O
untranslated,O,O
region,O,O
of,O,O
the,O,O
Drosophila,B,B
copia,I,I
retrotransposon,I,I
",",O,O
3,O,O
',O,O
to,O,O
the,O,O
left,O,O
LTR,O,O
",",O,O
a,O,O
sequence,O,O
for,O,O
transcriptional,O,O
regulation,O,O
by,O,O
homeoproteins,O,O
.,O,O
Nephrectomy,O,O
applied,O,O
to,O,O
cattle,O,O
The,O,O
8,O,O
patients,O,O
receiving,O,O
Ir192,O,B
implant,O,O
in,O,O
addition,O,O
to,O,O
external,O,O
radiation,O,O
showed,O,O
improved,O,O
(,O,O
p,O,O
=,O,O
0,O,O
.,O,O
06,O,O
),O,O
survival,O,O
compared,O,O
to,O,O
the,O,O
9,O,O
receiving,O,O
external,O,O
only,O,O
:,O,O
median,O,O
15,O,O
months,O,O
(,O,O
range,O,O
1,O,O
.,O,O
5,O,O
-,O,O
34,O,O
+,O,O
months,O,O
),O,O
versus,O,O
7,O,O
months,O,O
(,O,O
range,O,O
2,O,O
.,O,O
5,O,O
-,O,O
21,O,O
months,O,O
),O,O
.,O,O
The,O,O
electrodes,O,O
themselves,O,O
do,O,O
not,O,O
need,O,O
to,O,O
be,O,O
polished,O,O
prior,O,O
to,O,O
their,O,O
use,O,O
but,O,O
are,O,O
observed,O,O
to,O,O
be,O,O
slightly,O,O
recessed,O,O
from,O,O
the,O,O
surrounding,O,O
insulating,O,O
surface,O,O
.,O,O
In,O,O
hemodialyzed,O,O
patients,O,O
(,O,O
Epo,B,B
and,O,O
Non,O,B
-,O,I
Epo,B,I
group,O,O
),O,O
leptin,B,O
levels,O,O
were,O,O
significantly,O,O
higher,O,O
when,O,O
compared,O,O
to,O,O
CAPD,O,O
patients,O,O
(,O,O
Epo,B,B
and,O,O
Non,O,B
-,O,I
Epo,B,I
group,O,O
",",O,O
respectively,O,O
),O,O
.,O,O
Aryl,B,B
hydrocarbon,I,I
receptor,I,I
nuclear,I,I
translocator,I,I
(,O,O
ARNT,B,B
),O,O
is,O,O
a,O,O
component,O,O
of,O,O
the,O,O
transcription,O,O
factors,O,O
",",O,O
aryl,B,B
hydrocarbon,I,I
receptor,I,I
(,O,O
AhR,B,B
),O,O
and,O,O
hypoxia,B,O
-,I,O
inducible,I,O
factor,I,O
1,I,O
",",O,O
which,O,O
transactivate,O,O
their,O,O
target,O,O
genes,O,O
",",O,O
such,O,O
as,O,O
CYP1A1,B,B
and,O,O
erythropoietin,B,O
",",O,O
in,O,O
response,O,O
to,O,O
xenobiotic,O,O
aromatic,O,O
hydrocarbons,O,O
and,O,O
to,O,O
low,O,O
O2,O,O
concentration,O,O
",",O,O
respectively,O,O
.,O,O
Characterization,O,O
of,O,O
the,O,O
microtubule,O,B
binding,O,O
domain,O,O
of,O,O
microtubule,B,B
actin,I,I
crosslinking,I,I
factor,I,I
(,O,O
MACF,B,B
),O,O
:,O,O
identification,O,O
of,O,O
a,O,O
novel,O,O
group,O,O
of,O,O
microtubule,B,B
associated,I,I
proteins,I,I
.,O,O
Polysome,O,O
and,O,O
40S,B,O
ribosome,I,O
fractions,O,O
were,O,O
severely,O,O
decreased,O,O
in,O,O
the,O,O
krr1,B,O
mutant,I,O
and,O,O
Kri1p,B,O
-,O,O
depleted,O,O
cells,O,O
.,O,O
FASEB,O,O
Federal,O,O
Funding,O,O
Consensus,O,O
Conference,O,O
FY,O,O
2000,O,O
.,O,O
Analysis,O,O
of,O,O
a,O,O
set,O,O
of,O,O
deletion,O,O
constructs,O,O
in,O,O
transient,O,O
transfection,O,O
assays,O,O
measuring,O,O
heterologous,O,O
reporter,O,O
gene,O,O
(,O,O
luciferase,B,B
),O,O
activity,O,O
demonstrated,O,O
that,O,O
the,O,O
182,O,O
-,O,O
bp,O,O
5,O,O
',O,O
-,O,O
flanking,O,O
region,O,O
provides,O,O
full,O,O
promoter,O,O
activity,O,O
in,O,O
IL,B,O
-,I,O
2,I,O
-,O,O
stimulated,O,O
L2,O,O
cells,O,O
.,O,O
Our,O,O
results,O,O
indicate,O,O
that,O,O
the,O,O
KRAB,B,B
domain,I,O
present,O,O
in,O,O
the,O,O
non,O,O
-,O,O
finger,O,O
region,O,O
of,O,O
many,O,O
ZFP,B,B
genes,I,O
quenches,O,O
transcription,O,O
possibly,O,O
due,O,O
to,O,O
specific,O,O
protein,O,O
-,O,O
protein,O,O
interactions,O,O
between,O,O
the,O,O
KRAB,B,B
-,I,I
A,I,I
domain,I,O
and,O,O
components,O,O
of,O,O
the,O,O
proximal,O,O
transcriptional,O,O
apparatus,O,O
.,O,O
PATIENTS,O,O
AND,O,O
METHOD,O,O
:,O,O
Since,O,O
1986,O,O
",",O,O
62,O,O
patients,O,O
were,O,O
irradiated,O,O
stereotactically,O,O
.,O,O
Systematic,O,O
functional,O,O
analysis,O,O
of,O,O
V1a,B,B
/,I,O
V2,I,B
hybrid,I,I
receptors,I,O
showed,O,O
that,O,O
the,O,O
second,O,O
intracellular,O,O
loop,O,O
of,O,O
the,O,O
V1a,B,B
receptor,I,O
is,O,O
required,O,O
and,O,O
sufficient,O,O
for,O,O
efficient,O,O
coupling,O,O
to,O,O
Gq,B,O
/,I,O
11,I,O
",",O,O
whereas,O,O
the,O,O
third,O,O
intracellular,O,O
loop,O,O
of,O,O
the,O,O
V2,B,B
receptor,I,O
is,O,O
required,O,O
and,O,O
sufficient,O,O
for,O,O
coupling,O,O
to,O,O
Gs,B,O
.,O,O
A,O,O
genetic,O,B
screen,O,O
applied,O,O
to,O,O
mutants,O,O
in,O,O
the,O,O
branch,O,B
site,O,I
region,O,I
shows,O,O
that,O,O
all,O,O
positions,O,O
in,O,O
the,O,O
conserved,O,O
TACTAAC,O,B
sequence,O,I
are,O,O
important,O,O
for,O,O
intron,O,O
recognition,O,O
.,O,O
To,O,O
determine,O,O
whether,O,O
P35,B,B
could,O,O
activate,O,O
the,O,O
39k,O,B
promoter,O,O
in,O,O
the,O,O
absence,O,O
of,O,O
IE1,B,B
",",O,O
the,O,O
p35,B,B
open,O,I
reading,O,I
frame,O,I
was,O,O
cloned,O,O
under,O,O
the,O,O
control,O,O
of,O,O
the,O,O
ie1,B,B
promoter,I,O
.,O,O
Autoradiographic,O,O
localisation,O,O
of,O,O
its,O,O
cellular,O,O
distribution,O,O
in,O,O
the,O,O
kidney,O,O
.,O,O
Structure,O,O
and,O,O
expression,O,O
of,O,O
the,O,O
mouse,B,B
growth,I,I
hormone,I,I
receptor,I,I
/,O,O
growth,B,B
hormone,I,I
binding,I,I
protein,I,I
gene,I,I
.,O,O
Modification,O,O
of,O,O
enteral,O,O
resorption,O,O
by,O,O
cytostatic,O,O
therapy,O,O
We,O,O
report,O,O
two,O,O
patients,O,O
receiving,O,O
maintenance,O,O
valproate,O,O
",",O,O
one,O,O
with,O,O
resolving,O,O
acute,O,O
hepatitis,O,O
C,O,O
and,O,O
the,O,O
other,O,O
with,O,O
chronic,O,O
persistent,O,O
hepatitis,O,O
C,O,O
",",O,O
with,O,O
incidental,O,O
microvesicular,O,O
steatosis,O,O
demonstrated,O,O
on,O,O
oil,O,O
-,O,O
red,O,O
O,O,O
stains,O,O
.,O,O
Mutation,O,O
analysis,O,O
demonstrates,O,O
that,O,O
the,O,O
motif,O,O
TCCCCT,O,B
is,O,O
critical,O,O
for,O,O
PyRo1,B,B
interaction,O,O
.,O,O
This,O,O
loss,O,O
was,O,O
independent,O,O
of,O,O
drug,O,O
concentration,O,O
and,O,O
a,O,O
correction,O,O
factor,O,O
was,O,O
employed,O,O
to,O,O
calculate,O,O
the,O,O
true,O,O
free,O,O
diazepam,O,O
concentration,O,O
.,O,O
High,O,O
resolution,O,O
computed,O,O
tomography,O,O
of,O,O
the,O,O
lungs,O,O
in,O,O
patients,O,O
with,O,O
rheumatoid,O,O
arthritis,O,O
.,O,O
Therefore,O,O
",",O,O
high,O,O
set,O,O
-,O,O
up,O,O
accuracy,O,O
and,O,O
reproducibility,O,O
are,O,O
mandatory,O,O
.,O,O
Novel,O,O
intronic,O,O
promoter,O,O
in,O,O
the,O,O
rat,B,O
ER,I,B
alpha,I,I
gene,I,I
responsible,O,O
for,O,O
the,O,O
transient,O,O
transcription,O,O
of,O,O
a,O,O
variant,O,O
receptor,O,O
.,O,O
The,O,O
hypertension,O,O
with,O,O
elevated,O,O
PRA,O,B
",",O,O
however,O,O
",",O,O
was,O,O
resistant,O,O
to,O,O
the,O,O
angiotensin,B,O
II,I,O
(,O,O
AII,B,B
),O,O
analog,O,O
[,O,O
Sar1,O,O
",",O,O
Ile8,O,O
],O,O
ALL,O,O
.,O,O
Ivermectin,O,O
uptake,O,O
and,O,O
distribution,O,O
in,O,O
the,O,O
plasma,O,O
and,O,O
tissue,O,O
of,O,O
Sudanese,O,O
and,O,O
Mexican,O,O
patients,O,O
infected,O,O
with,O,O
Onchocerca,O,B
volvulus,O,I
.,O,O
Online,O,O
LATCH,O,O
demonstrates,O,O
a,O,O
shift,O,O
in,O,O
identification,O,O
of,O,O
the,O,O
library,O,O
as,O,O
an,O,O
isolated,O,O
unit,O,O
to,O,O
an,O,O
interactive,O,O
resource,O,O
center,O,O
.,O,O
No,O,O
mutations,O,O
were,O,O
found,O,O
in,O,O
follicular,O,O
adenomas,O,O
.,O,O
The,O,O
purpose,O,O
of,O,O
this,O,O
article,O,O
is,O,O
to,O,O
discuss,O,O
the,O,O
factors,O,O
involved,O,O
in,O,O
the,O,O
selection,O,O
of,O,O
antibodies,O,O
",",O,O
radionuclides,O,O
and,O,O
labeling,O,O
methods,O,O
in,O,O
the,O,O
development,O,O
of,O,O
radioimmunotherapy,O,O
(,O,O
RIT,O,O
),O,O
for,O,O
non,O,O
-,O,O
Hodgkin,O,O
',O,O
s,O,O
lymphoma,O,O
(,O,O
NHL,O,O
),O,O
from,O,O
a,O,O
single,O,O
clinical,O,O
study,O,O
site,O,O
through,O,O
multicenter,O,O
trials,O,O
and,O,O
commercialization,O,O
.,O,O
These,O,O
data,O,O
show,O,O
that,O,O
PTH,B,B
and,O,O
cAMP,O,B
can,O,O
repress,O,O
collagen,B,B
promoter,I,O
activity,O,O
in,O,O
calvariae,O,O
from,O,O
transgenic,O,O
mice,O,O
",",O,O
suggesting,O,O
that,O,O
the,O,O
alpha,B,B
1,I,I
(,I,I
I,I,I
),I,I
collagen,I,B
promoter,I,O
may,O,O
contain,O,O
cis,O,O
elements,O,O
down,O,O
-,O,O
stream,O,O
of,O,O
-,O,O
2,O,O
.,O,O
3,O,O
kilobases,O,O
that,O,O
mediate,O,O
PTH,B,B
and,O,O
cAMP,O,B
repression,O,O
of,O,O
collagen,B,B
gene,I,O
expression,O,O
in,O,O
bone,O,O
.,O,O
Reconstitution,O,O
of,O,O
complexes,O,O
containing,O,O
p62,B,B
and,O,O
the,O,O
src,B,B
family,I,I
kinase,I,I
p59fyn,B,B
in,O,O
HeLa,O,O
cells,O,O
demonstrated,O,O
that,O,O
complex,O,O
formation,O,O
resulted,O,O
in,O,O
tyrosine,O,O
phosphorylation,O,O
of,O,O
p62,B,B
and,O,O
was,O,O
mediated,O,O
by,O,O
both,O,O
the,O,O
SH3,B,O
and,O,O
SH2,B,O
domains,I,O
of,O,O
p59fyn,B,B
.,O,O
The,O,O
second,O,O
patient,O,O
had,O,O
received,O,O
pituitary,B,B
-,I,I
derived,I,I
growth,I,I
hormone,I,I
for,O,O
treatment,O,O
of,O,O
growth,B,O
hormone,I,O
deficiency,O,O
",",O,O
secondary,O,O
to,O,O
a,O,O
third,O,O
ventricle,O,O
teratoma,O,O
",",O,O
exised,O,O
13,O,O
yr,O,O
earlier,O,O
.,O,O
The,O,O
AGM,B,B
and,I,O
NIH,I,B
/,I,I
Swiss,I,I
mouse,I,I
CCR5,I,I
proteins,I,O
are,O,O
97,O,O
.,O,O
7,O,O
to,O,O
98,O,O
.,O,O
3,O,O
%,O,O
and,O,O
79,O,O
.,O,O
8,O,O
%,O,O
identical,O,O
to,O,O
the,O,O
human,O,B
protein,O,O
",",O,O
respectively,O,O
.,O,O
In,O,O
this,O,O
study,O,O
",",O,O
we,O,O
investigated,O,O
the,O,O
signal,O,O
transduction,O,O
pathways,O,O
that,O,O
are,O,O
involved,O,O
in,O,O
OM,B,O
-,O,O
induced,O,O
LDLR,B,B
transcription,O,O
.,O,O
A,O,O
study,O,O
was,O,O
performed,O,O
to,O,O
compare,O,O
the,O,O
ONLINE,O,O
and,O,O
EMIT,O,O
II,O,O
immunoassays,O,O
with,O,O
gas,O,O
chromatographic,O,O
/,O,O
mass,O,O
spectrometric,O,O
(,O,O
GC,O,O
/,O,O
MS,O,O
),O,O
analysis,O,O
of,O,O
methaqualone,O,O
metabolites,O,O
on,O,O
urine,O,O
using,O,O
samples,O,O
obtained,O,O
from,O,O
a,O,O
clinical,O,O
study,O,O
.,O,O
Adjuvant,O,O
therapy,O,O
for,O,O
colon,O,O
cancer,O,O
],O,O
Surgery,O,O
alone,O,O
may,O,O
fail,O,O
to,O,O
cure,O,O
a,O,O
considerable,O,O
number,O,O
of,O,O
locally,O,O
advanced,O,O
colon,O,O
cancers,O,O
.,O,O
Whole,O,O
-,O,O
mount,O,O
in,O,O
situ,O,O
hybridization,O,O
to,O,O
early,O,O
mouse,O,O
embryos,O,O
of,O,O
9,O,O
.,O,O
5,O,O
-,O,O
10,O,O
.,O,O
5,O,O
days,O,O
indicated,O,O
a,O,O
complex,O,O
pattern,O,O
of,O,O
Arp1,B,B
expression,O,O
spatially,O,O
overlapping,O,O
with,O,O
the,O,O
expression,O,O
of,O,O
All1,B,B
.,O,O
We,O,O
have,O,O
identified,O,O
and,O,O
characterized,O,O
the,O,O
structure,O,O
of,O,O
the,O,O
Spec1,B,B
gene,I,I
in,O,O
the,O,O
sea,O,O
urchin,O,O
Strongylocentrotus,O,B
purpuratus,O,I
.,O,O
To,O,O
begin,O,O
to,O,O
understand,O,O
this,O,O
role,O,O
",",O,O
we,O,O
overexpressed,O,O
ATF,B,B
-,I,I
2,I,I
in,O,O
a,O,O
human,O,B
cancer,O,I
cell,O,I
line,O,I
.,O,O
In,O,O
order,O,O
to,O,O
define,O,O
potential,O,O
candidate,O,O
genes,O,O
for,O,O
inherited,O,O
disorders,O,O
characterized,O,O
by,O,O
aberrant,O,O
gene,O,B
expression,O,I
",",O,O
we,O,O
utilized,O,O
Kruppel,B,B
-,I,I
related,I,I
sequences,I,I
to,O,O
isolate,O,O
zinc,O,B
finger,O,I
-,O,I
containing,O,I
cDNAs,O,I
.,O,O
Analysis,O,O
of,O,O
the,O,O
gag,B,B
and,O,O
rev,B,B
proteins,I,O
in,O,O
the,O,O
transfected,O,O
cells,O,O
demonstrated,O,O
that,O,O
these,O,O
proteins,O,O
were,O,O
not,O,O
detectable,O,O
in,O,O
cells,O,O
transfected,O,O
with,O,O
the,O,O
tat,B,B
mutants,I,O
but,O,O
could,O,O
be,O,O
readily,O,O
detected,O,O
when,O,O
the,O,O
mutations,O,O
were,O,O
complemented,O,O
in,O,O
trans,O,O
with,O,O
a,O,O
tat,B,B
expression,O,O
vector,O,O
.,O,O
The,O,O
ability,O,O
to,O,O
maintain,O,O
expression,O,O
of,O,O
FAS1,B,B
in,O,O
nmt1,B,O
-,O,O
451Dino2,B,O
Delta,O,O
cells,O,O
suggests,O,O
the,O,O
existence,O,O
of,O,O
another,O,O
transcription,O,O
factor,O,O
",",O,O
or,O,O
factors,O,O
",",O,O
whose,O,O
expression,O,O
/,O,O
activity,O,O
is,O,O
inversely,O,O
related,O,O
to,O,O
overall,O,O
levels,O,O
of,O,O
cellular,O,O
protein,O,O
N,O,B
-,O,I
myristoy,O,I
-,O,I
lation,O,I
.,O,O
Small,B,O
GTPases,I,B
of,O,O
the,O,O
Ypt,B,B
/,O,I
Rab,B,I
family,O,O
are,O,O
involved,O,O
in,O,O
the,O,O
regulation,O,O
of,O,O
vesicular,O,O
transport,O,O
.,O,O
Dopamine,B,B
beta,I,I
-,I,I
hydroxylase,I,I
(,O,O
DBH,B,B
),O,O
catalyzes,O,O
the,O,O
conversion,O,O
of,O,O
dopamine,O,O
to,O,O
noradrenaline,O,O
and,O,O
is,O,O
selectively,O,O
expressed,O,O
in,O,O
noradrenergic,O,O
and,O,O
adrenergic,O,O
neurons,O,O
and,O,O
neuroendocrine,O,O
cells,O,O
.,O,O
This,O,O
result,O,O
indicates,O,O
that,O,O
separate,O,O
complexes,O,O
exist,O,O
containing,O,O
ankyrin,B,B
and,O,O
fodrin,B,B
with,O,O
either,O,O
uvomorulin,B,B
or,O,O
Na,B,B
+,I,I
",",I,I
K,I,I
+,I,I
-,I,I
ATPase,I,I
.,O,O
Copyright,O,O
2001,O,O
Academic,O,O
Press,O,O
.,O,O
Indirect,O,O
plasma,O,O
parameters,O,O
such,O,O
as,O,O
vitamin,O,B
E,O,I
",",O,O
thiol,O,B
and,O,O
uric,O,B
acid,O,I
levels,O,O
were,O,O
also,O,O
quantified,O,O
.,O,O
These,O,O
results,O,O
indicate,O,O
that,O,O
baculovirus,O,O
-,O,O
expressed,O,O
TR,B,B
mediates,O,O
transcriptional,O,O
activation,O,O
and,O,O
repression,O,O
in,O,O
a,O,O
promoter,O,O
-,O,O
specific,O,O
manner,O,O
in,O,O
vitro,O,O
.,O,O
Certain,O,O
spt10,B,B
spontaneous,O,O
alleles,O,O
are,O,O
good,O,O
suppressors,O,O
but,O,O
have,O,O
a,O,O
normal,O,O
growth,O,O
rate,O,O
",",O,O
suggesting,O,O
that,O,O
the,O,O
SPT10,B,B
protein,I,O
may,O,O
have,O,O
two,O,O
distinct,O,O
functions,O,O
.,O,O
This,O,O
spindle,O,O
defect,O,O
of,O,O
pds1,B,B
mutants,I,O
results,O,O
from,O,O
a,O,O
temperature,O,O
-,O,O
sensitive,O,O
step,O,O
that,O,O
occurs,O,O
around,O,O
the,O,O
G1,O,O
/,O,O
S,O,O
boundary,O,O
about,O,O
the,O,O
time,O,O
of,O,O
spindle,O,O
assembly,O,O
.,O,O
Pitx2,B,B
rescues,O,O
the,O,O
GABAergic,O,O
differentiation,O,O
defect,O,O
and,O,O
partially,O,O
rescues,O,O
the,O,O
axon,O,O
guidance,O,O
and,O,O
behavioral,O,O
phenotypes,O,O
of,O,O
unc,B,B
-,I,I
30,I,I
mutants,I,O
",",O,O
indicating,O,O
a,O,O
high,O,O
degree,O,O
of,O,O
functional,O,O
conservation,O,O
between,O,O
these,O,O
evolutionarily,O,O
related,O,O
genes,O,O
.,O,O
Derepression,O,O
of,O,O
gene,O,B
expression,O,O
mediated,O,O
by,O,O
the,O,O
5,O,O
',O,O
upstream,O,O
region,O,O
of,O,O
the,O,O
isocitrate,B,B
lyase,I,I
gene,I,I
of,I,I
Candida,I,B
tropicalis,I,I
is,O,O
controlled,O,O
by,O,O
two,O,O
distinct,O,O
regulatory,O,O
pathways,O,O
in,O,O
Saccharomyces,O,B
cerevisiae,O,I
.,O,O
Stimulation,O,O
of,O,O
[,O,O
3H,O,O
],O,O
PA,O,O
production,O,O
upon,O,O
CD3,B,O
cross,O,O
-,O,O
linking,O,O
was,O,O
77,O,O
%,O,O
lower,O,O
in,O,O
permeabilized,O,O
CD45,B,O
-,I,O
cells,O,O
than,O,O
in,O,O
CD45,B,O
+,I,O
cells,O,O
",",O,O
consistent,O,O
with,O,O
the,O,O
reduced,O,O
activity,O,O
of,O,O
p59fyn,B,B
in,O,O
CD45,B,O
-,I,O
cells,O,O
.,O,O
Fenoldopam,O,O
",",O,O
a,O,O
dopamine,B,B
receptor,I,I
agonist,O,I
",",O,O
has,O,O
been,O,O
shown,O,O
",",O,O
in,O,O
animal,O,O
experiments,O,O
",",O,O
to,O,O
improve,O,O
renal,O,O
perfusion,O,O
.,O,O
One,O,O
-,O,O
third,O,O
of,O,O
the,O,O
men,O,O
with,O,O
azoospermia,O,O
and,O,O
with,O,O
sperm,O,O
density,O,O
of,O,O
less,O,O
than,O,O
10,O,O
million,O,O
had,O,O
marked,O,O
FSH,B,B
elevation,O,O
and,O,O
our,O,O
experience,O,O
confirms,O,O
the,O,O
work,O,O
of,O,O
others,O,O
that,O,O
this,O,O
indicates,O,O
a,O,O
poor,O,O
prognosis,O,O
.,O,O
The,O,O
resulting,O,O
R,B,B
protein,I,O
terminates,O,O
five,O,O
codons,O,O
downstream,O,O
of,O,O
the,O,O
frameshift,O,O
site,O,O
at,O,O
the,O,O
V,B,B
protein,I,O
stop,O,O
codon,O,O
.,O,O
Both,O,O
verapamil,O,O
and,O,O
propranolol,O,O
can,O,O
exhibit,O,O
additive,O,O
effects,O,O
with,O,O
adenosine,O,O
in,O,O
prolonging,O,O
AV,O,O
nodal,O,O
conduction,O,O
time,O,O
;,O,O
however,O,O
",",O,O
only,O,O
verapamil,O,O
can,O,O
reduce,O,O
the,O,O
dose,O,O
of,O,O
adenosine,O,O
required,O,O
to,O,O
produce,O,O
AV,O,O
nodal,O,O
block,O,O
.,O,O
Selected,O,O
parameters,O,O
:,O,O
heart,O,B
rate,O,I
(,O,O
HR,O,B
),O,O
",",O,O
arterial,O,B
blood,O,I
pressure,O,I
(,O,O
ABP,O,B
),O,O
and,O,O
arterial,O,B
O2,O,I
saturation,O,I
(,O,O
SaO2,O,B
),O,O
monitored,O,O
by,O,O
pulsoximetry,O,O
were,O,O
measured,O,O
during,O,O
the,O,O
procedure,O,O
.,O,O
The,O,O
PSD2,B,B
gene,I,I
was,O,O
heterologously,O,O
expressed,O,O
by,O,O
infection,O,O
of,O,O
Sf,O,O
-,O,O
9,O,O
insect,O,O
cells,O,O
with,O,O
recombinant,O,O
baculovirus,O,O
",",O,O
resulting,O,O
in,O,O
a,O,O
10,O,O
-,O,O
fold,O,O
increase,O,O
in,O,O
PSD,B,B
activity,O,O
.,O,O
Chrispeels,O,O
[,O,O
1993,O,O
],O,O
EMBO,O,O
J,O,O
12,O,O
:,O,O
2241,O,O
-,O,O
2247,O,O
),O,O
.,O,O
Co,O,O
-,O,O
transfection,O,O
of,O,O
a,O,O
tat,B,B
expressing,O,O
plasmid,O,O
with,O,O
these,O,O
viruses,O,O
containing,O,O
the,O,O
tat,B,B
ORF,I,I
mutations,O,O
resulted,O,O
in,O,O
higher,O,O
levels,O,O
of,O,O
virus,O,O
production,O,O
demonstrating,O,O
that,O,O
the,O,O
effects,O,O
of,O,O
both,O,O
mutants,O,O
are,O,O
tat,B,B
specific,O,O
.,O,O
It,O,O
has,O,O
been,O,O
reported,O,O
that,O,O
rat,O,O
blood,O,O
chloroform,O,O
levels,O,O
were,O,O
significantly,O,O
decreased,O,O
after,O,O
treatment,O,O
with,O,O
ClO2,O,O
.,O,O
63,O,O
.,O,O
3,O,O
micromol,O,O
/,O,O
1,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
01,O,O
),O,O
and,O,O
area,O,O
under,O,O
the,O,O
plasma,O,O
concentration,O,O
-,O,O
time,O,O
curve,O,O
extrapolated,O,O
to,O,O
infinity,O,O
AUC,O,O
9,O,O
(,O,O
0,O,O
-,O,O
infinity,O,O
),O,O
(,O,O
518,O,O
.,O,O
7,O,O
vs,O,O
.,O,O
We,O,O
also,O,O
show,O,O
by,O,O
immunogold,O,O
electron,O,O
microscopy,O,O
immunocytochemistry,O,O
that,O,O
amphiphysin,B,B
I,I,I
is,O,O
localized,O,O
in,O,O
the,O,O
nerve,O,O
terminal,O,O
cytomatrix,O,O
and,O,O
is,O,O
partially,O,O
associated,O,O
with,O,O
endocytic,O,O
intermediates,O,O
.,O,O
Infants,O,O
who,O,O
died,O,O
in,O,O
the,O,O
first,O,O
12,O,O
hours,O,O
from,O,O
',O,O
IVH,O,B
only,O,O
',O,O
had,O,O
suffered,O,O
severe,O,O
birth,O,O
asphyxia,O,O
but,O,O
in,O,O
those,O,O
who,O,O
died,O,O
later,O,O
the,O,O
main,O,O
symptom,O,O
was,O,O
recurrent,O,O
apnoea,O,O
.,O,O
The,O,O
H2,B,B
receptor,I,I
antagonists,O,I
and,O,O
sucralfate,O,O
cost,O,O
about,O,O
the,O,O
same,O,O
and,O,O
have,O,O
few,O,O
side,O,O
effects,O,O
.,O,O
The,O,O
normal,O,O
cell,O,O
cycle,O,O
is,O,O
regulated,O,O
by,O,O
several,O,O
molecules,O,O
",",O,O
such,O,O
as,O,O
the,O,O
tumor,B,O
-,I,O
suppressor,I,O
protein,I,O
pRb,I,B
",",O,O
the,O,O
G1,B,B
cyclins,I,I
",",O,O
the,O,O
cyclin,B,B
-,I,I
dependent,I,I
kinases,I,I
",",O,O
and,O,O
their,O,O
inhibitors,O,O
.,O,O
Analysis,O,O
of,O,O
clearance,O,O
curve,O,O
of,O,O
rose,O,B
bengal,O,I
-,O,I
I,O,I
-,O,I
131,O,O
Volume,O,O
of,O,O
distribution,O,O
of,O,O
total,O,O
DMDZ,O,B
(,O,O
range,O,O
",",O,O
1,O,O
.,O,O
33,O,O
to,O,O
6,O,O
.,O,O
30,O,O
l,O,O
/,O,O
kg,O,O
),O,O
and,O,O
of,O,O
unbound,O,O
DMDZ,O,B
after,O,O
correction,O,O
for,O,O
protein,O,O
binding,O,O
(,O,O
range,O,O
",",O,O
43,O,O
to,O,O
243,O,O
l,O,O
/,O,O
kg,O,O
),O,O
was,O,O
larger,O,O
in,O,O
women,O,O
than,O,O
in,O,O
men,O,O
of,O,O
all,O,O
ages,O,O
",",O,O
and,O,O
in,O,O
the,O,O
elderly,O,O
as,O,O
opposed,O,O
to,O,O
the,O,O
young,O,O
.,O,O
The,O,O
N,O,B
-,O,I
terminal,O,I
115,O,I
amino,O,I
acids,O,I
correspond,O,O
to,O,O
a,O,O
putative,O,O
DNA,O,O
-,O,O
binding,O,O
domain,O,O
and,O,O
show,O,O
significant,O,O
sequence,O,O
similarity,O,O
with,O,O
other,O,O
cloned,O,O
IFN,B,B
response,I,I
factors,I,I
(,O,O
IRF,B,B
-,I,I
1,I,I
and,O,O
IRF,B,B
-,I,I
2,I,I
),O,O
.,O,O
Three,O,O
experiments,O,O
contrasted,O,O
the,O,O
effects,O,O
of,O,O
6,O,O
-,O,O
hydroxydopamine,O,O
-,O,O
induced,O,O
lesions,O,O
of,O,O
the,O,O
ventral,O,O
noradrenergic,O,O
and,O,O
dorsal,O,O
noradrenergic,O,O
projections,O,O
",",O,O
predominantly,O,O
to,O,O
hypothalamus,O,O
and,O,O
cortex,O,O
",",O,O
respectively,O,O
",",O,O
upon,O,O
body,O,O
weight,O,O
changes,O,O
and,O,O
food,O,O
-,O,O
related,O,O
behaviour,O,O
in,O,O
the,O,O
rat,O,O
.,O,O
Hepatitis,O,B
B,O,I
vaccine,O,O
This,O,O
construct,O,O
",",O,O
termed,O,O
pDeltaCREC,B,O
/,O,O
EBP,B,O
",",O,O
binds,O,O
C,B,O
/,I,O
and,I,O
beta,I,O
but,O,O
not,O,O
CREB,B,O
",",O,O
yet,O,O
it,O,O
confers,O,O
a,O,O
nearly,O,O
complete,O,O
glucocorticoid,O,O
response,O,O
when,O,O
transiently,O,O
transfected,O,O
into,O,O
H4IIE,O,O
rat,O,O
hepatoma,O,O
cells,O,O
.,O,O
The,O,O
two,O,O
bases,O,O
immediately,O,O
flanking,O,O
the,O,O
5,O,O
',O,O
end,O,O
of,O,O
the,O,O
element,O,O
proved,O,O
to,O,O
be,O,O
very,O,O
important,O,O
to,O,O
its,O,O
function,O,O
as,O,O
a,O,O
UAS,O,O
element,O,O
as,O,O
did,O,O
the,O,O
two,O,O
bases,O,O
immediately,O,O
3,O,O
',O,O
of,O,O
the,O,O
bHLH,O,O
core,O,O
motif,O,O
.,O,O
For,O,O
the,O,O
5HT5A,B,B
receptor,I,O
the,O,O
addition,O,O
of,O,O
yohimbine,O,O
resulted,O,O
in,O,O
a,O,O
similar,O,O
but,O,O
smaller,O,O
effect,O,O
.,O,O
A,O,O
major,O,O
task,O,O
for,O,O
sports,O,O
scientists,O,O
may,O,O
be,O,O
to,O,O
verify,O,O
empirically,O,O
the,O,O
nature,O,O
of,O,O
an,O,O
integrated,O,O
model,O,O
of,O,O
the,O,O
sport,O,O
performer,O,O
.,O,O
In,O,O
the,O,O
cell,O,O
-,O,O
free,O,O
import,O,O
assay,O,O
",",O,O
beta,B,O
-,I,O
catenin,I,O
rapidly,O,O
migrates,O,O
into,O,O
the,O,O
nucleus,O,O
without,O,O
the,O,O
exogenous,O,O
addition,O,O
of,O,O
cytosol,O,O
",",O,O
Ran,B,O
",",O,O
or,O,O
ATP,O,O
/,O,O
GTP,O,O
.,O,O
Phosphorylation,O,O
of,O,O
myosin,B,B
-,I,I
binding,I,I
subunit,I,I
(,O,O
MBS,B,B
),O,O
of,O,O
myosin,B,B
phosphatase,I,I
by,O,O
Rho,B,O
-,I,O
kinase,I,O
in,O,O
vivo,O,O
.,O,O
Since,O,O
RCC1p,B,O
acts,O,O
as,O,O
GNRP,B,O
for,O,O
Ran,B,B
",",O,O
a,O,O
small,B,O
nuclear,I,O
GTPase,I,O
of,O,O
the,O,O
ras,B,O
superfamily,I,O
",",O,O
we,O,O
have,O,O
identified,O,O
two,O,O
homologs,O,O
of,O,O
Ran,B,B
in,O,O
S,O,O
.,O,O
cerevisiae,O,O
(,O,O
CNR1,B,B
and,O,O
CNR2,B,B
),O,O
.,O,O
SELECTION,O,O
CRITERIA,O,O
:,O,O
Randomised,O,O
and,O,O
possibly,O,O
randomised,O,O
trials,O,O
using,O,O
acupuncture,O,O
to,O,O
treat,O,O
asthma,O,O
and,O,O
asthma,O,O
-,O,O
like,O,O
symptoms,O,O
.,O,O
Although,O,O
previous,O,O
data,O,O
have,O,O
suggested,O,O
that,O,O
Rev,B,B
uses,O,O
the,O,O
same,O,O
export,O,O
pathway,O,O
as,O,O
uracil,O,B
-,O,I
rich,O,I
small,O,I
nuclear,O,I
RNAs,O,I
and,O,O
5S,B,B
ribosomal,I,I
RNA,I,I
",",O,O
the,O,O
CTE,O,B
seems,O,O
to,O,O
interact,O,O
with,O,O
evolutionarily,O,O
conserved,O,O
factors,O,O
that,O,O
are,O,O
essential,O,O
for,O,O
cellular,O,O
mRNA,O,B
export,O,O
.,O,O
The,O,O
two,O,O
ParA,B,B
proteins,I,O
that,O,O
are,O,O
produced,O,O
as,O,O
a,O,O
result,O,O
of,O,O
independent,O,O
translation,O,O
initiation,O,O
at,O,O
two,O,O
different,O,O
start,O,O
codons,O,O
within,O,O
the,O,O
same,O,O
open,O,O
reading,O,O
frame,O,O
were,O,O
overexpressed,O,O
in,O,O
Escherichia,O,B
coli,O,I
and,O,O
partially,O,O
purified,O,O
.,O,O
Such,O,O
an,O,O
increase,O,O
in,O,O
the,O,O
steady,O,O
-,O,O
state,O,O
testicular,B,O
TIMP,I,B
-,I,I
2,I,I
mRNA,I,O
level,O,O
apparently,O,O
is,O,O
not,O,O
the,O,O
result,O,O
of,O,O
an,O,O
up,O,O
-,O,O
regulation,O,O
by,O,O
germ,O,O
cells,O,O
because,O,O
germ,O,O
cells,O,O
cocultured,O,O
with,O,O
Sertoli,O,O
cells,O,O
failed,O,O
to,O,O
elicit,O,O
an,O,O
increase,O,O
in,O,O
the,O,O
Sertoli,O,O
cell,O,O
steady,O,O
-,O,O
state,O,O
TIMP,B,B
-,I,I
2,I,I
mRNA,I,O
level,O,O
.,O,O
Retroviral,O,O
transduction,O,O
of,O,O
T,B,O
/,I,O
T,I,O
(,I,O
L,I,O
),I,O
causes,O,O
a,O,O
rapidly,O,O
fatal,O,O
myeloproliferative,O,O
disease,O,O
in,O,O
a,O,O
murine,O,O
bone,O,O
marrow,O,O
transplant,O,O
(,O,O
BMT,O,O
),O,O
model,O,O
",",O,O
whereas,O,O
T,B,O
/,I,O
T,I,O
(,I,O
F,I,O
),I,O
causes,O,O
a,O,O
long,O,O
-,O,O
latency,O,O
",",O,O
pre,O,O
-,O,O
B,O,O
-,O,O
cell,O,O
lymphoblastic,O,O
lymphoma,O,O
.,O,O
Correlation,O,O
between,O,O
intraocular,O,O
involvement,O,O
and,O,O
systemic,O,O
outcome,O,O
was,O,O
poor,O,O
.,O,O
The,O,O
induced,O,O
respiratory,O,O
burst,O,O
was,O,O
investigated,O,O
by,O,O
the,O,O
intracellular,O,O
oxidative,O,O
transformation,O,O
of,O,O
dihydrorhodamine,O,O
123,O,O
to,O,O
the,O,O
fluorescent,O,O
dye,O,O
rhodamine,O,O
123,O,O
via,O,O
flow,O,O
cytometry,O,O
.,O,O
Data,O,O
from,O,O
119,O,O
men,O,O
and,O,O
40,O,O
women,O,O
undergoing,O,O
coronary,O,O
angiography,O,O
provide,O,O
an,O,O
opportunity,O,O
to,O,O
compare,O,O
these,O,O
associations,O,O
in,O,O
relation,O,O
to,O,O
a,O,O
direct,O,O
and,O,O
continuous,O,O
measure,O,O
of,O,O
atherosclerosis,O,O
while,O,O
controlling,O,O
for,O,O
age,O,O
",",O,O
sex,O,O
",",O,O
income,O,O
",",O,O
hypertension,O,O
",",O,O
serum,O,O
cholesterol,O,O
",",O,O
smoking,O,O
",",O,O
angina,O,O
",",O,O
diabetes,O,O
",",O,O
family,O,O
history,O,O
of,O,O
heart,O,O
disease,O,O
",",O,O
Type,O,O
A,O,O
behavior,O,O
pattern,O,O
",",O,O
and,O,O
hostility,O,O
.,O,O
SIN,O,O
-,O,O
1,O,O
had,O,O
no,O,O
influence,O,O
on,O,O
either,O,O
the,O,O
ischemic,O,O
parameters,O,O
in,O,O
the,O,O
surface,O,O
electrocardiogram,O,O
(,O,O
ECG,O,O
),O,O
or,O,O
the,O,O
intracoronary,O,O
ECG,O,O
.,O,O
The,O,O
E1,B,O
replication,I,O
protein,I,O
of,O,O
bovine,O,O
papillomavirus,O,O
type,O,O
1,O,O
contains,O,O
an,O,O
extended,O,O
nuclear,O,O
localization,O,O
signal,O,O
that,O,O
includes,O,O
a,O,O
p34cdc2,B,B
phosphorylation,O,O
site,O,O
.,O,O
Zhu,O,O
",",O,O
V,O,O
.,O,O
Young,O,O
CD,O,B
-,O,I
1,O,I
mice,O,O
",",O,O
4,O,O
days,O,O
old,O,O
",",O,O
exposed,O,O
to,O,O
0,O,O
.,O,O
1,O,O
%,O,O
nicotine,O,B
sulfate,O,O
on,O,O
gestational,O,O
days,O,O
6,O,O
-,O,O
20,O,O
were,O,O
compared,O,O
with,O,O
untreated,O,O
pups,O,O
of,O,O
the,O,O
same,O,O
age,O,O
to,O,O
determine,O,O
its,O,O
effect,O,O
on,O,O
the,O,O
development,O,O
of,O,O
mandibular,O,O
first,O,O
molars,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
the,O,O
lumenal,O,O
domains,O,O
of,O,O
Sec12p,B,B
",",O,O
Stl1p,B,B
and,O,O
Stl2p,B,B
are,O,O
very,O,O
different,O,O
in,O,O
size,O,O
and,O,O
do,O,O
not,O,O
show,O,O
any,O,O
appreciable,O,O
homology,O,O
.,O,O
Creatine,B,B
kinase,I,I
release,O,O
after,O,O
hepatic,O,O
artery,O,O
embolization,O,O
in,O,O
patients,O,O
with,O,O
carcinoid,O,O
tumors,O,O
.,O,O
Antidepressant,O,O
-,O,O
like,O,O
properties,O,O
of,O,O
some,O,O
serotonin,B,B
receptor,I,I
ligands,O,O
and,O,O
calcium,O,B
channel,O,I
antagonists,O,O
measured,O,O
with,O,O
the,O,O
forced,O,O
swimming,O,O
test,O,O
in,O,O
mice,O,O
.,O,O
Metformin,O,O
plasma,O,O
concentrations,O,O
remained,O,O
unchanged,O,O
except,O,O
for,O,O
patients,O,O
transferred,O,O
from,O,O
1,O,O
.,O,O
5,O,O
to,O,O
2,O,O
.,O,O
0,O,O
g,O,O
daily,O,O
to,O,O
850,O,O
mg,O,O
twice,O,O
daily,O,O
;,O,O
in,O,O
these,O,O
patients,O,O
plasma,O,O
concentrations,O,O
increased,O,O
from,O,O
1,O,O
.,O,O
83,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
87,O,O
to,O,O
2,O,O
.,O,O
50,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
89,O,O
micrograms,O,O
/,O,O
l,O,O
(,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
01,O,O
),O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
Turbutest,O,O
is,O,O
a,O,O
valuable,O,O
tool,O,O
in,O,O
asthmatic,O,O
patients,O,O
',O,O
training,O,O
",",O,O
allowing,O,O
identification,O,O
and,O,O
improvement,O,O
of,O,O
an,O,O
inadequate,O,O
inhalation,O,O
technique,O,O
with,O,O
Turbuhaler,O,O
.,O,O
Preliminary,O,O
use,O,O
of,O,O
the,O,O
Nottingham,O,B
Eczema,O,I
Severity,O,I
Score,O,I
would,O,O
support,O,O
further,O,O
development,O,O
as,O,O
a,O,O
research,O,O
tool,O,O
for,O,O
a,O,O
simple,O,O
assessment,O,O
of,O,O
disease,O,O
severity,O,O
that,O,O
could,O,O
be,O,O
used,O,O
in,O,O
epidemiological,O,O
studies,O,O
.,O,O
Like,O,O
Epo,B,B
",",O,O
HNF,B,B
-,I,I
4,I,I
is,O,O
expressed,O,O
in,O,O
kidney,O,O
",",O,O
liver,O,O
",",O,O
and,O,O
Hep3B,O,B
cells,O,O
but,O,O
not,O,O
in,O,O
HeLa,O,B
cells,O,O
.,O,O
In,O,O
a,O,O
screen,O,O
for,O,O
genes,O,O
with,O,O
oncogenic,O,O
potential,O,O
expressed,O,O
by,O,O
the,O,O
murine,O,O
B6SUtA1,O,B
myeloid,O,I
progenitor,O,I
cell,O,I
line,O,I
",",O,O
we,O,O
isolated,O,O
a,O,O
2,O,O
.,O,O
We,O,O
conducted,O,O
a,O,O
clinical,O,O
and,O,O
pathologic,O,O
review,O,O
of,O,O
nine,O,O
patients,O,O
with,O,O
immature,O,O
ovarian,O,O
teratoma,O,O
.,O,O
The,O,O
recovered,O,O
calves,O,O
were,O,O
tested,O,O
for,O,O
immunity,O,O
to,O,O
homologous,O,O
severe,O,O
challenge,O,O
",",O,O
50,O,O
or,O,O
73,O,O
days,O,O
after,O,O
the,O,O
first,O,O
infection,O,O
.,O,O
By,O,O
Felix,O,B
Lagrange,O,I
",",O,O
1918,O,O
.,O,O
Despite,O,O
significant,O,O
lethality,O,O
and,O,O
cardiovascular,O,O
dysfunction,O,O
",",O,O
in,O,O
the,O,O
septic,O,O
group,O,O
on,O,O
Days,O,O
1,O,O
and,O,O
2,O,O
",",O,O
septic,O,O
versus,O,O
control,O,O
animals,O,O
had,O,O
no,O,O
significant,O,O
differences,O,O
in,O,O
mean,O,O
metabolic,O,O
cart,O,O
measured,O,O
(,O,O
Vo2DIR,O,O
",",O,O
ml,O,O
/,O,O
kg,O,O
/,O,O
min,O,O
;,O,O
Day,O,O
1,O,O
:,O,O
11,O,O
.,O,O
9,O,O
versus,O,O
12,O,O
.,O,O
4,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
81,O,O
;,O,O
Day,O,O
2,O,O
:,O,O
14,O,O
.,O,O
2,O,O
versus,O,O
13,O,O
.,O,O
5,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
72,O,O
",",O,O
respectively,O,O
),O,O
and,O,O
intravascular,O,O
catheter,O,O
calculated,O,O
(,O,O
Vo2INDIR,O,O
",",O,O
ml,O,O
/,O,O
kg,O,O
/,O,O
min,O,O
;,O,O
Day,O,O
1,O,O
:,O,O
11,O,O
.,O,O
2,O,O
versus,O,O
11,O,O
.,O,O
2,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
99,O,O
;,O,O
Day,O,O
2,O,O
:,O,O
12,O,O
.,O,O
8,O,O
versus,O,O
15,O,O
.,O,O
4,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
49,O,O
",",O,O
respectively,O,O
),O,O
.,O,O
The,O,O
expression,O,O
of,O,O
the,O,O
yam8,B,B
(,I,O
+,I,O
),I,O
cDNA,I,O
in,O,O
the,O,O
mid1,B,O
mutant,I,O
cells,O,O
partially,O,O
remediated,O,O
the,O,O
mid,O,O
phenotype,O,O
and,O,O
resulted,O,O
in,O,O
a,O,O
slight,O,O
increase,O,O
in,O,O
Ca,O,B
(,O,O
2,O,I
+,O,I
),O,O
uptake,O,O
activity,O,O
.,O,O
Haycocknema,O,B
perplexum,O,I
n,O,I
.,O,O
g,O,O
.,O,O
",",O,O
n,O,O
.,O,O
sp,O,O
.,O,O
The,O,O
use,O,O
of,O,O
this,O,O
model,O,O
for,O,O
investigating,O,O
pathophysiologically,O,O
significant,O,O
issues,O,O
in,O,O
denervating,O,O
diseases,O,O
is,O,O
illustrated,O,O
with,O,O
five,O,O
different,O,O
sets,O,O
of,O,O
parameters,O,O
.,O,O
Two,O,O
of,O,O
these,O,O
six,O,O
cases,O,O
showed,O,O
mucosal,O,O
spread,O,O
without,O,O
stromal,O,O
invasion,O,O
(,O,O
type,O,O
A,O,O
),O,O
;,O,O
the,O,O
remaining,O,O
four,O,O
cases,O,O
presented,O,O
a,O,O
direct,O,O
extension,O,O
(,O,O
type,O,O
B,O,O
),O,O
from,O,O
muscle,O,O
-,O,O
invasive,O,O
carcinomas,O,O
of,O,O
the,O,O
bladder,O,O
.,O,O
The,O,O
promoter,O,O
of,O,O
the,O,O
rat,B,B
PGS,I,B
-,I,I
2,I,I
gene,I,O
contains,O,O
a,O,O
CAAT,B,O
enhancer,I,O
-,I,O
binding,I,O
protein,I,O
consensus,I,O
site,I,O
(,I,O
CAAT,I,O
box,I,O
),I,O
which,O,O
can,O,O
confer,O,O
hormone,O,O
inducibility,O,O
to,O,O
a,O,O
PGS,B,B
-,I,I
2,I,I
.,O,O
CAT,B,O
reporter,O,O
gene,O,O
",",O,O
as,O,O
well,O,O
as,O,O
a,O,O
putative,O,O
E,O,O
-,O,O
box,O,O
region,O,O
.,O,O
The,O,O
promoter,O,O
region,O,O
(,O,O
P1,O,O
),O,O
corresponding,O,O
to,O,O
the,O,O
main,O,O
group,O,O
of,O,O
transcription,O,O
initiation,O,O
sites,O,O
is,O,O
devoid,O,O
of,O,O
TATA,O,O
and,O,O
CAAT,O,O
boxes,O,O
but,O,O
has,O,O
putative,O,O
binding,O,O
sites,O,O
for,O,O
the,O,O
transcription,B,O
factor,I,O
SP1,I,O
and,O,O
is,O,O
embedded,O,O
in,O,O
a,O,O
large,O,O
G,O,O
+,O,O
C,O,O
-,O,O
rich,O,O
domain,O,O
of,O,O
a,O,O
CpG,O,O
island,O,O
",",O,O
features,O,O
shared,O,O
by,O,O
the,O,O
promoters,O,O
of,O,O
constitutively,O,O
expressed,O,O
housekeeping,O,O
genes,O,O
.,O,O
Tonsillectomy,O,O
is,O,O
an,O,O
effective,O,O
means,O,O
of,O,O
prophylaxis,O,O
for,O,O
upper,O,O
respiratory,O,O
infection,O,O
in,O,O
habitual,O,O
angina,O,O
patients,O,O
.,O,O
This,O,O
is,O,O
in,O,O
contrast,O,O
with,O,O
the,O,O
classical,O,O
',O,O
oxygen,O,O
debt,O,O
hypothesis,O,O
',O,O
",",O,O
which,O,O
states,O,O
that,O,O
the,O,O
oxygen,O,O
debt,O,O
and,O,O
lactate,O,O
clearance,O,O
are,O,O
linked,O,O
.,O,O
There,O,O
were,O,O
9,O,O
patients,O,O
in,O,O
NYHA,O,O
class,O,O
III,O,O
and,O,O
8,O,O
in,O,O
class,O,O
IV,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
250,O,O
WORDS,O,O
),O,O
All,O,O
of,O,O
these,O,O
data,O,O
suggest,O,O
that,O,O
replication,O,O
of,O,O
UV,O,O
-,O,O
damaged,O,O
templates,O,O
occurs,O,O
in,O,O
vitro,O,O
as,O,O
it,O,O
does,O,O
in,O,O
vivo,O,O
and,O,O
that,O,O
this,O,O
replication,O,O
results,O,O
in,O,O
mutation,O,O
fixation,O,O
.,O,O
Contrary,O,O
to,O,O
expectations,O,O
",",O,O
we,O,O
find,O,O
a,O,O
relatively,O,O
high,O,O
level,O,O
of,O,O
variation,O,O
in,O,O
the,O,O
stripe,B,O
2,I,O
enhancer,O,O
region,O,O
",",O,O
including,O,O
point,O,O
substitutions,O,O
and,O,O
insertion,O,O
/,O,O
deletions,O,O
in,O,O
binding,O,O
sites,O,O
",",O,O
and,O,O
a,O,O
comparable,O,O
level,O,O
of,O,O
variation,O,O
in,O,O
the,O,O
other,O,O
noncoding,O,O
regions,O,O
.,O,O
The,O,O
effect,O,O
of,O,O
six,O,O
arginine,O,B
mutations,O,O
of,O,O
oxidative,O,O
phosphorylation,O,O
and,O,O
AAC,B,B
expression,O,O
.,O,O
The,O,O
5,O,O
',O,O
ends,O,O
of,O,O
F3R,B,O
late,O,O
transcripts,O,O
were,O,O
located,O,O
to,O,O
an,O,O
A,O,O
within,O,O
the,O,O
sequence,O,O
5,O,O
',O,O
-,O,O
TAAAG,O,O
",",O,O
41,O,O
nt,O,O
downstream,O,O
from,O,O
the,O,O
early,O,O
promoter,O,O
and,O,O
17,O,O
nt,O,O
upstream,O,O
from,O,O
the,O,O
initiation,O,O
codon,O,O
.,O,O
The,O,O
detector,O,O
has,O,O
the,O,O
advantage,O,O
of,O,O
finding,O,O
both,O,O
ST,O,O
segment,O,O
deviations,O,O
and,O,O
entire,O,O
ST,O,O
-,O,O
T,O,O
complex,O,O
changes,O,O
thereby,O,O
providing,O,O
a,O,O
wider,O,O
characterization,O,O
of,O,O
the,O,O
potential,O,O
ischemic,O,O
events,O,O
.,O,O
The,O,O
following,O,O
evidence,O,O
indicates,O,O
that,O,O
the,O,O
69,O,B
-,O,I
kD,O,I
protein,O,I
is,O,O
a,O,O
common,O,O
",",O,O
rather,O,O
than,O,O
a,O,O
U1,B,O
-,O,O
specific,O,O
",",O,O
protein,O,O
",",O,O
possibly,O,O
associating,O,O
with,O,O
the,O,O
snRNP,O,O
core,O,O
particles,O,O
by,O,O
protein,O,O
-,O,O
protein,O,O
interaction,O,O
.,O,O
They,O,O
suggest,O,O
that,O,O
decreased,O,O
steady,O,O
-,O,O
state,O,O
levels,O,O
of,O,O
IME1,B,B
and,O,O
IME2,B,B
mRNA,I,I
were,O,O
not,O,O
merely,O,O
the,O,O
result,O,O
of,O,O
non,O,O
-,O,O
specific,O,O
adverse,O,O
affects,O,O
on,O,O
nucleic,O,O
acid,O,O
metabolism,O,O
caused,O,O
by,O,O
the,O,O
yvh1,B,O
disruption,O,O
.,O,O
The,O,O
Ets,B,B
-,I,I
1,I,I
binding,I,I
site,I,I
was,O,O
localized,O,O
to,O,O
a,O,O
17,O,O
-,O,O
base,O,O
pair,O,O
(,O,O
bp,O,O
),O,O
region,O,O
from,O,O
the,O,O
3,O,O
',O,O
end,O,O
of,O,O
T,B,B
alpha,I,I
2,I,I
.,O,O
We,O,O
remain,O,O
convinced,O,O
that,O,O
antilymphocyte,B,O
globulin,I,O
(,O,O
ALG,B,B
),O,O
is,O,O
a,O,O
potent,O,O
immunosuppressive,O,O
agent,O,O
in,O,O
humans,O,O
.,O,O
When,O,O
transiently,O,O
transfected,O,O
into,O,O
K562,O,O
cells,O,O
",",O,O
this,O,O
Lg,B,O
genomic,O,O
clone,O,O
is,O,O
actively,O,O
transcribed,O,O
",",O,O
suggesting,O,O
that,O,O
",",O,O
although,O,O
it,O,O
possesses,O,O
the,O,O
characteristics,O,O
of,O,O
a,O,O
processed,O,O
pseudogene,O,O
",",O,O
it,O,O
is,O,O
likely,O,O
to,O,O
correspond,O,O
to,O,O
the,O,O
gene,O,O
encoding,O,O
this,O,O
new,O,O
ferritin,B,B
subunit,I,I
.,O,O
Age,O,O
was,O,O
categorized,O,O
into,O,O
four,O,O
groups,O,O
:,O,O
20,O,O
-,O,O
44,O,O
",",O,O
45,O,O
-,O,O
64,O,O
",",O,O
65,O,O
-,O,O
74,O,O
",",O,O
and,O,O
75,O,O
+,O,O
.,O,O
RESULTS,O,O
:,O,O
At,O,O
the,O,O
initiation,O,O
of,O,O
dialysis,O,O
PD,O,B
patients,O,O
were,O,O
approximately,O,O
6,O,O
years,O,O
younger,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
0001,O,O
),O,O
than,O,O
HD,O,B
patients,O,O
.,O,O
The,O,O
effect,O,O
of,O,O
low,O,O
dosage,O,O
radiation,O,O
on,O,O
metabolism,O,O
and,O,O
function,O,O
of,O,O
the,O,O
rat,O,O
kidney,O,O
damaged,O,O
by,O,O
ischemia,O,O
The,O,O
temporal,O,O
and,O,O
static,O,O
plasma,O,O
concentration,O,O
-,O,O
effect,O,O
relationships,O,O
were,O,O
evaluated,O,O
by,O,O
pharmacodynamic,O,O
modeling,O,O
and,O,O
linear,O,O
regression,O,O
.,O,O
Serum,O,O
lipids,O,O
and,O,O
lipoproteins,O,O
of,O,O
29,O,O
insulin,B,B
dependent,O,I
diabetic,O,I
children,O,I
have,O,O
been,O,O
determined,O,O
and,O,O
related,O,O
to,O,O
the,O,O
metabolic,O,O
status,O,O
of,O,O
the,O,O
patients,O,O
.,O,O
Thus,O,O
",",O,O
TRAF2,B,B
initiates,O,O
SAPK,B,B
and,O,O
p38,B,B
activation,O,O
by,O,O
binding,O,O
two,O,O
proximal,O,O
protein,O,O
kinases,O,O
:,O,O
GCK,B,B
and,O,O
RIP,B,B
.,O,O
The,O,O
Cili,B,O
-,I,O
2,I,O
sequences,I,O
possess,O,O
similarity,O,O
to,O,O
the,O,O
RNaseH,B,B
domain,I,I
of,O,I
Lian,B,I
-,O,I
Aa1,B,I
",",O,O
a,O,O
mosquito,B,O
non,I,O
-,I,O
LTR,I,O
retrotransposon,I,O
.,O,O
Samples,O,O
from,O,O
1415,O,O
neurological,O,O
patients,O,O
were,O,O
used,O,O
to,O,O
study,O,O
the,O,O
diagnostic,O,O
value,O,O
of,O,O
acid,B,O
alpha,I,B
1,I,I
-,I,I
glycoprotein,I,I
in,O,O
the,O,O
lumbar,O,O
cerebrospinal,O,O
fluid,O,O
.,O,O
Protein,B,O
C,I,B
deficiency,O,I
or,O,O
protein,B,B
S,I,I
deficiency,O,I
was,O,O
the,O,O
only,O,O
identified,O,O
risk,O,O
factor,O,O
for,O,O
5,O,O
.,O,O
4,O,O
%,O,O
(,O,O
2,O,O
patients,O,O
),O,O
and,O,O
13,O,O
.,O,O
5,O,O
%,O,O
(,O,O
5,O,O
patients,O,O
),O,O
",",O,O
respectively,O,O
",",O,O
of,O,O
these,O,O
37,O,O
children,O,O
.,O,O
Conserved,O,O
and,O,O
distinct,O,O
roles,O,O
of,O,O
kreisler,B,B
in,O,O
regulation,O,O
of,O,O
the,O,O
paralogous,O,O
Hoxa3,B,B
and,O,O
Hoxb3,B,B
genes,I,O
.,O,O
Isolation,O,O
of,O,O
Weeksella,O,B
virosa,O,I
(,O,O
formerly,O,O
CDC,O,B
group,O,I
IIf,O,I
),O,O
from,O,O
a,O,O
vaginal,O,O
sample,O,O
.,O,O
Several,O,O
artifacts,O,O
occurred,O,O
that,O,O
interfered,O,O
with,O,O
visualization,O,O
of,O,O
the,O,O
diaphragm,O,O
.,O,O
Among,O,O
these,O,O
360,O,O
ZFPs,B,O
",",O,O
a,O,O
novel,O,O
ZFP,B,B
cDNA,I,I
named,O,O
HFHZ,B,B
(,O,O
human,B,B
fetal,I,I
heart,I,I
ZFP,I,I
),O,O
with,O,O
sequence,O,O
homology,O,O
to,O,O
a,O,O
Kruppel,B,B
-,I,I
associated,I,I
box,I,I
(,O,I
KRAB,B,I
),O,O
was,O,O
identified,O,O
.,O,O
The,O,O
responsiveness,O,O
of,O,O
visual,O,B
cortex,O,I
(,O,O
VC,O,B
),O,O
and,O,O
superior,O,B
colliculus,O,I
(,O,O
SC,O,B
),O,O
was,O,O
simultaneously,O,O
compared,O,O
following,O,O
conditioning,O,O
or,O,O
stimulation,O,O
",",O,O
in,O,O
the,O,O
rabbit,O,O
.,O,O
The,O,O
m7GpppN,O,O
cap,O,O
structure,O,O
of,O,O
eukaryotic,O,O
mRNA,O,O
is,O,O
formed,O,O
cotranscriptionally,O,O
by,O,O
the,O,O
sequential,O,O
action,O,O
of,O,O
three,O,O
enzymes,O,O
:,O,O
RNA,B,B
triphosphatase,I,I
",",O,O
RNA,B,B
guanylyltransferase,I,I
",",O,O
and,O,O
RNA,B,B
(,I,O
guanine,I,I
-,I,I
7,I,I
),I,I
-,I,I
methyltransferase,I,I
.,O,O
Following,O,O
seizure,O,O
induction,O,O
",",O,O
MABP,O,B
increased,O,O
to,O,O
105,O,O
mm,O,O
Hg,O,O
and,O,O
brain,O,O
pHi,O,O
fell,O,O
to,O,O
6,O,O
.,O,O
79,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
03,O,O
within,O,O
15,O,O
min,O,O
and,O,O
remained,O,O
at,O,O
this,O,O
level,O,O
for,O,O
1,O,O
h,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
.,O,O
Therefore,O,O
",",O,O
PC,B,B
-,I,I
PLC,I,I
is,O,O
a,O,O
component,O,O
of,O,O
a,O,O
signal,O,O
transduction,O,O
pathway,O,O
leading,O,O
to,O,O
transcription,O,O
of,O,O
c,B,O
-,I,O
fos,I,B
and,O,O
junB,B,B
that,O,O
collaborates,O,O
with,O,O
c,B,O
-,I,O
myc,I,B
and,O,O
is,O,O
independent,O,O
of,O,O
PKC,B,B
-,I,I
delta,I,I
and,O,O
Ras,B,B
activation,O,O
.,O,O
Mutations,O,O
in,O,O
the,O,O
VPS45,B,B
gene,I,O
",",O,O
a,O,O
SEC1,B,B
homologue,O,O
",",O,O
result,O,O
in,O,O
vacuolar,O,O
protein,O,O
sorting,O,O
defects,O,O
and,O,O
accumulation,O,O
of,O,O
membrane,O,O
vesicles,O,O
.,O,O
A,O,O
one,O,O
-,O,O
way,O,O
analysis,O,O
of,O,O
variance,O,O
",",O,O
performed,O,O
separately,O,O
for,O,O
men,O,O
and,O,O
women,O,O
for,O,O
differences,O,O
among,O,O
the,O,O
three,O,O
phobic,O,O
groups,O,O
on,O,O
field,O,O
dependence,O,O
",",O,O
showed,O,O
significance,O,O
(,O,O
rho,O,O
less,O,O
than,O,O
.,O,O
05,O,O
),O,O
for,O,O
the,O,O
females,O,O
",",O,O
with,O,O
the,O,O
famale,O,O
agoraphobic,O,O
being,O,O
more,O,O
field,O,O
dependent,O,O
than,O,O
the,O,O
female,O,O
simple,O,O
phobic,O,O
groups,O,O
",",O,O
but,O,O
not,O,O
for,O,O
the,O,O
males,O,O
.,O,O
They,O,O
also,O,O
negatively,O,O
modulate,O,O
the,O,O
PI,B,B
3,I,I
-,I,I
kinase,I,I
catalytic,O,I
activity,O,I
but,O,O
to,O,O
different,O,O
extents,O,O
",",O,O
dependent,O,O
on,O,O
the,O,O
unique,O,O
N,O,B
-,O,I
terminal,O,I
structure,O,I
of,O,O
each,O,O
isoform,O,O
.,O,O
Taken,O,O
together,O,O
",",O,O
these,O,O
results,O,O
suggest,O,O
that,O,O
silymarin,O,O
may,O,O
exert,O,O
a,O,O
strong,O,O
anticarcinogenic,O,O
effect,O,O
against,O,O
PCA,O,O
and,O,O
that,O,O
this,O,O
effect,O,O
is,O,O
likely,O,O
to,O,O
involve,O,O
impairment,O,O
of,O,O
erbB1,B,B
-,O,I
SHC,B,I
-,O,I
mediated,O,I
signaling,O,I
pathway,O,I
",",O,O
induction,O,O
of,O,O
CDKIs,B,B
",",O,O
and,O,O
a,O,O
resultant,O,O
G1,O,B
arrest,O,O
.,O,O
In,O,O
acute,O,O
-,O,O
phase,O,O
livers,O,O
",",O,O
we,O,O
observed,O,O
a,O,O
dramatic,O,O
reduction,O,O
in,O,O
HNF,B,B
-,I,I
3,I,I
alpha,I,I
expression,O,O
which,O,O
correlates,O,O
with,O,O
a,O,O
decrease,O,O
in,O,O
the,O,O
expression,O,O
of,O,O
its,O,O
target,O,O
gene,O,O
",",O,O
the,O,O
TTR,B,B
gene,I,O
.,O,O
The,O,O
identification,O,O
of,O,O
the,O,O
hepatitis,O,O
C,O,O
virus,O,O
as,O,O
the,O,O
major,O,O
cause,O,O
of,O,O
liver,O,O
disease,O,O
both,O,O
in,O,O
dialysis,O,O
patients,O,O
and,O,O
in,O,O
transplant,O,O
patients,O,O
has,O,O
focused,O,O
attention,O,O
on,O,O
the,O,O
epidemiology,O,O
and,O,O
the,O,O
impact,O,O
of,O,O
continuing,O,O
infection,O,O
in,O,O
these,O,O
patient,O,O
groups,O,O
.,O,O
Exposure,O,O
to,O,O
higher,O,O
TPA,O,B
concentrations,O,O
decreased,O,O
the,O,O
content,O,O
of,O,O
these,O,O
transcripts,O,O
.,O,O
PAO,O,B
blocks,O,O
turnover,O,O
of,O,O
the,O,O
phosphoryl,O,O
group,O,O
of,O,O
pp15,B,B
",",O,O
causing,O,O
its,O,O
accumulation,O,O
",",O,O
and,O,O
thereby,O,O
appears,O,O
to,O,O
interrupt,O,O
signal,O,O
transmission,O,O
from,O,O
the,O,O
receptor,O,O
to,O,O
the,O,O
glucose,O,O
-,O,O
transport,O,O
system,O,O
.,O,O
In,O,O
conclusion,O,O
:,O,O
(,O,O
i,O,O
),O,O
TECRA,O,O
kit,O,O
is,O,O
suggested,O,O
to,O,O
be,O,O
used,O,O
for,O,O
screening,O,O
SE,O,B
producing,O,O
strains,O,O
;,O,O
(,O,O
ii,O,O
),O,O
SET,O,B
-,O,I
RPLA,O,I
and,O,O
RIDASCREEN,O,B
kits,O,O
are,O,O
suitable,O,O
for,O,O
epidemiological,O,O
investigation,O,O
of,O,O
SE,O,B
types,O,O
",",O,O
but,O,O
the,O,O
lack,O,O
of,O,O
ability,O,O
for,O,O
detecting,O,O
SEE,O,B
",",O,O
long,O,O
time,O,O
required,O,O
for,O,O
testing,O,O
with,O,O
SET,O,B
-,O,I
RPLA,O,I
kit,O,O
and,O,O
high,O,O
background,O,O
when,O,O
using,O,O
RIDASCREEN,O,B
kit,O,O
must,O,O
be,O,O
overcome,O,O
;,O,O
and,O,O
(,O,O
iii,O,O
),O,O
because,O,O
of,O,O
the,O,O
complicated,O,O
test,O,O
procedures,O,O
and,O,O
the,O,O
lack,O,O
of,O,O
ability,O,O
for,O,O
detecting,O,O
SEE,O,B
",",O,O
the,O,O
practicality,O,O
of,O,O
SET,O,B
-,O,I
EIA,O,I
kit,O,O
in,O,O
screening,O,O
and,O,O
epidemiological,O,O
research,O,O
purposes,O,O
is,O,O
low,O,O
.,O,O
PURPOSE,O,O
:,O,O
The,O,O
objective,O,O
of,O,O
this,O,O
study,O,O
was,O,O
to,O,O
assess,O,O
first,O,O
embryo,O,O
cleavage,O,O
(,O,O
FEC,O,B
),O,O
25,O,O
-,O,O
27,O,O
h,O,O
after,O,O
intracytoplasmic,O,O
sperm,O,O
injection,O,O
(,O,O
ICSI,O,B
),O,O
as,O,O
a,O,O
parameter,O,O
for,O,O
the,O,O
embryo,O,O
selection,O,O
process,O,O
.,O,O
Mutagenesis,O,O
of,O,O
IM1,B,B
enhances,O,O
the,O,O
ability,O,O
of,O,O
c,B,O
-,I,O
Fos,I,B
to,O,O
activate,O,O
an,O,O
AP1,B,B
bearing,I,I
promoter,I,O
.,O,O
Sequence,O,O
analysis,O,O
revealed,O,O
that,O,O
the,O,O
MEMA,B,B
protein,I,O
is,O,O
identical,O,O
with,O,O
a,O,O
160,B,O
kDa,I,O
nuclear,I,O
',I,O
domain,I,O
rich,I,O
in,I,O
serines,I,O
',I,O
(,I,O
DRS,I,B
),I,O
protein,I,O
occurring,O,O
free,O,O
in,O,O
the,O,O
nucleoplasm,O,O
and,O,O
in,O,O
U2,B,B
-,I,I
ribonucleoprotein,I,I
structures,I,O
.,O,O
By,O,O
using,O,O
the,O,O
full,O,O
-,O,O
length,O,O
cytoplasmic,O,O
domain,O,O
and,O,O
mutants,O,O
with,O,O
progressive,O,O
carboxy,O,O
-,O,O
terminal,O,O
deletions,O,O
",",O,O
internal,O,O
deletions,O,O
",",O,O
or,O,O
point,O,O
mutations,O,O
",",O,O
we,O,O
identified,O,O
the,O,O
first,O,O
150,O,O
amino,O,O
acid,O,O
residues,O,O
of,O,O
LIFR,B,B
as,O,O
the,O,O
minimal,O,O
region,O,O
necessary,O,O
for,O,O
signaling,O,O
.,O,O
Methods,O,O
used,O,O
include,O,O
Cobb,O,O
angle,O,O
and,O,O
a,O,O
segmental,O,O
evaluation,O,O
(,O,O
T7,O,O
-,O,O
T12,O,O
),O,O
of,O,O
each,O,O
of,O,O
convex,O,O
and,O,O
concave,O,O
rib,O,O
-,O,O
vertebra,O,O
angles,O,O
(,O,O
RVAs,O,B
),O,O
",",O,O
rib,O,O
-,O,O
vertebra,O,O
angle,O,O
differences,O,O
(,O,O
RVADs,O,B
),O,O
",",O,O
vertebral,O,O
rotation,O,O
",",O,O
tilt,O,O
and,O,O
displacement,O,O
.,O,O
Here,O,O
we,O,O
present,O,O
evidence,O,O
that,O,O
the,O,O
distal,O,O
half,O,O
(,O,O
Stem,O,B
2,O,I
),O,O
of,O,O
the,O,O
conserved,O,O
base,O,O
-,O,O
paired,O,O
stem,O,O
structure,O,O
found,O,O
in,O,O
all,O,O
hY,B,B
RNAs,I,I
also,O,O
plays,O,O
a,O,O
critical,O,O
role,O,O
in,O,O
the,O,O
export,O,O
process,O,O
.,O,O
Value,O,O
of,O,O
the,O,O
method,O,O
of,O,O
passive,O,O
hemagglutination,O,O
with,O,O
polysaccharide,O,O
C,O,O
in,O,O
detecting,O,O
C,B,O
-,I,O
reactive,I,O
protein,I,O
as,O,O
compared,O,O
to,O,O
precipitation,O,O
in,O,O
capillaries,O,O
and,O,O
slide,O,O
latex,O,O
test,O,O
with,O,O
anti,B,O
-,I,O
CRP,I,B
serum,O,O
The,O,O
experimental,O,O
design,O,O
represents,O,O
a,O,O
2,O,O
x,O,O
3,O,O
factorial,O,O
arrangement,O,O
of,O,O
treatments,O,O
with,O,O
three,O,O
dietary,O,O
levels,O,O
of,O,O
incorporation,O,O
of,O,O
RSB,O,B
(,O,O
0,O,O
",",O,O
50,O,O
",",O,O
and,O,O
100,O,O
%,O,O
),O,O
",",O,O
and,O,O
chickens,O,O
either,O,O
infected,O,O
or,O,O
uninfected,O,O
.,O,O
Human,B,B
LAF,I,I
-,I,I
4,I,I
readily,O,O
hybridized,O,O
with,O,O
genes,O,O
in,O,O
mouse,O,B
and,O,O
chicken,O,B
",",O,O
thus,O,O
showing,O,O
that,O,O
this,O,O
gene,O,B
family,O,I
has,O,O
been,O,O
highly,O,O
conserved,O,O
during,O,O
vertebrate,O,O
evolution,O,O
.,O,O
These,O,O
incisors,O,O
were,O,O
studied,O,O
by,O,O
scanning,O,O
electron,O,O
microscopy,O,O
-,O,O
energy,O,O
dispersive,O,O
spectroscopy,O,O
analysis,O,O
(,O,O
SEM,O,O
-,O,O
EDS,O,O
),O,O
and,O,O
light,O,O
microscopy,O,O
to,O,O
examine,O,O
the,O,O
calciotraumatic,O,O
lines,O,O
of,O,O
strontium,O,O
in,O,O
the,O,O
rat,O,O
incisor,O,O
labial,O,O
dentin,O,O
.,O,O
The,O,O
elevations,O,O
achieved,O,O
by,O,O
LDEE,O,B
given,O,O
s,O,O
.,O,O
c,O,O
.,O,O
were,O,O
higher,O,O
than,O,O
those,O,O
achieved,O,O
after,O,O
i,O,O
.,O,O
p,O,O
.,O,O
administration,O,O
and,O,O
lasted,O,O
for,O,O
longer,O,O
periods,O,O
.,O,O
This,O,O
regulation,O,O
requires,O,O
two,O,O
HMG,B,B
-,I,I
box,I,I
proteins,I,O
:,O,O
the,O,O
ubiquitous,O,O
Ste11,B,B
transcription,I,O
factor,I,O
and,O,O
the,O,O
M,O,B
cell,O,I
-,O,I
controlling,O,I
protein,O,I
Mat1,B,B
-,I,I
Mc,I,I
.,O,O
Finger,B,O
associated,I,O
box,I,O
-,I,O
zinc,I,O
finger,I,O
proteins,I,O
(,O,O
FAX,B,B
-,I,I
ZFPs,I,I
),O,O
constitute,O,O
a,O,O
subfamily,O,O
of,O,O
the,O,O
many,O,O
C2H2,B,O
type,I,O
ZFPs,I,O
in,O,O
Xenopus,O,O
laevis,O,O
.,O,O
In,O,O
connective,O,O
tissue,O,O
",",O,O
cell,O,O
structure,O,O
contributes,O,O
to,O,O
type,B,O
I,I,O
collagen,I,B
expression,O,O
.,O,O
Evidence,O,O
for,O,O
a,O,O
novel,O,O
MAPKKK,B,B
-,O,I
independent,O,I
pathway,O,I
controlling,O,I
the,O,I
stress,O,I
activated,O,I
Sty1,B,B
/,O,I
Spc1,B,I
MAP,O,I
kinase,O,I
in,O,I
fission,O,I
yeast,O,I
.,O,O
This,O,O
means,O,O
that,O,O
the,O,O
loss,O,O
of,O,O
recessives,O,O
must,O,O
be,O,O
calculated,O,O
by,O,O
using,O,O
a,O,O
hypergeometric,O,O
and,O,O
not,O,O
a,O,O
binomial,O,O
model,O,O
as,O,O
Fisher,O,O
did,O,O
.,O,O
A,O,O
sheep,O,B
testicular,O,I
cDNA,O,I
library,O,O
constructed,O,O
in,O,O
pcDNA1,O,O
vector,O,O
was,O,O
screened,O,O
with,O,O
a,O,O
probe,O,O
generated,O,O
by,O,O
polymerase,O,O
chain,O,O
reaction,O,O
(,O,O
PCR,O,O
),O,O
and,O,O
corresponding,O,O
to,O,O
a,O,O
1,O,O
.,O,O
6,O,O
kb,O,O
fragment,O,O
of,O,O
the,O,O
rat,B,B
luteinizing,I,I
hormone,I,I
receptor,I,I
cDNA,I,I
.,O,O
The,O,O
mobility,O,O
shift,O,O
assay,O,O
of,O,O
the,O,O
65,O,O
bp,O,O
(,O,O
-,O,O
318,O,O
/,O,O
-,O,O
254,O,O
),O,O
fragment,O,O
with,O,O
nuclear,O,O
extract,O,O
from,O,O
the,O,O
dark,O,O
-,O,O
adapted,O,O
sample,O,O
showed,O,O
an,O,O
additional,O,O
band,O,O
",",O,O
not,O,O
seen,O,O
with,O,O
the,O,O
light,O,O
-,O,O
grown,O,O
sample,O,O
.,O,O
The,O,O
activity,O,O
of,O,O
Rac1,B,B
leads,O,O
to,O,O
STAT3,B,B
translocation,O,O
to,O,O
the,O,O
nucleus,O,O
coincident,O,O
with,O,O
STAT3,B,B
-,O,I
dependent,O,I
gene,O,I
expression,O,I
.,O,O
Piperacillin,O,O
-,O,O
tazobactam,O,O
can,O,O
be,O,O
used,O,O
for,O,O
the,O,O
treatment,O,O
of,O,O
infections,O,O
caused,O,O
by,O,O
gram,O,O
-,O,O
negative,O,O
",",O,O
gram,O,O
-,O,O
positive,O,O
",",O,O
aerobic,O,O
",",O,O
and,O,O
anaerobic,O,O
bacteria,O,O
.,O,O
Subjects,O,O
were,O,O
16,O,O
male,O,O
chronic,O,O
schizophrenics,O,O
consisting,O,O
of,O,O
8,O,O
DST,O,O
suppressors,O,O
and,O,O
8,O,O
nonsuppressors,O,O
.,O,O
In,O,O
Denmark,O,O
only,O,O
1,O,O
-,O,O
3,O,O
cases,O,O
of,O,O
transfusion,O,O
-,O,O
associated,O,O
hepatitis,O,O
NANB,O,B
(,O,O
TAH,O,B
-,O,I
NANB,O,I
),O,O
are,O,O
registered,O,O
annually,O,O
or,O,O
about,O,O
1,O,O
case,O,O
per,O,O
100,O,O
",",O,O
000,O,O
units,O,O
transfused,O,O
.,O,O
The,O,O
GEF,B,B
and,O,O
GAP,B,B
activities,O,O
for,O,O
Ypt1p,B,B
localize,O,O
to,O,O
particulate,O,O
cellular,O,O
fractions,O,O
.,O,O
RESULTS,O,O
:,O,O
The,O,O
cardiac,O,O
index,O,O
significantly,O,O
changed,O,O
with,O,O
varying,O,O
PaCO2,O,B
levels,O,O
(,O,O
hypocapnia,O,O
",",O,O
-,O,O
9,O,O
%,O,O
;,O,O
hypercapnia,O,O
",",O,O
13,O,O
%,O,O
),O,O
.,O,O
A,O,O
mouse,B,B
brain,I,I
beta,I,I
-,I,I
spectrin,I,I
of,O,O
cDNA,O,O
was,O,O
identified,O,O
within,O,O
a,O,O
lambda,O,O
Gt11,O,O
expression,O,O
library,O,O
using,O,O
an,O,O
antibody,O,O
which,O,O
specifically,O,O
binds,O,O
with,O,O
the,O,O
235,B,B
kDa,I,I
spectrin,I,I
beta,I,I
-,I,I
subunit,I,I
.,O,O
Upon,O,O
tyrosine,O,O
phosphorylation,O,O
at,O,O
the,O,O
ITIMs,O,O
",",O,O
these,O,O
molecules,O,O
recruit,O,O
SH2,B,B
domain,O,I
-,O,I
containing,O,I
phosphatases,O,I
such,O,O
as,O,O
SH2,B,B
-,O,I
containing,O,I
tyrosine,B,I
phosphatase,I,I
-,I,I
1,I,I
and,O,O
negatively,O,O
regulate,O,O
cell,O,O
activity,O,O
.,O,O
The,O,O
promoter,O,O
for,O,O
HMG,B,B
-,I,I
CoA,I,I
synthase,I,I
contains,O,O
two,O,O
binding,O,O
sites,O,O
for,O,O
the,O,O
sterol,B,O
regulatory,I,O
element,I,O
-,I,O
binding,I,O
proteins,I,O
(,O,O
SREBPs,B,B
),O,O
.,O,O
Repeated,O,O
administration,O,O
of,O,O
GRg2,O,O
20,O,O
mg,O,O
/,O,O
kg,O,O
i,O,O
.,O,O
p,O,O
.,O,O
significantly,O,O
improved,O,O
the,O,O
CYP,O,B
-,O,I
induced,O,I
recognitional,O,I
deficits,O,I
by,O,O
increasing,O,O
the,O,O
CYP,O,B
-,O,I
decreased,O,I
rate,O,I
from,O,O
55,O,O
.,O,O
8,O,O
+,O,O
/,O,O
-,O,O
9,O,O
.,O,O
6,O,O
to,O,O
80,O,O
.,O,O
8,O,O
+,O,O
/,O,O
-,O,O
4,O,O
.,O,O
2,O,O
in,O,O
d,O,O
3,O,O
learning,O,O
acquisition,O,O
(,O,O
F,O,O
(,O,O
1,O,O
",",O,O
14,O,O
),O,O
=,O,O
5,O,O
.,O,O
6,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
05,O,O
),O,O
",",O,O
from,O,O
53,O,O
.,O,O
4,O,O
+,O,O
/,O,O
-,O,O
8,O,O
.,O,O
4,O,O
to,O,O
60,O,O
.,O,O
0,O,O
+,O,O
/,O,O
-,O,O
8,O,O
.,O,O
2,O,O
in,O,O
48,O,O
h,O,O
memory,O,O
acquisition,O,O
(,O,O
F,O,O
(,O,O
1,O,O
",",O,O
14,O,O
),O,O
=,O,O
7,O,O
.,O,O
5,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
05,O,O
),O,O
and,O,O
from,O,O
55,O,O
.,O,O
0,O,O
+,O,O
/,O,O
-,O,O
5,O,O
.,O,O
5,O,O
to,O,O
88,O,O
.,O,O
3,O,O
+,O,O
/,O,O
-,O,O
2,O,O
.,O,O
5,O,O
in,O,O
24,O,O
h,O,O
memory,O,O
retention,O,O
(,O,O
F,O,O
(,O,O
1,O,O
",",O,O
12,O,O
),O,O
27,O,O
.,O,O
5,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
01,O,O
),O,O
as,O,O
well,O,O
as,O,O
from,O,O
60,O,O
.,O,O
0,O,O
+,O,O
/,O,O
-,O,O
6,O,O
.,O,O
8,O,O
to,O,O
85,O,O
.,O,O
6,O,O
+,O,O
/,O,O
-,O,O
6,O,O
.,O,O
9,O,O
in,O,O
48,O,O
h,O,O
memory,O,O
retrieval,O,O
(,O,O
F,O,O
(,O,O
1,O,O
",",O,O
12,O,O
),O,O
=,O,O
5,O,O
.,O,O
2,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
05,O,O
",",O,O
respectively,O,O
.,O,O
Forty,O,O
4,O,O
-,O,O
month,O,O
old,O,O
SD,O,O
female,O,O
rats,O,O
were,O,O
randomly,O,O
divided,O,O
into,O,O
four,O,O
groups,O,O
",",O,O
namely,O,O
sham,O,O
operation,O,O
",",O,O
bilateral,O,O
ovariectomy,O,O
",",O,O
ovariectomy,O,O
plus,O,O
supplementary,O,O
ethinyl,O,O
estradiol,O,O
(,O,O
0,O,O
.,O,O
2,O,O
microgram,O,O
/,O,O
100,O,O
g,O,O
B,O,O
.,O,O
Defects,O,O
in,O,O
the,O,O
Schizosaccharomyces,O,B
pombe,O,I
(,O,O
Sp,O,B
),O,O
cell,O,O
cycle,O,O
-,O,O
controlling,O,O
genes,O,O
prevent,O,O
the,O,O
cell,O,O
cycle,O,O
progression,O,O
.,O,O
Perfusion,O,O
technique,O,O
for,O,O
perfusion,O,O
-,O,O
assisted,O,O
direct,O,O
coronary,O,O
artery,O,O
bypass,O,O
(,O,O
PADCAB,O,B
),O,O
.,O,O
Here,O,O
we,O,O
provide,O,O
the,O,O
first,O,O
evidence,O,O
for,O,O
the,O,O
involvement,O,O
of,O,O
GCN1,B,B
-,O,I
GCN2,B,B
interaction,O,O
in,O,O
activation,O,O
of,O,O
GCN2,B,B
per,O,O
se,O,O
.,O,O
The,O,O
7,O,O
-,O,O
day,O,O
treatment,O,O
resulted,O,O
in,O,O
a,O,O
decrease,O,O
in,O,O
mitochondrial,O,O
uptake,O,O
of,O,O
Rh123,O,B
and,O,O
an,O,O
increase,O,O
in,O,O
NAO,O,B
uptake,O,O
.,O,O
The,O,O
results,O,O
raise,O,O
the,O,O
possibility,O,O
that,O,O
pH,O,O
induced,O,O
post,O,O
-,O,O
translational,O,O
modifications,O,O
of,O,O
DdRPA,B,B
are,O,O
involved,O,O
in,O,O
events,O,O
that,O,O
halt,O,O
cell,O,O
proliferation,O,O
and,O,O
induce,O,O
differentiation,O,O
in,O,O
Dictyostelium,O,O
.,O,O
Liquid,O,O
chromatographic,O,O
method,O,O
for,O,O
analysis,O,O
of,O,O
all,O,O
-,O,O
rac,O,B
-,O,I
alpha,O,I
-,O,I
tocopheryl,O,I
acetate,O,I
and,O,O
retinyl,O,B
palmitate,O,I
in,O,O
milk,O,O
-,O,O
based,O,O
infant,O,O
formula,O,O
using,O,O
matrix,O,O
solid,O,O
-,O,O
phase,O,O
dispersion,O,O
.,O,O
This,O,O
transcriptional,O,O
regulation,O,O
occurs,O,O
through,O,O
modulation,O,O
of,O,O
the,O,O
forkhead,B,B
transcription,I,I
factor,I,I
FKHR,B,I
-,I,I
L1,I,I
",",O,O
and,O,O
IL,B,B
-,I,I
3,I,I
inhibited,O,O
FKHR,B,B
-,I,I
L1,I,I
activity,O,O
in,O,O
a,O,O
PI3K,B,B
-,O,I
dependent,O,I
manner,O,O
.,O,O
TIP30,B,B
has,O,O
an,O,O
intrinsic,O,O
kinase,O,O
activity,O,O
required,O,O
for,O,O
up,O,O
-,O,O
regulation,O,O
of,O,O
a,O,O
subset,O,O
of,O,O
apoptotic,O,O
genes,O,O
.,O,O
Analysis,O,O
of,O,O
hematopoietic,B,O
growth,I,O
factor,I,O
prescriptions,O,O
in,O,O
19,O,O
french,O,O
cancer,O,O
centers,O,O
We,O,O
propose,O,O
that,O,O
CTS1,B,B
and,I,O
CTS2,I,B
of,I,O
Ci,I,O
are,O,O
members,O,O
of,O,O
two,O,O
distinct,O,O
classes,O,O
of,O,O
fungal,B,O
chitinases,I,O
",",O,O
an,O,O
observation,O,O
not,O,O
previously,O,O
reported,O,O
for,O,O
a,O,O
single,O,O
fungus,O,O
.,O,O
The,O,O
HiNF,B,B
-,I,I
D,I,I
(,O,O
CDP,B,B
/,O,I
cut,B,I
),O,O
complex,O,O
with,O,O
the,O,O
H4,B,O
promoter,I,O
is,O,O
immunoreactive,O,O
with,O,O
antibodies,O,O
against,O,O
CDP,B,B
/,O,I
cut,B,I
and,O,O
pRB,B,O
but,O,O
not,O,O
p107,B,O
",",O,O
whereas,O,O
the,O,O
CDP,B,B
/,O,I
cut,B,I
complex,O,O
with,O,O
a,O,O
nonhistone,O,O
promoter,O,O
(,O,O
gp91,B,O
-,O,O
phox,B,O
),O,O
reacts,O,O
only,O,O
with,O,O
CDP,B,B
and,O,O
p107,B,O
antibodies,O,O
.,O,O
The,O,O
biosynthesis,O,O
and,O,O
stability,O,O
of,O,O
the,O,O
three,O,O
mutant,O,O
proteins,O,O
were,O,O
similar,O,O
to,O,O
those,O,O
of,O,O
the,O,O
wild,B,O
-,I,O
type,I,O
erbB,I,B
protein,I,O
",",O,O
and,O,O
all,O,O
three,O,O
retained,O,O
the,O,O
ability,O,O
to,O,O
transform,O,O
chicken,O,O
embryo,O,O
fibroblasts,O,O
.,O,O
Binding,O,O
activity,O,O
in,O,O
rat,O,B
liver,O,I
nuclear,O,I
extracts,O,O
includes,O,O
these,O,O
orphan,O,O
receptors,O,O
as,O,O
judged,O,O
from,O,O
electromobility,O,O
supershift,O,O
experiments,O,O
and,O,O
from,O,O
results,O,O
obtained,O,O
with,O,O
expressed,O,O
receptors,O,O
",",O,O
although,O,O
the,O,O
element,O,O
in,O,O
CYP2C11,B,B
did,O,O
not,O,O
bind,O,O
HNF,B,B
-,I,I
4,I,I
.,O,O
Isolation,O,O
and,O,O
characterization,O,O
of,O,O
the,O,O
rat,O,B
chromosomal,O,I
gene,O,I
for,O,O
a,O,O
polypeptide,O,O
(,O,O
pS1,B,B
),O,O
antigenically,O,O
related,O,O
to,O,O
statin,B,O
.,O,O
The,O,O
experience,O,O
of,O,O
the,O,O
lateral,O,O
rhinotomy,O,O
approach,O,O
in,O,O
transsphenoidal,O,O
surgery,O,O
of,O,O
acromegaly,O,B
has,O,O
been,O,O
favourable,O,O
.,O,O
This,O,O
unique,O,O
location,O,O
of,O,O
cavernous,O,O
malformation,O,O
is,O,O
associated,O,O
with,O,O
a,O,O
risk,O,O
of,O,O
permanent,O,O
loss,O,O
of,O,O
the,O,O
vision,O,O
.,O,O
The,O,O
study,O,O
of,O,O
calcium,O,O
metabolism,O,O
in,O,O
ten,O,O
thalassaemic,O,O
children,O,O
comperatively,O,O
with,O,O
controls,O,O
after,O,O
oral,O,O
administration,O,O
of,O,O
47Ca,O,B
has,O,O
shown,O,O
diminished,O,O
intestinal,O,O
absorption,O,O
.,O,O
Sak,B,B
kinase,I,I
gene,O,I
structure,O,O
and,O,O
transcriptional,O,O
regulation,O,O
.,O,O
This,O,O
paper,O,O
presents,O,O
the,O,O
reasons,O,O
why,O,O
countries,O,O
to,O,O
which,O,O
Chagas,O,B
disease,O,I
is,O,O
endemic,O,O
should,O,O
carry,O,O
out,O,O
the,O,O
relevant,O,O
research,O,O
themselves,O,O
.,O,O
These,O,O
data,O,O
reveal,O,O
a,O,O
complex,O,O
network,O,O
of,O,O
interactions,O,O
between,O,O
GTPases,B,B
in,O,O
the,O,O
ARF,B,B
family,I,I
and,O,O
their,O,O
effectors,O,O
and,O,O
reveal,O,O
a,O,O
potential,O,O
for,O,O
cross,O,O
-,O,O
talk,O,O
not,O,O
demonstrated,O,O
previously,O,O
.,O,O
The,O,O
interferon,B,B
-,O,I
induced,O,I
RNA,B,I
-,I,I
dependent,I,I
protein,I,I
kinase,I,I
(,O,O
PKR,B,B
),O,O
is,O,O
considered,O,O
to,O,O
play,O,O
an,O,O
important,O,O
role,O,O
in,O,O
the,O,O
cellular,O,O
defense,O,O
against,O,O
viral,O,O
infection,O,O
and,O,O
",",O,O
in,O,O
addition,O,O
",",O,O
has,O,O
been,O,O
suggested,O,O
to,O,O
be,O,O
a,O,O
tumor,O,O
suppressor,O,O
gene,O,O
because,O,O
of,O,O
its,O,O
growth,O,O
-,O,O
suppressive,O,O
properties,O,O
.,O,O
Immunoreactive,O,O
AR,B,B
content,O,O
in,O,O
transfected,O,O
COS,O,O
-,O,O
1,O,O
cells,O,O
was,O,O
not,O,O
influenced,O,O
by,O,O
exposure,O,O
to,O,O
8,O,O
-,O,O
Br,O,O
-,O,O
cAMP,O,O
.,O,O
A,O,O
peculiar,O,O
people,O,O
:,O,O
dSLBP,B,B
alleles,I,O
support,O,O
zygotic,O,O
development,O,O
but,O,O
cause,O,O
female,O,O
sterility,O,O
.,O,O
The,O,O
transverse,O,O
magnetization,O,O
decays,O,O
mentioned,O,O
above,O,O
exhibited,O,O
two,O,O
components,O,O
",",O,O
a,O,O
T2,O,B
fast,O,I
(,O,I
T2f,O,I
),O,I
and,O,O
a,O,O
T2,O,B
slow,O,I
(,O,I
T2s,O,I
),O,I
component,O,O
.,O,O
Molecular,O,O
cloning,O,O
and,O,O
functional,O,O
characterization,O,O
of,O,O
murine,B,B
sphingosine,I,I
kinase,I,I
.,O,O
Substrates,O,O
for,O,O
p210,B,B
(,O,O
bcr,B,B
-,O,I
abl,B,I
),O,O
are,O,O
likely,O,O
to,O,O
be,O,O
involved,O,O
in,O,O
the,O,O
pathogenesis,O,O
of,O,O
CML,O,O
.,O,O
The,O,O
CCAAT,O,O
core,O,O
sequence,O,O
mutants,O,O
in,O,O
which,O,O
both,O,O
CIII,O,O
and,O,O
CI,O,O
/,O,O
CII,O,O
were,O,O
abolished,O,O
",",O,O
also,O,O
increased,O,O
the,O,O
promoter,O,O
activity,O,O
.,O,O
In,O,O
cellular,O,O
supernatant,O,O
fraction,O,O
",",O,O
SHRSP,O,B
showed,O,O
a,O,O
decrease,O,O
of,O,O
magnesium,O,O
in,O,O
many,O,O
tissues,O,O
and,O,O
an,O,O
elevation,O,O
of,O,O
the,O,O
calcium,O,O
to,O,O
magnesium,O,O
ratio,O,O
when,O,O
compared,O,O
to,O,O
age,O,O
-,O,O
matched,O,O
WKY,O,O
and,O,O
SHRSR,O,O
.,O,O
This,O,O
sequence,O,O
is,O,O
almost,O,O
identical,O,O
with,O,O
that,O,O
of,O,O
human,B,B
luteinizing,I,I
hormone,I,I
(,O,O
Sairam,O,O
",",O,O
M,O,O
.,O,O
We,O,O
now,O,O
demonstrate,O,O
that,O,O
CCAAT,B,O
/,I,O
enhancer,I,O
-,I,O
binding,I,O
protein,I,O
(,I,O
C,I,B
/,I,I
EBP,I,I
),I,O
delta,I,O
is,O,O
a,O,O
major,O,O
component,O,O
of,O,O
a,O,O
PGE2,O,O
-,O,O
stimulated,O,O
DNA,O,O
-,O,O
protein,O,O
complex,O,O
involving,O,O
HS3D,B,O
and,O,O
find,O,O
that,O,O
C,B,B
/,I,I
EBPdelta,I,I
transactivates,O,O
IGF,B,B
-,I,I
I,I,I
promoter,I,I
1,I,I
through,O,O
this,O,O
site,O,O
.,O,O
Protein,B,O
cHMGI,I,B
binds,O,O
preferentially,O,O
to,O,O
AT,O,B
-,O,I
rich,O,I
DNA,O,I
with,O,O
a,O,O
half,O,O
-,O,O
saturation,O,O
value,O,O
of,O,O
1,O,O
.,O,O
1,O,O
nM,O,O
.,O,O
The,O,O
patients,O,O
were,O,O
divided,O,O
into,O,O
ischaemia,O,O
and,O,O
non,O,O
-,O,O
ischaemia,O,O
groups,O,O
on,O,O
the,O,O
basis,O,O
of,O,O
the,O,O
change,O,O
in,O,O
lactate,O,O
extraction,O,O
ratio,O,O
during,O,O
balloon,O,O
inflation,O,O
.,O,O
PABP,B,B
is,O,O
a,O,O
modular,O,O
protein,O,O
",",O,O
with,O,O
four,O,O
N,O,B
-,O,I
terminal,O,I
RNA,O,I
-,O,I
binding,O,I
domains,O,O
and,O,O
an,O,O
extensive,O,O
C,O,B
terminus,O,I
.,O,O
RESULTS,O,O
:,O,O
Glaucoma,O,O
suspects,O,O
were,O,O
divided,O,O
into,O,O
two,O,O
groups,O,O
according,O,O
to,O,O
their,O,O
SWAP,O,B
results,O,O
:,O,O
high,O,O
risk,O,O
(,O,O
with,O,O
SWAP,O,B
abnormalities,O,O
),O,O
and,O,O
low,O,O
risk,O,O
(,O,O
with,O,O
normal,O,O
SWAP,O,B
result,O,O
),O,O
.,O,O
Factors,O,O
influencing,O,O
direct,O,O
-,O,O
immersion,O,O
(,O,O
DI,O,O
),O,O
-,O,O
SPME,O,O
process,O,O
were,O,O
also,O,O
checked,O,O
and,O,O
chosen,O,O
experimentally,O,O
.,O,O
Polarised,O,O
expression,O,O
of,O,O
human,O,B
intestinal,O,I
N,B,I
-,I,I
benzoyl,I,I
-,I,I
L,I,I
-,I,I
tyrosyl,I,I
-,I,I
p,I,I
-,I,I
aminobenzoic,I,I
acid,I,I
hydrolase,I,I
(,O,O
human,B,B
meprin,I,I
),O,O
alpha,O,O
and,O,O
beta,O,O
subunits,O,O
in,O,O
Madin,O,O
-,O,O
Darby,O,O
canine,O,O
kidney,O,O
cells,O,O
.,O,O
Transactivation,O,O
of,O,O
oIFNtau,B,B
enhancer,O,O
-,O,O
reporter,O,O
constructs,O,O
was,O,O
primarily,O,O
regulated,O,O
by,O,O
three,O,O
regions,O,O
containing,O,O
AP,B,B
-,I,I
1,I,I
site,I,O
",",O,O
GATA,B,B
like,I,I
sequence,I,I
and,O,O
site,O,O
(,O,O
s,O,O
),O,O
unidentified,O,O
.,O,O
Reporter,O,O
gene,O,O
expression,O,O
analyses,O,O
indicate,O,O
that,O,O
both,O,O
WASP,B,B
promoters,I,O
show,O,O
high,O,O
levels,O,O
of,O,O
expression,O,O
in,O,O
different,O,O
hematopoietic,O,O
cell,O,O
lines,O,O
.,O,O
Single,O,O
amino,O,O
acid,O,O
substitutions,O,O
at,O,O
the,O,O
acyl,O,B
-,O,I
CoA,O,I
-,O,I
binding,O,I
domain,O,O
interrupt,O,O
14,O,O
[,O,O
C,O,B
],O,O
palmitoyl,O,O
-,O,O
CoA,O,B
binding,O,I
of,O,O
ACBP2,B,B
",",O,O
an,O,O
Arabidopsis,O,O
acyl,B,B
-,I,I
CoA,I,I
-,I,I
binding,I,I
protein,I,O
with,O,O
ankyrin,B,O
repeats,O,O
.,O,O
Urine,O,O
antibodies,O,O
could,O,O
not,O,O
be,O,O
demonstrated,O,O
in,O,O
any,O,O
other,O,O
cases,O,O
.,O,O
Advanced,O,O
adenoma,O,O
was,O,O
defined,O,O
as,O,O
an,O,O
adenoma,O,O
larger,O,O
than,O,O
10,O,O
mm,O,O
or,O,O
an,O,O
adenoma,O,O
of,O,O
any,O,O
size,O,O
with,O,O
villous,O,O
component,O,O
",",O,O
high,O,O
-,O,O
grade,O,O
dysplasia,O,O
or,O,O
invasive,O,O
carcinoma,O,O
.,O,O
The,O,O
customary,O,O
coupling,O,O
reagent,O,O
sulfanilic,O,B
acid,O,I
has,O,O
been,O,O
replaced,O,O
by,O,O
1,O,O
",",O,O
3,O,O
-,O,O
dimethylbarbituric,O,B
acid,O,I
;,O,O
CNCl,O,O
is,O,O
produced,O,O
in,O,O
the,O,O
flow,O,O
through,O,O
system,O,O
directly,O,O
from,O,O
KCN,O,O
and,O,O
chloramine,O,B
T,O,I
.,O,O
This,O,O
sequenced,O,O
region,O,O
of,O,O
the,O,O
V,O,O
beta,O,O
locus,O,O
contains,O,O
an,O,O
average,O,O
number,O,O
of,O,O
repetitive,O,O
DNA,O,O
elements,O,O
(,O,O
21,O,O
Alu,B,B
",",O,O
three,O,O
L1,B,B
",",O,O
three,O,O
MER,O,B
",",O,O
and,O,O
three,O,O
retrovirus,O,B
-,O,I
related,O,I
elements,O,I
.,O,O
Defects,O,O
of,O,O
fibrillin,B,B
(,O,O
FBN1,B,B
),O,O
",",O,O
a,O,O
glycoprotein,O,O
component,O,O
of,O,O
the,O,O
extracellular,O,O
microfibril,O,O
",",O,O
cause,O,O
Marfan,O,O
syndrome,O,O
.,O,O
The,O,O
requirement,O,O
of,O,O
3,O,O
',O,O
complementarity,O,O
for,O,O
a,O,O
ligation,O,O
reaction,O,O
is,O,O
reaffirmed,O,O
by,O,O
results,O,O
from,O,O
1,O,O
nt,O,O
insertions,O,O
on,O,O
either,O,O
the,O,O
3,O,O
',O,O
-,O,O
or,O,O
5,O,O
',O,O
-,O,O
side,O,O
of,O,O
the,O,O
nick,O,O
.,O,O
Transcriptional,O,O
activity,O,O
was,O,O
measured,O,O
by,O,O
slot,O,O
-,O,O
blot,O,O
hybridization,O,O
with,O,O
steady,O,O
-,O,O
state,O,O
RNA,O,O
isolated,O,O
from,O,O
lacZ,B,O
+,I,O
M,I,O
.,I,O
smegmatis,I,O
clones,O,O
.,O,O
Furthermore,O,O
",",O,O
strains,O,O
with,O,O
mutant,B,O
RPM1,I,B
genes,I,O
also,O,O
accumulate,O,O
precursor,B,O
Rpm1r,I,B
",",O,O
suggesting,O,O
that,O,O
mutations,O,O
in,O,O
either,O,O
gene,O,O
can,O,O
lead,O,O
to,O,O
similar,O,O
biogenesis,O,O
defects,O,O
.,O,O
Nonvascular,O,O
ophthalmic,O,O
and,O,O
neurologic,O,O
disorders,O,O
that,O,O
can,O,O
be,O,O
confused,O,O
with,O,O
amaurosis,O,O
fugax,O,O
are,O,O
listed,O,O
",",O,O
and,O,O
an,O,O
algorithm,O,O
for,O,O
evaluation,O,O
(,O,O
which,O,O
includes,O,O
ophthalmic,O,O
examination,O,O
",",O,O
laboratory,O,O
studies,O,O
",",O,O
and,O,O
noninvasive,O,O
carotid,O,O
artery,O,O
studies,O,O
),O,O
is,O,O
given,O,O
.,O,O
Fans,O,O
in,O,O
tunnels,O,O
and,O,O
open,O,O
windows,O,O
at,O,O
aboveground,O,O
locations,O,O
appeared,O,O
to,O,O
greatly,O,O
reduce,O,O
the,O,O
likelihood,O,O
of,O,O
high,O,O
PH3,O,B
concentrations,O,O
in,O,O
enclosed,O,O
areas,O,O
.,O,O
SELECTION,O,O
CRITERIA,O,O
:,O,O
Randomised,O,O
trials,O,O
comparing,O,O
children,O,O
undergoing,O,O
systematic,O,O
therapy,O,O
focusing,O,O
on,O,O
the,O,O
family,O,O
in,O,O
conjunction,O,O
with,O,O
asthma,O,O
medication,O,O
",",O,O
with,O,O
children,O,O
taking,O,O
asthma,O,O
medication,O,O
only,O,O
.,O,O
Midge,O,O
control,O,O
in,O,O
flood,O,O
channels,O,O
.,O,O
In,O,O
19,O,O
patients,O,O
vagotomy,O,O
not,O,O
only,O,O
curbed,O,O
the,O,O
bleeding,O,O
but,O,O
provided,O,O
definitive,O,O
therapy,O,O
(,O,O
Visick,O,O
I,O,O
-,O,O
II,O,O
),O,O
;,O,O
4,O,O
patients,O,O
died,O,O
(,O,O
mortality,O,O
rate,O,O
16,O,O
%,O,O
),O,O
.,O,O
Here,O,O
we,O,O
show,O,O
that,O,O
these,O,O
synthetic,O,O
binding,O,O
sites,O,O
have,O,O
a,O,O
more,O,O
restricted,O,O
and,O,O
specific,O,O
ability,O,O
to,O,O
enhance,O,O
transcription,O,O
when,O,O
assayed,O,O
in,O,O
transformed,O,O
embryos,O,O
.,O,O
Workload,O,O
",",O,O
UAPs,O,O
",",O,O
and,O,O
you,O,O
.,O,O
One,O,O
of,O,O
these,O,O
elements,O,O
",",O,O
the,O,O
homeodomain,B,O
-,I,O
binding,I,O
element,I,O
",",O,O
was,O,O
identified,O,O
to,O,O
mediate,O,O
negative,O,O
regulation,O,O
.,O,O
The,O,O
therapeutic,O,O
action,O,O
of,O,O
cyclosporin,O,O
A,O,O
(,O,O
Sandimmun,O,O
),O,O
:,O,O
its,O,O
application,O,O
in,O,O
rheumatoid,O,O
arthritis,O,O
.,O,O
This,O,O
study,O,O
indicates,O,O
that,O,O
the,O,O
phenotype,O,O
of,O,O
myofibrillar,O,O
disarray,O,O
seen,O,O
in,O,O
HCM,O,B
patients,O,O
which,O,O
harbor,O,O
either,O,O
of,O,O
these,O,O
two,O,O
mutations,O,O
may,O,O
not,O,O
be,O,O
directly,O,O
due,O,O
to,O,O
the,O,O
failure,O,O
of,O,O
the,O,O
mutant,B,O
myosin,I,B
heavy,I,I
chain,I,I
protein,I,I
to,O,O
assemble,O,O
and,O,O
form,O,O
normal,O,O
sarcomeres,O,O
",",O,O
but,O,O
may,O,O
rather,O,O
be,O,O
a,O,O
secondary,O,O
effect,O,O
possibly,O,O
resulting,O,O
from,O,O
the,O,O
chronic,O,O
stress,O,O
of,O,O
decreased,O,O
beta,B,O
MHC,I,B
function,O,O
.,O,O
On,O,O
long,O,O
-,O,O
term,O,O
follow,O,O
-,O,O
up,O,O
",",O,O
there,O,O
was,O,O
no,O,O
significant,O,O
difference,O,O
in,O,O
the,O,O
incidence,O,O
of,O,O
hospitalizations,O,O
(,O,O
1,O,O
per,O,O
2,O,O
.,O,O
1,O,O
vs,O,O
.,O,O
Three,O,O
mutants,O,O
(,O,O
pms1,B,B
",",O,O
pms2,B,B
and,O,O
pms3,B,B
),O,O
isolated,O,O
earlier,O,O
from,O,O
MW104,O,O
-,O,O
1B,O,O
were,O,O
shown,O,O
to,O,O
correct,O,O
in,O,O
vitro,O,O
constructed,O,O
plasmids,O,O
with,O,O
defined,O,O
DNA,O,B
mismatches,O,O
(,O,O
G,O,B
/,O,I
T,O,I
",",O,O
A,O,B
/,O,I
C,O,I
",",O,O
G,O,B
/,O,I
G,O,I
",",O,O
etc,O,O
.,O,O
),O,O
poorly,O,O
(,O,O
Kramer,O,B
et,O,I
al,O,I
.,O,O
",",O,O
1989a,O,O
-,O,O
specific,O,O
areas,O,O
(,O,O
e,O,O
.,O,O
g,O,O
.,O,O
Wernicke,O,B
",",O,O
left,O,O
fusiform,O,B
gyrus,O,I
",",O,O
Broca,O,B
BA44,O,I
",",O,O
supramarginal,O,B
gyrus,O,I
),O,O
",",O,O
appear,O,O
to,O,O
cope,O,O
with,O,O
the,O,O
computations,O,O
relevant,O,O
to,O,O
making,O,O
contact,O,O
with,O,O
these,O,O
more,O,O
abstract,O,O
dimensions,O,O
.,O,O
Platelet,O,B
counts,O,I
and,O,O
function,O,O
as,O,O
well,O,O
as,O,O
fibrinogen,B,B
and,O,O
von,B,B
Willebrand,I,I
factor,I,I
(,O,I
vWF,B,I
),O,O
levels,O,O
were,O,O
determined,O,O
in,O,O
each,O,O
sample,O,O
.,O,O
The,O,O
DNase,B,B
I,I,I
footprint,O,I
extended,O,O
5,O,O
',O,O
in,O,O
the,O,O
silencer,O,O
region,O,O
to,O,O
include,O,O
an,O,O
inverted,O,O
repeat,O,O
of,O,O
a,O,O
six,O,O
-,O,O
nucleotide,O,O
motif,O,O
(,O,O
epsilon,O,B
-,O,I
267,O,I
to,O,I
-,O,I
278,O,I
bp,O,I
),O,O
which,O,O
shares,O,O
5,O,O
of,O,O
6,O,O
bases,O,O
with,O,O
the,O,O
GATA,B,B
-,I,I
1,I,I
consensus,I,I
sequence,I,I
.,O,O
Because,O,O
results,O,O
of,O,O
recent,O,O
randomized,O,O
trials,O,O
indicate,O,O
minimal,O,O
efficacy,O,O
of,O,O
continuing,O,O
MAC,O,B
prophylaxis,O,I
in,O,O
patients,O,O
who,O,O
respond,O,O
to,O,O
potent,O,O
combination,O,O
antiretroviral,O,O
therapy,O,O
",",O,O
the,O,O
observed,O,O
high,O,O
incidence,O,O
of,O,O
macrolide,O,O
-,O,O
resistant,O,O
bacterial,O,O
colonization,O,O
of,O,O
the,O,O
respiratory,O,O
tract,O,O
in,O,O
this,O,O
trial,O,O
supports,O,O
the,O,O
discontinuation,O,O
of,O,O
macrolide,O,O
prophylaxis,O,O
in,O,O
all,O,O
AIDS,O,O
patients,O,O
whose,O,O
CD4,B,B
counts,O,I
have,O,O
risen,O,O
above,O,O
100,O,O
cells,O,O
/,O,O
microL,O,O
.,O,O
With,O,O
certain,O,O
exceptions,O,O
the,O,O
method,O,O
was,O,O
considered,O,O
suitable,O,O
in,O,O
the,O,O
routine,O,O
intravenous,O,O
cholangiography,O,O
.,O,O
These,O,O
data,O,O
should,O,O
be,O,O
useful,O,O
in,O,O
developing,O,O
reagents,O,O
for,O,O
heterozygote,O,O
detection,O,O
and,O,O
prenatal,O,O
diagnosis,O,O
of,O,O
11,B,B
beta,I,I
-,I,I
hydroxylase,I,I
deficiency,O,I
",",O,O
the,O,O
second,O,O
most,O,O
frequent,O,O
cause,O,O
of,O,O
congenital,O,O
adrenal,O,O
hyperplasia,O,O
.,O,O
Effects,O,O
of,O,O
a,O,O
low,O,O
-,O,O
energy,O,O
laser,O,O
beam,O,O
on,O,O
the,O,O
cells,O,O
of,O,O
the,O,O
newt,O,O
embryo,O,O
One,O,O
of,O,O
these,O,O
is,O,O
surrounded,O,O
by,O,O
an,O,O
adenine,O,B
-,O,I
uridine,O,I
rich,O,I
region,O,O
that,O,O
can,O,O
form,O,O
an,O,O
11,O,O
-,O,O
base,O,O
pair,O,O
stem,O,O
structure,O,O
.,O,O
No,O,O
evidence,O,O
of,O,O
either,O,O
positive,O,O
or,O,O
negative,O,O
chemography,O,O
was,O,O
found,O,O
.,O,O
The,O,O
first,O,O
identification,O,O
of,O,O
the,O,O
active,O,O
37LRP,B,B
/,O,I
p40,B,I
gene,O,O
presented,O,O
in,O,O
this,O,O
study,O,O
is,O,O
a,O,O
critical,O,O
step,O,O
toward,O,O
the,O,O
isolation,O,O
of,O,O
the,O,O
corresponding,O,O
human,O,B
gene,O,O
and,O,O
the,O,O
understanding,O,O
of,O,O
the,O,O
molecular,O,O
mechanisms,O,O
involved,O,O
in,O,O
the,O,O
up,O,O
-,O,O
regulation,O,O
of,O,O
its,O,O
expression,O,O
during,O,O
tumor,O,O
invasion,O,O
and,O,O
metastasis,O,O
.,O,O
Inclusion,O,O
in,O,O
this,O,O
family,O,O
of,O,O
proteins,O,O
suggests,O,O
that,O,O
FliQ,B,B
and,O,O
FliR,B,B
may,O,O
participate,O,O
in,O,O
an,O,O
export,O,O
pathway,O,O
required,O,O
for,O,O
flagellum,O,O
assembly,O,O
.,O,O
Both,O,O
factors,O,O
demonstrated,O,O
significant,O,O
correlations,O,O
with,O,O
rCBF,O,B
in,O,O
the,O,O
medial,O,O
prefrontal,O,O
cortex,O,O
and,O,O
frontal,O,O
polar,O,O
cortex,O,O
while,O,O
for,O,O
each,O,O
factor,O,O
there,O,O
were,O,O
also,O,O
unique,O,O
patterns,O,O
of,O,O
correlations,O,O
with,O,O
posterior,O,O
brain,O,O
regions,O,O
.,O,O
In,O,O
our,O,O
studies,O,O
",",O,O
we,O,O
utilized,O,O
HIV,O,B
-,O,I
1,O,I
HXB2,B,I
and,O,O
HIV,O,B
-,O,I
1,O,I
Z2Z6,B,I
core,I,O
enhancers,I,O
because,O,O
the,O,O
Z2Z6,B,O
strain,O,O
has,O,O
a,O,O
single,O,O
point,O,O
mutation,O,O
flanking,O,O
the,O,O
right,O,O
ETS,B,O
-,I,O
binding,I,O
site,I,O
.,O,O
We,O,O
also,O,O
found,O,O
that,O,O
environmental,O,O
conditions,O,O
for,O,O
meiosis,O,O
finely,O,O
regulate,O,O
the,O,O
transcript,O,O
levels,O,O
of,O,O
KIN28,B,B
and,O,O
CCL1,B,B
",",O,O
such,O,O
that,O,O
nitrogen,O,O
starvation,O,O
first,O,O
elevates,O,O
them,O,O
but,O,O
subsequent,O,O
alkalization,O,O
of,O,O
medium,O,O
decreases,O,O
them,O,O
.,O,O
In,O,O
sterilized,O,O
milk,O,O
there,O,O
was,O,O
a,O,O
slight,O,O
decrease,O,O
of,O,O
linoleic,O,B
acid,O,I
(,O,O
C18,O,B
:,O,I
2n6,O,I
;,O,O
-,O,O
0,O,O
.,O,O
7,O,O
%,O,O
vs,O,O
;,O,O
P,O,O
=,O,O
0,O,O
.,O,O
006,O,O
),O,O
and,O,O
arachidonic,O,B
acid,O,I
(,O,O
C20,O,B
:,O,I
4n6,O,I
;,O,O
-,O,O
2,O,O
.,O,O
5,O,O
%,O,O
;,O,O
P,O,O
=,O,O
0,O,O
.,O,O
045,O,O
.,O,O
Eight,O,O
-,O,O
four,O,O
ACOAs,O,O
were,O,O
tested,O,O
in,O,O
order,O,O
to,O,O
examine,O,O
the,O,O
fit,O,O
of,O,O
the,O,O
model,O,O
to,O,O
the,O,O
data,O,O
by,O,O
path,O,O
analysis,O,O
with,O,O
LISREL,O,O
VII,O,O
.,O,O
Platelet,B,O
-,I,O
derived,I,O
growth,I,O
factor,I,O
-,O,O
dependent,O,O
activation,O,O
of,O,O
phosphatidylinositol,B,O
3,I,O
-,I,O
kinase,I,O
is,O,O
regulated,O,O
by,O,O
receptor,O,O
binding,O,O
of,O,O
SH2,B,B
-,I,I
domain,I,I
-,I,I
containing,I,I
proteins,I,I
which,O,O
influence,O,O
Ras,B,B
activity,O,O
.,O,O
Relatively,O,O
large,O,O
DNA,O,O
rearrangements,O,O
spanning,O,O
the,O,O
region,O,O
with,O,O
tandem,O,O
direct,O,O
repeats,O,O
encoding,O,O
the,O,O
carboxy,O,O
-,O,O
terminal,O,O
histone,B,O
H1,I,B
-,I,I
like,I,I
structure,O,I
of,O,O
AlgP,B,B
were,O,O
detected,O,O
in,O,O
several,O,O
strains,O,O
upon,O,O
conversion,O,O
from,O,O
the,O,O
mucoid,O,O
to,O,O
the,O,O
nonmucoid,O,O
phenotype,O,O
.,O,O
A,O,O
study,O,O
in,O,O
vivo,O,O
of,O,O
adrenergic,B,O
receptors,I,O
in,O,O
the,O,O
rectum,O,O
and,O,O
in,O,O
the,O,O
internal,O,O
and,O,O
sphincter,O,O
of,O,O
the,O,O
cat,O,O
.,O,O
Dermatology,O,O
is,O,O
no,O,O
exception,O,O
.,O,O
A,O,O
2,O,O
kb,O,O
transcript,O,O
was,O,O
isolated,O,O
from,O,O
brain,O,O
that,O,O
encodes,O,O
a,O,O
approximately,O,O
57,O,O
kDa,O,O
protein,O,O
;,O,O
the,O,O
predicted,O,O
protein,O,O
contains,O,O
the,O,O
known,O,O
N,B,O
-,I,O
terminal,I,O
Ets,I,O
domain,I,O
of,O,O
PE1,B,O
and,O,O
a,O,O
novel,O,O
C,O,O
-,O,O
terminal,O,O
domain,O,O
with,O,O
signficant,O,O
homology,O,O
to,O,O
murine,B,O
ERF,I,O
.,O,O
The,O,O
recovery,O,O
rates,O,O
for,O,O
the,O,O
MB,O,O
/,O,O
BacT,O,O
",",O,O
MGIT,O,O
960,O,O
",",O,O
and,O,O
solid,O,O
media,O,O
were,O,O
91,O,O
.,O,O
6,O,O
",",O,O
87,O,O
.,O,O
4,O,O
",",O,O
and,O,O
54,O,O
.,O,O
7,O,O
%,O,O
",",O,O
respectively,O,O
",",O,O
for,O,O
all,O,O
mycobacteria,O,O
;,O,O
the,O,O
recovery,O,O
rates,O,O
were,O,O
93,O,O
.,O,O
6,O,O
",",O,O
88,O,O
.,O,O
9,O,O
",",O,O
and,O,O
63,O,O
.,O,O
4,O,O
%,O,O
",",O,O
respectively,O,O
",",O,O
for,O,O
M,O,O
.,O,O
tuberculosis,O,O
complex,O,O
alone,O,O
",",O,O
and,O,O
87,O,O
.,O,O
5,O,O
",",O,O
84,O,O
.,O,O
4,O,O
",",O,O
and,O,O
37,O,O
.,O,O
5,O,O
%,O,O
",",O,O
respectively,O,O
",",O,O
for,O,O
all,O,O
nontuberculous,O,O
mycobacteria,O,O
.,O,O
The,O,O
somatoform,O,O
conundrum,O,O
:,O,O
a,O,O
question,O,O
of,O,O
nosological,O,O
valves,O,O
.,O,O
The,O,O
muskox,O,O
is,O,O
a,O,O
new,O,O
host,O,O
record,O,O
for,O,O
T,O,B
.,O,O
gondii,O,O
.,O,O
Sequence,O,O
analysis,O,O
and,O,O
identification,O,O
of,O,O
two,O,O
hyp,B,O
regulatory,I,O
mutants,I,O
.,O,O
However,O,O
",",O,O
the,O,O
signaling,O,O
cascade,O,O
utilized,O,O
by,O,O
the,O,O
urokinase,B,O
receptor,I,O
is,O,O
only,O,O
incompletely,O,O
understood,O,O
.,O,O
Proteinuria,O,O
in,O,O
a,O,O
young,O,O
man,O,O
.,O,O
The,O,O
high,B,O
density,I,O
lipoprotein,I,O
(,I,O
HDL,I,B
),I,O
receptor,I,O
mediates,O,O
the,O,O
uptake,O,O
of,O,O
cholesterol,O,O
and,O,O
cholesteryl,O,O
esters,O,O
",",O,O
substrates,O,O
for,O,O
steroidogenesis,O,O
",",O,O
from,O,O
an,O,O
HDL,B,B
particle,O,O
in,O,O
the,O,O
adrenal,O,O
gland,O,O
and,O,O
gonads,O,O
.,O,O
The,O,O
mechanism,O,O
involves,O,O
Gbetagamma,B,B
subunit,O,I
-,O,I
mediated,O,O
increases,O,O
in,O,O
tyrosine,O,O
phosphorylation,O,O
of,O,O
the,O,O
Shc,B,B
adapter,I,I
protein,I,I
",",O,O
Shc,B,B
*,O,I
Grb2,B,I
complex,O,I
formation,O,I
",",O,O
and,O,O
recruitment,O,O
of,O,O
Ras,B,B
guanine,I,I
nucleotide,I,I
exchange,I,I
factor,I,I
activity,O,I
.,O,O
Regarding,O,O
.,O,O
Kaposi,O,B
',O,O
s,O,O
sarcoma,O,O
-,O,O
associated,O,O
herpesvirus,O,B
viral,B,I
interferon,I,I
regulatory,I,I
factor,I,I
confers,O,O
resistance,O,O
to,O,O
the,O,O
antiproliferative,O,O
effect,O,O
of,O,O
interferon,B,O
-,I,O
alpha,I,O
.,O,O
Adjuvant,O,O
and,O,O
neoadjuvant,O,O
treatment,O,O
of,O,O
breast,O,O
cancer,O,O
.,O,O
The,O,O
enhanced,O,O
binding,O,O
of,O,O
c,B,O
-,I,O
Abl,I,B
to,O,O
DNA,O,O
containing,O,O
5,O,O
-,O,O
methylcytosine,O,O
residues,O,O
may,O,O
result,O,O
from,O,O
an,O,O
increased,O,O
propensity,O,O
of,O,O
the,O,O
double,O,O
helix,O,O
to,O,O
denature,O,O
locally,O,O
coupled,O,O
with,O,O
a,O,O
protein,O,O
-,O,O
induced,O,O
reduction,O,O
in,O,O
the,O,O
base,O,O
stacking,O,O
interaction,O,O
.,O,O
Enterococcus,O,B
faecium,O,I
strains,O,O
with,O,O
vanA,O,B
-,O,I
mediated,O,I
glycopeptide,O,I
resistance,O,O
were,O,O
isolated,O,O
by,O,O
enrichment,O,O
culture,O,O
from,O,O
the,O,O
intestines,O,O
and,O,O
feces,O,O
of,O,O
several,O,O
animal,O,O
species,O,O
",",O,O
mainly,O,O
horses,O,O
and,O,O
dogs,O,O
(,O,O
8,O,O
%,O,O
positive,O,O
),O,O
",",O,O
chickens,O,O
(,O,O
7,O,O
%,O,O
positive,O,O
),O,O
",",O,O
and,O,O
pigs,O,O
(,O,O
6,O,O
%,O,O
positive,O,O
),O,O
.,O,O
Most,O,O
likely,O,O
they,O,O
might,O,O
represent,O,O
regulatory,O,O
RNAs,O,O
or,O,O
transcribed,O,O
transposable,O,O
elements,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
gel,O,O
mobility,O,O
shift,O,O
experiments,O,O
have,O,O
failed,O,O
to,O,O
reveal,O,O
that,O,O
HAP2,B,B
or,O,O
HAP3,B,B
binds,O,O
to,O,O
domain,O,O
1,O,O
or,O,O
that,O,O
hap3,B,B
mutations,O,O
affect,O,O
the,O,O
complexes,O,O
bound,O,O
to,O,O
it,O,O
.,O,O
One,O,O
group,O,O
(,O,O
n,O,O
=,O,O
9,O,O
),O,O
was,O,O
premedicated,O,O
with,O,O
midazolam,O,O
",",O,O
0,O,O
.,O,O
1,O,O
mg,O,O
kg,O,O
-,O,O
1,O,O
",",O,O
and,O,O
atropine,O,O
0,O,O
.,O,O
2,O,O
-,O,O
0,O,O
.,O,O
4,O,O
mg,O,O
i,O,O
.,O,O
m,O,O
.,O,O
The,O,O
evaluation,O,O
was,O,O
performed,O,O
using,O,O
a,O,O
retrospective,O,O
study,O,O
design,O,O
with,O,O
newborn,O,O
blood,O,O
samples,O,O
from,O,O
three,O,O
screening,O,O
centres,O,O
.,O,O
Here,O,O
we,O,O
report,O,O
the,O,O
purification,O,O
of,O,O
this,O,O
larger,O,O
form,O,O
as,O,O
an,O,O
approximately,O,O
320,O,O
-,O,O
kDa,O,O
particle,O,O
that,O,O
contains,O,O
mRNP3,B,B
+,I,I
4,I,I
and,O,O
nine,O,O
additional,O,O
polypeptides,O,O
",",O,O
including,O,O
mRNA,O,B
-,O,I
binding,O,I
polypeptides,O,I
of,O,O
34,O,O
and,O,O
36,O,O
kDa,O,O
and,O,O
a,O,O
doublet,O,O
of,O,O
110,O,O
/,O,O
105,O,O
kDa,O,O
that,O,O
proved,O,O
to,O,O
be,O,O
nucleolin,B,B
.,O,O
Yeast,O,O
mutants,O,O
lacking,O,O
a,O,O
functional,O,O
NOP1,B,B
gene,I,O
can,O,O
be,O,O
complemented,O,O
by,O,O
human,B,B
fibrillarin,I,I
but,O,O
are,O,O
temperature,O,O
sensitive,O,O
for,O,O
growth,O,O
and,O,O
impaired,O,O
in,O,O
pre,O,O
-,O,O
rRNA,O,O
processing,O,O
.,O,O
Once,O,O
the,O,O
proliferation,O,O
of,O,O
fibroblasts,O,O
and,O,O
collagen,B,O
synthesis,O,O
had,O,O
led,O,O
to,O,O
an,O,O
increase,O,O
of,O,O
mechanical,O,O
strength,O,O
",",O,O
no,O,O
negative,O,O
effect,O,O
on,O,O
wound,O,O
healing,O,O
could,O,O
be,O,O
detected,O,O
applying,O,O
the,O,O
same,O,O
chemotherapeutic,O,O
agents,O,O
.,O,O
We,O,O
calculated,O,O
differences,O,O
in,O,O
late,O,O
occlusion,O,O
rates,O,O
by,O,O
the,O,O
chi2,O,O
(,O,O
chi,O,B
-,O,I
square,O,I
),O,O
test,O,O
",",O,O
and,O,O
found,O,O
these,O,O
differences,O,O
were,O,O
significant,O,O
(,O,O
P,O,O
=,O,O
.,O,O
04,O,O
),O,O
.,O,O
In,O,O
co,O,O
-,O,O
transfection,O,O
studies,O,O
",",O,O
the,O,O
expression,O,O
of,O,O
c,B,B
-,I,I
Jun,I,I
plus,O,O
c,B,B
-,I,I
Fos,I,I
enhanced,O,O
the,O,O
transactivation,O,O
of,O,O
oIFNtau,B,O
-,O,O
CAT,B,O
but,O,O
the,O,O
expression,O,O
of,O,O
GATA,B,B
-,I,I
1,I,I
",",O,O
GATA,B,B
-,I,I
2,I,I
or,O,O
GATA,B,B
-,I,I
3,I,I
did,O,O
not,O,O
.,O,O
Another,O,O
stem,O,O
-,O,O
loop,O,O
called,O,O
structure,O,O
III,O,O
near,O,O
the,O,O
3,O,O
',O,O
-,O,O
end,O,O
of,O,O
repY,B,O
sequesters,O,O
both,O,O
the,O,O
5,O,O
',O,O
-,O,O
rCGCC,O,O
-,O,O
3,O,O
',O,O
sequence,O,O
and,O,O
the,O,O
repZ,B,O
ribosome,I,O
-,I,O
binding,I,O
site,I,O
.,O,O
The,O,O
results,O,O
indicate,O,O
that,O,O
the,O,O
relationship,O,O
between,O,O
comprehension,O,O
and,O,O
production,O,O
is,O,O
different,O,O
at,O,O
different,O,O
stages,O,O
in,O,O
development,O,O
.,O,O
An,O,O
epidemiological,O,O
survey,O,O
of,O,O
rheumatic,O,O
valve,O,O
disease,O,O
and,O,O
rheumatic,O,O
fever,O,O
in,O,O
primary,O,O
and,O,O
secondary,O,O
school,O,O
students,O,O
in,O,O
Jiangxi,O,O
Province,O,O
Finally,O,O
",",O,O
some,O,O
point,O,O
mutations,O,O
in,O,O
the,O,O
Gag,B,B
-,O,I
Pol,B,I
PR,O,I
domain,O,I
inhibited,O,O
activation,O,O
of,O,O
RT,B,B
in,O,O
trans,O,O
by,O,O
a,O,O
wild,O,O
-,O,O
type,O,O
PR,B,I
",",O,O
suggesting,O,O
that,O,O
the,O,O
correct,O,O
conformation,O,O
of,O,O
the,O,O
PR,B,I
domain,O,I
in,O,O
Gag,B,B
-,O,I
Pol,B,I
is,O,O
prerequisite,O,O
for,O,O
activation,O,O
of,O,O
RT,B,B
.,O,O
Women,O,O
',O,O
s,O,O
opportunities,O,O
for,O,O
paid,O,O
work,O,O
outside,O,O
the,O,O
home,O,O
are,O,O
constrained,O,O
by,O,O
their,O,O
role,O,O
as,O,O
primary,O,O
carer,O,O
within,O,O
the,O,O
family,O,O
",",O,O
writes,O,O
Trudy,O,O
Wynne,O,O
.,O,O
The,O,O
activity,O,O
of,O,O
the,O,O
EGF,B,B
receptor,I,I
promoter,I,O
can,O,O
be,O,O
modulated,O,O
by,O,O
E1A,B,B
protein,I,O
and,O,O
receptor,O,B
RNA,O,I
levels,O,O
increased,O,O
by,O,O
stimulation,O,O
with,O,O
phorbol,O,O
ester,O,O
or,O,O
fetal,O,O
calf,O,O
serum,O,O
.,O,O
Electrophoretic,O,O
mobility,O,O
shift,O,O
assays,O,O
revealed,O,O
that,O,O
Sp1,B,B
binds,O,O
to,O,O
two,O,O
different,O,O
regions,O,O
in,O,O
the,O,O
proximal,O,O
promoter,O,O
",",O,O
a,O,O
typical,O,O
Sp1,B,B
site,I,O
located,O,O
at,O,O
(,O,O
-,O,O
38,O,O
;,O,O
-,O,O
33,O,O
),O,O
and,O,O
a,O,O
G,O,B
/,O,I
C,O,I
-,O,I
rich,O,I
region,O,I
between,O,O
(,O,O
-,O,O
67,O,O
;,O,O
-,O,O
62,O,O
),O,O
.,O,O
Changes,O,O
in,O,O
immunologic,O,O
reactivity,O,O
in,O,O
subjects,O,O
receiving,O,O
transfer,B,O
factor,I,O
could,O,O
not,O,O
be,O,O
distinguished,O,O
from,O,O
those,O,O
in,O,O
subjects,O,O
receiving,O,O
placebo,O,O
.,O,O
A,O,O
pre,O,O
-,O,O
boutonniere,O,O
deformity,O,O
was,O,O
simulated,O,O
by,O,O
dividing,O,O
the,O,O
central,O,O
slip,O,O
.,O,O
Identification,O,O
of,O,O
a,O,O
consensus,O,O
cyclin,B,B
-,I,I
dependent,I,I
kinase,I,I
phosphorylation,I,O
site,I,O
unique,O,O
to,O,O
the,O,O
nuclear,O,O
form,O,O
of,O,O
human,B,B
deoxyuridine,I,I
triphosphate,I,I
nucleotidohydrolase,I,I
.,O,O
In,O,O
contrast,O,O
",",O,O
neither,O,O
I,O,O
.,O,O
argentina,O,O
nor,O,O
I,O,O
.,O,O
theezans,O,O
exerted,O,O
any,O,O
effect,O,O
on,O,O
BF,O,O
or,O,O
intestinal,O,O
propulsion,O,O
.,O,O
BiP670,B,B
retains,O,O
basal,O,O
and,O,O
Ca2,O,B
+,O,I
ionophore,O,O
A23187,O,O
-,O,O
inducible,O,O
activities,O,O
.,O,O
Antimicrobial,O,O
Susceptibility,O,O
of,O,O
Klebsiella,O,B
pneumoniae,O,I
Producing,O,O
Extended,B,O
-,I,O
Spectrum,I,O
beta,I,O
-,I,O
lactamase,I,O
(,O,O
ESBL,B,B
),O,O
Isolated,O,O
in,O,O
Hospitals,O,O
in,O,O
Brazil,O,O
.,O,O
The,O,O
LTR,O,B
-,O,I
binding,O,I
activities,O,I
of,O,O
VBP,B,B
",",O,O
a1,B,B
/,I,I
EBP,I,I
",",O,O
and,O,O
B,B,B
-,I,I
cell,I,I
nuclear,I,I
extract,I,I
protein,I,I
were,O,O
compared,O,O
and,O,O
mapped,O,O
by,O,O
gel,O,O
shift,O,O
",",O,O
DNase,B,O
I,I,O
footprinting,O,O
",",O,O
and,O,O
methylation,O,O
interference,O,O
assays,O,O
.,O,O
Estral,O,O
cycle,O,O
in,O,O
white,O,O
rats,O,O
in,O,O
the,O,O
low,O,O
and,O,O
high,O,O
mountains,O,O
of,O,O
Kirghizia,O,O
These,O,O
results,O,O
indicate,O,O
that,O,O
ATF,B,B
-,I,I
2,I,I
plays,O,O
a,O,O
central,O,O
role,O,O
in,O,O
TGF,B,B
-,I,I
beta,I,I
signaling,O,O
by,O,O
acting,O,O
as,O,O
a,O,O
common,O,O
nuclear,O,O
target,O,O
of,O,O
both,O,O
Smad,B,B
and,O,O
TAK1,B,B
pathways,O,O
.,O,O
Similarly,O,O
",",O,O
in,O,O
mammalian,O,O
cells,O,O
PBP74,B,B
is,O,O
synthesized,O,O
as,O,O
a,O,O
pre,O,O
-,O,O
protein,O,O
that,O,O
requires,O,O
membrane,O,O
potential,O,O
-,O,O
dependent,O,O
import,O,O
into,O,O
mitochondria,O,O
for,O,O
its,O,O
maturation,O,O
.,O,O
Capnography,O,O
curves,O,O
of,O,O
40,O,O
HVS,O,O
patients,O,O
",",O,O
40,O,O
non,O,O
-,O,O
HVS,O,O
patients,O,O
with,O,O
psycho,O,O
-,O,O
somatic,O,O
complaints,O,O
and,O,O
26,O,O
healthy,O,O
controls,O,O
were,O,O
analyzed,O,O
.,O,O
Topological,O,O
and,O,O
mutational,O,O
analysis,O,O
of,O,O
Saccharomyces,B,B
cerevisiae,I,I
Ste14p,I,I
",",O,O
founding,O,O
member,O,O
of,O,O
the,O,O
isoprenylcysteine,B,O
carboxyl,I,O
methyltransferase,I,O
family,I,O
.,O,O
This,O,O
model,O,O
is,O,O
supported,O,O
by,O,O
experiments,O,O
showing,O,O
that,O,O
Cdr2,B,B
associates,O,O
with,O,O
the,O,O
N,B,O
-,I,O
terminal,I,O
regulatory,I,O
domain,I,O
of,I,O
Wee1,I,B
in,O,O
cell,O,O
lysates,O,O
and,O,O
phosphorylates,O,O
Wee1,B,B
in,O,O
vitro,O,O
.,O,O
These,O,O
results,O,O
support,O,O
a,O,O
model,O,O
in,O,O
which,O,O
p53,B,B
protein,I,O
contributes,O,O
to,O,O
the,O,O
maintenance,O,O
of,O,O
genomic,O,O
integrity,O,O
through,O,O
recombinational,O,O
repair,O,O
.,O,O
TG,O,O
-,O,O
day,O,O
and,O,O
TG,O,O
-,O,O
night,O,O
were,O,O
19,O,O
.,O,O
4,O,O
+,O,O
/,O,O
-,O,O
6,O,O
.,O,O
1,O,O
%,O,O
",",O,O
26,O,O
.,O,O
6,O,O
+,O,O
/,O,O
-,O,O
5,O,O
.,O,O
3,O,O
%,O,O
",",O,O
(,O,O
750,O,O
mm3,O,O
<,O,O
T,O,O
.,O,O
Consistent,O,O
with,O,O
previous,O,O
reports,O,O
",",O,O
addition,O,O
of,O,O
a,O,O
myristoylation,O,O
signal,O,O
to,O,O
mSos1,B,O
(,O,O
MyrSos1,B,O
),O,O
rendered,O,O
it,O,O
transforming,O,O
for,O,O
NIH,O,O
3T3,O,O
cells,O,O
and,O,O
deletion,O,O
of,O,O
the,O,O
mSos,B,O
C,I,O
terminus,I,O
(,O,O
MyrSos1,B,O
-,I,O
deltaC,I,O
),O,O
did,O,O
not,O,O
interfere,O,O
with,O,O
this,O,O
activity,O,O
.,O,O
The,O,O
U14,B,B
genes,I,O
of,O,O
mouse,O,B
as,O,O
well,O,O
as,O,O
rat,O,B
",",O,O
hamster,O,B
",",O,O
human,O,B
",",O,O
Xenopus,O,B
and,O,O
trout,O,B
are,O,O
encoded,O,O
within,O,O
introns,O,O
of,O,O
the,O,O
constitutively,O,O
expressed,O,O
70,B,O
-,I,O
kDa,I,O
-,I,O
cognate,I,O
-,I,O
heat,I,O
-,I,O
shock,I,O
protein,I,O
gene,I,O
(,O,O
hsc70,B,B
),O,O
.,O,O
Expression,O,O
of,O,O
human,B,B
RACK1,I,B
efficiently,O,O
relieves,O,O
E1A,B,O
-,O,O
mediated,O,O
growth,O,O
inhibition,O,O
in,O,O
HF7c,O,O
and,O,O
protects,O,O
human,O,B
tumor,O,O
cells,O,O
from,O,O
E1A,B,O
-,O,O
induced,O,O
apoptosis,O,O
.,O,O
The,O,O
mutations,O,O
did,O,O
not,O,O
affect,O,O
the,O,O
repression,O,O
of,O,O
CPA1,B,B
by,O,O
arginine,O,O
.,O,O
Therefore,O,O
",",O,O
this,O,O
study,O,O
has,O,O
demonstrated,O,O
that,O,O
prenatal,O,O
disturbance,O,O
can,O,O
induce,O,O
a,O,O
lasting,O,O
change,O,O
in,O,O
cytokine,O,O
biology,O,O
",",O,O
which,O,O
persists,O,O
well,O,O
beyond,O,O
the,O,O
fetal,O,O
and,O,O
infant,O,O
stage,O,O
.,O,O
Dynamics,O,O
of,O,O
hospital,O,O
stay,O,O
in,O,O
peptic,O,O
ulcer,O,O
patients,O,O
In,O,O
all,O,O
cells,O,O
",",O,O
the,O,O
accumulation,O,O
of,O,O
high,O,O
Dsg,B,B
protein,I,I
levels,O,I
required,O,O
calcium,O,O
and,O,O
was,O,O
not,O,O
observed,O,O
in,O,O
low,O,O
calcium,O,O
(,O,O
0,O,O
.,O,O
05,O,O
-,O,O
0,O,O
.,O,O
07,O,O
mM,O,O
),O,O
media,O,O
.,O,O
During,O,O
a,O,O
28,O,O
-,O,O
week,O,O
promotion,O,O
bioassay,O,O
",",O,O
groups,O,O
of,O,O
30,O,O
male,O,O
CD,O,B
-,O,I
1,O,I
mice,O,O
were,O,O
treated,O,O
once,O,O
with,O,O
50,O,O
microliter,O,O
of,O,O
either,O,O
DMBA,O,B
(,O,O
1,O,O
.,O,O
0,O,O
mg,O,O
/,O,O
ml,O,O
),O,O
or,O,O
acetone,O,O
",",O,O
rested,O,O
for,O,O
2,O,O
weeks,O,O
",",O,O
and,O,O
then,O,O
treated,O,O
twice,O,O
per,O,O
week,O,O
with,O,O
test,O,O
material,O,O
for,O,O
the,O,O
remaining,O,O
25,O,O
weeks,O,O
.,O,O
Here,O,O
",",O,O
we,O,O
identified,O,O
three,O,O
cis,O,O
-,O,O
elements,O,O
required,O,O
for,O,O
replication,O,O
within,O,O
the,O,O
200,O,O
bp,O,O
promoter,O,O
",",O,O
using,O,O
autonomously,O,O
replicating,O,O
plasmids,O,O
carrying,O,O
various,O,O
mutations,O,O
and,O,O
deletions,O,O
.,O,O
The,O,O
foregoing,O,O
results,O,O
show,O,O
that,O,O
CXD,O,B
has,O,O
high,O,O
efficacy,O,O
and,O,O
safety,O,O
and,O,O
it,O,O
can,O,O
be,O,O
said,O,O
that,O,O
it,O,O
is,O,O
a,O,O
drug,O,O
required,O,O
in,O,O
the,O,O
pediatric,O,O
field,O,O
.,O,O
Taken,O,O
together,O,O
",",O,O
these,O,O
observations,O,O
indicate,O,O
that,O,O
inhibition,O,O
of,O,O
p27,B,B
(,O,O
KIP1,B,B
),O,O
transcription,O,O
through,O,O
PI3K,B,B
-,O,I
induced,O,I
FKHR,B,B
-,I,I
L1,I,I
phosphorylation,O,O
provides,O,O
a,O,O
novel,O,O
mechanism,O,O
of,O,O
regulating,O,O
cytokine,O,O
-,O,O
mediated,O,O
survival,O,O
and,O,O
proliferation,O,O
.,O,O
Following,O,O
EPI,O,B
-,O,I
C0401,O,I
",",O,O
but,O,O
not,O,O
saline,O,O
or,O,O
DepoFoam,O,O
vehicle,O,O
",",O,O
there,O,O
were,O,O
transient,O,O
(,O,O
<,O,O
72,O,O
hr,O,O
),O,O
decreases,O,O
in,O,O
food,O,O
consumption,O,O
",",O,O
arousal,O,O
",",O,O
hindlimb,O,O
muscle,O,O
tone,O,O
",",O,O
and,O,O
body,O,O
temperature,O,O
.,O,O
Morphogenesis,O,O
of,O,O
the,O,O
trochanter,O,O
produced,O,O
by,O,O
femoral,O,O
regeneration,O,O
in,O,O
the,O,O
phasmid,O,O
Carausius,O,B
morosus,O,I
Br,O,I
Rarely,O,O
",",O,O
patients,O,O
with,O,O
locally,O,O
advanced,O,O
",",O,O
uncontrollable,O,O
",",O,O
non,O,O
-,O,O
metastatic,O,O
prostatic,O,O
cancer,O,O
enjoy,O,O
prolonged,O,O
survival,O,O
.,O,O
We,O,O
observed,O,O
abundant,O,O
levels,O,O
of,O,O
Rev,B,B
-,O,I
erbA,B,I
alpha,I,I
mRNA,O,O
in,O,O
dividing,O,O
C2C12,O,O
myoblasts,O,O
",",O,O
which,O,O
were,O,O
suppressed,O,O
when,O,O
the,O,O
cells,O,O
differentiated,O,O
into,O,O
postmitotic,O,O
multinucleated,O,O
myotubes,O,O
.,O,O
Fowlpox,O,O
virus,O,O
encodes,O,O
nonessential,O,O
homologs,O,O
of,O,O
cellular,B,O
alpha,I,I
-,I,I
SNAP,I,I
",",O,O
PC,B,B
-,I,I
1,I,I
",",O,O
and,O,O
an,O,O
orphan,O,O
human,O,O
homolog,O,O
of,O,O
a,O,O
secreted,O,O
nematode,O,O
protein,O,O
.,O,O
The,O,O
case,O,O
for,O,O
completing,O,O
the,O,O
lymphadenectomy,O,O
when,O,O
positive,O,O
lymph,O,B
nodes,O,I
are,O,O
found,O,O
during,O,O
radical,O,O
hysterectomy,O,O
for,O,O
cervical,O,O
carcinoma,O,O
.,O,O
A,O,O
chicken,B,O
paxillin,I,B
cDNA,I,O
was,O,O
also,O,O
cloned,O,O
and,O,O
is,O,O
predicted,O,O
to,O,O
encode,O,O
a,O,O
protein,O,O
approximately,O,O
90,O,O
%,O,O
identical,O,O
to,O,O
human,B,B
paxil,I,I
-,I,I
lin,I,I
.,O,O
SvO2,O,O
can,O,O
be,O,O
determined,O,O
in,O,O
vitro,O,O
and,O,O
in,O,O
vivo,O,O
.,O,O
The,O,O
gene,O,B
is,O,O
contained,O,O
within,O,O
a,O,O
1,O,O
.,O,O
8,O,O
-,O,O
kilobase,O,O
AccI,B,O
-,O,O
EcoRI,B,O
restriction,O,O
fragment,O,O
mapping,O,O
at,O,O
map,O,O
coordinates,O,O
0,O,O
.,O,O
136,O,O
to,O,O
0,O,O
.,O,O
148,O,O
in,O,O
the,O,O
UL,O,O
region,O,O
of,O,O
the,O,O
EHV,O,O
-,O,O
1,O,O
genome,O,O
and,O,O
is,O,O
transcribed,O,O
from,O,O
right,O,O
to,O,O
left,O,O
.,O,O
RESULTS,O,O
:,O,O
The,O,O
main,O,O
effect,O,O
of,O,O
muscle,O,O
pain,O,O
",",O,O
compared,O,O
to,O,O
non,O,O
-,O,O
painful,O,O
stimulation,O,O
",",O,O
was,O,O
a,O,O
significant,O,O
and,O,O
long,O,O
-,O,O
lasting,O,O
increase,O,O
of,O,O
delta,O,O
(,O,O
1,O,O
-,O,O
3,O,O
Hz,O,O
),O,O
power,O,O
and,O,O
an,O,O
alpha,O,O
-,O,O
1,O,O
(,O,O
9,O,O
-,O,O
11,O,O
Hz,O,O
),O,O
power,O,O
increase,O,O
over,O,O
the,O,O
contralateral,O,O
parietal,O,O
locus,O,O
.,O,O
WR,O,O
-,O,O
2721,O,O
(,O,O
S,O,B
-,O,I
2,O,I
-,O,I
(,O,O
3,O,B
aminopropylamino,O,I
),O,O
ethylphosphorothioic,O,O
acid,O,O
),O,O
has,O,O
been,O,O
investigated,O,O
for,O,O
its,O,O
ability,O,O
to,O,O
protect,O,O
gut,O,O
",",O,O
lung,O,O
",",O,O
and,O,O
testis,O,O
",",O,O
as,O,O
well,O,O
as,O,O
fibrosarcoma,O,B
(,O,I
FSa,O,I
),O,O
tumor,O,O
nodules,O,O
",",O,O
in,O,O
the,O,O
lungs,O,O
of,O,O
mice,O,O
from,O,O
gamma,O,O
-,O,O
radiation,O,O
injury,O,O
.,O,O
Naturally,O,O
acquired,O,O
antibodies,O,O
were,O,O
demonstrated,O,O
in,O,O
some,O,O
rabbits,O,O
kept,O,O
on,O,O
commercial,O,O
farms,O,O
.,O,O
Potency,O,O
of,O,O
enflurane,O,B
in,O,O
dogs,O,O
:,O,O
comparison,O,O
with,O,O
halothane,O,B
and,O,O
isoflurane,O,B
.,O,O
Classification,O,O
according,O,O
to,O,O
the,O,O
ILAR,O,O
criteria,O,O
was,O,O
possible,O,O
in,O,O
321,O,O
patients,O,O
;,O,O
290,O,O
patients,O,O
had,O,O
a,O,O
disease,O,O
duration,O,O
>,O,O
or,O,O
=,O,O
3,O,O
months,O,O
and,O,O
were,O,O
classified,O,O
according,O,O
to,O,O
the,O,O
EULAR,O,O
criteria,O,O
.,O,O
The,O,O
purpose,O,O
of,O,O
this,O,O
study,O,O
is,O,O
twofold,O,O
:,O,O
(,O,O
1,O,O
),O,O
to,O,O
present,O,O
a,O,O
parallel,O,O
form,O,O
of,O,O
the,O,O
Gudjonsson,O,B
Suggestibility,O,I
Scale,O,I
(,O,O
GSS,O,B
",",O,O
Form,O,O
1,O,O
),O,O
;,O,O
(,O,O
2,O,O
),O,O
to,O,O
study,O,O
test,O,O
-,O,O
retest,O,O
reliabilities,O,O
of,O,O
interrogative,O,O
suggestibility,O,O
.,O,O
Two,O,O
patients,O,O
were,O,O
treated,O,O
successfully,O,O
with,O,O
a,O,O
combination,O,O
of,O,O
metronidazole,O,O
(,O,O
a,O,O
tissue,O,O
amoebicide,O,O
),O,O
and,O,O
diloxanide,O,O
(,O,O
a,O,O
lumenal,O,O
amoebicide,O,O
),O,O
.,O,O
Transcription,O,O
initiation,O,O
sites,O,O
of,O,O
the,O,O
rat,O,O
II,B,B
beta,I,I
-,I,I
",",I,O
III,I,B
beta,I,I
",",I,O
and,I,O
O,I,B
beta,I,I
-,I,I
globin,I,I
genes,O,O
were,O,O
determined,O,O
to,O,O
be,O,O
52,O,O
base,O,O
pairs,O,O
(,O,O
bp,O,O
),O,O
5,O,O
',O,O
-,O,O
upstream,O,O
of,O,O
the,O,O
translation,O,O
initiation,O,O
codon,O,O
(,O,O
ATG,O,O
),O,O
",",O,O
in,O,O
each,O,O
gene,O,O
by,O,O
primer,O,O
extension,O,O
analysis,O,O
.,O,O
The,O,O
GPI,O,B
anchor,O,I
moiety,O,I
is,O,O
either,O,O
absent,O,O
or,O,O
present,O,O
at,O,O
a,O,O
very,O,O
low,O,O
level,O,O
in,O,O
the,O,O
polypeptide,O,O
expressed,O,O
from,O,O
the,O,O
cDNA,O,O
that,O,O
contained,O,O
both,O,O
the,O,O
signal,O,O
peptide,O,O
and,O,O
GPI,O,B
signal,O,I
sequences,O,I
.,O,O
All,O,O
samples,O,O
exhibited,O,O
a,O,O
decline,O,O
in,O,O
ethanol,O,O
concentration,O,O
",",O,O
with,O,O
most,O,O
losses,O,O
falling,O,O
within,O,O
the,O,O
expected,O,O
20,O,O
to,O,O
40,O,O
mg,O,O
%,O,O
range,O,O
.,O,O
A,O,O
chimeric,O,O
VP16,B,B
-,O,I
Tat,B,B
construct,O,O
containing,O,O
the,O,O
leucine,O,O
mutations,O,O
showed,O,O
no,O,O
increased,O,O
AP,B,B
-,I,I
1,I,I
responsiveness,O,O
in,O,O
comparison,O,O
with,O,O
that,O,O
of,O,O
the,O,O
VP16,B,B
activation,I,O
domain,I,O
alone,O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
This,O,O
randomized,O,O
study,O,O
shows,O,O
that,O,O
Vivostat,O,O
fibrin,B,O
sealant,O,O
is,O,O
effective,O,O
in,O,O
preventing,O,O
air,O,O
leakage,O,O
after,O,O
small,O,O
lung,O,O
resections,O,O
in,O,O
pigs,O,O
",",O,O
even,O,O
at,O,O
high,O,O
inspiratory,O,O
pressures,O,O
.,O,O
Splice,O,O
variations,O,O
in,O,O
genes,O,O
coding,O,O
for,O,O
the,O,O
transmembrane,B,O
FGF,I,B
receptor,I,I
(,O,O
FGFR,B,B
),O,O
result,O,O
in,O,O
isoforms,O,O
that,O,O
vary,O,O
in,O,O
the,O,O
ectodomain,O,O
",",O,O
intracellular,O,O
juxtamembrane,O,O
domain,O,O
",",O,O
and,O,O
the,O,O
intracellular,O,O
kinase,O,O
domain,O,O
.,O,O
A,O,O
short,O,O
sequence,O,O
surrounding,O,O
the,O,O
major,O,O
JNK,B,B
phosphorylation,O,O
site,O,O
of,O,O
c,B,O
-,I,O
Jun,I,O
is,O,O
conserved,O,O
in,O,O
c,B,O
-,I,O
Fos,I,O
and,O,O
is,O,O
part,O,O
of,O,O
its,O,O
activation,O,O
domain,O,O
",",O,O
suggesting,O,O
that,O,O
c,B,O
-,I,O
Fos,I,O
may,O,O
be,O,O
similarly,O,O
regulated,O,O
.,O,O
Essential,O,O
features,O,O
of,O,O
this,O,O
model,O,O
are,O,O
bending,O,O
of,O,O
the,O,O
DNA,O,B
double,O,I
helix,O,I
and,O,O
contact,O,O
of,O,O
operator,O,O
sites,O,O
with,O,O
repressor,O,O
domains,O,O
bearing,O,O
sequence,O,O
homologies,O,O
with,O,O
the,O,O
helix,O,B
-,O,I
turn,O,I
-,O,I
helix,O,I
(,O,O
HTH,O,B
),O,O
motifs,O,O
of,O,O
other,O,O
DNA,O,B
-,O,I
binding,O,I
proteins,O,I
.,O,O
Staphylococcal,B,O
enterotoxin,I,O
A,I,O
involvement,O,O
in,O,O
the,O,O
illness,O,O
of,O,O
a,O,O
20,O,O
-,O,O
month,O,O
-,O,O
old,O,O
burn,O,O
patient,O,O
.,O,O
The,O,O
variable,O,O
phenotype,O,O
of,O,O
the,O,O
allotetraploids,O,O
could,O,O
not,O,O
be,O,O
explained,O,O
by,O,O
cytological,O,O
abnormalities,O,O
.,O,O
In,O,O
HCMV,O,B
(,O,O
Towne,O,O
),O,O
HF,O,O
cells,O,O
at,O,O
24,O,O
to,O,O
48,O,O
h,O,O
",",O,O
IE2,B,B
also,O,O
accumulated,O,O
in,O,O
newly,O,O
formed,O,O
viral,O,O
DNA,O,O
replication,O,O
compartments,O,O
containing,O,O
the,O,O
polymerase,B,O
processivity,I,O
factor,I,O
(,O,O
UL44,B,B
),O,O
",",O,O
the,O,O
single,B,O
-,I,O
stranded,I,O
DNA,I,O
binding,I,O
protein,I,O
(,O,O
SSB,B,B
;,O,O
UL57,B,B
),O,O
",",O,O
the,O,O
UL112,B,B
-,I,I
113,I,I
accessory,I,I
protein,I,I
",",O,O
and,O,O
newly,O,O
incorporated,O,O
bromodeoxyuridine,O,O
(,O,O
BrdU,O,B
),O,O
.,O,O
We,O,O
have,O,O
followed,O,O
37,O,O
phenytoin,O,O
-,O,O
treated,O,O
patients,O,O
with,O,O
reduced,O,O
serum,B,O
IgA,I,B
concentrations,O,O
for,O,O
2,O,O
-,O,O
7,O,O
years,O,O
.,O,O
Identification,O,O
of,O,O
mutations,O,O
in,O,O
the,O,O
coding,O,O
sequence,O,O
of,O,O
the,O,O
proto,B,O
-,I,O
oncogene,I,O
c,I,B
-,I,I
kit,I,I
in,O,O
a,O,O
human,O,O
mast,O,O
cell,O,O
leukemia,O,O
cell,O,O
line,O,O
causing,O,O
ligand,O,O
-,O,O
independent,O,O
activation,O,O
of,O,O
c,B,B
-,I,I
kit,I,I
product,I,O
.,O,O
During,O,O
the,O,O
years,O,O
1980,O,O
-,O,O
87,O,O
a,O,O
total,O,O
of,O,O
287,O,O
persons,O,O
received,O,O
disability,O,O
pensions,O,O
in,O,O
the,O,O
municipality,O,O
of,O,O
Nordreisa,O,O
in,O,O
northern,O,O
Norway,O,O
.,O,O
A,O,O
method,O,O
for,O,O
establishing,O,O
stimulus,O,O
control,O,O
of,O,O
ethanol,O,B
responding,O,O
was,O,O
developed,O,O
.,O,O
Three,O,O
classes,O,O
of,O,O
test,O,O
objects,O,O
were,O,O
considered,O,O
:,O,O
(,O,O
1,O,O
),O,O
a,O,O
multicompartment,O,O
test,O,O
object,O,O
for,O,O
31P,O,O
MRS,O,O
measurements,O,O
performed,O,O
with,O,O
slice,O,O
-,O,O
selective,O,O
sequences,O,O
;,O,O
(,O,O
2,O,O
),O,O
a,O,O
two,O,O
-,O,O
compartment,O,O
test,O,O
object,O,O
for,O,O
volume,O,O
-,O,O
selection,O,O
1H,O,O
MRS,O,O
;,O,O
and,O,O
(,O,O
3,O,O
),O,O
two,O,O
-,O,O
compartment,O,O
test,O,O
objects,O,O
for,O,O
assessing,O,O
the,O,O
performance,O,O
of,O,O
experimental,O,O
systems,O,O
using,O,O
ISIS,O,B
as,O,O
volume,O,O
localization,O,O
sequence,O,O
in,O,O
31P,O,O
MRS,O,O
.,O,O
Airflow,O,O
through,O,O
the,O,O
dust,O,O
trap,O,O
was,O,O
controlled,O,O
with,O,O
a,O,O
vacuum,O,O
pump,O,O
.,O,O
Moreover,O,O
",",O,O
Lck,B,B
was,O,O
reversibly,O,O
co,O,O
-,O,O
immunoprecipitated,O,O
with,O,O
p95Vav,B,O
",",O,O
and,O,O
the,O,O
stoichiometry,O,O
of,O,O
binding,O,O
increased,O,O
in,O,O
anti,B,O
-,I,O
CD3,I,O
-,O,O
treated,O,O
Jurkat,O,O
cells,O,O
.,O,O
The,O,O
binding,O,O
of,O,O
PH,B,O
domains,I,O
to,O,O
Gbetagamma,B,O
was,O,O
inhibited,O,O
by,O,O
preincubation,O,O
of,O,O
Gbetagamma,B,O
with,O,O
the,O,O
GDP,O,O
-,O,O
bound,O,O
but,O,O
not,O,O
the,O,O
GTP,O,O
-,O,O
bound,O,O
form,O,O
of,O,O
Gialpha,B,O
.,O,O
A,O,O
mutation,O,O
in,O,O
the,O,O
C,O,B
domain,O,I
of,O,I
Rb,B,B
",",O,O
L901Q,O,B
",",O,O
has,O,O
been,O,O
identified,O,O
that,O,O
completely,O,O
abolishes,O,O
cdk4,B,B
/,O,I
D1,B,I
phosphorylation,O,O
of,O,O
the,O,O
isolated,O,O
C,O,B
domain,O,I
.,O,O
The,O,O
highly,O,O
amyloidogenic,O,O
42,O,O
-,O,O
residue,O,O
form,O,O
of,O,O
Abeta,B,B
(,O,O
Abeta42,B,B
),O,O
is,O,O
the,O,O
first,O,O
species,O,O
to,O,O
be,O,O
deposited,O,O
in,O,O
both,O,O
sporadic,O,O
and,O,O
familial,O,O
AD,O,O
.,O,O
A,O,O
strong,O,O
trithorax,B,B
binding,I,I
site,I,I
was,O,O
found,O,O
at,O,O
the,O,O
cytological,O,O
location,O,O
of,O,O
the,O,O
fork,B,O
head,I,O
gene,I,O
",",O,O
a,O,O
region,O,O
-,O,O
specific,O,O
homeotic,B,O
gene,I,O
not,O,O
located,O,O
within,O,O
a,O,O
homeotic,B,O
complex,I,O
.,O,O
Copyright,O,O
2000,O,O
John,O,B
Wiley,O,I
&,O,I
Sons,O,I
",",O,O
Ltd,O,O
.,O,O
Protein,B,O
kinase,I,O
A,I,O
-,I,O
Ialpha,I,B
subunit,O,I
-,O,I
directed,O,O
antisense,O,O
inhibition,O,O
of,O,O
ovarian,O,O
cancer,O,O
cell,O,O
growth,O,O
:,O,O
crosstalk,O,O
with,O,O
tyrosine,B,O
kinase,I,O
signaling,O,O
pathway,O,O
.,O,O
This,O,O
short,O,O
communication,O,O
compares,O,O
a,O,O
novel,O,O
fluorimetric,O,O
microplate,O,O
enzyme,O,O
immunoassay,O,O
(,O,O
FEIA,O,O
),O,O
with,O,O
a,O,O
commercial,O,O
time,O,O
-,O,O
resolved,O,O
fluoroimmunoassay,O,O
for,O,O
the,O,O
determination,O,O
of,O,O
thyrotropin,B,O
in,O,O
dried,O,O
blood,O,O
spots,O,O
.,O,O
One,O,O
of,O,O
these,O,O
factors,O,O
",",O,O
HRF,B,B
-,I,I
1,I,I
",",O,O
recognizes,O,O
a,O,O
cis,O,O
element,O,O
consisting,O,O
of,O,O
an,O,O
inverted,O,O
palindromic,O,O
motif,O,O
.,O,O
The,O,O
regulation,O,O
of,O,O
PGHS,B,B
-,I,I
2,I,I
mRNA,I,O
and,O,O
protein,O,O
was,O,O
studied,O,O
in,O,O
primary,O,O
cultures,O,O
of,O,O
bovine,O,O
uterine,O,O
stromal,O,O
cells,O,O
stimulated,O,O
with,O,O
phorbol,O,O
12,O,O
-,O,O
myristate,O,O
13,O,O
-,O,O
acetate,O,O
(,O,O
PMA,O,O
;,O,O
100,O,O
nM,O,O
),O,O
.,O,O
Because,O,O
the,O,O
DPPD,B,B
gene,I,O
is,O,O
not,O,O
present,O,O
in,O,O
non,O,O
-,O,O
tuberculous,O,O
bacilli,O,O
",",O,O
these,O,O
results,O,O
suggest,O,O
that,O,O
this,O,O
molecule,O,O
can,O,O
be,O,O
an,O,O
additional,O,O
tool,O,O
for,O,O
a,O,O
more,O,O
specific,O,O
diagnosis,O,O
of,O,O
tuberculosis,O,O
.,O,O
Using,O,O
PRL,B,B
-,I,I
R,I,I
tagged,O,O
both,O,O
in,O,O
the,O,O
N,O,B
-,O,I
terminal,O,I
or,O,O
C,O,B
-,O,I
terminal,O,I
regions,O,O
of,O,O
the,O,O
mature,O,O
receptor,O,O
excludes,O,O
the,O,O
possibility,O,O
of,O,O
a,O,O
cleaved,O,O
fragment,O,O
which,O,O
could,O,O
have,O,O
been,O,O
subsequently,O,O
imported,O,O
into,O,O
the,O,O
nucleus,O,O
.,O,O
Double,O,O
mutant,O,O
analysis,O,O
suggests,O,O
that,O,O
Rad54p,B,B
and,O,O
Mus81p,B,B
act,O,O
in,O,O
one,O,O
pathway,O,O
for,O,O
the,O,O
repair,O,O
of,O,O
",",O,O
or,O,O
tolerance,O,O
to,O,O
",",O,O
UV,O,O
-,O,O
induced,O,O
DNA,O,O
damage,O,O
.,O,O
Furthermore,O,O
",",O,O
we,O,O
demonstrated,O,O
that,O,O
Galpha11,B,B
Q209L,I,I
stimulated,O,O
Src,B,B
family,I,I
kinase,O,I
activity,O,O
and,O,O
induced,O,O
tyrosine,O,O
phosphorylation,O,O
of,O,O
several,O,O
proteins,O,O
in,O,O
HEK,O,O
-,O,O
293,O,O
cells,O,O
.,O,O
The,O,O
similar,O,O
phenotypes,O,O
of,O,O
bur6,B,B
and,O,O
bur3,B,B
(,O,O
mot1,B,I
),O,O
mutations,O,O
suggest,O,O
that,O,O
Bur6p,B,B
and,O,O
Mot1p,B,B
have,O,O
related,O,O
",",O,O
but,O,O
not,O,O
identical,O,O
",",O,O
functions,O,O
in,O,O
modulating,O,O
the,O,O
activity,O,O
of,O,O
the,O,O
general,O,O
transcription,O,O
machinery,O,O
in,O,O
vivo,O,O
.,O,O
Sp1,B,B
binds,O,O
two,O,O
sites,O,O
in,O,O
the,O,O
CD11c,B,B
promoter,I,O
in,O,O
vivo,O,O
specifically,O,O
in,O,O
myeloid,O,O
cells,O,O
and,O,O
cooperates,O,O
with,O,O
AP1,B,B
to,O,O
activate,O,O
transcription,O,O
.,O,O
An,O,O
additional,O,O
9,O,O
patients,O,O
achieved,O,O
normal,O,O
levels,O,O
with,O,O
adjunctive,O,O
drug,O,O
therapy,O,O
.,O,O
Small,B,O
Maf,I,B
proteins,I,O
heterodimerize,O,O
with,O,O
Fos,B,B
and,O,O
may,O,O
act,O,O
as,O,O
competitive,O,O
repressors,O,O
of,O,O
the,O,O
NF,B,B
-,I,I
E2,I,I
transcription,I,O
factor,I,O
.,O,O
The,O,O
isolated,O,O
POT1,B,B
clones,O,O
hybridized,O,O
to,O,O
a,O,O
1,O,O
.,O,O
4,O,O
kb,O,O
RNA,O,O
species,O,O
",",O,O
which,O,O
was,O,O
induced,O,O
approximately,O,O
30,O,O
-,O,O
fold,O,O
when,O,O
oleate,O,O
was,O,O
the,O,O
carbon,O,O
source,O,O
.,O,O
TcPO2,O,O
measurement,O,O
appears,O,O
to,O,O
be,O,O
a,O,O
reliable,O,O
technique,O,O
that,O,O
can,O,O
influence,O,O
ischaemic,O,O
ulcer,O,O
management,O,O
.,O,O
As,O,O
a,O,O
part,O,O
of,O,O
a,O,O
large,O,O
examination,O,O
",",O,O
total,O,O
and,O,O
free,O,O
serum,O,O
cholesterol,O,O
",",O,O
total,O,O
lipid,O,O
and,O,O
triglyceride,O,O
levels,O,O
were,O,O
determined,O,O
.,O,O
In,O,O
the,O,O
10,O,O
patients,O,O
with,O,O
a,O,O
more,O,O
severe,O,O
degree,O,O
of,O,O
steatorrhea,O,O
the,O,O
decrease,O,O
in,O,O
fat,O,O
loss,O,O
approached,O,O
20,O,O
%,O,O
and,O,O
a,O,O
close,O,O
relationship,O,O
was,O,O
found,O,O
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
84,O,O
",",O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
01,O,O
),O,O
between,O,O
the,O,O
extent,O,O
of,O,O
the,O,O
fatty,O,O
acid,O,O
loss,O,O
on,O,O
placebo,O,O
and,O,O
the,O,O
decrease,O,O
of,O,O
this,O,O
loss,O,O
on,O,O
taurine,O,O
.,O,O
Naltrexone,O,B
hydrochloride,O,I
is,O,O
a,O,O
synthetic,O,O
opioid,B,O
receptor,I,O
antagonist,O,O
recently,O,O
used,O,O
in,O,O
efforts,O,O
to,O,O
provide,O,O
rapid,O,O
opioid,O,O
detoxification,O,O
.,O,O
Uses,O,O
of,O,O
orthoclone,O,B
OKT3,O,I
for,O,O
prophylaxis,O,O
of,O,O
rejection,O,O
and,O,O
induction,O,O
in,O,O
initial,O,O
nonfunction,O,O
in,O,O
kidney,O,O
transplantation,O,O
.,O,O
Uses,O,O
of,O,O
orthoclone,O,B
OKT3,B,I
for,O,O
prophylaxis,O,O
of,O,O
rejection,O,O
and,O,O
induction,O,O
in,O,O
initial,O,O
nonfunction,O,O
in,O,O
kidney,O,O
transplantation,O,O
.,O,O
Genomic,O,O
DNA,O,O
hybridization,O,O
suggests,O,O
that,O,O
SpSHR2,B,B
is,O,O
a,O,O
single,O,O
-,O,O
copy,O,O
gene,O,O
in,O,O
the,O,O
S,O,O
.,O,O
purpuratus,O,O
genome,O,O
.,O,O
We,O,O
concluded,O,O
that,O,O
activation,O,O
of,O,O
c,B,O
-,I,O
fosER,I,O
mediated,O,O
transcriptional,O,O
inhibition,O,O
of,O,O
p21,B,O
(,O,O
Cip1,B,B
/,O,I
WAF1,B,I
),O,O
through,O,O
a,O,O
previously,O,O
uncharacterized,O,O
AP,B,O
-,I,O
1,I,O
site,I,O
",",O,O
revealing,O,O
an,O,O
important,O,O
role,O,O
for,O,O
c,B,O
-,I,O
fos,I,O
in,O,O
negative,O,O
control,O,O
of,O,O
cell,O,O
cycle,O,O
regulatory,O,O
genes,O,O
.,O,O
Treatment,O,O
of,O,O
ischemic,O,O
heart,O,O
disease,O,O
in,O,O
the,O,O
elderly,O,O
An,O,O
inactive,O,O
analog,O,O
of,O,O
wortmannin,O,O
",",O,O
WM12,O,O
",",O,O
did,O,O
not,O,O
affect,O,O
TCR,B,O
/,O,O
CD3,B,O
-,O,O
induced,O,O
Erk2,B,B
activation,O,O
",",O,O
and,O,O
wortmannin,O,O
had,O,O
no,O,O
effect,O,O
on,O,O
the,O,O
activity,O,O
of,O,O
Erk2,B,B
when,O,O
added,O,O
directly,O,O
to,O,O
the,O,O
in,O,O
vitro,O,O
assays,O,O
.,O,O
There,O,O
were,O,O
no,O,O
interfering,O,O
peaks,O,O
in,O,O
the,O,O
quantitation,O,O
of,O,O
sulbactam,O,O
.,O,O
A,O,O
larval,B,O
albumin,I,O
-,I,O
like,I,O
protein,I,O
was,O,O
not,O,O
detectable,O,O
by,O,O
silver,O,O
staining,O,O
in,O,O
serum,O,O
of,O,O
tadpoles,O,O
before,O,O
the,O,O
beginning,O,O
of,O,O
metamorphosis,O,O
at,O,O
stage,O,O
48,O,O
.,O,O
Western,O,O
blotting,O,O
(,O,O
immunoblotting,O,O
),O,O
with,O,O
an,O,O
antiserum,O,O
to,O,O
a,O,O
partial,O,O
SOD,B,B
expressed,O,O
in,O,O
Escherichia,O,B
coli,O,I
revealed,O,O
two,O,O
proteins,O,O
with,O,O
estimated,O,O
molecular,O,O
masses,O,O
of,O,O
19,O,O
and,O,O
29,O,O
kDa,O,O
.,O,O
The,O,O
mouse,B,B
M,I,I
-,I,I
lysozyme,I,I
downstream,I,I
enhancer,I,I
has,O,O
been,O,O
previously,O,O
characterized,O,O
on,O,O
several,O,O
levels,O,O
of,O,O
gene,O,O
regulation,O,O
.,O,O
The,O,O
above,O,O
results,O,O
mean,O,O
that,O,O
the,O,O
increase,O,O
in,O,O
alpha,B,O
-,I,O
adrenergic,I,O
receptors,I,O
makes,O,O
the,O,O
prostate,O,O
",",O,O
which,O,O
has,O,O
been,O,O
already,O,O
hypertrophied,O,O
",",O,O
less,O,O
elastic,O,O
",",O,O
inhibiting,O,O
external,O,O
urinary,O,O
sphincter,O,O
function,O,O
.,O,O
Sweet,O,O
oranges,O,O
",",O,O
mandarin,O,O
",",O,O
grapefruit,O,O
",",O,O
lemon,O,O
",",O,O
and,O,O
lime,O,O
are,O,O
generally,O,O
used,O,O
for,O,O
processing,O,O
.,O,O
Plasmids,O,O
were,O,O
constructed,O,O
with,O,O
the,O,O
mouse,O,B
promoter,O,I
region,O,I
linked,O,O
to,O,O
the,O,O
reporter,B,O
gene,I,O
chloramphenicol,I,B
acetyltransferase,I,I
(,O,I
CAT,B,I
),O,O
",",O,O
and,O,O
transiently,O,O
and,O,O
stably,O,O
transfected,O,O
in,O,O
the,O,O
INS,O,B
-,O,I
1,O,I
cells,O,O
.,O,O
These,O,O
results,O,O
are,O,O
very,O,O
useful,O,O
for,O,O
deciding,O,O
on,O,O
the,O,O
doses,O,O
of,O,O
hormones,O,O
and,O,O
the,O,O
expected,O,O
serum,O,O
estradiol,O,O
level,O,O
in,O,O
HRT,O,O
for,O,O
Japanese,O,O
women,O,O
.,O,O
Hypothermia,O,O
After,O,O
Cardiac,O,O
Arrest,O,O
(,O,O
HACA,O,B
),O,O
Study,O,O
Group,O,O
.,O,O
TRAF2,B,B
is,O,O
known,O,O
to,O,O
associate,O,O
with,O,O
TRADD,B,O
",",O,O
and,O,O
expression,O,O
of,O,O
a,O,O
dominant,O,O
-,O,O
negative,O,O
N,O,O
-,O,O
terminal,O,O
deletion,O,O
TRAF2,B,B
mutant,I,O
was,O,O
found,O,O
to,O,O
partially,O,O
inhibit,O,O
LMP1,B,O
-,O,O
induced,O,O
JNK,B,B
activation,O,O
in,O,O
293,O,O
cells,O,O
.,O,O
Lung,O,O
function,O,O
tests,O,O
(,O,O
EFR,O,O
),O,O
were,O,O
performed,O,O
on,O,O
these,O,O
patients,O,O
for,O,O
a,O,O
period,O,O
of,O,O
19,O,O
.,O,O
2,O,O
+,O,O
/,O,O
-,O,O
3,O,O
.,O,O
4,O,O
months,O,O
.,O,O
RESULTS,O,O
:,O,O
Factors,O,O
associated,O,O
with,O,O
significantly,O,O
(,O,O
P,O,O
<,O,O
.,O,O
05,O,O
),O,O
increased,O,O
risk,O,O
of,O,O
treatment,O,O
failure,O,O
in,O,O
a,O,O
Cox,O,O
multivariate,O,O
analysis,O,O
included,O,O
age,O,O
older,O,O
than,O,O
45,O,O
years,O,O
(,O,O
relative,O,O
hazard,O,O
",",O,O
1,O,O
.,O,O
17,O,O
;,O,O
95,O,O
%,O,O
confidence,O,O
interval,O,O
[,O,O
CI,O,O
],O,O
-,O,O
1,O,O
.,O,O
33,O,O
),O,O
performance,O,O
score,O,O
less,O,O
than,O,O
90,O,O
%,O,O
(,O,O
1,O,O
.,O,O
27,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
1,O,O
.,O,O
07,O,O
-,O,O
1,O,O
.,O,O
51,O,O
),O,O
",",O,O
absence,O,O
of,O,O
hormone,O,O
receptors,O,O
(,O,O
1,O,O
.,O,O
31,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
1,O,O
.,O,O
15,O,O
(,O,O
1,O,O
.,O,O
31,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
1,O,O
.,O,O
10,O,O
-,O,O
1,O,O
.,O,O
56,O,O
),O,O
",",O,O
initial,O,O
disease,O,O
-,O,O
free,O,O
survival,O,O
interval,O,O
after,O,O
adjuvant,O,O
treatment,O,O
of,O,O
no,O,O
more,O,O
than,O,O
18,O,O
months,O,O
(,O,O
1,O,O
.,O,O
99,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
1,O,O
.,O,O
62,O,O
-,O,O
2,O,O
.,O,O
43,O,O
),O,O
",",O,O
metastases,O,O
in,O,O
the,O,O
liver,O,O
(,O,O
1,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
1,O,O
.,O,O
20,O,O
-,O,O
1,O,O
.,O,O
80,O,O
),O,O
or,O,O
central,O,O
nervous,O,O
system,O,O
(,O,O
1,O,O
.,O,O
56,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
0,O,O
.,O,O
99,O,O
-,O,O
2,O,O
.,O,O
46,O,O
[,O,O
approaches,O,O
significance,O,O
],O,O
),O,O
vs,O,O
soft,O,O
tissue,O,O
",",O,O
bone,O,O
",",O,O
or,O,O
lung,O,O
",",O,O
3,O,O
or,O,O
more,O,O
sites,O,O
of,O,O
metastatic,O,O
disease,O,O
(,O,O
1,O,O
.,O,O
32,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
1,O,O
.,O,O
13,O,O
-,O,O
1,O,O
.,O,O
54,O,O
),O,O
response,O,O
vs,O,O
complete,O,O
response,O,O
to,O,O
standard,O,O
-,O,O
dose,O,O
chemotherapy,O,O
(,O,O
1,O,O
.,O,O
65,O,O
;,O,O
95,O,O
%,O,O
CI,O,O
",",O,O
1,O,O
.,O,O
36,O,O
-,O,O
1,O,O
.,O,O
99,O,O
),O,O
.,O,O
A,O,O
contiguous,O,O
and,O,O
sequentially,O,O
occupied,O,O
secondary,O,O
Fur,B,B
-,I,I
binding,I,I
site,I,I
in,O,O
entC,B,B
was,O,O
protected,O,O
at,O,O
higher,O,O
Fur,B,B
concentrations,O,O
",",O,O
extending,O,O
the,O,O
protected,O,O
region,O,O
to,O,O
+,O,O
49,O,O
",",O,O
and,O,O
sequestering,O,O
the,O,O
putative,O,O
Shine,O,B
-,O,I
Dalgarno,O,I
sequence,O,I
.,O,O
As,O,O
a,O,O
result,O,O
",",O,O
beta,O,B
-,O,I
apo,O,I
-,O,I
8,O,I
',O,I
-,O,I
carotenoic,O,I
acid,O,I
ethyl,O,I
ester,O,I
(,O,O
apo,O,B
-,O,I
EE,O,I
),O,O
was,O,O
used,O,O
as,O,O
a,O,O
reference,O,O
standard,O,O
in,O,O
Experiments,O,O
4,O,O
to,O,O
6,O,O
.,O,O
The,O,O
evidence,O,O
in,O,O
support,O,O
of,O,O
this,O,O
was,O,O
derived,O,O
from,O,O
the,O,O
fact,O,O
that,O,O
the,O,O
affinity,O,O
or,O,O
interaction,O,O
between,O,O
the,O,O
two,O,O
subunits,O,O
was,O,O
impaired,O,O
as,O,O
indicated,O,O
by,O,O
the,O,O
first,O,O
order,O,O
rate,O,O
constant,O,O
of,O,O
hCG,B,B
alpha,I,I
1,I,I
beta,I,I
(,O,O
km,O,O
=,O,O
4,O,O
.,O,O
1,O,O
x,O,O
10,O,O
(,O,O
-,O,O
2,O,O
),O,O
min,O,O
-,O,O
1,O,O
),O,O
at,O,O
pH,O,O
3,O,O
.,O,O
0,O,O
at,O,O
23,O,O
degrees,O,O
C,O,O
which,O,O
is,O,O
one,O,O
order,O,O
of,O,O
magnitude,O,O
greater,O,O
relative,O,O
to,O,O
rehCG,B,O
(,O,O
kw,O,O
=,O,O
4,O,O
.,O,O
6,O,O
x,O,O
10,O,O
(,O,O
-,O,O
3,O,O
),O,O
min,O,O
-,O,O
1,O,O
),O,O
.,O,O
The,O,O
differential,O,O
diagnosis,O,O
of,O,O
both,O,O
affections,O,O
is,O,O
based,O,O
on,O,O
the,O,O
clinical,O,O
course,O,O
",",O,O
sialography,O,O
and,O,O
CT,O,O
examination,O,O
which,O,O
along,O,O
with,O,O
modern,O,O
ATB,O,O
treatment,O,O
significantly,O,O
modify,O,O
hitherto,O,O
used,O,O
surgical,O,O
therapy,O,O
.,O,O
To,O,O
identify,O,O
nuclear,O,O
regulatory,O,O
factors,O,O
",",O,O
we,O,O
have,O,O
located,O,O
and,O,O
functionally,O,O
characterized,O,O
the,O,O
CCR5,B,B
gene,I,I
promoter,I,O
.,O,O
A,O,O
single,O,O
NMSC,O,O
was,O,O
present,O,O
in,O,O
69,O,O
.,O,O
4,O,O
%,O,O
",",O,O
two,O,O
in,O,O
16,O,O
%,O,O
",",O,O
three,O,O
in,O,O
6,O,O
.,O,O
4,O,O
%,O,O
",",O,O
four,O,O
in,O,O
3,O,O
.,O,O
5,O,O
%,O,O
",",O,O
five,O,O
to,O,O
nine,O,O
in,O,O
4,O,O
.,O,O
2,O,O
%,O,O
",",O,O
and,O,O
0,O,O
.,O,O
5,O,O
%,O,O
had,O,O
ten,O,O
or,O,O
more,O,O
.,O,O
Epstein,B,B
-,I,I
Barr,I,I
virus,I,I
-,I,I
encoded,I,I
latent,I,I
membrane,I,I
protein,I,I
1,I,I
activates,O,O
the,O,O
JNK,B,B
pathway,O,I
through,O,O
its,O,O
extreme,O,O
C,O,O
terminus,O,O
via,O,O
a,O,O
mechanism,O,O
involving,O,O
TRADD,B,B
and,O,O
TRAF2,B,B
.,O,O
OBJECTIVES,O,O
:,O,O
The,O,O
objective,O,O
of,O,O
this,O,O
review,O,O
was,O,O
to,O,O
assess,O,O
the,O,O
effects,O,O
of,O,O
prophylactic,O,O
prostaglandin,O,O
use,O,O
in,O,O
the,O,O
third,O,O
stage,O,O
of,O,O
labour,O,O
.,O,O
Successful,O,O
use,O,O
of,O,O
transureteroureterostomy,O,O
to,O,O
salvage,O,O
ureterosigmoidostomy,O,O
after,O,O
anastomotic,O,O
failure,O,O
.,O,O
Analysis,O,O
of,O,O
promoter,O,O
and,O,O
androgen,O,B
regulatory,O,I
sequences,O,O
required,O,O
for,O,O
optimal,O,O
transcription,O,O
of,O,O
the,O,O
rat,O,O
androgen,B,B
-,I,I
binding,I,I
protein,I,I
gene,O,O
.,O,O
Botulinum,B,O
toxin,I,O
:,O,O
preferred,O,O
treatment,O,O
for,O,O
hemifacial,O,O
spasm,O,O
.,O,O
25,O,O
-,O,O
OH,O,O
-,O,O
D3,O,O
did,O,O
not,O,O
adversely,O,O
affect,O,O
animal,O,O
health,O,O
at,O,O
the,O,O
proposed,O,O
use,O,O
level,O,O
of,O,O
99,O,O
micrograms,O,O
/,O,O
kg,O,O
feed,O,O
when,O,O
replacing,O,O
vitamin,O,O
D3,O,O
in,O,O
turkey,O,O
rations,O,O
.,O,O
The,O,O
other,O,O
transmembrane,O,O
regions,O,O
as,O,O
well,O,O
as,O,O
the,O,O
nucleoplasmic,O,O
domain,O,O
are,O,O
not,O,O
required,O,O
for,O,O
sorting,O,O
.,O,O
During,O,O
organogenesis,O,O
",",O,O
HFH,B,B
-,I,I
8,I,I
expression,O,O
is,O,O
found,O,O
in,O,O
the,O,O
splanchnic,O,O
mesoderm,O,O
in,O,O
close,O,O
apposition,O,O
of,O,O
the,O,O
gut,O,O
endoderm,O,O
",",O,O
suggesting,O,O
a,O,O
role,O,O
in,O,O
mesenchymal,O,O
-,O,O
epithelial,O,O
induction,O,O
of,O,O
lung,O,O
and,O,O
gut,O,O
morphogenesis,O,O
.,O,O
Angiotensin,B,B
II,I,I
induces,O,O
nuclear,B,O
factor,I,O
(,I,O
NF,I,B
),I,O
-,I,O
kappaB1,I,O
isoforms,I,O
to,O,O
bind,O,O
the,O,O
angiotensinogen,B,B
gene,I,O
acute,O,O
-,O,O
phase,O,O
response,O,O
element,O,O
:,O,O
a,O,O
stimulus,O,O
-,O,O
specific,O,O
pathway,O,O
for,O,O
NF,B,B
-,I,O
kappaB,I,I
activation,O,O
.,O,O
Furthermore,O,O
",",O,O
this,O,O
kinase,O,O
-,O,O
deficient,O,O
mutant,O,O
inhibited,O,O
2,O,O
-,O,O
MeSADP,O,O
-,O,O
induced,O,O
caspase,B,O
-,I,O
3,I,O
stimulation,O,O
and,O,O
the,O,O
associated,O,O
decrease,O,O
in,O,O
cell,O,O
number,O,O
.,O,O
C,B,O
/,I,O
EBPbeta,I,B
LIP,I,I
overexpressing,O,O
HC11,O,B
cells,O,O
did,O,O
not,O,O
express,O,O
beta,B,B
-,I,I
casein,I,I
mRNA,I,O
(,O,O
mammary,O,O
epithelial,O,O
cell,O,O
differentiation,O,O
marker,O,O
),O,O
in,O,O
response,O,O
to,O,O
lactogenic,O,O
hormones,O,O
.,O,O
Bacteria,O,O
can,O,O
also,O,O
cause,O,O
a,O,O
labyrinthitis,O,O
acting,O,O
directly,O,O
on,O,O
the,O,O
inner,O,O
ear,O,O
:,O,O
among,O,O
these,O,O
",",O,O
Treponemas,O,B
Pallidum,O,I
",",O,O
a,O,O
spirochaete,O,O
which,O,O
causes,O,O
syphilis,O,O
and,O,O
Borrelia,O,B
Burgdorferi,O,I
",",O,O
a,O,O
spirochaete,O,O
that,O,O
causes,O,O
Lyme,O,O
Disease,O,O
",",O,O
must,O,O
be,O,O
mentioned,O,O
.,O,O
Factor,B,O
VIII,I,B
procoagulant,O,O
activity,O,O
",",O,O
antigen,O,O
concentration,O,O
and,O,O
von,B,B
Willebrand,I,I
activity,O,I
as,O,O
ristocetin,B,O
cofactor,I,O
were,O,O
determined,O,O
several,O,O
times,O,O
in,O,O
10,O,O
patients,O,O
with,O,O
DIC,O,O
.,O,O
The,O,O
git1,B,B
",",O,O
git3,B,B
",",O,O
git5,B,B
",",O,O
git7,B,B
",",O,O
git8,B,B
and,O,O
git10,B,B
genes,I,O
act,O,O
upstream,O,O
of,O,O
adenylate,B,O
cyclase,I,O
",",O,O
presumably,O,O
encoding,O,O
an,O,O
adenylate,B,O
cyclase,I,O
activation,O,O
pathway,O,O
.,O,O
Intravesical,O,O
chemotherapy,O,O
.,O,O
The,O,O
study,O,O
included,O,O
139,O,O
eyes,O,O
with,O,O
presumed,O,O
ocular,O,O
histoplasmosis,O,O
syndrome,O,O
(,O,O
POHS,O,B
),O,O
and,O,O
age,O,O
-,O,O
related,O,O
macular,O,O
degeneration,O,O
(,O,O
AMD,O,B
),O,O
.,O,O
HBB,O,B
concentration,O,O
in,O,O
the,O,O
fetuses,O,O
indicated,O,O
little,O,O
",",O,O
if,O,O
any,O,O
accumulation,O,O
.,O,O
In,O,O
a,O,O
heterologous,O,O
transcriptional,O,O
system,O,O
in,O,O
which,O,O
the,O,O
upstream,O,O
regions,O,O
of,O,O
oIFNtau,B,B
were,O,O
inserted,O,O
in,O,O
front,O,O
of,O,O
simian,B,O
virus,I,O
40,I,O
(,I,O
SV40,I,B
),I,O
promoter,I,O
",",O,O
the,O,O
regions,O,O
between,O,O
bases,O,O
-,O,O
654,O,O
and,O,O
-,O,O
555,O,O
were,O,O
determined,O,O
as,O,O
being,O,O
the,O,O
enhancer,O,O
region,O,O
required,O,O
for,O,O
oIFNtau,B,B
-,O,I
SV40,O,I
-,O,I
CAT,B,I
transactivation,O,O
.,O,O
RVEF,O,O
and,O,O
LVEF,O,O
both,O,O
increased,O,O
by,O,O
about,O,O
14,O,O
%,O,O
(,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
05,O,O
and,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
01,O,O
.,O,O
Consistent,O,O
with,O,O
the,O,O
hypothesis,O,O
that,O,O
it,O,O
acts,O,O
as,O,O
transcriptional,O,O
regulator,O,O
",",O,O
wild,B,O
-,I,O
type,I,O
p53,I,B
protein,I,O
binds,O,O
DNA,O,O
and,O,O
activates,O,O
transcription,O,O
of,O,O
several,O,O
promoters,O,O
.,O,O
To,O,O
search,O,O
for,O,O
transcriptional,O,O
regulators,O,O
",",O,O
we,O,O
used,O,O
a,O,O
fragment,O,O
of,O,O
the,O,O
SpHE,B,B
promoter,I,O
containing,O,O
several,O,O
individual,O,O
elements,O,O
instead,O,O
of,O,O
the,O,O
conventional,O,O
bait,O,O
that,O,O
contains,O,O
a,O,O
multimerized,O,O
cis,O,O
element,O,O
.,O,O
However,O,O
",",O,O
mandibular,O,O
position,O,O
(,O,O
S,O,B
-,O,I
N,O,I
-,O,I
B,O,I
and,O,O
S,O,B
-,O,I
N,O,I
-,O,I
Pog,O,I
),O,O
was,O,O
found,O,O
to,O,O
be,O,O
significantly,O,O
more,O,O
retrusive,O,O
in,O,O
Class,O,O
II,O,O
when,O,O
compared,O,O
with,O,O
Class,O,O
I,O,O
subjects,O,O
.,O,O
These,O,O
data,O,O
support,O,O
a,O,O
possible,O,O
biological,O,O
significance,O,O
of,O,O
the,O,O
frameshift,O,O
to,O,O
occur,O,O
at,O,O
this,O,O
position,O,O
of,O,O
the,O,O
large,O,O
overlap,O,O
by,O,O
including,O,O
the,O,O
putative,O,O
RNA,O,B
template,O,I
-,O,I
binding,O,I
site,O,I
of,O,O
the,O,O
PLRV,B,B
replicase,I,I
in,O,O
the,O,O
ORF2a,B,O
/,I,O
ORF2b,I,O
transframe,I,O
protein,I,O
.,O,O
Consequently,O,O
",",O,O
significant,O,O
differences,O,O
between,O,O
the,O,O
measured,O,O
and,O,O
calculated,O,O
methods,O,O
were,O,O
noted,O,O
in,O,O
oxygen,O,O
uptake,O,O
(,O,O
213,O,O
+,O,O
/,O,O
-,O,O
41,O,O
ml,O,O
/,O,O
min,O,O
vs,O,O
193,O,O
+,O,O
/,O,O
-,O,O
25,O,O
ml,O,O
/,O,O
min,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
",",O,O
oxygen,O,O
delivery,O,O
(,O,O
780,O,O
+,O,O
/,O,O
-,O,O
297,O,O
ml,O,O
/,O,O
min,O,O
vs,O,O
716,O,O
+,O,O
/,O,O
-,O,O
296,O,O
ml,O,O
/,O,O
min,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
",",O,O
and,O,O
cardiac,O,O
output,O,O
(,O,O
5,O,O
.,O,O
2,O,O
5,O,O
.,O,O
3,O,O
+,O,O
/,O,O
-,O,O
1,O,O
.,O,O
8,O,O
L,O,O
/,O,O
min,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
.,O,O
The,O,O
mRNAs,O,O
of,O,O
the,O,O
GRF,B,B
genes,I,O
are,O,O
encoded,O,O
by,O,O
six,O,O
exons,O,O
interrupted,O,O
by,O,O
five,O,O
introns,O,O
.,O,O
For,O,O
this,O,O
purpose,O,O
",",O,O
a,O,O
simple,O,O
respiration,O,O
-,O,O
control,O,O
device,O,O
has,O,O
been,O,O
developed,O,O
that,O,O
enables,O,O
the,O,O
patient,O,O
to,O,O
monitor,O,O
breath,O,O
-,O,O
holding,O,O
during,O,O
successive,O,O
scans,O,O
.,O,O
In,O,O
an,O,O
attempt,O,O
to,O,O
understand,O,O
Wee1,B,B
regulation,O,O
during,O,O
cell,O,O
cycle,O,O
",",O,O
yeast,O,O
two,O,O
-,O,O
hybrid,O,O
screening,O,O
was,O,O
used,O,O
to,O,O
identify,O,O
Wee1,B,B
-,I,I
binding,I,I
protein,I,I
(,I,O
s,I,O
),I,O
.,O,O
C,B,O
/,I,O
EBP,I,B
alpha,I,I
also,O,O
activates,O,O
the,O,O
promoter,O,O
of,O,O
the,O,O
rat,B,O
class,I,O
-,I,O
I,I,O
ADH,I,B
gene,I,O
in,O,O
a,O,O
sequence,O,O
-,O,O
specific,O,O
manner,O,O
[,O,O
Potter,O,O
et,O,O
al,O,O
.,O,O
",",O,O
Arch,O,O
.,O,O
C,B,O
/,I,O
EBP,I,B
alpha,I,I
also,O,O
activates,O,O
the,O,O
promoter,O,O
of,O,O
the,O,O
rat,B,O
class,I,O
-,I,O
I,I,O
ADH,I,B
gene,I,O
in,O,O
a,O,O
sequence,O,O
-,O,O
specific,O,O
manner,O,O
[,O,O
Potter,O,O
et,O,O
al,O,O
.,O,O
sites,O,O
were,O,O
used,O,O
",",O,O
one,O,O
at,O,O
the,O,O
end,O,O
of,O,O
the,O,O
early,B,O
(,I,O
E,I,B
),I,O
region,I,O
of,O,O
the,O,O
viral,O,O
DNA,O,O
",",O,O
the,O,O
other,O,O
at,O,O
the,O,O
end,O,O
of,O,O
the,O,O
late,B,O
(,I,O
L,I,B
),I,O
region,I,O
.,O,O
Examination,O,O
of,O,O
DNA,O,B
:,O,O
protein,O,O
binding,O,O
complexes,O,O
by,O,O
gel,O,O
-,O,O
shift,O,O
analysis,O,O
indicated,O,O
that,O,O
nuclear,O,O
factors,O,O
from,O,O
both,O,O
proliferative,O,O
and,O,O
growth,O,O
-,O,O
arrested,O,O
cells,O,O
bound,O,O
to,O,O
the,O,O
DNA,O,B
fragment,O,O
spanning,O,O
-,O,O
949,O,O
-,O,O
-,O,O
722,O,O
bp,O,O
.,O,O
A,O,O
new,O,O
vector,O,O
",",O,O
pHBK280,O,O
",",O,O
was,O,O
designed,O,O
to,O,O
facilitate,O,O
this,O,O
analysis,O,O
.,O,O
Our,O,O
results,O,O
confirm,O,O
the,O,O
participation,O,O
of,O,O
intron,O,O
1,O,O
in,O,O
transcriptional,O,O
regulation,O,O
of,O,O
the,O,O
c,B,O
-,I,O
myb,I,B
gene,I,O
(,O,O
in,O,O
mouse,O,O
and,O,O
human,O,B
),O,O
and,O,O
implicate,O,O
multiple,O,O
and,O,O
complex,O,O
regulatory,O,O
mechanisms,O,O
of,O,O
activation,O,O
during,O,O
myelomonocytic,O,O
differentiation,O,O
and,O,O
leukemic,O,O
cell,O,O
growth,O,O
control,O,O
.,O,O
This,O,O
TC,B,O
-,I,O
II,I,O
enhanson,I,O
",",O,O
which,O,O
is,O,O
identical,O,O
to,O,O
the,O,O
kappa,B,B
B,I,I
motif,I,I
from,O,O
the,O,O
kappa,B,B
chain,I,I
enhancer,I,I
",",O,O
was,O,O
active,O,O
in,O,O
both,O,O
lymphoid,O,O
and,O,O
non,O,O
-,O,O
lymphoid,O,O
cells,O,O
",",O,O
which,O,O
contrasts,O,O
with,O,O
the,O,O
previously,O,O
reported,O,O
lymphoid,O,O
cell,O,O
specificity,O,O
of,O,O
the,O,O
kappa,B,B
B,I,I
motif,I,I
.,O,O
50,O,O
kDa,O,O
and,O,O
130,O,O
-,O,O
170,O,O
kDa,O,O
were,O,O
detected,O,O
.,O,O
The,O,O
coefficient,O,O
of,O,O
determination,O,O
",",O,O
r2,O,O
",",O,O
of,O,O
the,O,O
other,O,O
scores,O,O
ranged,O,O
from,O,O
0,O,O
.,O,O
56,O,O
to,O,O
0,O,O
.,O,O
61,O,O
.,O,O
Mutations,O,O
in,O,O
the,O,O
nuclear,B,O
gene,I,B
CBP1,I,B
of,I,O
Saccharomyces,I,B
cerevisiae,I,I
result,O,O
in,O,O
degradation,O,O
of,O,O
mitochondrially,B,O
encoded,I,O
cytochrome,I,B
b,I,I
(,O,O
cob,B,B
),O,O
RNA,O,O
;,O,O
thus,O,O
",",O,O
the,O,O
cells,O,O
are,O,O
unable,O,O
to,O,O
respire,O,O
.,O,O
Plasma,B,O
secretin,I,O
",",O,O
pancreozymin,B,O
",",O,O
and,O,O
somatostatin,B,O
-,I,O
like,I,O
hormone,I,O
in,O,O
chronic,O,O
renal,O,O
failure,O,O
patients,O,O
.,O,O
DNase,B,O
I,I,O
genomic,O,O
footprinting,O,O
revealed,O,O
that,O,O
the,O,O
c,B,O
-,I,O
Myb,I,B
site,I,O
is,O,O
occupied,O,O
in,O,O
a,O,O
tissue,O,O
-,O,O
specific,O,O
fashion,O,O
in,O,O
vivo,O,O
.,O,O
Minor,O,O
differences,O,O
were,O,O
noted,O,O
with,O,O
latamoxef,O,B
producing,O,O
mild,O,O
persistant,O,O
elevation,O,O
of,O,O
prothrombin,B,B
time,O,I
(,O,O
0,O,O
.,O,O
7,O,O
second,O,O
),O,O
associated,O,O
with,O,O
depression,O,O
of,O,O
factor,B,B
II,I,I
and,O,O
factor,B,B
VII,I,I
.,O,O
A,O,O
deletion,O,O
series,O,O
of,O,O
the,O,O
5,O,O
',O,O
flanking,O,O
region,O,O
was,O,O
created,O,O
from,O,O
position,O,O
-,O,O
1329,O,O
to,O,O
-,O,O
74,O,O
relative,O,O
to,O,O
the,O,O
transcriptional,O,O
initiation,O,O
site,O,O
and,O,O
similarly,O,O
examined,O,O
in,O,O
transgenic,O,O
tobacco,O,O
.,O,O
Consistent,O,O
with,O,O
these,O,O
findings,O,O
",",O,O
relatively,O,O
weak,O,O
transcriptional,O,O
silencing,O,O
by,O,O
the,O,O
native,O,O
VDR,B,B
was,O,O
observed,O,O
using,O,O
the,O,O
osteopontin,B,B
VDRE,O,I
.,O,O
The,O,O
U17,B,B
/,O,I
U16,B,B
and,O,O
the,O,O
U16,B,B
+,I,I
gene,I,O
products,I,O
transactivated,O,O
the,O,O
HIV,B,B
LTR,I,I
.,O,O
We,O,O
conclude,O,O
that,O,O
",",O,O
in,O,O
comparison,O,O
to,O,O
reports,O,O
from,O,O
other,O,O
regions,O,O
",",O,O
Scandinavian,O,O
renal,O,O
transplant,O,O
recipients,O,O
are,O,O
at,O,O
high,O,O
risk,O,O
of,O,O
dying,O,O
of,O,O
IHD,O,B
.,O,O
Monospecific,O,O
antibodies,O,O
raised,O,O
against,O,O
rat,B,B
cytochrome,I,I
P,I,I
-,I,I
450,I,I
1A1,I,I
recognized,O,O
a,O,O
protein,O,O
in,O,O
the,O,O
hepatic,O,O
microsomes,O,O
of,O,O
the,O,O
double,O,O
-,O,O
crested,O,O
cormorant,O,O
",",O,O
and,O,O
also,O,O
in,O,O
those,O,O
of,O,O
the,O,O
great,O,O
blue,O,O
heron,O,O
(,O,O
Ardea,O,B
herodias,O,I
),O,O
",",O,O
using,O,O
immunoblotting,O,O
.,O,O
Implication,O,O
of,O,O
PAF,B,B
and,O,O
acetylhydrolase,B,O
(,O,O
PAF,B,B
-,I,I
AH,I,I
),O,O
activity,O,O
in,O,O
periodontal,O,O
disease,O,O
.,O,O
Botulinum,B,B
toxin,I,I
A,I,I
in,O,O
the,O,O
treatment,O,O
of,O,O
hemiplegic,O,O
spastic,O,O
foot,O,O
drop,O,O
-,O,O
-,O,O
clinical,O,O
and,O,O
functional,O,O
outcomes,O,O
.,O,O
Results,O,O
of,O,O
this,O,O
study,O,O
indicate,O,O
that,O,O
GLC,O,O
of,O,O
short,O,O
chain,O,O
fatty,O,O
acids,O,O
produced,O,O
on,O,O
agar,O,O
medium,O,O
by,O,O
anaerobes,O,O
",",O,O
combined,O,O
with,O,O
simple,O,O
tests,O,O
such,O,O
as,O,O
Gram,O,O
',O,O
s,O,O
stain,O,O
and,O,O
colonial,O,O
morphology,O,O
",",O,O
may,O,O
allow,O,O
fir,O,O
direct,O,O
presumptive,O,O
genus,O,O
identification,O,O
from,O,O
an,O,O
initial,O,O
pure,O,O
agar,O,O
culture,O,O
.,O,O
We,O,O
describe,O,O
a,O,O
novel,O,O
cytoplasmic,B,O
tyrosine,I,O
kinase,I,O
",",O,O
termed,O,O
BPK,B,B
(,O,O
B,B,B
cell,I,I
progenitor,I,I
kinase,I,I
),O,O
",",O,O
which,O,O
is,O,O
expressed,O,O
in,O,O
all,O,O
stages,O,O
of,O,O
the,O,O
B,O,B
lineage,O,I
and,O,O
in,O,O
myeloid,O,O
cells,O,O
.,O,O
The,O,O
enzyme,O,O
displays,O,O
optimal,O,O
activity,O,O
at,O,O
about,O,O
0,O,O
.,O,O
5,O,O
mM,O,O
pantoate,O,O
(,O,O
k,O,O
(,O,O
cat,O,O
),O,O
0,O,O
.,O,O
63,O,O
s,O,O
(,O,O
-,O,O
1,O,O
),O,O
pH,O,O
7,O,O
.,O,O
8,O,O
.,O,O
During,O,O
the,O,O
period,O,O
from,O,O
May,O,O
to,O,O
August,O,O
",",O,O
1978,O,O
",",O,O
an,O,O
epidemic,O,O
of,O,O
hand,O,O
",",O,O
foot,O,O
and,O,O
mouth,O,O
disease,O,O
(,O,O
HFMD,O,O
),O,O
occurred,O,O
in,O,O
Gifu,O,O
prefecture,O,O
.,O,O
The,O,O
interaction,O,O
between,O,O
piroxicam,O,B
and,O,O
poloxamer,O,B
was,O,O
studied,O,O
by,O,O
x,O,O
-,O,O
ray,O,O
diffractometry,O,O
(,O,O
XRD,O,O
),O,O
",",O,O
infrared,O,O
(,O,O
IR,O,O
),O,O
spectroscopy,O,O
and,O,O
differential,O,O
thermal,O,O
analysis,O,O
(,O,O
DTA,O,O
),O,O
with,O,O
a,O,O
solid,O,O
dispersion,O,O
",",O,O
coprecipitate,O,O
",",O,O
or,O,O
physical,O,O
mixture,O,O
.,O,O
RNase,B,O
protection,O,O
analysis,O,O
of,O,O
two,O,O
rRNA,O,B
fragments,O,O
whose,O,O
genes,O,O
are,O,O
adjacent,O,O
provided,O,O
evidence,O,O
for,O,O
a,O,O
polycistronic,O,O
transcript,O,O
containing,O,O
sequences,O,O
from,O,O
both,O,O
",",O,O
as,O,O
well,O,O
as,O,O
separate,O,O
small,O,O
RNAs,O,B
.,O,O
PATIENTS,O,O
AND,O,O
METHODS,O,O
:,O,O
We,O,O
report,O,O
our,O,O
experience,O,O
with,O,O
seven,O,O
children,O,O
with,O,O
active,O,O
small,O,O
bowel,O,O
Crohn,O,B
',O,I
s,O,I
disease,O,I
given,O,O
a,O,O
casein,B,O
-,O,O
based,O,O
",",O,O
polymeric,O,O
feed,O,O
rich,O,O
in,O,O
TGF,B,B
-,I,I
beta,I,I
2,I,I
(,O,O
Specific,O,O
Polymeric,O,O
Diet,O,O
;,O,O
Nestle,O,O
-,O,O
Clintec,O,O
;,O,O
Vevey,O,O
",",O,O
Switzerland,O,O
),O,O
as,O,O
complete,O,O
nutrition,O,O
for,O,O
8,O,O
weeks,O,O
.,O,O
Consistent,O,O
effects,O,O
on,O,O
pVHL,B,B
function,O,O
were,O,O
observed,O,O
for,O,O
all,O,O
mutations,O,O
within,O,O
each,O,O
subclass,O,O
.,O,O
Interestingly,O,O
",",O,O
the,O,O
interaction,O,O
of,O,O
ZAP,B,B
-,I,I
70,I,I
with,O,O
the,O,O
motif,O,O
was,O,O
dependent,O,O
on,O,O
the,O,O
presence,O,O
of,O,O
both,O,O
ZAP,B,B
-,I,I
70,I,I
SH2,B,I
domains,I,O
and,O,O
both,O,O
of,O,O
the,O,O
tyrosine,O,O
residues,O,O
in,O,O
the,O,O
motif,O,O
",",O,O
suggesting,O,O
that,O,O
ZAP,B,B
-,I,I
70,I,I
interacts,O,O
with,O,O
two,O,O
phosphotyrosine,O,O
residues,O,O
and,O,O
that,O,O
the,O,O
binding,O,O
of,O,O
the,O,O
two,O,O
SH2,B,I
domains,I,O
is,O,O
cooperative,O,O
.,O,O
Neither,O,O
mutant,O,O
exhibited,O,O
derepression,O,O
of,O,O
the,O,O
silent,B,O
mating,I,O
type,I,O
loci,I,O
.,O,O
Pokeweed,B,B
mitogen,I,I
(,O,O
PWM,B,B
),O,O
or,O,O
anti,B,O
-,I,O
CD3,I,B
significantly,O,O
increases,O,O
c,B,O
-,I,O
jun,I,B
messenger,I,I
RNA,I,I
(,I,O
mRNA,I,B
),I,O
levels,O,O
in,O,O
T,O,O
cells,O,O
.,O,O
There,O,O
is,O,O
now,O,O
a,O,O
significative,O,O
difference,O,O
between,O,O
age,O,O
group,O,O
1,O,O
-,O,O
5,O,O
and,O,O
the,O,O
others,O,O
(,O,O
p,O,O
Less,O,O
Than,O,O
0,O,O
",",O,O
02,O,O
),O,O
.,O,O
Apart,O,O
from,O,O
two,O,O
proline,O,B
-,O,I
rich,O,I
regions,O,I
(,O,O
amino,O,O
acids,O,O
1,O,O
-,O,O
117,O,O
and,O,O
239,O,O
-,O,O
270,O,O
),O,O
",",O,O
p230,B,B
contains,O,O
a,O,O
very,O,O
high,O,O
frequency,O,O
of,O,O
heptad,O,O
repeats,O,O
",",O,O
characteristic,O,O
of,O,O
alpha,O,O
-,O,O
helices,O,O
that,O,O
form,O,O
dimeric,O,O
coiled,O,O
-,O,O
coil,O,O
structures,O,O
.,O,O
p230,B,O
also,O,O
includes,O,O
the,O,O
sequence,O,O
ESLALEELEL,O,B
(,O,O
amino,O,O
acids,O,O
538,O,O
-,O,O
546,O,O
),O,O
",",O,O
a,O,O
motif,O,O
found,O,O
in,O,O
the,O,O
granin,B,O
family,I,O
of,O,O
acidic,O,O
proteins,O,O
present,O,O
in,O,O
secretory,O,O
granules,O,O
of,O,O
neuroendocrine,O,O
cells,O,O
.,O,O
This,O,O
implies,O,O
that,O,O
the,O,O
groups,O,O
do,O,O
not,O,O
just,O,O
differ,O,O
along,O,O
one,O,O
dimension,O,O
",",O,O
but,O,O
along,O,O
three,O,O
dimensions,O,O
.,O,O
The,O,O
genome,O,O
organization,O,O
of,O,O
the,O,O
mite,O,O
-,O,O
transmitted,O,O
wheat,O,O
streak,O,O
mosaic,O,O
virus,O,O
(,O,O
WSMV,O,B
),O,O
appears,O,O
to,O,O
parallel,O,O
that,O,O
of,O,O
members,O,O
of,O,O
the,O,O
Potyviridae,O,O
with,O,O
monopartite,O,O
genomes,O,O
",",O,O
but,O,O
there,O,O
are,O,O
substantial,O,O
amino,O,O
acid,O,O
dissimilarities,O,O
with,O,O
other,O,O
potyviral,O,O
polyproteins,O,O
.,O,O
Treatment,O,O
of,O,O
Graves,O,B
',O,I
disease,O,O
.,O,O
The,O,O
carboxyl,O,O
-,O,O
terminal,O,O
CCCC,O,O
module,O,O
is,O,O
structurally,O,O
related,O,O
to,O,O
the,O,O
DNA,O,O
-,O,O
binding,O,O
domain,O,O
of,O,O
the,O,O
erythroid,B,O
transcription,I,O
factor,I,O
GATA,I,B
-,I,I
1,I,I
.,O,O
Three,O,O
women,O,O
have,O,O
had,O,O
abnormal,O,O
endocervical,O,O
follow,O,O
up,O,O
cytology,O,O
suggestive,O,O
of,O,O
residual,O,O
disease,O,O
.,O,O
Taste,O,O
reactivity,O,O
tests,O,O
were,O,O
used,O,O
to,O,O
examine,O,O
the,O,O
orofacial,O,O
responses,O,O
of,O,O
alcohol,O,O
preferring,O,O
(,O,O
P,O,O
),O,O
rats,O,O
and,O,O
alcohol,O,O
nonpreferring,O,O
(,O,O
NP,O,O
),O,O
rats,O,O
to,O,O
the,O,O
taste,O,O
of,O,O
alcohol,O,O
.,O,O
The,O,O
cis,O,O
-,O,O
acting,O,O
elements,O,O
that,O,O
control,O,O
promoter,O,O
activity,O,O
include,O,O
binding,O,O
sites,O,O
for,O,O
transcription,O,O
factors,O,O
Sp1,B,B
and,O,O
alphaCbf,B,B
",",O,O
a,O,O
60,B,O
-,I,O
kDa,I,O
CCAAT,I,O
box,I,O
-,I,O
binding,I,O
protein,I,O
.,O,O
The,O,O
level,O,O
of,O,O
serum,B,O
creatine,I,O
kinase,I,O
was,O,O
significantly,O,O
high,O,O
2,O,O
days,O,O
after,O,O
ESWIB,O,O
",",O,O
but,O,O
it,O,O
recovered,O,O
in,O,O
a,O,O
week,O,O
.,O,O
CONCLUSION,O,O
:,O,O
Our,O,O
results,O,O
suggest,O,O
that,O,O
AIF,O,O
peak,O,O
saturation,O,O
leads,O,O
to,O,O
a,O,O
significant,O,O
systematic,O,O
error,O,O
in,O,O
the,O,O
determination,O,O
of,O,O
CBV,O,B
and,O,O
CBF,O,B
values,O,O
and,O,O
has,O,O
necessarily,O,O
to,O,O
be,O,O
taken,O,O
into,O,O
account,O,O
for,O,O
dynamic,O,O
contrast,O,O
-,O,O
enhanced,O,O
MR,O,O
perfusion,O,O
studies,O,O
.,O,O
Rice,B,B
dwarf,I,I
phytoreovirus,I,I
segment,I,O
S12,I,O
transcript,I,O
is,O,O
tricistronic,O,O
in,O,O
vitro,O,O
.,O,O
We,O,O
found,O,O
no,O,O
correlation,O,O
between,O,O
plasma,O,O
COP,O,B
and,O,O
body,O,O
weight,O,O
at,O,O
the,O,O
same,O,O
age,O,O
(,O,O
r2,O,O
=,O,O
0,O,O
.,O,O
05,O,O
",",O,O
P,O,O
=,O,O
0,O,O
.,O,O
155,O,O
),O,O
.,O,O
Human,O,B
T,O,I
-,O,I
cell,O,I
leukemia,O,I
virus,O,I
type,O,I
I,O,I
(,O,O
HTLV,O,B
-,O,I
I,O,I
),O,O
encodes,O,O
a,O,O
40,O,O
-,O,O
kDa,O,O
nuclear,O,O
protein,O,O
",",O,O
Tax,B,O
",",O,O
which,O,O
stimulates,O,O
transcription,O,O
from,O,O
three,O,O
21,O,O
-,O,O
base,O,O
pair,O,O
(,O,O
bp,O,O
),O,O
repeats,O,O
in,O,O
its,O,O
U3,O,O
region,O,O
.,O,O
The,O,O
other,O,O
two,O,O
clones,O,O
",",O,O
Ash,B,B
-,I,I
m,I,I
and,I,O
-,I,O
s,I,O
",",O,O
had,O,O
nucleotide,O,O
sequences,O,O
identical,O,O
with,O,O
Ash,B,B
-,I,I
l,I,I
cDNA,O,I
in,O,O
the,O,O
amino,O,O
-,O,O
terminal,O,O
region,O,O
.,O,O
A,O,O
note,O,O
on,O,O
some,O,O
consequences,O,O
of,O,O
UV,O,O
vision,O,O
in,O,O
birds,O,O
.,O,O
Two,O,O
US,O,O
commercial,O,O
cultivars,O,O
(,O,O
Tehama,O,O
and,O,O
Vina,O,O
),O,O
",",O,O
three,O,O
European,O,O
commercial,O,O
cultivars,O,O
(,O,O
Esterhazy,O,O
",",O,O
139,O,O
",",O,O
G120,O,O
),O,O
and,O,O
five,O,O
New,O,O
Zealand,O,O
selections,O,O
(,O,O
Rex,O,O
",",O,O
Dublin,O,O
',O,O
s,O,O
Glory,O,O
",",O,O
Meyric,O,O
",",O,O
McKinster,O,O
",",O,O
Stanley,O,O
),O,O
were,O,O
evaluated,O,O
.,O,O
Diagnosis,O,O
:,O,O
progressive,O,O
multifocal,O,O
leukoencephalopathy,O,O
.,O,O
Our,O,O
results,O,O
suggest,O,O
that,O,O
WASP,B,B
activates,O,O
transcription,O,O
following,O,O
TCR,B,O
stimulation,O,O
in,O,O
a,O,O
manner,O,O
that,O,O
is,O,O
independent,O,O
of,O,O
its,O,O
role,O,O
in,O,O
Arp2,B,O
/,I,O
3,I,O
-,O,O
directed,O,O
actin,B,O
polymerization,O,O
.,O,O
Mouse,B,O
growth,I,O
hormone,I,O
transcription,I,O
factor,I,O
Zn,I,B
-,I,I
16,I,I
:,O,O
unique,O,O
bipartite,O,O
structure,O,O
containing,O,O
tandemly,O,O
repeated,O,O
zinc,O,O
finger,O,O
domains,O,O
not,O,O
reported,O,O
in,O,O
rat,B,O
Zn,I,B
-,I,I
15,I,I
.,O,O
Furthermore,O,O
",",O,O
stable,O,O
expression,O,O
of,O,O
a,O,O
constitutively,O,O
active,O,O
form,O,O
of,O,O
chicken,O,B
Notch1,B,B
or,O,O
Notch2,B,B
in,O,O
a,O,O
B,O,O
cell,O,O
line,O,O
results,O,O
in,O,O
a,O,O
down,O,O
-,O,O
regulation,O,O
of,O,O
surface,O,O
IgM,B,B
expression,O,O
",",O,O
which,O,O
is,O,O
accompanied,O,O
by,O,O
the,O,O
reduction,O,O
of,O,O
IgH,B,B
gene,I,I
transcripts,I,I
.,O,O
Deep,O,O
tans,O,O
were,O,O
induced,O,O
over,O,O
the,O,O
backs,O,O
of,O,O
volunteers,O,O
with,O,O
repeated,O,O
exposure,O,O
to,O,O
longwave,O,O
ultraviolet,O,O
radiation,O,O
(,O,O
UV,O,B
-,O,I
A,O,I
),O,O
.,O,O
Postcoital,O,O
contraception,O,O
:,O,O
a,O,O
family,O,O
planning,O,O
study,O,O
.,O,O
Merlie,O,O
",",O,O
Cold,O,O
Spring,O,O
Harbor,O,O
Symp,O,O
.,O,O
The,O,O
human,O,B
cDNA,O,I
was,O,O
used,O,O
to,O,O
demonstrate,O,O
that,O,O
tumor,B,O
necrosis,I,O
factor,I,O
-,I,O
alpha,I,O
could,O,O
rapidly,O,O
stimulate,O,O
MARCKS,B,B
gene,I,I
transcription,O,O
in,O,O
the,O,O
human,O,O
promyelocytic,O,O
leukemia,O,O
cell,O,O
line,O,O
HL60,O,O
.,O,O
Interleukin,B,B
-,I,I
1,I,I
levels,O,O
remained,O,O
low,O,O
throughout,O,O
the,O,O
course,O,O
.,O,O
Intracellular,O,O
localization,O,O
studies,O,O
using,O,O
the,O,O
mDAP,B,B
-,I,I
3,I,I
/,O,I
EGFP,B,I
fusion,O,I
protein,O,I
",",O,O
cell,O,O
fractionation,O,O
and,O,O
protease,O,O
protection,O,O
experiments,O,O
localized,O,O
mDAP,B,B
-,I,I
3,I,I
to,O,O
the,O,O
mitochondrial,O,O
matrix,O,O
.,O,O
This,O,O
compound,O,O
is,O,O
the,O,O
main,O,O
bioactive,O,O
metabolite,O,O
of,O,O
trimebutine,O,O
II,O,O
(,O,O
Debridat,O,O
",",O,O
CAS,O,O
39133,O,O
-,O,O
31,O,O
-,O,O
8,O,O
),O,O
",",O,O
an,O,O
antispasmodic,O,O
widely,O,O
used,O,O
for,O,O
intestinal,O,O
diseases,O,O
since,O,O
1969,O,O
.,O,O
Unexpectedly,O,O
",",O,O
all,O,O
ENK,B,B
-,I,I
specific,I,I
motifs,I,O
formed,O,O
specific,O,O
and,O,O
highly,O,O
abundant,O,O
protein,O,O
-,O,O
DNA,O,O
complexes,O,O
when,O,O
nuclear,O,O
extracts,O,O
from,O,O
the,O,O
human,O,B
tumor,O,I
cell,O,I
line,O,I
(,O,O
HeLa,O,B
),O,O
",",O,O
which,O,O
does,O,O
not,O,O
express,O,O
ENK,B,O
",",O,O
were,O,O
used,O,O
.,O,O
Negative,O,O
-,O,O
staining,O,O
",",O,O
refractile,O,O
mycobacteria,O,O
in,O,O
Romanowsky,O,O
-,O,O
stained,O,O
smears,O,O
.,O,O
Recombinant,B,O
HRMT1L2,I,B
protein,I,O
encoded,O,O
by,O,O
the,O,O
most,O,O
common,O,O
5,O,O
',O,O
-,O,O
variant,O,O
exhibited,O,O
methyltransferase,O,O
activity,O,O
in,O,O
vitro,O,O
.,O,O
We,O,O
have,O,O
attempted,O,O
to,O,O
clone,O,O
two,O,O
recessive,O,O
extragenic,O,O
suppressors,O,O
of,O,O
such,O,O
ts,O,O
mutants,O,O
(,O,O
sdp1,B,B
for,O,O
mutation,B,O
pol3,I,B
-,I,I
14,I,I
and,O,O
sdp5,B,B
-,I,I
1,I,I
for,O,O
mutation,B,O
pol3,I,B
-,I,I
11,I,I
),O,O
by,O,O
transforming,O,O
thermoresistant,O,O
haploid,O,O
strains,O,O
pol3,B,B
-,I,I
14,I,I
sdp1,I,B
and,O,O
pol3,B,B
-,I,I
11,I,I
sdp5,I,B
-,I,I
1,I,I
with,O,O
wild,O,O
-,O,O
type,O,O
genomic,O,O
libraries,O,O
in,O,O
singlecopy,O,O
or,O,O
multicopy,O,O
vectors,O,O
.,O,O
RNA,B,B
polymerase,I,I
IIA,I,I
was,O,O
recovered,O,O
in,O,O
transcriptionally,O,O
active,O,O
complexes,O,O
in,O,O
reactions,O,O
in,O,O
which,O,O
the,O,O
input,O,O
enzyme,O,O
was,O,O
RNA,B,B
polymerase,I,I
IIA,I,I
.,O,O
RESULTS,O,O
:,O,O
Using,O,O
information,O,O
in,O,O
the,O,O
dbEST,O,O
database,O,O
of,O,O
expressed,O,O
sequence,O,O
tags,O,O
",",O,O
we,O,O
isolated,O,O
an,O,O
Arabidopsis,O,B
thaliana,O,I
gene,O,O
(,O,O
GCR1,B,B
),O,O
that,O,O
encodes,O,O
a,O,O
protein,O,O
with,O,O
seven,O,O
predicted,O,O
membrane,O,O
-,O,O
spanning,O,O
domains,O,O
and,O,O
other,O,O
features,O,O
characteristic,O,O
of,O,O
7TM,B,O
receptors,I,O
.,O,O
Cytogenetic,O,O
analysis,O,O
of,O,O
LOH,O,B
mutants,O,O
by,O,O
chromosome,O,O
painting,O,O
indicated,O,O
a,O,O
mosaic,O,O
of,O,O
chromosomal,O,O
aberrations,O,O
involving,O,O
chromosome,O,O
17,O,B
",",O,O
in,O,O
which,O,O
partial,O,O
chromosome,O,O
deletions,O,O
",",O,O
amplifications,O,O
",",O,O
and,O,O
multiple,O,O
translocations,O,O
appeared,O,O
heterogeneously,O,O
in,O,O
a,O,O
single,O,O
mutant,O,O
.,O,O
Derivation,O,O
and,O,O
initial,O,O
characterization,O,O
of,O,O
a,O,O
mouse,O,O
mammary,O,O
tumor,O,O
cell,O,O
line,O,O
carrying,O,O
the,O,O
polyomavirus,B,O
middle,I,O
T,I,O
antigen,I,O
:,O,O
utility,O,O
in,O,O
the,O,O
development,O,O
of,O,O
novel,O,O
cancer,O,O
therapeutics,O,O
.,O,O
The,O,O
results,O,O
indicate,O,O
that,O,O
folate,O,B
compounds,O,O
decrease,O,O
formate,O,O
accumulation,O,O
after,O,O
methanol,O,O
by,O,O
stimulating,O,O
formate,O,O
oxidation,O,O
or,O,O
utilization,O,O
and,O,O
suggest,O,O
a,O,O
possible,O,O
use,O,O
for,O,O
folates,O,O
in,O,O
the,O,O
treatment,O,O
of,O,O
certain,O,O
cases,O,O
of,O,O
human,O,B
methanol,O,O
poisoning,O,O
.,O,O
Using,O,O
gel,O,O
retardation,O,O
assays,O,O
with,O,O
HepG2,O,B
nuclear,O,I
extract,O,I
",",O,O
we,O,O
demonstrated,O,O
the,O,O
presence,O,O
of,O,O
a,O,O
specific,O,O
protein,O,O
which,O,O
bound,O,O
to,O,O
the,O,O
NRE,O,B
fragment,O,O
.,O,O
In,O,O
64,O,O
%,O,O
a,O,O
small,O,O
cardiac,O,O
vein,O,O
does,O,O
not,O,O
exist,O,O
",",O,O
but,O,O
its,O,O
origin,O,O
",",O,O
the,O,O
right,O,O
marginal,O,O
vein,O,O
",",O,O
joins,O,O
the,O,O
system,O,O
of,O,O
anterior,O,O
cardiac,O,O
veins,O,O
.,O,O
These,O,O
data,O,O
are,O,O
consistent,O,O
with,O,O
a,O,O
model,O,O
in,O,O
which,O,O
GATA,B,B
-,I,I
5,I,I
performs,O,O
a,O,O
unique,O,O
temporally,O,O
and,O,O
spatially,O,O
restricted,O,O
function,O,O
in,O,O
the,O,O
embryonic,O,O
heart,O,O
and,O,O
lung,O,O
.,O,O
Although,O,O
heart,O,O
rate,O,O
and,O,O
diastolic,O,O
pressure,O,O
rose,O,O
in,O,O
some,O,O
degree,O,O
1,O,O
min,O,O
after,O,O
intubation,O,O
",",O,O
free,O,O
and,O,O
total,O,O
CA,O,B
concentrations,O,O
did,O,O
not,O,O
increase,O,O
during,O,O
study,O,O
period,O,O
.,O,O
Consistent,O,O
with,O,O
ErbB,B,B
-,I,I
2,I,I
being,O,O
a,O,O
shared,O,O
receptor,O,O
subunit,O,O
",",O,O
its,O,O
tyrosine,O,O
phosphorylation,O,O
was,O,O
increased,O,O
by,O,O
both,O,O
heterologous,O,O
ligands,O,O
and,O,O
it,O,O
mediated,O,O
a,O,O
trans,O,O
-,O,O
inhibitory,O,O
effect,O,O
of,O,O
NDF,B,O
on,O,O
EGF,B,O
binding,O,O
.,O,O
The,O,O
p97,B,O
-,O,O
depleted,O,O
nuclei,O,O
remained,O,O
largely,O,O
competent,O,O
for,O,O
nuclear,O,O
protein,O,O
import,O,O
.,O,O
AMDA,O,O
white,O,O
paper,O,O
identifies,O,O
ways,O,O
to,O,O
improve,O,O
pharmaceutical,O,O
care,O,O
in,O,O
SNFs,O,O
.,O,O
Erythrocytic,O,O
stages,O,O
of,O,O
mammalian,O,O
malarial,O,O
parasites,O,O
contain,O,O
acristate,O,O
mitochondria,O,O
whose,O,O
functions,O,O
are,O,O
not,O,O
well,O,O
understood,O,O
.,O,O
For,O,O
steers,O,O
the,O,O
urinary,O,O
N,O,B
values,O,O
were,O,O
403,O,O
and,O,O
295,O,O
mg,O,O
/,O,O
kg,O,O
W0,O,O
.,O,O
75,O,O
at,O,O
200,O,O
and,O,O
350,O,O
kg,O,O
live,O,O
weight,O,O
respectively,O,O
and,O,O
total,O,O
N,O,B
excretion,O,O
including,O,O
faecal,O,O
N,O,B
was,O,O
408,O,O
and,O,O
320,O,O
mg,O,O
/,O,O
kg,O,O
W0,O,O
.,O,O
75,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
a,O,O
potent,O,O
splicing,O,O
enhancer,O,O
sequence,O,O
isolated,O,O
in,O,O
the,O,O
selection,O,O
specifically,O,O
binds,O,O
a,O,O
20,B,O
-,I,O
kDa,I,O
SR,I,B
protein,I,O
.,O,O
Deletion,O,O
studies,O,O
identified,O,O
a,O,O
distal,O,O
response,O,O
element,O,O
that,O,O
is,O,O
responsible,O,O
for,O,O
the,O,O
cytokine,O,O
response,O,O
and,O,O
has,O,O
properties,O,O
of,O,O
an,O,O
inducible,O,O
transcriptional,O,O
enhancer,O,O
.,O,O
Therefore,O,O
",",O,O
analogs,O,O
of,O,O
vitamin,O,O
D3,O,B
have,O,O
been,O,O
investigated,O,O
in,O,O
a,O,O
number,O,O
of,O,O
trials,O,O
showing,O,O
improvement,O,O
of,O,O
psoriasis,O,O
.,O,O
A,O,O
cause,O,O
of,O,O
increase,O,O
of,O,O
alkaline,B,O
phosphatase,I,O
in,O,O
children,O,O
On,O,O
the,O,O
other,O,O
hand,O,O
",",O,O
the,O,O
structures,O,O
of,O,O
the,O,O
b,O,B
-,O,I
Zip,O,I
domain,O,I
are,O,O
well,O,O
conserved,O,O
among,O,O
these,O,O
Maf,B,O
-,I,O
related,I,O
proteins,I,O
.,O,O
Cloning,O,O
of,O,O
individual,O,O
ZI,O,B
domains,O,O
upstream,O,O
of,O,O
a,O,O
minimal,O,O
promoter,O,O
demonstrated,O,O
that,O,O
the,O,O
ZIA,O,B
",",O,O
ZIC,O,B
",",O,O
and,O,O
ZID,O,B
domains,O,O
",",O,O
but,O,O
not,O,O
the,O,O
ZIB,O,B
domain,O,I
",",O,O
are,O,O
TPA,O,O
responsive,O,O
.,O,O
In,O,O
the,O,O
clinical,O,O
study,O,O
",",O,O
the,O,O
defect,O,O
size,O,O
shown,O,O
by,O,O
BMIPP,O,B
imaging,O,O
was,O,O
greater,O,O
in,O,O
anterior,O,O
than,O,O
in,O,O
inferior,O,O
infarcts,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
and,O,O
correlated,O,O
well,O,O
with,O,O
the,O,O
risk,O,O
area,O,O
revealed,O,O
by,O,O
contrast,O,O
ventriculography,O,O
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
80,O,O
",",O,O
p,O,O
<,O,O
0,O,O
.,O,O
0001,O,O
),O,O
CONCLUSION,O,O
:,O,O
The,O,O
above,O,O
preliminary,O,O
data,O,O
",",O,O
admittedly,O,O
from,O,O
a,O,O
small,O,O
group,O,O
of,O,O
patients,O,O
",",O,O
suggest,O,O
that,O,O
tomographic,O,O
BMIPP,O,B
imaging,O,O
provides,O,O
an,O,O
accurate,O,O
quantification,O,O
of,O,O
defect,O,O
size,O,O
by,O,O
means,O,O
of,O,O
a,O,O
simple,O,O
threshold,O,O
technique,O,O
and,O,O
",",O,O
in,O,O
the,O,O
subacute,O,O
phase,O,O
",",O,O
permits,O,O
determination,O,O
of,O,O
the,O,O
amount,O,O
of,O,O
myocardium,O,O
at,O,O
risk,O,O
after,O,O
acute,O,O
myocardial,O,O
infarction,O,O
.,O,O
The,O,O
integrity,O,O
of,O,O
the,O,O
cDNA,O,O
sequence,O,O
was,O,O
confirmed,O,O
by,O,O
analysis,O,O
of,O,O
several,O,O
overlapping,O,O
genomic,O,O
clones,O,O
that,O,O
span,O,O
the,O,O
GAR1,B,B
gene,I,O
.,O,O
Manipulation,O,O
of,O,O
the,O,O
checkpoint,O,O
regulators,O,O
involved,O,O
in,O,O
cell,O,O
cycle,O,O
arrest,O,O
and,O,O
apoptosis,O,O
may,O,O
thus,O,O
provide,O,O
a,O,O
novel,O,O
strategy,O,O
to,O,O
cancer,O,O
therapy,O,O
.,O,O
We,O,O
here,O,O
demonstrate,O,O
that,O,O
a,O,O
temperature,O,O
-,O,O
sensitive,O,O
fission,O,O
yeast,O,O
mutant,O,O
which,O,O
has,O,O
a,O,O
mutation,O,O
in,O,O
a,O,O
homologous,O,O
gene,O,O
",",O,O
and,O,O
two,O,O
of,O,O
three,O,O
additional,O,O
(,O,O
mtr1,B,B
/,O,I
prp20,B,I
/,O,I
srm1,B,I
),O,O
mutants,O,O
accumulate,O,O
nuclear,O,O
poly,O,O
(,O,O
A,O,O
),O,O
+,O,O
RNA,O,O
at,O,O
37,O,O
degrees,O,O
C,O,O
.,O,O
Clinically,O,O
meaningful,O,O
decreases,O,O
due,O,O
to,O,O
alkalinization,O,O
alone,O,O
within,O,O
30,O,O
minutes,O,O
are,O,O
unlikely,O,O
.,O,O
The,O,O
gene,O,O
encoding,O,O
the,O,O
receptor,O,O
for,O,O
macrophage,B,O
colony,I,O
-,I,O
stimulating,I,O
factor,I,O
1,I,O
(,O,O
CSF,B,B
-,I,I
1,I,I
),O,O
",",O,O
the,O,O
c,B,O
-,I,O
fms,I,O
protooncogene,I,O
",",O,O
is,O,O
selectively,O,O
expressed,O,O
in,O,O
immature,O,O
and,O,O
mature,O,O
mononuclear,O,O
phagocytes,O,O
and,O,O
trophoblasts,O,O
.,O,O
The,O,O
most,O,O
common,O,O
cause,O,O
of,O,O
renal,O,O
deterioration,O,O
in,O,O
the,O,O
spinal,O,O
cord,O,O
injured,O,O
patient,O,O
is,O,O
irreversible,O,O
vesicoureteral,O,O
reflux,O,O
.,O,O
Isolated,O,O
proteinuria,O,O
(,O,O
i,O,O
.,O,O
e,O,O
.,O,O
without,O,O
hematuria,O,O
and,O,O
/,O,O
or,O,O
pyuria,O,O
),O,O
is,O,O
a,O,O
frequent,O,O
finding,O,O
.,O,O
Significant,O,O
correlations,O,O
were,O,O
obtained,O,O
between,O,O
changes,O,O
in,O,O
SSEP,O,O
in,O,O
response,O,O
to,O,O
AS,O,O
and,O,O
the,O,O
presence,O,O
of,O,O
not,O,O
deep,O,O
residual,O,O
-,O,O
organic,O,O
disturbances,O,O
",",O,O
so,O,O
-,O,O
called,O,O
in,O,O
psychogenic,O,O
disorders,O,O
.,O,O
Patients,O,O
with,O,O
a,O,O
secondary,O,O
cardiac,O,O
event,O,O
had,O,O
more,O,O
common,O,O
Type,O,O
A,O,O
behavior,O,O
patterns,O,O
and,O,O
higher,O,O
Bortner,O,B
scores,O,O
than,O,O
patients,O,O
without,O,O
a,O,O
secondary,O,O
cardiac,O,O
event,O,O
.,O,O
Electrophoretic,O,O
mobility,O,O
-,O,O
shift,O,O
assays,O,O
performed,O,O
with,O,O
the,O,O
HNF,B,B
-,I,I
3,I,I
X,O,I
and,O,O
Y,O,I
sites,O,O
demonstrated,O,O
that,O,O
both,O,O
sites,O,O
are,O,O
capable,O,O
of,O,O
binding,O,O
HNF,B,B
-,I,I
3alpha,I,I
and,O,O
HNF,B,B
-,I,I
3beta,I,I
.,O,O
An,O,O
unusual,O,O
cysteine,O,O
triplet,O,O
conserved,O,O
in,O,O
the,O,O
sequences,O,O
of,O,O
TB,B,B
domains,I,O
is,O,O
localized,O,O
to,O,O
the,O,O
hydrophobic,O,O
core,O,O
",",O,O
at,O,O
the,O,O
C,O,B
-,O,I
terminus,O,I
of,O,O
an,O,O
alpha,O,O
-,O,O
helix,O,O
.,O,O
The,O,O
C,O,O
/,O,O
D,O,O
ratio,O,O
was,O,O
equal,O,O
to,O,O
or,O,O
over,O,O
0,O,O
.,O,O
6,O,O
in,O,O
9,O,O
cases,O,O
(,O,O
16,O,O
eyes,O,O
),O,O
",",O,O
and,O,O
the,O,O
values,O,O
were,O,O
inconsistent,O,O
between,O,O
both,O,O
eyes,O,O
in,O,O
55,O,O
%,O,O
of,O,O
the,O,O
patients,O,O
.,O,O
The,O,O
Rlm1,B,O
protein,I,O
",",O,O
a,O,O
member,O,O
of,O,O
the,O,O
MADS,B,O
box,I,O
family,I,O
of,O,O
transcription,O,O
factors,O,O
",",O,O
functions,O,O
downstream,O,O
of,O,O
Mpk1,B,O
in,O,O
the,O,O
pathway,O,O
.,O,O
The,O,O
observed,O,O
phenotypes,O,O
may,O,O
be,O,O
explained,O,O
by,O,O
(,O,O
i,O,O
),O,O
a,O,O
selective,O,O
disruption,O,O
of,O,O
very,B,O
-,I,O
low,I,O
-,I,O
density,I,O
lipoprotein,I,O
secretion,O,O
due,O,O
to,O,O
decreased,O,O
expression,O,O
of,O,O
genes,O,O
encoding,O,O
apolipoprotein,B,B
B,I,I
and,O,O
microsomal,B,O
triglyceride,I,O
transfer,I,O
protein,I,O
",",O,O
(,O,O
ii,O,O
),O,O
an,O,O
increase,O,O
in,O,O
hepatic,O,O
cholesterol,O,O
uptake,O,O
due,O,O
to,O,O
increased,O,O
expression,O,O
of,O,O
the,O,O
major,O,O
high,B,O
-,I,O
density,I,O
lipoprotein,I,O
receptor,I,O
",",O,O
scavenger,B,O
receptor,I,O
BI,I,O
",",O,O
and,O,O
(,O,O
iii,O,O
),O,O
a,O,O
decrease,O,O
in,O,O
bile,O,O
acid,O,O
uptake,O,O
to,O,O
the,O,O
liver,O,O
due,O,O
to,O,O
down,O,O
-,O,O
regulation,O,O
of,O,O
the,O,O
major,O,O
basolateral,B,O
bile,I,O
acid,I,O
transporters,I,O
sodium,I,O
taurocholate,I,O
cotransporter,I,O
protein,I,O
and,O,O
organic,B,O
anion,I,O
transporter,I,O
protein,I,O
1,I,O
.,O,O
RESULTS,O,O
:,O,O
Surprisingly,O,O
",",O,O
PAF,B,B
blockade,O,O
increased,O,O
mortality,O,O
after,O,O
trauma,O,O
(,O,O
5,O,O
of,O,O
11,O,O
WEB,O,B
-,O,I
2086,O,I
animals,O,O
versus,O,O
1,O,O
of,O,O
9,O,O
vehicle,O,O
animals,O,O
;,O,O
p,O,O
=,O,O
0,O,O
.,O,O
15,O,O
cardiac,O,O
index,O,O
and,O,O
O2,O,O
delivery,O,O
at,O,O
72,O,O
hours,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
05,O,O
),O,O
.,O,O
Children,O,O
',O,O
s,O,O
temperament,O,O
and,O,O
maternal,O,O
socialization,O,O
at,O,O
Time,O,O
1,O,O
(,O,O
n,O,O
=,O,O
103,O,O
",",O,O
aged,O,O
2,O,O
-,O,O
3,O,O
years,O,O
),O,O
were,O,O
considered,O,O
predictors,O,O
of,O,O
future,O,O
conscience,O,O
",",O,O
assessed,O,O
using,O,O
new,O,O
observational,O,O
and,O,O
narrative,O,O
measures,O,O
.,O,O
The,O,O
N,O,B
-,O,I
terminal,O,I
small,O,I
segment,O,I
of,O,I
yeast,B,B
TAF145,I,I
(,O,O
yTAF145,B,B
),O,O
binds,O,O
to,O,O
TBP,B,B
and,O,O
thereby,O,O
inhibits,O,O
TBP,B,B
function,O,O
.,O,O
MATERIAL,O,O
AND,O,O
METHODS,O,O
:,O,O
Of,O,O
the,O,O
17,O,O
men,O,O
and,O,O
17,O,O
women,O,O
",",O,O
who,O,O
were,O,O
21,O,O
to,O,O
80,O,O
years,O,O
of,O,O
age,O,O
",",O,O
27,O,O
had,O,O
hereditary,O,O
motor,O,O
and,O,O
sensory,O,O
neuropathy,O,O
type,O,O
I,O,O
and,O,O
7,O,O
had,O,O
acquired,O,O
demyelinating,O,O
polyneuropathy,O,O
.,O,O
A,O,O
recent,O,O
index,O,O
(,O,O
Fluorosis,O,O
Risk,O,O
Index,O,O
),O,O
developed,O,O
by,O,O
Pendrys,O,B
(,O,O
1990,O,O
),O,O
is,O,O
also,O,O
included,O,O
in,O,O
this,O,O
review,O,O
.,O,O
Southern,O,O
analysis,O,O
on,O,O
genomic,O,O
DNA,O,O
isolated,O,O
from,O,O
tissues,O,O
and,O,O
cell,O,O
lines,O,O
from,O,O
several,O,O
mouse,O,B
strains,O,O
using,O,O
mCD22,B,B
cDNA,I,I
demonstrated,O,O
that,O,O
the,O,O
Cd22,B,B
locus,I,O
encoding,O,O
mCD22,B,B
is,O,O
a,O,O
single,O,O
copy,O,O
gene,O,O
of,O,O
<,O,O
or,O,O
=,O,O
30,O,O
kb,O,O
.,O,O
Further,O,O
",",O,O
they,O,O
are,O,O
consistent,O,O
with,O,O
the,O,O
suggestion,O,O
that,O,O
sites,O,O
homologous,O,O
to,O,O
the,O,O
CAR1,B,O
URS,I,O
may,O,O
be,O,O
situated,O,O
in,O,O
the,O,O
5,O,O
',O,O
-,O,O
flanking,O,O
regions,O,O
of,O,O
multiple,O,O
unrelated,O,O
yeast,O,O
genes,O,O
.,O,O
Relatively,O,O
little,O,O
is,O,O
known,O,O
regarding,O,O
the,O,O
role,O,O
of,O,O
5,B,B
-,I,I
HT2,I,I
receptor,I,I
activity,O,O
in,O,O
male,O,O
rat,O,O
sexual,O,O
behavior,O,O
.,O,O
It,O,O
was,O,O
demonstrated,O,O
that,O,O
the,O,O
processing,O,O
signals,O,O
in,O,O
the,O,O
transcript,O,O
",",O,O
i,O,O
.,O,O
e,O,O
.,O,O
both,O,O
donor,O,O
splice,O,O
sites,O,O
and,O,O
the,O,O
polyadenylation,O,O
site,O,O
located,O,O
in,O,O
the,O,O
muscle,O,O
-,O,O
specific,O,O
intron,O,O
",",O,O
have,O,O
to,O,O
be,O,O
weak,O,O
.,O,O
Possible,O,O
pathogenetic,O,O
mechanisms,O,O
of,O,O
hemopoietic,O,O
changes,O,O
in,O,O
response,O,O
to,O,O
space,O,O
flight,O,O
effects,O,O
are,O,O
described,O,O
.,O,O
The,O,O
patients,O,O
were,O,O
divided,O,O
into,O,O
3,O,O
subgroups,O,O
:,O,O
1,O,O
),O,O
13,O,O
N,O,B
+,O,O
patients,O,O
with,O,O
multiple,O,O
hot,O,O
spots,O,O
(,O,O
greater,O,O
than,O,O
2,O,O
),O,O
(,O,O
N,O,B
+,O,O
IM,O,O
),O,O
;,O,O
2,O,O
),O,O
24,O,O
N,O,B
+,O,O
patients,O,O
with,O,O
single,O,O
hot,O,O
spots,O,O
(,O,O
less,O,O
than,O,O
or,O,O
equal,O,O
to,O,O
2,O,O
),O,O
(,O,O
N,O,B
+,O,O
IS,O,O
),O,O
;,O,O
3,O,O
),O,O
12,O,O
N,O,B
-,O,O
patients,O,O
with,O,O
single,O,O
hot,O,O
spots,O,O
(,O,O
less,O,O
than,O,O
or,O,O
equal,O,O
to,O,O
2,O,O
),O,O
(,O,O
N,O,B
-,O,O
IS,O,O
),O,O
.,O,O
Xenopus,B,B
homolog,I,O
of,I,O
the,I,O
mos,I,B
protooncogene,I,I
transforms,O,O
mammalian,O,O
fibroblasts,O,O
and,O,O
induces,O,O
maturation,O,O
of,O,O
Xenopus,O,B
oocytes,O,O
.,O,O
TNF,B,O
Treatment,O,O
of,O,O
cell,O,O
activated,O,O
the,O,O
p38,B,B
MAP,I,I
kinase,I,I
pathway,O,O
",",O,O
as,O,O
revealed,O,O
by,O,O
increased,O,O
phosphorylation,O,O
of,O,O
p38,B,B
MAP,I,I
kinase,I,I
itself,O,O
",",O,O
activation,O,O
of,O,O
the,O,O
substrate,O,O
protein,O,O
MAPKAP,B,B
kinase,I,I
-,I,I
2,I,I
",",O,O
and,O,O
culminating,O,O
in,O,O
the,O,O
phosphorylation,O,O
of,O,O
the,O,O
heat,B,O
shock,I,O
protein,I,O
27,I,O
(,O,O
hsp27,B,B
),O,O
.,O,O
The,O,O
deduced,O,O
amino,O,O
acid,O,O
sequence,O,O
of,O,O
the,O,O
gene,O,O
has,O,O
significant,O,O
homology,O,O
to,O,O
the,O,O
interferon,B,B
regulatory,I,I
factors,I,I
(,O,O
IRFs,B,B
),O,O
is,O,O
involved,O,O
in,O,O
endosperm,O,O
rupture,O,O
and,O,O
high,O,O
-,O,O
level,O,O
betaGLU,B,B
I,I,I
expression,O,O
;,O,O
but,O,O
",",O,O
it,O,O
does,O,O
not,O,O
affect,O,O
the,O,O
spatial,O,O
and,O,O
temporal,O,O
pattern,O,O
of,O,O
betaGLU,B,B
I,I,I
expression,O,O
.,O,O
PURPOSE,O,O
:,O,O
Previous,O,O
WR,O,O
-,O,O
2721,O,O
human,O,O
pharmacokinetic,O,O
studies,O,O
were,O,O
limited,O,O
to,O,O
plasma,O,O
levels,O,O
in,O,O
patients,O,O
receiving,O,O
platinum,O,O
-,O,O
based,O,O
compounds,O,O
",",O,O
and,O,O
none,O,O
includes,O,O
the,O,O
effects,O,O
of,O,O
WR,O,O
-,O,O
2721,O,O
on,O,O
endogenous,O,O
thiols,O,O
.,O,O
Retinal,O,O
changes,O,O
in,O,O
pigmentary,O,O
retinopathy,O,O
in,O,O
children,O,O
Bepridil,O,O
",",O,O
a,O,O
calcium,O,B
antagonist,O,I
with,O,O
a,O,O
half,O,O
-,O,O
life,O,O
of,O,O
approximately,O,O
42,O,O
hours,O,O
",",O,O
was,O,O
compared,O,O
with,O,O
placebo,O,O
in,O,O
a,O,O
double,O,O
-,O,O
blind,O,O
",",O,O
randomized,O,O
",",O,O
crossover,O,O
trial,O,O
.,O,O
Early,O,O
indicators,O,O
of,O,O
the,O,O
effect,O,O
of,O,O
a,O,O
breast,O,O
cancer,O,O
screening,O,O
program,O,O
for,O,O
low,O,O
-,O,O
income,O,O
women,O,O
.,O,O
Five,O,O
of,O,O
the,O,O
Aeromonas,O,B
strains,O,O
and,O,O
one,O,O
of,O,O
V,O,B
cholerae,O,I
non,O,I
-,O,I
O1,O,I
were,O,O
positive,O,O
for,O,O
enterotoxin,O,O
activity,O,O
.,O,O
We,O,O
have,O,O
used,O,O
mutation,O,O
-,O,O
directed,O,O
chemical,O,O
cross,O,O
-,O,O
linking,O,O
with,O,O
bis,O,O
(,O,O
sulfosuccinimidyl,O,O
),O,O
suberate,O,O
(,O,O
BS3,O,B
),O,O
to,O,O
investigate,O,O
the,O,O
architecture,O,O
of,O,O
the,O,O
gp41,B,B
oligomer,I,O
.,O,O
NF,B,B
-,I,I
kappa,I,I
B,I,I
/,O,I
Rel,B,I
transcription,O,O
factors,O,O
participate,O,O
in,O,O
the,O,O
activation,O,O
of,O,O
numerous,O,O
genes,O,O
involved,O,O
in,O,O
immune,O,O
regulation,O,O
/,O,O
inflammation,O,O
including,O,O
cytokines,O,O
",",O,O
cell,O,O
surface,O,O
receptors,O,O
",",O,O
adhesion,O,O
molecules,O,O
",",O,O
and,O,O
acute,O,O
phase,O,O
proteins,O,O
.,O,O
Manganese,O,O
ions,O,O
were,O,O
found,O,O
to,O,O
be,O,O
essential,O,O
for,O,O
autophosphorylation,O,O
of,O,O
BGLF4,B,B
",",O,O
and,O,O
magnesium,O,O
can,O,O
stimulate,O,O
the,O,O
activity,O,O
.,O,O
Tyrosine,O,O
phosphorylation,O,O
of,O,O
cellular,O,O
proteins,O,O
is,O,O
the,O,O
earliest,O,O
identifiable,O,O
event,O,O
following,O,O
T,B,O
-,I,O
cell,I,O
antigen,I,O
receptor,I,O
(,O,O
TCR,B,B
),O,O
stimulation,O,O
and,O,O
is,O,O
essential,O,O
for,O,O
activating,O,O
downstream,O,O
signaling,O,O
machinery,O,O
.,O,O
A,O,O
5,O,O
-,O,O
month,O,O
-,O,O
old,O,O
infant,O,O
with,O,O
persistent,O,O
congenital,O,O
stridor,O,O
and,O,O
acute,O,O
respiratory,O,O
distress,O,O
is,O,O
presented,O,O
.,O,O
RESULTS,O,O
:,O,O
256,O,O
Periods,O,O
of,O,O
TTP,O,O
or,O,O
PUNP,O,O
were,O,O
reported,O,O
by,O,O
men,O,O
and,O,O
174,O,O
by,O,O
women,O,O
.,O,O
Additionally,O,O
",",O,O
the,O,O
enzyme,O,O
shows,O,O
activity,O,O
towards,O,O
triglycerides,O,O
such,O,O
as,O,O
olive,O,O
oil,O,O
and,O,O
tributyrin,O,O
and,O,O
towards,O,O
egg,O,O
-,O,O
yolk,O,O
emulsions,O,O
.,O,O
The,O,O
Drosophila,B,B
melanogaster,I,I
suppressor,I,O
of,I,O
sable,I,O
gene,I,O
",",O,O
su,B,B
(,I,O
),I,O
",",O,O
encodes,O,O
a,O,O
novel,O,O
",",O,O
150,O,O
-,O,O
kDa,O,O
nuclear,O,O
RNA,O,O
binding,O,O
protein,O,O
",",O,O
SU,B,B
(,I,O
S,I,I
),I,O
",",O,O
that,O,O
negatively,O,O
regulates,O,O
RNA,O,O
accumulation,O,O
from,O,O
mutant,O,O
alleles,O,O
of,O,O
other,O,O
genes,O,O
that,O,O
have,O,O
transposon,O,O
insertions,O,O
in,O,O
the,O,O
5,O,O
',O,O
transcribed,O,O
region,O,O
.,O,O
There,O,O
was,O,O
no,O,O
difference,O,O
in,O,O
apnea,O,O
duration,O,O
between,O,O
the,O,O
supine,O,O
and,O,O
prone,O,O
positions,O,O
.,O,O
The,O,O
interaction,O,O
between,O,O
DDB,B,B
and,O,O
E2F1,B,B
can,O,O
also,O,O
be,O,O
detected,O,O
by,O,O
coimmunoprecipitation,O,O
experiments,O,O
.,O,O
Multiple,O,O
SWI6,B,B
-,O,I
dependent,O,I
cis,O,I
-,O,I
acting,O,I
elements,O,I
control,O,O
SWI4,B,B
transcription,O,O
through,O,O
the,O,O
cell,O,O
cycle,O,O
.,O,O
Northern,O,O
analyses,O,O
of,O,O
RNAs,O,O
from,O,O
mouse,O,O
tissues,O,O
and,O,O
cell,O,O
lines,O,O
indicated,O,O
that,O,O
p11,B,B
mRNA,I,O
levels,O,O
vary,O,O
widely,O,O
.,O,O
In,O,O
the,O,O
past,O,O
",",O,O
immunology,O,O
in,O,O
Singapore,O,O
was,O,O
mainly,O,O
confined,O,O
to,O,O
serology,O,O
for,O,O
the,O,O
diagnosis,O,O
of,O,O
certain,O,O
infectious,O,O
diseases,O,O
.,O,O
The,O,O
method,O,O
is,O,O
accurate,O,O
",",O,O
with,O,O
good,O,O
precision,O,O
and,O,O
adequate,O,O
sensitivity,O,O
.,O,O
To,O,O
determine,O,O
whether,O,O
vanadate,O,O
could,O,O
inhibit,O,O
PEPCK,B,B
gene,I,O
transcription,O,O
",",O,O
a,O,O
series,O,O
of,O,O
chimeric,O,O
genes,O,O
containing,O,O
several,O,O
deletions,O,O
in,O,O
the,O,O
P,B,B
-,I,I
enolypyruvate,I,I
carboxykinase,I,I
promoter,I,O
between,O,O
-,O,O
550,O,O
and,O,O
-,O,O
68,O,O
was,O,O
linked,O,O
to,O,O
the,O,O
structural,O,O
genes,O,O
for,O,O
either,O,O
amino,B,O
-,I,O
3,I,O
-,I,O
glycosyl,I,O
phosphotransferase,I,O
(,O,O
neo,B,O
),O,O
or,O,O
chloramphenicol,B,O
acetyltransferase,I,O
and,O,O
introduced,O,O
into,O,O
hepatoma,O,O
cells,O,O
using,O,O
three,O,O
methods,O,O
:,O,O
(,O,O
a,O,O
),O,O
infection,O,O
with,O,O
a,O,O
Moloney,O,O
murine,O,O
leukemia,O,O
virus,O,O
-,O,O
based,O,O
retrovirus,O,O
",",O,O
(,O,O
b,O,O
),O,O
transfection,O,O
and,O,O
stable,O,O
selection,O,O
for,O,O
neo,B,O
expression,O,O
",",O,O
or,O,O
(,O,O
c,O,O
),O,O
transient,O,O
expression,O,O
of,O,O
chloroamphenicol,B,O
acetyltransferase,I,O
.,O,O
During,O,O
activity,O,O
III,O,O
",",O,O
one,O,O
patient,O,O
developed,O,O
angina,O,O
.,O,O
The,O,O
effects,O,O
on,O,O
reflex,O,O
latencies,O,O
but,O,O
not,O,O
on,O,O
paCO2,O,O
or,O,O
pHa,O,O
were,O,O
blocked,O,O
by,O,O
naloxone,O,O
(,O,O
2,O,O
mg,O,O
/,O,O
kg,O,O
),O,O
",",O,O
and,O,O
were,O,O
not,O,O
present,O,O
in,O,O
morphine,O,B
-,O,I
tolerant,O,I
animals,O,O
.,O,O
We,O,O
hypothesize,O,O
that,O,O
proprioception,O,O
may,O,O
be,O,O
used,O,O
to,O,O
calibrate,O,O
the,O,O
efference,O,O
copy,O,O
during,O,O
development,O,O
and,O,O
in,O,O
response,O,O
to,O,O
perturbations,O,O
by,O,O
signaling,O,O
potential,O,O
mismatches,O,O
between,O,O
eye,O,O
movement,O,O
information,O,O
derived,O,O
from,O,O
the,O,O
efferent,O,O
command,O,O
and,O,O
the,O,O
actual,O,O
motion,O,O
of,O,O
the,O,O
eye,O,O
transduced,O,O
by,O,O
the,O,O
proprioceptive,O,O
organs,O,O
.,O,O
Based,O,O
on,O,O
analytic,O,O
precisions,O,O
",",O,O
a,O,O
+,O,O
/,O,O
-,O,O
2,O,O
%,O,O
urine,O,O
-,O,O
plasma,O,O
difference,O,O
was,O,O
set,O,O
as,O,O
the,O,O
cut,O,O
-,O,O
off,O,O
value,O,O
.,O,O
Prior,O,O
to,O,O
meals,O,O
2,O,O
to,O,O
3,O,O
times,O,O
daily,O,O
",",O,O
1,O,O
-,O,O
2,O,O
tablespoons,O,O
of,O,O
Alzoon,O,O
are,O,O
recommended,O,O
.,O,O
The,O,O
expression,O,O
of,O,O
alpha,B,B
-,I,I
amylase,I,I
can,O,O
be,O,O
transactivated,O,O
by,O,O
the,O,O
transcription,O,O
factor,O,O
GAMyb,B,B
",",O,O
which,O,O
is,O,O
itself,O,O
induced,O,O
by,O,O
GA,O,O
.,O,O
If,O,O
facilities,O,O
for,O,O
measurements,O,O
of,O,O
O2,O,B
consumption,O,I
and,O,O
hence,O,O
metabolic,O,O
rate,O,O
are,O,O
available,O,O
",",O,O
these,O,O
should,O,O
be,O,O
utilized,O,O
.,O,O
Furthermore,O,O
",",O,O
transfection,O,O
of,O,O
cells,O,O
with,O,O
the,O,O
spacer,O,O
-,O,O
RING,O,B
domain,O,I
alone,O,O
suppressed,O,O
the,O,O
antiapoptotic,O,O
function,O,O
of,O,O
the,O,O
N,O,O
-,O,O
terminal,O,O
BIR,B,B
domain,O,I
of,O,O
c,B,O
-,I,O
IAP1,I,B
and,O,O
induced,O,O
apoptosis,O,O
.,O,O
Mutually,O,O
exclusive,O,O
interaction,O,O
of,O,O
the,O,O
adenovirus,B,O
E4,I,B
-,I,I
6,I,I
/,I,I
7,I,I
protein,I,I
and,O,O
the,O,O
retinoblastoma,B,B
gene,I,I
product,I,I
with,O,O
internal,O,O
domains,O,O
of,O,O
E2F,B,B
-,I,I
1,I,I
and,O,O
DP,B,B
-,I,I
1,I,I
.,O,O
Comparable,O,O
amounts,O,O
of,O,O
alpha,B,B
5,I,I
beta,I,I
1,I,I
integrin,I,I
were,O,O
isolated,O,O
from,O,O
these,O,O
cells,O,O
by,O,O
chromatography,O,O
of,O,O
detergent,O,O
extracts,O,O
on,O,O
a,O,O
fibronectin,B,O
cell,O,O
-,O,O
binding,O,O
fragment,O,O
affinity,O,O
column,O,O
and,O,O
elution,O,O
with,O,O
EDTA,O,O
.,O,O
Under,O,O
the,O,O
same,O,O
hematocrit,O,O
and,O,O
flow,O,O
conditions,O,O
",",O,O
the,O,O
rate,O,O
of,O,O
oxygen,O,O
saturation,O,O
decrease,O,O
was,O,O
significantly,O,O
higher,O,O
for,O,O
the,O,O
sickle,O,O
cells,O,O
than,O,O
for,O,O
normal,O,O
cells,O,O
.,O,O
Sequence,O,O
analysis,O,O
revealed,O,O
significant,O,O
differences,O,O
between,O,O
the,O,O
5,O,O
',O,O
region,O,O
of,O,O
the,O,O
beta,O,B
subunit,O,I
gene,O,I
and,O,O
the,O,O
corresponding,O,O
regions,O,O
of,O,O
the,O,O
homologous,B,O
GlyR,I,B
alpha,I,I
subunit,I,I
genes,I,O
;,O,O
it,O,O
also,O,O
identified,O,O
a,O,O
novel,O,O
exon,O,O
(,O,O
exon,O,O
0,O,O
),O,O
that,O,O
encodes,O,O
most,O,O
of,O,O
the,O,O
5,O,O
',O,O
-,O,O
untranslated,O,O
portion,O,O
of,O,O
the,O,O
GlyR,B,B
beta,I,I
mRNA,I,I
.,O,O
The,O,O
different,O,O
holoenzyme,B,O
RNA,I,O
polymerases,I,O
generated,O,O
upon,O,O
reconstituting,O,O
these,O,O
mutants,O,O
independently,O,O
with,O,O
core,B,O
RNA,I,O
polymerase,I,O
(,O,O
alpha2beta,B,B
beta,I,I
',I,I
),O,O
have,O,O
shown,O,O
reduced,O,O
transcriptional,O,O
activity,O,O
in,O,O
comparison,O,O
to,O,O
the,O,O
enzyme,O,O
containing,O,O
wild,B,O
-,I,O
type,I,O
sigma,I,B
factor,I,I
.,O,O
Its,O,O
organization,O,O
and,O,O
regulation,O,O
indicate,O,O
that,O,O
the,O,O
S,B,B
.,I,O
pombe,I,I
URA1,I,B
gene,I,I
product,I,I
appears,O,O
very,O,O
similar,O,O
to,O,O
the,O,O
S,B,B
.,I,O
cerevisiae,I,I
URA2,I,B
gene,I,I
product,I,I
.,O,O
These,O,O
data,O,O
show,O,O
that,O,O
the,O,O
alpha,O,O
-,O,O
helix,O,O
domain,O,O
of,O,O
p57,B,B
(,O,O
Kip2,B,I
),O,O
",",O,O
which,O,O
is,O,O
conserved,O,O
in,O,O
the,O,O
Cip,B,B
/,O,I
Kip,B,I
proteins,O,I
",",O,O
is,O,O
implicated,O,O
in,O,O
protein,O,O
-,O,O
protein,O,O
interaction,O,O
and,O,O
confers,O,O
a,O,O
specific,O,O
regulatory,O,O
mechanism,O,O
",",O,O
outside,O,O
of,O,O
their,O,O
Cdk,B,B
-,O,I
inhibitory,O,I
activity,O,I
",",O,O
by,O,O
which,O,O
the,O,O
p57,B,B
(,O,O
Kip2,B,I
),O,O
family,O,O
members,O,O
positively,O,O
act,O,O
on,O,O
myogenic,O,O
differentiation,O,O
.,O,O
Badcock,O,B
and,O,O
Westheimer,O,B
(,O,O
Spatial,O,B
Vision,O,I
1,O,I
(,O,O
1,O,O
),O,O
",",O,O
3,O,O
-,O,O
11,O,O
",",O,O
1985,O,O
),O,O
showed,O,O
that,O,O
a,O,O
thin,O,O
vertical,O,O
line,O,O
induces,O,O
nearby,O,O
zones,O,O
of,O,O
attraction,O,O
and,O,O
repulsion,O,O
;,O,O
this,O,O
study,O,O
extends,O,O
those,O,O
results,O,O
by,O,O
more,O,O
closely,O,O
examining,O,O
the,O,O
horizontal,O,O
and,O,O
vertical,O,O
extents,O,O
of,O,O
the,O,O
repulsion,O,O
zone,O,O
and,O,O
by,O,O
using,O,O
an,O,O
illusory,O,O
contour,O,O
to,O,O
induce,O,O
repulsion,O,O
.,O,O
Because,O,O
the,O,O
human,B,B
Antp,I,B
TATAA,I,I
binding,I,I
protein,I,I
is,O,O
expressed,O,O
in,O,O
both,O,O
lymphoid,O,O
and,O,O
non,O,O
-,O,O
lymphoid,O,O
cells,O,O
",",O,O
we,O,O
suggest,O,O
that,O,O
this,O,O
homeobox,B,B
gene,I,I
has,O,O
evolved,O,O
a,O,O
more,O,O
general,O,O
transcriptional,O,O
regulatory,O,O
function,O,O
in,O,O
higher,O,O
eukaryotic,O,O
cells,O,O
.,O,O
The,O,O
pyrR,B,B
and,O,O
pyrP,B,B
genes,I,I
encoded,O,O
polypeptides,O,O
with,O,O
calculated,O,O
molecular,O,O
masses,O,O
of,O,O
19,O,O
.,O,O
9,O,O
and,O,O
45,O,O
.,O,O
2,O,O
kDa,O,O
",",O,O
respectively,O,O
.,O,O
Instead,O,O
",",O,O
they,O,O
contained,O,O
dendritic,O,O
cells,O,O
that,O,O
express,O,O
melanogenic,O,O
marker,O,O
proteins,O,O
such,O,O
as,O,O
tyrosinase,B,B
and,O,O
tyrosinase,B,B
-,I,I
related,I,I
protein,I,I
1,I,I
.,O,O
Since,O,O
AP,B,B
-,I,I
1,I,I
is,O,O
an,O,O
important,O,O
mediator,O,O
of,O,O
tumor,O,O
promoter,O,O
action,O,O
",",O,O
these,O,O
findings,O,O
may,O,O
explain,O,O
the,O,O
anti,O,O
-,O,O
tumor,O,O
-,O,O
promoting,O,O
activity,O,O
of,O,O
phenolic,O,O
antioxidants,O,O
.,O,O
Mean,O,O
fluorosis,O,O
scores,O,O
",",O,O
however,O,O
",",O,O
were,O,O
similar,O,O
.,O,O
The,O,O
RAT3,B,B
gene,I,O
encodes,O,O
an,O,O
1157,O,O
-,O,O
amino,O,O
protein,O,O
without,O,O
similarity,O,O
to,O,O
other,O,O
known,O,O
proteins,O,O
.,O,O
All,O,O
four,O,O
domains,O,O
were,O,O
linked,O,O
via,O,O
proline,O,O
-,O,O
threonine,O,O
-,O,O
rich,O,O
peptides,O,O
.,O,O
Viruses,O,O
were,O,O
isolated,O,O
from,O,O
9,O,O
lungs,O,O
:,O,O
7,O,O
with,O,O
PI,O,O
-,O,O
3V,O,O
",",O,O
1,O,O
with,O,O
NCP,O,O
BVDV,O,O
type,O,O
1,O,O
",",O,O
and,O,O
1,O,O
with,O,O
both,O,O
BVHV,O,O
-,O,O
1,O,O
and,O,O
BVDV,O,O
.,O,O
Demonstration,O,O
of,O,O
tissue,O,O
lesions,O,O
after,O,O
intramuscular,O,O
injection,O,O
by,O,O
determination,O,O
of,O,O
creatine,B,B
kinase,I,I
in,O,O
blood,O,O
Most,O,O
strains,O,O
(,O,O
95,O,O
%,O,O
),O,O
of,O,O
S,O,B
.,O,O
lugdunensis,O,I
produced,O,O
a,O,O
delta,B,O
hemolysin,I,O
like,O,O
that,O,O
seen,O,O
with,O,O
nine,O,O
other,O,O
species,O,O
of,O,O
CNS,O,O
.,O,O
The,O,O
promoter,O,O
was,O,O
stimulated,O,O
8,O,O
-,O,O
20,O,O
-,O,O
fold,O,O
by,O,O
phorbol,O,O
esters,O,O
accounting,O,O
for,O,O
the,O,O
previously,O,O
observed,O,O
transcriptional,O,O
activation,O,O
of,O,O
protein,B,O
kinase,I,B
C,I,I
beta,I,I
.,O,O
Previously,O,O
",",O,O
we,O,O
reported,O,O
that,O,O
scanthrough,O,O
translation,O,O
",",O,O
where,O,O
the,O,O
initiating,O,O
AUG,O,B
of,O,O
a,O,O
primary,O,O
open,O,O
reading,O,O
frame,O,O
is,O,O
bypassed,O,O
",",O,O
is,O,O
most,O,O
likely,O,O
to,O,O
account,O,O
for,O,O
the,O,O
presentation,O,O
of,O,O
cryptic,O,O
epitopes,O,O
from,O,O
alternative,O,O
reading,O,O
frames,O,O
within,O,O
the,O,O
influenza,B,B
A,I,I
PR,I,I
/,I,I
8,I,I
/,I,I
34,I,I
nucleoprotein,I,I
gene,I,I
.,O,O
SCOB,O,O
testing,O,O
of,O,O
food,O,O
-,O,O
restricted,O,O
animals,O,O
",",O,O
using,O,O
a,O,O
multiple,O,O
fixed,O,O
ratio,O,O
(,O,O
FR,O,O
),O,O
/,O,O
fixed,O,O
interval,O,O
(,O,O
FI,O,O
),O,O
schedule,O,O
(,O,O
FR20,O,O
:,O,O
FI120,O,O
),O,O
",",O,O
was,O,O
conducted,O,O
prior,O,O
to,O,O
each,O,O
exposure,O,O
to,O,O
maintain,O,O
the,O,O
operant,O,O
behavior,O,O
;,O,O
the,O,O
data,O,O
from,O,O
Weeks,O,O
-,O,O
1,O,O
",",O,O
4,O,O
",",O,O
8,O,O
",",O,O
and,O,O
13,O,O
were,O,O
evaluated,O,O
for,O,O
evidence,O,O
of,O,O
neurotoxicity,O,O
.,O,O
Higher,O,O
fasting,O,O
serum,O,O
gastrin,B,B
concentration,O,O
(,O,O
102,O,O
.,O,O
0,O,O
+,O,O
/,O,O
-,O,O
21,O,O
.,O,O
1,O,O
vs,O,O
63,O,O
.,O,O
3,O,O
+,O,O
/,O,O
-,O,O
8,O,O
.,O,O
3,O,O
ng,O,O
.,O,O
l,O,O
-,O,O
1,O,O
),O,O
",",O,O
and,O,O
greater,O,O
postprandial,O,O
gastrin,B,B
release,O,O
(,O,O
AUC0,O,O
-,O,O
120,O,O
:,O,O
16690,O,O
+,O,O
/,O,O
-,O,O
2648,O,O
vs,O,O
10654,O,O
+,O,O
/,O,O
-,O,O
1283,O,O
ng,O,O
.,O,O
l,O,O
-,O,O
1,O,O
min,O,O
),O,O
were,O,O
observed,O,O
after,O,O
VTP,O,O
-,O,O
HM,O,O
than,O,O
after,O,O
VTP,O,O
-,O,O
Cas,O,O
.,O,O
Mutations,O,O
within,O,O
conserved,O,O
region,O,O
2,O,O
(,O,O
CR2,O,B
),O,O
of,O,O
E1A,B,B
that,O,O
inhibit,O,O
the,O,O
binding,O,O
of,O,O
E1A,B,B
to,O,O
the,O,O
retinoblastoma,B,B
gene,I,I
product,I,I
(,O,O
pRb,B,B
),O,O
further,O,O
enhanced,O,O
the,O,O
stimulation,O,O
of,O,O
transcription,O,O
from,O,O
the,O,O
PEPCK,B,B
promoter,I,O
by,O,O
2,O,O
3,O,O
-,O,O
fold,O,O
compared,O,O
with,O,O
wild,B,O
type,I,O
E1A,I,B
.,O,O
Several,O,O
of,O,O
the,O,O
exon,O,O
boundaries,O,O
correspond,O,O
to,O,O
the,O,O
boundaries,O,O
of,O,O
functional,O,O
domains,O,O
in,O,O
the,O,O
p55,B,B
protein,I,O
.,O,O
It,O,O
is,O,O
thus,O,O
one,O,O
of,O,O
the,O,O
key,O,O
enzymes,O,O
involved,O,O
in,O,O
the,O,O
triiodothyronine,O,B
-,O,I
mediated,O,I
control,O,O
of,O,O
growth,O,O
",",O,O
differentiation,O,O
and,O,O
basal,O,O
metabolism,O,O
in,O,O
vertebrates,O,O
.,O,O
We,O,O
used,O,O
stored,O,O
plasma,O,O
samples,O,O
from,O,O
409,O,O
patients,O,O
in,O,O
the,O,O
National,O,O
Institute,O,O
of,O,O
Neurological,O,O
Diseases,O,O
and,O,O
Stroke,O,O
(,O,O
NINDS,O,O
),O,O
tissue,B,O
plasminogen,I,O
activator,I,O
(,O,O
t,B,O
-,I,O
PA,I,O
),O,O
Stroke,O,O
Trial,O,O
to,O,O
examine,O,O
the,O,O
relationship,O,O
between,O,O
an,O,O
apolipoprotein,B,B
(,I,O
Apo,I,B
),I,O
E2,I,O
or,O,O
an,O,O
Apo,B,B
E4,I,O
phenotype,O,O
and,O,O
a,O,O
favorable,O,O
outcome,O,O
3,O,O
months,O,O
after,O,O
stroke,O,O
",",O,O
the,O,O
risk,O,O
of,O,O
intracerebral,O,O
hemorrhage,O,O
",",O,O
and,O,O
the,O,O
response,O,O
to,O,O
intravenous,O,O
t,B,O
-,I,O
PA,I,O
therapy,O,O
.,O,O
Mapping,O,O
of,O,O
intracellular,O,O
localization,O,O
domains,O,O
and,O,O
evidence,O,O
for,O,O
colocalization,O,O
interactions,O,O
between,O,O
the,O,O
IE110,B,B
and,O,O
IE175,B,B
nuclear,O,O
transactivator,O,O
proteins,O,O
of,O,O
herpes,O,O
simplex,O,O
virus,O,O
.,O,O
The,O,O
Stryker,O,O
frame,O,O
modification,O,O
to,O,O
the,O,O
standard,O,O
Dornier,O,O
HM3,O,O
lithotriptor,O,O
allows,O,O
for,O,O
improved,O,O
visualization,O,O
and,O,O
easier,O,O
localization,O,O
of,O,O
distal,O,O
ureteral,O,O
calculi,O,O
compared,O,O
to,O,O
the,O,O
standard,O,O
gantry,O,O
.,O,O
Vimentin,B,B
positivity,O,O
was,O,O
noted,O,O
in,O,O
the,O,O
undifferentiated,O,O
and,O,O
fibroblastic,O,O
components,O,O
.,O,O
Both,O,O
immunophilins,B,O
may,O,O
have,O,O
important,O,O
roles,O,O
in,O,O
receptor,O,O
assembly,O,O
and,O,O
may,O,O
represent,O,O
a,O,O
new,O,O
category,O,O
of,O,O
ligand,O,O
-,O,O
and,O,O
calcium,O,O
-,O,O
dependent,O,O
modulators,O,O
of,O,O
protein,O,O
function,O,O
.,O,O
Cytohesin,B,B
-,I,I
1,I,I
",",O,O
a,O,O
protein,O,O
abundant,O,O
in,O,O
cells,O,O
of,O,O
the,O,O
immune,O,O
system,O,O
",",O,O
has,O,O
been,O,O
proposed,O,O
to,O,O
be,O,O
a,O,O
human,O,O
homolog,O,O
of,O,O
the,O,O
Saccharomyces,B,B
cerevisiae,I,I
Sec7,I,I
gene,I,I
product,I,I
",",O,O
which,O,O
is,O,O
crucial,O,O
in,O,O
protein,O,O
transport,O,O
.,O,O
Increased,O,O
erythropoietin,B,B
synthesis,O,O
in,O,O
patients,O,O
with,O,O
COLD,O,O
or,O,O
left,O,O
heart,O,O
failure,O,O
is,O,O
related,O,O
to,O,O
alterations,O,O
in,O,O
renal,O,O
haemodynamics,O,O
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
Cdc42p,B,B
is,O,O
in,O,O
fact,O,O
required,O,O
for,O,O
pheromone,O,O
response,O,O
and,O,O
that,O,O
interaction,O,O
with,O,O
the,O,O
PAK,B,B
Ste20p,B,I
is,O,O
critical,O,O
for,O,O
that,O,O
role,O,O
.,O,O
The,O,O
Lp,B,O
mouse,I,O
mutant,I,O
provides,O,O
a,O,O
model,O,O
for,O,O
the,O,O
severe,O,O
human,O,B
neural,O,I
tube,O,I
defect,O,I
(,O,O
NTD,O,O
),O,O
",",O,O
cranio,O,O
-,O,O
rachischisis,O,O
.,O,O
These,O,O
results,O,O
implicate,O,O
a,O,O
precursor,O,O
-,O,O
specific,O,O
base,O,O
-,O,O
paired,O,O
structure,O,O
involving,O,O
sequences,O,O
on,O,O
both,O,O
sides,O,O
of,O,O
the,O,O
mature,O,O
cleavage,O,O
site,O,O
in,O,O
the,O,O
3,O,O
',O,O
processing,O,O
of,O,O
human,B,B
U2,I,I
RNA,I,I
.,O,O
Taken,O,O
together,O,O
",",O,O
these,O,O
results,O,O
indicate,O,O
that,O,O
MAP,B,B
kinase,I,I
stimulates,O,O
the,O,O
hPL,B,B
-,I,I
B,I,I
enhancer,I,I
by,O,O
an,O,O
NF,B,B
-,I,I
IL,I,I
-,I,I
6,I,I
-,O,I
dependent,O,I
pathway,O,I
.,O,O
The,O,O
discussion,O,O
focuses,O,O
primarily,O,O
on,O,O
the,O,O
newer,O,O
drugs,O,O
like,O,O
angiotensin,B,B
converting,I,I
enzyme,I,I
inhibitors,O,I
",",O,O
alpha,B,B
-,I,I
adrenergic,I,I
receptor,I,I
blockers,O,I
",",O,O
and,O,O
calcium,O,B
antagonists,O,I
.,O,O
Specific,O,O
IgE,B,B
levels,O,O
decreased,O,O
slightly,O,O
",",O,O
but,O,O
always,O,O
remained,O,O
within,O,O
the,O,O
pathological,O,O
range,O,O
.,O,O
Two,O,O
patients,O,O
with,O,O
recurrent,O,O
tumors,O,O
had,O,O
high,O,O
S,O,B
-,O,I
phase,O,I
fractions,O,O
both,O,O
on,O,O
the,O,O
first,O,O
resected,O,O
specimens,O,O
and,O,O
at,O,O
the,O,O
time,O,O
of,O,O
the,O,O
second,O,O
operation,O,O
.,O,O
Comparison,O,O
of,O,O
immunoassay,O,O
kits,O,O
for,O,O
detection,O,O
of,O,O
staphylococcal,B,O
enterotoxins,I,O
produced,O,O
by,O,O
Staphylococcus,O,B
aureus,O,I
Transfection,O,O
analyses,O,O
indicated,O,O
that,O,O
the,O,O
expression,O,O
of,O,O
Tbxas1,B,B
is,O,O
controlled,O,O
by,O,O
a,O,O
short,O,O
(,O,O
70,O,O
-,O,O
bp,O,O
),O,O
positive,O,O
regulatory,O,O
sequence,O,O
and,O,O
several,O,O
upstream,O,O
repressive,O,O
elements,O,O
.,O,O
Polycythemia,O,B
-,O,I
1973,O,O
.,O,O
Computer,O,O
analysis,O,O
included,O,O
digital,O,O
averaging,O,O
",",O,O
followed,O,O
by,O,O
digital,O,O
filtering,O,O
in,O,O
different,O,O
frequency,O,O
bands,O,O
in,O,O
order,O,O
to,O,O
determine,O,O
the,O,O
frequency,O,O
range,O,O
corresponding,O,O
to,O,O
notches,O,O
and,O,O
slurs,O,O
.,O,O
Effect,O,O
of,O,O
castration,O,O
on,O,O
pituitary,B,O
and,I,O
serum,I,O
LH,I,B
and,O,O
FSH,B,B
in,O,O
testosterone,O,O
-,O,O
sterilized,O,O
rats,O,O
.,O,O
265,O,O
",",O,O
1102,O,O
-,O,O
1110,O,O
.,O,O
Use,O,O
of,O,O
free,O,O
-,O,O
access,O,O
minerals,O,O
.,O,O
The,O,O
application,O,O
of,O,O
the,O,O
biotechnology,O,O
at,O,O
the,O,O
plants,O,O
for,O,O
treatment,O,O
of,O,O
the,O,O
surface,O,O
storm,O,O
waters,O,O
from,O,O
the,O,O
industrial,O,O
zone,O,O
Telychka,O,O
of,O,O
the,O,O
city,O,O
of,O,O
Kyiv,O,O
has,O,O
allowed,O,O
the,O,O
content,O,O
of,O,O
petroleum,O,O
in,O,O
water,O,O
dropped,O,O
to,O,O
the,O,O
Dnieper,O,O
to,O,O
be,O,O
constantly,O,O
reduced,O,O
50,O,O
-,O,O
100,O,O
times,O,O
.,O,O
Eight,O,O
cats,O,O
infected,O,O
with,O,O
H,O,B
were,O,O
used,O,O
in,O,O
the,O,O
study,O,O
.,O,O
After,O,O
a,O,O
year,O,O
of,O,O
planning,O,O
in,O,O
the,O,O
Laboratory,O,O
Assistants,O,O
',O,O
School,O,O
in,O,O
Stockholm,O,O
:,O,O
new,O,O
education,O,O
for,O,O
laboratory,O,O
assistants,O,O
is,O,O
now,O,O
arranged,O,O
Substantial,O,O
evidence,O,O
supports,O,O
a,O,O
critical,O,O
role,O,O
for,O,O
the,O,O
activation,O,O
of,O,O
the,O,O
Raf,B,B
-,I,I
1,I,I
/,O,I
MEK,B,B
/,O,I
mitogen,B,I
-,I,I
activated,I,I
protein,I,I
kinase,I,I
pathway,O,O
in,O,O
oncogenic,O,O
Ras,B,B
-,O,I
mediated,O,I
transformation,O,O
.,O,O
The,O,O
amino,O,O
acid,O,O
sequence,O,O
alignment,O,O
of,O,O
TC,B,B
II,I,I
with,O,O
that,O,O
of,O,O
other,O,O
Cbl,B,B
binding,I,O
proteins,I,O
(,O,O
rat,B,O
intrinsic,I,O
factor,I,O
",",O,O
human,B,B
transcobalamin,I,I
I,I,I
and,O,O
porcine,B,O
haptocorrin,I,O
),O,O
revealed,O,O
only,O,O
33,O,O
%,O,O
overall,O,O
homology,O,O
.,O,O
A,O,O
reciprocal,O,O
binding,O,O
assay,O,O
using,O,O
IM,O,O
-,O,O
9,O,O
cells,O,O
as,O,O
a,O,O
source,O,O
of,O,O
SHP,B,B
-,I,I
1,I,I
and,O,O
SHP,B,B
-,I,I
2,I,I
revealed,O,O
specific,O,O
association,O,O
of,O,O
SHP,B,B
-,I,I
2,I,I
(,O,O
but,O,O
not,O,O
SHP,B,B
-,I,I
1,I,I
),O,O
with,O,O
a,O,O
glutathione,B,O
S,I,O
-,I,O
transferase,I,O
fusion,I,O
incorporating,O,O
GHR,B,O
cytoplasmic,I,O
domain,I,O
residues,I,O
485,I,O
-,I,O
620,I,O
",",O,O
but,O,O
only,O,O
if,O,O
the,O,O
fusion,O,O
was,O,O
first,O,O
rendered,O,O
tyrosine,O,O
-,O,O
phosphorylated,O,O
.,O,O
Several,O,O
mutations,O,O
disrupted,O,O
the,O,O
endonuclease,O,B
and,O,O
helicase,B,B
activities,O,O
;,O,O
however,O,O
",",O,O
only,O,O
one,O,O
amino,B,B
-,I,I
terminal,I,I
-,I,I
charge,I,I
cluster,I,I
mutant,I,I
protein,I,O
(,O,O
D40A,O,B
-,O,I
D42A,O,I
-,O,I
D44A,O,I
),O,O
completely,O,O
lost,O,O
AAV,O,B
hairpin,O,I
DNA,O,I
binding,O,I
activity,O,O
.,O,O
The,O,O
antinociceptive,O,O
properties,O,O
",",O,O
as,O,O
measured,O,O
by,O,O
the,O,O
tail,O,O
-,O,O
flick,O,O
and,O,O
hot,O,O
-,O,O
plate,O,O
tests,O,O
",",O,O
and,O,O
the,O,O
motor,O,O
effects,O,O
of,O,O
an,O,O
intrathecally,O,O
-,O,O
administered,O,O
benzodiazepine,O,O
agonist,O,O
midazolam,O,O
",",O,O
alone,O,O
",",O,O
and,O,O
in,O,O
combination,O,O
with,O,O
morphine,O,O
",",O,O
was,O,O
examined,O,O
in,O,O
rats,O,O
.,O,O
Insulin,B,B
-,I,I
like,I,I
growth,I,I
factor,I,I
1,I,I
(,O,O
IGF,B,B
-,I,I
1,I,I
),O,O
in,O,O
burn,O,O
patients,O,O
.,O,O
The,O,O
84,B,O
.,I,O
1C,I,O
mAb,I,O
recognizes,O,O
a,O,O
site,O,O
on,O,O
IgE,B,B
which,O,O
is,O,O
identical,O,O
or,O,O
very,O,O
close,O,O
to,O,O
the,O,O
Fc,B,O
epsilon,I,O
R,I,O
binding,I,O
site,I,O
",",O,O
and,O,O
95,O,O
.,O,O
3,O,O
recognizes,O,O
a,O,O
site,O,O
on,O,O
IgE,B,B
which,O,O
is,O,O
related,O,O
",",O,O
but,O,O
not,O,O
identical,O,O
to,O,O
the,O,O
Fc,B,O
epsilon,I,O
R,I,O
binding,I,O
site,I,O
.,O,O
The,O,O
models,O,O
were,O,O
tested,O,O
by,O,O
studying,O,O
their,O,O
response,O,O
to,O,O
disturbances,O,O
of,O,O
the,O,O
afferent,O,O
signal,O,O
from,O,O
the,O,O
bladder,O,O
.,O,O
Abrogation,O,O
of,O,O
p53,B,B
function,O,O
by,O,O
E6,B,B
resulted,O,O
in,O,O
an,O,O
increase,O,O
in,O,O
the,O,O
spontaneous,O,O
mutation,O,O
frequencies,O,O
at,O,O
the,O,O
heterozygous,O,O
thymidine,B,B
kinase,I,I
(,O,O
TK,B,B
),O,O
locus,O,O
but,O,O
not,O,O
at,O,O
the,O,O
hemizygous,O,O
hypoxanthine,B,B
phosphoribosyl,I,I
transferase,I,I
(,O,O
HPRT,B,B
),O,O
locus,O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
ChromaFlo,O,O
-,O,O
enhanced,O,O
IVUS,O,O
demonstrates,O,O
colorized,O,O
blood,O,O
flow,O,O
inside,O,O
the,O,O
vessel,O,O
lumen,O,O
",",O,O
which,O,O
is,O,O
helpful,O,O
in,O,O
distinguishing,O,O
echolucent,O,O
disease,O,O
from,O,O
luminal,O,O
blood,O,O
flow,O,O
and,O,O
can,O,O
also,O,O
be,O,O
used,O,O
to,O,O
perform,O,O
peripheral,O,O
interventions,O,O
in,O,O
patients,O,O
with,O,O
renal,O,O
failure,O,O
or,O,O
allergy,O,O
",",O,O
avoiding,O,O
the,O,O
use,O,O
of,O,O
contrast,O,O
media,O,O
.,O,O
In,O,O
contrast,O,O
to,O,O
the,O,O
selective,O,O
expression,O,O
of,O,O
the,O,O
receptor,O,O
",",O,O
FL,B,B
expression,O,O
was,O,O
detected,O,O
in,O,O
90,O,O
-,O,O
100,O,O
%,O,O
of,O,O
the,O,O
various,O,O
cell,O,O
types,O,O
of,O,O
leukemia,O,O
cell,O,O
lines,O,O
from,O,O
all,O,O
hematopoietic,O,O
cell,O,O
lineages,O,O
.,O,O
The,O,O
cDNA,O,O
has,O,O
an,O,O
open,O,O
reading,O,O
frame,O,O
of,O,O
900,O,O
amino,O,O
acids,O,O
capable,O,O
of,O,O
encoding,O,O
a,O,O
97,O,O
-,O,O
kDa,O,O
protein,O,O
.,O,O
Antihistamines,O,O
in,O,O
asthma,O,O
.,O,O
In,O,O
view,O,O
of,O,O
the,O,O
presence,O,O
of,O,O
SECIS,O,B
elements,O,I
in,O,O
the,O,O
open,O,O
reading,O,O
frames,O,O
(,O,O
ORFs,O,O
),O,O
of,O,O
bacterial,B,O
selenoproteins,I,O
",",O,O
we,O,O
examine,O,O
the,O,O
effects,O,O
in,O,O
the,O,O
type,B,O
1,I,O
deiodinase,I,O
of,O,O
extending,O,O
the,O,O
ORF,O,O
into,O,O
the,O,O
SECIS,O,B
element,O,I
",",O,O
and,O,O
find,O,O
that,O,O
this,O,O
dramatically,O,O
inhibits,O,O
SECIS,O,B
function,O,O
.,O,O
In,O,O
the,O,O
8,O,O
patients,O,O
the,O,O
difference,O,O
betweent,O,O
he,O,O
mean,O,O
diastolic,O,O
values,O,O
of,O,O
delta,O,O
PU,O,O
and,O,O
delta,O,O
PM,O,O
was,O,O
-,O,O
0,O,O
.,O,O
54,O,O
+,O,O
/,O,O
-,O,O
1,O,O
.,O,O
0,O,O
(,O,O
SD,O,O
),O,O
mmHg,O,O
.,O,O
For,O,O
immunological,O,O
methods,O,O
",",O,O
identification,O,O
of,O,O
such,O,O
antigens,O,O
with,O,O
intermolecular,O,O
variability,O,O
",",O,O
e,O,O
.,O,O
g,O,O
.,O,O
",",O,O
the,O,O
structural,O,O
aescin,O,O
analogs,O,O
",",O,O
is,O,O
of,O,O
unknown,O,O
validity,O,O
.,O,O
CONCLUSION,O,O
:,O,O
The,O,O
MTD,O,O
for,O,O
CPT,O,B
-,O,I
11,O,I
administered,O,O
in,O,O
a,O,O
3,O,O
consecutive,O,O
-,O,O
days,O,O
-,O,O
every,O,O
-,O,O
3,O,O
weeks,O,O
schedule,O,O
in,O,O
this,O,O
patient,O,O
population,O,O
is,O,O
115,O,O
mg,O,O
/,O,O
m2,O,O
/,O,O
day,O,O
.,O,O
The,O,O
hormonal,O,O
response,O,O
to,O,O
a,O,O
standardized,O,O
bicycle,O,O
exercise,O,O
test,O,O
was,O,O
studied,O,O
in,O,O
11,O,O
male,O,O
cadets,O,O
exposed,O,O
to,O,O
a,O,O
course,O,O
of,O,O
107,O,O
h,O,O
of,O,O
continuous,O,O
activity,O,O
with,O,O
less,O,O
than,O,O
2,O,O
h,O,O
sleep,O,O
.,O,O
Under,O,O
our,O,O
conditions,O,O
",",O,O
the,O,O
combination,O,O
O3,O,O
/,O,O
UV,O,O
did,O,O
not,O,O
improve,O,O
the,O,O
degradation,O,O
rate,O,O
obtained,O,O
by,O,O
ozonation,O,O
.,O,O
A,O,O
second,O,O
important,O,O
molecule,O,O
in,O,O
TCR,B,B
signal,O,I
transduction,O,I
is,O,O
the,O,O
guanine,B,B
nucleotide,I,I
binding,I,I
protein,I,I
",",O,O
p21ras,B,B
",",O,O
which,O,O
is,O,O
coupled,O,O
to,O,O
the,O,O
TCR,B,O
by,O,O
a,O,O
protein,B,O
tyrosine,I,O
kinase,I,O
dependent,O,O
mechanism,O,O
.,O,O
However,O,O
",",O,O
while,O,O
the,O,O
sequence,O,O
similarity,O,O
between,O,O
the,O,O
membrane,O,O
exons,O,O
of,O,O
avian,B,O
mIgY,I,B
and,O,O
mammalian,B,O
mIgG,I,B
and,I,O
IgE,I,B
is,O,O
striking,O,O
",",O,O
the,O,O
overall,O,O
similarity,O,O
with,O,O
Xenopus,B,O
mIgY,I,B
is,O,O
very,O,O
low,O,O
.,O,O
2,O,O
),O,O
The,O,O
time,O,O
-,O,O
sharing,O,O
principle,O,O
was,O,O
applied,O,O
to,O,O
gain,O,O
high,O,O
stability,O,O
.,O,O
The,O,O
contribution,O,O
that,O,O
alternative,O,O
splicing,O,O
events,O,O
in,O,O
c,B,O
-,I,O
myb,I,O
expression,O,O
may,O,O
make,O,O
on,O,O
c,B,O
-,I,O
myb,I,O
function,O,O
remains,O,O
to,O,O
be,O,O
elucidated,O,O
.,O,O
The,O,O
Nostoc,O,B
petBD,B,I
genes,I,O
are,O,O
not,O,O
closely,O,O
linked,O,O
to,O,O
the,O,O
psbB,B,B
gene,I,O
(,O,O
encoding,O,O
the,O,O
51,O,O
-,O,O
kDa,O,O
photosystem,B,O
II,I,O
polypeptide,I,O
),O,O
and,O,O
do,O,O
not,O,O
contain,O,O
introns,O,O
as,O,O
do,O,O
the,O,O
closely,O,O
related,O,O
chloroplast,O,O
genes,O,O
.,O,O
The,O,O
first,O,O
case,O,O
of,O,O
HCV,O,B
seroconversion,O,O
in,O,O
Portugal,O,O
after,O,O
the,O,O
introduction,O,O
of,O,O
HCV,O,B
NAT,O,I
screening,O,O
.,O,O
Detection,O,O
of,O,O
exercise,O,O
-,O,O
induced,O,O
asynergy,O,O
by,O,O
M,O,B
-,O,I
mode,O,I
echocardiography,O,I
.,O,O
Colorectal,O,O
cancer,O,O
was,O,O
shown,O,O
to,O,O
disproportionately,O,O
overburden,O,O
Ashkenazi,O,B
Jews,O,I
",",O,O
who,O,O
may,O,O
also,O,O
be,O,O
at,O,O
increased,O,O
risk,O,O
for,O,O
ovarian,O,B
",",O,O
pancreatic,O,B
and,O,O
stomach,O,B
cancer,O,I
",",O,O
and,O,O
non,O,O
-,O,O
Hodgkin,O,B
',O,I
s,O,I
lymphoma,O,I
.,O,O
Statins,B,O
:,O,O
lower,O,O
lipids,O,O
and,O,O
better,O,O
bones,O,O
?,O,O
Although,O,O
statins,O,O
are,O,O
widely,O,O
used,O,O
as,O,O
cholesterol,O,O
-,O,O
lowering,O,O
drugs,O,O
",",O,O
a,O,O
recent,O,O
study,O,O
suggests,O,O
that,O,O
these,O,O
compounds,O,O
have,O,O
anabolic,O,O
effects,O,O
on,O,O
bone,O,O
and,O,O
could,O,O
be,O,O
developed,O,O
into,O,O
new,O,O
treatments,O,O
for,O,O
common,O,O
metabolic,O,O
bone,O,O
diseases,O,O
such,O,O
as,O,O
osteoporosis,O,O
We,O,O
propose,O,O
a,O,O
model,O,O
in,O,O
which,O,O
Sro7,B,B
function,O,O
is,O,O
involved,O,O
in,O,O
the,O,O
targeting,O,O
of,O,O
the,O,O
myosin,B,B
proteins,I,I
to,O,O
their,O,O
intrinsic,O,O
pathways,O,O
.,O,O
A,O,O
study,O,O
of,O,O
chromosomes,O,O
of,O,O
lymphocytes,O,O
from,O,O
patients,O,O
treated,O,O
with,O,O
hycanthone,O,O
.,O,O
The,O,O
rate,O,O
of,O,O
enzymic,O,O
stimulation,O,O
induced,O,O
by,O,O
a,O,O
given,O,O
nitrate,O,O
correlates,O,O
closely,O,O
with,O,O
the,O,O
rate,O,O
of,O,O
measured,O,O
NO,O,B
production,O,O
from,O,O
the,O,O
nitrate,O,O
molecule,O,O
.,O,O
We,O,O
conclude,O,O
that,O,O
the,O,O
alpha,O,B
-,O,I
subunit,O,I
of,O,O
the,O,O
telomere,B,B
-,I,I
binding,I,I
protein,I,I
",",O,O
like,O,O
many,O,O
transcription,O,O
factors,O,O
",",O,O
has,O,O
separable,O,O
DNA,O,B
-,O,I
binding,O,I
and,O,O
protein,O,O
-,O,O
protein,O,O
interaction,O,O
domains,O,O
.,O,O
The,O,O
calcium,O,O
requirement,O,O
for,O,O
hypothermic,O,O
storage,O,O
of,O,O
the,O,O
cardiac,O,O
explant,O,O
.,O,O
A,O,O
subset,O,O
of,O,O
these,O,O
DMP1,B,B
recognition,I,O
sequences,I,O
containing,O,O
a,O,O
GGA,O,B
trinucleotide,O,I
core,O,I
can,O,O
also,O,O
function,O,O
as,O,O
Ets,B,B
-,I,I
responsive,I,I
elements,I,I
.,O,O
However,O,O
",",O,O
by,O,O
immobilized,O,O
metal,O,O
affinity,O,O
chromatography,O,O
assay,O,O
",",O,O
self,O,O
-,O,O
association,O,O
of,O,O
PR,B,B
-,I,I
A,I,I
was,O,O
3,O,O
.,O,O
5,O,O
-,O,O
fold,O,O
more,O,O
efficient,O,O
than,O,O
that,O,O
of,O,O
either,O,O
the,O,O
DhLBD,O,B
or,O,O
hLBD,O,B
constructs,O,O
.,O,O
A,O,O
large,O,O
deletion,O,O
in,O,O
the,O,O
CTD,B,O
-,I,O
binding,I,O
motif,I,O
blocks,O,O
down,O,O
-,O,O
regulation,O,O
but,O,O
does,O,O
not,O,O
affect,O,O
the,O,O
essential,O,O
function,O,O
of,O,O
Nrd1,B,B
.,O,O
Modeling,O,O
also,O,O
revealed,O,O
a,O,O
very,O,O
hydrophobic,O,O
surface,O,O
due,O,O
to,O,O
the,O,O
absence,O,O
of,O,O
H12,O,B
",",O,O
exposing,O,O
residues,O,O
from,O,O
H3,O,B
",",O,O
loop,O,O
3,O,O
-,O,O
4,O,O
",",O,O
H4,O,B
",",O,O
and,O,O
H11,O,B
.,O,O
These,O,O
similarities,O,O
suggest,O,O
that,O,O
these,O,O
E2,B,B
proteins,I,O
are,O,O
structurally,O,O
and,O,O
evolutionarily,O,O
related,O,O
.,O,O
Anti,B,O
-,I,O
CRK,I,B
antibodies,I,O
detect,O,O
a,O,O
53kDa,O,O
protein,O,O
in,O,O
extracts,O,O
of,O,O
C,O,O
.,O,O
fasciculata,O,O
in,O,O
agreement,O,O
with,O,O
the,O,O
size,O,O
predicted,O,O
from,O,O
the,O,O
nucleotide,O,O
sequence,O,O
of,O,O
the,O,O
cloned,O,O
gene,O,O
.,O,O
When,O,O
two,O,O
-,O,O
dimensional,O,O
polyacrylamide,O,O
gel,O,O
electrophoretic,O,O
patterns,O,O
of,O,O
[,O,O
35S,O,O
],O,O
methionine,O,O
-,O,O
labeled,O,O
proteins,O,O
secreted,O,O
from,O,O
cells,O,O
infected,O,O
with,O,O
parental,O,O
and,O,O
recombinant,O,O
viruses,O,O
were,O,O
compared,O,O
",",O,O
a,O,O
spot,O,O
missing,O,O
from,O,O
the,O,O
latter,O,O
corresponded,O,O
in,O,O
molecular,O,O
weigh,O,O
and,O,O
isoelectric,O,O
point,O,O
with,O,O
that,O,O
predicted,O,O
from,O,O
the,O,O
N1L,B,O
ORF,I,O
.,O,O
Secretory,B,O
IgA,I,B
and,O,O
serum,B,O
immunoglobulins,I,O
as,O,O
indices,O,O
of,O,O
the,O,O
local,O,O
immunity,O,O
of,O,O
the,O,O
intestinal,O,O
mucosa,O,O
in,O,O
acute,O,O
leukemias,O,O
A,O,O
20,O,O
-,O,O
base,O,O
pair,O,O
oligonucleotide,O,O
containing,O,O
this,O,O
nonamer,O,O
confers,O,O
up,O,O
-,O,O
regulation,O,O
by,O,O
hypoxia,O,O
and,O,O
inhibition,O,O
by,O,O
unsaturated,O,O
fatty,O,O
acids,O,O
when,O,O
placed,O,O
upstream,O,O
of,O,O
a,O,O
heterologous,O,O
promoter,O,O
in,O,O
a,O,O
lacZ,B,O
reporter,I,O
construct,I,O
.,O,O
Fecal,O,O
samples,O,O
were,O,O
collected,O,O
at,O,O
the,O,O
beginning,O,O
and,O,O
end,O,O
of,O,O
each,O,O
trial,O,O
period,O,O
and,O,O
were,O,O
analyzed,O,O
for,O,O
gastrointestinal,O,O
nematode,O,O
eggs,O,O
and,O,O
Giardia,O,B
cyst,O,I
.,O,O
The,O,O
MET4,B,B
gene,O,O
was,O,O
cloned,O,O
",",O,O
and,O,O
its,O,O
sequence,O,O
reveals,O,O
that,O,O
it,O,O
encodes,O,O
a,O,O
protein,O,O
related,O,O
to,O,O
the,O,O
family,O,O
of,O,O
the,O,O
bZIP,B,O
transcriptional,I,O
activators,I,O
.,O,O
Immunofluorescence,O,O
studies,O,O
in,O,O
C2C12,O,O
myotubes,O,O
show,O,O
that,O,O
Smad2,B,B
and,O,O
MEF2A,B,B
co,O,O
-,O,O
localise,O,O
in,O,O
the,O,O
nucleus,O,O
of,O,O
multinuclear,O,O
myotubes,O,O
during,O,O
differentiation,O,O
.,O,O
Tumor,B,B
necrosis,I,I
factor,I,I
signaling,O,O
to,O,O
stress,B,O
-,I,O
activated,I,O
protein,I,O
kinase,I,O
(,O,O
SAPK,B,B
),O,O
/,O,O
Jun,B,B
NH2,I,I
-,I,I
terminal,I,I
kinase,I,I
(,O,O
JNK,B,B
),O,O
and,O,O
p38,B,B
.,O,O
Inefficacy,O,O
of,O,O
phosphine,O,O
fumigation,O,O
against,O,O
ticks,O,O
.,O,O
The,O,O
tumor,B,O
-,I,O
suppressor,I,O
protein,I,O
p53,I,B
is,O,O
involved,O,O
in,O,O
maintaining,O,O
genomic,O,O
stability,O,O
.,O,O
Gel,O,O
filtration,O,O
and,O,O
co,O,O
-,O,O
immunoprecipitation,O,O
analyses,O,O
reveal,O,O
that,O,O
Mad2p,B,B
tightly,O,O
associates,O,O
with,O,O
another,O,O
spindle,O,O
checkpoint,O,O
component,O,O
",",O,O
Mad1p,B,B
.,O,O
Southern,O,O
blot,O,O
analysis,O,O
of,O,O
genomic,O,O
DNA,O,O
from,O,O
somatic,O,O
cell,O,O
hybrids,O,O
showed,O,O
that,O,O
endothelial,B,O
-,I,O
TACC,I,B
-,I,I
cDNA,I,O
maps,O,O
to,O,O
chromosome,O,O
10,O,O
.,O,O
AMY,B,B
-,I,I
1,I,I
was,O,O
localized,O,O
in,O,O
the,O,O
cytoplasm,O,O
in,O,O
cells,O,O
expressing,O,O
c,B,O
-,I,O
myc,I,O
at,O,O
low,O,O
levels,O,O
",",O,O
but,O,O
in,O,O
the,O,O
nucleus,O,O
in,O,O
the,O,O
cells,O,O
of,O,O
a,O,O
high,O,O
c,B,O
-,I,O
myc,I,O
expression,O,O
in,O,O
transiently,O,O
transfected,O,O
cells,O,O
.,O,O
The,O,O
paramyxovirus,B,B
fusion,I,I
(,I,O
F,I,B
),I,O
protein,I,O
mediates,O,O
membrane,O,O
fusion,O,O
.,O,O
This,O,O
region,O,O
of,O,O
hsp90,B,B
mediates,O,O
ATP,O,O
-,O,O
independent,O,O
chaperone,O,O
activity,O,O
",",O,O
overlaps,O,O
the,O,O
hsp90,B,B
dimerization,I,I
domain,I,I
",",O,O
and,O,O
includes,O,O
structural,O,O
elements,O,O
important,O,O
for,O,O
steroid,B,O
receptor,I,O
interaction,O,O
.,O,O
Maternal,O,O
lactation,O,O
A,O,O
particularly,O,O
striking,O,O
HpaII,B,O
tiny,O,O
fragment,O,O
island,O,O
",",O,O
extending,O,O
over,O,O
nearly,O,O
2,O,O
",",O,O
000,O,O
base,O,O
pairs,O,O
",",O,O
surrounds,O,O
the,O,O
USF2,B,B
translation,I,I
initiation,I,I
site,I,I
.,O,O
A,O,O
724,O,O
-,O,O
bp,O,O
segment,O,O
of,O,O
the,O,O
5,O,O
',O,O
-,O,O
flanking,O,O
region,O,O
consisting,O,O
of,O,O
the,O,O
proximal,O,O
E,O,B
-,O,I
box,O,I
flanked,O,O
upstream,O,O
by,O,O
a,O,O
mammalian,O,O
-,O,O
specific,O,O
352,O,O
-,O,O
bp,O,O
region,O,O
was,O,O
sufficient,O,O
for,O,O
maximal,O,O
transcriptional,O,O
activation,O,O
in,O,O
postconfluent,O,O
BC3H1,O,O
myoblasts,O,O
.,O,O
Comparisons,O,O
with,O,O
other,O,O
known,O,O
germins,B,O
and,O,O
germin,B,O
-,I,O
like,I,O
proteins,I,O
indicate,O,O
that,O,O
these,O,O
Arabidopsis,O,B
GLP,B,I
subfamilies,O,I
are,O,O
unique,O,O
from,O,O
wheat,O,O
germin,B,O
.,O,O
Also,O,O
",",O,O
the,O,O
amplitude,O,O
of,O,O
the,O,O
oscillatory,O,O
potentials,O,O
(,O,O
O1,O,B
+,O,I
O2,O,B
+,O,I
O3,O,B
+,O,I
O4,O,B
),O,O
was,O,O
significantly,O,O
reduced,O,O
in,O,O
the,O,O
early,O,O
postoperative,O,O
period,O,O
.,O,O
Serum,B,O
insulin,I,B
-,I,I
like,I,I
growth,I,I
factor,I,I
I,I,B
(,O,O
IGF,B,B
-,I,I
I,I,I
),O,O
SD,O,O
score,O,O
increased,O,O
from,O,O
-,O,O
2,O,O
.,O,O
2,O,O
and,O,O
-,O,O
4,O,O
.,O,O
2,O,O
in,O,O
men,O,O
and,O,O
women,O,O
",",O,O
respectively,O,O
",",O,O
to,O,O
1,O,O
.,O,O
8,O,O
and,O,O
-,O,O
0,O,O
.,O,O
9,O,O
at,O,O
6,O,O
months,O,O
and,O,O
0,O,O
.,O,O
8,O,O
and,O,O
-,O,O
0,O,O
.,O,O
7,O,O
at,O,O
12,O,O
months,O,O
.,O,O
The,O,O
cDNA,O,O
segment,O,O
is,O,O
flanked,O,O
by,O,O
the,O,O
immunoglobulin,B,B
gene,I,I
recombination,I,I
signal,I,I
sequences,I,I
so,O,O
that,O,O
the,O,O
cDNA,O,O
segment,O,O
can,O,O
invert,O,O
and,O,O
the,O,O
human,B,B
IL,I,I
-,I,I
2R,I,I
L,I,I
chain,I,I
is,O,O
subsequently,O,O
expressed,O,O
under,O,O
the,O,O
control,O,O
of,O,O
the,O,O
SV40,B,O
promoter,I,O
.,O,O
Glycemic,O,O
response,O,O
to,O,O
malted,O,O
",",O,O
popped,O,O
and,O,O
roller,O,O
dried,O,O
wheat,O,O
-,O,O
legume,O,O
based,O,O
foods,O,O
in,O,O
normal,O,O
subjects,O,O
.,O,O
Sequence,O,O
comparisons,O,O
strongly,O,O
suggest,O,O
that,O,O
the,O,O
S27a,B,B
and,O,O
the,O,O
ubiquitin,B,B
coding,O,O
sequences,O,O
found,O,O
in,O,O
the,O,O
genome,O,O
of,O,O
CP,O,O
Rit,O,O
were,O,O
both,O,O
derived,O,O
from,O,O
a,O,O
bovine,O,O
mRNA,O,O
encoding,O,O
a,O,O
hybrid,O,O
protein,O,O
with,O,O
the,O,O
structure,O,O
NH2,O,O
-,O,O
ubiquitin,B,B
-,O,O
S27a,B,B
-,O,O
COOH,O,O
.,O,O
The,O,O
previously,O,O
described,O,O
enhanced,O,O
translation,O,O
of,O,O
spinach,O,O
L12,B,O
mRNA,I,O
from,O,O
its,O,O
two,O,O
tandem,O,O
AUG,O,O
codons,O,O
and,O,O
the,O,O
two,O,O
functional,O,O
rpl12,B,O
genes,I,O
in,O,O
Arabidopsis,O,O
probably,O,O
provide,O,O
two,O,O
mechanisms,O,O
for,O,O
generating,O,O
the,O,O
four,O,O
copies,O,O
of,O,O
L12,B,O
/,I,O
chloroplast,I,O
ribosome,I,O
",",O,O
qualitatively,O,O
different,O,O
from,O,O
those,O,O
attempted,O,O
in,O,O
eubacteria,O,O
.,O,O
In,O,O
such,O,O
conditions,O,O
",",O,O
the,O,O
following,O,O
kinetic,O,O
reactions,O,O
have,O,O
been,O,O
studied,O,O
:,O,O
N2,O,B
(,O,O
A,O,O
),O,O
+,O,O
N2,O,B
(,O,O
A,O,O
),O,O
-,O,O
-,O,O
>,O,O
N2,O,B
(,O,O
C,O,O
",",O,O
B,O,O
",",O,O
V,O,O
),O,O
+,O,O
N2,O,B
(,O,O
X,O,O
),O,O
",",O,O
N2,O,B
(,O,O
A,O,O
),O,O
+,O,O
N2,O,B
(,O,O
X,O,O
",",O,O
V,O,O
>,O,O
5,O,O
),O,O
-,O,O
-,O,O
>,O,O
N2,O,B
(,O,O
X,O,O
),O,O
+,O,O
N2,O,B
(,O,O
B,O,O
",",O,O
V,O,O
),O,O
in,O,O
pure,O,O
N2,O,B
post,O,O
-,O,O
discharges,O,O
and,O,O
N2,O,B
(,O,O
A,O,O
),O,O
+,O,O
CH4,O,O
-,O,O
-,O,O
>,O,O
products,O,O
",",O,O
C,O,O
+,O,O
N,O,O
+,O,O
M2,O,O
-,O,O
-,O,O
>,O,O
CN,O,B
(,O,O
B,O,O
",",O,O
V,O,O
),O,O
+,O,O
M2,O,O
",",O,O
N2,O,B
(,O,O
X,O,O
",",O,O
V,O,O
>,O,O
4,O,O
),O,O
+,O,O
CN,O,B
-,O,O
-,O,O
>,O,O
N2,O,B
(,O,O
X,O,O
),O,O
+,O,O
CN,O,B
(,O,O
B,O,O
",",O,O
A,O,O
",",O,O
V,O,O
),O,O
",",O,O
in,O,O
N2,O,B
-,O,O
1,O,O
%,O,O
CH4,O,O
post,O,O
-,O,O
discharges,O,O
.,O,O
Nucleotide,O,O
sequence,O,O
analysis,O,O
revealed,O,O
that,O,O
TAR,B,B
-,I,I
binding,I,I
protein,I,I
is,O,O
very,O,O
similar,O,O
to,O,O
the,O,O
CREB2,B,B
protein,I,I
.,O,O
Oncogenic,O,O
signalling,O,O
by,O,O
E2F1,B,B
has,O,O
recently,O,O
been,O,O
linked,O,O
to,O,O
stabilization,O,O
and,O,O
activation,O,O
of,O,O
the,O,O
tumour,O,O
suppressor,O,O
p53,B,B
(,O,O
refs,O,O
1,O,O
",",O,O
3,O,O
",",O,O
4,O,O
),O,O
.,O,O
Congruent,O,O
with,O,O
empirical,O,O
predictions,O,O
",",O,O
the,O,O
most,O,O
homesick,O,O
children,O,O
perceived,O,O
low,O,O
control,O,O
over,O,O
homesickness,O,O
and,O,O
separation,O,O
",",O,O
and,O,O
coped,O,O
by,O,O
relinquishing,O,O
control,O,O
.,O,O
Working,O,O
session,O,O
report,O,O
:,O,O
in,O,O
vivo,O,O
-,O,O
in,O,O
vitro,O,O
screening,O,O
.,O,O
The,O,O
frequency,O,O
of,O,O
positive,O,O
anti,B,O
-,I,O
GM1,I,B
antibody,I,I
titers,O,O
in,O,O
the,O,O
Guillain,O,O
-,O,O
Barre,O,O
syndrome,O,O
patients,O,O
with,O,O
PEN,O,O
19,O,O
isolates,O,O
was,O,O
higher,O,O
than,O,O
that,O,O
in,O,O
the,O,O
Guillain,O,O
-,O,O
Barre,O,O
syndrome,O,O
and,O,O
Fisher,O,O
',O,O
s,O,O
syndrome,O,O
patients,O,O
without,O,O
PEN,O,O
19,O,O
isolates,O,O
.,O,O
Primary,O,O
and,O,O
secondary,O,O
structural,O,O
elements,O,O
required,O,O
for,O,O
synthesis,O,O
of,O,O
barley,O,O
yellow,O,O
dwarf,O,O
virus,O,O
subgenomic,O,O
RNA1,O,O
.,O,O
TBP,B,B
can,O,O
be,O,O
phosphorylated,O,O
in,O,O
vitro,O,O
by,O,O
extracts,O,O
of,O,O
U937,O,B
cells,O,O
or,O,O
by,O,O
bacterially,O,O
expressed,O,O
activated,O,O
ERK2,B,B
;,O,O
the,O,O
phosphorylation,O,O
sites,O,O
were,O,O
mapped,O,O
to,O,O
ERK,B,B
kinase,I,I
consensus,I,I
sites,I,I
in,O,O
the,O,O
TBP,B,B
amino,I,I
-,I,I
terminal,I,I
domain,I,I
.,O,O
Although,O,O
RAD17,B,B
",",O,O
RAD24,B,B
and,O,O
MEC3,B,B
are,O,O
not,O,O
required,O,O
for,O,O
cell,O,O
cycle,O,O
arrest,O,O
when,O,O
S,O,O
phase,O,O
is,O,O
inhibited,O,O
by,O,O
hydroxyurea,O,O
(,O,O
HU,O,O
),O,O
",",O,O
they,O,O
do,O,O
contribute,O,O
to,O,O
the,O,O
viability,O,O
of,O,O
yeast,O,O
cells,O,O
grown,O,O
in,O,O
the,O,O
presence,O,O
of,O,O
HU,O,O
",",O,O
possibly,O,O
because,O,O
they,O,O
are,O,O
required,O,O
for,O,O
the,O,O
repair,O,O
of,O,O
HU,O,O
-,O,O
induced,O,O
DNA,O,O
damage,O,O
.,O,O
DESIGN,O,O
:,O,O
Serum,O,O
aldosterone,O,B
and,O,O
plasma,B,O
renin,I,B
activity,O,O
were,O,O
measured,O,O
supine,O,O
prior,O,O
to,O,O
and,O,O
60,O,O
",",O,O
90,O,O
",",O,O
120,O,O
minutes,O,O
after,O,O
oral,O,O
captopril,O,O
",",O,O
25,O,O
mg,O,O
.,O,O
Serotonin,O,O
concentration,O,O
in,O,O
the,O,O
blood,O,O
of,O,O
patients,O,O
with,O,O
hemorrhagic,O,O
fever,O,O
with,O,O
renal,O,O
syndrome,O,O
We,O,O
report,O,O
the,O,O
construction,O,O
of,O,O
an,O,O
approximately,O,O
1,O,O
.,O,O
7,O,O
-,O,O
Mb,O,O
sequence,O,O
-,O,O
ready,O,O
YAC,O,O
/,O,O
BAC,O,O
clone,O,O
contig,O,O
of,O,O
8p22,O,O
-,O,O
p23,O,O
.,O,O
We,O,O
have,O,O
found,O,O
that,O,O
the,O,O
expression,O,O
of,O,O
GTPase,B,B
-,O,I
deficient,O,I
mutants,O,O
of,O,O
alpha,B,B
12,I,I
(,O,O
alpha,B,B
12Q229L,I,I
),O,O
or,O,O
alpha,B,B
13,I,I
(,O,O
alpha,B,B
13Q226L,I,I
),O,O
leads,O,O
to,O,O
robust,O,O
activation,O,O
of,O,O
the,O,O
Jun,B,O
kinase,I,O
/,O,O
stress,B,O
-,I,O
activated,I,O
protein,I,O
kinase,I,O
(,O,O
JNK,B,B
/,O,O
SAPK,B,O
),O,O
pathway,O,O
.,O,O
The,O,O
abluminal,O,O
surface,O,O
is,O,O
often,O,O
almost,O,O
entirely,O,O
encircled,O,O
by,O,O
a,O,O
thick,O,O
layer,O,O
of,O,O
fibrillary,O,O
connective,O,O
tissue,O,O
.,O,O
The,O,O
effect,O,O
of,O,O
nitric,B,B
oxide,I,I
synthase,I,I
inhibitor,O,I
on,O,O
reperfusion,O,O
injury,O,O
of,O,O
the,O,O
brain,O,O
under,O,O
hypothermic,O,O
circulatory,O,O
arrest,O,O
.,O,O
Seven,O,O
of,O,O
these,O,O
had,O,O
counterparts,O,O
in,O,O
the,O,O
US,O,O
of,O,O
herpes,O,B
simplex,O,I
type,O,I
1,O,I
(,O,O
HSV,O,B
-,O,I
1,O,I
),O,O
",",O,O
pseudorabies,O,B
virus,O,I
(,O,O
PRV,O,B
),O,O
",",O,O
and,O,O
equine,O,B
herpesvirus,O,I
type,O,I
1,O,I
(,O,O
EHV,O,B
-,O,I
1,O,I
),O,O
.,O,O
Deregulation,O,O
of,O,O
their,O,O
expression,O,O
may,O,O
contribute,O,O
to,O,O
malignant,O,O
transformation,O,O
associated,O,O
with,O,O
HTLV,O,B
-,O,I
1,O,I
infection,O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
In,O,O
addition,O,O
to,O,O
the,O,O
superiority,O,O
of,O,O
octafluoropropane,O,B
-,O,I
filled,O,I
microspheres,O,I
to,O,O
air,O,O
-,O,O
filled,O,O
microspheres,O,O
for,O,O
LV,O,O
opacification,O,O
",",O,O
the,O,O
efficacy,O,O
of,O,O
OCTA,O,B
is,O,O
relatively,O,O
unaffected,O,O
by,O,O
impaired,O,O
LV,O,O
function,O,O
and,O,O
is,O,O
less,O,O
susceptible,O,O
to,O,O
the,O,O
effects,O,O
of,O,O
poor,O,O
echogenicity,O,O
than,O,O
AIR,O,B
.,O,O
The,O,O
effect,O,O
of,O,O
acetazolamide,O,B
(,O,O
ACZ,O,B
),O,O
on,O,O
HCO3,O,O
-,O,O
and,O,O
Cl,O,O
-,O,O
activities,O,O
in,O,O
inner,O,O
ear,O,O
fluid,O,O
was,O,O
investigated,O,O
by,O,O
ion,O,O
-,O,O
selective,O,O
microelectrode,O,O
methods,O,O
.,O,O
Pseudomembranous,O,O
conjunctivitis,O,O
following,O,O
bone,O,O
marrow,O,O
transplantation,O,O
:,O,O
immunopathological,O,O
and,O,O
ultrastructural,O,O
study,O,O
of,O,O
one,O,O
case,O,O
.,O,O
In,O,O
support,O,O
of,O,O
this,O,O
interpretation,O,O
we,O,O
demonstrate,O,O
that,O,O
MQ9b,B,B
binds,O,O
strongly,O,O
5,O,O
of,O,O
17,O,O
motif,O,O
-,O,O
positive,O,O
",",O,O
pathogen,O,O
-,O,O
derived,O,O
synthetic,O,O
peptides,O,O
.,O,O
In,O,O
electrophoretic,O,O
mobility,O,O
shift,O,O
assays,O,O
",",O,O
the,O,O
PERE,B,B
formed,O,O
three,O,O
major,O,O
complexes,O,O
(,O,O
P1,O,O
",",O,O
P2,O,O
and,O,O
P3,O,O
),O,O
with,O,O
proteins,O,O
in,O,O
nuclear,O,O
extracts,O,O
from,O,O
HeLa,O,O
or,O,O
293,O,O
cells,O,O
.,O,O
We,O,O
also,O,O
review,O,O
the,O,O
role,O,O
of,O,O
grains,O,O
in,O,O
the,O,O
formation,O,O
of,O,O
complex,O,O
molecules,O,O
in,O,O
interstellar,O,O
molecular,O,O
clouds,O,O
.,O,O
99mTc,O,B
phytate,O,I
",",O,O
198Au,O,B
colloid,O,I
",",O,O
and,O,O
99mTc,O,B
antimony,O,I
sulfide,O,I
have,O,O
been,O,O
used,O,O
;,O,O
the,O,O
last,O,O
appears,O,O
to,O,O
have,O,O
been,O,O
the,O,O
most,O,O
satisfactory,O,O
.,O,O
The,O,O
present,O,O
data,O,O
also,O,O
indicate,O,O
that,O,O
patients,O,O
with,O,O
TGBM,O,B
nephropathy,O,I
often,O,O
have,O,O
concomitant,O,O
IgA,B,B
nephropathy,O,I
and,O,O
mesangial,O,O
proliferative,O,O
glomerulonephritis,O,O
.,O,O
We,O,O
previously,O,O
showed,O,O
that,O,O
this,O,O
proteolysis,O,O
1,O,O
),O,O
can,O,O
be,O,O
acutely,O,O
promoted,O,O
by,O,O
the,O,O
phorbol,O,O
ester,O,O
phorbol,O,O
12,O,O
-,O,O
myristate,O,O
13,O,O
-,O,O
acetate,O,O
(,O,O
PMA,O,B
),O,O
",",O,O
2,O,O
),O,O
requires,O,O
a,O,O
metalloprotease,B,O
activity,O,O
",",O,O
3,O,O
),O,O
generates,O,O
both,O,O
shed,O,O
GHBP,B,B
and,O,O
a,O,O
membrane,B,O
-,I,O
associated,I,O
GHR,I,B
transmembrane,I,I
/,I,I
cytoplasmic,I,I
domain,I,I
remnant,O,I
",",O,O
and,O,O
4,O,O
),O,O
results,O,O
in,O,O
down,O,O
-,O,O
regulation,O,O
of,O,O
GHR,B,B
abundance,O,O
and,O,O
GH,B,B
signaling,O,O
.,O,O
Praziquantel,O,O
and,O,O
Albendazole,O,O
were,O,O
found,O,O
effective,O,O
in,O,O
the,O,O
treatment,O,O
of,O,O
neurocysticercosis,O,O
",",O,O
but,O,O
because,O,O
of,O,O
serious,O,O
side,O,O
effects,O,O
encountered,O,O
in,O,O
some,O,O
cases,O,O
",",O,O
the,O,O
drugs,O,O
should,O,O
be,O,O
used,O,O
cautiously,O,O
in,O,O
selected,O,O
cases,O,O
only,O,O
.,O,O
The,O,O
tip,O,O
of,O,O
the,O,O
button,O,O
caused,O,O
a,O,O
perforation,O,O
of,O,O
the,O,O
posterior,O,O
stomach,O,O
wall,O,O
",",O,O
leading,O,O
to,O,O
death,O,O
.,O,O
Postnatal,O,O
volumetric,O,O
development,O,O
of,O,O
the,O,O
prefrontal,O,O
cortex,O,O
in,O,O
the,O,O
rat,O,O
.,O,O
All,O,O
groups,O,O
were,O,O
challenged,O,O
subsequently,O,O
with,O,O
naloxone,O,O
(,O,O
0,O,O
.,O,O
4,O,O
mg,O,O
/,O,O
kg,O,O
),O,O
in,O,O
the,O,O
distinctive,O,O
environment,O,O
and,O,O
then,O,O
observed,O,O
for,O,O
signs,O,O
of,O,O
opiate,O,O
withdrawal,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
the,O,O
PPSF,O,O
+,O,O
DBP,O,O
side,O,O
showed,O,O
large,O,O
amounts,O,O
of,O,O
bone,O,O
formation,O,O
",",O,O
and,O,O
bone,O,O
almost,O,O
covered,O,O
the,O,O
implant,O,O
.,O,O
The,O,O
role,O,O
of,O,O
DNA,O,B
rearrangement,O,I
and,O,O
alternative,O,O
RNA,O,B
processing,O,I
in,O,O
the,O,O
expression,O,O
of,O,O
immunoglobulin,B,O
delta,I,O
genes,I,O
.,O,O
In,O,O
silicosis,O,O
",",O,O
significant,O,O
relationships,O,O
between,O,O
patients,O,O
and,O,O
sons,O,O
were,O,O
not,O,O
seen,O,O
with,O,O
respect,O,O
to,O,O
arterial,O,O
blood,O,O
gas,O,O
determinations,O,O
and,O,O
ventilatory,O,O
responses,O,O
except,O,O
for,O,O
Paco2,O,O
of,O,O
patients,O,O
and,O,O
hypercapnic,O,O
ventilatory,O,O
responses,O,O
of,O,O
sons,O,O
.,O,O
Blood,O,O
GSH,B,B
-,I,I
Px,I,I
activity,O,O
was,O,O
measured,O,O
with,O,O
a,O,O
spectrophotometer,O,O
",",O,O
using,O,O
a,O,O
modification,O,O
of,O,O
a,O,O
previously,O,O
described,O,O
assay,O,O
.,O,O
The,O,O
TraD,B,B
protein,I,O
(,I,O
83,I,O
",",I,O
899,I,O
Da,I,O
),I,O
contains,O,O
three,O,O
hydrophobic,O,O
regions,O,O
",",O,O
of,O,O
which,O,O
two,O,O
are,O,O
located,O,O
near,O,O
the,O,O
amino,O,O
-,O,O
terminal,O,O
region,O,O
.,O,O
However,O,O
",",O,O
by,O,O
an,O,O
NS35,B,B
-,I,I
specific,I,I
RNA,I,I
capture,O,I
assay,O,O
",",O,O
the,O,O
multimers,O,O
were,O,O
shown,O,O
to,O,O
possess,O,O
the,O,O
RNA,O,B
-,O,I
binding,O,I
activity,O,O
previously,O,O
demonstrated,O,O
for,O,O
NS35,B,B
.,O,O
BACKGROUND,O,O
AND,O,O
OBJECTIVES,O,O
:,O,O
The,O,O
sexually,O,O
transmitted,O,O
diseases,O,O
(,O,O
STD,O,O
),O,O
control,O,O
program,O,O
for,O,O
female,O,O
sex,O,O
workers,O,O
(,O,O
FSW,O,O
),O,O
in,O,O
Lima,O,O
",",O,O
Peru,O,O
",",O,O
provided,O,O
periodic,O,O
serological,O,O
tests,O,O
for,O,O
syphilis,O,O
and,O,O
cervical,O,O
smears,O,O
for,O,O
gonococci,O,O
",",O,O
but,O,O
not,O,O
medication,O,O
for,O,O
STD,O,O
or,O,O
condoms,O,O
.,O,O
Hydrocortisone,O,O
seems,O,O
to,O,O
be,O,O
unable,O,O
to,O,O
hinder,O,O
the,O,O
postdenervation,O,O
changes,O,O
in,O,O
the,O,O
muscle,O,O
membrane,O,O
whereas,O,O
high,O,O
doses,O,O
of,O,O
the,O,O
hormone,O,O
are,O,O
able,O,O
to,O,O
induce,O,O
changes,O,O
in,O,O
the,O,O
muscle,O,O
membrane,O,O
.,O,O
RESULTS,O,O
:,O,O
An,O,O
herpetic,O,O
seroconversion,O,O
is,O,O
observed,O,O
with,O,O
presence,O,O
of,O,O
type,O,O
I,O,B
herpes,O,I
simplex,O,I
virus,O,I
(,O,O
HSV,O,B
I,O,I
),O,O
nucleic,O,O
acids,O,O
in,O,O
the,O,O
recipient,O,O
',O,O
s,O,O
aqueous,O,O
humor,O,O
.,O,O
Sp1,B,B
and,O,O
two,O,O
Sp3,B,B
isoforms,I,O
were,O,O
detected,O,O
as,O,O
the,O,O
primary,O,O
cellular,O,O
constituents,O,O
of,O,O
DNA,O,O
-,O,O
protein,O,O
complexes,O,O
formed,O,O
with,O,O
the,O,O
NF,B,B
-,I,I
kappaB,I,I
-,I,I
proximal,I,I
site,I,I
.,O,O
The,O,O
first,O,O
open,O,O
reading,O,O
frame,O,O
of,O,O
the,O,O
blueberry,O,B
scorch,O,I
carlavirus,O,I
(,O,O
BBScV,O,B
),O,O
genome,O,O
encodes,O,O
a,O,O
putative,O,O
replication,O,O
-,O,O
associated,O,O
protein,O,O
of,O,O
223,O,O
kDa,O,O
(,O,O
p223,B,B
),O,O
.,O,O
Spontaneous,O,O
sensitization,O,O
to,O,O
cross,O,O
-,O,O
reacting,O,O
chemicals,O,O
in,O,O
a,O,O
proportion,O,O
of,O,O
control,O,O
animals,O,O
is,O,O
strongly,O,O
suggested,O,O
",",O,O
somewhat,O,O
akin,O,O
to,O,O
spontaneous,O,O
sensitization,O,O
in,O,O
patients,O,O
with,O,O
anaphylactoid,O,O
reactions,O,O
to,O,O
neuromuscular,O,O
blockers,O,O
on,O,O
first,O,O
exposure,O,O
",",O,O
and,O,O
in,O,O
whom,O,O
IgE,B,O
antibodies,I,O
are,O,O
detected,O,O
.,O,O
This,O,O
may,O,O
account,O,O
",",O,O
at,O,O
least,O,O
in,O,O
part,O,O
",",O,O
for,O,O
the,O,O
ability,O,O
of,O,O
excess,O,O
wt,B,O
p53,I,B
to,O,O
inhibit,O,O
cell,O,O
proliferation,O,O
and,O,O
to,O,O
interfere,O,O
with,O,O
neoplastic,O,O
processes,O,O
.,O,O
IgG,B,O
and,O,O
IgM,B,O
antibody,O,O
activity,O,O
was,O,O
determined,O,O
by,O,O
adding,O,O
a,O,O
1,O,O
:,O,O
100,O,O
dilution,O,O
of,O,O
serum,O,O
to,O,O
plates,O,O
coated,O,O
with,O,O
A60,B,B
antigen,I,O
.,O,O
For,O,O
monocytes,O,O
",",O,O
as,O,O
measured,O,O
on,O,O
the,O,O
Hematrak,O,O
",",O,O
it,O,O
was,O,O
13,O,O
.,O,O
4,O,O
%,O,O
.,O,O
We,O,O
demonstrate,O,O
here,O,O
that,O,O
the,O,O
-,O,O
DEDDDL,O,B
sequence,O,O
stabilizes,O,O
GDP,O,B
binding,O,O
to,O,O
Ran,B,B
",",O,O
and,O,O
that,O,O
the,O,O
domain,O,O
is,O,O
required,O,O
for,O,O
high,O,O
affinity,O,O
interaction,O,O
with,O,O
a,O,O
Ran,B,B
-,I,O
binding,I,O
protein,I,O
",",O,O
HTF9A,B,B
/,O,O
RanBP1,B,B
.,O,O
The,O,O
major,O,O
transcription,O,O
factors,O,O
controlling,O,O
arginine,O,O
metabolism,O,O
in,O,O
Escherichia,O,B
coli,O,I
and,O,O
Bacillus,O,B
subtilis,O,I
",",O,O
ArgR,B,B
and,O,O
AhrC,B,B
",",O,O
respectively,O,O
",",O,O
are,O,O
homologous,O,O
multimeric,O,O
proteins,O,O
that,O,O
form,O,O
l,O,O
-,O,O
arginine,O,O
-,O,O
dependent,O,O
DNA,O,O
-,O,O
binding,O,O
complexes,O,O
capable,O,O
of,O,O
repressing,O,O
transcription,O,O
of,O,O
the,O,O
biosynthetic,O,O
genes,O,O
(,O,O
both,O,O
),O,O
",",O,O
activating,O,O
transcription,O,O
of,O,O
catabolic,O,O
genes,O,O
(,O,O
AhrC,B,B
only,O,O
),O,O
or,O,O
facilitating,O,O
plasmid,O,O
dimer,O,O
resolution,O,O
(,O,O
both,O,O
),O,O
.,O,O
Based,O,O
on,O,O
the,O,O
current,O,O
literature,O,O
",",O,O
the,O,O
mechanisms,O,O
involved,O,O
in,O,O
the,O,O
toxicity,O,O
of,O,O
OA,B,B
indicate,O,O
three,O,O
major,O,O
effects,O,O
:,O,O
(,O,O
1,O,O
),O,O
inhibition,O,O
of,O,O
mitochondrial,O,O
respiration,O,O
correlated,O,O
with,O,O
a,O,O
depletion,O,O
of,O,O
ATP,O,B
;,O,O
(,O,O
2,O,O
),O,O
inhibition,O,O
of,O,O
tRNA,B,B
-,I,I
synthetase,I,I
accompanied,O,O
by,O,O
a,O,O
reduced,O,O
protein,O,O
synthesis,O,O
;,O,O
and,O,O
(,O,O
3,O,O
),O,O
enhanced,O,O
lipid,O,O
peroxidation,O,O
.,O,O
E2F1,B,B
-,O,I
mediated,O,I
transcriptional,O,I
inhibition,O,O
of,O,O
the,O,O
plasminogen,B,B
activator,I,I
inhibitor,I,I
type,I,I
1,I,I
gene,I,O
.,O,O
We,O,O
also,O,O
show,O,O
that,O,O
p65,B,B
binds,O,O
to,O,O
these,O,O
targets,O,O
with,O,O
almost,O,O
equal,O,O
affinity,O,O
and,O,O
that,O,O
different,O,O
residues,O,O
have,O,O
variable,O,O
roles,O,O
in,O,O
binding,O,O
different,O,O
kappaB,B,O
targets,I,O
.,O,O
The,O,O
RNase,B,B
MRP,I,I
RNA,I,I
gene,I,O
was,O,O
deleted,O,O
by,O,O
insertional,O,O
replacement,O,O
and,O,O
found,O,O
to,O,O
be,O,O
essential,O,O
for,O,O
cellular,O,O
viability,O,O
",",O,O
indicating,O,O
a,O,O
critical,O,O
nuclear,O,O
role,O,O
for,O,O
RNase,B,B
MRP,I,I
.,O,O
We,O,O
have,O,O
measured,O,O
the,O,O
MBF,O,B
on,O,O
incisors,O,O
and,O,O
its,O,O
direction,O,O
in,O,O
three,O,O
dimensions,O,O
for,O,O
different,O,O
jaw,O,O
openings,O,O
in,O,O
ten,O,O
subjects,O,O
.,O,O
Its,O,O
predicted,O,O
amino,O,O
acid,O,O
sequence,O,O
shows,O,O
extensive,O,O
homology,O,O
to,O,O
those,O,O
of,O,O
Drosophila,B,B
hsp70,I,I
",",O,O
trout,B,B
hsp70,I,I
",",O,O
Xenopus,B,B
hsp70,I,I
",",O,O
yeast,B,B
hsp70,I,I
",",O,O
and,O,O
some,O,O
homology,O,O
to,O,O
the,O,O
heat,B,O
-,I,O
inducible,I,O
dnaK,I,B
gene,I,I
product,I,I
of,O,O
Escherichia,O,B
coli,O,I
.,O,O
Reactivities,O,O
to,O,O
horse,B,O
anti,I,O
-,I,O
lymphocyte,I,O
globulin,I,O
.,O,O
SRE,O,O
activity,O,O
is,O,O
dependent,O,O
upon,O,O
the,O,O
activation,O,O
by,O,O
phosphorylation,O,O
of,O,O
a,O,O
ternary,O,O
complex,O,O
factor,O,O
;,O,O
included,O,O
among,O,O
the,O,O
ternary,O,O
complex,O,O
factors,O,O
is,O,O
Elk,B,B
-,I,I
1,I,I
.,O,O
Isolation,O,O
by,O,O
PCR,O,O
of,O,O
a,O,O
cDNA,O,O
clone,O,O
from,O,O
pea,O,O
petals,O,O
with,O,O
similarity,O,O
to,O,O
petunia,O,O
and,O,O
wheat,B,O
zinc,I,O
finger,I,O
proteins,I,O
.,O,O
INTERVENTIONS,O,O
:,O,O
Patients,O,O
received,O,O
rt,B,O
-,I,O
PA,I,O
",",O,O
heparin,O,O
",",O,O
and,O,O
aspirin,O,O
.,O,O
A,O,O
poor,O,O
correlation,O,O
was,O,O
also,O,O
observed,O,O
between,O,O
PbB,O,O
and,O,O
ALAD,B,B
activity,O,O
of,O,O
the,O,O
stearate,O,O
workers,O,O
.,O,O
Binding,O,O
of,O,O
meAda,B,O
is,O,O
necessary,O,O
to,O,O
activate,O,O
transcription,O,O
of,O,O
the,O,O
adaptive,O,O
response,O,O
genes,O,O
;,O,O
accordingly,O,O
",",O,O
in,O,O
vitro,O,O
transcription,O,O
of,O,O
aidB,B,B
is,O,O
dependent,O,O
on,O,O
the,O,O
presence,O,O
of,O,O
meAda,B,O
.,O,O
How,O,O
does,O,O
a,O,O
nurse,O,O
go,O,O
about,O,O
maintaining,O,O
her,O,O
level,O,O
of,O,O
competence,O,O
when,O,O
she,O,O
is,O,O
one,O,O
of,O,O
the,O,O
few,O,O
local,O,O
practitioners,O,O
in,O,O
her,O,O
field,O,O
?,O,O
Vancouver,O,O
sex,O,O
therapist,O,O
Bianca,O,O
Rucker,O,O
is,O,O
doing,O,O
it,O,O
by,O,O
cultivating,O,O
a,O,O
network,O,O
of,O,O
colleagues,O,O
and,O,O
mentors,O,O
in,O,O
related,O,O
fields,O,O
both,O,O
at,O,O
home,O,O
and,O,O
across,O,O
the,O,O
continent,O,O
.,O,O
Experience,O,O
with,O,O
the,O,O
tensor,O,B
fasciae,O,I
latae,O,I
free,O,I
flap,O,I
.,O,O
Screening,O,O
",",O,O
counseling,O,O
",",O,O
and,O,O
treatment,O,O
for,O,O
alcohol,O,B
and,O,O
illicit,O,O
drug,O,O
use,O,O
should,O,O
be,O,O
essential,O,O
components,O,O
in,O,O
comprehensive,O,O
HBP,O,O
care,O,O
.,O,O
These,O,O
findings,O,O
suggest,O,O
a,O,O
functional,O,O
cross,O,O
-,O,O
talk,O,O
between,O,O
RB,B,B
protein,I,I
and,O,O
p21ras,B,B
",",O,O
which,O,O
balances,O,O
the,O,O
cell,O,O
phenotype,O,O
between,O,O
normal,O,O
and,O,O
transformed,O,O
states,O,O
.,O,O
UDP,B,B
-,I,I
GlcNAc,I,I
:,O,O
alpha,B,O
-,I,O
6,I,O
-,I,O
D,I,O
-,I,O
mannoside,I,O
beta,I,O
-,I,O
1,I,O
",",I,O
2,I,O
-,I,O
N,I,O
-,I,O
acetylglucosaminyltransferase,I,O
II,I,O
(,O,O
GnT,B,B
II,I,I
;,O,O
EC,B,O
2,I,O
.,I,O
4,I,O
.,I,O
1,I,O
.,I,O
143,I,O
),O,O
is,O,O
essential,O,O
for,O,O
the,O,O
normal,O,O
assembly,O,O
of,O,O
complex,O,O
Asn,O,B
-,O,I
linked,O,I
glycans,O,I
.,O,O
Initial,O,O
control,O,O
of,O,O
bleeding,O,O
is,O,O
similar,O,O
",",O,O
but,O,O
eradication,O,O
is,O,O
achieved,O,O
in,O,O
fewer,O,O
sessions,O,O
with,O,O
EVL,O,O
.,O,O
Processing,O,O
",",O,O
secretion,O,O
",",O,O
and,O,O
immunoreactivity,O,O
of,O,O
carboxy,B,O
terminally,I,O
truncated,I,O
dengue,I,B
-,I,I
2,I,I
virus,I,I
envelope,I,I
proteins,I,I
expressed,O,O
in,O,O
insect,O,O
cells,O,O
by,O,O
recombinant,O,O
baculoviruses,O,O
.,O,O
Problems,O,O
common,O,O
to,O,O
pediatrics,O,O
and,O,O
anesthesiology,O,O
GH,B,O
failed,O,O
to,O,O
stimulate,O,O
phosphorylation,O,O
or,O,O
activation,O,O
of,O,O
Jun,B,B
N,I,I
-,I,I
terminal,I,I
kinase,I,I
under,O,O
the,O,O
conditions,O,O
used,O,O
.,O,O
SELECTION,O,O
CRITERIA,O,O
:,O,O
All,O,O
controlled,O,O
trials,O,O
where,O,O
adults,O,O
with,O,O
schizophrenia,O,O
or,O,O
similar,O,O
illnesses,O,O
were,O,O
randomised,O,O
to,O,O
quetiapine,O,O
",",O,O
placebo,O,O
or,O,O
other,O,O
neuroleptic,O,O
drugs,O,O
and,O,O
where,O,O
clinically,O,O
relevant,O,O
outcomes,O,O
were,O,O
reported,O,O
.,O,O
The,O,O
ERH,B,B
expression,O,O
profile,O,O
is,O,O
similar,O,O
",",O,O
to,O,O
that,O,O
of,O,O
An3,B,B
",",O,O
which,O,O
localizes,O,O
to,O,O
the,O,O
animal,O,O
hemisphere,O,O
of,O,O
oocytes,O,O
and,O,O
is,O,O
abundantly,O,O
expressed,O,O
in,O,O
the,O,O
embryo,O,O
.,O,O
Three,O,O
subgenomes,O,O
also,O,O
comprised,O,O
15,O,O
to,O,O
75,O,O
nucleotides,O,O
derived,O,O
from,O,O
the,O,O
5,O,O
',O,O
part,O,O
of,O,O
the,O,O
NS2,B,B
gene,I,I
.,O,O
Results,O,O
of,O,O
the,O,O
recognition,O,O
task,O,O
revealed,O,O
significant,O,O
effects,O,O
of,O,O
consonant,O,O
voicing,O,O
",",O,O
position,O,O
and,O,O
vowel,O,O
context,O,O
on,O,O
syllable,O,O
recognition,O,O
.,O,O
Effect,O,O
of,O,O
variations,O,O
in,O,O
time,O,O
interval,O,O
between,O,O
treatment,O,O
with,O,O
BCG,O,B
and,O,O
quartz,O,O
dust,O,O
on,O,O
translocation,O,O
of,O,O
quartz,O,O
dust,O,O
from,O,O
the,O,O
lungs,O,O
to,O,O
their,O,O
regional,O,O
lymph,O,O
nodes,O,O
.,O,O
It,O,O
is,O,O
",",O,O
however,O,O
",",O,O
extremely,O,O
homologous,O,O
to,O,O
a,O,O
third,O,O
',O,O
non,O,O
-,O,O
classical,O,O
',O,O
gene,O,O
",",O,O
HLA,B,B
-,I,I
5,I,I
.,I,O
4,I,O
",",O,O
and,O,O
to,O,O
the,O,O
chimpanzee,O,O
gene,O,O
",",O,O
Ch28,B,B
.,O,O
Stylohyoid,O,O
chain,O,O
ossification,O,O
:,O,O
choice,O,O
of,O,O
the,O,O
surgical,O,O
approach,O,O
.,O,O
The,O,O
p130,B,B
and,O,O
p62,B,B
tyrosine,O,O
-,O,O
phosphorylated,O,O
proteins,O,O
that,O,O
complexed,O,O
v,B,O
-,I,O
Src,I,B
SH2,B,O
in,O,O
vitro,O,O
also,O,O
associated,O,O
with,O,O
v,B,O
-,I,O
Src,I,B
in,O,O
v,B,O
-,I,O
src,I,O
-,O,O
transformed,O,O
Rat,O,O
-,O,O
2,O,O
cells,O,O
;,O,O
this,O,O
in,O,O
vivo,O,O
binding,O,O
was,O,O
dependent,O,O
on,O,O
the,O,O
v,B,O
-,I,O
Src,I,B
SH2,B,O
domain,O,O
.,O,O
A,O,O
polymorphic,O,O
bipartite,O,O
motif,O,O
signals,O,O
nuclear,O,O
targeting,O,O
of,O,O
early,O,O
auxin,O,O
-,O,O
inducible,O,O
proteins,O,O
related,O,O
to,O,O
PS,B,B
-,I,I
IAA4,I,I
from,I,O
pea,I,O
(,I,O
Pisum,I,B
sativum,I,I
),I,O
.,O,O
OBJECTIVE,O,O
:,O,O
This,O,O
study,O,O
was,O,O
designed,O,O
to,O,O
analyze,O,O
the,O,O
common,O,O
cause,O,O
of,O,O
asthenopia,O,O
",",O,O
mixed,O,O
astigmatism,O,O
.,O,O
Uptake,O,O
of,O,O
ofloxacin,O,O
by,O,O
Escherichia,O,B
coli,O,I
Previously,O,O
",",O,O
we,O,O
showed,O,O
that,O,O
the,O,O
APRE,O,O
is,O,O
a,O,O
cytokine,O,O
[,O,O
tumor,B,B
necrosis,I,I
factor,I,I
-,I,I
alpha,I,I
(,O,O
TNFalpha,B,B
),O,O
],O,O
enhancer,O,O
by,O,O
binding,O,O
the,O,O
heterodimeric,B,O
nuclear,I,O
factor,I,O
-,I,O
kappaB,I,O
(,O,O
NF,B,B
-,I,I
kappaB,I,I
),O,O
complex,O,O
Rel,B,O
A,I,O
x,O,O
NF,B,B
-,I,I
kappaB1,I,I
.,O,O
Of,O,O
the,O,O
remaining,O,O
seven,O,O
",",O,O
five,O,O
reacted,O,O
either,O,O
with,O,O
immediate,O,O
and,O,O
strong,O,O
symptoms,O,O
or,O,O
had,O,O
spontaneously,O,O
reduced,O,O
gluten,B,O
intake,O,O
",",O,O
or,O,O
had,O,O
an,O,O
acquired,O,O
IgA,B,B
deficiency,O,I
.,O,O
The,O,O
possible,O,O
roles,O,O
of,O,O
HRMT1L1,B,B
and,O,O
HRMT1L2,B,B
in,O,O
human,O,B
disease,O,I
are,O,O
currently,O,O
unknown,O,O
.,O,O
None,O,O
of,O,O
the,O,O
cystometrograms,O,O
showed,O,O
uninhibited,O,O
detrusor,O,O
contractions,O,O
.,O,O
Independent,O,O
splicing,O,O
events,O,O
involve,O,O
three,O,O
previously,O,O
described,O,O
cassette,O,O
exons,O,O
",",O,O
which,O,O
are,O,O
predicted,O,O
to,O,O
encode,O,O
most,O,O
of,O,O
the,O,O
second,O,O
transmembrane,O,O
domain,O,O
.,O,O
As,O,O
no,O,O
complete,O,O
PPARgamma,B,B
antagonists,O,O
have,O,O
been,O,O
described,O,O
hitherto,O,O
",",O,O
we,O,O
have,O,O
constructed,O,O
a,O,O
dominant,O,O
-,O,O
negative,O,O
mutant,O,O
receptor,O,O
to,O,O
inhibit,O,O
wild,O,O
-,O,O
type,O,O
PPARgamma,B,B
action,O,O
.,O,O
A,O,O
second,O,O
study,O,O
group,O,O
",",O,O
with,O,O
intact,O,O
cardiac,O,O
innervation,O,O
",",O,O
consisted,O,O
of,O,O
19,O,O
patients,O,O
with,O,O
stable,O,O
angina,O,O
pectoris,O,O
class,O,O
I,O,O
to,O,O
III,O,O
.,O,O
Finally,O,O
",",O,O
we,O,O
present,O,O
evidence,O,O
that,O,O
fimbrin,B,B
is,O,O
a,O,O
third,O,O
distinct,O,O
plastin,B,O
isoform,I,O
which,O,O
is,O,O
specifically,O,O
expressed,O,O
at,O,O
high,O,O
levels,O,O
in,O,O
the,O,O
small,O,O
intestine,O,O
.,O,O
Sterile,O,O
mutants,O,O
of,O,O
Saccharomyces,O,B
cerevisiae,O,I
were,O,O
isolated,O,O
from,O,O
alpha,O,O
*,O,O
cells,O,O
having,O,O
the,O,O
a,B,O
/,I,O
alpha,I,O
aar1,I,O
-,I,O
6,I,O
genotype,O,O
(,O,O
exhibiting,O,O
alpha,O,O
mating,O,O
ability,O,O
and,O,O
weak,O,O
a,O,O
mating,O,O
ability,O,O
as,O,O
a,O,O
result,O,O
of,O,O
a,O,O
defect,O,O
in,O,O
a1,B,O
-,I,O
alpha,I,O
2,I,O
repression,O,O
),O,O
.,O,O
PRL,B,B
-,I,I
1,I,O
is,O,O
able,O,O
to,O,O
dephosphorylate,O,O
phosphotyrosine,O,O
substrates,O,O
",",O,O
and,O,O
mutation,O,O
of,O,O
the,O,O
active,O,O
-,O,O
site,O,O
cysteine,O,O
residue,O,O
abolishes,O,O
this,O,O
activity,O,O
.,O,O
In,O,O
the,O,O
absence,O,O
of,O,O
histological,O,O
criteria,O,O
",",O,O
which,O,O
it,O,O
is,O,O
difficult,O,O
to,O,O
demand,O,O
in,O,O
view,O,O
of,O,O
the,O,O
variability,O,O
of,O,O
results,O,O
and,O,O
potential,O,O
dangers,O,O
of,O,O
endomyocardial,O,O
biopsy,O,O
involving,O,O
such,O,O
thin,O,O
and,O,O
fragile,O,O
ventricular,O,O
walls,O,O
",",O,O
the,O,O
diagnosis,O,O
of,O,O
ACRV,O,B
is,O,O
based,O,O
upon,O,O
the,O,O
concomitant,O,O
existence,O,O
of,O,O
:,O,O
(,O,O
1,O,O
),O,O
electrophysiological,O,O
criteria,O,O
:,O,O
ventricular,O,O
arrhythmias,O,O
",",O,O
in,O,O
particular,O,O
sustained,O,O
monomorphous,O,O
VT,O,O
",",O,O
with,O,O
the,O,O
particular,O,O
feature,O,O
of,O,O
a,O,O
very,O,O
high,O,O
degree,O,O
of,O,O
sensitivity,O,O
to,O,O
adrenergic,O,O
stimulation,O,O
(,O,O
exercise,O,O
),O,O
",",O,O
the,O,O
existence,O,O
of,O,O
late,O,O
potentials,O,O
on,O,O
the,O,O
high,O,O
amplification,O,O
ECG,O,O
",",O,O
a,O,O
highly,O,O
specific,O,O
sign,O,O
",",O,O
though,O,O
unfortunately,O,O
of,O,O
poor,O,O
sensitivity,O,O
in,O,O
localized,O,O
froms,O,O
",",O,O
those,O,O
which,O,O
are,O,O
most,O,O
difficult,O,O
to,O,O
identify,O,O
(,O,O
2,O,O
),O,O
;,O,O
segmentary,O,O
morphological,O,O
and,O,O
kinetic,O,O
RV,O,O
abnormalities,O,O
",",O,O
most,O,O
often,O,O
resulting,O,O
in,O,O
localized,O,O
akinetic,O,O
or,O,O
dyskinetic,O,O
parietal,O,O
vaulting,O,O
",",O,O
with,O,O
stasis,O,O
.,O,O
The,O,O
present,O,O
paper,O,O
elucidates,O,O
the,O,O
existing,O,O
discrepancies,O,O
",",O,O
and,O,O
offers,O,O
a,O,O
consistent,O,O
terminology,O,O
incorporating,O,O
also,O,O
such,O,O
terms,O,O
as,O,O
",",O,O
",",O,O
and,O,O
.,O,O
Our,O,O
results,O,O
demonstrated,O,O
that,O,O
50,O,O
%,O,O
of,O,O
the,O,O
hepatic,O,O
artery,O,O
-,O,O
alone,O,O
ALT,O,O
graft,O,O
showed,O,O
almost,O,O
normal,O,O
structure,O,O
histologically,O,O
at,O,O
1,O,O
month,O,O
after,O,O
grafting,O,O
",",O,O
with,O,O
bile,O,O
secretion,O,O
preserved,O,O
.,O,O
The,O,O
transverse,O,O
relaxation,O,O
time,O,O
(,O,O
T2,O,B
),O,O
and,O,O
apparent,O,O
diffusion,O,O
coefficient,O,O
of,O,O
water,O,O
were,O,O
determined,O,O
.,O,O
Leukemia,B,B
-,I,I
inhibitory,I,I
factor,I,I
(,O,O
LIF,B,B
),O,O
is,O,O
a,O,O
neuropoietin,B,O
able,O,O
to,O,O
regulate,O,O
the,O,O
differentiation,O,O
and,O,O
the,O,O
survival,O,O
of,O,O
many,O,O
cell,O,O
types,O,O
",",O,O
which,O,O
include,O,O
some,O,O
neuronal,O,O
populations,O,O
.,O,O
The,O,O
lemdr1,B,B
gene,I,I
was,O,O
cloned,O,O
in,O,O
the,O,O
expression,O,O
vector,O,O
pALTNEO,O,O
and,O,O
transfected,O,O
into,O,O
wild,O,O
-,O,O
type,O,O
L,O,O
.,O,O
enriettii,O,O
and,O,O
the,O,O
resulting,O,O
transfected,O,O
cells,O,O
were,O,O
resistant,O,O
to,O,O
vinblastine,O,B
but,O,O
at,O,O
lower,O,O
levels,O,O
than,O,O
in,O,O
the,O,O
selected,O,O
mutant,O,O
cells,O,O
.,O,O
We,O,O
describe,O,O
a,O,O
genetic,O,O
system,O,O
for,O,O
further,O,O
characterizing,O,O
the,O,O
role,O,O
of,O,O
the,O,O
extreme,O,O
C,O,O
-,O,O
terminus,O,O
of,O,O
the,O,O
beta,O,O
subunit,O,O
of,O,O
E,B,O
.,I,O
coli,I,O
RNA,I,O
polymerase,I,O
.,O,O
Release,O,O
of,O,O
this,O,O
selective,O,O
pressure,O,O
",",O,O
however,O,O
",",O,O
gave,O,O
way,O,O
to,O,O
homologous,O,O
resolution,O,O
of,O,O
the,O,O
cointegrate,O,O
structures,O,O
.,O,O
When,O,O
ligated,O,O
to,O,O
the,O,O
proIL,B,B
-,I,I
1,I,I
beta,I,I
cap,I,I
site,I,I
-,I,I
proximal,I,I
region,I,I
(,O,O
located,O,O
between,O,O
-,O,O
131,O,O
to,O,O
+,O,O
12,O,O
),O,O
",",O,O
both,O,O
the,O,O
proIL,B,B
-,I,I
1,I,I
beta,I,I
and,O,O
the,O,O
simian,B,O
virus,I,O
40,I,O
enhancer,I,O
elements,I,O
functioned,O,O
more,O,O
efficiently,O,O
in,O,O
monocytes,O,O
than,O,O
in,O,O
HeLa,O,O
cells,O,O
",",O,O
which,O,O
are,O,O
not,O,O
normally,O,O
competent,O,O
for,O,O
IL,B,B
-,I,I
1,I,I
beta,I,I
expression,O,O
.,O,O
The,O,O
network,O,O
evolution,O,O
was,O,O
interpreted,O,O
by,O,O
an,O,O
approach,O,O
based,O,O
on,O,O
the,O,O
Flory,O,O
model,O,O
.,O,O
Molecular,O,O
cloning,O,O
and,O,O
expression,O,O
of,O,O
human,B,B
UDP,I,B
-,I,I
d,I,I
-,I,I
Xylose,I,I
:,I,O
proteoglycan,I,O
core,I,O
protein,I,O
beta,B,B
-,I,I
d,I,I
-,I,I
xylosyltransferase,I,I
and,O,O
its,O,O
first,O,O
isoform,B,O
XT,I,B
-,I,I
II,I,I
.,O,O
The,O,O
gene,O,O
is,O,O
1,O,O
",",O,O
139,O,O
base,O,O
pairs,O,O
(,O,O
bp,O,O
),O,O
long,O,O
",",O,O
and,O,O
",",O,O
like,O,O
other,O,O
members,O,O
of,O,O
the,O,O
SIG,B,O
family,I,O
",",O,O
the,O,O
beta,B,B
TG,I,I
gene,I,O
is,O,O
divided,O,O
into,O,O
3,O,O
exons,O,O
.,O,O
Nucleotide,O,O
sequence,O,O
",",O,O
genome,O,O
organization,O,O
and,O,O
phylogenetic,O,O
analysis,O,O
of,O,O
pineapple,O,O
mealybug,O,O
wilt,O,O
-,O,O
associated,O,O
virus,O,O
-,O,O
2,O,O
.,O,O
However,O,O
",",O,O
serial,O,O
passages,O,O
of,O,O
fetal,O,O
lamb,O,O
kidney,O,O
(,O,O
FLK,O,B
),O,O
cells,O,O
",",O,O
which,O,O
are,O,O
sensitive,O,O
to,O,O
infection,O,O
with,O,O
BLV,O,B
",",O,O
after,O,O
transient,O,O
transfection,O,O
revealed,O,O
that,O,O
mutation,O,O
of,O,O
a,O,O
second,O,O
tyrosine,O,O
residue,O,O
in,O,O
the,O,O
N,O,B
-,O,I
terminal,O,I
motif,O,I
completely,O,O
prevented,O,O
the,O,O
propagation,O,O
of,O,O
the,O,O
virus,O,O
.,O,O
Using,O,O
a,O,O
conditional,O,O
-,O,O
lethal,O,O
mutant,O,O
allele,O,O
of,O,O
SUP45,B,B
(,O,O
sup45,B,B
-,I,I
2,I,I
),O,O
and,O,O
a,O,O
combination,O,O
of,O,O
in,O,O
vivo,O,O
and,O,O
in,O,O
vitro,O,O
approaches,O,O
",",O,O
we,O,O
demonstrate,O,O
that,O,O
the,O,O
product,O,O
of,O,O
the,O,O
SUP45,B,B
gene,I,O
(,O,O
Sup45p,B,B
or,O,O
eRF1,B,B
),O,O
is,O,O
a,O,O
factor,O,O
required,O,O
for,O,O
translation,O,O
termination,O,O
in,O,O
yeast,O,O
.,O,O
Expression,O,O
of,O,O
lacZ,B,B
from,O,O
the,O,O
promoter,O,O
of,O,O
the,O,O
Escherichia,B,B
coli,I,I
spc,I,I
operon,I,I
cloned,O,O
into,O,O
vectors,O,O
carrying,O,O
the,O,O
W205,O,O
trp,B,O
-,O,O
lac,B,O
fusion,O,O
.,O,O
Treadmill,O,O
training,O,O
at,O,O
least,O,O
for,O,O
2,O,O
weeks,O,O
can,O,O
reduce,O,O
the,O,O
infarction,O,O
size,O,O
and,O,O
edema,O,O
caused,O,O
by,O,O
MCA,O,B
occlusion,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
01,O,O
),O,O
.,O,O
In,O,O
addition,O,O
",",O,O
a,O,O
microsatellite,O,O
repeat,O,O
polymorphism,O,O
with,O,O
a,O,O
heterozygosity,O,O
of,O,O
71,O,O
%,O,O
at,O,O
the,O,O
RET,B,B
locus,I,O
and,O,O
a,O,O
restriction,O,O
fragment,O,O
length,O,O
polymorphism,O,O
with,O,O
a,O,O
heterozygosity,O,O
of,O,O
42,O,O
%,O,O
detected,O,O
by,O,O
a,O,O
lambda,O,O
clone,O,O
from,O,O
the,O,O
D10S94,B,B
locus,I,O
have,O,O
been,O,O
developed,O,O
for,O,O
high,O,O
-,O,O
resolution,O,O
genetic,O,O
linkage,O,O
mapping,O,O
and,O,O
predictive,O,O
diagnostic,O,O
testing,O,O
.,O,O
We,O,O
have,O,O
now,O,O
tested,O,O
all,O,O
known,O,O
mammalian,B,B
Groucho,I,I
family,I,I
members,I,I
for,O,O
their,O,O
ability,O,O
to,O,O
interact,O,O
specifically,O,O
with,O,O
individual,O,O
Tcf,B,B
/,O,I
Lef,B,I
family,O,I
members,O,I
.,O,O
A,O,O
cDNA,O,O
clone,O,O
corresponding,O,O
to,O,O
the,O,O
putative,O,O
GA,B,B
20,I,I
-,O,I
oxidase,B,I
genomic,O,I
sequence,O,I
was,O,O
constructed,O,O
with,O,O
the,O,O
reverse,O,O
transcription,O,O
-,O,O
PCR,O,O
method,O,O
",",O,O
and,O,O
the,O,O
identity,O,O
of,O,O
the,O,O
cDNA,O,O
clone,O,O
was,O,O
confirmed,O,O
by,O,O
analyzing,O,O
the,O,O
capability,O,O
of,O,O
the,O,O
fusion,O,O
protein,O,O
expressed,O,O
in,O,O
Escherichia,O,B
coli,O,I
to,O,O
convert,O,O
GA53,B,B
to,O,O
GA44,B,B
and,O,O
GA19,B,B
to,O,O
GA20,B,B
.,O,O
Parasitological,O,O
and,O,O
pathological,O,O
findings,O,O
in,O,O
capuchin,O,O
monkeys,O,O
infected,O,O
with,O,O
Schistosoma,O,B
japonicum,O,I
or,O,O
Schistosoma,O,B
mansoni,O,I
.,O,O
The,O,O
5,O,O
',O,O
-,O,O
terminus,O,O
of,O,O
the,O,O
p,B,O
-,I,O
gvpF,I,O
-,I,O
M,I,O
mRNA,I,O
was,O,O
located,O,O
169,O,O
nucleotides,O,O
upstream,O,O
of,O,O
p,B,O
-,I,O
gvpF,I,O
within,O,O
p,B,O
-,I,O
gvpE,I,O
.,O,O
There,O,O
were,O,O
differences,O,O
between,O,O
males,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
05,O,O
),O,O
for,O,O
most,O,O
of,O,O
the,O,O
characteristics,O,O
studied,O,O
.,O,O
We,O,O
also,O,O
isolated,O,O
two,O,O
alternatively,O,O
spliced,O,O
forms,O,O
of,O,O
human,B,B
CD6,I,B
cDNA,I,I
lacking,O,O
sequences,O,O
encoding,O,O
membrane,O,O
-,O,O
proximal,O,O
regions,O,O
of,O,O
the,O,O
cytoplasmic,O,O
domain,O,O
which,O,O
maintain,O,O
the,O,O
same,O,O
reading,O,O
frame,O,O
as,O,O
CD6,B,B
-,O,I
PB1,B,I
.,O,O
The,O,O
arrangement,O,O
of,O,O
these,O,O
cutoff,O,O
-,O,O
levels,O,O
leads,O,O
to,O,O
a,O,O
sensitivity,O,O
of,O,O
85,O,O
%,O,O
at,O,O
a,O,O
specificity,O,O
of,O,O
55,O,O
%,O,O
for,O,O
Protein,B,B
S100,I,I
when,O,O
measured,O,O
by,O,O
RIA,O,O
",",O,O
and,O,O
to,O,O
a,O,O
sensitivity,O,O
of,O,O
77,O,O
%,O,O
at,O,O
a,O,O
specificity,O,O
of,O,O
61,O,O
%,O,O
when,O,O
measured,O,O
by,O,O
LIA,O,O
.,O,O
This,O,O
revealed,O,O
a,O,O
minimum,O,O
of,O,O
six,O,O
novel,O,O
OSBP,B,B
-,I,I
related,I,I
proteins,I,I
",",O,O
designated,O,O
ORP,B,B
-,I,I
1,I,I
to,O,O
ORP,B,B
-,I,I
6,I,I
.,O,O
Instead,O,O
",",O,O
mRNA,O,O
of,O,O
2,O,O
.,O,O
0,O,O
and,O,O
2,O,O
.,O,O
8,O,O
kb,O,O
are,O,O
detected,O,O
in,O,O
varying,O,O
abundance,O,O
.,O,O
These,O,O
results,O,O
were,O,O
compared,O,O
with,O,O
the,O,O
estimates,O,O
of,O,O
penetration,O,O
from,O,O
steady,O,O
-,O,O
state,O,O
calculations,O,O
",",O,O
square,O,O
root,O,O
of,O,O
time,O,O
calculations,O,O
",",O,O
and,O,O
a,O,O
biologically,O,O
based,O,O
mathematical,O,O
model,O,O
.,O,O
Which,O,O
cineangiographically,O,O
assessed,O,O
anatomic,O,O
variable,O,O
correlates,O,O
best,O,O
with,O,O
functional,O,O
measurements,O,O
of,O,O
stenosis,O,O
severity,O,O
?,O,O
A,O,O
comparison,O,O
of,O,O
quantitative,O,O
analysis,O,O
of,O,O
the,O,O
coronary,O,O
cineangiogram,O,O
with,O,O
measured,O,O
coronary,O,O
flow,O,O
reserve,O,O
and,O,O
exercise,O,O
/,O,O
redistribution,O,O
thallium,O,O
-,O,O
201,O,O
scintigraphy,O,O
.,O,O
Climatic,O,O
treatment,O,O
of,O,O
children,O,O
with,O,O
respiratory,O,O
allergy,O,O
These,O,O
results,O,O
further,O,O
support,O,O
an,O,O
important,O,O
role,O,O
for,O,O
CBF2,B,B
in,O,O
mediating,O,O
EBNA2,B,B
transactivation,O,O
;,O,O
they,O,O
identify,O,O
the,O,O
hnRNP,B,B
protein,I,I
AUF1,I,B
as,O,O
a,O,O
major,O,O
component,O,O
of,O,O
CBF2,B,B
and,O,O
are,O,O
also,O,O
the,O,O
first,O,O
evidence,O,O
of,O,O
a,O,O
cis,O,O
-,O,O
acting,O,O
sequence,O,O
other,O,O
than,O,O
a,O,O
CBF1,B,B
binding,I,I
element,I,I
that,O,O
is,O,O
able,O,O
to,O,O
confer,O,O
responsiveness,O,O
to,O,O
EBNA2,B,B
.,O,O
The,O,O
absolute,O,O
configuration,O,O
at,O,O
C,O,O
-,O,O
2,O,O
in,O,O
monocrotalic,O,B
acid,O,I
.,O,O
To,O,O
understand,O,O
whether,O,O
Shc,B,B
localization,O,O
in,O,O
membrane,O,O
rafts,O,O
is,O,O
sufficient,O,O
to,O,O
regulate,O,O
Shc,B,B
function,O,O
",",O,O
we,O,O
constructed,O,O
a,O,O
Shc,B,B
chimera,I,O
containing,O,O
the,O,O
Ras,B,B
membrane,I,O
localization,I,O
motif,I,O
at,O,O
the,O,O
C,O,O
-,O,O
terminus,O,O
.,O,O
CM,O,O
reduced,O,O
the,O,O
nuclear,O,O
binding,O,O
activity,O,O
of,O,O
transcription,B,O
factor,I,O
AP,I,B
-,I,I
1,I,I
.,O,O
Furthermore,O,O
",",O,O
competitor,O,O
containing,O,O
the,O,O
YY1,B,B
consensus,I,I
sequence,I,I
competed,O,O
for,O,O
protein,B,O
B,I,B
binding,O,O
",",O,O
whereas,O,O
competitor,O,O
containing,O,O
a,O,O
perfect,O,O
yeast,B,O
ABF,I,B
-,I,I
1,I,I
consensus,I,I
sequence,I,I
did,O,O
not,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
400,O,O
WORDS,O,O
),O,O
With,O,O
such,O,O
analysis,O,O
",",O,O
one,O,O
can,O,O
test,O,O
hypotheses,O,O
about,O,O
the,O,O
structure,O,O
of,O,O
latent,O,O
variability,O,O
within,O,O
a,O,O
given,O,O
data,O,O
set,O,O
.,O,O
A,O,O
general,O,O
model,O,O
for,O,O
ARE,O,O
-,O,O
mediated,O,O
mRNA,O,O
degradation,O,O
involving,O,O
a,O,O
potential,O,O
role,O,O
for,O,O
certain,O,O
heterogeneous,O,O
nuclear,O,O
ribonucleoproteins,O,O
and,O,O
ARE,B,O
-,I,O
binding,I,O
proteins,I,O
is,O,O
proposed,O,O
.,O,O
A,O,O
late,O,O
diagnosis,O,O
of,O,O
retinoblastoma,O,B
is,O,O
an,O,O
unquestionable,O,O
fact,O,O
that,O,O
allows,O,O
its,O,O
growth,O,O
and,O,O
leads,O,O
to,O,O
a,O,O
deterioration,O,O
in,O,O
the,O,O
outlook,O,O
.,O,O
633,O,O
+,O,O
/,O,O
-,O,O
258,O,O
aggregates,O,O
/,O,O
ml,O,O
at,O,O
0,O,O
rpm,O,O
;,O,O
P,O,O
<,O,O
0,O,O
.,O,O
001,O,O
.,O,O
A,O,O
segment,O,O
of,O,O
mRNA,O,O
encoding,O,O
the,O,O
leader,O,O
peptide,O,O
of,O,O
the,O,O
CPA1,B,B
gene,I,O
confers,O,O
repression,O,O
by,O,O
arginine,O,O
on,O,O
a,O,O
heterologous,O,O
yeast,O,O
gene,O,O
transcript,O,O
.,O,O
These,O,O
observations,O,O
provide,O,O
strong,O,O
support,O,O
for,O,O
the,O,O
idea,O,O
that,O,O
expression,O,O
of,O,O
mutant,O,O
tRNA,O,O
can,O,O
confer,O,O
a,O,O
mutator,O,O
phenotype,O,O
",",O,O
including,O,O
the,O,O
UVM,O,O
-,O,O
constitutive,O,O
phenotype,O,O
observed,O,O
in,O,O
mutA,B,O
and,O,O
mutC,B,O
cells,O,O
.,O,O
Diverse,O,O
endogenous,O,O
light,O,O
chains,O,O
contribute,O,O
to,O,O
basement,O,O
membrane,O,O
reactivity,O,O
in,O,O
nonautoimmune,O,O
mice,O,O
transgenic,O,O
for,O,O
an,O,O
anti,B,O
-,I,O
laminin,I,B
Ig,B,I
heavy,I,I
chain,I,I
.,O,O
The,O,O
serum,O,O
erythropoietin,B,B
(,O,O
EPO,B,B
),O,O
concentrations,O,O
of,O,O
15,O,O
male,O,O
triathletes,O,O
(,O,O
26,O,O
.,O,O
3,O,O
U,O,O
.,O,O
ml,O,O
-,O,O
1,O,O
),O,O
were,O,O
significantly,O,O
lower,O,O
than,O,O
those,O,O
of,O,O
45,O,O
male,O,O
distance,O,O
runners,O,O
(,O,O
31,O,O
.,O,O
6,O,O
U,O,B
.,O,O
ml,O,O
-,O,O
1,O,O
;,O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
05,O,O
),O,O
.,O,O
At,O,O
the,O,O
C,O,O
-,O,O
terminus,O,O
of,O,O
the,O,O
protein,O,O
is,O,O
a,O,O
domain,O,O
that,O,O
contains,O,O
sequences,O,O
very,O,O
similar,O,O
to,O,O
those,O,O
found,O,O
in,O,O
the,O,O
breakpoint,O,O
cluster,O,O
region,O,O
gene,O,B
product,O,O
",",O,O
n,B,B
-,I,I
chimerin,I,I
",",O,O
and,O,O
rho,B,B
GAP,I,I
",",O,O
all,O,O
of,O,O
which,O,O
have,O,O
been,O,O
shown,O,O
to,O,O
possess,O,O
intrinsic,O,O
GAP,B,B
activity,O,O
on,O,O
small,B,O
GTPases,I,O
.,O,O
Both,O,O
of,O,O
these,O,O
dogs,O,O
had,O,O
low,O,O
serum,O,O
IgG,B,B
(,O,O
3,O,O
.,O,O
5,O,O
to,O,O
7,O,O
.,O,O
2,O,O
mg,O,O
/,O,O
ml,O,O
),O,O
and,O,O
the,O,O
second,O,O
littermate,O,O
also,O,O
had,O,O
reduced,O,O
serum,O,O
IgA,B,B
(,O,O
<,O,O
0,O,O
.,O,O
1,O,O
to,O,O
0,O,O
.,O,O
15,O,O
mg,O,O
/,O,O
ml,O,O
),O,O
.,O,O
Studies,O,O
were,O,O
performed,O,O
on,O,O
several,O,O
superficial,O,O
veins,O,O
from,O,O
the,O,O
rabbit,O,O
face,O,O
to,O,O
examine,O,O
the,O,O
relationship,O,O
between,O,O
beta,B,O
adrenoceptor,I,O
subtype,I,O
distribution,O,O
",",O,O
intrinsic,O,O
myogenic,O,O
tone,O,O
and,O,O
sympathetic,O,O
nerve,O,O
innervation,O,O
.,O,O
The,O,O
previously,O,O
described,O,O
four,O,O
sets,O,O
of,O,O
13,O,O
-,O,O
to,O,O
18,O,O
-,O,O
base,O,O
-,O,O
pair,O,O
interspersed,O,O
repeat,O,O
elements,O,O
between,O,O
-,O,O
55,O,O
and,O,O
-,O,O
580,O,O
provide,O,O
most,O,O
of,O,O
the,O,O
high,O,O
basal,O,O
transcriptional,O,O
strength,O,O
",",O,O
whereas,O,O
the,O,O
arrangement,O,O
of,O,O
further,O,O
upstream,O,O
tandemly,O,O
repeated,O,O
NF1,B,B
-,I,I
binding,I,I
sites,I,I
may,O,O
contribute,O,O
significantly,O,O
to,O,O
the,O,O
expanded,O,O
biological,O,O
host,O,O
range,O,O
for,O,O
expression,O,O
of,O,O
SCMV,B,B
IE94,I,I
compared,O,O
with,O,O
HCMV,B,B
IE68,I,I
.,O,O
Lower,O,O
extremity,O,O
weight,O,O
bearing,O,O
under,O,O
various,O,O
standing,O,O
conditions,O,O
in,O,O
independently,O,O
ambulatory,O,O
patients,O,O
with,O,O
hemiparesis,O,O
.,O,O
Overexpression,O,O
of,O,O
wild,B,O
-,I,O
type,I,O
p53,I,B
also,O,O
induces,O,O
apoptosis,O,O
in,O,O
an,O,O
LCL,O,B
.,O,O
The,O,O
blood,O,O
levels,O,O
of,O,O
lactate,O,O
",",O,O
pyruvate,O,O
and,O,O
amino,O,O
acids,O,O
were,O,O
not,O,O
elevated,O,O
.,O,O
Conclusion,O,O
:,O,O
inlet,O,O
type,O,O
VSD,O,O
and,O,O
perimembranous,O,O
type,O,O
TOF,O,O
have,O,O
anatomic,O,O
features,O,O
in,O,O
which,O,O
the,O,O
proximal,O,O
His,O,O
bundle,O,O
tends,O,O
to,O,O
be,O,O
jeopardized,O,O
by,O,O
suturing,O,O
for,O,O
VSD,O,O
closure,O,O
.,O,O
Terbutaline,O,O
;,O,O
a,O,O
beta2,O,B
-,O,I
adrenergic,O,I
agonist,O,I
",",O,O
and,O,O
aminophyllin,O,O
",",O,O
a,O,O
phosphodiesterase,O,O
inhibitor,O,O
",",O,O
were,O,O
given,O,O
separately,O,O
",",O,O
or,O,O
in,O,O
combination,O,O
",",O,O
to,O,O
rabbit,O,O
fetuses,O,O
on,O,O
the,O,O
28th,O,O
day,O,O
of,O,O
gestation,O,O
.,O,O
Slap,B,O
negatively,O,O
regulates,O,O
Src,B,B
mitogenic,O,I
function,O,I
but,O,O
does,O,O
not,O,O
revert,O,O
Src,B,B
-,O,I
induced,O,I
cell,O,I
morphology,O,I
changes,O,I
.,O,O
Unlike,O,O
wild,B,O
-,I,O
type,I,O
p53,I,B
",",O,O
the,O,O
delta,B,O
proAE,I,O
mutant,I,O
cDNA,I,O
can,O,O
be,O,O
stably,O,O
expressed,O,O
in,O,O
tumor,O,O
derived,O,O
cell,O,O
lines,O,O
with,O,O
few,O,O
immediate,O,O
detrimental,O,O
effects,O,O
.,O,O
RT,O,O
-,O,O
PCR,O,O
analysis,O,O
showed,O,O
that,O,O
PLP,B,B
-,I,I
H,I,I
as,O,O
well,O,O
as,O,O
PLP,B,B
-,I,I
C,I,I
and,O,O
PLP,B,B
-,I,I
D,I,I
are,O,O
expressed,O,O
in,O,O
all,O,O
rat,O,O
strains,O,O
examined,O,O
",",O,O
confirming,O,O
that,O,O
PLP,B,B
diversity,O,O
is,O,O
not,O,O
due,O,O
to,O,O
strain,O,O
differences,O,O
.,O,O
Previous,O,O
work,O,O
showed,O,O
that,O,O
repA,B,O
(,O,O
initiator,O,O
protein,O,O
),O,O
expression,O,O
requires,O,O
tap,B,O
(,O,O
leader,O,O
peptide,O,O
),O,O
translation,O,O
.,O,O
Furthermore,O,O
",",O,O
LB1,B,B
gene,I,O
mapped,O,O
to,O,O
chromosome,O,O
13q14,O,O
",",O,O
a,O,O
region,O,O
that,O,O
has,O,O
been,O,O
involved,O,O
as,O,O
a,O,O
chromosomal,O,O
breakpoint,O,O
in,O,O
DLBL,O,O
.,O,O
Thus,O,O
",",O,O
the,O,O
human,B,B
D1A,I,I
gene,I,O
belongs,O,O
to,O,O
the,O,O
category,O,O
of,O,O
tissue,O,O
-,O,O
specific,O,O
",",O,O
regulated,O,O
genes,O,O
that,O,O
have,O,O
housekeeping,O,O
-,O,O
type,O,O
promoters,O,O
.,O,O
This,O,O
led,O,O
to,O,O
the,O,O
conclusion,O,O
that,O,O
the,O,O
metatarsal,O,O
artery,O,O
should,O,O
be,O,O
used,O,O
for,O,O
toe,O,O
MP,O,O
joint,O,O
grafts,O,O
",",O,O
while,O,O
the,O,O
unilateral,O,O
proper,O,O
digital,O,O
artery,O,O
is,O,O
suitable,O,O
for,O,O
toe,O,O
PIP,O,O
joint,O,O
grafts,O,O
",",O,O
together,O,O
with,O,O
concomitant,O,O
or,O,O
dorsal,O,O
cutaneous,O,O
vein,O,O
.,O,O
In,O,O
Rat,O,O
1a,O,O
cells,O,O
",",O,O
m1R,B,B
stimulation,O,O
of,O,O
phospholipase,B,O
C,I,O
beta,I,O
and,O,O
the,O,O
marked,O,O
rise,O,O
in,O,O
intracellular,O,O
calcium,O,O
stimulated,O,O
cyclic,O,O
AMP,O,B
(,O,O
cAMP,O,I
),O,O
synthesis,O,O
",",O,O
resulting,O,O
in,O,O
the,O,O
activation,O,O
of,O,O
protein,B,O
kinase,I,O
A,I,O
.,O,O
Five,O,O
patients,O,O
developed,O,O
metastatic,O,O
spread,O,O
",",O,O
and,O,O
all,O,O
of,O,O
them,O,O
died,O,O
of,O,O
tumor,O,O
.,O,O
The,O,O
monoexponential,O,O
rate,O,O
of,O,O
clearance,O,O
of,O,O
tracer,O,O
-,O,O
-,O,O
obtained,O,O
from,O,O
the,O,O
portion,O,O
of,O,O
the,O,O
residue,O,O
-,O,O
detection,O,O
curve,O,O
reflecting,O,O
metabolism,O,O
of,O,O
fatty,O,O
acid,O,O
incorporated,O,O
into,O,O
neutral,O,O
lipids,O,O
-,O,O
-,O,O
correlated,O,O
directly,O,O
with,O,O
induced,O,O
changes,O,O
in,O,O
tension,O,O
-,O,O
time,O,O
index,O,O
after,O,O
injections,O,O
into,O,O
the,O,O
left,O,O
atrium,O,O
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
96,O,O
",",O,O
n,O,O
=,O,O
12,O,O
),O,O
",",O,O
right,O,O
atrium,O,O
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
86,O,O
",",O,O
n,O,O
=,O,O
14,O,O
),O,O
",",O,O
and,O,O
ear,O,O
vein,O,O
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
93,O,O
",",O,O
n,O,O
=,O,O
14,O,O
),O,O
.,O,O
The,O,O
optimal,O,O
care,O,O
of,O,O
CHF,O,O
patient,O,O
includes,O,O
the,O,O
recognition,O,O
and,O,O
management,O,O
of,O,O
these,O,O
electrolyte,O,O
disturbances,O,O
.,O,O
Because,O,O
the,O,O
mutant,O,O
defective,O,O
in,O,O
DNA,O,B
binding,O,O
also,O,O
fails,O,O
to,O,O
stimulate,O,O
Abf1,B,O
ARS1,O,O
DNA,O,B
-,O,I
binding,O,O
activity,O,O
",",O,O
our,O,O
results,O,O
suggest,O,O
that,O,O
Cdc6,B,O
DNA,O,B
-,O,I
binding,O,O
activity,O,O
may,O,O
play,O,O
a,O,O
pivotal,O,O
role,O,O
in,O,O
the,O,O
initiation,O,O
of,O,O
DNA,O,B
replication,O,O
.,O,O
Tensile,O,O
bond,O,O
strengths,O,O
between,O,O
resin,O,O
composite,O,O
and,O,O
bovine,O,O
dentin,O,O
using,O,O
dentin,O,O
adhesive,O,O
systems,O,O
(,O,O
Clearfil,O,O
Liner,O,O
Bond,O,O
II,O,O
:,O,O
LB,O,B
II,O,I
;,O,O
Scotchbond,O,O
Multi,O,O
-,O,O
Purpose,O,O
:,O,O
MP,O,B
),O,O
bonding,O,O
systems,O,O
showed,O,O
a,O,O
large,O,O
scatter,O,O
among,O,O
students,O,O
and,O,O
dentists,O,O
.,O,O
The,O,O
statistical,O,O
analysis,O,O
of,O,O
data,O,O
of,O,O
TRH,B,O
test,O,O
on,O,O
a,O,O
sample,O,O
of,O,O
57,O,O
healthy,O,O
volunteers,O,O
has,O,O
permitted,O,O
an,O,O
evaluation,O,O
of,O,O
the,O,O
upper,O,O
limits,O,O
of,O,O
the,O,O
normal,O,O
thyrotropin,B,B
response,O,O
;,O,O
the,O,O
secretory,O,O
area,O,O
(,O,O
As,O,B
),O,O
was,O,O
shown,O,O
to,O,O
be,O,O
more,O,O
discriminating,O,O
.,O,O
Neither,O,O
gene,O,B
possesses,O,O
a,O,O
distinct,O,O
transcriptional,O,O
start,O,O
site,O,O
as,O,O
shown,O,O
by,O,O
nuclease,B,O
S1,I,O
analysis,O,O
.,O,O
The,O,O
variability,O,O
is,O,O
most,O,O
likely,O,O
a,O,O
result,O,O
of,O,O
alternative,O,O
splicing,O,O
of,O,O
exons,O,O
from,O,O
the,O,O
primary,O,O
elastin,B,O
transcripts,I,O
.,O,O
OBJECTIVE,O,O
:,O,O
Our,O,O
purpose,O,O
was,O,O
to,O,O
determine,O,O
the,O,O
simultaneous,O,O
concentrations,O,O
of,O,O
serum,O,O
cotinine,O,O
in,O,O
both,O,O
fetal,O,O
and,O,O
maternal,O,O
blood,O,O
.,O,O
This,O,O
conformer,O,O
features,O,O
a,O,O
Type,O,O
I,O,B
beta,O,I
-,O,I
turn,O,I
and,O,O
has,O,O
extensive,O,O
hydrophobic,O,O
contacts,O,O
with,O,O
the,O,O
FKBP12,B,B
binding,O,I
surface,O,I
.,O,O
Consistent,O,O
with,O,O
the,O,O
hepatic,O,O
and,O,O
epidermal,O,O
expression,O,O
of,O,O
histidase,B,B
",",O,O
this,O,O
finding,O,O
suggests,O,O
that,O,O
histidase,B,B
transcription,O,O
may,O,O
be,O,O
regulated,O,O
by,O,O
these,O,O
factors,O,O
.,O,O
The,O,O
objectives,O,O
of,O,O
the,O,O
present,O,O
study,O,O
were,O,O
to,O,O
evaluate,O,O
the,O,O
effects,O,O
of,O,O
adding,O,O
Equex,O,O
to,O,O
a,O,O
TRIS,O,O
-,O,O
extender,O,O
",",O,O
diluting,O,O
the,O,O
semen,O,O
in,O,O
1,O,O
or,O,O
2,O,O
steps,O,O
",",O,O
freezing,O,O
according,O,O
to,O,O
2,O,O
methods,O,O
",",O,O
thawing,O,O
at,O,O
2,O,O
rates,O,O
",",O,O
and,O,O
the,O,O
interactions,O,O
between,O,O
these,O,O
treatments,O,O
",",O,O
on,O,O
the,O,O
post,O,O
-,O,O
thaw,O,O
survival,O,O
of,O,O
dog,O,O
spermatozoa,O,O
at,O,O
38,O,O
degrees,O,O
C,O,O
.,O,O
In,O,O
Saccharomyces,O,B
cerevisiae,O,I
",",O,O
eIF6,B,B
is,O,O
encoded,O,O
by,O,O
a,O,O
single,O,O
-,O,O
copy,O,O
essential,O,O
gene,O,O
.,O,O
When,O,O
the,O,O
degree,O,O
of,O,O
exercise,O,O
was,O,O
maximal,O,O
",",O,O
mPAP,O,B
was,O,O
maintained,O,O
",",O,O
SVI,O,B
decreased,O,O
",",O,O
HR,O,B
was,O,O
unchanged,O,O
",",O,O
and,O,O
CO,O,B
and,O,O
VO2,O,B
decreased,O,O
.,O,O
Results,O,O
of,O,O
the,O,O
official,O,O
inspection,O,O
of,O,O
the,O,O
commercial,O,O
anti,O,O
-,O,O
inflammatory,O,O
enzyme,O,O
preparations,O,O
containing,O,O
chymotrypsin,B,B
and,O,O
trypsin,B,B
by,O,O
means,O,O
of,O,O
modified,O,O
NF,O,O
13,O,O
methods,O,O
Detection,O,O
of,O,O
poisoning,O,O
by,O,O
Impila,O,B
(,O,O
Callilepis,O,B
laureola,O,I
),O,O
in,O,O
a,O,O
mother,O,O
and,O,O
child,O,O
.,O,O
Regulation,O,O
of,O,O
irgA,B,B
by,O,O
iron,O,O
in,O,O
V,O,B
.,O,O
cholerae,O,I
occurs,O,O
at,O,O
the,O,O
transcriptional,O,O
level,O,O
",",O,O
and,O,O
there,O,O
is,O,O
an,O,O
interrupted,O,O
dyad,O,O
symmetric,O,O
sequence,O,O
in,O,O
the,O,O
vicinity,O,O
of,O,O
the,O,O
promoter,O,O
that,O,O
is,O,O
homologous,O,O
to,O,O
Fur,B,B
binding,I,O
sites,I,O
of,O,O
E,O,B
.,O,O
coli,O,I
.,O,O
Copyright,O,O
2001,O,O
S,O,B
.,O,O
We,O,O
recently,O,O
characterized,O,O
a,O,O
single,O,O
yeast,B,O
hnRNP,I,B
methyltransferase,I,I
(,O,O
HMT1,B,B
),O,O
.,O,O
We,O,O
recently,O,O
characterized,O,O
a,O,O
single,O,O
yeast,B,O
hnRNP,I,B
methyltransferase,I,I
(,O,O
HMT1,B,B
),O,O
.,O,O
This,O,O
study,O,O
underlines,O,O
the,O,O
importance,O,O
of,O,O
terminal,O,O
SC5b,B,O
-,I,O
9,I,O
complement,I,O
complex,I,O
as,O,O
a,O,O
suitable,O,O
marker,O,O
in,O,O
the,O,O
evaluation,O,O
of,O,O
complement,O,O
activation,O,O
during,O,O
cardiopulmonary,O,O
bypass,O,O
.,O,O
Furthermore,O,O
",",O,O
a,O,O
minor,O,O
start,O,O
site,O,O
was,O,O
localized,O,O
179,O,O
bp,O,O
upstream,O,O
of,O,O
the,O,O
major,O,O
site,O,O
using,O,O
reverse,B,O
transcriptase,I,O
-,O,O
polymerase,O,O
chain,O,O
reaction,O,O
with,O,O
various,O,O
P1,O,O
primers,O,O
(,O,O
primer,O,O
walking,O,O
),O,O
",",O,O
primer,O,O
extension,O,O
",",O,O
and,O,O
cDNA,O,O
cloning,O,O
.,O,O
Emphysematous,O,O
cholecystitis,O,O
:,O,O
sonographic,O,O
findings,O,O
.,O,O
Factors,O,O
influencing,O,O
the,O,O
bond,O,O
strength,O,O
between,O,O
glass,O,O
polyalkenoate,O,O
(,O,O
ionomer,O,O
),O,O
cements,O,O
and,O,O
dentine,O,O
.,O,O
Extramedullary,O,O
plasmacytoma,O,O
of,O,O
the,O,O
parotid,O,O
gland,O,O
LY290181,O,B
appears,O,O
to,O,O
inhibit,O,O
uPA,B,B
promoter,I,O
activation,O,O
by,O,O
blocking,O,O
phorbol,O,O
ester,O,O
-,O,O
stimulated,O,O
binding,O,O
of,O,O
nuclear,O,O
proteins,O,O
to,O,O
the,O,O
uPA,B,B
PEA3,B,B
/,O,I
12,O,I
-,O,I
0,O,I
-,O,I
tetradecanoylphorbol,O,I
13,O,I
-,O,I
acetate,O,I
responsive,O,I
element,O,I
(,O,I
TRE,O,I
),O,O
.,O,O
Methyl,O,B
mercury,O,I
intoxication,O,O
in,O,O
rat,O,O
kidneys,O,O
.,O,O
The,O,O
histochemistry,O,O
and,O,O
ultrastructure,O,O
of,O,O
calcified,O,O
cerebellar,O,O
deposits,O,O
described,O,O
by,O,O
Tonge,O,B
et,O,O
al,O,O
.,O,O
Reward,O,O
value,O,O
of,O,O
prosodic,O,O
features,O,O
of,O,O
language,O,O
for,O,O
autistic,O,O
",",O,O
mentally,O,O
retarded,O,O
",",O,O
and,O,O
normal,O,O
children,O,O
.,O,O
The,O,O
divergence,O,O
in,O,O
primary,O,O
structure,O,O
between,O,O
the,O,O
sheep,O,B
CRF1,B,I
and,O,O
the,O,O
other,O,O
mammalian,B,O
CRF1s,I,O
is,O,O
primarily,O,O
localized,O,O
to,O,O
the,O,O
extracellular,O,O
amino,O,O
terminal,O,O
domain,O,O
of,O,O
the,O,O
receptor,O,O
(,O,O
18,O,O
of,O,O
22,O,O
divergent,O,O
residues,O,O
",",O,O
ovine,O,O
vs,O,O
human,B,B
CRF1,I,I
),O,O
.,O,O
Chirality,O,O
-,O,O
glass,O,O
and,O,O
spin,O,O
-,O,O
glass,O,O
correlations,O,O
in,O,O
the,O,O
two,O,O
-,O,O
dimensional,O,O
random,O,O
-,O,O
bond,O,O
XY,O,O
model,O,O
.,O,O
Chem,O,O
.,O,O
We,O,O
then,O,O
demonstrated,O,O
that,O,O
1,O,O
),O,O
GAL4,B,B
-,O,I
REV,B,I
-,O,I
erbA,B,I
alpha,I,I
chimeras,O,O
that,O,O
contain,O,O
the,O,O
',O,O
AB,O,O
',O,O
region,O,O
and,O,O
lack,O,O
the,O,O
',O,O
E,O,O
',O,O
region,O,O
activated,O,O
transcription,O,O
of,O,O
GAL4,B,O
response,I,O
elements,I,O
in,O,O
the,O,O
presence,O,O
of,O,O
8,O,O
-,O,O
Br,O,O
-,O,O
cAMP,O,O
and,O,O
2,O,O
),O,O
the,O,O
ligand,O,O
-,O,O
binding,O,O
domain,O,O
(,O,O
LBD,O,O
),O,O
contains,O,O
an,O,O
active,O,O
transcriptional,O,O
silencer,O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
Our,O,O
findings,O,O
suggest,O,O
that,O,O
pre,O,O
-,O,O
treatment,O,O
with,O,O
coenzyme,O,B
Q10,O,I
may,O,O
play,O,O
a,O,O
protective,O,O
role,O,O
during,O,O
routine,O,O
vascular,O,O
procedures,O,O
requiring,O,O
abdominal,O,O
aortic,O,O
cross,O,O
clamping,O,O
by,O,O
attenuating,O,O
the,O,O
degree,O,O
of,O,O
peroxidative,O,O
damage,O,O
.,O,O
The,O,O
protein,O,O
folds,O,O
correctly,O,O
with,O,O
two,O,O
disulfide,O,O
bonds,O,O
and,O,O
a,O,O
free,O,O
thiol,O,O
group,O,O
at,O,O
Cys25,O,B
.,O,O
The,O,O
circadian,O,O
rhythm,O,O
",",O,O
however,O,O
",",O,O
was,O,O
not,O,O
affected,O,O
and,O,O
the,O,O
difference,O,O
between,O,O
minimum,O,O
(,O,O
12,O,O
.,O,O
00,O,O
h,O,O
),O,O
and,O,O
maximum,O,O
(,O,O
18,O,O
.,O,O
50,O,O
h,O,O
),O,O
serum,O,O
concentrations,O,O
was,O,O
31,O,O
.,O,O
3,O,O
%,O,O
.,O,O
In,O,O
35,O,O
of,O,O
those,O,O
patients,O,O
DD,O,B
was,O,O
measured,O,O
also,O,O
with,O,O
microlatex,O,O
tests,O,O
-,O,O
-,O,O
Tinaquant,O,O
and,O,O
BC,O,B
d,O,I
-,O,I
dimer,O,I
.,O,O
J,O,O
.,O,O
This,O,O
site,O,O
is,O,O
upstream,O,O
from,O,O
the,O,O
TATA,O,B
box,O,I
used,O,O
in,O,O
somatic,O,O
cells,O,O
.,O,O
Identical,O,O
c,B,O
-,I,O
erbB3,I,B
transcripts,I,O
are,O,O
expressed,O,O
in,O,O
normal,O,O
human,O,B
placental,O,O
tissues,O,O
.,O,O
The,O,O
Clb5,B,O
kinase,I,O
",",O,O
which,O,O
promotes,O,O
S,O,O
phase,O,O
",",O,O
remains,O,O
active,O,O
during,O,O
the,O,O
G2,O,O
-,O,O
phase,O,O
arrest,O,O
of,O,O
cells,O,O
of,O,O
the,O,O
parental,O,O
strain,O,O
",",O,O
but,O,O
its,O,O
activity,O,O
declines,O,O
rapidly,O,O
in,O,O
sim,B,O
mutants,I,O
.,O,O
We,O,O
also,O,O
show,O,O
that,O,O
activation,O,O
of,O,O
protein,B,O
kinase,I,O
A,I,O
(,O,O
PKA,B,B
),O,O
signaling,O,O
is,O,O
sufficient,O,O
to,O,O
down,O,O
-,O,O
regulate,O,O
caveolin,B,O
-,I,O
1,I,O
protein,I,O
expression,O,O
and,O,O
promoter,O,O
activity,O,O
.,O,O
Fluorometric,O,O
methods,O,O
can,O,O
also,O,O
provide,O,O
information,O,O
about,O,O
porphyrin,O,B
binding,O,O
sites,O,O
that,O,O
is,O,O
useful,O,O
in,O,O
understanding,O,O
porphyrin,O,B
transport,O,O
and,O,O
clearance,O,O
.,O,O
The,O,O
3,O,O
.,O,O
3,O,O
-,O,O
fold,O,O
higher,O,O
expression,O,O
in,O,O
the,O,O
fetal,O,O
heart,O,O
than,O,O
in,O,O
the,O,O
adult,O,O
heart,O,O
suggests,O,O
that,O,O
HFHZ,B,B
mRNA,I,O
is,O,O
downregulated,O,O
in,O,O
the,O,O
process,O,O
of,O,O
development,O,O
.,O,O
Genomic,O,O
locus,O,O
of,O,O
chCTCF,B,B
contains,O,O
a,O,O
GC,O,O
-,O,O
rich,O,O
untranslated,O,O
exon,O,O
separated,O,O
from,O,O
seven,O,O
coding,O,O
exons,O,O
by,O,O
a,O,O
long,O,O
intron,O,O
.,O,O
The,O,O
outer,O,O
diameter,O,O
and,O,O
the,O,O
thickness,O,O
of,O,O
the,O,O
rotor,O,O
are,O,O
60,O,O
mm,O,O
and,O,O
8,O,O
mm,O,O
",",O,O
respectively,O,O
.,O,O
No,O,O
effect,O,O
was,O,O
found,O,O
on,O,O
grooming,O,O
behavior,O,O
.,O,O
In,O,O
this,O,O
study,O,O
",",O,O
we,O,O
elucidate,O,O
signaling,O,O
pathways,O,O
induced,O,O
by,O,O
photodynamic,O,O
therapy,O,O
(,O,O
PDT,O,O
),O,O
with,O,O
hypericin,O,O
.,O,O
A,O,O
xylE,B,O
transcriptional,I,O
fusion,I,O
to,O,O
the,O,O
putative,O,O
mxbD,B,B
promoter,I,O
showed,O,O
low,O,O
-,O,O
level,O,O
expression,O,O
in,O,O
wild,O,O
-,O,O
type,O,O
cells,O,O
grown,O,O
on,O,O
one,O,O
-,O,O
carbon,O,O
(,O,O
C1,O,O
),O,O
compounds,O,O
and,O,O
no,O,O
detectable,O,O
expression,O,O
in,O,O
cells,O,O
grown,O,O
on,O,O
succinate,O,O
.,O,O
Protein,O,O
phosphatases,O,O
play,O,O
a,O,O
critical,O,O
role,O,O
in,O,O
the,O,O
regulation,O,O
of,O,O
the,O,O
eukaryotic,O,O
cell,O,O
cycle,O,O
and,O,O
signal,O,O
transduction,O,O
.,O,O
Heat,O,O
-,O,O
labile,O,O
-,O,O
like,O,O
enterotoxin,O,O
(,O,O
LT,B,B
),O,O
was,O,O
produced,O,O
by,O,O
26,O,O
of,O,O
42,O,O
stool,O,O
isolates,O,O
(,O,O
62,O,O
%,O,O
),O,O
",",O,O
while,O,O
only,O,O
1,O,O
of,O,O
the,O,O
42,O,O
isolates,O,O
(,O,O
2,O,O
%,O,O
),O,O
produced,O,O
enterotoxinlike,O,O
activity,O,O
in,O,O
suckling,O,O
mice,O,O
;,O,O
65,O,O
%,O,O
of,O,O
the,O,O
cytotoxin,O,O
-,O,O
producing,O,O
strains,O,O
also,O,O
produced,O,O
an,O,O
LT,B,B
-,I,O
like,I,O
material,O,O
.,O,O
Changes,O,O
of,O,O
thirtynine,O,O
serum,O,O
protein,O,O
components,O,O
following,O,O
surgical,O,O
stress,O,O
.,O,O
Tolerance,O,O
in,O,O
renal,O,O
transplantation,O,O
after,O,O
allogeneic,O,O
bone,O,O
marrow,O,O
transplantation,O,O
-,O,O
6,O,O
-,O,O
year,O,O
follow,O,O
-,O,O
up,O,O
.,O,O
For,O,O
EPV,O,O
3,O,O
",",O,O
10,O,O
",",O,O
or,O,O
40,O,O
",",O,O
the,O,O
bias,O,O
exceeded,O,O
25,O,O
%,O,O
for,O,O
7,O,O
",",O,O
3,O,O
",",O,O
and,O,O
1,O,O
in,O,O
the,O,O
8,O,O
-,O,O
predictor,O,O
model,O,O
respectively,O,O
",",O,O
when,O,O
a,O,O
conventional,O,O
selection,O,O
criterion,O,O
was,O,O
used,O,O
(,O,O
alpha,O,O
=,O,O
0,O,O
.,O,O
05,O,O
),O,O
.,O,O
Transfer,O,O
RNA,O,B
genes,O,O
from,O,O
Dictyostelium,O,B
discoideum,O,I
are,O,O
frequently,O,O
associated,O,O
with,O,O
repetitive,O,O
elements,O,O
and,O,O
contain,O,O
consensus,O,O
boxes,O,O
in,O,O
their,O,O
5,O,O
',O,O
and,O,O
3,O,O
',O,O
-,O,O
flanking,O,O
regions,O,O
.,O,O
In,O,O
the,O,O
present,O,O
study,O,O
",",O,O
we,O,O
show,O,O
that,O,O
SRm160,B,B
/,I,I
300,I,I
is,O,O
required,O,O
for,O,O
a,O,O
purine,O,O
-,O,O
rich,O,O
ESE,B,O
to,O,O
promote,O,O
the,O,O
splicing,O,O
of,O,O
a,O,O
pre,O,O
-,O,O
mRNA,O,O
derived,O,O
from,O,O
the,O,O
Drosophila,B,B
doublesex,I,I
gene,I,I
.,O,O
Mature,O,O
mRNA,O,O
for,O,O
cytosolic,B,O
phosphoenolpyruvate,I,B
carboxykinase,I,I
of,I,O
the,I,O
chicken,I,O
is,O,O
2,O,O
.,O,O
8,O,O
kilobases,O,O
in,O,O
length,O,O
",",O,O
similar,O,O
to,O,O
that,O,O
previously,O,O
noted,O,O
for,O,O
mRNA,O,O
coding,O,O
for,O,O
the,O,O
same,O,O
enzyme,O,O
in,O,O
the,O,O
rat,O,O
.,O,O
Polysorbate,O,O
80,O,O
did,O,O
not,O,O
have,O,O
a,O,O
direct,O,O
stimulant,O,O
or,O,O
relaxant,O,O
effect,O,O
on,O,O
either,O,O
guinea,O,O
pig,O,O
ileum,O,O
or,O,O
rat,O,O
uterus,O,O
",",O,O
however,O,O
",",O,O
it,O,O
antagonised,O,O
the,O,O
contractions,O,O
induced,O,O
by,O,O
acetylcholine,O,O
",",O,O
histamine,O,O
",",O,O
barium,O,O
",",O,O
5,O,O
-,O,O
hydroxytryptamine,O,O
and,O,O
carbachol,O,O
in,O,O
a,O,O
dose,O,O
-,O,O
dependent,O,O
manner,O,O
.,O,O
Further,O,O
evidence,O,O
for,O,O
a,O,O
clustered,O,O
organization,O,O
of,O,O
FAX,B,B
-,O,I
ZFP,B,I
transcription,O,I
units,O,I
is,O,O
provided,O,O
by,O,O
Southern,O,O
blot,O,O
analysis,O,O
of,O,O
large,O,O
genomic,O,O
restriction,O,O
fragments,O,O
separated,O,O
by,O,O
transverse,O,O
field,O,O
gel,O,O
electrophoresis,O,O
",",O,O
and,O,O
by,O,O
in,O,O
situ,O,O
hybridization,O,O
on,O,O
intact,O,O
chromosomes,O,O
.,O,O
In,O,O
adherent,O,O
macrophages,O,O
",",O,O
absence,O,O
of,O,O
CD45,B,B
led,O,O
to,O,O
the,O,O
hyperphosphorylation,O,O
and,O,O
hyperactivation,O,O
of,O,O
p56,B,B
/,I,I
59,I,I
(,O,O
hck,B,B
),O,O
and,O,O
p53,B,B
/,I,I
56,I,I
(,O,O
lyn,B,B
),O,O
",",O,O
but,O,O
not,O,O
of,O,O
p58,B,B
(,O,O
c,B,I
-,I,I
fgr,I,I
),O,O
.,O,O
The,O,O
structural,O,O
study,O,O
of,O,O
peptides,O,O
belonging,O,O
to,O,O
the,O,O
terminal,O,O
domains,O,O
of,O,O
histone,B,B
H1,I,I
can,O,O
be,O,O
considered,O,O
as,O,O
a,O,O
step,O,O
toward,O,O
the,O,O
understanding,O,O
of,O,O
the,O,O
function,O,O
of,O,O
H1,B,B
in,O,O
chromatin,O,O
.,O,O
Cold,O,O
cardioplegia,O,O
was,O,O
administered,O,O
at,O,O
45,O,O
mm,O,O
Hg,O,O
every,O,O
20,O,O
minutes,O,O
for,O,O
2,O,O
hours,O,O
.,O,O
These,O,O
disorders,O,O
include,O,O
low,O,O
-,O,O
back,O,O
pain,O,O
",",O,O
saddle,O,O
anesthesia,O,O
",",O,O
bilateral,O,O
sciatica,O,O
",",O,O
then,O,O
motor,O,O
weakness,O,O
of,O,O
the,O,O
lower,O,O
extremities,O,O
or,O,O
chronic,O,O
paraplegia,O,O
and,O,O
",",O,O
bladder,O,O
dysfunction,O,O
.,O,O
W,O,O
.,O,O
G,O,O
.,O,O
The,O,O
model,O,O
also,O,O
predicts,O,O
that,O,O
blood,O,O
flow,O,O
shunt,O,O
fraction,O,O
(,O,O
Qs,O,O
/,O,O
QT,O,O
),O,O
is,O,O
directly,O,O
related,O,O
to,O,O
the,O,O
oxygen,O,O
sine,O,O
-,O,O
wave,O,O
amplitude,O,O
perturbations,O,O
transmitted,O,O
to,O,O
end,O,O
-,O,O
expired,O,O
air,O,O
and,O,O
arterial,O,O
and,O,O
mixed,O,O
-,O,O
venous,O,O
blood,O,O
through,O,O
two,O,O
simple,O,O
equations,O,O
.,O,O
No,O,O
significant,O,O
differences,O,O
were,O,O
identified,O,O
between,O,O
groups,O,O
for,O,O
pH,O,O
",",O,O
PaCO2,O,O
",",O,O
intracranial,O,O
pressure,O,O
",",O,O
heart,O,O
rate,O,O
",",O,O
brain,O,O
temperature,O,O
",",O,O
or,O,O
glucose,O,O
levels,O,O
.,O,O
In,O,O
our,O,O
previous,O,O
studies,O,O
",",O,O
transcriptional,O,O
activation,O,O
was,O,O
shown,O,O
to,O,O
correlate,O,O
with,O,O
IEP86,B,B
binding,O,O
to,O,O
both,O,O
the,O,O
TATA,B,B
-,I,I
box,I,I
binding,I,I
protein,I,I
(,O,O
TBP,B,B
),O,O
and,O,O
the,O,O
transcription,O,O
factor,O,O
bound,O,O
upstream,O,O
.,O,O
Cloning,O,O
of,O,O
a,O,O
human,O,B
cDNA,O,I
encoding,O,O
a,O,O
CDC2,B,B
-,I,I
related,I,I
kinase,I,I
by,O,O
complementation,O,O
of,O,O
a,O,O
budding,B,O
yeast,I,O
cdc28,I,B
mutation,O,O
.,O,O
These,O,O
results,O,O
support,O,O
the,O,O
view,O,O
that,O,O
clonidine,O,B
and,O,O
6,O,O
-,O,O
OHDA,O,O
",",O,O
but,O,O
not,O,O
alpha,O,O
-,O,O
MD,O,O
",",O,O
have,O,O
central,O,O
pressor,O,O
actions,O,O
in,O,O
the,O,O
rat,O,O
that,O,O
oppose,O,O
their,O,O
antihypertensive,O,O
action,O,O
.,O,O
Peroxisome,B,B
proliferator,I,I
-,I,I
activated,I,I
receptors,I,I
(,O,O
PPARs,B,B
),O,O
and,O,O
retinoid,B,B
X,I,I
receptors,I,I
(,O,O
RXRs,B,B
),O,O
are,O,O
nuclear,B,O
hormone,I,O
receptors,I,O
that,O,O
are,O,O
activated,O,O
by,O,O
fatty,O,O
acids,O,O
and,O,O
9,O,O
-,O,O
cis,O,O
-,O,O
retinoic,O,O
acid,O,O
",",O,O
respectively,O,O
.,O,O
Using,O,O
mutagenesis,O,O
",",O,O
we,O,O
have,O,O
identified,O,O
two,O,O
mutations,O,O
of,O,O
the,O,O
second,O,O
actin,B,O
-,I,O
binding,I,O
domain,I,O
that,O,O
can,O,O
also,O,O
suppress,O,O
the,O,O
act1,B,O
mutations,O,O
of,O,O
interest,O,O
.,O,O
A,O,O
point,O,O
mutation,O,O
in,O,O
Galphao,B,B
and,O,O
Galphai1,B,B
blocks,O,O
interaction,O,O
with,O,O
regulator,O,O
of,O,O
G,B,O
protein,I,O
signaling,O,O
proteins,O,O
.,O,O
Survival,O,O
was,O,O
calculated,O,O
both,O,O
from,O,O
the,O,O
date,O,O
of,O,O
onset,O,O
and,O,O
from,O,O
the,O,O
date,O,O
of,O,O
diagnosis,O,O
.,O,O
Areas,O,O
with,O,O
significantly,O,O
greater,O,O
rCBF,O,O
for,O,O
targeting,O,O
were,O,O
the,O,O
left,O,O
motor,O,O
cortex,O,O
",",O,O
left,O,O
intraparietal,O,O
sulcus,O,O
",",O,O
and,O,O
left,O,O
caudate,O,O
.,O,O
Activation,O,O
of,O,O
PKA,B,B
by,O,O
8,O,O
-,O,O
bromo,O,O
-,O,O
cyclic,O,O
AMP,O,O
or,O,O
forskolin,O,O
",",O,O
and,O,O
inhibition,O,O
of,O,O
PKC,B,B
by,O,O
calphostin,O,O
C,O,O
",",O,O
resulted,O,O
in,O,O
a,O,O
significant,O,O
decrease,O,O
in,O,O
3TP,B,O
activity,O,O
as,O,O
well,O,O
as,O,O
in,O,O
vitro,O,O
ERK,B,B
kinase,I,I
activity,O,I
in,O,O
CRAC,O,O
.,O,O
The,O,O
growing,O,O
drug,O,O
problem,O,O
is,O,O
also,O,O
reflected,O,O
in,O,O
the,O,O
increasing,O,O
number,O,O
of,O,O
cases,O,O
of,O,O
hepatitis,O,O
B,O,B
and,O,O
of,O,O
drug,O,O
-,O,O
related,O,O
deaths,O,O
.,O,O
We,O,O
had,O,O
previously,O,O
analyzed,O,O
repair,O,O
rates,O,O
of,O,O
cyclobutane,O,O
pyrimidine,O,O
dimers,O,O
at,O,O
nucleotide,O,O
resolution,O,O
along,O,O
the,O,O
human,B,B
JUN,I,I
gene,I,O
in,O,O
normal,O,O
fibroblasts,O,O
and,O,O
found,O,O
very,O,O
efficient,O,O
repair,O,O
of,O,O
sequences,O,O
near,O,O
the,O,O
transcription,O,O
initiation,O,O
site,O,O
but,O,O
slow,O,O
repair,O,O
along,O,O
the,O,O
promoter,O,O
.,O,O
Radiation,O,O
-,O,O
induced,O,O
changes,O,O
in,O,O
the,O,O
area,O,O
of,O,O
alveoli,O,O
and,O,O
septa,O,O
as,O,O
well,O,O
as,O,O
collagen,B,O
content,O,O
were,O,O
seen,O,O
11,O,O
weeks,O,O
after,O,O
irradiation,O,O
.,O,O
At,O,O
both,O,O
companies,O,O
sites,O,O
Salmonella,O,B
enteritidis,O,I
and,O,O
Salmonella,O,B
typhimurium,O,I
Tr104,O,O
were,O,O
also,O,O
isolated,O,O
occasionally,O,O
from,O,O
various,O,O
locations,O,O
.,O,O
Our,O,O
results,O,O
suggest,O,O
that,O,O
the,O,O
C,O,O
-,O,O
terminal,O,O
region,O,O
of,O,O
Crk,B,O
contains,O,O
negative,O,O
regulatory,O,O
elements,O,O
important,O,O
for,O,O
both,O,O
Abl,B,B
and,O,O
FAK,B,B
dependent,O,O
signal,O,O
pathways,O,O
",",O,O
and,O,O
offers,O,O
a,O,O
paradigm,O,O
for,O,O
an,O,O
autoinhibitory,O,O
region,O,O
in,O,O
the,O,O
SH3,B,O
linker,O,O
/,O,O
C,O,O
-,O,O
terminal,O,O
SH3,B,O
domain,O,O
.,O,O
The,O,O
sequence,O,O
and,O,O
isolated,O,O
cDNAs,O,O
will,O,O
provide,O,O
useful,O,O
reagents,O,O
for,O,O
studying,O,O
the,O,O
expression,O,O
of,O,O
Brca1,B,B
in,O,O
the,O,O
mouse,O,O
",",O,O
and,O,O
for,O,O
testing,O,O
the,O,O
importance,O,O
of,O,O
the,O,O
evolutionarily,O,O
conserved,O,O
domains,O,O
.,O,O
Analysis,O,O
of,O,O
regulatory,O,O
regions,O,O
in,O,O
the,O,O
promoter,O,O
of,O,O
the,O,O
ctr4,B,B
(,I,O
+,I,O
),I,O
copper,I,O
transporter,I,O
gene,I,O
in,O,O
fission,O,O
yeast,O,O
Schizosaccharomyces,O,B
pombe,O,I
reveals,O,O
the,O,O
identity,O,O
of,O,O
a,O,O
conserved,O,O
copper,O,O
-,O,O
signaling,O,O
element,O,O
(,O,O
CuSE,O,B
),O,O
",",O,O
which,O,O
is,O,O
recognized,O,O
by,O,O
the,O,O
transcription,B,O
factor,I,O
Cuf1,I,B
.,O,O
RVR,B,O
',O,O
loss,O,O
of,O,O
function,O,O
',O,O
studies,O,O
by,O,O
constitutive,O,O
over,O,O
-,O,O
expression,O,O
of,O,O
a,O,O
dominant,O,O
negative,O,O
RVR,B,O
delta,I,O
E,I,O
resulted,O,O
in,O,O
increased,O,O
levels,O,O
of,O,O
p21Cip1,B,B
/,O,I
Waf1,B,I
and,O,O
myogenin,B,B
mRNAs,I,O
after,O,O
serum,O,O
withdrawal,O,O
.,O,O
This,O,O
soluble,O,O
form,O,O
of,O,O
the,O,O
HGFr,B,B
(,O,O
sHGFr,B,B
),O,O
bound,O,O
HGF,B,O
with,O,O
an,O,O
affinity,O,O
similar,O,O
to,O,O
that,O,O
of,O,O
the,O,O
authentic,O,O
",",O,O
membrane,O,O
-,O,O
associated,O,O
receptor,O,O
.,O,O
The,O,O
effect,O,O
of,O,O
ligustrazine,O,B
hydrochloride,O,I
(,O,O
LTH,O,B
),O,O
on,O,O
depressing,O,O
pulmonary,O,O
artery,O,O
hypertension,O,O
has,O,O
been,O,O
proved,O,O
in,O,O
recent,O,O
studies,O,O
.,O,O
Splicing,O,O
of,O,O
the,O,O
K,B,B
-,I,I
SAM,I,I
alternative,O,I
exon,O,I
of,O,O
the,O,O
fibroblast,B,O
growth,I,O
factor,I,O
receptor,I,O
2,I,O
gene,I,O
is,O,O
heavily,O,O
dependent,O,O
on,O,O
the,O,O
U,O,B
-,O,I
rich,O,I
sequence,O,I
IAS1,B,I
lying,O,O
immediately,O,O
downstream,O,O
from,O,O
its,O,O
5,O,O
',O,O
splice,O,O
site,O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
There,O,O
is,O,O
a,O,O
relation,O,O
in,O,O
the,O,O
topography,O,O
of,O,O
some,O,O
visual,O,O
field,O,O
areas,O,O
assessed,O,O
by,O,O
SWAP,O,O
and,O,O
the,O,O
inferotemporal,O,O
neuroretinal,O,O
rim,O,O
area,O,O
",",O,O
which,O,O
may,O,O
play,O,O
a,O,O
role,O,O
in,O,O
the,O,O
diagnosis,O,O
and,O,O
follow,O,O
-,O,O
up,O,O
of,O,O
suspected,O,O
glaucoma,O,O
.,O,O
In,O,O
conclusion,O,O
",",O,O
these,O,O
studies,O,O
indicate,O,O
that,O,O
LiCl,O,B
(,O,O
1,O,O
),O,O
decreases,O,O
histamine,O,O
-,O,O
stimulated,O,O
gastric,O,O
acid,O,O
secretion,O,O
",",O,O
and,O,O
(,O,O
2,O,O
),O,O
diminishes,O,O
bile,O,O
-,O,O
induced,O,O
disruption,O,O
of,O,O
the,O,O
gastric,O,O
mucosal,O,O
barrier,O,O
in,O,O
the,O,O
canine,O,O
Heidenhain,O,O
pouch,O,O
.,O,O
Diagnosis,O,O
of,O,O
phenylalanine,B,B
hydroxylase,I,I
deficiency,O,I
(,O,O
phenylketonuria,O,B
),O,O
.,O,O
They,O,O
self,O,O
-,O,O
completed,O,O
the,O,O
SF,O,O
-,O,O
36,O,O
questionnaire,O,O
and,O,O
their,O,O
QoL,O,O
was,O,O
described,O,O
and,O,O
retrospectively,O,O
compared,O,O
to,O,O
that,O,O
of,O,O
historical,O,O
controls,O,O
.,O,O
Growth,O,O
of,O,O
tracheal,O,O
anastomoses,O,O
in,O,O
growing,O,O
animals,O,O
Patients,O,O
with,O,O
detectable,O,O
serum,O,O
TNF,B,B
levels,O,O
had,O,O
significantly,O,O
lower,O,O
serum,O,O
T3,O,B
concentrations,O,O
compared,O,O
to,O,O
those,O,O
with,O,O
undetectable,O,O
levels,O,O
[,O,O
1,O,O
.,O,O
072,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
588,O,O
vs,O,O
.,O,O
Finally,O,O
",",O,O
antibody,O,O
binding,O,O
to,O,O
site,O,O
IIIa,O,O
on,O,O
the,O,O
hCG,B,B
-,I,I
ectodomain,I,I
complex,I,I
was,O,O
also,O,O
hindered,O,O
by,O,O
an,O,O
anti,O,O
-,O,O
peptide,O,O
mAb,O,O
directed,O,O
against,O,O
a,O,O
peptide,O,O
encoded,O,O
by,O,O
the,O,O
eighth,O,O
exon,O,O
(,O,O
pE,O,B
x,O,I
8,O,I
),O,O
of,O,O
the,O,O
LHR,B,B
.,O,O
2,O,O
.,O,O
Pressure,O,O
ulcers,O,O
.,O,O
The,O,O
mean,O,O
(,O,O
+,O,O
/,O,O
-,O,O
SD,O,O
),O,O
PaO2,O,O
increased,O,O
from,O,O
80,O,O
.,O,O
8,O,O
+,O,O
/,O,O
-,O,O
26,O,O
.,O,O
9,O,O
mmHg,O,O
before,O,O
to,O,O
89,O,O
.,O,O
8,O,O
+,O,O
/,O,O
-,O,O
27,O,O
.,O,O
3,O,O
mmHg,O,O
after,O,O
the,O,O
infusion,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
05,O,O
),O,O
and,O,O
the,O,O
PaCO2,O,O
decreased,O,O
from,O,O
42,O,O
.,O,O
4,O,O
+,O,O
/,O,O
-,O,O
8,O,O
.,O,O
3,O,O
to,O,O
39,O,O
.,O,O
6,O,O
+,O,O
/,O,O
-,O,O
7,O,O
.,O,O
9,O,O
mmHg,O,O
(,O,O
P,O,O
<,O,O
0,O,O
.,O,O
05,O,O
),O,O
.,O,O
As,O,O
well,O,O
",",O,O
mixtures,O,O
of,O,O
(,O,O
LA,O,O
),O,O
(,O,O
12,O,O
),O,O
with,O,O
the,O,O
longer,O,O
chain,O,O
PEs,O,O
exhibit,O,O
unusual,O,O
biomodal,O,O
enthalpy,O,O
variations,O,O
",",O,O
suggesting,O,O
peptide,O,O
immiscibility,O,O
in,O,O
thicker,O,O
gel,O,O
state,O,O
bilayers,O,O
.,O,O
The,O,O
limit,O,O
between,O,O
the,O,O
cecum,O,O
and,O,O
the,O,O
ascending,O,O
colon,O,O
was,O,O
externally,O,O
marked,O,O
by,O,O
the,O,O
sulcus,O,O
cecocolicus,O,O
dorsalis,O,O
and,O,O
ventralis,O,O
.,O,O
The,O,O
PSS,B,B
gene,I,I
was,O,O
subcloned,O,O
into,O,O
a,O,O
1,O,O
.,O,O
1,O,O
-,O,O
kb,O,O
fragment,O,O
of,O,O
the,O,O
yeast,O,O
DNA,O,O
on,O,O
the,O,O
YEp13,O,O
vector,O,O
.,O,O
The,O,O
second,O,O
method,O,O
",",O,O
the,O,O
assay,O,O
",",O,O
has,O,O
a,O,O
sensitivity,O,O
range,O,O
of,O,O
0,O,O
.,O,O
03,O,O
-,O,O
5,O,O
.,O,O
0,O,O
micrograms,O,O
phosphorus,O,O
with,O,O
100,O,O
-,O,O
500,O,O
microliters,O,O
HClO4,O,O
.,O,O
Recently,O,O
",",O,O
an,O,O
alternatively,O,O
spliced,O,O
form,O,O
of,O,O
c,B,B
-,I,I
mRNA,I,I
has,O,O
been,O,O
identified,O,O
in,O,O
murine,O,O
cells,O,O
containing,O,O
either,O,O
normal,O,O
or,O,O
rearranged,O,O
c,B,B
myb,I,I
genes,I,I
.,O,O
The,O,O
hyperacute,O,O
phase,O,O
of,O,O
posterolateral,O,O
myocardial,O,O
infarction,O,O
.,O,O
RegA,B,O
is,O,O
a,O,O
positive,O,O
yet,O,O
nonessential,O,O
regulator,O,O
of,O,O
tol,B,B
expression,O,I
.,O,O
Northern,O,O
(,O,O
RNA,O,O
),O,O
analysis,O,O
demonstrated,O,O
expression,O,O
of,O,O
human,O,B
PI,B,I
3,I,I
in,O,O
all,O,O
tissues,O,O
and,O,O
cell,O,O
lines,O,O
tested,O,O
.,O,O
A,O,O
patient,O,O
suffering,O,O
from,O,O
heparin,O,B
-,O,I
associated,O,I
thrombocytopenia,O,I
(,O,O
HAT,O,B
),O,O
",",O,O
recurrent,O,O
arteriothromboses,O,O
",",O,O
and,O,O
acute,O,O
renal,O,O
failure,O,O
after,O,O
treatment,O,O
with,O,O
standard,O,O
heparin,O,B
is,O,O
described,O,O
.,O,O
It,O,O
is,O,O
likely,O,O
that,O,O
the,O,O
sequence,O,O
similarities,O,O
reflect,O,O
a,O,O
common,O,O
molecular,O,O
architecture,O,O
of,O,O
the,O,O
two,O,O
heme,O,O
binding,O,O
sites,O,O
and,O,O
of,O,O
a,O,O
copper,O,O
binding,O,O
site,O,O
in,O,O
these,O,O
enzymes,O,O
.,O,O
Collectively,O,O
",",O,O
this,O,O
study,O,O
emphasizes,O,O
a,O,O
critical,O,O
role,O,O
of,O,O
Phox2a,B,B
as,O,O
well,O,O
as,O,O
its,O,O
functional,O,O
synergism,O,O
with,O,O
other,O,O
transcription,O,O
factors,O,O
(,O,O
e,O,O
.,O,O
g,O,O
.,O,O
",",O,O
CREB,B,B
",",O,O
AP2,B,B
",",O,O
and,O,O
Sp1,B,B
),O,O
in,O,O
transcriptional,O,O
activation,O,O
of,O,O
the,O,O
DBH,B,B
gene,I,O
.,O,O
The,O,O
RNA,B,O
polymerase,I,O
III,I,O
-,I,O
recruiting,I,O
factor,I,O
TFIIIB,I,B
induces,O,O
a,O,O
DNA,O,O
bend,O,O
between,O,O
the,O,O
TATA,O,O
box,O,O
and,O,O
the,O,O
transcriptional,O,O
start,O,O
site,O,O
.,O,O
Our,O,O
data,O,O
demonstrate,O,O
directly,O,O
that,O,O
Rpm1r,B,B
is,O,O
transcribed,O,O
with,O,O
its,O,O
substrates,O,O
",",O,O
tRNA,B,B
met,I,I
f,I,I
and,O,O
tRNAPro,B,B
",",O,O
from,O,O
a,O,O
promoter,O,O
located,O,O
upstream,O,O
of,O,O
the,O,O
tRNA,B,B
met,I,I
f,I,I
gene,I,O
and,O,O
suggest,O,O
that,O,O
a,O,O
portion,O,O
also,O,O
originates,O,O
from,O,O
a,O,O
second,O,O
promoter,O,O
",",O,O
located,O,O
between,O,O
the,O,O
tRNA,B,B
met,I,I
f,I,I
gene,I,O
and,O,O
RPM1,B,B
.,O,O
Scanning,O,O
mutations,O,O
throughout,O,O
the,O,O
AC,O,O
element,O,O
interfered,O,O
with,O,O
induction,O,O
but,O,O
allowed,O,O
us,O,O
to,O,O
define,O,O
five,O,O
overlapping,O,O
sites,O,O
for,O,O
regulatory,O,O
factors,O,O
in,O,O
AC,O,O
and,O,O
to,O,O
design,O,O
probes,O,O
binding,O,O
just,O,O
one,O,O
or,O,O
two,O,O
factors,O,O
.,O,O
Blood,O,O
from,O,O
dams,O,O
was,O,O
collected,O,O
prior,O,O
to,O,O
inoculation,O,O
and,O,O
at,O,O
time,O,O
of,O,O
necropsy,O,O
for,O,O
measurement,O,O
of,O,O
IgM,B,O
and,O,O
IgG,B,O
antibodies,I,O
to,O,O
M,O,B
.,O,O
pulmonis,O,O
.,O,O
Consistent,O,O
with,O,O
this,O,O
model,O,O
",",O,O
a,O,O
synthetic,O,O
construct,O,O
containing,O,O
three,O,O
tandem,O,O
copies,O,O
of,O,O
the,O,O
native,O,O
LDL,B,B
receptor,I,I
SREBP,B,I
site,O,I
linked,O,O
to,O,O
a,O,O
single,O,O
Sp1,B,B
site,I,I
was,O,O
also,O,O
significantly,O,O
activated,O,O
in,O,O
a,O,O
buttonhead,B,O
-,O,O
independent,O,O
fashion,O,O
.,O,O
Alternatively,O,O
",",O,O
PC12,O,O
-,O,O
E2,O,O
cells,O,O
were,O,O
submitted,O,O
to,O,O
treatment,O,O
with,O,O
antibodies,O,O
to,O,O
the,O,O
fibroblast,B,O
growth,I,O
factor,I,O
(,I,O
FGF,I,B
),I,O
receptor,I,O
",",O,O
inhibitors,O,O
of,O,O
the,O,O
nonreceptor,B,O
tyrosine,I,O
kinase,I,O
p59,B,B
(,O,O
fyn,B,B
),O,O
",",O,O
PLC,B,B
",",O,O
PKC,B,B
and,O,O
MEK,B,B
and,O,O
an,O,O
activator,O,O
of,O,O
PKC,B,B
",",O,O
phorbol,O,O
-,O,O
12,O,O
-,O,O
myristate,O,O
-,O,O
13,O,O
-,O,O
acetate,O,O
(,O,O
PMA,O,B
),O,O
.,O,O
Story,O,O
of,O,O
a,O,O
hospital,O,O
that,O,O
filmed,O,O
its,O,O
employee,O,O
orientation,O,O
program,O,O
.,O,O
The,O,O
new,O,O
semi,O,O
-,O,O
synthetic,O,O
oral,O,O
cephalosporin,O,B
",",O,O
CGP,O,B
9,O,I
",",O,I
000,O,I
",",O,O
has,O,O
been,O,O
evaluated,O,O
in,O,O
a,O,O
large,O,O
number,O,O
of,O,O
hospitalized,O,O
patients,O,O
with,O,O
urinary,O,O
infections,O,O
.,O,O
The,O,O
distribution,O,O
of,O,O
body,O,O
fluids,O,O
following,O,O
hemorrhage,O,O
and,O,O
resuscitation,O,O
in,O,O
combat,O,O
casualties,O,O
.,O,O
In,O,O
the,O,O
present,O,O
study,O,O
",",O,O
we,O,O
have,O,O
isolated,O,O
and,O,O
sequenced,O,O
several,O,O
p15E,B,B
cDNA,I,I
gene,I,I
fragments,I,I
amplified,O,O
by,O,O
means,O,O
of,O,O
polymerase,O,O
chain,O,O
reaction,O,O
(,O,O
PCR,O,O
),O,O
from,O,O
parental,O,O
(,O,O
P815,O,O
),O,O
and,O,O
xenogenized,O,O
(,O,O
P815,O,O
/,O,O
DTIC,O,O
),O,O
tumour,O,O
cells,O,O
.,O,O
We,O,O
have,O,O
previously,O,O
identified,O,O
",",O,O
by,O,O
screening,O,O
a,O,O
lambda,O,O
gt11,O,O
expression,O,O
library,O,O
",",O,O
murine,B,B
protein,I,O
mXBP,I,B
",",O,O
which,O,O
binds,O,O
to,O,O
a,O,O
sequence,O,O
which,O,O
overlaps,O,O
the,O,O
3,O,O
',O,O
end,O,O
of,O,O
the,O,O
murine,B,O
class,I,O
II,I,O
major,I,O
histocompatibility,I,O
complex,I,O
A,I,B
alpha,I,I
gene,I,I
X,I,I
box,I,I
",",O,O
a,O,O
conserved,O,O
transcription,O,O
element,O,O
found,O,O
upstream,O,O
of,O,O
all,O,O
class,O,O
II,O,O
genes,O,O
.,O,O
This,O,O
study,O,O
indicates,O,O
that,O,O
this,O,O
dose,O,O
-,O,O
intense,O,O
regimen,O,O
can,O,O
be,O,O
safely,O,O
administered,O,O
",",O,O
even,O,O
with,O,O
the,O,O
use,O,O
of,O,O
purged,O,O
marrow,O,O
",",O,O
with,O,O
an,O,O
acceptable,O,O
toxicity,O,O
profile,O,O
.,O,O
Cyclin,B,B
-,I,I
dependent,I,I
kinase,I,I
-,I,I
2,I,I
(,O,O
Cdk2,B,B
),O,O
forms,O,O
an,O,O
inactive,O,O
complex,O,O
with,O,O
cyclin,B,O
D1,I,O
since,O,O
Cdk2,B,B
associated,O,I
with,O,I
cyclin,B,I
D1,I,I
is,O,O
not,O,O
phosphorylated,O,O
by,O,O
Cdk7,B,B
-,O,I
cyclin,B,I
-,I,I
H,I,I
.,O,O
The,O,O
number,O,O
of,O,O
fecal,O,O
pellets,O,O
ingested,O,O
peaked,O,O
at,O,O
5,O,O
to,O,O
6,O,O
weeks,O,O
old,O,O
(,O,O
13,O,O
pellets,O,O
/,O,O
day,O,O
),O,O
and,O,O
gradually,O,O
decreased,O,O
",",O,O
thereafter,O,O
(,O,O
2,O,O
.,O,O
1,O,O
pellets,O,O
at,O,O
78,O,O
weeks,O,O
old,O,O
",",O,O
1,O,O
.,O,O
5,O,O
pellets,O,O
at,O,O
104,O,O
weeks,O,O
old,O,O
),O,O
.,O,O
Expression,O,O
of,O,O
the,O,O
second,O,O
gene,O,B
(,O,O
XT3,B,B
),O,O
was,O,O
found,O,O
to,O,O
be,O,O
conserved,O,O
in,O,O
human,O,B
kidney,O,O
",",O,O
and,O,O
partial,O,O
sequence,O,O
was,O,O
obtained,O,O
from,O,O
a,O,O
human,O,B
cDNA,O,O
library,O,O
.,O,O
The,O,O
next,O,O
twenty,O,O
years,O,O
of,O,O
prevention,O,O
in,O,O
Indian,O,B
country,O,O
:,O,O
visionary,O,O
",",O,O
complex,O,O
",",O,O
and,O,O
practical,O,O
.,O,O
A,O,O
human,O,B
cytoplasmic,O,I
signaling,O,I
protein,O,I
has,O,O
been,O,O
cloned,O,O
that,O,O
possesses,O,O
the,O,O
same,O,O
structural,O,O
arrangement,O,O
of,O,O
SH3,B,B
-,O,I
SH2,B,I
-,O,I
SH3,B,I
domains,O,O
as,O,O
Grb2,B,B
.,O,O
CO2,O,O
assimilation,O,O
by,O,O
chloroplasts,O,O
illuminated,O,O
on,O,O
filter,O,O
paper,O,O
.,O,O
Liver,O,B
transplantation,O,O
in,O,O
one,O,O
patient,O,O
resolved,O,O
metabolic,O,O
complications,O,O
but,O,O
did,O,O
not,O,O
improve,O,O
PMN,O,B
count,O,O
or,O,O
the,O,O
infectious,O,O
status,O,O
",",O,O
while,O,O
neutropenia,O,O
was,O,O
corrected,O,O
by,O,O
G,B,B
-,I,I
CSF,I,I
.,O,O
According,O,O
to,O,O
the,O,O
published,O,O
sequence,O,O
of,O,O
the,O,O
CHS1,B,B
gene,I,O
",",O,O
this,O,O
fragment,O,O
contains,O,O
four,O,O
repeats,O,O
of,O,O
a,O,O
TGAAACA,O,B
consensus,O,O
sequence,O,O
previously,O,O
identified,O,O
in,O,O
the,O,O
alpha,B,O
-,I,O
factor,I,O
-,O,O
inducible,O,O
BAR1,B,B
promoter,I,O
[,O,O
Kronstad,O,O
",",O,O
J,O,O
.,O,O
These,O,O
lesions,O,O
were,O,O
asymptomatic,O,O
",",O,O
but,O,O
both,O,O
were,O,O
characterized,O,O
clinically,O,O
by,O,O
central,O,O
ulceration,O,O
.,O,O
Experiments,O,O
on,O,O
narcotized,O,O
cats,O,O
demonstrated,O,O
that,O,O
the,O,O
derivatives,O,O
of,O,O
2,O,O
-,O,O
mercaptobenzimidazole,O,O
possessing,O,O
the,O,O
properties,O,O
of,O,O
specific,O,O
bradycardic,O,O
agents,O,O
and,O,O
coded,O,O
as,O,O
CM,O,B
-,O,I
251,O,I
",",O,O
CM,O,B
-,O,I
266,O,I
",",O,O
and,O,O
CM,O,B
-,O,I
345,O,I
",",O,O
reduce,O,O
the,O,O
mean,O,O
rise,O,O
of,O,O
segment,O,O
ST,O,O
on,O,O
numerous,O,O
leads,O,O
of,O,O
the,O,O
epicardial,O,O
electrogram,O,O
during,O,O
5,O,O
-,O,O
min,O,O
occlusion,O,O
of,O,O
the,O,O
anterior,O,O
descending,O,O
branch,O,O
of,O,O
the,O,O
left,O,O
coronary,O,O
artery,O,O
.,O,O
The,O,O
results,O,O
suggest,O,O
that,O,O
GATA,B,B
-,I,I
5,I,I
may,O,O
have,O,O
specific,O,O
downstream,O,O
targets,O,O
and,O,O
that,O,O
GATA,B,B
-,I,I
4,I,I
",",I,O
-,I,O
5,I,O
",",I,O
and,I,O
-,I,O
6,I,O
can,O,O
only,O,O
partially,O,O
substitute,O,O
for,O,O
each,O,O
other,O,O
in,O,O
cardiogenesis,O,O
.,O,O
SERS,O,O
spectra,O,O
were,O,O
obtained,O,O
by,O,O
vacuum,O,O
evaporation,O,O
and,O,O
casting,O,O
of,O,O
p,O,O
-,O,O
NTP,O,O
onto,O,O
silver,O,O
island,O,O
films,O,O
",",O,O
and,O,O
also,O,O
from,O,O
colloidal,O,O
silver,O,O
solutions,O,O
.,O,O
The,O,O
epidermal,B,O
growth,I,O
factor,I,O
(,I,O
EGF,I,B
),I,O
receptor,I,O
",",O,O
which,O,O
exhibits,O,O
intrinsic,O,O
protein,B,O
tyrosine,I,O
kinase,I,O
activity,O,O
",",O,O
undergoes,O,O
a,O,O
rapid,O,O
",",O,O
intramolecular,O,O
self,O,O
-,O,O
phosphorylation,O,O
reaction,O,O
following,O,O
EGF,B,O
activation,O,O
.,O,O
Lysine,B,O
-,I,O
ketoglutarate,I,O
reductase,I,O
and,O,O
saccharopine,B,O
dehydrogenase,I,O
from,O,O
Arabidopsis,O,B
thaliana,O,I
:,O,O
nucleotide,O,O
sequence,O,O
and,O,O
characterization,O,O
.,O,O
The,O,O
single,O,O
most,O,O
important,O,O
element,O,O
",",O,O
by,O,O
linker,O,O
-,O,O
scanning,O,O
analysis,O,O
",",O,O
is,O,O
a,O,O
10,O,O
-,O,O
bp,O,O
region,O,O
that,O,O
contains,O,O
a,O,O
CCAAT,O,B
motif,O,I
.,O,O
However,O,O
",",O,O
tyrA,B,B
can,O,O
be,O,O
expressed,O,O
efficiently,O,O
from,O,O
an,O,O
internal,O,O
promoter,O,O
which,O,O
appears,O,O
to,O,O
lie,O,O
within,O,O
the,O,O
3,O,O
',O,O
portion,O,O
of,O,O
aroF,B,O
.,O,O
Molecular,O,O
cloning,O,O
of,O,O
a,O,O
novel,O,O
human,B,B
I,I,I
-,I,I
mfa,I,I
domain,I,I
-,I,I
containing,I,I
protein,I,I
that,O,O
differently,O,O
regulates,O,O
human,O,O
T,O,B
-,O,I
cell,O,I
leukemia,O,I
virus,O,I
type,O,I
I,O,I
and,O,O
HIV,O,B
-,O,I
1,O,I
expression,O,O
.,O,O
The,O,O
rational,O,O
for,O,O
the,O,O
prophylactic,O,O
treatment,O,O
",",O,O
the,O,O
therapy,O,O
of,O,O
the,O,O
meningopathy,O,O
and,O,O
AIL,O,O
-,O,O
AIEOP,O,O
protocols,O,O
are,O,O
exposed,O,O
.,O,O
Topical,O,O
L,O,B
-,O,I
NNA,O,I
attenuated,O,O
the,O,O
hypercapnic,O,O
increase,O,O
of,O,O
CoBF,O,B
by,O,O
52,O,O
+,O,O
/,O,O
-,O,O
6,O,O
%,O,O
and,O,O
CeBF,O,B
by,O,O
29,O,O
+,O,O
/,O,O
-,O,O
5,O,O
%,O,O
after,O,O
45,O,O
-,O,O
min,O,O
exposure,O,O
.,O,O
Duration,O,O
of,O,O
remission,O,O
in,O,O
advanced,O,O
gastric,O,O
cancer,O,O
patients,O,O
responding,O,O
to,O,O
sequential,O,O
dose,O,O
of,O,O
MTX,O,B
and,O,O
5,O,O
-,O,O
FU,O,B
OKA,O,B
and,O,O
calyculin,O,O
A,O,B
do,O,O
not,O,O
decrease,O,O
OCFRE,B,B
DNA,O,I
-,O,I
protein,O,I
interactions,O,I
",",O,O
suggesting,O,O
that,O,O
important,O,O
protein,O,O
-,O,O
protein,O,O
interactions,O,O
are,O,O
phosphatase,O,O
regulated,O,O
.,O,O
The,O,O
data,O,O
indicate,O,O
that,O,O
etr,B,B
-,I,I
1,I,I
is,O,O
essential,O,O
for,O,O
muscle,O,O
development,O,O
in,O,O
C,O,O
.,O,O
elegans,O,O
",",O,O
perhaps,O,O
by,O,O
playing,O,O
a,O,O
role,O,O
in,O,O
post,O,O
-,O,O
transcriptional,O,O
processing,O,O
of,O,O
some,O,O
muscle,O,O
component,O,O
",",O,O
and,O,O
thus,O,O
suggesting,O,O
a,O,O
possible,O,O
conservation,O,O
of,O,O
gene,O,O
function,O,O
with,O,O
human,B,B
CUG,I,I
-,I,I
bp,I,I
.,O,O
The,O,O
poly,O,O
(,O,O
A,O,O
),O,O
segment,O,O
of,O,O
the,O,O
RNA,O,O
was,O,O
selectively,O,O
cross,O,O
-,O,O
linked,O,O
to,O,O
the,O,O
72,O,O
",",O,O
000,O,O
-,O,O
molecular,O,O
-,O,O
weight,O,O
protein,O,O
(,O,O
72K,O,B
protein,O,I
),O,O
.,O,O
Nuclease,O,O
probing,O,O
and,O,O
structure,O,O
-,O,O
directed,O,O
mutagenesis,O,O
revealed,O,O
that,O,O
the,O,O
105,O,O
-,O,O
nt,O,O
TE,O,B
(,O,O
TE105,O,O
),O,O
forms,O,O
a,O,O
cruciform,O,O
secondary,O,O
structure,O,O
containing,O,O
four,O,O
helices,O,O
connected,O,O
by,O,O
single,O,O
-,O,O
stranded,O,O
regions,O,O
.,O,O
Though,O,O
the,O,O
BACTEC,O,O
9000,O,O
MB,O,O
system,O,O
is,O,O
recommended,O,O
for,O,O
respiratory,O,O
specimens,O,O
",",O,O
we,O,O
demonstrated,O,O
that,O,O
it,O,O
can,O,O
be,O,O
successfully,O,O
used,O,O
also,O,O
for,O,O
recovery,O,O
of,O,O
mycobacteria,O,O
from,O,O
clinical,O,O
specimens,O,O
from,O,O
various,O,O
extrapulmonary,O,O
sites,O,O
.,O,O
In,O,O
all,O,O
instances,O,O
the,O,O
apparent,O,O
alcohol,O,O
responses,O,O
were,O,O
very,O,O
small,O,O
and,O,O
never,O,O
exceeded,O,O
a,O,O
reading,O,O
of,O,O
1,O,O
microgram,O,O
/,O,O
100ml,O,O
for,O,O
breath,O,O
samples,O,O
more,O,O
than,O,O
10min,O,O
post,O,O
-,O,O
exposure,O,O
.,O,O
O,B,O
.,I,O
novo,I,B
-,I,I
ulmi,I,I
RNA,I,I
-,I,I
7,I,I
",",O,O
previously,O,O
believed,O,O
to,O,O
be,O,O
a,O,O
satellite,O,O
-,O,O
like,O,O
RNA,O,O
",",O,O
is,O,O
shown,O,O
to,O,O
be,O,O
a,O,O
defective,O,O
RNA,O,O
",",O,O
derived,O,O
from,O,O
OnuMV4,B,B
-,I,I
Ld,I,I
RNA,I,I
by,O,O
multiple,O,O
internal,O,O
deletions,O,O
.,O,O
SCID,O,B
V,B,O
(,O,O
D,B,O
),O,O
J,B,O
recombination,O,O
can,O,O
be,O,O
partly,O,O
rescued,O,O
in,O,O
T,O,O
-,O,O
lymphocytes,O,O
by,O,O
either,O,O
DNA,O,O
-,O,O
damaging,O,O
agents,O,O
(,O,O
gamma,O,B
-,O,I
irradiation,O,I
and,O,O
bieomycin,O,O
),O,O
or,O,O
a,O,O
mutation,O,O
of,O,O
the,O,O
p53,B,B
gene,I,O
",",O,O
possibly,O,O
because,O,O
of,O,O
transiently,O,O
elevated,O,O
DNA,O,O
repair,O,O
activity,O,O
in,O,O
response,O,O
to,O,O
DNA,O,O
damage,O,O
or,O,O
to,O,O
delayed,O,O
apoptosis,O,O
in,O,O
the,O,O
absence,O,O
of,O,O
p53,B,B
.,O,O
Sensitization,O,O
to,O,O
hyperlactatemia,O,O
induced,O,O
by,O,O
phenformin,O,O
after,O,O
subtotal,O,O
ablation,O,O
of,O,O
the,O,O
pancreas,O,O
.,O,O
Examination,O,O
of,O,O
immediate,B,O
-,I,O
early,I,O
transcription,I,O
factor,I,O
expression,O,O
during,O,O
the,O,O
MDI,O,O
regimen,O,O
revealed,O,O
that,O,O
RA,O,O
mediated,O,O
an,O,O
elevated,O,O
",",O,O
prolonged,O,O
expression,O,O
of,O,O
c,B,O
-,I,O
Jun,I,B
mRNA,I,O
accompanied,O,O
by,O,O
diminished,O,O
expression,O,O
of,O,O
c,B,O
-,I,O
Fos,I,O
and,O,O
Jun,B,B
-,I,I
B,I,I
mRNAs,I,O
.,O,O
Circulatory,O,O
arrest,O,O
in,O,O
the,O,O
operating,O,O
room,O,O
.,O,O
At,O,O
an,O,O
ambient,O,O
temperature,O,O
of,O,O
25,O,O
degrees,O,O
C,O,O
",",O,O
the,O,O
responses,O,O
to,O,O
spinal,O,O
cooling,O,O
are,O,O
reduced,O,O
during,O,O
the,O,O
dark,O,O
phase,O,O
.,O,O
These,O,O
cells,O,O
fail,O,O
to,O,O
generate,O,O
the,O,O
signals,O,O
to,O,O
phosphorylate,O,O
CREB,B,B
and,O,O
produce,O,O
significantly,O,O
less,O,O
of,O,O
the,O,O
cytokine,O,O
Interleukin,B,B
-,I,I
2,I,I
(,O,O
IL,B,B
-,I,I
2,I,I
),O,O
in,O,O
response,O,O
to,O,O
agents,O,O
that,O,O
either,O,O
increase,O,O
intracellular,O,O
Ca2,O,O
+,O,O
and,O,O
/,O,O
or,O,O
activate,O,O
protein,B,O
kinase,I,O
C,I,O
.,O,O
One,O,O
P1,O,O
genomic,O,O
clone,O,O
and,O,O
six,O,O
subsequent,O,O
plasmid,O,O
subclones,O,O
were,O,O
isolated,O,O
and,O,O
analyzed,O,O
for,O,O
the,O,O
exon,O,O
-,O,O
intron,O,O
organization,O,O
of,O,O
the,O,O
Ctpct,B,B
gene,I,O
.,O,O
Treating,O,O
renal,O,O
anaemia,O,O
with,O,O
recombinant,O,O
human,O,B
erythropoietin,B,I
.,O,O
Five,O,O
modalities,O,O
of,O,O
nonpharmacologic,O,O
approaches,O,O
are,O,O
recommended,O,O
at,O,O
present,O,O
for,O,O
lifestyle,O,O
modification,O,O
and,O,O
control,O,O
of,O,O
arterial,O,O
blood,O,O
pressure,O,O
elevation,O,O
:,O,O
1,O,O
),O,O
weight,O,O
reduction,O,O
to,O,O
ideal,O,O
body,O,O
weight,O,O
",",O,O
since,O,O
it,O,O
reduces,O,O
risk,O,O
of,O,O
hypertension,O,O
as,O,O
well,O,O
as,O,O
overall,O,O
cardiovascular,O,O
morbidity,O,O
and,O,O
mortality,O,O
;,O,O
2,O,O
),O,O
dietary,O,O
sodium,O,O
restriction,O,O
to,O,O
less,O,O
than,O,O
2,O,O
g,O,O
a,O,O
day,O,O
",",O,O
without,O,O
assurance,O,O
that,O,O
it,O,O
will,O,O
normalize,O,O
arterial,O,O
pressure,O,O
although,O,O
it,O,O
may,O,O
help,O,O
reduce,O,O
dosage,O,O
and,O,O
numbers,O,O
of,O,O
prescribed,O,O
antihypertensive,O,O
drugs,O,O
;,O,O
3,O,O
),O,O
moderation,O,O
of,O,O
alcohol,O,O
consumption,O,O
to,O,O
less,O,O
than,O,O
1,O,O
ounce,O,O
a,O,O
day,O,O
;,O,O
4,O,O
),O,O
a,O,O
regular,O,O
isotonic,O,O
exercise,O,O
program,O,O
;,O,O
and,O,O
5,O,O
),O,O
cessation,O,O
of,O,O
tobacco,O,O
consumption,O,O
.,O,O
The,O,O
activated,O,O
glucocorticoid,B,B
receptor,I,O
forms,O,O
a,O,O
complex,O,O
with,O,O
Stat5,B,B
and,O,O
enhances,O,O
Stat5,B,B
-,O,I
mediated,O,I
transcriptional,O,I
induction,O,O
.,O,O
The,O,O
currently,O,O
proposed,O,O
extended,O,O
arch,O,O
repair,O,O
should,O,O
be,O,O
reserved,O,O
for,O,O
the,O,O
small,O,O
group,O,O
of,O,O
infants,O,O
with,O,O
transverse,O,O
aortic,O,O
arch,O,O
to,O,O
ascending,O,O
aorta,O,O
diameter,O,O
ratios,O,O
(,O,O
arch,O,O
indices,O,O
),O,O
of,O,O
less,O,O
than,O,O
0,O,O
.,O,O
25,O,O
conclude,O,O
that,O,O
RPMS,B,B
acts,O,O
as,O,O
a,O,O
negative,O,O
regulator,O,O
of,O,O
EBNA2,B,B
and,O,O
Notch,B,B
activity,O,O
through,O,O
its,O,O
interactions,O,O
with,O,O
the,O,O
CBF1,B,B
-,I,I
associated,I,I
corepressor,I,I
complex,I,I
.,O,O
The,O,O
4,O,O
degrees,O,O
stimuli,O,O
were,O,O
found,O,O
to,O,O
elicit,O,O
scalp,O,O
distributions,O,O
for,O,O
the,O,O
pattern,O,O
reversal,O,O
P100,O,O
and,O,O
the,O,O
pattern,O,O
onset,O,O
C1,O,O
consistent,O,O
with,O,O
striate,O,O
and,O,O
extrastriate,O,O
visual,O,O
cortical,O,O
origins,O,O
respectively,O,O
.,O,O
The,O,O
human,B,B
ABCG1,I,B
gene,I,O
encodes,O,O
a,O,O
member,O,O
of,O,O
the,O,O
ATP,B,B
-,I,I
binding,I,I
cassette,I,I
(,O,O
ABC,B,B
),O,O
superfamily,O,O
of,O,O
transporter,B,O
proteins,I,O
and,O,O
is,O,O
highly,O,O
induced,O,O
when,O,O
macrophages,O,O
are,O,O
incubated,O,O
with,O,O
oxysterols,O,O
.,O,O
Here,O,O
we,O,O
describe,O,O
an,O,O
in,O,O
vitro,O,O
assay,O,O
where,O,O
the,O,O
NS3,B,B
-,I,I
4A,I,I
polyprotein,I,O
",",O,O
NS3,B,B
",",O,O
the,O,O
serine,B,O
proteinase,I,O
domain,I,O
(,I,O
the,I,O
N,I,B
-,I,I
terminal,I,I
181,I,I
residues,I,I
of,I,I
NS3,I,I
),I,O
",",O,O
and,O,O
the,O,O
NS4A,B,B
cofactor,I,O
were,O,O
produced,O,O
by,O,O
cell,O,O
-,O,O
free,O,O
translation,O,O
and,O,O
tested,O,O
for,O,O
trans,O,O
-,O,O
processing,O,O
of,O,O
radiolabeled,O,O
substrates,O,O
.,O,O
RNA,O,B
gel,O,I
retardation,O,I
and,O,O
competition,O,O
analyses,O,O
indicate,O,O
that,O,O
TRP,B,B
-,I,I
185,I,I
binding,O,O
is,O,O
strongly,O,O
dependent,O,O
on,O,O
the,O,O
TAR,O,B
RNA,O,I
loop,O,I
sequences,O,I
.,O,O
The,O,O
genomic,O,O
and,O,O
transcriptional,O,O
complexity,O,O
of,O,O
the,O,O
Crry,B,B
and,O,O
Crry,B,B
-,O,I
ps,B,I
genes,O,O
.,O,O
These,O,O
results,O,O
indicate,O,O
that,O,O
the,O,O
PCNA,B,B
gene,I,O
is,O,O
a,O,O
likely,O,O
target,O,O
gene,O,O
of,O,O
E2F,B,B
.,O,O
SBF,B,B
binds,O,O
to,O,O
the,O,O
promoter,O,O
prior,O,O
to,O,O
the,O,O
activation,O,O
of,O,O
transcription,O,O
in,O,O
late,O,O
G1,O,O
",",O,O
suggesting,O,O
that,O,O
Cln,B,B
/,O,I
Cdc28,B,I
kinase,O,O
regulates,O,O
the,O,O
ability,O,O
of,O,O
previously,O,O
bound,O,O
SBF,B,B
to,O,O
activate,O,O
transcription,O,O
.,O,O
Altogether,O,O
these,O,O
results,O,O
suggest,O,O
that,O,O
",",O,O
in,O,O
KG1a,O,O
cells,O,O
",",O,O
TNFalpha,B,B
can,O,O
stimulate,O,O
in,O,O
parallel,O,O
PC,B,B
-,I,I
PLC,I,I
and,O,O
PLD,B,B
",",O,O
whose,O,O
lipid,O,O
products,O,O
activate,O,O
in,O,O
turn,O,O
mitogen,B,O
-,I,O
activated,I,O
protein,I,O
kinase,I,O
(,O,O
MAP,B,B
kinase,I,I
),O,O
and,O,O
NF,B,B
-,I,I
kappaB,I,I
signalling,O,O
respectively,O,O
.,O,O
The,O,O
RI,B,B
alpha,I,I
gene,I,O
is,O,O
composed,O,O
of,O,O
nine,O,O
coding,O,O
exons,O,O
of,O,O
varying,O,O
lengths,O,O
",",O,O
separated,O,O
by,O,O
introns,O,O
",",O,O
giving,O,O
the,O,O
gene,O,O
a,O,O
total,O,O
length,O,O
of,O,O
at,O,O
least,O,O
21,O,O
kb,O,O
.,O,O
our,O,O
recent,O,O
cloning,O,O
of,O,O
a,O,O
processed,O,O
RI,B,B
alpha,I,I
pseudogene,I,I
with,O,O
a,O,O
5,O,O
',O,O
-,O,O
noncoding,O,O
region,O,O
different,O,O
from,O,O
the,O,O
previously,O,O
reported,O,O
RI,B,B
alpha,I,I
complementary,I,I
RNA,I,I
indicated,O,O
that,O,O
the,O,O
RI,B,B
alpha,I,I
gene,I,I
may,O,O
have,O,O
multiple,O,O
leader,O,O
exons,O,O
giving,O,O
rise,O,O
to,O,O
alternately,O,O
spliced,O,O
messenger,O,O
RNAs,O,O
(,O,O
mRNAs,O,O
),O,O
.,O,O
While,O,O
mutations,O,O
in,O,O
K,B,B
-,I,I
Rev,I,I
that,O,O
inactivate,O,O
any,O,O
one,O,O
of,O,O
these,O,O
properties,O,O
also,O,O
blocked,O,O
K,B,B
-,I,I
Rev,I,I
-,O,I
dependent,O,I
nuclear,O,I
RNA,O,I
export,O,I
",",O,O
several,O,O
K,B,B
-,I,I
Rev,I,I
mutants,I,O
were,O,O
comparable,O,O
to,O,O
wild,O,O
type,O,O
when,O,O
assayed,O,O
for,O,O
any,O,O
of,O,O
these,O,O
individual,O,O
activities,O,O
yet,O,O
nevertheless,O,O
defective,O,O
for,O,O
RNA,O,I
export,O,I
.,O,O
Interspecific,O,O
backcross,O,O
analysis,O,O
using,O,O
progeny,O,O
derived,O,O
from,O,O
matings,O,O
of,O,O
(,O,O
C57BL,O,B
/,O,I
6J,O,I
x,O,O
Mus,O,B
spretus,O,I
),O,O
F1,O,O
x,O,O
C57BL,O,B
/,O,I
6J,O,I
mice,O,O
indicates,O,O
that,O,O
the,O,O
thrombospondin,B,B
gene,I,I
is,O,O
tightly,O,O
linked,O,O
to,O,O
the,O,O
Fshb,B,B
",",O,O
Actcl,B,B
",",O,O
Ltk,B,B
",",O,O
and,O,O
B2M,B,B
loci,I,O
on,O,O
murine,O,O
chromosome,O,O
2,O,O
.,O,O
Transcription,O,O
factors,O,O
containing,O,O
a,O,O
basic,O,O
helix,O,O
-,O,O
loop,O,O
-,O,O
helix,O,O
(,O,O
bHLH,O,B
),O,O
motif,O,O
regulate,O,O
the,O,O
expression,O,O
of,O,O
tissue,O,O
-,O,O
specific,O,O
genes,O,O
in,O,O
a,O,O
number,O,O
of,O,O
mammalian,O,O
and,O,O
insect,O,O
systems,O,O
.,O,O
This,O,O
observation,O,O
suggests,O,O
that,O,O
the,O,O
methyl,O,B
-,O,I
directed,O,I
repair,O,I
system,O,I
utilizes,O,O
the,O,O
proximal,O,O
d,O,B
(,O,O
GATC,O,B
),O,O
sequence,O,O
to,O,O
direct,O,O
correction,O,O
.,O,O
Surprisingly,O,O
",",O,O
Northern,O,O
(,O,O
RNA,O,O
),O,O
blot,O,O
analysis,O,O
and,O,O
reverse,B,O
transcriptase,I,O
-,O,O
PCRs,O,O
performed,O,O
after,O,O
transfection,O,O
of,O,O
COS,O,O
-,O,O
7,O,O
or,O,O
HeLa,O,O
cells,O,O
with,O,O
these,O,O
viral,O,O
RNAs,O,O
revealed,O,O
that,O,O
Y88S,B,O
and,O,O
Y88L,B,O
RNAs,I,O
replicated,O,O
at,O,O
only,O,O
very,O,O
low,O,O
levels,O,O
.,O,O
FISH,O,O
using,O,O
a,O,O
whole,O,O
chromosome,O,O
4,O,B
paint,O,O
demonstrated,O,O
multiple,O,O
rearrangements,O,O
involving,O,O
chromosome,O,O
4,O,B
in,O,O
MCF,O,O
-,O,O
7,O,O
AdVp3000,O,O
and,O,O
MCF,O,O
-,O,O
7,O,O
MX,O,O
",",O,O
while,O,O
S1,O,O
-,O,O
M1,O,O
-,O,O
80,O,O
contained,O,O
only,O,O
a,O,O
simple,O,O
reciprocal,O,O
translocation,O,O
.,O,O
Handling,O,O
on,O,O
PND,O,O
9,O,O
did,O,O
not,O,O
result,O,O
in,O,O
elevated,O,O
CORT,O,B
levels,O,O
in,O,O
any,O,O
of,O,O
the,O,O
groups,O,O
.,O,O
Tissue,B,O
plasminogen,I,O
activator,I,O
",",O,O
its,O,O
inhibitor,O,O
and,O,O
other,O,O
parameters,O,O
of,O,O
fibrinolysis,O,O
in,O,O
blood,O,O
of,O,O
patients,O,O
operated,O,O
for,O,O
mild,O,O
hypertrophy,O,O
of,O,O
the,O,O
prostate,O,O
Determination,O,O
of,O,O
three,O,O
-,O,O
dimensional,O,O
imaging,O,O
properties,O,O
of,O,O
a,O,O
light,O,O
microscope,O,O
system,O,O
.,O,O
METHODS,O,O
:,O,O
Fifty,O,O
-,O,O
one,O,O
healthy,O,O
eyes,O,O
",",O,O
169,O,O
ocular,O,O
hypertensive,O,O
eyes,O,O
with,O,O
normal,O,O
visual,O,O
fields,O,O
",",O,O
and,O,O
132,O,O
glaucomatous,O,O
eyes,O,O
with,O,O
early,O,O
visual,O,O
field,O,O
defects,O,O
were,O,O
evaluated,O,O
with,O,O
qualitative,O,O
and,O,O
quantitative,O,O
measures,O,O
of,O,O
structural,O,O
damage,O,O
to,O,O
the,O,O
optic,O,O
nerve,O,O
and,O,O
nerve,O,O
fiber,O,O
layer,O,O
.,O,O
The,O,O
rationale,O,O
for,O,O
continuous,O,O
dopaminergic,O,O
stimulation,O,O
in,O,O
patients,O,O
with,O,O
Parkinson,O,B
',O,I
s,O,I
disease,O,I
.,O,O
Deletion,O,O
analyses,O,O
implicate,O,O
the,O,O
N,O,B
-,O,I
terminal,O,I
110,O,I
amino,O,I
acids,O,I
of,O,O
Grb14,B,B
and,O,O
ankyrin,B,B
repeats,O,I
10,O,I
-,O,I
19,O,I
of,O,O
tankyrase,B,B
2,I,I
in,O,O
mediating,O,O
this,O,O
interaction,O,O
.,O,O
Most,O,O
of,O,O
them,O,O
were,O,O
situated,O,O
at,O,O
Sylvius,O,O
fissure,O,O
(,O,O
13,O,O
cases,O,O
),O,O
.,O,O
The,O,O
results,O,O
presented,O,O
suggest,O,O
that,O,O
TIQ,O,O
reduces,O,O
the,O,O
turnover,O,O
rate,O,O
of,O,O
the,O,O
nigrostriatal,O,O
dopamine,O,O
neurons,O,O
after,O,O
repeated,O,O
administration,O,O
for,O,O
a,O,O
long,O,O
period,O,O
in,O,O
mice,O,O
.,O,O
The,O,O
STAT,B,B
-,I,I
1,I,I
signaling,O,O
pathway,O,O
provides,O,O
at,O,O
least,O,O
one,O,O
mechanism,O,O
for,O,O
activation,O,O
of,O,O
the,O,O
CAEV,B,B
LTR,I,I
by,O,O
IFN,B,O
-,I,O
gamma,I,O
in,O,O
monocytes,O,O
.,O,O
Patients,O,O
were,O,O
subclassified,O,O
into,O,O
age,O,O
-,O,O
matched,O,O
groups,O,O
of,O,O
primary,O,O
untreated,O,O
cancer,O,O
(,O,O
21,O,O
),O,O
",",O,O
recurrent,O,O
cancer,O,O
(,O,O
18,O,O
),O,O
",",O,O
and,O,O
patients,O,O
who,O,O
had,O,O
been,O,O
free,O,O
of,O,O
disease,O,O
for,O,O
at,O,O
least,O,O
9,O,O
months,O,O
(,O,O
16,O,O
),O,O
.,O,O
Findings,O,O
of,O,O
positive,O,O
potentials,O,O
showed,O,O
that,O,O
N1,O,B
originated,O,O
in,O,O
the,O,O
area,O,O
of,O,O
ventral,O,O
gray,O,O
matter,O,O
through,O,O
the,O,O
ventro,O,O
-,O,O
lateral,O,O
column,O,O
and,O,O
N2,O,B
through,O,O
the,O,O
dorsal,O,O
column,O,O
.,O,O
Plasma,O,O
CCK,B,B
levels,O,O
were,O,O
determined,O,O
at,O,O
regular,O,O
intervals,O,O
.,O,O
Aplastic,O,O
crisis,O,O
in,O,O
sickle,O,O
cell,O,O
disorders,O,O
:,O,O
bone,O,O
marrow,O,O
necrosis,O,O
and,O,O
human,O,B
parvovirus,O,I
infection,O,I
.,O,O
The,O,O
algorithm,O,O
also,O,O
limited,O,O
TG,O,B
to,O,O
20,O,O
and,O,O
64,O,O
%,O,O
",",O,O
apoB,B,B
to,O,O
6,O,O
and,O,O
20,O,O
%,O,O
",",O,O
and,O,O
Lp,B,B
(,I,I
a,I,I
),I,O
to,O,O
15,O,O
and,O,O
56,O,O
%,O,O
",",O,O
of,O,O
low,O,O
-,O,O
and,O,O
high,O,O
-,O,O
risk,O,O
groups,O,O
",",O,O
respectively,O,O
.,O,O
135,O,O
students,O,O
had,O,O
a,O,O
count,O,O
of,O,O
less,O,O
than,O,O
50,O,O
eggs,O,O
/,O,O
10,O,O
ml,O,O
.,O,O
urine,O,O
and,O,O
56,O,O
had,O,O
more,O,O
than,O,O
50,O,O
eggs,O,O
/,O,O
10ml,O,O
.,O,O
These,O,O
probable,O,O
border,O,O
sequences,O,O
are,O,O
closely,O,O
related,O,O
to,O,O
those,O,O
of,O,O
other,O,O
known,O,O
T,O,O
-,O,O
regions,O,O
and,O,O
define,O,O
a,O,O
second,O,O
T,O,O
-,O,O
region,O,O
of,O,O
pTiChry5,O,O
",",O,O
called,O,O
T,O,O
-,O,O
right,O,O
(,O,O
TR,O,O
),O,O
",",O,O
that,O,O
confers,O,O
production,O,O
of,O,O
the,O,O
Amadoriopines,O,O
.,O,O
These,O,O
results,O,O
are,O,O
consistent,O,O
with,O,O
the,O,O
roles,O,O
that,O,O
CCK,B,B
and,O,O
trypsin,B,B
inhibitors,O,I
are,O,O
believed,O,O
to,O,O
play,O,O
in,O,O
the,O,O
negative,O,O
feedback,O,O
control,O,O
of,O,O
pancreatic,O,O
exocrine,O,O
function,O,O
.,O,O
Pax,B,B
-,I,I
3,I,I
is,O,O
a,O,O
paired,B,O
-,I,O
type,I,O
homeobox,I,O
gene,I,O
that,O,O
is,O,O
specifically,O,O
expressed,O,O
in,O,O
the,O,O
dorsal,O,O
and,O,O
posterior,O,O
neural,O,O
tube,O,O
.,O,O
A,O,O
family,O,O
of,O,O
RNA,O,O
molecules,O,O
in,O,O
the,O,O
2,O,O
.,O,O
0,O,O
-,O,O
2,O,O
.,O,O
2,O,O
-,O,O
kilobase,O,O
range,O,O
identified,O,O
with,O,O
a,O,O
probe,O,O
from,O,O
this,O,O
gene,O,B
was,O,O
overexpressed,O,O
in,O,O
the,O,O
resistant,O,O
cells,O,O
.,O,O
By,O,O
DNase,B,O
I,I,O
footprint,O,O
analysis,O,O
of,O,O
the,O,O
PNR,O,O
element,O,O
",",O,O
a,O,O
palindrome,O,O
of,O,O
two,O,O
high,O,O
-,O,O
affinity,O,O
Ets,B,B
-,I,I
binding,I,I
sites,I,I
(,O,O
CTTCCCTGGAAG,O,O
),O,O
was,O,O
identified,O,O
.,O,O
Response,O,O
to,O,O
treatment,O,O
was,O,O
better,O,O
in,O,O
patients,O,O
with,O,O
less,O,O
pretreatment,O,O
(,O,O
one,O,O
-,O,O
two,O,O
prior,O,O
treatments,O,O
),O,O
than,O,O
in,O,O
heavily,O,O
pretreated,O,O
ones,O,O
(,O,O
more,O,O
than,O,O
three,O,O
),O,O
and,O,O
this,O,O
relation,O,O
was,O,O
found,O,O
to,O,O
be,O,O
statistically,O,O
significant,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
05,O,O
),O,O
.,O,O
Surprisingly,O,O
",",O,O
the,O,O
COOH,O,O
-,O,O
terminal,O,O
domain,O,O
of,O,O
RanGAP1,B,B
was,O,O
also,O,O
found,O,O
to,O,O
harbor,O,O
a,O,O
nuclear,O,O
localization,O,O
signal,O,O
.,O,O
An,O,O
8,O,O
-,O,O
h,O,O
exposure,O,O
to,O,O
10,O,O
mg,O,O
DMEA,O,B
/,O,O
m3,O,O
corresponds,O,O
to,O,O
a,O,O
postexposure,O,O
plasma,O,O
concentration,O,O
and,O,O
2,O,O
-,O,O
h,O,O
postexposure,O,O
urinary,O,O
excretion,O,O
of,O,O
4,O,O
.,O,O
9,O,O
mumol,O,O
/,O,O
l,O,O
and,O,O
75,O,O
mmol,O,O
/,O,O
mol,O,O
creatinine,O,O
",",O,O
respectively,O,O
.,O,O
Quantitative,O,O
analysis,O,O
of,O,O
the,O,O
coronary,O,O
stenosis,O,O
was,O,O
assessed,O,O
before,O,O
and,O,O
after,O,O
PTCA,O,O
",",O,O
and,O,O
the,O,O
dilatation,O,O
resulted,O,O
in,O,O
an,O,O
increase,O,O
in,O,O
minimal,O,O
luminal,O,O
cross,O,O
-,O,O
sectional,O,O
area,O,O
from,O,O
1,O,O
.,O,O
1,O,O
+,O,O
/,O,O
-,O,O
0,O,O
+,O,O
/,O,O
-,O,O
1,O,O
.,O,O
2,O,O
mm2,O,O
.,O,O
Mechanism,O,O
of,O,O
enhancement,O,O
of,O,O
DNA,O,B
expression,O,O
consequent,O,O
to,O,O
cointernalization,O,O
of,O,O
a,O,O
replication,O,O
-,O,O
deficient,O,O
adenovirus,O,B
and,O,O
unmodified,O,O
plasmid,O,O
DNA,O,B
.,O,O
CCAAT,B,O
/,I,O
enhancer,I,O
-,I,O
binding,I,O
protein,I,O
isoforms,I,O
beta,I,B
and,I,O
delta,I,B
are,O,O
expressed,O,O
in,O,O
mammary,O,O
epithelial,O,O
cells,O,O
and,O,O
bind,O,O
to,O,O
multiple,O,O
sites,O,O
in,O,O
the,O,O
beta,B,B
-,I,I
casein,I,I
gene,I,I
promoter,I,I
.,O,O
We,O,O
show,O,O
here,O,O
that,O,O
the,O,O
in,O,O
vitro,O,O
transcription,O,O
extract,O,O
contains,O,O
a,O,O
binding,O,O
activity,O,O
that,O,O
is,O,O
specific,O,O
for,O,O
the,O,O
initiator,O,O
element,O,O
and,O,O
thus,O,O
may,O,O
participate,O,O
in,O,O
recruiting,O,O
RNA,B,B
polymerase,I,I
II,I,I
to,O,O
the,O,O
SL,O,B
RNA,O,I
gene,O,I
promoter,O,I
.,O,O
The,O,O
deduced,O,O
amino,O,B
acid,O,I
sequence,O,I
has,O,O
the,O,O
greatest,O,O
homology,O,O
(,O,O
61,O,O
%,O,O
),O,O
to,O,O
the,O,O
green,B,O
alga,I,O
Scenedemus,I,B
obliquus,I,I
plastocyanin,I,I
.,O,O
Chloroplast,B,O
mutator,I,O
(,O,O
chm,B,B
),O,O
of,O,O
Arabidopsis,O,O
is,O,O
a,O,O
recessive,O,O
nuclear,O,O
mutation,O,O
that,O,O
causes,O,O
green,O,O
and,O,O
white,O,O
variegation,O,O
in,O,O
leaves,O,O
and,O,O
is,O,O
inherited,O,O
in,O,O
a,O,O
non,O,O
-,O,O
Mendelian,O,O
fashion,O,O
.,O,O
(,O,O
1996a,O,O
),O,O
Biochemistry,O,O
35,O,O
",",O,O
1589,O,O
-,O,O
1598,O,O
],O,O
with,O,O
a,O,O
short,O,O
postexposure,O,O
time,O,O
and,O,O
a,O,O
dioxin,O,B
burden,O,O
>,O,O
0,O,O
.,O,O
6,O,O
pg,O,O
/,O,O
m3,O,O
had,O,O
a,O,O
significantly,O,O
higher,O,O
risk,O,O
of,O,O
hypoergy,O,O
than,O,O
unexposed,O,O
subjects,O,O
(,O,O
hypoergy,O,O
I,O,O
:,O,O
OR,O,O
=,O,O
9,O,O
.,O,O
51,O,O
",",O,O
95,O,O
%,O,O
CI,O,O
=,O,O
1,O,O
.,O,O
96,O,O
-,O,O
42,O,O
.,O,O
02,O,O
;,O,O
hypoergy,O,O
II,O,O
:,O,O
OR,O,O
=,O,O
2,O,O
.,O,O
92,O,O
",",O,O
95,O,O
%,O,O
CI,O,O
=,O,O
1,O,O
.,O,O
14,O,O
-,O,O
7,O,O
.,O,O
5,O,O
),O,O
single,O,O
1,O,O
.,O,O
8,O,O
-,O,O
kb,O,O
transcript,O,O
mRNA,O,O
was,O,O
detected,O,O
by,O,O
Northern,O,O
(,O,O
RNA,O,O
),O,O
blot,O,O
analysis,O,O
",",O,O
and,O,O
its,O,O
5,O,O
',O,O
end,O,O
maps,O,O
to,O,O
a,O,O
position,O,O
51,O,O
bp,O,O
upstream,O,O
from,O,O
the,O,O
site,O,O
of,O,O
initiation,O,O
of,O,O
protein,O,O
synthesis,O,O
.,O,O
The,O,O
enhancer,O,O
region,O,O
of,O,O
Akv,O,B
murine,O,I
leukemia,O,I
virus,O,I
contains,O,O
the,O,O
sequence,O,O
motif,O,O
ACAGATGG,O,B
.,O,O
The,O,O
concentrations,O,O
of,O,O
vitamin,O,O
A,O,O
precursors,O,O
and,O,O
vitamin,O,O
E,O,O
in,O,O
the,O,O
hay,O,O
were,O,O
below,O,O
currently,O,O
recommended,O,O
dietary,O,O
levels,O,O
for,O,O
llamas,O,O
",",O,O
and,O,O
alfalfa,O,O
hay,O,O
appears,O,O
to,O,O
provide,O,O
an,O,O
unreliable,O,O
source,O,O
of,O,O
vitamins,O,O
A,O,O
and,O,O
E,O,O
in,O,O
this,O,O
species,O,O
.,O,O
Co,O,O
-,O,O
administration,O,O
of,O,O
5FU,O,B
",",O,O
angiotensin,B,O
II,I,O
and,O,O
microspheres,O,O
via,O,O
the,O,O
hepatic,O,O
artery,O,O
may,O,O
reduce,O,O
drug,O,O
exposure,O,O
in,O,O
the,O,O
systemic,O,O
compartment,O,O
and,O,O
therefore,O,O
may,O,O
increase,O,O
the,O,O
therapeutic,O,O
ratio,O,O
of,O,O
5FU,O,B
administration,O,O
via,O,O
the,O,O
hepatic,O,O
artery,O,O
.,O,O
Biol,O,O
.,O,O
The,O,O
reduced,O,O
NO,O,B
production,O,O
in,O,O
these,O,O
cells,O,O
was,O,O
associated,O,O
with,O,O
low,O,O
levels,O,O
of,O,O
mRNA,O,O
of,O,O
inducible,B,O
NO,I,B
synthetase,I,O
.,O,O
Sequence,O,O
analysis,O,O
of,O,O
the,O,O
isolated,O,O
genomic,O,O
clone,O,O
revealed,O,O
that,O,O
the,O,O
DNA,O,O
binding,O,O
domain,O,O
of,O,O
this,O,O
orphan,O,O
receptor,O,O
is,O,O
most,O,O
homologous,O,O
to,O,O
the,O,O
human,B,B
TR2,I,I
receptor,I,O
.,O,O
5,O,O
',O,O
-,O,O
RACE,O,O
analysis,O,O
suggested,O,O
a,O,O
single,O,O
transcription,O,O
initiation,O,O
site,O,O
187,O,O
bp,O,O
upstream,O,O
from,O,O
the,O,O
translational,O,O
start,O,O
site,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
2,O,O
",",O,O
397,O,O
(,O,O
74,O,O
%,O,O
),O,O
had,O,O
one,O,O
or,O,O
more,O,O
risk,O,O
factors,O,O
(,O,O
not,O,O
low,O,O
risk,O,O
),O,O
;,O,O
of,O,O
these,O,O
",",O,O
5,O,O
.,O,O
3,O,O
%,O,O
died,O,O
in,O,O
6,O,O
weeks,O,O
(,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
001,O,O
),O,O
.,O,O
It,O,O
is,O,O
largely,O,O
predicted,O,O
by,O,O
lupus,O,B
anticoagulant,O,I
(,O,O
estimated,O,O
by,O,O
activated,O,O
partial,O,O
thromboplastin,B,O
time,O,O
),O,O
and,O,O
/,O,O
or,O,O
antibody,O,O
to,O,O
cardiolipin,O,O
.,O,O
E,O,O
.,O,O
",",O,O
Hession,O,B
",",O,O
C,O,B
",",O,O
D,O,B
",",O,O
B,O,B
",",O,O
R,O,B
",",O,O
B,O,B
-,O,I
Rosso,O,I
",",O,O
G,O,B
Lobb,O,B
",",O,O
R,O,B
.,O,O
1990,O,O
),O,O
Cell,O,O
63,O,O
",",O,O
1349,O,O
-,O,O
1356,O,O
),O,O
.,O,O
Iodine,O,O
metabolism,O,O
in,O,O
chronic,O,O
thyroiditis,O,O
.,O,O
Schlegel,O,O
",",O,O
J,O,O
.,O,O
Mutational,O,O
analysis,O,O
of,O,O
mRNA,B,O
capping,I,O
enzyme,I,O
identifies,O,O
amino,O,O
acids,O,O
involved,O,O
in,O,O
GTP,O,O
binding,O,O
",",O,O
enzyme,O,O
-,O,O
guanylate,O,O
formation,O,O
",",O,O
and,O,O
GMP,O,O
transfer,O,O
to,O,O
RNA,O,O
.,O,O
The,O,O
concentrations,O,O
of,O,O
apo,B,B
A,I,I
-,I,I
I,I,I
and,O,O
apo,B,B
A,I,I
-,I,I
II,I,I
of,O,O
abstainers,O,O
decreased,O,O
significantly,O,O
compared,O,O
with,O,O
the,O,O
corresponding,O,O
changes,O,O
in,O,O
controls,O,O
.,O,O
Hormonal,O,O
regulation,O,O
of,O,O
multiple,O,O
promoters,O,O
of,O,O
the,O,O
rat,B,B
mitochondrial,I,I
glycerol,I,I
-,I,I
3,I,I
-,I,I
phosphate,I,I
dehydrogenase,I,I
gene,I,I
:,O,O
identification,O,O
of,O,O
a,O,O
complex,O,O
hormone,O,O
-,O,O
response,O,O
element,O,O
in,O,O
the,O,O
ubiquitous,O,O
promoter,O,O
B,O,B
.,O,O
Imaging,O,O
features,O,O
of,O,O
splenic,O,O
epidermoid,O,O
cyst,O,O
with,O,O
pathologic,O,O
correlation,O,O
.,O,O
TNFalpha,B,B
and,O,O
IL,B,B
-,I,I
6,I,I
levels,O,O
were,O,O
determined,O,O
in,O,O
the,O,O
culture,O,O
supernatants,O,O
.,O,O
Effects,O,O
of,O,O
spatial,O,O
and,O,O
temporal,O,O
smoothing,O,O
on,O,O
stimulated,O,O
brillouin,O,O
scattering,O,O
in,O,O
the,O,O
independent,O,O
-,O,O
hot,O,O
-,O,O
spot,O,O
model,O,O
limit,O,O
The,O,O
influence,O,O
of,O,O
laser,O,O
beam,O,O
smoothing,O,O
on,O,O
stimulated,O,O
Brillouin,O,O
backscattering,O,O
(,O,O
SBBS,O,B
),O,O
is,O,O
studied,O,O
analytically,O,O
in,O,O
the,O,O
limit,O,O
of,O,O
the,O,O
independent,O,O
hot,O,O
spot,O,O
model,O,O
.,O,O
To,O,O
identify,O,O
the,O,O
precise,O,O
location,O,O
of,O,O
the,O,O
phosphorylation,O,O
site,O,O
on,O,O
the,O,O
64,O,O
-,O,O
kDa,O,O
protein,O,O
",",O,O
a,O,O
step,O,O
-,O,O
by,O,O
-,O,O
step,O,O
mutagenesis,O,O
procedures,O,O
was,O,O
followed,O,O
.,O,O
Among,O,O
these,O,O
",",O,O
ACT1,B,B
was,O,O
isolated,O,O
four,O,O
times,O,O
",",O,O
and,O,O
NSR1,B,B
three,O,O
times,O,O
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
leader,O,O
-,O,O
mRNA,O,O
fusion,O,O
in,O,O
coronavirus,O,O
transcription,O,O
does,O,O
not,O,O
require,O,O
direct,O,O
RNA,O,O
-,O,O
RNA,O,O
interaction,O,O
between,O,O
complementary,O,O
sequences,O,O
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
leader,O,O
-,O,O
mRNA,O,O
fusion,O,O
in,O,O
coronavirus,O,O
transcription,O,O
does,O,O
not,O,O
require,O,O
direct,O,O
RNA,O,O
-,O,O
RNA,O,O
interaction,O,O
between,O,O
complementary,O,O
sequences,O,O
.,O,O
60th,O,O
birthday,O,O
of,O,O
colonel,O,O
prof,O,O
.,O,O
e,O,B
.,O,I
cerny,O,I
m,O,I
.,O,I
d,O,I
.,O,O
The,O,O
phenotypes,O,O
of,O,O
the,O,O
ICP0,B,B
nonsense,O,I
mutants,O,I
were,O,O
intermediate,O,O
between,O,O
those,O,O
of,O,O
the,O,O
wild,O,O
-,O,O
type,O,O
virus,O,O
and,O,O
7134,O,O
in,O,O
that,O,O
the,O,O
more,O,O
ICP0,B,B
-,I,I
coding,I,I
sequence,I,I
expressed,O,O
by,O,O
a,O,O
given,O,O
nonsense,O,I
mutant,O,I
",",O,O
the,O,O
more,O,O
wild,O,O
type,O,O
-,O,O
like,O,O
was,O,O
its,O,O
phenotype,O,O
.,O,O
Female,O,O
mice,O,O
were,O,O
significantly,O,O
more,O,O
resistant,O,O
to,O,O
infection,O,O
than,O,O
males,O,O
.,O,O
From,O,O
sequence,O,O
alignments,O,O
with,O,O
phylogenetically,O,O
related,O,O
viruses,O,O
",",O,O
including,O,O
tymoviruses,O,O
",",O,O
we,O,O
predicted,O,O
that,O,O
p223,B,B
contained,O,O
a,O,O
papain,B,O
-,I,O
like,I,O
proteinase,I,O
domain,I,O
with,O,O
a,O,O
putative,O,O
catalytic,O,O
cysteine994,O,B
and,O,O
histidine1075,O,B
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
the,O,O
c,B,O
-,I,O
met,I,O
gene,I,O
is,O,O
also,O,O
a,O,O
target,O,O
of,O,O
p53,B,B
gene,I,O
regulation,O,O
.,O,O
The,O,O
salient,O,O
clinical,O,O
features,O,O
",",O,O
the,O,O
problems,O,O
of,O,O
management,O,O
and,O,O
the,O,O
modern,O,O
approaches,O,O
to,O,O
the,O,O
reconstruction,O,O
of,O,O
facial,O,O
deformities,O,O
seen,O,O
in,O,O
this,O,O
disease,O,O
are,O,O
described,O,O
.,O,O
She,O,O
was,O,O
able,O,O
to,O,O
stand,O,O
unaided,O,O
by,O,O
3,O,O
years,O,O
of,O,O
age,O,O
with,O,O
then,O,O
progressive,O,O
worsening,O,O
of,O,O
motor,O,O
abilities,O,O
.,O,O
During,O,O
skeletal,O,O
muscle,O,O
development,O,O
",",O,O
different,O,O
types,O,O
of,O,O
muscle,O,O
fibers,O,O
are,O,O
generated,O,O
",",O,O
which,O,O
express,O,O
different,O,O
combinations,O,O
of,O,O
muscle,O,O
-,O,O
specific,O,O
gene,O,B
products,O,O
.,O,O
Six,O,O
hours,O,O
after,O,O
the,O,O
last,O,O
administration,O,O
",",O,O
uterus,O,O
of,O,O
Gf,O,O
and,O,O
Cv,O,O
mice,O,O
were,O,O
weight,O,O
337,O,O
.,O,O
6,O,O
mg,O,O
%,O,O
and,O,O
423,O,O
.,O,O
5,O,O
mg,O,O
%,O,O
respectively,O,O
",",O,O
the,O,O
difference,O,O
was,O,O
statistically,O,O
significant,O,O
(,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
01,O,O
),O,O
.,O,O
We,O,O
examine,O,O
current,O,O
models,O,O
of,O,O
the,O,O
effects,O,O
of,O,O
aging,O,O
on,O,O
mean,O,O
response,O,O
time,O,O
and,O,O
show,O,O
how,O,O
they,O,O
might,O,O
be,O,O
reinterpreted,O,O
.,O,O
The,O,O
possibility,O,O
of,O,O
a,O,O
hereditary,O,O
disorder,O,O
leading,O,O
to,O,O
a,O,O
minor,O,O
defect,O,O
in,O,O
elastic,O,O
fibre,O,O
structure,O,O
which,O,O
could,O,O
be,O,O
responsible,O,O
for,O,O
the,O,O
spontaneous,O,O
lesions,O,O
is,O,O
discussed,O,O
.,O,O
It,O,O
is,O,O
believed,O,O
that,O,O
these,O,O
domains,O,O
are,O,O
important,O,O
for,O,O
directing,O,O
specific,O,O
protein,O,B
-,O,I
protein,O,I
interactions,O,O
necessary,O,O
for,O,O
the,O,O
proper,O,O
functioning,O,O
of,O,O
Src,B,B
.,O,O
By,O,O
contrast,O,O
",",O,O
all,O,O
proteins,O,O
initiated,O,O
with,O,O
a,O,O
methionine,O,B
placed,O,O
one,O,O
residue,O,O
upstream,O,O
of,O,O
the,O,O
natural,O,O
N,O,O
terminus,O,O
of,O,O
PR,B,B
failed,O,O
to,O,O
show,O,O
specific,O,O
proteolysis,O,O
.,O,O
BSE,O,B
and,O,O
farmworkers,O,O
.,O,O
Here,O,O
",",O,O
we,O,O
present,O,O
evidence,O,O
for,O,O
a,O,O
model,O,O
in,O,O
which,O,O
mRNA,O,B
sequences,O,O
up,O,O
to,O,O
around,O,O
100,O,O
nucleotides,O,O
downstream,O,O
from,O,O
the,O,O
start,O,O
codon,O,O
of,O,O
21K,O,B
fold,O,O
back,O,O
and,O,O
base,O,O
-,O,O
pair,O,O
to,O,O
the,O,O
21K,O,B
translation,O,O
initiation,O,O
region,O,O
",",O,O
thereby,O,O
decreasing,O,O
the,O,O
translation,O,O
initiation,O,O
frequency,O,O
.,O,O
Escherichia,O,B
coli,O,I
BL21,O,I
(,O,O
DE3,O,I
),O,O
plysS,O,O
",",O,O
harbouring,O,O
a,O,O
recombinant,O,O
plasmid,O,O
containing,O,O
the,O,O
catalase,B,B
-,O,I
peroxidase,B,I
gene,O,I
",",O,O
produced,O,O
a,O,O
large,O,O
amount,O,O
of,O,O
proteins,O,O
that,O,O
co,O,O
-,O,O
migrated,O,O
on,O,O
SDS,O,O
/,O,O
PAGE,O,O
with,O,O
the,O,O
native,O,O
enzyme,O,O
.,O,O
However,O,O
",",O,O
the,O,O
action,O,O
of,O,O
each,O,O
cognate,O,O
ligand,O,O
and,O,O
the,O,O
accessory,O,O
cellular,O,O
factors,O,O
that,O,O
can,O,O
differentially,O,O
regulate,O,O
the,O,O
transcriptional,O,O
responses,O,O
of,O,O
a,O,O
heterodimer,O,O
-,O,O
DNA,O,O
complex,O,O
are,O,O
not,O,O
well,O,O
understood,O,O
.,O,O
Using,O,O
adenoviral,O,O
transfer,O,O
of,O,O
IkappaBalpha,B,B
(,O,O
IkappaBalpha,B,B
overexpression,O,O
),O,O
",",O,O
the,O,O
production,O,O
of,O,O
TNF,B,B
-,I,I
alpha,I,I
induced,O,O
by,O,O
whole,O,O
GBS,O,O
was,O,O
inhibited,O,O
by,O,O
only,O,O
20,O,O
%,O,O
.,O,O
METHODS,O,O
:,O,O
The,O,O
former,O,O
group,O,O
included,O,O
patients,O,O
who,O,O
had,O,O
been,O,O
treated,O,O
with,O,O
at,O,O
least,O,O
four,O,O
PGE1,O,B
alpha,O,I
-,O,I
ciclodestrina,O,I
",",O,O
short,O,O
-,O,O
term,O,O
treatment,O,O
cycles,O,O
per,O,O
year,O,O
while,O,O
the,O,O
latter,O,O
was,O,O
a,O,O
historical,O,O
reference,O,O
group,O,O
managed,O,O
without,O,O
prostaglandins,O,O
.,O,O
We,O,O
describe,O,O
the,O,O
identification,O,O
and,O,O
initial,O,O
characterization,O,O
of,O,O
neurobeachin,B,B
",",O,O
a,O,O
neuron,O,O
-,O,O
specific,O,O
multidomain,O,O
protein,O,O
of,O,O
327,O,O
kDa,O,O
with,O,O
a,O,O
high,O,O
-,O,O
affinity,O,O
binding,O,O
site,O,O
(,O,O
K,O,B
(,O,O
d,O,O
),O,O
",",O,O
10,O,O
nm,O,O
the,O,O
type,B,O
II,I,O
regulatory,I,O
subunit,I,O
of,I,O
protein,I,O
kinase,I,O
A,I,O
(,O,O
PKA,B,B
RII,I,I
),O,O
.,O,O
Both,O,O
groups,O,O
were,O,O
subjected,O,O
to,O,O
tests,O,O
of,O,O
delayed,O,O
hypersensitivity,O,O
with,O,O
Candidin,B,B
",",O,O
Trycophytin,B,B
and,O,O
Tuberculin,B,B
.,O,O
The,O,O
characterized,O,O
Y,B,B
',I,I
repeated,I,I
sequence,I,I
families,I,I
provide,O,O
an,O,O
experimental,O,O
system,O,O
in,O,O
which,O,O
repeated,O,O
sequence,O,O
interactions,O,O
and,O,O
subsequent,O,O
evolution,O,O
can,O,O
be,O,O
studied,O,O
.,O,O
Two,O,O
putative,O,O
Rev,B,B
proteins,I,O
with,O,O
apparent,O,O
molecular,O,O
masses,O,O
of,O,O
18,O,O
and,O,O
16,O,O
kDa,O,O
were,O,O
expressed,O,O
by,O,O
p2,B,O
/,I,O
2,I,O
and,O,O
p176,B,O
",",O,O
while,O,O
p20,B,O
expressed,O,O
only,O,O
a,O,O
16,O,O
-,O,O
kDa,O,O
species,O,O
.,O,O
TaqMan,O,O
analysis,O,O
of,O,O
gene,O,B
expression,O,O
following,O,O
chronic,O,O
FA,O,O
treatment,O,O
showed,O,O
neither,O,O
a,O,O
decrease,O,O
in,O,O
the,O,O
amount,O,O
of,O,O
leptin,B,B
receptor,I,I
(,O,O
Ob,B,B
-,I,I
R,I,I
),O,O
mRNA,O,O
",",O,O
nor,O,O
an,O,O
increase,O,O
in,O,O
the,O,O
negative,O,O
regulators,O,O
of,O,O
STAT,B,B
signalling,O,O
",",O,O
SOCS3,B,B
(,O,O
suppressors,B,O
of,I,O
cytokine,I,O
signalling,I,O
),O,O
or,O,O
cytokine,B,O
inducible,I,O
sequence,I,O
(,O,O
CIS,B,B
),O,O
.,O,O
The,O,O
hatcher,O,O
incubators,O,O
of,O,O
both,O,O
companies,O,O
were,O,O
also,O,O
persistently,O,O
contaminated,O,O
with,O,O
Salmonella,O,B
livingstone,O,I
and,O,O
Salmonella,O,B
thomasville,O,I
in,O,O
company,O,O
A,O,O
and,O,O
with,O,O
Salmonella,O,B
senftenberg,O,I
in,O,O
company,O,O
B,O,O
.,O,O
Overexpression,O,O
of,O,O
BAG,B,B
-,I,I
1,I,O
also,O,O
protected,O,O
certain,O,O
cell,O,O
lines,O,O
from,O,O
heat,O,O
shock,O,O
-,O,O
induced,O,O
cell,O,O
death,O,O
.,O,O
The,O,O
overall,O,O
incidence,O,O
of,O,O
SIDS,O,B
was,O,O
1,O,O
.,O,O
43,O,O
per,O,O
1,O,O
",",O,O
000,O,O
live,O,O
births,O,O
.,O,O
That,O,O
sequence,O,O
strongly,O,O
promoted,O,O
the,O,O
transcription,O,O
of,O,O
the,O,O
promotorless,O,O
chloramphenicol,B,B
acetyltranferase,I,I
(,O,I
CAT,B,I
),O,O
gene,O,O
in,O,O
cells,O,O
of,O,O
pancreatic,O,O
origin,O,O
(,O,O
AR,O,B
-,O,I
42J,O,I
),O,O
but,O,O
not,O,O
in,O,O
cells,O,O
of,O,O
non,O,O
-,O,O
pancreatic,O,O
origin,O,O
(,O,O
Rat,O,O
2,O,O
and,O,O
IEC,O,O
6,O,O
),O,O
.,O,O
Clinical,O,O
course,O,O
and,O,O
nursing,O,O
care,O,O
of,O,O
patients,O,O
with,O,O
decubitus,O,O
ulcer,O,O
-,O,O
-,O,O
use,O,O
of,O,O
pillows,O,O
stuffed,O,O
with,O,O
buckwheat,O,O
chaff,O,O
Fructokinase,B,B
activity,O,O
is,O,O
elevated,O,O
up,O,O
to,O,O
twofold,O,O
when,O,O
Z,O,B
.,O,O
mobilis,O,I
was,O,O
grown,O,O
on,O,O
fructose,O,O
instead,O,O
of,O,O
glucose,O,O
",",O,O
and,O,O
there,O,O
was,O,O
a,O,O
parallel,O,O
increase,O,O
in,O,O
frk,B,B
mRNA,I,I
levels,O,O
.,O,O
We,O,O
have,O,O
determined,O,O
the,O,O
nucleotide,O,O
(,O,O
nt,O,O
),O,O
sequence,O,O
of,O,O
the,O,O
7,B,O
.,I,O
5,I,O
-,I,O
kb,I,O
COR,I,O
segment,I,O
that,O,O
encompasses,O,O
a,O,O
cluster,O,O
of,O,O
six,O,O
genes,O,O
(,O,O
CYC1,B,B
",",O,O
UTR1,B,B
",",O,O
UTR3,B,B
",",O,O
OSM1,B,B
",",O,O
tRNA,B,O
(,I,O
Gly,I,B
),I,O
and,O,O
RAD7,B,B
),O,O
located,O,O
on,O,O
chromosome,O,O
X,O,O
of,O,O
the,O,O
yeast,O,O
Saccharomyces,O,O
cerevisiae,O,O
.,O,O
You,O,O
make,O,O
the,O,O
diagnosis,O,O
.,O,O
Coronary,O,O
vasoconstriction,O,O
caused,O,O
by,O,O
endothelin,B,B
-,I,I
1,I,I
is,O,O
enhanced,O,O
by,O,O
ischemia,O,O
-,O,O
reperfusion,O,O
and,O,O
by,O,O
norepinephrine,O,O
present,O,O
in,O,O
concentrations,O,O
typically,O,O
observed,O,O
after,O,O
neonatal,O,O
cardiopulmonary,O,O
bypass,O,O
.,O,O
RUSH,B,B
-,I,I
1,I,I
beta,I,I
is,O,O
a,O,O
95,O,O
-,O,O
kDa,O,O
truncated,O,O
version,O,O
of,O,O
RUSH,B,B
-,I,I
1,I,I
alpha,I,I
that,O,O
results,O,O
from,O,O
alternative,O,O
splicing,O,O
of,O,O
a,O,O
57,O,O
-,O,O
bp,O,O
exon,O,O
as,O,O
confirmed,O,O
by,O,O
genomic,O,O
cloning,O,O
.,O,O
We,O,O
have,O,O
therefore,O,O
evaluated,O,O
the,O,O
efficacy,O,O
and,O,O
safety,O,O
of,O,O
doxazosin,O,O
",",O,O
a,O,O
new,O,O
orally,O,O
active,O,O
selective,O,O
alpha,B,O
1,I,O
blocker,O,O
",",O,O
in,O,O
patients,O,O
with,O,O
systemic,O,O
hypertension,O,O
with,O,O
concomitant,O,O
airflow,O,O
limitation,O,O
.,O,O
Thus,O,O
",",O,O
the,O,O
positive,O,O
effect,O,O
of,O,O
NS1,B,B
on,O,O
the,O,O
steady,O,O
-,O,O
state,O,O
levels,O,O
of,O,O
P4,B,B
transcripts,I,O
depends,O,O
on,O,O
the,O,O
amplification,O,O
of,O,O
gene,O,B
copy,O,I
number,O,I
and,O,O
the,O,O
integrity,O,O
of,O,O
the,O,O
terminal,O,O
repeats,O,O
.,O,O
CONCLUSION,O,O
:,O,O
NBP,O,O
pre,O,O
-,O,O
treatment,O,O
or,O,O
post,O,O
-,O,O
treatment,O,O
markedly,O,O
enhanced,O,O
the,O,O
rCBF,O,O
to,O,O
striatum,O,O
in,O,O
RMCAO,O,O
rats,O,O
.,O,O
Intracellular,O,O
activity,O,O
studies,O,O
indicated,O,O
that,O,O
",",O,O
at,O,O
ten,O,O
times,O,O
MBC,O,O
",",O,O
only,O,O
penicillin,O,B
had,O,O
any,O,O
significant,O,O
activity,O,O
against,O,O
intracellular,O,O
staphylococci,O,O
",",O,O
reducing,O,O
survival,O,O
by,O,O
28,O,O
%,O,O
.,O,O
Anti,B,O
-,I,O
nucleolin,I,B
mAb,I,O
was,O,O
used,O,O
to,O,O
confirm,O,O
the,O,O
antigenic,O,O
properties,O,O
of,O,O
this,O,O
p95,B,B
component,I,O
.,O,O
Transcription,O,O
of,O,O
these,O,O
genes,O,O
was,O,O
also,O,O
elevated,O,O
in,O,O
gut,O,O
and,O,O
lung,O,O
during,O,O
freezing,O,O
",",O,O
but,O,O
mRNA,O,O
levels,O,O
in,O,O
these,O,O
tissues,O,O
were,O,O
lower,O,O
than,O,O
in,O,O
liver,O,O
.,O,O
However,O,O
",",O,O
mean,O,O
food,O,O
intake,O,O
in,O,O
the,O,O
40,O,O
%,O,O
group,O,O
was,O,O
half,O,O
that,O,O
of,O,O
the,O,O
ACT,O,O
group,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
001,O,O
),O,O
and,O,O
significantly,O,O
less,O,O
(,O,O
p,O,O
<,O,O
0,O,O
.,O,O
01,O,O
),O,O
than,O,O
the,O,O
SEP,O,O
group,O,O
",",O,O
which,O,O
consumed,O,O
amounts,O,O
equivalent,O,O
to,O,O
65,O,O
%,O,O
of,O,O
daily,O,O
requirement,O,O
.,O,O
In,O,O
light,O,O
of,O,O
the,O,O
importance,O,O
of,O,O
GnRHR,B,B
",",O,O
the,O,O
molecular,O,O
mechanisms,O,O
underlying,O,O
the,O,O
transcriptional,O,O
regulation,O,O
of,O,O
the,O,O
human,B,B
GnRHR,I,I
(,O,O
hGnRHR,B,B
),O,O
gene,O,O
become,O,O
a,O,O
key,O,O
issue,O,O
in,O,O
understanding,O,O
human,O,B
reproduction,O,O
.,O,O
There,O,O
was,O,O
a,O,O
trend,O,O
in,O,O
all,O,O
studies,O,O
favouring,O,O
PVI,O,B
.,O,O
The,O,O
EPO,B,B
levels,O,O
were,O,O
distinctly,O,O
increased,O,O
before,O,O
transfusion,O,O
;,O,O
they,O,O
did,O,O
not,O,O
significantly,O,O
change,O,O
just,O,O
after,O,O
transfusion,O,O
",",O,O
but,O,O
subsequently,O,O
decreased,O,O
.,O,O
Overexpression,O,O
of,O,O
Trdpm1,B,B
in,O,O
a,O,O
dpm1,B,B
(,I,O
+,I,O
),I,O
:,O,O
:,O,O
his7,B,O
/,I,O
dpm1,I,B
(,I,O
+,I,O
),I,O
S,O,O
.,O,O
pombe,O,O
diploid,O,O
resulted,O,O
in,O,O
a,O,O
4,O,O
-,O,O
fold,O,O
increase,O,O
in,O,O
specific,O,O
DPM,B,B
synthase,I,I
activity,O,O
.,O,O
A,O,O
full,O,O
-,O,O
length,O,O
cDNA,O,O
clone,O,O
isolated,O,O
from,O,O
a,O,O
rat,O,O
lung,O,O
library,O,O
was,O,O
predicted,O,O
to,O,O
encode,O,O
a,O,O
55,O,O
-,O,O
kDa,O,O
protein,O,O
containing,O,O
at,O,O
its,O,O
amino,O,O
terminus,O,O
a,O,O
targeting,O,O
domain,O,O
that,O,O
binds,O,O
to,O,O
the,O,O
ANP,B,B
-,I,I
receptor,I,I
kinase,I,I
-,I,I
like,I,I
domain,I,I
and,O,O
containing,O,O
at,O,O
its,O,O
carboxyl,O,O
terminus,O,O
a,O,O
putative,O,O
protein,B,O
-,I,O
serine,I,O
phosphatase,I,O
domain,O,O
.,O,O
This,O,O
dynamic,O,O
response,O,O
strongly,O,O
suggests,O,O
that,O,O
the,O,O
p53,B,B
and,O,O
Rb,B,B
tumor,O,I
suppressor,O,I
pathways,O,I
are,O,O
intact,O,O
in,O,O
HeLa,O,O
cells,O,O
and,O,O
that,O,O
repression,O,O
of,O,O
HPV,B,B
E6,I,I
and,O,O
E7,B,B
mobilizes,O,O
these,O,O
pathways,O,O
in,O,O
an,O,O
orderly,O,O
fashion,O,O
to,O,O
deliver,O,O
growth,O,O
inhibitory,O,O
signals,O,O
to,O,O
the,O,O
cells,O,O
.,O,O
The,O,O
Y,O,B
.,O,O
lipolytica,O,I
genomic,O,O
POT1,B,B
gene,O,O
was,O,O
disrupted,O,O
by,O,O
replacing,O,O
120,O,O
bp,O,O
of,O,O
its,O,O
coding,O,O
sequence,O,O
with,O,O
2,O,O
.,O,O
7,O,O
kbp,O,O
of,O,O
DNA,O,O
including,O,O
the,O,O
Y,O,B
.,O,O
lipolytica,O,I
LEU2,B,B
gene,I,O
.,O,O
Electron,O,O
microscopic,O,O
picture,O,O
of,O,O
the,O,O
cerebral,O,O
cortex,O,O
in,O,O
rats,O,O
cooled,O,O
to,O,O
22,O,O
degrees,O,O
C,O,O
This,O,O
enabled,O,O
the,O,O
formation,O,O
of,O,O
stem,O,O
-,O,O
loop,O,O
templates,O,O
with,O,O
the,O,O
fusion,O,O
point,O,O
of,O,O
the,O,O
chimeric,O,O
transcript,O,O
in,O,O
the,O,O
loop,O,O
and,O,O
the,O,O
use,O,O
of,O,O
MLL,B,B
primers,O,O
in,O,O
two,O,O
-,O,O
sided,O,O
PCR,O,O
.,O,O
Analysis,O,O
of,O,O
the,O,O
promoter,O,O
sequence,O,O
revealed,O,O
the,O,O
presence,O,O
of,O,O
a,O,O
major,O,O
transcriptional,O,O
start,O,O
site,O,O
",",O,O
a,O,O
canonical,O,O
TATA,O,O
box,O,O
and,O,O
putative,O,O
cis,O,O
regulatory,O,O
elements,O,O
for,O,O
pituitary,O,O
specific,O,O
expression,O,O
as,O,O
well,O,O
as,O,O
an,O,O
E,O,B
-,O,I
responsive,O,I
element,O,I
.,O,O
The,O,O
synthetic,O,O
DNA,O,O
sequence,O,O
was,O,O
constructed,O,O
to,O,O
achieve,O,O
efficient,O,O
base,O,O
pairing,O,O
with,O,O
Escherichia,B,B
coli,I,I
16S,I,I
ribosomal,I,I
RNA,I,I
",",O,O
avoidance,O,O
of,O,O
internal,O,O
secondary,O,O
structure,O,O
",",O,O
and,O,O
optimal,O,O
codon,O,O
usage,O,O
for,O,O
high,O,O
-,O,O
level,O,O
protein,O,O
expression,O,O
in,O,O
accord,O,O
with,O,O
the,O,O
known,O,O
preferences,O,O
in,O,O
E,O,B
.,O,O
coli,O,O
.,O,O
The,O,O
results,O,O
from,O,O
the,O,O
first,O,O
five,O,O
years,O,O
of,O,O
follow,O,O
up,O,O
in,O,O
1972,O,O
showed,O,O
a,O,O
4,O,O
.,O,O
7,O,O
-,O,O
fold,O,O
excess,O,O
mortality,O,O
for,O,O
ischaemic,O,O
and,O,O
other,O,O
heart,O,O
diseases,O,O
(,O,O
ICD,O,B
A83,O,I
-,O,I
A84,O,I
),O,O
compared,O,O
with,O,O
a,O,O
comparable,O,O
reference,O,O
cohort,O,O
of,O,O
paper,O,O
mill,O,O
workers,O,O
.,O,O
Endothelium,O,O
of,O,O
the,O,O
central,O,O
ear,O,O
artery,O,O
of,O,O
an,O,O
anesthetized,O,O
rabbit,O,O
is,O,O
damaged,O,O
by,O,O
placing,O,O
artery,O,O
forceps,O,O
on,O,O
the,O,O
ear,O,O
directly,O,O
over,O,O
the,O,O
vessel,O,O
.,O,O
Comparison,O,O
of,O,O
1,O,O
.,O,O
5,O,O
Tesla,O,O
and,O,O
0,O,O
.,O,O
35,O,O
Tesla,O,O
field,O,O
strength,O,O
magnetic,O,O
resonance,O,O
imaging,O,O
scans,O,O
in,O,O
the,O,O
morphometric,O,O
evaluation,O,O
of,O,O
the,O,O
lumbar,O,O
intervertebral,O,O
foramina,O,O
.,O,O
Stable,O,O
expression,O,O
of,O,O
the,O,O
chimeric,O,O
alpha,B,B
i,I,I
(,I,O
54,I,O
),I,O
/,I,O
s,I,O
polypeptide,O,O
in,O,O
Chinese,O,B
hamster,O,I
ovary,O,I
(,O,O
CHO,O,B
),O,O
cells,O,O
constitutively,O,O
increased,O,O
both,O,O
cAMP,O,B
synthesis,O,O
and,O,O
cAMP,B,B
-,I,I
dependent,I,I
protein,I,I
kinase,I,I
activity,O,O
.,O,O
The,O,O
specific,O,O
interaction,O,O
between,O,O
a,O,O
defined,O,O
structural,O,O
element,O,O
of,O,O
the,O,O
human,O,B
immunodeficiency,O,I
virus,O,I
mRNA,O,I
(,O,O
RRE,B,B
",",O,O
the,O,O
Rev,B,B
response,I,I
element,I,I
),O,O
and,O,O
the,O,O
virus,B,O
-,I,O
encoded,I,O
protein,I,O
Rev,I,B
has,O,O
been,O,O
implicated,O,O
in,O,O
the,O,O
regulation,O,O
of,O,O
the,O,O
export,O,O
of,O,O
unspliced,O,O
or,O,O
singly,O,O
spliced,O,O
mRNA,O,I
from,O,O
the,O,O
nucleus,O,O
to,O,O
the,O,O
cytoplasm,O,O
.,O,O
Tele,O,O
-,O,O
Talk,O,O
has,O,O
the,O,O
extra,O,O
capability,O,O
of,O,O
operating,O,O
in,O,O
live,O,O
conference,O,O
situations,O,O
using,O,O
microphone,O,O
input,O,O
.,O,O
The,O,O
present,O,O
study,O,O
reports,O,O
visual,O,O
evoked,O,O
potential,O,O
responses,O,O
to,O,O
pattern,O,O
reversal,O,O
(,O,O
VEP,O,B
-,O,I
P,O,I
),O,O
in,O,O
ten,O,O
third,O,O
trimester,O,O
pregnant,O,O
women,O,O
and,O,O
changes,O,O
in,O,O
latency,O,O
of,O,O
NPN,O,B
complex,O,I
when,O,O
compared,O,O
with,O,O
these,O,O
responses,O,O
in,O,O
the,O,O
non,O,O
pregnant,O,O
state,O,O
.,O,O
No,O,O
causal,O,O
relations,O,O
may,O,O
be,O,O
inferred,O,O
from,O,O
the,O,O
correlation,O,O
between,O,O
the,O,O
level,O,O
of,O,O
trapezius,O,O
activity,O,O
and,O,O
complaints,O,O
",",O,O
though,O,O
it,O,O
indicates,O,O
that,O,O
individual,O,O
",",O,O
inexpedient,O,O
muscle,O,O
activity,O,O
patterns,O,O
may,O,O
constitute,O,O
an,O,O
important,O,O
risk,O,O
factor,O,O
for,O,O
development,O,O
of,O,O
musculo,O,O
-,O,O
skeletal,O,O
complaints,O,O
.,O,O
Recent,O,O
studies,O,O
have,O,O
demonstrated,O,O
that,O,O
the,O,O
U1,B,B
snRNP,I,I
is,O,O
recruited,O,O
to,O,O
the,O,O
5,O,O
',O,O
splice,O,O
site,O,O
by,O,O
protein,O,O
/,O,O
protein,O,O
interactions,O,O
involving,O,O
the,O,O
SR,B,B
domains,O,I
of,O,O
the,O,O
U1,B,B
-,I,I
70K,I,I
protein,I,I
and,O,O
SF2,B,B
/,O,I
ASF,B,I
.,O,O
Human,O,B
T,O,I
-,O,I
cell,O,I
leukemia,O,I
virus,O,I
type,O,I
I,O,I
Tax,B,I
activation,O,O
of,O,O
NF,B,B
-,I,I
kappa,I,I
B,I,I
/,O,I
Rel,B,I
involves,O,O
phosphorylation,O,O
and,O,O
degradation,O,O
of,O,O
I,B,B
kappa,I,I
B,I,I
alpha,I,I
and,O,O
RelA,B,B
(,I,I
p65,I,I
),I,O
-,O,O
mediated,O,O
induction,O,O
of,O,O
the,O,O
c,B,B
-,I,I
rel,I,I
gene,I,I
.,O,O
Active,O,O
lambda,B,B
and,I,O
kappa,I,B
antibody,I,I
gene,I,I
rearrangement,O,I
in,O,O
Abelson,O,B
murine,O,I
leukemia,O,I
virus,O,I
-,O,I
transformed,O,I
pre,O,I
-,O,I
B,O,I
cell,O,I
lines,O,I
.,O,O
A,O,O
centromere,O,O
in,O,O
S,O,B
.,O,O
cerevisiae,O,O
consists,O,O
of,O,O
a,O,O
region,O,O
of,O,O
DNA,O,O
",",O,O
approximately,O,O
150,O,O
bp,O,O
in,O,O
length,O,O
",",O,O
containing,O,O
three,O,O
important,O,O
sequence,O,O
elements,O,O
",",O,O
which,O,O
are,O,O
folded,O,O
with,O,O
proteins,O,O
into,O,O
a,O,O
specific,O,O
conformation,O,O
in,O,O
the,O,O
chromatin,O,O
(,O,O
the,O,O
yeast,O,O
kinetochore,O,O
),O,O
.,O,O
1,O,O
(,O,O
and,O,O
the,O,O
HML,O,B
method,O,O
.,O,O
Gastric,O,O
CO2,O,O
/,O,O
HCO3,O,O
was,O,O
determined,O,O
in,O,O
absence,O,O
of,O,O
simultaneous,O,O
inhibition,O,O
of,O,O
acid,O,O
secretion,O,O
by,O,O
intra,O,O
-,O,O
and,O,O
extragastric,O,O
pCO2,O,O
/,O,O
pH,O,O
measurements,O,O
in,O,O
23,O,O
persons,O,O
and,O,O
calculated,O,O
using,O,O
the,O,O
equation,O,O
of,O,O
Henderson,O,B
-,O,I
Hasselbalch,O,I
.,O,O
pCO2,O,O
was,O,O
measured,O,O
with,O,O
use,O,O
of,O,O
a,O,O
new,O,O
electrode,O,O
.,O,O
The,O,O
rats,O,O
were,O,O
used,O,O
for,O,O
the,O,O
study,O,O
of,O,O
the,O,O
effects,O,O
of,O,O
sepsis,O,O
on,O,O
the,O,O
utilization,O,O
of,O,O
exogenous,O,O
fat,O,O
emulsion,O,O
.,O,O
Transient,O,O
overexpression,O,O
of,O,O
c,B,B
-,I,I
Jun,I,I
induced,O,O
tenascin,B,B
-,I,I
C,I,I
expression,O,O
in,O,O
primary,O,O
REF,O,O
and,O,O
in,O,O
FR3T3,O,O
",",O,O
an,O,O
established,O,O
fibroblast,O,O
cell,O,O
line,O,O
.,O,O
Ozagrel,O,O
",",O,O
ifenprodil,O,O
",",O,O
cinnarizine,O,O
and,O,O
dilazep,O,O
were,O,O
more,O,O
effective,O,O
than,O,O
pentoxifylline,O,O
in,O,O
increasing,O,O
rCBF,O,O
at,O,O
the,O,O
HPC,O,O
.,O,O
In,O,O
contrast,O,O
to,O,O
the,O,O
morphological,O,O
criteria,O,O
",",O,O
the,O,O
few,O,O
data,O,O
available,O,O
from,O,O
recent,O,O
studies,O,O
at,O,O
the,O,O
genetic,O,O
level,O,O
have,O,O
suggested,O,O
that,O,O
EPVs,O,B
infecting,O,O
different,O,O
insect,O,O
orders,O,O
are,O,O
phylogenetically,O,O
distant,O,O
.,O,O
D5,B,B
/,I,O
D1,I,B
(,I,O
CT,I,O
),I,O
or,O,O
D5,B,B
/,I,O
D1D,I,B
(,I,O
CT,I,O
),I,O
tail,O,O
substitution,O,O
mutants,O,O
displayed,O,O
a,O,O
rank,O,O
order,O,O
of,O,O
potency,O,O
and,O,O
agonist,O,O
affinities,O,O
virtually,O,O
mimicking,O,O
wild,B,O
-,I,O
type,I,O
(,I,O
wt,I,O
),I,O
D1,I,B
receptors,I,O
",",O,O
as,O,O
indexed,O,O
by,O,O
both,O,O
ligand,O,O
binding,O,O
and,O,O
dopamine,O,O
-,O,O
stimulated,O,O
cAMP,O,O
accumulation,O,O
assays,O,O
",",O,O
and,O,O
",",O,O
similar,O,O
to,O,O
wt,O,O
D1,B,B
receptors,I,O
",",O,O
did,O,O
not,O,O
exhibit,O,O
receptor,O,O
constitutive,O,O
activity,O,O
or,O,O
responsiveness,O,O
to,O,O
inverse,O,O
agonists,O,O
.,O,O
2,O,O
-,O,O
AP,O,O
induced,O,O
marked,O,O
",",O,O
steady,O,O
rises,O,O
in,O,O
mRNA,O,O
accumulation,O,O
from,O,O
both,O,O
transfected,O,O
and,O,O
chromosomally,O,O
integrated,O,O
HIV,O,B
-,O,I
1,O,I
constructs,O,O
but,O,O
no,O,O
increases,O,O
from,O,O
an,O,O
endogenous,O,O
gene,O,O
encoding,O,O
gamma,B,B
-,I,I
actin,I,I
or,O,O
glucose,B,B
6,I,I
-,I,I
phosphate,I,I
dehydrogenase,I,I
.,O,O
The,O,O
risk,O,O
for,O,O
these,O,O
complications,O,O
is,O,O
increased,O,O
by,O,O
the,O,O
following,O,O
factors,O,O
:,O,O
multiple,O,O
gestation,O,O
",",O,O
the,O,O
combination,O,O
of,O,O
magnesium,O,O
sulfate,O,O
and,O,O
beta,O,O
-,O,O
adrenergic,O,O
agonist,O,O
",",O,O
and,O,O
the,O,O
use,O,O
of,O,O
adrenocortico,O,O
-,O,O
steroids,O,O
to,O,O
hasten,O,O
fetal,O,O
pulmonary,O,O
maturity,O,O
.,O,O
The,O,O
serum,O,O
levels,O,O
of,O,O
beta,B,B
-,I,I
human,I,I
chorionic,I,I
gonadotropin,I,I
(,O,O
HCG,B,B
),O,O
and,O,O
placental,B,B
alkaline,I,I
phosphatase,I,I
(,O,O
PLAP,B,B
),O,O
were,O,O
not,O,O
elevated,O,O
.,O,O
Merosin,B,O
positive,O,O
congenital,O,O
muscular,O,O
dystrophy,O,O
with,O,O
mental,O,O
deficiency,O,O
",",O,O
epilepsy,O,O
and,O,O
MRI,O,O
changes,O,O
in,O,O
the,O,O
cerebral,O,O
white,O,O
matter,O,O
.,O,O
Gel,O,O
filtration,O,O
",",O,O
sedimentation,O,O
velocity,O,O
",",O,O
and,O,O
immunoprecipitation,O,O
experiments,O,O
revealed,O,O
that,O,O
beta4,O,B
is,O,O
a,O,O
component,O,O
of,O,O
a,O,O
multisubunit,O,O
complex,O,O
(,O,O
AP,B,B
-,I,I
4,I,I
),O,O
that,O,O
also,O,O
contains,O,O
the,O,O
sigma4,O,B
polypeptide,O,I
and,O,O
two,O,O
additional,O,O
adaptor,O,O
subunit,O,O
homologs,O,O
named,O,O
mu4,O,B
(,O,O
mu,O,I
-,O,I
ARP2,O,I
),O,O
and,O,O
epsilon,O,B
.,O,O
The,O,O
2,O,O
cDNAs,O,O
differed,O,O
in,O,O
the,O,O
length,O,O
of,O,O
their,O,O
respective,O,O
3,O,O
',O,O
untranslated,O,O
regions,O,O
",",O,O
of,O,O
577,O,O
bp,O,O
in,O,O
Cp,B,O
.,I,O
F6,I,O
and,O,O
72,O,O
bp,O,O
in,O,O
Cp,B,O
.,I,O
F10,I,O
",",O,O
in,O,O
both,O,O
of,O,O
which,O,O
a,O,O
putative,O,O
polyadenylation,O,O
signal,O,O
was,O,O
identified,O,O
.,O,O
Prevention,O,O
",",O,O
differential,O,O
diagnosis,O,O
and,O,O
therapy,O,O
of,O,O
travel,O,O
diarrhea,O,O
The,O,O
present,O,O
investigation,O,O
conducted,O,O
in,O,O
a,O,O
population,O,O
of,O,O
258,O,O
dentally,O,O
aware,O,O
individuals,O,O
in,O,O
the,O,O
age,O,O
range,O,O
20,O,O
-,O,O
69,O,O
years,O,O
",",O,O
was,O,O
initiated,O,O
to,O,O
elucidate,O,O
the,O,O
relationship,O,O
between,O,O
tobacco,O,O
smoking,O,O
and,O,O
supragingival,O,O
calculus,O,O
",",O,O
taking,O,O
into,O,O
account,O,O
possible,O,O
confounding,O,O
factors,O,O
such,O,O
as,O,O
age,O,O
",",O,O
gender,O,O
",",O,O
oral,O,O
hygiene,O,O
and,O,O
gingival,O,O
inflammation,O,O
.,O,O
Using,O,O
Southern,O,O
blot,O,O
analysis,O,O
and,O,O
restriction,O,O
mapping,O,O
of,O,O
genomic,O,O
YAC,O,O
(,O,O
yeast,O,O
artificial,O,O
chromosome,O,O
),O,O
and,O,O
cosmid,O,O
clones,O,O
",",O,O
we,O,O
located,O,O
the,O,O
human,B,B
RIL,I,B
gene,I,O
240,O,O
-,O,O
260,O,O
kb,O,O
telomeric,O,O
to,O,O
the,O,O
IRF1,B,B
gene,I,O
and,O,O
characterized,O,O
its,O,O
genomic,O,O
structure,O,O
.,O,O
Total,O,O
cholesterol,O,O
was,O,O
also,O,O
reduced,O,O
at,O,O
week,O,O
12,O,O
by,O,O
17,O,O
.,O,O
0,O,O
%,O,O
(,O,O
20,O,O
mg,O,O
/,O,O
day,O,O
),O,O
and,O,O
15,O,O
.,O,O
7,O,O
%,O,O
(,O,O
20,O,O
-,O,O
30,O,O
mg,O,O
/,O,O
day,O,O
),O,O
",",O,O
and,O,O
at,O,O
week,O,O
52,O,O
by,O,O
20,O,O
.,O,O
4,O,O
%,O,O
(,O,O
<,O,O
or,O,O
=,O,O
20,O,O
mg,O,O
/,O,O
day,O,O
),O,O
and,O,O
19,O,O
.,O,O
2,O,O
%,O,O
(,O,O
>,O,O
or,O,O
=,O,O
30,O,O
mg,O,O
/,O,O
day,O,O
),O,O
.,O,O
However,O,O
",",O,O
primary,O,O
transcripts,O,O
of,O,O
a,O,O
variant,B,O
tRNA,I,O
(,I,O
Val,I,B
),I,O
(,I,O
UAC,I,B
),I,O
gene,I,O
are,O,O
processing,O,O
deficient,O,O
under,O,O
standard,O,O
growth,O,O
conditions,O,O
(,O,O
30,O,O
degrees,O,O
C,O,O
),O,O
",",O,O
due,O,O
to,O,O
a,O,O
slightly,O,O
altered,O,O
5,O,O
',O,O
flanking,O,O
region,O,O
.,O,O
Left,O,O
atrial,O,O
volumes,O,O
were,O,O
greater,O,O
in,O,O
old,O,O
compared,O,O
with,O,O
young,O,O
subjects,O,O
(,O,O
maximal,O,O
:,O,O
31,O,O
+,O,O
/,O,O
-,O,O
10,O,O
cm3,O,O
/,O,O
m2,O,O
vs,O,O
24,O,O
+,O,O
/,O,O
-,O,O
8,O,O
cm3,O,O
/,O,O
m2,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
02,O,O
;,O,O
at,O,O
onset,O,O
of,O,O
atrial,O,O
systole,O,O
:,O,O
23,O,O
+,O,O
/,O,O
-,O,O
8,O,O
cm3,O,O
/,O,O
m2,O,O
vs,O,O
15,O,O
+,O,O
/,O,O
-,O,O
5,O,O
cm3,O,O
/,O,O
m2,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
0002,O,O
;,O,O
minimal,O,O
:,O,O
13,O,O
+,O,O
/,O,O
-,O,O
5,O,O
cm3,O,O
/,O,O
m2,O,O
vs,O,O
9,O,O
+,O,O
/,O,O
-,O,O
4,O,O
cm3,O,O
/,O,O
m2,O,O
",",O,O
p,O,O
=,O,O
0,O,O
.,O,O
001,O,O
),O,O
.,O,O
Effects,O,O
of,O,O
long,O,O
-,O,O
term,O,O
parenteral,O,O
nutrition,O,O
on,O,O
gastrin,B,O
release,O,O
in,O,O
dogs,O,O
.,O,O
Cytoskeletal,O,O
polarization,O,O
of,O,O
T,O,B
cells,O,O
is,O,O
regulated,O,O
by,O,O
an,O,O
immunoreceptor,O,O
tyrosine,O,O
-,O,O
based,O,O
activation,O,O
motif,O,O
-,O,O
dependent,O,O
mechanism,O,O
.,O,O
The,O,O
binding,O,O
of,O,O
transcription,O,O
factor,O,O
AP,B,B
-,I,I
1,I,I
and,O,O
vitamin,B,O
D,I,B
receptor,I,O
(,O,O
VDR,B,B
),O,O
to,O,O
the,O,O
composite,O,O
AP,B,B
-,I,I
1,I,I
plus,I,O
vitamin,I,O
-,I,O
D,I,B
-,I,I
responsive,I,I
promoter,I,O
region,O,O
(,O,O
AP,B,B
-,I,I
1,I,I
+,I,O
VDRE,I,O
),O,O
of,O,O
the,O,O
human,B,B
osteocalcin,I,I
gene,I,O
was,O,O
characterized,O,O
in,O,O
osteocalcin,B,B
-,O,I
producing,O,I
(,O,O
MG,O,B
-,O,I
63,O,I
),O,O
and,O,O
non,O,O
-,O,O
producing,O,O
(,O,O
U2,O,B
-,O,I
Os,O,I
",",O,O
SaOs,O,B
-,O,I
2,O,I
),O,O
human,O,B
osteosarcoma,O,I
cell,O,I
lines,O,O
.,O,O
Comparison,O,O
of,O,O
propofol,O,B
and,O,O
thiopentone,O,B
as,O,O
anaesthetic,O,O
agents,O,O
for,O,O
electroconvulsive,O,O
therapy,O,O
.,O,O
Transfection,O,O
of,O,O
non,O,O
-,O,O
deleted,O,O
expression,O,O
vector,O,O
into,O,O
NIH3T3,O,B
cells,O,O
results,O,O
in,O,O
acquisition,O,O
of,O,O
focus,O,O
-,O,O
forming,O,O
activity,O,O
while,O,O
a,O,O
deleted,O,O
form,O,O
of,O,O
expression,O,O
vector,O,O
fails,O,O
to,O,O
show,O,O
this,O,O
activity,O,O
even,O,O
in,O,O
the,O,O
presence,O,O
of,O,O
basic,B,O
FGF,I,B
.,O,O
The,O,O
effect,O,O
of,O,O
osmotic,O,O
flow,O,O
on,O,O
the,O,O
distribution,O,O
of,O,O
horseradish,B,B
peroxidase,I,I
within,O,O
the,O,O
intercellular,O,O
spaces,O,O
of,O,O
toad,O,O
bladder,O,O
epithelium,O,O
.,O,O
3,O,O
.,O,O
The,O,O
binding,O,O
of,O,O
NF,B,B
-,I,I
ATp,I,I
",",O,O
although,O,O
not,O,O
NF,B,B
-,I,I
AT4,I,I
",",O,O
to,O,O
this,O,O
enhancer,O,O
also,O,O
occurs,O,O
along,O,O
with,O,O
HTLV,O,O
-,O,O
I,O,O
-,O,O
mediated,O,O
infection,O,O
of,O,O
human,O,B
peripheral,O,I
blood,O,I
T,O,I
-,O,I
cells,O,I
.,O,O
Recombinant,B,O
Ffh,I,B
has,O,O
a,O,O
melting,O,O
point,O,O
of,O,O
tm,O,O
=,O,O
89,O,O
degreesC,O,O
.,O,O
Pilot,O,O
study,O,O
of,O,O
blood,O,O
coagulation,O,O
in,O,O
gout,O,O
patients,O,O
.,O,O
Restriction,O,O
enzyme,O,O
mapping,O,O
",",O,O
subcloning,O,O
",",O,O
and,O,O
DNA,O,O
sequencing,O,O
analysis,O,O
of,O,O
recombinant,O,O
phage,O,O
lambda,O,O
and,O,O
P1,O,O
clones,O,O
revealed,O,O
that,O,O
exons,O,O
encoding,O,O
the,O,O
1,O,O
.,O,O
9,O,O
-,O,O
kb,O,O
mouse,B,B
TS,I,I
mRNA,I,I
are,O,O
dispersed,O,O
over,O,O
>,O,O
150,O,O
kb,O,O
genomic,O,O
DNA,O,O
.,O,O
To,O,O
better,O,O
understand,O,O
the,O,O
role,O,O
of,O,O
Ets,B,B
proteins,I,O
in,O,O
Ras,B,B
transformation,O,O
",",O,O
we,O,O
have,O,O
now,O,O
analyzed,O,O
the,O,O
effects,O,O
of,O,O
stably,O,O
expressing,O,O
a,O,O
variety,O,O
of,O,O
Ets2,B,B
constructs,I,O
in,O,O
Ras,B,B
-,O,I
transformed,O,I
NIH3T3,O,I
(,O,O
DT,O,O
),O,O
cells,O,O
.,O,O
Peroxisome,B,B
proliferator,I,I
-,I,I
activated,I,I
receptors,I,I
(,O,O
PPAR,B,B
),O,O
modulate,O,O
transcription,O,O
by,O,O
binding,O,O
to,O,O
specific,O,O
peroxisome,O,O
proliferator,O,O
-,O,O
response,O,O
elements,O,O
(,O,O
PPRE,O,B
),O,O
through,O,O
heterodimerization,O,O
with,O,O
the,O,O
9,B,O
-,I,O
cis,I,O
retinoic,I,O
acid,I,O
receptor,I,O
(,O,O
RXR,B,B
),O,O
.,O,O
The,O,O
probability,O,O
of,O,O
treatment,O,O
with,O,O
lamotrigine,O,O
being,O,O
maintained,O,O
for,O,O
six,O,O
months,O,O
was,O,O
86,O,O
%,O,O
",",O,O
for,O,O
twelve,O,O
months,O,O
61,O,O
%,O,O
and,O,O
for,O,O
three,O,O
years,O,O
31,O,O
%,O,O
.,O,O
Therefore,O,O
",",O,O
in,O,O
order,O,O
to,O,O
search,O,O
for,O,O
the,O,O
latent,O,O
genes,O,O
",",O,O
we,O,O
used,O,O
allotype,O,O
-,O,O
specific,O,O
oligonucleotides,O,O
for,O,O
b5,O,B
",",O,O
b6,O,B
and,O,O
b9,O,B
to,O,O
probe,O,O
DNAs,O,O
from,O,O
both,O,O
normal,O,O
and,O,O
T,O,O
.,O,O
brucei,O,O
-,O,O
infected,O,O
rabbits,O,O
by,O,O
Southern,O,O
blotting,O,O
.,O,O
Mutational,O,O
analyses,O,O
have,O,O
demonstrated,O,O
the,O,O
importance,O,O
of,O,O
sequences,O,O
within,O,O
the,O,O
327,O,O
bp,O,O
segment,O,O
that,O,O
contain,O,O
a,O,O
putative,O,O
cyclic,B,O
AMP,I,O
responsive,I,O
element,I,O
binding,I,O
protein,I,O
(,O,O
CREB,B,B
),O,O
binding,O,O
site,O,O
for,O,O
TGF,B,O
-,I,O
beta,I,O
1,I,O
and,O,O
PMA,O,O
responsiveness,O,O
and,O,O
putative,O,O
PU,B,B
-,I,I
1,I,I
and,O,O
Sp1,B,B
binding,I,O
sites,I,O
for,O,O
basal,O,O
promoter,O,O
activity,O,O
.,O,O
When,O,O
this,O,O
CCAAT,O,B
box,O,I
was,O,O
inserted,O,O
into,O,O
a,O,O
heterologous,O,O
promoter,O,O
construct,O,O
",",O,O
OA,O,O
induction,O,O
was,O,O
dependent,O,O
on,O,O
an,O,O
intact,O,O
CCAAT,O,B
box,O,I
.,O,O
Hemorrhagic,O,O
shock,O,O
and,O,O
bacterial,O,O
translocation,O,O
in,O,O
a,O,O
swine,O,O
model,O,O
.,O,O
The,O,O
Ng,B,B
/,I,O
RC3,I,B
and,O,O
PKC,B,B
-,I,I
gamma,I,I
genes,I,O
have,O,O
a,O,O
similar,O,O
expression,O,O
pattern,O,O
in,O,O
the,O,O
brain,O,O
during,O,O
development,O,O
.,O,O
Along,O,O
with,O,O
previously,O,O
mapped,O,O
genes,O,O
including,O,O
Ly,B,B
-,I,I
1,I,I
and,O,O
CD20,B,B
",",O,O
OSBP,B,B
defines,O,O
a,O,O
new,O,O
conserved,O,O
syntenic,O,O
group,O,O
on,O,O
the,O,O
long,O,O
arm,O,O
of,O,O
chromosome,O,O
11,O,O
in,O,O
the,O,O
human,O,O
and,O,O
the,O,O
proximal,O,O
end,O,O
of,O,O
chromosome,O,O
19,O,O
in,O,O
the,O,O
mouse,O,O
.,O,O
In,O,O
a,O,O
gntR,B,B
deletion,I,O
mutant,I,O
",",O,O
the,O,O
expression,O,O
of,O,O
a,O,O
chromosomal,O,O
gntT,B,B
:,O,O
:,O,O
lacZ,B,O
fusion,O,O
is,O,O
both,O,O
high,O,O
and,O,O
constitutive,O,O
",",O,O
confirming,O,O
that,O,O
GntR,B,B
is,O,O
the,O,O
negative,O,O
regulator,O,O
of,O,O
gntT,B,B
.,O,O
The,O,O
chloramphenicol,B,O
-,I,O
resistance,I,O
transposon,I,O
Tn4451,B,O
undergoes,O,O
precise,O,O
conjugative,O,O
deletion,O,O
from,O,O
its,O,O
parent,O,O
plasmid,O,O
plP401,O,O
in,O,O
Clostridium,O,O
perfringens,O,O
and,O,O
precise,O,O
spontaneous,O,O
excision,O,O
from,O,O
multicopy,O,O
plasmids,O,O
in,O,O
Escherichia,O,O
coli,O,O
.,O,O
Also,O,O
like,O,O
the,O,O
thrombin,B,B
receptor,I,I
",",O,O
PAR2,B,B
can,O,O
be,O,O
activated,O,O
by,O,O
the,O,O
hexapeptide,O,O
corresponding,O,O
to,O,O
its,O,O
tethered,O,O
ligand,O,O
sequence,O,O
independent,O,O
of,O,O
receptor,O,O
cleavage,O,O
.,O,O
Pre,B,O
-,I,O
beta,I,O
-,I,O
1,I,O
lipoprotein,I,O
and,O,O
early,O,O
detection,O,O
of,O,O
risk,O,O
factors,O,O
for,O,O
coronary,O,O
heart,O,O
disease,O,O
.,O,O
Twenty,O,O
-,O,O
two,O,O
consecutive,O,O
patients,O,O
with,O,O
ischaemic,O,O
ulcers,O,O
had,O,O
tcPO2,O,O
measured,O,O
and,O,O
the,O,O
ankle,O,O
/,O,O
brachial,O,O
(,O,O
ABI,O,O
),O,O
and,O,O
toe,O,O
/,O,O
brachial,O,O
(,O,O
TBI,O,O
),O,O
indices,O,O
calculated,O,O
.,O,O
Periodic,O,O
breathing,O,O
and,O,O
apnea,O,O
in,O,O
preterm,O,O
infants,O,O
.,O,O
Expression,O,O
of,O,O
a,O,O
hybrid,O,O
protein,O,O
containing,O,O
the,O,O
cytoplasmic,O,O
C,O,O
-,O,O
terminal,O,O
half,O,O
of,O,O
UhpB,B,B
fused,O,O
to,O,O
glutathione,B,B
S,I,I
-,I,I
transferase,I,I
(,O,O
GST,B,B
),O,O
also,O,O
interfered,O,O
with,O,O
Uhp,B,B
signaling,O,O
.,O,O
The,O,O
concept,O,O
of,O,O
is,O,O
employed,O,O
in,O,O
this,O,O
analysis,O,O
to,O,O
determine,O,O
which,O,O
model,O,O
parameters,O,O
can,O,O
be,O,O
and,O,O
which,O,O
cannot,O,O
be,O,O
determined,O,O
from,O,O
given,O,O
input,O,O
-,O,O
output,O,O
data,O,O
;,O,O
a,O,O
step,O,O
-,O,O
by,O,O
-,O,O
step,O,O
procedure,O,O
based,O,O
on,O,O
an,O,O
extension,O,O
of,O,O
this,O,O
concept,O,O
is,O,O
presented,O,O
for,O,O
adapting,O,O
the,O,O
overall,O,O
approach,O,O
to,O,O
the,O,O
experimental,O,O
design,O,O
problem,O,O
.,O,O
A,O,O
five,O,O
-,O,O
phase,O,O
experiment,O,O
was,O,O
designed,O,O
to,O,O
investigate,O,O
(,O,O
a,O,O
),O,O
whether,O,O
contingent,O,O
music,O,O
-,O,O
listening,O,O
would,O,O
act,O,O
as,O,O
a,O,O
reinforcer,O,O
to,O,O
increase,O,O
arithmetic,O,O
performance,O,O
of,O,O
EMR,O,O
children,O,O
and,O,O
(,O,O
b,O,O
),O,O
whether,O,O
this,O,O
contingent,O,O
reinforcement,O,O
would,O,O
affect,O,O
preference,O,O
for,O,O
that,O,O
reinforcer,O,O
.,O,O
Genomic,O,O
DNA,O,O
clones,O,O
containing,O,O
the,O,O
T,B,O
-,I,O
cell,I,O
-,I,O
specific,I,O
human,I,B
MAL,I,I
gene,I,O
were,O,O
isolated,O,O
.,O,O
Since,O,O
1968,O,O
",",O,O
a,O,O
steep,O,O
decrease,O,O
in,O,O
the,O,O
number,O,O
of,O,O
strains,O,O
resistant,O,O
to,O,O
three,O,O
or,O,O
more,O,O
antibiotics,O,O
(,O,O
multiple,O,O
-,O,O
resistant,O,O
),O,O
and,O,O
in,O,O
strains,O,O
of,O,O
the,O,O
83A,O,O
complex,O,O
was,O,O
noticed,O,O
.,O,O
99mTc,O,O
-,O,O
HMPAO,O,O
was,O,O
distributed,O,O
in,O,O
the,O,O
territories,O,O
of,O,O
the,O,O
ACA,O,O
and,O,O
MCA,O,O
in,O,O
the,O,O
two,O,O
patients,O,O
who,O,O
were,O,O
treated,O,O
with,O,O
intraarterial,O,O
infusion,O,O
of,O,O
papaverine,O,O
from,O,O
the,O,O
C4,O,O
segment,O,O
",",O,O
but,O,O
was,O,O
distributed,O,O
only,O,O
to,O,O
the,O,O
territory,O,O
of,O,O
the,O,O
ACA,O,O
in,O,O
four,O,O
patients,O,O
who,O,O
were,O,O
treated,O,O
with,O,O
intraarterial,O,O
infusion,O,O
of,O,O
papaverine,O,O
from,O,O
the,O,O
C1,O,O
segment,O,O
at,O,O
1,O,O
ml,O,O
/,O,O
min,O,O
.,O,O
Biol,O,O
.,O,O
While,O,O
these,O,O
findings,O,O
may,O,O
reflect,O,O
the,O,O
sensitivity,O,O
of,O,O
a,O,O
thick,O,O
myocardial,O,O
wall,O,O
to,O,O
ischaemia,O,O
during,O,O
surgery,O,O
",",O,O
the,O,O
postoperative,O,O
recovery,O,O
was,O,O
not,O,O
related,O,O
to,O,O
the,O,O
serum,B,O
CK,I,B
-,I,I
MB,I,I
level,O,O
.,O,O
Morphology,O,O
of,O,O
bacteriophages,O,O
of,O,O
Klebsiella,O,B
bacilli,O,I
.,O,O
Significantly,O,O
",",O,O
two,O,O
proximal,O,O
GATA,B,B
-,I,I
1,I,I
-,I,I
binding,I,I
sites,I,O
(,O,O
-,O,O
118,O,O
/,O,O
-,O,O
113,O,O
and,O,O
-,O,O
98,O,O
/,O,O
-,O,O
93,O,O
),O,O
and,O,O
a,O,O
region,O,O
located,O,O
within,O,O
-,O,O
518,O,O
to,O,O
-,O,O
315bp,O,O
of,O,O
the,O,O
mouse,B,O
ALAS2,I,B
promoter,I,O
were,O,O
essential,O,O
for,O,O
transcriptional,O,O
activation,O,O
during,O,O
chemically,O,O
induced,O,O
differentiation,O,O
of,O,O
MEL,O,O
cells,O,O
",",O,O
implying,O,O
their,O,O
importance,O,O
in,O,O
conferring,O,O
erythroid,O,O
specificity,O,O
to,O,O
the,O,O
ALAS2,B,B
transcriptional,O,O
activation,O,O
.,O,O
In,O,O
rlf2,B,B
mutants,I,O
",",O,O
telomeric,O,O
chromatin,O,O
is,O,O
perturbed,O,O
:,O,O
Telomeric,O,O
silencing,O,O
is,O,O
reduced,O,O
and,O,O
Rap1p,B,B
localization,O,O
is,O,O
altered,O,O
.,O,O
The,O,O
MXR,B,B
gene,I,O
encodes,O,O
a,O,O
half,O,O
-,O,O
transporter,O,O
and,O,O
the,O,O
absence,O,O
of,O,O
cytogenetic,O,O
evidence,O,O
of,O,O
coamplification,O,O
of,O,O
other,O,O
regions,O,O
suggests,O,O
that,O,O
a,O,O
partner,O,O
may,O,O
not,O,O
be,O,O
overexpressed,O,O
",",O,O
and,O,O
instead,O,O
the,O,O
MXR,B,B
half,I,O
-,I,O
transporter,I,O
homodimerizes,O,O
to,O,O
mediate,O,O
drug,O,O
transport,O,O
.,O,O
These,O,O
kinases,O,O
belong,O,O
to,O,O
a,O,O
new,O,O
subfamily,O,O
related,O,O
to,O,O
the,O,O
Trk,B,B
subfamily,I,O
.,O,O
Hybridization,O,O
signals,O,O
were,O,O
also,O,O
detected,O,O
with,O,O
total,O,O
DNAs,O,O
of,O,O
Rhizobium,O,B
leguminosarum,O,I
bv,O,I
.,O,O
phaseoli,O,B
",",O,O
Rhodobacter,O,B
capsulatus,O,I
and,O,O
Escherichia,O,B
coli,O,I
",",O,O
but,O,O
not,O,O
those,O,O
of,O,O
Xanthomonas,O,B
campestris,O,I
pv,O,I
.,O,O
campestris,O,B
and,O,O
Pseudomonas,O,B
putida,O,I
.,O,O
Nerve,O,O
stimulation,O,O
(,O,O
1,O,O
.,O,O
5,O,O
-,O,O
12,O,O
cycles,O,O
/,O,O
s,O,O
),O,O
produced,O,O
frequency,O,O
-,O,O
dependent,O,O
reductions,O,O
in,O,O
CBF,O,B
",",O,O
a,O,O
decrease,O,O
of,O,O
50,O,O
percent,O,O
occurring,O,O
with,O,O
the,O,O
highest,O,O
frequency,O,O
.,O,O
The,O,O
circadian,O,O
rhythmicity,O,O
of,O,O
sleep,O,O
was,O,O
pronounced,O,O
.,O,O
The,O,O
only,O,O
abundant,O,O
viral,O,O
transcript,O,O
expressed,O,O
during,O,O
latency,O,O
is,O,O
the,O,O
latency,B,O
-,I,O
related,I,O
(,O,O
LR,B,B
),O,O
RNA,O,O
.,O,O
Taken,O,O
together,O,O
",",O,O
these,O,O
results,O,O
demonstrate,O,O
that,O,O
the,O,O
RP,B,B
",",O,O
like,O,O
the,O,O
20S,B,O
proteasome,I,O
",",O,O
is,O,O
functionally,O,O
and,O,O
structurally,O,O
conserved,O,O
among,O,O
eukaryotes,O,O
and,O,O
indicate,O,O
that,O,O
the,O,O
plant,B,O
RPT,I,B
subunits,I,O
",",O,O
like,O,O
their,O,O
yeast,O,O
counterparts,O,O
",",O,O
have,O,O
non,O,O
-,O,O
redundant,O,O
functions,O,O
.,O,O
On,O,O
the,O,O
amount,O,O
and,O,O
significance,O,O
of,O,O
the,O,O
effective,O,O
glucose,O,B
level,O,O
in,O,O
tumors,O,O
.,O,O
Solution,O,O
structure,O,O
and,O,O
mechanism,O,O
of,O,O
the,O,O
MutT,B,B
pyrophosphohydrolase,I,I
.,O,O
Luteinizing,B,O
hormone,I,O
-,I,O
releasing,I,O
hormone,I,O
analog,O,O
therapy,O,O
of,O,O
uterine,O,O
fibroid,O,O
:,O,O
analysis,O,O
of,O,O
results,O,O
obtained,O,O
with,O,O
buserelin,O,O
administered,O,O
intranasally,O,O
and,O,O
goserelin,O,O
administered,O,O
subcutaneously,O,O
as,O,O
a,O,O
monthly,O,O
depot,O,O
.,O,O
NH2,O,O
-,O,O
terminal,O,O
trimming,O,O
of,O,O
Xenopus,O,B
and,O,O
mammalian,B,B
FGF3s,I,I
may,O,O
therefore,O,O
be,O,O
a,O,O
prerequisite,O,O
of,O,O
optimal,O,O
biological,O,O
activity,O,O
.,O,O
Immunohistochemical,O,O
staining,O,O
with,O,O
MIB,B,B
-,I,I
1,I,I
and,O,O
p53,B,B
antibodies,I,I
showed,O,O
low,O,O
(,O,O
<,O,O
1,O,O
%,O,O
),O,O
and,O,O
negative,O,O
reaction,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
exogenous,B,O
PTHrP1,I,B
-,I,I
34,I,I
and,I,O
1,I,O
-,I,O
86,I,O
peptides,I,O
did,O,O
not,O,O
significantly,O,O
affect,O,O
IL,B,O
-,I,O
8,I,O
production,O,O
;,O,O
moreover,O,O
",",O,O
PTHrP,B,B
-,I,I
neutralizing,I,I
antibodies,I,I
did,O,O
not,O,O
inhibit,O,O
the,O,O
production,O,O
of,O,O
IL,B,O
-,I,O
8,I,O
by,O,O
transfected,O,O
PTHrP,B,B
.,O,O
(,O,O
ii,O,O
),O,O
An,O,O
AF,O,B
G,B,I
-,I,I
CSF,I,I
level,O,O
>,O,O
2000,O,O
pg,O,O
/,O,O
ml,O,O
is,O,O
a,O,O
strong,O,O
positive,O,O
predictor,O,O
of,O,O
CAM,O,O
.,O,O
Segments,O,O
with,O,O
more,O,O
reduced,O,O
BMIPP,O,B
uptake,O,O
than,O,O
MIBI,O,B
uptake,O,O
(,O,O
mismatching,O,O
),O,O
showed,O,O
either,O,O
normal,O,O
wall,O,O
motion,O,O
or,O,O
demonstrated,O,O
inotropic,O,O
reserve,O,O
during,O,O
dobutamine,O,O
stimulation,O,O
.,O,O
A,O,O
second,O,O
promoter,O,O
activity,O,O
was,O,O
identified,O,O
in,O,O
the,O,O
region,O,O
between,O,O
the,O,O
two,O,O
major,O,O
transcriptional,O,O
start,O,O
sites,O,O
.,O,O
One,O,O
CKD,O,B
patient,O,O
',O,O
s,O,O
journey,O,O
.,O,O
CONTEXT,O,O
:,O,O
ThinPrep,O,O
",",O,O
AutoPap,O,O
",",O,O
and,O,O
Papnet,O,O
are,O,O
3,O,O
new,O,O
technologies,O,O
that,O,O
increase,O,O
the,O,O
sensitivity,O,O
and,O,O
cost,O,O
of,O,O
cervical,O,O
cancer,O,O
screening,O,O
.,O,O
Six,O,O
of,O,O
the,O,O
gstC,B,B
',I,O
mutants,I,O
",",O,O
primarily,O,O
in,O,O
the,O,O
C,O,B
-,O,I
terminal,O,I
half,O,I
of,O,I
C,B,B
',I,I
",",O,O
exhibited,O,O
a,O,O
defect,O,O
in,O,O
the,O,O
ability,O,O
to,O,O
bind,O,O
L,B,B
protein,I,O
.,O,O
The,O,O
model,O,O
is,O,O
able,O,O
to,O,O
anticipate,O,O
why,O,O
the,O,O
effect,O,O
of,O,O
water,O,O
fluoridation,O,O
on,O,O
caries,O,O
prevalence,O,O
is,O,O
most,O,O
pronounced,O,O
when,O,O
caries,O,O
is,O,O
diagnosed,O,O
at,O,O
cavity,O,O
level,O,O
.,O,O
Reversal,O,O
of,O,O
the,O,O
increase,O,O
in,O,O
apomorphine,O,B
-,O,I
induced,O,I
stereotypy,O,I
and,O,O
aggression,O,O
in,O,O
REM,O,O
sleep,O,O
deprived,O,O
rats,O,O
by,O,O
dopamine,O,B
agonist,O,I
pretreatments,O,O
.,O,O
Chem,O,O
.,O,O
With,O,O
both,O,O
wild,O,O
-,O,O
type,O,O
and,O,O
the,O,O
mutant,O,O
enzymes,O,O
",",O,O
ATP,O,O
activates,O,O
both,O,O
[,O,O
14C,O,O
],O,O
Asp,O,O
in,O,O
equilibrium,O,O
N,O,O
-,O,O
carbamyl,O,O
-,O,O
L,O,O
-,O,O
aspartate,O,O
(,O,O
C,O,O
-,O,O
Asp,O,O
),O,O
and,O,O
the,O,O
[,O,O
32P,O,O
],O,O
carbamyl,O,O
phosphate,O,O
(,O,O
C,O,O
-,O,O
P,O,O
),O,O
in,O,O
equilibrium,O,O
Pi,O,O
exchanges,O,O
.,O,O
Histological,O,O
examination,O,O
revealed,O,O
a,O,O
small,O,O
simple,O,O
renal,O,B
cyst,O,I
associated,O,O
with,O,O
renal,O,B
cell,O,I
carcinoma,O,I
.,O,O
Flavonoids,O,O
from,O,O
Brosimum,O,B
acutifolium,O,I
.,O,O
New,O,O
Langevin,O,O
equations,O,O
for,O,O
a,O,O
translating,O,O
and,O,O
simultaneously,O,O
rotating,O,O
asymmetric,O,O
top,O,O
.,O,O
Analysis,O,O
with,O,O
additional,O,O
anti,O,O
-,O,O
peptide,O,O
antibodies,O,O
specific,O,O
for,O,O
alpha,B,B
",",I,O
beta,I,B
",",I,O
or,I,O
gamma,I,B
PKC,I,I
indicated,O,O
that,O,O
all,O,O
three,O,O
types,O,O
of,O,O
PKC,B,I
are,O,O
expressed,O,O
in,O,O
JK,O,O
cells,O,O
;,O,O
however,O,O
",",O,O
JKPE,O,O
cells,O,O
lost,O,O
a,O,O
major,O,O
approximately,O,O
82,O,O
kDa,O,O
immunoreactive,O,O
cytosolic,O,O
protein,O,O
detectable,O,O
with,O,O
anti,B,O
-,I,O
PKC,I,I
alpha,I,I
antibody,I,O
.,O,O
Effects,O,O
of,O,O
Trypanosoma,O,B
vivax,O,I
on,O,O
pregnancy,O,O
of,O,O
Yankasa,O,O
sheep,O,O
and,O,O
the,O,O
results,O,O
of,O,O
homidum,O,O
chloride,O,O
chemotherapy,O,O
.,O,O
Propagation,O,O
and,O,O
hormone,O,O
production,O,O
by,O,O
human,O,B
normal,O,I
and,O,I
malignant,O,I
trophoblast,O,I
in,O,O
rats,O,O
.,O,O
The,O,O
imino,O,O
proton,O,O
of,O,O
T3,O,B
in,O,O
the,O,O
O6meG,O,O
.,O,O
T,O,O
12,O,O
-,O,O
mer,O,O
and,O,O
G3,O,B
in,O,O
the,O,O
O6meG,O,O
.,O,O
N,O,O
12,O,O
-,O,O
mer,O,O
helix,O,O
",",O,O
which,O,O
are,O,O
associated,O,O
with,O,O
the,O,O
modification,O,O
site,O,O
",",O,O
resonate,O,O
at,O,O
unusually,O,O
high,O,O
field,O,O
(,O,O
8,O,O
.,O,O
5,O,O
to,O,O
9,O,O
.,O,O
0,O,O
ppm,O,O
),O,O
compared,O,O
to,O,O
imino,O,O
protons,O,O
in,O,O
Watson,O,B
-,O,I
Crick,O,I
base,O,I
pairs,O,I
(,O,O
12,O,O
.,O,O
5,O,O
to,O,O
14,O,O
.,O,O
5,O,O
ppm,O,O
),O,O
urinary,O,O
protein,O,O
",",O,O
serum,O,O
albumin,B,O
",",O,O
BUN,O,O
and,O,O
SCr,O,O
all,O,O
had,O,O
very,O,O
significant,O,O
improvement,O,O
.,O,O
MEKs,B,B
and,O,O
ERKs,B,B
inhibited,O,O
IL,B,O
-,I,O
6,I,O
activation,O,O
of,O,O
Stat3,B,O
harboring,O,O
a,O,O
mutation,O,O
at,O,O
serine,O,O
-,O,O
727,O,O
",",O,O
the,O,O
major,O,O
site,O,O
for,O,O
serine,O,O
phosphorylation,O,O
",",O,O
similar,O,O
to,O,O
inhibition,O,O
of,O,O
wild,B,O
-,I,O
type,I,O
Stat3,I,O
",",O,O
and,O,O
inhibited,O,O
Janus,B,B
kinases,I,I
Jak1,B,B
and,O,O
Jak2,B,B
upstream,O,O
of,O,O
Stat3,B,O
in,O,O
the,O,O
Jak,B,O
-,O,O
STAT,B,O
-,O,O
signaling,O,O
pathway,O,O
.,O,O
A,O,O
proposal,O,O
of,O,O
50,O,O
performance,O,O
indicators,O,O
divided,O,O
into,O,O
five,O,O
different,O,O
groups,O,O
is,O,O
presented,O,O
here,O,O
",",O,O
namely,O,O
structural,O,O
indicators,O,O
",",O,O
operational,O,O
indicators,O,O
",",O,O
water,O,O
and,O,O
service,O,O
quality,O,O
indicators,O,O
",",O,O
personnel,O,O
indicators,O,O
and,O,O
economic,O,O
indicators,O,O
.,O,O
Tryptic,O,O
cleavage,O,O
and,O,O
peptide,O,O
sequence,O,O
analysis,O,O
demonstrated,O,O
that,O,O
the,O,O
98,O,O
-,O,O
kD,O,O
protein,O,O
is,O,O
identical,O,O
to,O,O
a,O,O
recently,O,O
cloned,O,O
protein,O,O
",",O,O
special,B,O
A,I,B
-,I,I
-,I,I
rich,I,I
binding,I,I
protein,I,I
1,I,I
(,O,O
SATB1,B,B
),O,O
",",O,O
that,O,O
binds,O,O
selectively,O,O
to,O,O
nuclear,O,O
matrix,O,O
/,O,O
scaffold,O,O
-,O,O
associated,O,O
regions,O,O
of,O,O
DNA,O,O
(,O,O
MARs,O,O
/,O,O
SARs,O,O
),O,O
.,O,O
Study,O,O
of,O,O
the,O,O
physico,O,O
-,O,O
chemical,O,O
state,O,O
of,O,O
plutonium,O,B
-,O,I
239,O,I
in,O,O
a,O,O
citrate,O,O
solution,O,O
-,O,O
blood,O,O
system,O,O
The,O,O
predicted,O,O
domain,O,O
structures,O,O
of,O,O
FkbB,B,B
and,O,O
FkbC,B,B
are,O,O
analogous,O,O
to,O,O
that,O,O
of,O,O
FkbA,B,B
and,O,O
comprise,O,O
30,O,O
fatty,B,O
-,I,O
acid,I,O
-,I,O
synthase,I,O
(,O,O
FAS,B,B
),O,O
-,O,O
like,O,O
domains,O,O
arranged,O,O
in,O,O
6,O,O
modules,O,O
.,O,O
An,O,O
amino,O,O
-,O,O
acid,O,O
sequence,O,O
comparison,O,O
revealed,O,O
that,O,O
Bacillus,B,B
YM55,I,I
-,I,I
1,I,I
aspartase,I,O
shared,O,O
71,O,O
%,O,O
homology,O,O
with,O,O
Bacillus,B,B
subtilis,I,I
aspartase,I,O
and,O,O
49,O,O
%,O,O
with,O,O
Escherichia,O,B
coli,O,I
and,O,O
Pseudomonas,B,B
fluorescens,I,I
aspartases,I,O
.,O,O
On,O,O
the,O,O
other,O,O
hand,O,O
",",O,O
if,O,O
the,O,O
measured,O,O
angle,O,O
ANB,O,B
is,O,O
smaller,O,O
than,O,O
the,O,O
calculated,O,O
angle,O,O
",",O,O
the,O,O
skeletal,O,O
relation,O,O
is,O,O
Class,O,O
III,O,O
.,O,O
The,O,O
equivalent,O,O
of,O,O
the,O,O
third,O,O
ligand,O,O
",",O,O
H,O,B
-,O,I
87,O,I
",",O,O
is,O,O
T,O,B
-,O,I
47,O,I
in,O,O
the,O,O
PSTAIRE,O,O
sequence,O,O
motif,O,O
.,O,O
To,O,O
identify,O,O
additional,O,O
non,O,O
-,O,O
Sir,B,O
factors,I,O
that,O,O
affect,O,O
rDNA,O,O
silencing,O,O
",",O,O
we,O,O
performed,O,O
a,O,O
genetic,O,O
screen,O,O
designed,O,O
to,O,O
isolate,O,O
mutations,O,O
which,O,O
alter,O,O
the,O,O
expression,O,O
of,O,O
reporter,O,O
genes,O,O
integrated,O,O
within,O,O
the,O,O
rDNA,O,O
.,O,O
CONCLUSIONS,O,O
:,O,O
Valproate,O,O
appears,O,O
to,O,O
inhibit,O,O
the,O,O
glucuronidation,O,O
of,O,O
carbamazepine,O,B
-,O,I
10,O,I
",",O,O
11,O,O
-,O,O
trans,O,O
-,O,O
diol,O,O
",",O,O
and,O,O
probably,O,O
also,O,O
inhibits,O,O
the,O,O
conversion,O,O
of,O,O
carbamazepine,O,B
-,O,I
10,O,I
",",O,O
11,O,O
-,O,O
epoxide,O,O
to,O,O
this,O,O
trans,O,O
-,O,O
diol,O,O
derivative,O,O
",",O,O
rather,O,O
than,O,O
simply,O,O
inhibiting,O,O
the,O,O
latter,O,O
reaction,O,O
only,O,O
.,O,O
Sequencing,O,O
of,O,O
a,O,O
40,O,O
-,O,O
kb,O,O
DNA,O,O
segment,O,O
of,O,O
the,O,O
FK506,O,B
gene,O,I
cluster,O,I
from,O,O
Streptomyces,O,O
sp,O,O
.,O,O
S2F,B,O
",",O,O
a,O,O
leaf,O,O
-,O,O
specific,O,O
trans,O,O
-,O,O
acting,O,O
factor,O,O
",",O,O
binds,O,O
to,O,O
a,O,O
novel,O,O
cis,O,O
-,O,O
acting,O,O
element,O,O
and,O,O
differentially,O,O
activates,O,O
the,O,O
RPL21,B,B
gene,I,O
.,O,O
This,O,O
brief,O,O
review,O,O
analyses,O,O
these,O,O
interactions,O,O
and,O,O
defines,O,O
clinical,O,O
settings,O,O
where,O,O
antibiotic,O,O
-,O,O
induced,O,O
endotoxin,O,O
release,O,O
may,O,O
prove,O,O
to,O,O
be,O,O
clinically,O,O
relevant,O,O
.,O,O
We,O,O
further,O,O
demonstrate,O,O
that,O,O
the,O,O
Stress,B,O
-,I,O
Activated,I,O
-,I,O
Protein,I,O
-,I,O
(,O,O
SAPK,B,B
),O,O
target,O,O
sites,O,O
of,O,O
ATF2,B,B
",",O,O
Thr69,O,O
and,O,O
Thr71,O,O
are,O,O
not,O,O
required,O,O
for,O,O
the,O,O
formation,O,O
of,O,O
the,O,O
p300,B,O
/,O,O
CBP,B,O
-,O,O
ATF2,B,B
multiprotein,O,O
complex,O,O
.,O,O
Bites,O,O
by,O,O
two,O,O
species,O,O
of,O,O
adders,O,O
(,O,O
Vipera,O,B
aspis,O,I
and,O,O
Vipera,O,B
berus,O,I
),O,O
can,O,O
lead,O,O
to,O,O
extensive,O,O
swelling,O,O
with,O,O
multiorgan,O,O
failure,O,O
.,O,O
Tissue,O,O
pressure,O,O
",",O,O
rCBF,O,O
",",O,O
and,O,O
water,O,O
content,O,O
were,O,O
measured,O,O
from,O,O
gray,O,O
matter,O,O
in,O,O
the,O,O
central,O,O
core,O,O
and,O,O
the,O,O
peripheral,O,O
margin,O,O
of,O,O
the,O,O
MCA,O,O
territory,O,O
over,O,O
6,O,O
h,O,O
after,O,O
MCAO,O,O
.,O,O
A,O,O
736,O,O
-,O,O
bp,O,O
sequence,O,O
of,O,O
the,O,O
5,O,O
',O,O
flanking,O,O
region,O,O
adjacent,O,O
to,O,O
the,O,O
cap,O,O
site,O,O
of,O,O
the,O,O
human,B,B
AFP,I,I
gene,I,O
shows,O,O
a,O,O
61,O,O
%,O,O
similarity,O,O
with,O,O
the,O,O
corresponding,O,O
region,O,O
of,O,O
the,O,O
mouse,B,O
AFP,I,B
gene,I,O
.,O,O
The,O,O
titer,O,O
of,O,O
anti,B,O
HSV,I,B
type,I,I
1,I,I
and,O,O
anti,B,O
HSV,I,B
type,I,I
2,I,I
antibodies,I,O
in,O,O
the,O,O
mothers,O,O
',O,O
and,O,O
cord,O,O
blood,O,O
was,O,O
determined,O,O
and,O,O
compared,O,O
.,O,O
1,O,O
",",O,O
among,O,O
which,O,O
nine,O,O
have,O,O
been,O,O
cloned,O,O
and,O,O
two,O,O
(,O,O
potentially,O,O
functional,O,O
),O,O
sequenced,O,O
.,O,O
This,O,O
suggests,O,O
that,O,O
while,O,O
underpredictions,O,O
of,O,O
pain,O,O
do,O,O
not,O,O
hurt,O,O
more,O,O
",",O,O
disruption,O,O
on,O,O
primary,O,O
tasks,O,O
and,O,O
physiological,O,O
impact,O,O
are,O,O
higher,O,O
.,O,O
In,O,O
all,O,O
sessions,O,O
under,O,O
IFN,B,B
",",O,O
the,O,O
latency,O,O
of,O,O
the,O,O
P100,O,B
component,O,O
of,O,O
the,O,O
VEP,O,B
was,O,O
shortened,O,O
as,O,O
compared,O,O
to,O,O
baseline,O,O
conditions,O,O
.,O,O
The,O,O
primary,O,O
structure,O,O
of,O,O
the,O,O
GAL7,B,B
5,I,I
',I,I
flanking,I,I
region,I,I
has,O,O
many,O,O
features,O,O
common,O,O
to,O,O
those,O,O
of,O,O
multicellular,O,O
eukaryotic,O,O
genes,O,O
.,O,O
The,O,O
major,O,O
urinary,O,O
metabolites,O,O
were,O,O
3,O,O
-,O,O
(,O,O
3,O,O
-,O,O
carboxyphenyl,O,B
),O,O
-,O,O
5,O,O
-,O,O
hydroxymethyl,O,O
-,O,O
2,O,O
-,O,O
oxazolidinone,O,O
and,O,O
a,O,O
glucuronide,O,O
of,O,O
toloxatone,O,B
.,O,O
One,O,O
complex,O,O
containing,O,O
a,O,O
70,O,O
D,O,O
protein,O,O
was,O,O
found,O,O
to,O,O
be,O,O
associated,O,O
specifically,O,O
with,O,O
transcriptionally,O,O
active,O,O
leukemia,O,O
cells,O,O
.,O,O
Analysis,O,O
of,O,O
disassociation,O,O
rates,O,O
indicates,O,O
that,O,O
the,O,O
Grf10,B,B
-,O,I
Swi5,B,B
-,O,I
DNA,O,I
complex,O,O
has,O,O
a,O,O
longer,O,O
half,O,O
-,O,O
life,O,O
than,O,O
protein,O,O
-,O,O
DNA,O,O
complexes,O,O
that,O,O
contain,O,O
only,O,O
Swi5,B,B
or,O,O
Grf10,B,B
.,O,O
Veterinary,O,O
certification,O,O
for,O,O
livestock,O,O
export,O,O
.,O,O
Several,O,O
genes,O,O
or,O,O
transcriptional,O,O
units,O,O
were,O,O
identified,O,O
",",O,O
including,O,O
the,O,O
3,O,O
',O,O
end,O,O
of,O,O
ribosomal,B,O
s6,I,B
kinase,I,I
(,O,O
Rsk3,B,B
),O,O
;,O,O
two,O,O
apparently,O,O
intronless,O,O
and,O,O
ORF,O,O
-,O,O
less,O,O
genes,O,O
;,O,O
and,O,O
Gpr31,B,B
",",O,O
an,O,O
intronless,O,O
",",O,O
putative,O,O
G,B,O
-,I,O
protein,I,O
coupled,I,O
receptor,I,O
.,O,O
Complex,O,O
repetitive,O,O
discharges,O,O
were,O,O
observed,O,O
in,O,O
muscles,O,O
of,O,O
mdx,O,B
mice,O,O
but,O,O
no,O,O
complex,O,O
repetitive,O,O
discharges,O,O
or,O,O
other,O,O
abnormalities,O,O
were,O,O
observed,O,O
in,O,O
muscles,O,O
of,O,O
normal,O,O
control,O,O
mice,O,O
.,O,O
Unaided,O,O
attempts,O,O
to,O,O
quit,O,O
smoking,O,O
are,O,O
generally,O,O
unsuccessful,O,O
.,O,O
EXAFS,O,O
measurements,O,O
around,O,O
the,O,O
Ge,O,B
-,O,I
K,O,I
edge,O,O
have,O,O
been,O,O
carried,O,O
out,O,O
for,O,O
liquid,O,O
Ge,O,B
-,O,I
Si,O,I
alloys,O,O
for,O,O
the,O,O
first,O,O
time,O,O
to,O,O
investigate,O,O
the,O,O
local,O,O
structure,O,O
around,O,O
a,O,O
Ge,O,B
atom,O,O
.,O,O
Improving,O,O
the,O,O
evidence,O,O
base,O,O
for,O,O
anaesthesia,O,O
.,O,O
Its,O,O
transcription,O,O
product,O,O
",",O,O
a,O,O
1,O,O
.,O,O
3,O,O
kb,O,O
mRNA,O,O
",",O,O
is,O,O
polyadenylated,O,O
at,O,O
a,O,O
site,O,O
containing,O,O
consensus,O,O
eukaryotic,O,O
polyadenylation,O,O
signals,O,O
and,O,O
mapping,O,O
87,O,O
bp,O,O
downstream,O,O
of,O,O
the,O,O
translation,O,O
termination,O,O
codon,O,O
for,O,O
CG30,B,B
.,O,O
Mus81p,B,B
also,O,O
shares,O,O
homology,O,O
with,O,O
motifs,O,O
found,O,O
in,O,O
the,O,O
XPF,B,B
endonuclease,I,I
superfamily,I,I
.,O,O
Elimination,O,O
of,O,O
bagassosis,O,O
in,O,O
Louisiana,O,O
paper,O,O
manufacturing,O,O
plant,O,O
workers,O,O
.,O,O
Although,O,O
not,O,O
common,O,O
",",O,O
the,O,O
disorder,O,O
is,O,O
the,O,O
most,O,O
frequently,O,O
diagnosed,O,O
disturbance,O,O
of,O,O
porphyrin,O,B
metabolism,O,O
in,O,O
many,O,O
countries,O,O
",",O,O
and,O,O
further,O,O
insight,O,O
into,O,O
its,O,O
unusual,O,O
pathogenesis,O,O
may,O,O
clarify,O,O
the,O,O
hepatotoxic,O,O
effects,O,O
of,O,O
the,O,O
4,O,O
etiologic,O,O
agents,O,O
.,O,O
Aggravating,O,O
process,O,O
induced,O,O
by,O,O
indomethacin,O,O
on,O,O
chronic,O,O
gastric,O,O
lesion,O,O
in,O,O
rat,O,O
.,O,O
AP,O,O
was,O,O
induced,O,O
by,O,O
intraductal,O,O
infusion,O,O
of,O,O
two,O,O
different,O,O
concentrations,O,O
of,O,O
glycodeoxycholic,O,B
acid,O,I
(,O,O
GDOC,O,B
17,O,I
mmol,O,I
and,O,O
34,O,B
mmol,O,I
),O,O
.,O,O
Plectin,B,O
and,O,O
desmoplakin,B,O
have,O,O
GSR,O,B
-,O,I
containing,O,I
domains,O,I
at,O,O
their,O,O
C,O,O
-,O,O
termini,O,O
and,O,O
we,O,O
further,O,O
demonstrate,O,O
that,O,O
the,O,O
GSR,O,B
-,O,I
containing,O,I
domain,O,I
of,O,O
plectin,B,O
",",O,O
but,O,O
not,O,O
desmoplakin,B,O
",",O,O
can,O,O
bind,O,O
to,O,O
MTs,O,O
in,O,O
vivo,O,O
.,O,O
The,O,O
difficulties,O,O
to,O,O
analyse,O,O
prostaglandins,O,B
(,O,O
PG,O,B
),O,O
by,O,O
gas,O,O
-,O,O
liquid,O,O
chromatography,O,O
are,O,O
mainly,O,O
due,O,O
to,O,O
the,O,O
lack,O,O
of,O,O
sensitivity,O,O
of,O,O
the,O,O
gas,O,O
-,O,O
chromatograph,O,O
itself,O,O
(,O,O
higher,O,O
than,O,O
200,O,O
ng,O,O
),O,O
and,O,O
to,O,O
the,O,O
poor,O,O
resolution,O,O
of,O,O
the,O,O
packed,O,O
columns,O,O
.,O,O
Linear,O,O
regression,O,O
analysis,O,O
was,O,O
performed,O,O
and,O,O
the,O,O
following,O,O
result,O,O
was,O,O
obtained,O,O
:,O,O
clearance,O,O
(,O,O
HMPAO,O,O
),O,O
=,O,O
0,O,O
.,O,O
07,O,O
+,O,O
0,O,O
.,O,O
43,O,O
.,O,O
rCBF,O,O
with,O,O
a,O,O
high,O,O
significance,O,O
(,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
001,O,O
.,O,O
Two,O,O
new,O,O
artifacts,O,O
in,O,O
automated,O,O
coagulation,O,O
testing,O,O
.,O,O
The,O,O
small,O,O
copepod,O,O
Pseudonychocamptus,O,B
proximus,O,I
progressively,O,O
replaced,O,O
the,O,O
large,O,O
Tisbe,O,O
furcata,O,O
in,O,O
sand,O,O
filters,O,O
during,O,O
the,O,O
fall,O,O
of,O,O
1995,O,O
and,O,O
was,O,O
responsible,O,O
for,O,O
the,O,O
large,O,O
increase,O,O
in,O,O
meiofaunal,O,O
biomass,O,O
observed,O,O
after,O,O
spring,O,O
1996,O,O
.,O,O
In,O,O
the,O,O
BF,O,B
ECT,O,I
group,O,O
the,O,O
-,O,O
age,O,O
based,O,O
dose,O,O
would,O,O
have,O,O
been,O,O
similarly,O,O
dependent,O,O
on,O,O
the,O,O
initial,O,O
seizure,O,O
threshold,O,O
level,O,O
.,O,O
Interaction,O,O
of,O,O
HRI,B,B
with,O,O
Hsc70,B,B
was,O,O
required,O,O
for,O,O
the,O,O
transformation,O,O
of,O,O
HRI,B,B
",",O,O
as,O,O
the,O,O
Hsc70,B,B
antagonist,O,O
clofibric,O,O
acid,O,O
inhibited,O,O
the,O,O
folding,O,O
of,O,O
HRI,B,B
into,O,O
a,O,O
mature,O,O
-,O,O
competent,O,O
conformation,O,O
.,O,O
Fifteen,O,O
light,O,O
for,O,O
dates,O,O
infants,O,O
and,O,O
their,O,O
placentae,O,O
were,O,O
compared,O,O
to,O,O
15,O,O
well,O,O
-,O,O
grown,O,O
infants,O,O
and,O,O
their,O,O
placentae,O,O
.,O,O
Evidence,O,O
from,O,O
the,O,O
structure,O,O
of,O,O
a,O,O
number,O,O
of,O,O
cDNA,O,O
clones,O,O
",",O,O
as,O,O
well,O,O
as,O,O
S1,B,O
nuclease,I,O
and,O,O
primer,O,O
extension,O,O
studies,O,O
supports,O,O
the,O,O
hypothesis,O,O
that,O,O
the,O,O
gene,I,O
contains,O,O
at,O,O
least,O,O
two,O,O
mRNA,O,O
transcription,O,O
start,O,O
points,O,O
that,O,O
define,O,O
two,O,O
putative,O,O
regulatory,O,O
domains,O,O
.,O,O
The,O,O
proteasome,O,B
is,O,O
a,O,O
large,O,O
complex,O,O
consisting,O,O
of,O,O
two,O,O
multisubunit,O,O
structures,O,O
",",O,O
the,O,O
20S,B,B
and,O,O
19S,B,B
(,O,O
PA700,B,B
),O,O
or,O,O
P28,B,B
complexes,I,O
",",O,O
that,O,O
combine,O,O
to,O,O
form,O,O
the,O,O
26S,B,B
particles,I,O
.,O,O
Current,O,O
status,O,O
of,O,O
chemotherapy,O,O
for,O,O
Hodgkin,O,B
',O,O
s,O,O
disease,O,O
Behavioural,O,O
tests,O,O
with,O,O
192,O,O
specimen,O,O
of,O,O
the,O,O
roman,O,O
garden,O,O
snail,O,O
Helix,O,B
pomatia,O,I
L,O,I
.,O,O
were,O,O
performed,O,O
in,O,O
order,O,O
to,O,O
clarify,O,O
whether,O,O
the,O,O
thermopreferendum,O,O
of,O,O
this,O,O
pulmonate,O,O
is,O,O
influenced,O,O
not,O,O
only,O,O
by,O,O
the,O,O
temperature,O,O
of,O,O
the,O,O
substratum,O,O
but,O,O
also,O,O
by,O,O
air,O,O
temperature,O,O
.,O,O
The,O,O
performance,O,O
of,O,O
pH,O,O
-,O,O
sensitive,O,O
particles,O,O
is,O,O
attributed,O,O
to,O,O
their,O,O
ability,O,O
to,O,O
release,O,O
the,O,O
drug,O,O
selectively,O,O
in,O,O
the,O,O
upper,O,O
part,O,O
of,O,O
the,O,O
intestine,O,O
in,O,O
a,O,O
molecular,O,O
or,O,O
amorphous,O,O
form,O,O
.,O,O
In,O,O
the,O,O
present,O,O
study,O,O
we,O,O
demonstrated,O,O
a,O,O
unique,O,O
mechanism,O,O
of,O,O
action,O,O
of,O,O
8,O,O
-,O,O
Cl,O,B
-,O,I
cAMP,O,I
in,O,O
the,O,O
regulation,O,O
of,O,O
these,O,O
kinase,O,O
isozymes,O,O
in,O,O
HL,O,B
-,O,I
60,O,I
human,O,O
promyelocytic,O,O
leukemia,O,O
cells,O,O
.,O,O
Thus,O,O
",",O,O
we,O,O
have,O,O
separated,O,O
the,O,O
signal,O,O
function,O,O
from,O,O
the,O,O
anchor,O,O
function,O,O
of,O,O
the,O,O
6,O,O
.,O,O
7K,O,B
SA,O,I
domain,O,I
.,O,O
The,O,O
SSB,B,O
-,O,O
poly,O,O
(,O,O
dT,O,O
),O,O
affinity,O,O
is,O,O
too,O,O
high,O,O
to,O,O
measure,O,O
in,O,O
buffers,O,O
containing,O,O
even,O,O
5,O,O
M,O,O
NaCl,O,O
;,O,O
however,O,O
",",O,O
in,O,O
1,O,O
.,O,O
8,O,O
-,O,O
2,O,O
.,O,O
5,O,O
M,O,O
NaBr,O,O
",",O,O
we,O,O
measure,O,O
alpha,O,O
log,O,O
Kobsd,O,O
/,O,O
alpha,O,O
log,O,O
[,O,O
NaBr,O,O
],O,O
=,O,O
-,O,O
5,O,O
.,O,O
7,O,O
+,O,O
/,O,O
-,O,O
0,O,O
.,O,O
7,O,O
",",O,O
with,O,O
a,O,O
lower,O,O
value,O,O
of,O,O
omega,O,O
T,O,O
/,O,O
O,O,O
=,O,O
130,O,O
+,O,O
/,O,O
-,O,O
70,O,O
.,O,O
Topics,O,O
reviewed,O,O
here,O,O
include,O,O
:,O,O
data,O,O
supporting,O,O
the,O,O
association,O,O
of,O,O
myositis,O,B
with,O,O
cancer,O,O
and,O,O
the,O,O
appropriate,O,O
evaluations,O,O
for,O,O
malignancy,O,O
in,O,O
a,O,O
myositis,O,B
patient,O,O
;,O,O
an,O,O
approach,O,O
to,O,O
the,O,O
assessment,O,O
of,O,O
patients,O,O
with,O,O
dermatomyositis,O,B
sine,O,I
myositis,O,I
;,O,O
the,O,O
usefulness,O,O
of,O,O
the,O,O
clinicopathological,O,O
and,O,O
serological,O,O
classifications,O,O
;,O,O
a,O,O
discussion,O,O
of,O,O
whether,O,O
childhood,O,O
and,O,O
adult,O,O
myositis,O,B
are,O,O
the,O,O
same,O,O
or,O,O
different,O,O
entities,O,O
;,O,O
a,O,O
review,O,O
of,O,O
those,O,O
prognostic,O,O
factors,O,O
to,O,O
consider,O,O
in,O,O
the,O,O
clinical,O,O
management,O,O
of,O,O
myositis,O,B
patients,O,O
;,O,O
current,O,O
approaches,O,O
and,O,O
their,O,O
limitations,O,O
for,O,O
assessing,O,O
disease,O,O
activity,O,O
and,O,O
damage,O,O
.,O,O
Two,O,O
classes,O,O
of,O,O
inactive,O,O
receptors,O,O
were,O,O
identified,O,O
:,O,O
one,O,O
in,O,O
which,O,O
both,O,O
transcriptional,O,O
activation,O,O
and,O,O
dimerization,O,O
were,O,O
compromised,O,O
and,O,O
a,O,O
second,O,O
in,O,O
which,O,O
only,O,O
transcriptional,O,O
activation,O,O
was,O,O
abolished,O,O
.,O,O
Man,O,O
and,O,O
insect,O,O
",",O,O
past,O,O
",",O,O
present,O,O
",",O,O
future,O,O
Agonist,O,O
-,O,O
induced,O,O
receptor,O,O
internalization,O,O
",",O,O
determined,O,O
as,O,O
the,O,O
percent,O,O
of,O,O
total,O,O
[,O,O
125I,O,B
],O,O
Tyr0,B,I
-,I,I
oCRF,I,I
bound,O,O
located,O,O
in,O,O
the,O,O
acid,O,O
-,O,O
resistant,O,O
fraction,O,O
of,O,O
transfected,O,O
Cos,O,O
7,O,O
cells,O,O
",",O,O
increased,O,O
with,O,O
time,O,O
(,O,O
0,O,O
-,O,O
60,O,O
min,O,O
at,O,O
37,O,O
degrees,O,O
C,O,O
),O,O
for,O,O
both,O,O
wild,O,O
-,O,O
type,O,O
and,O,O
variant,O,O
oCRF1,B,B
.,O,O
All,O,O
of,O,O
the,O,O
indigo,O,B
-,O,I
producing,O,I
bacteria,O,O
had,O,O
an,O,O
indoxyl,B,B
phosphatase,I,O
with,O,O
a,O,O
pI,O,O
of,O,O
6,O,O
.,O,O
4,O,O
.,O,O
Toward,O,O
this,O,O
end,O,O
",",O,O
we,O,O
prepared,O,O
synthetic,O,O
proteins,O,O
with,O,O
either,O,O
the,O,O
catalytic,O,O
domain,O,O
of,O,O
FAP,B,B
-,I,I
1,I,I
(,I,O
C,I,O
-,I,O
terminal,I,O
399,I,O
amino,I,O
acids,I,O
),I,O
or,O,O
its,O,O
inactive,O,O
form,O,O
(,O,O
Cys2408,O,B
-,O,I
-,O,I
>,O,O
Ser,O,B
),O,O
fused,O,O
to,O,O
glutathione,B,O
-,I,O
S,I,O
-,I,O
transferase,I,O
(,O,O
GST,B,B
),O,O
.,O,O
TGF,B,B
beta,I,I
1,I,I
expression,O,O
is,O,O
largely,O,O
governed,O,O
by,O,O
three,O,O
AP,B,O
-,I,O
1,I,O
binding,I,O
sites,I,O
located,O,O
in,O,O
two,O,O
different,O,O
promoters,O,O
of,O,O
this,O,O
gene,O,O
.,O,O
Structure,O,O
and,O,O
expression,O,O
of,O,O
the,O,O
alternative,O,O
sigma,B,O
factor,I,O
",",O,O
RpoN,B,B
",",O,O
in,O,O
Rhodobacter,O,O
capsulatus,O,O
;,O,O
physiological,O,O
relevance,O,O
of,O,O
an,O,O
autoactivated,O,O
nifU2,B,B
-,O,I
rpoN,B,I
superoperon,O,I
.,O,O
It,O,O
could,O,O
be,O,O
detected,O,O
exclusively,O,O
in,O,O
the,O,O
culture,O,O
medium,O,O
of,O,O
cDNA,O,O
-,O,O
transfected,O,O
COS,O,O
cells,O,O
.,O,O
Here,O,O
we,O,O
focused,O,O
on,O,O
the,O,O
role,O,O
of,O,O
the,O,O
5,O,O
',O,O
proximal,O,O
regulatory,O,O
cassette,O,O
(,O,O
-,O,O
190,O,O
;,O,O
+,O,O
53,O,O
bp,O,O
),O,O
of,O,O
the,O,O
rat,B,B
enkephalin,I,I
(,O,O
rENK,B,B
),O,O
gene,O,O
in,O,O
the,O,O
developmental,O,O
regulation,O,O
of,O,O
the,O,O
enkephalin,B,B
phenotype,O,O
.,O,O
The,O,O
observed,O,O
triplexes,O,O
depend,O,O
on,O,O
the,O,O
length,O,O
of,O,O
the,O,O
repeat,O,O
.,O,O
Artificial,O,O
ventilation,O,O
was,O,O
conducted,O,O
using,O,O
a,O,O
tidal,O,O
volume,O,O
of,O,O
10,O,O
ml,O,O
X,O,O
kg,O,O
-,O,O
1,O,O
and,O,O
a,O,O
rate,O,O
of,O,O
10,O,O
to,O,O
12,O,O
c,O,O
X,O,O
min,O,O
-,O,O
1,O,O
.,O,O
Accumulations,O,O
of,O,O
Tl,O,B
+,O,I
1,O,I
(,O,O
202Tl,O,B
label,O,O
),O,O
were,O,O
6,O,O
times,O,O
those,O,O
for,O,O
Ga,O,B
or,O,O
In,O,B
in,O,O
the,O,O
brain,O,O
and,O,O
muscles,O,O
",",O,O
and,O,O
.,O,O
1,O,O
times,O,O
in,O,O
plasma,O,O
.,O,O
The,O,O
transcription,O,O
factor,O,O
Jun,B,B
(,O,O
c,B,I
-,I,I
Jun,I,I
),O,O
functions,O,O
as,O,O
a,O,O
recipient,O,O
of,O,O
extracellular,O,O
growth,O,O
signals,O,O
and,O,O
converts,O,O
them,O,O
into,O,O
patterns,O,O
of,O,O
gene,O,O
expression,O,O
.,O,O
This,O,O
paper,O,O
describes,O,O
the,O,O
results,O,O
of,O,O
an,O,O
initial,O,O
study,O,O
on,O,O
the,O,O
application,O,O
of,O,O
linear,O,O
solvation,O,O
energy,O,O
relationships,O,O
(,O,O
LSERs,O,B
),O,O
to,O,O
the,O,O
prediction,O,O
of,O,O
internal,O,O
standard,O,O
compounds,O,O
in,O,O
reversed,O,O
-,O,O
phase,O,O
liquid,O,O
chromatographic,O,O
(,O,O
RPLC,O,O
),O,O
method,O,O
development,O,O
.,O,O
Phd,B,O
antibody,O,O
-,O,O
immunoreactive,O,O
peptides,O,O
are,O,O
seen,O,O
in,O,O
light,O,O
-,O,O
adapted,O,O
mouse,O,O
retinal,O,O
cytosolic,O,O
and,O,O
nuclear,O,O
extracts,O,O
.,O,O
The,O,O
biochemistry,O,O
of,O,O
amniotic,O,O
fluid,O,O
with,O,O
poor,O,O
fetal,O,O
growth,O,O
.,O,O
We,O,O
obtained,O,O
the,O,O
prevalence,O,O
of,O,O
IgG,B,B
antibodies,I,O
against,O,O
Trypanosoma,O,B
cruzi,O,I
among,O,O
1076,O,O
blood,O,O
donors,O,O
at,O,O
the,O,O
Instituto,O,O
Nacional,O,O
de,O,O
Cardiologia,O,O
in,O,O
Mexico,O,O
City,O,O
.,O,O
Using,O,O
immunochemical,O,O
co,O,O
-,O,O
precipitation,O,O
methods,O,O
",",O,O
we,O,O
also,O,O
found,O,O
that,O,O
the,O,O
two,O,O
proteins,O,O
are,O,O
bound,O,O
in,O,O
vivo,O,O
.,O,O
The,O,O
AD,O,O
components,O,O
were,O,O
markedly,O,O
more,O,O
dependent,O,O
on,O,O
the,O,O
affective,O,O
state,O,O
of,O,O
the,O,O
rat,O,O
then,O,O
was,O,O
the,O,O
V1,O,O
component,O,O
.,O,O
Specific,O,O
binding,O,O
was,O,O
not,O,O
observed,O,O
with,O,O
either,O,O
the,O,O
orthologous,O,O
rat,O,O
or,O,O
mouse,O,O
fragments,O,O
using,O,O
human,O,B
or,O,O
rodent,O,O
extracts,O,O
.,O,O
Effects,O,O
of,O,O
aerosol,O,O
-,O,O
vapor,O,O
JP,O,B
-,O,I
8,O,I
jet,O,O
fuel,O,O
on,O,O
the,O,O
functional,O,O
observational,O,O
battery,O,O
",",O,O
and,O,O
learning,O,O
and,O,O
memory,O,O
in,O,O
the,O,O
rat,O,O
.,O,O
Our,O,O
observations,O,O
suggest,O,O
that,O,O
members,O,O
of,O,O
the,O,O
HMG,B,B
-,I,I
I,I,I
family,I,O
play,O,O
an,O,O
important,O,O
role,O,O
in,O,O
SRF,B,O
-,O,O
dependent,O,O
transcription,O,O
and,O,O
that,O,O
their,O,O
effect,O,O
is,O,O
mediated,O,O
primarily,O,O
by,O,O
a,O,O
protein,O,O
-,O,O
protein,O,O
interaction,O,O
.,O,O
Expression,O,O
of,O,O
the,O,O
dibasic,O,O
proprotein,O,O
processing,O,O
enzyme,O,O
furin,B,B
is,O,O
directed,O,O
by,O,O
multiple,O,O
promoters,O,O
.,O,O
John,O,O
leonard,O,O
dawson,O,O
Ligand,O,O
-,O,O
independent,O,O
activation,O,O
of,O,O
platelet,B,O
-,I,O
derived,I,O
growth,I,O
factor,I,O
receptor,I,O
is,O,O
a,O,O
necessary,O,O
intermediate,O,O
in,O,O
lysophosphatidic,O,O
",",O,O
acid,O,O
-,O,O
stimulated,O,O
mitogenic,O,O
activity,O,O
in,O,O
L,O,O
cells,O,O
.,O,O
A,O,O
suspected,O,O
hypothalamic,O,O
dysfunction,O,O
and,O,O
a,O,O
slightly,O,O
impaired,O,O
pituitary,O,O
function,O,O
manifested,O,O
as,O,O
GH,B,B
deficiency,O,O
were,O,O
their,O,O
common,O,O
endocrinological,O,O
features,O,O
.,O,O
The,O,O
NarX,B,B
and,O,O
NarQ,B,B
proteins,I,O
with,O,O
amino,O,O
acid,O,O
substitutions,O,O
at,O,O
the,O,O
first,O,O
conserved,O,O
histidine,O,O
position,O,O
were,O,O
also,O,O
unable,O,O
to,O,O
dephosphorylate,O,O
NarL,B,B
-,O,I
phosphate,O,I
in,O,O
vitro,O,O
.,O,O
There,O,O
was,O,O
a,O,O
significant,O,O
correlation,O,O
between,O,O
tubular,O,O
diameter,O,O
and,O,O
spg,O,O
(,O,O
r,O,O
=,O,O
0,O,O
.,O,O
68,O,O
",",O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
001,O,O
),O,O
suggesting,O,O
that,O,O
tubular,O,O
diameter,O,O
measurements,O,O
in,O,O
histological,O,O
sections,O,O
could,O,O
be,O,O
used,O,O
to,O,O
predict,O,O
sperm,O,O
production,O,O
.,O,O
Using,O,O
immunogold,O,O
electron,O,O
microscopy,O,O
",",O,O
we,O,O
found,O,O
that,O,O
p58,B,B
/,O,O
p45,B,B
and,O,O
p54,B,B
are,O,O
localized,O,O
on,O,O
both,O,O
sides,O,O
of,O,O
the,O,O
nuclear,O,O
pore,O,O
complex,O,O
",",O,O
like,O,O
p62,B,B
.,O,O
[,O,O
Treatment,O,O
of,O,O
early,O,O
T1,O,O
small,O,O
T2N,O,O
breast,O,O
cancers,O,O
.,O,O
The,O,O
development,O,O
of,O,O
a,O,O
data,O,O
base,O,O
is,O,O
described,O,O
which,O,O
can,O,O
be,O,O
used,O,O
as,O,O
common,O,O
reference,O,O
for,O,O
ECG,O,O
computer,O,O
programs,O,O
analyzing,O,O
12,O,O
or,O,O
15,O,O
simultaneously,O,O
recorded,O,O
leads,O,O
.,O,O
Our,O,O
results,O,O
indicate,O,O
that,O,O
the,O,O
minimal,O,O
requirements,O,O
for,O,O
induction,O,O
of,O,O
PEPCK,B,B
by,O,O
PKA,B,B
and,O,O
inhibition,O,O
by,O,O
insulin,B,O
include,O,O
:,O,O
1,O,O
),O,O
the,O,O
CREB,B,B
activation,I,O
domain,I,O
",",O,O
2,O,O
),O,O
the,O,O
PEPCK,B,B
TATA,I,I
sequence,I,I
",",O,O
and,O,O
3,O,O
),O,O
insulin,B,O
-,O,O
responsive,O,O
hepatoma,O,O
cells,O,O
.,O,O
Regulation,O,O
of,O,O
Gax,B,B
homeobox,B,I
gene,I,I
transcription,O,O
by,O,O
a,O,O
combination,O,O
of,O,O
positive,O,O
factors,O,O
including,O,O
myocyte,B,O
-,I,O
specific,I,O
enhancer,I,O
factor,I,O
2,I,O
.,O,O
At,O,O
the,O,O
very,O,O
high,O,O
dose,O,O
levels,O,O
used,O,O
",",O,O
sodium,O,B
saccharin,O,I
and,O,O
sodium,O,B
cyclamate,O,I
were,O,O
weak,O,O
solitary,O,O
carcinogens,O,O
producing,O,O
4,O,O
/,O,O
253,O,O
and,O,O
3,O,O
/,O,O
228,O,O
bladder,O,O
tumours,O,O
respectively,O,O
",",O,O
and,O,O
the,O,O
first,O,O
of,O,O
these,O,O
tumours,O,O
did,O,O
not,O,O
appear,O,O
for,O,O
more,O,O
than,O,O
80,O,O
weeks,O,O
.,O,O
Upon,O,O
differentiation,O,O
with,O,O
retinoic,O,O
acid,O,O
(,O,O
RA,O,B
),O,O
",",O,O
transcription,O,O
of,O,O
the,O,O
Rex,B,B
-,I,I
1,I,I
gene,I,O
decreases,O,O
rapidly,O,O
.,O,O
A,O,O
significant,O,O
relationship,O,O
existed,O,O
during,O,O
the,O,O
evolution,O,O
of,O,O
the,O,O
disease,O,O
between,O,O
CRS,O,O
/,O,O
BW,O,O
and,O,O
gas,O,O
exchange,O,O
parameters,O,O
(,O,O
FIO2,O,O
and,O,O
a,O,O
/,O,O
AO2,O,O
ratio,O,O
),O,O
(,O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
01,O,O
),O,O
",",O,O
but,O,O
gas,O,O
exchange,O,O
improved,O,O
earlier,O,O
than,O,O
lung,O,O
mechanics,O,O
.,O,O
The,O,O
experiment,O,O
results,O,O
showed,O,O
:,O,O
(,O,O
i,O,O
),O,O
not,O,O
only,O,O
1O2,O,O
",",O,O
but,O,O
also,O,O
free,O,O
radicals,O,O
(,O,O
O2,O,B
-,O,I
.,O,O
.,O,O
OH,O,O
and,O,O
YHPD,O,B
-,O,I
.,O,O
),O,O
can,O,O
be,O,O
formed,O,O
by,O,O
the,O,O
aid,O,O
of,O,O
YHPD,O,B
;,O,O
and,O,O
(,O,O
ii,O,O
),O,O
as,O,O
to,O,O
the,O,O
ability,O,O
of,O,O
producing,O,O
1O2,O,O
",",O,O
YHPD,O,B
less,O,O
than,O,O
BHPD,O,O
",",O,O
while,O,O
for,O,O
generating,O,O
O2,O,O
-,O,O
.,O,O
and,O,O
.,O,O
OH,O,O
",",O,O
YHPD,O,B
greater,O,O
than,O,O
BHPD,O,O
.,O,O
Critical,O,O
evaluation,O,O
of,O,O
various,O,O
methods,O,O
of,O,O
determining,O,O
markers,O,O
of,O,O
fetal,O,O
maturity,O,O
in,O,O
amniotic,O,O
fluid,O,O
Mitochondrial,B,O
Mas70p,I,O
signal,I,O
anchor,I,O
sequence,I,O
.,O,O
To,O,O
get,O,O
further,O,O
insights,O,O
into,O,O
the,O,O
molecular,O,O
mechanisms,O,O
that,O,O
control,O,O
tal,B,B
-,I,I
1,I,I
expression,O,O
",",O,O
we,O,O
have,O,O
isolated,O,O
5,O,O
',O,O
sequences,O,O
of,O,O
the,O,O
murine,O,B
gene,O,O
and,O,O
compared,O,O
them,O,O
to,O,O
their,O,O
human,O,B
counterparts,O,O
.,O,O
Although,O,O
the,O,O
Src,B,B
tyrosine,I,O
kinase,I,O
induces,O,O
constitutive,O,O
Stat3,B,B
phosphorylation,O,O
on,O,O
tyrosine,O,O
",",O,O
activation,O,O
of,O,O
Stat3,B,B
-,O,I
mediated,O,I
gene,O,O
regulation,O,O
requires,O,O
both,O,O
tyrosine,O,O
and,O,O
serine,O,O
phosphorylation,O,O
of,O,O
Stat3,B,B
.,O,O
Using,O,O
appropriate,O,O
synthetic,O,O
HSE,O,B
oligonucleotides,O,O
",",O,O
three,O,O
types,O,O
of,O,O
clones,O,O
with,O,O
potential,O,O
HSE,O,B
binding,O,I
domains,O,I
were,O,O
isolated,O,O
from,O,O
a,O,O
tomato,O,O
lambda,O,O
gt11,O,O
expression,O,O
library,O,O
by,O,O
DNA,O,O
-,O,O
ligand,O,O
screening,O,O
.,O,O
The,O,O
corresponding,O,O
orifice,O,O
voltages,O,O
for,O,O
the,O,O
three,O,O
instruments,O,O
were,O,O
20,O,O
/,O,O
50,O,O
/,O,O
80,O,O
V,O,O
(,O,O
API,O,O
365,O,O
),O,O
",",O,O
30,O,O
/,O,O
90,O,O
/,O,O
130,O,O
V,O,O
(,O,O
API,O,O
2000,O,O
),O,O
and,O,O
40,O,O
/,O,O
80,O,O
/,O,O
120,O,O
V,O,O
(,O,O
API,O,O
3000,O,O
),O,O
.,O,O
Transcriptional,O,O
regulation,O,O
of,O,O
the,O,O
mouse,B,B
cytosolic,I,I
chaperonin,I,I
subunit,I,I
gene,I,I
Ccta,B,B
/,I,I
t,I,I
-,I,I
complex,I,I
polypeptide,I,I
1,I,I
by,O,O
selenocysteine,B,O
tRNA,I,O
gene,I,O
transcription,I,O
activating,I,O
factor,I,O
family,I,O
zinc,I,O
finger,I,O
proteins,I,O
.,O,O
The,O,O
recognition,O,O
specificity,O,O
of,O,O
the,O,O
p55,B,O
PDZ,B,O
domain,I,O
appears,O,O
to,O,O
be,O,O
unique,O,O
",",O,O
since,O,O
the,O,O
three,O,O
PDZ,B,O
domains,I,O
of,O,O
hDlg,B,O
(,O,O
human,O,B
lymphocyte,O,I
homologue,O,I
of,O,I
the,O,I
Drosophila,B,I
discs,I,I
large,I,I
tumor,I,I
suppressor,I,I
),O,O
do,O,O
not,O,O
bind,O,O
the,O,O
cytoplasmic,O,O
domain,O,O
of,O,O
glycophorin,B,B
C,I,I
.,O,O
A,O,O
synthetic,O,O
oligonucleotide,O,O
containing,O,O
the,O,O
SRE,O,B
sequence,O,O
from,O,O
the,O,O
mouse,B,B
c,I,I
-,I,I
fos,I,I
gene,I,I
promoter,I,O
(,O,O
-,O,O
299,O,O
to,O,O
-,O,O
322,O,O
),O,O
was,O,O
radioactively,O,O
labeled,O,O
",",O,O
used,O,O
as,O,O
a,O,O
probe,O,O
for,O,O
the,O,O
mobility,O,O
shift,O,O
assay,O,O
and,O,O
Southwestern,O,O
(,O,O
DNA,O,O
-,O,O
protein,O,O
),O,O
blotting,O,O
",",O,O
and,O,O
also,O,O
used,O,O
for,O,O
sequence,O,O
-,O,O
specific,O,O
affinity,O,O
chromatography,O,O
.,O,O
Buflomedil,O,O
(,O,O
i,O,B
.,O,O
v,O,O
.,O,O
),O,O
induced,O,O
a,O,O
dose,O,O
-,O,O
dependent,O,O
increase,O,O
of,O,O
cardiac,O,O
output,O,O
at,O,O
0,O,O
.,O,O
16,O,O
-,O,O
0,O,O
.,O,O
64,O,O
mg,O,O
/,O,O
kg,O,O
",",O,O
biphasic,O,O
changes,O,O
at,O,O
1,O,O
.,O,O
28,O,O
and,O,O
2,O,O
.,O,O
56,O,O
mg,O,O
/,O,O
kg,O,O
and,O,O
a,O,O
marked,O,O
decrease,O,O
and,O,O
subsequent,O,O
slight,O,O
increase,O,O
at,O,O
a,O,O
large,O,O
dose,O,O
of,O,O
5,O,O
.,O,O
12,O,O
mg,O,O
/,O,O
kg,O,O
.,O,O
Hence,O,O
",",O,O
the,O,O
replacement,O,O
of,O,O
Phe,O,B
-,O,I
62,O,I
with,O,O
Ser,O,B
specifically,O,O
affects,O,O
a,O,O
determinant,O,O
on,O,O
the,O,O
lambda,B,O
I,I,O
light,I,O
chain,I,O
that,O,O
is,O,O
necessary,O,O
for,O,O
the,O,O
intracellular,O,O
transport,O,O
of,O,O
this,O,O
molecule,O,O
.,O,O
Cytosolic,B,O
acetyl,I,B
-,I,I
CoA,I,I
synthetase,I,I
(,O,O
AceCS1,B,B
),O,O
activates,O,O
acetate,O,O
to,O,O
supply,O,O
the,O,O
cells,O,O
with,O,O
acetyl,O,B
-,O,I
CoA,O,I
for,O,O
lipid,O,O
synthesis,O,O
.,O,O
Domain,O,O
II,O,O
is,O,O
highly,O,O
homologous,O,O
to,O,O
the,O,O
LDL,B,B
receptor,I,I
and,O,O
contains,O,O
four,O,O
repeats,O,O
with,O,O
perfect,O,O
conservation,O,O
of,O,O
all,O,O
6,O,O
consecutive,O,O
cysteines,O,O
.,O,O
Microcirculatory,O,O
oxygenation,O,O
and,O,O
shunting,O,O
in,O,O
sepsis,O,O
and,O,O
shock,O,O
.,O,O
The,O,O
Sarns,O,B
51F,O,I
cavoatrial,O,O
cannula,O,O
decompressed,O,O
the,O,O
venous,O,O
system,O,O
as,O,O
efficiently,O,O
as,O,O
the,O,O
double,O,O
caval,O,O
cannulas,O,O
.,O,O
However,O,O
",",O,O
no,O,O
genetic,O,O
alteration,O,O
was,O,O
detected,O,O
in,O,O
any,O,O
of,O,O
the,O,O
cancers,O,O
examined,O,O
.,O,O
Delayed,O,O
mortality,O,O
of,O,O
mice,O,O
following,O,O
inhalation,O,O
of,O,O
acute,O,O
doses,O,O
of,O,O
CH2O,O,B
",",O,O
SO2Cl2,O,B
",",O,O
and,O,O
Br2,O,B
.,O,O
Experimental,O,O
chlorpromazine,O,O
cataracts,O,O
.,O,O
Echo,O,O
modulation,O,O
in,O,O
Pr3,O,B
+,O,I
:,O,I
YAlO3,O,O
.,O,O
There,O,O
was,O,O
no,O,O
evidence,O,O
of,O,O
any,O,O
persistent,O,O
oscillation,O,O
within,O,O
the,O,O
ULF,O,O
band,O,O
.,O,O
Cephradine,O,O
250,O,O
mg,O,O
at,O,O
night,O,O
for,O,O
12,O,O
months,O,O
was,O,O
given,O,O
as,O,O
a,O,O
prophylactic,O,O
measure,O,O
to,O,O
33,O,O
female,O,O
patients,O,O
of,O,O
mean,O,O
age,O,O
41,O,O
.,O,O
6,O,O
years,O,O
",",O,O
who,O,O
had,O,O
a,O,O
history,O,O
in,O,O
the,O,O
preceding,O,O
12,O,O
months,O,O
of,O,O
between,O,O
three,O,O
and,O,O
24,O,O
(,O,O
median,O,O
=,O,O
7,O,O
),O,O
episodes,O,O
of,O,O
frequency,O,O
and,O,O
/,O,O
or,O,O
dysuria,O,O
.,O,O
The,O,O
Cdk2,B,B
-,O,I
cyclin,B,I
-,I,I
D1,I,I
complex,O,O
did,O,O
not,O,O
phosphorylate,O,O
any,O,O
tested,O,O
substrates,O,O
",",O,O
such,O,O
as,O,O
H1,B,O
histone,I,O
",",O,O
pRB,B,O
",",O,O
SV40,B,O
large,I,O
T,I,O
antigen,I,O
",",O,O
p53,B,O
",",O,O
E2F,B,O
-,I,O
1,I,O
or,O,O
a,O,O
preparation,O,O
of,O,O
nuclear,O,O
proteins,O,O
from,O,O
HeLa,O,O
cells,O,O
;,O,O
in,O,O
contrast,O,O
",",O,O
Cdk2,B,B
-,O,I
cyclin,B,I
-,I,I
E,I,I
and,O,O
Cdk2,B,B
-,O,I
cyclin,B,I
-,I,I
A,I,I
phosphorylated,O,O
these,O,O
proteins,O,O
.,O,O
However,O,O
",",O,O
other,O,O
regions,O,O
of,O,O
the,O,O
plasmid,O,O
are,O,O
also,O,O
efficiently,O,O
repaired,O,O
.,O,O
The,O,O
relatively,O,O
mild,O,O
defects,O,O
observed,O,O
in,O,O
Rpd3,B,B
mutants,I,O
suggest,O,O
that,O,O
the,O,O
recently,O,O
identified,O,O
Groucho,B,B
and,O,O
dCtBP,B,B
corepressor,I,O
proteins,I,O
do,O,O
not,O,O
function,O,O
solely,O,O
through,O,O
the,O,O
recruitment,O,O
of,O,O
histone,B,O
deacetylases,I,O
.,O,O
The,O,O
severity,O,O
of,O,O
clinical,O,O
course,O,O
was,O,O
expressed,O,O
by,O,O
means,O,O
of,O,O
SOFA,O,B
score,O,O
(,O,O
group,O,O
A,O,O
0,O,O
.,O,O
3,O,O
-,O,O
1,O,O
-,O,O
1,O,O
.,O,O
3,O,O
point,O,O
",",O,O
group,O,O
B,O,O
2,O,O
.,O,O
2,O,O
-,O,O
2,O,O
.,O,O
9,O,O
-,O,O
2,O,O
.,O,O
6,O,O
point,O,O
",",O,O
group,O,O
C,O,O
7,O,O
.,O,O
4,O,O
-,O,O
8,O,O
.,O,O
3,O,O
-,O,O
7,O,O
.,O,O
7,O,O
point,O,O
),O,O
and,O,O
APACHE,O,O
II,O,O
score,O,O
(,O,O
group,O,O
A,O,O
3,O,O
.,O,O
7,O,O
-,O,O
8,O,O
.,O,O
6,O,O
-,O,O
11,O,O
.,O,O
1,O,O
-,O,O
10,O,O
.,O,O
5,O,O
point,O,O
",",O,O
group,O,O
C,O,O
16,O,O
.,O,O
3,O,O
-,O,O
15,O,O
.,O,O
2,O,O
-,O,O
14,O,O
.,O,O
3,O,O
point,O,O
),O,O
.,O,O
A,O,O
mutant,O,O
(,O,O
residues,O,O
1,O,O
-,O,O
332,O,O
),O,O
showed,O,O
complete,O,O
Ca2,O,B
+,O,I
/,O,I
CaM,B,I
-,O,I
dependent,O,I
activity,O,O
.,O,O
The,O,O
PETCO2,O,O
measurement,O,O
during,O,O
precordial,O,O
compression,O,O
predicted,O,O
the,O,O
success,O,O
of,O,O
defibrillation,O,O
with,O,O
return,O,O
of,O,O
spontaneous,O,O
circulation,O,O
.,O,O
These,O,O
data,O,O
further,O,O
define,O,O
a,O,O
role,O,O
for,O,O
TRADD,B,B
and,O,O
TRAF2,B,B
in,O,O
JNK,B,B
activation,O,O
and,O,O
confirm,O,O
that,O,O
LMP1,B,B
utilizes,O,O
signalling,O,O
mechanisms,O,O
used,O,O
by,O,O
the,O,O
TNF,B,B
receptor,I,I
/,O,I
CD40,B,I
family,O,I
to,O,O
elicit,O,O
its,O,O
pleiotropic,O,O
activities,O,O
.,O,O
CONCLUSION,O,O
:,O,O
Our,O,O
study,O,O
shows,O,O
that,O,O
(,O,O
1,O,O
),O,O
total,O,O
body,O,O
BMD,O,O
and,O,O
femoral,O,O
neck,O,O
BMD,O,O
were,O,O
significantly,O,O
higher,O,O
in,O,O
the,O,O
study,O,O
group,O,O
that,O,O
performed,O,O
weight,O,O
-,O,O
bearing,O,O
exercises,O,O
than,O,O
in,O,O
control,O,O
subjects,O,O
",",O,O
(,O,O
2,O,O
),O,O
swimming,O,O
exercise,O,O
had,O,O
no,O,O
effect,O,O
on,O,O
BMD,O,O
",",O,O
and,O,O
(,O,O
3,O,O
),O,O
although,O,O
swimming,O,O
is,O,O
not,O,O
a,O,O
bone,O,O
-,O,O
building,O,O
exercise,O,O
",",O,O
it,O,O
can,O,O
significantly,O,O
improve,O,O
shoulder,O,O
",",O,O
back,O,O
",",O,O
and,O,O
grip,O,O
muscle,O,O
strength,O,O
.,O,O
After,O,O
base,O,O
-,O,O
line,O,O
CBF,O,O
was,O,O
established,O,O
",",O,O
hexamethonium,O,O
bromide,O,O
(,O,O
2,O,O
mg,O,O
/,O,O
kg,O,O
iv,O,O
),O,O
",",O,O
ipratropium,O,O
bromide,O,O
(,O,O
0,O,O
.,O,O
5,O,O
microgram,O,O
/,O,O
kg,O,O
iv,O,O
),O,O
",",O,O
indomethacin,O,O
(,O,O
2,O,O
mg,O,O
/,O,O
kg,O,O
iv,O,O
),O,O
",",O,O
or,O,O
intravenous,O,O
0,O,O
.,O,O
9,O,O
%,O,O
saline,O,O
was,O,O
administered,O,O
.,O,O
These,O,O
results,O,O
demonstrate,O,O
the,O,O
existence,O,O
of,O,O
different,O,O
PI,B,B
3,I,I
-,I,I
kinase,I,I
isoforms,I,O
and,O,O
define,O,O
a,O,O
family,O,O
of,O,O
genes,O,O
encoding,O,O
distinct,O,O
PI,B,B
3,I,I
-,I,I
kinase,I,I
catalytic,I,I
subunits,I,I
that,O,O
can,O,O
associate,O,O
with,O,O
p85,B,O
.,O,O
Xylose,O,O
-,O,O
and,O,O
arabinose,O,O
-,O,O
containing,O,O
polymers,O,O
were,O,O
better,O,O
digested,O,O
than,O,O
was,O,O
cellulose,O,O
for,O,O
both,O,O
breads,O,O
.,O,O
Cycles,O,O
were,O,O
repeated,O,O
every,O,O
3,O,O
weeks,O,O
.,O,O
The,O,O
immune,O,O
system,O,O
is,O,O
closely,O,O
integrated,O,O
with,O,O
the,O,O
neuroendocrine,O,O
system,O,O
",",O,O
and,O,O
infection,O,O
-,O,O
induced,O,O
increases,O,O
in,O,O
cytokines,O,O
such,O,O
as,O,O
IL,B,B
-,I,I
1,I,I
",",O,O
IL,B,B
-,I,I
6,I,I
and,O,O
TNF,B,B
have,O,O
numerous,O,O
effects,O,O
on,O,O
the,O,O
central,O,O
nervous,O,O
system,O,O
.,O,O
Thus,O,O
",",O,O
the,O,O
tri,O,O
-,O,O
snRNP,O,B
-,O,I
specific,O,I
27K,O,B
protein,O,I
could,O,O
potentially,O,O
be,O,O
involved,O,O
in,O,O
SR,B,O
protein,O,O
-,O,O
mediated,O,O
protein,O,O
/,O,O
protein,O,O
interactions,O,O
and,O,O
",",O,O
additionally,O,O
",",O,O
its,O,O
phosphorylation,O,O
state,O,O
could,O,O
modulate,O,O
pre,O,O
-,O,O
mRNA,O,O
splicing,O,O
.,O,O
Here,O,O
we,O,O
localize,O,O
a,O,O
transferable,O,O
40,O,O
-,O,O
amino,O,O
acid,O,O
region,O,O
within,O,O
the,O,O
LBDs,B,O
of,O,O
RXR,B,B
",",O,O
RAR,B,B
",",O,O
TR,B,B
",",O,O
and,O,O
chicken,B,O
ovalbumin,I,O
upstream,I,O
promoter,I,O
transcription,I,O
factor,I,O
that,O,O
is,O,O
critical,O,O
for,O,O
determining,O,O
identity,O,O
in,O,O
the,O,O
heterodimeric,O,O
interaction,O,O
and,O,O
for,O,O
high,O,O
-,O,O
affinity,O,O
DNA,O,O
binding,O,O
.,O,O
P,B,O
-,I,O
CIP1,I,B
",",O,O
a,O,O
novel,O,O
protein,O,O
that,O,O
interacts,O,O
with,O,O
the,O,O
cytosolic,O,O
domain,O,O
of,O,O
peptidylglycine,B,B
alpha,I,I
-,I,I
amidating,I,I
monooxygenase,I,I
",",O,O
is,O,O
associated,O,O
with,O,O
endosomes,O,O
.,O,O
Null,O,O
mutations,O,O
in,O,O
daf,B,B
-,I,I
3,I,I
suppress,O,O
mutations,O,O
in,O,O
genes,O,O
encoding,O,O
this,O,O
TGF,B,B
-,I,I
beta,I,I
signal,O,I
",",O,O
its,O,O
receptors,O,O
",",O,O
and,O,O
associated,O,O
Smad,B,B
signal,I,I
transduction,I,I
proteins,I,O
.,O,O
daf,B,O
-,I,O
3,I,O
encodes,O,O
a,O,O
Smad,B,B
protein,I,O
that,O,O
is,O,O
most,O,O
closely,O,O
related,O,O
to,O,O
mammalian,B,O
DPC4,I,B
",",O,O
and,O,O
is,O,O
expressed,O,O
throughout,O,O
development,O,O
in,O,O
many,O,O
of,O,O
the,O,O
tissues,O,O
that,O,O
are,O,O
remodeled,O,O
during,O,O
dauer,O,O
development,O,O
.,O,O
Specifically,O,O
",",O,O
this,O,O
study,O,O
determined,O,O
the,O,O
influence,O,O
of,O,O
:,O,O
(,O,O
1,O,O
),O,O
an,O,O
awareness,O,O
strategy,O,O
",",O,O
(,O,O
2,O,O
),O,O
a,O,O
non,O,O
-,O,O
awareness,O,O
strategy,O,O
",",O,O
(,O,O
3,O,O
),O,O
a,O,O
Five,O,O
-,O,O
Step,O,O
Approach,O,O
strategy,O,O
and,O,O
(,O,O
4,O,O
),O,O
a,O,O
control,O,O
condition,O,O
.,O,O
Mean,O,O
increase,O,O
of,O,O
milk,O,O
protein,O,B
yield,O,O
was,O,O
46,O,O
g,O,O
/,O,O
d,O,O
with,O,O
Met,O,B
plus,O,O
Lys,O,B
",",O,O
and,O,O
mean,O,O
increase,O,O
of,O,O
true,O,O
protein,O,B
content,O,O
was,O,O
1,O,O
.,O,O
1,O,O
g,O,O
/,O,O
kg,O,O
of,O,O
milk,O,O
.,O,O
Two,O,O
points,O,O
are,O,O
indicated,O,O
:,O,O
first,O,O
",",O,O
the,O,O
photosensitized,O,O
damage,O,O
of,O,O
YHPD,O,B
is,O,O
interrelated,O,O
to,O,O
not,O,O
only,O,O
1O2,O,O
",",O,O
but,O,O
also,O,O
free,O,O
radicals,O,O
(,O,O
O2,O,B
-,O,I
.,O,O
.,O,O
and,O,O
YHPD,O,B
-,O,I
.,O,O
),O,O
;,O,O
second,O,O
",",O,O
although,O,O
the,O,O
photosensitized,O,O
damage,O,O
of,O,O
YHPD,O,B
is,O,O
stronger,O,O
than,O,O
that,O,O
of,O,O
BHPD,O,O
",",O,O
yet,O,O
the,O,O
photosensitized,O,O
damage,O,O
is,O,O
negatively,O,O
correlated,O,O
to,O,O
the,O,O
yield,O,O
of,O,O
1O2,O,O
but,O,O
positively,O,O
correlated,O,O
to,O,O
those,O,O
of,O,O
O2,O,B
-,O,I
.,O,O
and,O,O
OH,O,O
.,O,O
Introductory,O,O
remarks,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
a,O,O
similar,O,O
fragment,O,O
lacking,O,O
the,O,O
38,O,O
-,O,O
base,O,O
-,O,O
pair,O,O
region,O,O
had,O,O
no,O,O
such,O,O
stabilizing,O,O
effect,O,O
.,O,O
Mutation,O,O
of,O,O
the,O,O
octamer,O,O
element,O,O
also,O,O
significantly,O,O
reduced,O,O
the,O,O
ability,O,O
of,O,O
HDAC1,B,O
to,O,O
confer,O,O
repression,O,O
of,O,O
inducible,O,O
HLA,B,B
-,I,I
DRA,I,I
promoter,I,O
activation,O,O
.,O,O
The,O,O
AtERF,B,B
genes,I,O
were,O,O
differentially,O,O
regulated,O,O
by,O,O
ethylene,O,O
and,O,O
by,O,O
abiotic,O,O
stress,O,O
conditions,O,O
",",O,O
such,O,O
as,O,O
wounding,O,O
",",O,O
cold,O,O
",",O,O
high,O,O
salinity,O,O
",",O,O
or,O,O
drought,O,O
",",O,O
via,O,O
ETHYLENE,B,B
-,I,I
INSENSITIVE2,I,I
(,O,O
EIN2,B,B
),O,O
-,O,O
dependent,O,O
or,O,O
-,O,O
independent,O,O
pathways,O,O
.,O,O
Effect,O,O
of,O,O
heparin,O,O
on,O,O
the,O,O
inactivation,O,O
of,O,O
serum,B,O
lipoprotein,I,O
lipase,I,O
by,O,O
the,O,O
liver,O,O
in,O,O
unanesthetized,O,O
dogs,O,O
.,O,O
Staphylococcus,O,B
aureus,O,I
and,O,O
CNS,O,B
showed,O,O
high,O,O
or,O,O
moderate,O,O
resistance,O,O
rates,O,O
to,O,O
methicillin,O,O
(,O,O
DMPPC,O,B
),O,O
.,O,O
The,O,O
prevalence,O,O
of,O,O
tobacco,O,O
dependence,O,O
diagnosed,O,O
according,O,O
to,O,O
the,O,O
ICD,O,O
-,O,O
10,O,O
criteria,O,O
was,O,O
higher,O,O
in,O,O
alcohol,O,O
-,O,O
dependent,O,O
individuals,O,O
(,O,O
58,O,O
.,O,O
1,O,O
%,O,O
),O,O
than,O,O
in,O,O
nondrinkers,O,O
or,O,O
social,O,O
drinkers,O,O
(,O,O
12,O,O
.,O,O
8,O,O
%,O,O
),O,O
.,O,O
Bacteriostatic,O,O
and,O,O
bacteriacidal,O,O
activity,O,O
of,O,O
hydroxy,O,O
-,O,O
9,O,O
ellipticine,O,O
in,O,O
vitro,O,O
In,O,O
vitro,O,O
interaction,O,O
studies,O,O
",",O,O
using,O,O
proteins,O,O
fused,O,O
to,O,O
glutathione,B,O
-,I,O
S,I,O
-,I,O
transferase,I,O
",",O,O
showed,O,O
that,O,O
RBP,B,B
-,I,I
J,I,I
kappa,I,I
and,O,O
Su,B,B
(,I,I
H,I,I
),I,I
bind,O,O
directly,O,O
to,O,O
the,O,O
RAM23,B,O
regions,I,O
of,O,O
mouse,B,O
Notch1,I,B
and,O,O
Drosophila,B,O
Notch,I,B
",",O,O
respectively,O,O
.,O,O
Therefore,O,O
",",O,O
we,O,O
conclude,O,O
that,O,O
DnaA,B,B
may,O,O
contact,O,O
the,O,O
beta,O,B
subunit,O,I
of,O,O
RNA,B,B
polymerase,I,I
during,O,O
activation,O,O
of,O,O
the,O,O
pR,B,O
promoter,I,O
.,O,O
Physiol,O,O
.,O,O
The,O,O
presence,O,O
of,O,O
truncated,O,O
receptor,O,O
isoforms,O,O
in,O,O
diverse,O,O
species,O,O
suggests,O,O
that,O,O
these,O,O
proteins,O,O
may,O,O
have,O,O
important,O,O
functional,O,O
roles,O,O
in,O,O
regulating,O,O
EGFR,B,B
activity,O,O
.,O,O
Naltrexone,O,B
has,O,O
been,O,O
recently,O,O
approved,O,O
by,O,O
the,O,O
Food,O,O
and,O,O
Drug,O,O
Administration,O,O
for,O,O
the,O,O
treatment,O,O
of,O,O
alcohol,O,O
dependence,O,O
.,O,O
It,O,O
is,O,O
present,O,O
in,O,O
the,O,O
nucleus,O,O
of,O,O
the,O,O
cells,O,O
in,O,O
which,O,O
it,O,O
is,O,O
expressed,O,O
and,O,O
can,O,O
phosphorylate,O,O
and,O,O
activate,O,O
the,O,O
cyclic,B,O
AMP,I,O
response,I,O
element,I,O
binding,I,O
proteins,I,O
CREB,B,B
and,O,O
CREM,B,B
tau,I,I
in,O,O
a,O,O
manner,O,O
analogous,O,O
to,O,O
protein,B,O
kinase,I,O
A,I,O
.,O,O
The,O,O
telomerase,B,B
RNA,I,I
-,I,I
protein,I,I
complex,I,I
responsible,O,O
for,O,O
maintenance,O,O
of,O,O
telomeric,O,O
DNA,O,O
at,O,O
chromosome,O,O
ends,O,O
",",O,O
is,O,O
usually,O,O
inactive,O,O
in,O,O
most,O,O
primary,O,O
somatic,O,O
human,O,B
cells,O,O
",",O,O
but,O,O
is,O,O
specifically,O,O
activated,O,O
with,O,O
in,O,O
vitro,O,O
immortalization,O,O
and,O,O
during,O,O
tumorigenesis,O,O
.,O,O
These,O,O
results,O,O
demonstrate,O,O
that,O,O
a,O,O
diverse,O,O
set,O,O
of,O,O
carboxyl,O,O
-,O,O
terminal,O,O
sequence,O,O
motifs,O,O
and,O,O
posttranslational,O,O
modifications,O,O
lead,O,O
to,O,O
functional,O,O
Ras,B,B
proteins,I,O
in,O,O
yeast,O,O
.,O,O
We,O,O
postulate,O,O
that,O,O
CaM,B,O
binding,O,O
by,O,O
HIV,B,O
envelope,I,O
proteins,I,O
is,O,O
likely,O,O
to,O,O
exert,O,O
diverse,O,O
modulatory,O,O
effects,O,O
",",O,O
and,O,O
the,O,O
mechanism,O,O
for,O,O
HIV,O,O
-,O,O
induced,O,O
cytotoxicity,O,O
may,O,O
involve,O,O
",",O,O
in,O,O
part,O,O
",",O,O
inhibition,O,O
of,O,O
CaM,B,O
-,O,O
regulated,O,O
cellular,O,O
functions,O,O
.,O,O
Further,O,O
",",O,O
Ser,O,B
/,O,O
Thr,O,B
phosphorylation,O,O
of,O,O
downstream,O,O
molecules,O,O
Akt,B,B
and,O,O
p70,B,B
S6,I,I
kinase,I,I
was,O,O
inhibited,O,O
.,O,O
An,O,O
approximately,O,O
2,B,O
-,I,O
kilobase,I,O
B2,I,B
transcript,I,O
was,O,O
expressed,O,O
in,O,O
all,O,O
alfalfa,O,O
organs,O,O
tested,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
expected,O,O
decreases,O,O
in,O,O
ATIC,B,B
enzymatic,O,O
function,O,O
in,O,O
ATIC,B,B
-,O,I
ALK,B,I
-,O,I
containing,O,I
lymphomas,O,O
may,O,O
render,O,O
these,O,O
tumors,O,O
more,O,O
sensitive,O,O
to,O,O
antifolate,O,O
drugs,O,O
such,O,O
as,O,O
methotrexate,O,O
.,O,O
We,O,O
conclude,O,O
that,O,O
c,B,O
-,I,O
Myb,I,B
regulates,O,O
the,O,O
RAG,B,B
-,I,I
2,I,I
promoter,I,O
in,O,O
T,O,O
cells,O,O
by,O,O
binding,O,O
to,O,O
this,O,O
consensus,B,O
c,I,O
-,I,O
Myb,I,B
binding,I,O
site,I,O
.,O,O
We,O,O
show,O,O
that,O,O
the,O,O
mouse,O,O
genome,O,O
contains,O,O
four,O,O
copies,O,O
of,O,O
the,O,O
ubc,B,B
-,I,I
9,I,I
gene,I,O
.,O,O
The,O,O
present,O,O
chemotherapy,O,O
of,O,O
AE,O,O
is,O,O
based,O,O
on,O,O
the,O,O
administration,O,O
of,O,O
benzimidazole,O,O
carbamate,O,O
derivatives,O,O
",",O,O
such,O,O
as,O,O
mebendazole,O,O
and,O,O
albendazole,O,O
.,O,O
Microscopic,O,O
anatomy,O,O
and,O,O
cell,O,O
population,O,O
dynamics,O,O
.,O,O
The,O,O
malate,B,O
synthase,I,O
gene,I,O
",",O,O
MLS1,B,B
",",O,O
of,O,O
the,O,O
yeast,O,O
Saccharomyces,O,B
cerevisiae,O,I
is,O,O
transcriptionally,O,O
regulated,O,O
by,O,O
the,O,O
carbon,O,O
source,O,O
in,O,O
the,O,O
growth,O,O
medium,O,O
.,O,O
IMPLICATIONS,O,O
:,O,O
Given,O,O
the,O,O
small,O,O
size,O,O
of,O,O
this,O,O
study,O,O
and,O,O
the,O,O
inconsistency,O,O
of,O,O
results,O,O
among,O,O
the,O,O
few,O,O
prospective,O,O
studies,O,O
of,O,O
ovarian,O,O
cancer,O,O
conducted,O,O
to,O,O
test,O,O
these,O,O
associations,O,O
",",O,O
replications,O,O
of,O,O
these,O,O
findings,O,O
are,O,O
highly,O,O
desirable,O,O
.,O,O
The,O,O
carboxyl,O,B
-,O,I
terminal,O,I
transactivation,O,I
domain,O,I
of,O,O
heat,B,B
shock,I,I
factor,I,I
1,I,I
is,O,O
negatively,O,O
regulated,O,O
and,O,O
stress,O,O
responsive,O,O
.,O,O
Ras,B,B
-,I,I
and,I,I
ultra,I,I
-,I,I
violet,I,I
-,I,I
responsive,I,I
protein,I,I
kinases,I,I
that,O,O
phosphorylate,O,O
c,B,B
-,I,I
Jun,I,I
on,O,O
serine,O,B
residues,O,I
at,O,O
positions,O,O
63,O,O
and,O,O
73,O,O
its,O,O
transcriptional,O,O
activity,O,O
have,O,O
been,O,O
identified,O,O
.,O,O
Amikacin,O,B
was,O,O
the,O,O
most,O,O
stable,O,O
and,O,O
tobramycin,O,B
was,O,O
the,O,O
least,O,O
stable,O,O
aminoglycoside,O,O
under,O,O
the,O,O
conditions,O,O
tested,O,O
.,O,O
Secretion,O,O
in,O,O
milk,O,O
and,O,O
transplacental,O,O
transfer,O,O
of,O,O
two,O,O
iodized,O,O
oils,O,O
",",O,O
Lipiodol,O,B
UF,O,I
and,O,O
Oriodol,O,B
",",O,O
in,O,O
rabbits,O,O
.,O,O
The,O,O
hBRAG,B,B
gene,I,O
was,O,O
localized,O,O
to,O,O
the,O,O
long,O,O
arm,O,O
of,O,O
chromosome,O,O
10,O,O
(,O,O
10q26,O,O
),O,O
.,O,O
MEASUREMENTS,O,O
AND,O,O
MAIN,O,O
RESULTS,O,O
:,O,O
Lung,O,O
elastance,O,O
(,O,O
EL,O,B
),O,O
and,O,O
resistance,O,O
(,O,O
RL,O,B
),O,O
were,O,O
calculated,O,O
from,O,O
measurements,O,O
of,O,O
airway,O,O
pressure,O,O
",",O,O
esophageal,O,O
pressure,O,O
",",O,O
and,O,O
airway,O,O
flow,O,O
in,O,O
five,O,O
anesthetized,O,O
",",O,O
paralyzed,O,O
dogs,O,O
during,O,O
sinusoidal,O,O
forcing,O,O
at,O,O
a,O,O
constant,O,O
mean,O,O
airway,O,O
pressure,O,O
of,O,O
10,O,O
cmH2O,O,O
in,O,O
a,O,O
wide,O,O
range,O,O
of,O,O
breathing,O,O
frequencies,O,O
(,O,O
0,O,O
.,O,O
2,O,O
to,O,O
1,O,O
.,O,O
0,O,O
Hz,O,O
in,O,O
intervals,O,O
of,O,O
0,O,O
.,O,O
2,O,O
volumes,O,O
(,O,O
50,O,O
",",O,O
100,O,O
",",O,O
200,O,O
",",O,O
and,O,O
to,O,O
300,O,O
mL,O,O
),O,O
.,O,O
Habituation,O,O
of,O,O
completely,O,O
isolated,O,O
neurons,O,O
of,O,O
the,O,O
edible,O,O
snail,O,O
to,O,O
electrical,O,O
stimulation,O,O
.,O,O
Additionally,O,O
",",O,O
MIP,B,B
-,I,I
2A,I,I
antagonizes,O,O
cell,O,O
growth,O,O
regulatory,O,O
role,O,O
of,O,O
MBP,B,B
-,I,I
1,I,I
.,O,O
The,O,O
average,O,O
deviations,O,O
in,O,O
the,O,O
X,O,O
-,O,O
ray,O,O
counts,O,O
of,O,O
the,O,O
constant,O,O
elements,O,O
from,O,O
the,O,O
series,O,O
means,O,O
were,O,O
used,O,O
to,O,O
correct,O,O
the,O,O
recorded,O,O
count,O,O
of,O,O
the,O,O
variable,O,O
element,O,O
in,O,O
each,O,O
block,O,O
.,O,O
At,O,O
temperatures,O,O
permissive,O,O
for,O,O
transformation,O,O
",",O,O
6m2,O,O
cells,O,O
contain,O,O
P58gag,B,B
produced,O,O
from,O,O
the,O,O
4,O,O
.,O,O
0,O,O
-,O,O
kilobase,O,O
(,O,O
kb,O,O
),O,O
viral,O,O
RNA,O,O
genome,O,O
and,O,O
P85gag,B,B
-,O,I
mos,B,I
translated,O,O
from,O,O
a,O,O
3,O,O
.,O,O
5,O,O
-,O,O
kb,O,O
spliced,O,O
mRNA,O,O
.,O,O
ENV,B,B
also,O,O
was,O,O
secreted,O,O
from,O,O
P,O,O
.,O,O
pastoris,O,O
using,O,O
the,O,O
S,B,O
.,I,O
cerevisiae,I,O
alpha,I,O
-,I,O
factor,I,O
prepro,I,O
secretion,I,O
leader,I,O
and,O,O
the,O,O
S,B,O
.,I,O
cerevisiae,I,B
invertase,I,O
signal,I,O
sequence,I,O
.,O,O
Functional,O,O
rearranged,O,O
antibody,O,O
genes,O,O
were,O,O
detected,O,O
with,O,O
JH,B,B
and,O,O
VH,B,B
heavy,I,O
chain,I,O
probes,O,O
and,O,O
with,O,O
Jk,B,B
and,O,O
Vk,B,B
light,I,O
chain,I,O
probes,O,O
.,O,O
Differential,O,O
association,O,O
of,O,O
products,O,O
of,O,O
alternative,O,O
transcripts,O,O
of,O,O
the,O,O
candidate,O,O
tumor,B,O
suppressor,I,O
ING1,I,B
with,O,O
the,O,O
mSin3,B,B
/,O,I
HDAC1,B,I
transcriptional,O,O
corepressor,O,O
complex,O,O
.,O,O
A,O,O
Golgi,O,B
study,O,O
of,O,O
the,O,O
sixth,O,O
layer,O,O
of,O,O
the,O,O
cerebral,O,B
cortex,O,I
.,O,O
During,O,O
both,O,O
encephalopathy,O,O
episodes,O,O
",",O,O
CSF,O,O
protein,O,O
and,O,O
immunoglobulin,B,O
G,I,B
(,O,O
IgG,B,B
),O,O
levels,O,O
were,O,O
elevated,O,O
without,O,O
an,O,O
increased,O,O
IgG,B,B
index,O,O
or,O,O
IgG,B,B
synthesis,O,O
rate,O,O
.,O,O
Significantly,O,O
lower,O,O
heart,O,O
rate,O,O
reactivity,O,O
and,O,O
significantly,O,O
less,O,O
pronounced,O,O
left,O,O
temporal,O,O
artery,O,O
pulse,O,O
amplitude,O,O
responses,O,O
were,O,O
found,O,O
in,O,O
non,O,O
-,O,O
medicated,O,O
TH,O,B
subjects,O,O
than,O,O
in,O,O
controls,O,O
.,O,O
Treatment,O,O
of,O,O
unstable,O,O
angina,O,O
:,O,O
role,O,O
of,O,O
antithrombotic,O,O
therapy,O,O
.,O,O
Expression,O,O
of,O,O
h6,O,B
.,O,O
1,O,O
in,O,O
COS,O,O
-,O,O
1,O,O
cells,O,O
led,O,O
to,O,O
the,O,O
production,O,O
of,O,O
a,O,O
typical,O,O
type,B,O
IV,I,O
PDE,I,O
activity,O,O
in,O,O
that,O,O
cAMP,O,B
",",O,O
but,O,O
not,O,O
cGMP,O,B
",",O,O
served,O,O
as,O,O
substrate,O,O
and,O,O
its,O,O
activity,O,O
was,O,O
insensitive,O,O
to,O,O
either,O,O
Ca2,O,O
+,O,O
/,O,O
CaM,B,O
or,O,O
cGMP,O,B
but,O,O
was,O,O
inhibited,O,O
by,O,O
low,O,O
concentrations,O,O
of,O,O
rolipram,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
400,O,O
WORDS,O,O
),O,O
The,O,O
hybrid,O,O
viruses,O,O
were,O,O
found,O,O
to,O,O
accumulate,O,O
to,O,O
high,O,O
levels,O,O
in,O,O
infected,O,O
plants,O,O
",",O,O
to,O,O
form,O,O
stable,O,O
virions,O,O
",",O,O
and,O,O
to,O,O
be,O,O
mechanically,O,O
transmissible,O,O
.,O,O
The,O,O
mean,O,O
times,O,O
to,O,O
detection,O,O
of,O,O
all,O,O
mycobacteria,O,O
with,O,O
BACTEC,O,B
9000,O,I
MB,O,I
and,O,O
BACTEC,O,B
460,O,I
TB,O,I
were,O,O
similar,O,O
(,O,O
10,O,O
.,O,O
3,O,O
and,O,O
10,O,O
.,O,O
0,O,O
days,O,O
",",O,O
respectively,O,O
),O,O
.,O,O
The,O,O
amino,O,O
acid,O,O
sequences,O,O
of,O,O
the,O,O
predicted,O,O
RfbA,B,B
and,O,O
RfbB,B,B
homologs,I,O
showed,O,O
identities,O,O
of,O,O
75,O,O
.,O,O
7,O,O
%,O,O
(,O,O
87,O,O
.,O,O
9,O,O
%,O,O
total,O,O
similarity,O,O
),O,O
and,O,O
78,O,O
.,O,O
0,O,O
%,O,O
(,O,O
86,O,O
.,O,O
5,O,O
%,O,O
total,O,O
similarity,O,O
),O,O
",",O,O
respectively,O,O
.,O,O
In,O,O
vitro,O,O
penetration,O,O
tests,O,O
of,O,O
human,O,B
sperm,O,I
into,O,O
cervical,O,O
mucus,O,O
were,O,O
introduced,O,O
in,O,O
order,O,O
to,O,O
study,O,O
the,O,O
interaction,O,O
between,O,O
sperm,O,B
and,O,O
cervical,O,O
mucus,O,O
.,O,O
Striking,O,O
sequence,O,O
similarities,O,O
(,O,O
57,O,O
and,O,O
53,O,O
%,O,O
),O,O
were,O,O
observed,O,O
with,O,O
yeast,O,O
mitochondrial,O,O
proteins,O,O
",",O,O
SMF1,B,B
and,O,O
SMF2,B,B
",",O,O
especially,O,O
within,O,O
putative,O,O
functional,O,O
domains,O,O
:,O,O
exon,O,O
6,O,O
encoding,O,O
the,O,O
second,O,O
transmembrane,O,O
spanning,O,O
domain,O,O
",",O,O
site,O,O
of,O,O
the,O,O
murine,B,O
susceptibility,I,O
mutation,O,O
;,O,O
and,O,O
exon,O,O
11,O,O
encoding,O,O
a,O,O
conserved,O,O
transport,O,O
motif,O,O
.,O,O
We,O,O
also,O,O
examined,O,O
the,O,O
relationship,O,O
between,O,O
the,O,O
side,O,O
of,O,O
sinusitis,O,O
and,O,O
the,O,O
cleft,O,O
side,O,O
in,O,O
patients,O,O
with,O,O
unilateral,O,O
cleft,O,O
palate,O,O
.,O,O
Malaria,O,O
had,O,O
diminished,O,O
significantly,O,O
by,O,O
the,O,O
early,O,O
1940s,O,O
",",O,O
and,O,O
this,O,O
paper,O,O
queries,O,O
whether,O,O
that,O,O
reduction,O,O
was,O,O
due,O,O
to,O,O
the,O,O
control,O,O
projects,O,O
of,O,O
the,O,O
thirties,O,O
",",O,O
and,O,O
",",O,O
if,O,O
so,O,O
",",O,O
whether,O,O
such,O,O
projects,O,O
should,O,O
be,O,O
a,O,O
model,O,O
for,O,O
the,O,O
current,O,O
developing,O,O
world,O,O
",",O,O
where,O,O
malaria,O,O
is,O,O
a,O,O
growing,O,O
problem,O,O
today,O,O
.,O,O
The,O,O
nucleotide,O,O
sequences,O,O
of,O,O
the,O,O
human,B,B
and,I,O
murine,I,B
ornithine,I,I
decarboxylase,I,I
mRNAs,I,O
share,O,O
an,O,O
85,O,O
%,O,O
homology,O,O
",",O,O
even,O,O
in,O,O
their,O,O
3,O,O
',O,O
-,O,O
noncoding,O,O
regions,O,O
.,O,O
These,O,O
data,O,O
locate,O,O
the,O,O
aniridia,B,B
gene,I,I
(,O,O
AN2,B,B
),O,O
and,O,O
a,O,O
recurrent,O,O
T,B,B
-,I,I
cell,I,I
leukemia,I,I
breakpoint,I,I
(,O,O
TCL2,B,B
),O,O
in,O,O
the,O,O
marker,O,O
sequence,O,O
",",O,O
on,O,O
opposite,O,O
sides,O,O
of,O,O
MIC1,B,B
.,O,O
Dopaminergic,O,O
modulation,O,O
of,O,O
transcallosal,O,O
activity,O,O
of,O,O
cat,O,O
motor,O,O
cortical,O,O
neurons,O,O
.,O,O
In,O,O
vivo,O,O
association,O,O
between,O,O
Shb,B,B
-,O,I
SH3,B,I
domain,O,I
proteins,O,O
v,B,O
-,I,O
Src,I,B
and,O,O
Eps8,B,B
was,O,O
detected,O,O
by,O,O
coimmunoprecipitation,O,O
.,O,O
IE2,B,B
-,O,I
IE2,B,I
interactions,O,O
were,O,O
mapped,O,O
to,O,O
a,O,O
domain,O,O
containing,O,O
a,O,O
putative,O,O
helix,O,O
-,O,O
turn,O,O
-,O,O
helix,O,O
motif,O,O
located,O,O
near,O,O
the,O,O
C,O,O
terminus,O,O
of,O,O
IE2,B,B
",",O,O
between,O,O
amino,O,O
acids,O,O
456,O,O
and,O,O
539,O,O
.,O,O
There,O,O
are,O,O
",",O,O
however,O,O
",",O,O
several,O,O
differences,O,O
between,O,O
the,O,O
two,O,O
new,O,O
ars,O,O
sequences,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
another,O,O
derivative,O,O
of,O,O
pCMVJS21,O,O
(,O,O
pCMVJS21DeltaGP,O,O
),O,O
in,O,O
which,O,O
the,O,O
gag,B,B
",",O,O
pol,B,B
(,O,O
and,O,O
orf,B,B
-,I,I
x,I,I
),O,O
coding,O,O
sequences,O,O
were,O,O
deleted,O,O
also,O,O
gave,O,O
transformed,O,O
foci,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
over,O,O
-,O,O
expression,O,O
of,O,O
RAR,B,B
beta,I,I
only,O,O
poorly,O,O
restored,O,O
differentiation,O,O
",",O,O
although,O,O
it,O,O
could,O,O
replace,O,O
RAR,B,B
gamma,I,I
for,O,O
the,O,O
activation,O,O
of,O,O
target,O,O
genes,O,O
.,O,O
Effect,O,O
of,O,O
the,O,O
methods,O,O
of,O,O
cutaneous,O,O
administration,O,O
of,O,O
methyl,O,B
isobutyl,O,I
ketone,O,I
on,O,O
its,O,O
toxicity,O,O
Analysis,O,O
of,O,O
the,O,O
protein,O,O
sequences,O,O
of,O,O
these,O,O
two,O,O
replicases,B,O
",",O,O
together,O,O
with,O,O
previously,O,O
characterized,O,O
H,B,B
.,I,O
pylori,I,I
plasmid,I,I
replication,I,I
proteins,I,I
",",O,O
supports,O,O
the,O,O
formation,O,O
of,O,O
a,O,O
distinct,O,O
class,O,O
of,O,O
H,B,B
.,I,O
pylori,I,I
plasmid,I,I
proteins,I,I
.,O,O
In,O,O
adulthood,O,O
these,O,O
rats,O,O
were,O,O
hyperactive,O,O
and,O,O
learned,O,O
the,O,O
active,O,O
avoidance,O,O
response,O,O
later,O,O
than,O,O
the,O,O
controls,O,O
.,O,O
At,O,O
Cabras,O,O
(,O,O
Oristano,O,O
),O,O
",",O,O
a,O,O
town,O,O
characterized,O,O
by,O,O
a,O,O
high,O,O
incidence,O,O
of,O,O
thalassaemia,O,B
and,O,O
G6PD,B,B
deficiency,O,O
less,O,O
than,O,O
half,O,O
the,O,O
people,O,O
between,O,O
18,O,O
and,O,O
35,O,O
have,O,O
a,O,O
fair,O,O
knowledge,O,O
of,O,O
genetic,O,O
diseases,O,O
and,O,O
of,O,O
their,O,O
prevention,O,O
.,O,O
The,O,O
438,B,O
bp,I,O
EcoRI,I,B
fragment,I,O
",",O,O
which,O,O
was,O,O
detected,O,O
by,O,O
Southern,O,O
hybridization,O,O
",",O,O
reveals,O,O
an,O,O
open,O,O
reading,O,O
frame,O,O
which,O,O
encodes,O,O
a,O,O
protein,O,O
of,O,O
103,O,O
amino,O,O
acids,O,O
.,O,O
The,O,O
coding,O,O
sequences,O,O
of,O,O
the,O,O
Crry,B,B
gene,I,O
encompass,O,O
over,O,O
25,O,O
kb,O,O
of,O,O
DNA,O,O
",",O,O
whereas,O,O
the,O,O
Crry,B,B
-,O,I
ps,B,I
sequences,O,I
are,O,O
included,O,O
within,O,O
a,O,O
single,O,O
5,B,O
.,I,O
6,I,O
-,I,O
kb,I,O
Eco,I,B
-,I,I
R1,I,I
fragment,I,O
.,O,O
Thus,O,O
",",O,O
included,O,O
in,O,O
the,O,O
KG1a,O,O
EST,O,O
dataset,O,O
are,O,O
candidates,O,O
for,O,O
new,O,O
human,O,B
genes,O,O
that,O,O
may,O,O
play,O,O
roles,O,O
in,O,O
hematopoietic,O,O
differentiative,O,O
progression,O,O
and,O,O
lineage,O,O
commitment,O,O
.,O,O
These,O,O
cells,O,O
produced,O,O
P2Y,B,B
(,I,O
11,I,O
),I,O
mRNA,I,O
during,O,O
culture,O,O
.,O,O
Patient,O,O
characteristics,O,O
associated,O,O
with,O,O
deep,O,O
wounds,O,O
as,O,O
well,O,O
as,O,O
patient,O,O
and,O,O
wound,O,O
characteristics,O,O
predictive,O,O
of,O,O
the,O,O
extent,O,O
of,O,O
healing,O,O
and,O,O
time,O,O
required,O,O
for,O,O
healing,O,O
were,O,O
identified,O,O
.,O,O
Because,O,O
the,O,O
biosynthetic,O,O
pathway,O,O
to,O,O
the,O,O
vacuole,O,O
intersects,O,O
with,O,O
the,O,O
endocytic,O,O
pathway,O,O
",",O,O
internalization,O,O
of,O,O
a,O,O
bulk,O,O
membrane,O,O
endocytic,O,O
marker,O,O
FM,O,B
4,O,I
-,O,I
64,O,I
was,O,O
assayed,O,O
in,O,O
the,O,O
sop,B,O
mutants,I,O
.,O,O
Propranolol,O,O
also,O,O
effectively,O,O
controlled,O,O
her,O,O
familial,O,O
tremor,O,O
.,O,O
Echinostomiasis,O,O
is,O,O
aggravated,O,O
by,O,O
socioeconomic,O,O
factors,O,O
such,O,O
as,O,O
poverty,O,O
",",O,O
malnutrition,O,O
",",O,O
an,O,O
explosively,O,O
growing,O,O
free,O,O
-,O,O
food,O,O
market,O,O
",",O,O
a,O,O
lack,O,O
of,O,O
supervised,O,O
food,O,O
inspection,O,O
",",O,O
poor,O,O
or,O,O
insufficient,O,O
sanitation,O,O
",",O,O
other,O,O
helminthiases,O,O
",",O,O
and,O,O
declining,O,O
economic,O,O
conditions,O,O
.,O,O
Evoked,O,O
potential,O,O
and,O,O
single,O,O
unit,O,O
responses,O,O
to,O,O
olfactory,O,O
nerve,O,O
volleys,O,O
in,O,O
the,O,O
isolated,O,O
turtle,O,O
olfactory,O,O
bulb,O,O
.,O,O
We,O,O
found,O,O
that,O,O
PML,B,B
was,O,O
expressed,O,O
at,O,O
a,O,O
lower,O,O
level,O,O
in,O,O
S,O,O
",",O,O
G2,O,O
",",O,O
and,O,O
M,O,O
phases,O,O
and,O,O
at,O,O
a,O,O
significantly,O,O
higher,O,O
level,O,O
in,O,O
G1,O,O
phase,O,O
.,O,O
Mechanisms,O,O
of,O,O
visible,O,O
-,O,O
light,O,O
emission,O,O
from,O,O
electro,O,O
-,O,O
oxidized,O,O
porous,O,O
silicon,O,O
.,O,O
Each,O,O
dietary,O,O
treatment,O,O
was,O,O
fed,O,O
to,O,O
six,O,O
pen,O,O
replicates,O,O
of,O,O
five,O,O
chicks,O,O
per,O,O
pen,O,O
for,O,O
21,O,O
d,O,O
.,O,O
The,O,O
localization,O,O
of,O,O
ZAP,B,B
-,I,I
70,I,I
to,O,O
the,O,O
cell,O,O
cortex,O,O
is,O,O
",",O,O
therefore,O,O
",",O,O
regulated,O,O
by,O,O
the,O,O
activity,O,O
of,O,O
SRC,B,B
-,I,I
family,I,I
kinases,I,I
",",O,O
independently,O,O
of,O,O
their,O,O
ability,O,O
to,O,O
phosphorylate,O,O
immunoreceptor,O,O
tyrosine,O,O
-,O,O
based,O,O
activation,O,O
motifs,O,O
of,O,O
the,O,O
TCR,B,B
.,O,O
However,O,O
",",O,O
we,O,O
could,O,O
not,O,O
find,O,O
the,O,O
homologous,O,O
regions,O,O
with,O,O
guanine,B,B
nucleotide,I,I
exchange,I,I
factors,I,I
or,O,O
GTPase,B,B
-,I,I
activating,I,I
proteins,I,I
in,O,O
the,O,O
c,B,O
-,I,O
cbl,I,O
gene,I,O
.,O,O
Interleukin,B,B
-,I,I
8,I,I
(,O,O
IL,B,B
-,I,I
8,I,I
),O,O
is,O,O
a,O,O
potent,O,O
inflammatory,O,O
mediator,O,O
that,O,O
belongs,O,O
to,O,O
the,O,O
family,O,O
of,O,O
C,B,O
-,I,O
X,I,O
-,I,O
C,I,O
chemokines,I,O
.,O,O
The,O,O
227,O,O
-,O,O
to,O,O
-,O,O
239,O,O
region,O,O
blocked,O,O
ADR1,B,B
activity,O,O
independently,O,O
of,O,O
the,O,O
TAD,B,O
present,O,O
on,O,O
ADR1,B,B
",",O,O
ADR1,B,B
DNA,O,I
binding,O,I
",",O,O
and,O,O
specific,O,O
ADH2,B,B
promoter,I,I
sequences,I,I
.,O,O
Repair,O,O
of,O,O
double,O,O
-,O,O
strand,O,O
breaks,O,O
(,O,O
DSBs,O,B
),O,O
in,O,O
chromosomal,O,O
DNA,O,O
by,O,O
nonhomologous,O,O
end,O,O
-,O,O
joining,O,O
(,O,O
NHEJ,O,B
),O,O
is,O,O
not,O,O
well,O,O
characterized,O,O
in,O,O
the,O,O
yeast,O,O
Saccharomyces,O,B
cerevisiae,O,I
.,O,O
Significant,O,O
alterations,O,O
in,O,O
CBC,O,O
results,O,O
and,O,O
serum,B,O
CRP,I,B
concentration,O,O
",",O,O
compared,O,O
with,O,O
baseline,O,O
values,O,O
",",O,O
were,O,O
lacking,O,O
in,O,O
dogs,O,O
of,O,O
the,O,O
control,O,O
group,O,O
.,O,O
Our,O,O
results,O,O
show,O,O
that,O,O
CVN,B,B
specifically,O,O
recognizes,O,O
with,O,O
nanomolar,O,O
affinity,O,O
Man,O,B
(,O,O
9,O,I
),O,O
GlcNAc,O,B
(,O,O
2,O,I
),O,O
and,O,O
the,O,O
D1D3,O,O
isomer,O,O
of,O,O
Man,O,B
(,O,O
8,O,I
),O,O
GlcNAc,O,B
(,O,O
2,O,I
),O,O
.,O,O
Erythrocyte,O,O
protoporphyrin,O,O
concentration,O,O
increased,O,O
significantly,O,O
(,O,O
P,O,O
less,O,O
than,O,O
0,O,O
.,O,O
05,O,O
),O,O
by,O,O
14,O,O
days,O,O
in,O,O
dogs,O,O
fed,O,O
the,O,O
basal,O,O
diet,O,O
",",O,O
and,O,O
remained,O,O
significantly,O,O
high,O,O
relative,O,O
to,O,O
that,O,O
in,O,O
dogs,O,O
of,O,O
the,O,O
other,O,O
dietary,O,O
groups,O,O
for,O,O
the,O,O
remainder,O,O
of,O,O
the,O,O
study,O,O
.,O,O
The,O,O
controversy,O,O
of,O,O
significance,O,O
testing,O,O
:,O,O
misconceptions,O,O
and,O,O
alternatives,O,O
.,O,O
SL1,B,O
trans,O,O
-,O,O
splicing,O,O
specified,O,O
by,O,O
AU,O,O
-,O,O
rich,O,O
synthetic,O,O
RNA,O,O
inserted,O,O
at,O,O
the,O,O
5,O,O
',O,O
end,O,O
of,O,O
Caenorhabditis,O,B
elegans,O,I
pre,O,I
-,O,I
mRNA,O,I
.,O,O
The,O,O
seventh,O,O
cysteine,O,O
residue,O,O
of,O,O
CTSE,B,B
is,O,O
located,O,O
within,O,O
the,O,O
activation,O,O
peptide,O,O
region,O,O
of,O,O
the,O,O
proenzyme,O,O
.,O,O
The,O,O
chick,O,O
axon,O,O
-,O,O
associated,O,O
surface,O,O
glycoprotein,O,O
neurofascin,B,B
is,O,O
implicated,O,O
in,O,O
axonal,O,O
growth,O,O
and,O,O
fasciculation,O,O
as,O,O
revealed,O,O
by,O,O
antibody,O,O
perturbation,O,O
experiments,O,O
.,O,O
These,O,O
mutations,O,O
create,O,O
stop,O,O
codons,O,O
in,O,O
exon,O,O
7,O,O
and,O,O
8,O,O
",",O,O
respectively,O,O
",",O,O
and,O,O
probably,O,O
result,O,O
in,O,O
truncated,O,O
proteins,O,O
lacking,O,O
HLH,O,B
-,O,I
Zip,O,I
or,O,O
Zip,O,B
structure,O,O
.,O,O
The,O,O
unphosphorylated,O,O
form,O,O
of,O,O
RNA,B,O
polymerase,I,O
II,I,O
is,O,O
designated,O,O
IIA,O,B
",",O,O
whereas,O,O
the,O,O
phosphorylated,O,O
form,O,O
is,O,O
designated,O,O
IIO,O,B
.,O,O
Cdk2,B,B
formed,O,O
a,O,O
complex,O,O
with,O,O
cyclin,B,O
D1,I,O
in,O,O
this,O,O
system,O,O
.,O,O
Five,O,O
cell,O,O
strains,O,O
of,O,O
human,O,B
dermal,O,I
fibroblasts,O,I
were,O,O
each,O,O
treated,O,O
with,O,O
three,O,O
samples,O,O
of,O,O
burn,O,O
blister,O,O
fluid,O,O
and,O,O
the,O,O
effect,O,O
compared,O,O
with,O,O
the,O,O
rate,O,O
of,O,O
contraction,O,O
of,O,O
free,O,O
floating,O,O
fibroblast,O,O
populated,O,O
collagen,B,O
lattices,O,O
(,O,O
FPCL,O,B
),O,O
.,O,O
Deletion,O,O
analysis,O,O
of,O,O
rOC,B,B
promoter,I,O
-,O,O
chloramphenicol,B,O
acetyltransferase,I,O
constructs,O,O
demonstrates,O,O
that,O,O
an,O,O
AML,B,B
-,I,I
1,I,I
-,I,I
binding,I,I
sequence,I,I
within,O,O
the,O,O
proximal,O,O
promoter,O,O
(,O,O
-,O,O
138,O,O
to,O,O
-,O,O
130,O,O
nt,O,O
),O,O
contributes,O,O
to,O,O
75,O,O
%,O,O
of,O,O
the,O,O
level,O,O
of,O,O
osteocalcin,B,B
gene,I,I
expression,O,O
.,O,O
Trial,O,O
3,O,O
broiler,O,O
chickens,O,O
were,O,O
maintained,O,O
on,O,O
control,O,O
feed,O,O
until,O,O
they,O,O
reached,O,O
3,O,O
weeks,O,O
of,O,O
age,O,O
at,O,O
which,O,O
time,O,O
they,O,O
were,O,O
taken,O,O
off,O,O
of,O,O
feed,O,O
for,O,O
2,O,O
.,O,O
5,O,O
hr,O,O
and,O,O
then,O,O
placed,O,O
on,O,O
either,O,O
control,O,O
feed,O,O
or,O,O
feed,O,O
containing,O,O
4,O,O
.,O,O
0,O,O
ppm,O,O
ochratoxin,O,B
A,O,I
",",O,O
and,O,O
heart,O,O
rate,O,O
and,O,O
blood,O,O
pressure,O,O
were,O,O
measured,O,O
every,O,O
half,O,O
hour,O,O
through,O,O
7,O,O
hr,O,O
.,O,O
DIBA,O,B
was,O,O
more,O,O
sensitive,O,O
and,O,O
had,O,O
a,O,O
better,O,O
negative,O,O
predictive,O,O
value,O,O
and,O,O
a,O,O
lower,O,O
false,O,O
negative,O,O
percentage,O,O
than,O,O
DFAT,O,O
.,O,O
Teratological,O,O
studies,O,O
on,O,O
SF,O,O
-,O,O
837,O,O
.,O,O
N,O,O
.,O,O
",",O,O
and,O,O
Fanning,O,O
",",O,O
E,O,O
.,O,O
Recent,O,O
studies,O,O
using,O,O
isolated,O,O
rat,O,O
adipocytes,O,O
and,O,O
chemically,O,O
synthesized,O,O
PIG,O,B
compounds,O,O
point,O,O
to,O,O
IRS1,B,B
/,I,I
3,I,I
tyrosine,O,O
phosphorylation,O,O
by,O,O
p59Lyn,B,O
kinase,I,O
as,O,O
the,O,O
site,O,O
of,O,O
cross,O,O
-,O,O
talk,O,O
",",O,O
the,O,O
negative,O,O
regulation,O,O
of,O,O
which,O,O
by,O,O
interaction,O,O
with,O,O
caveolin,B,O
is,O,O
apparently,O,O
abrogated,O,O
by,O,O
PIG,O,B
.,O,O
METHODS,O,O
:,O,O
rHb1,B,B
.,I,O
1,I,O
or,O,O
human,B,B
serum,I,I
albumin,I,I
was,O,O
administered,O,O
intravenously,O,O
to,O,O
fasting,O,O
male,O,O
volunteers,O,O
.,O,O
We,O,O
have,O,O
tested,O,O
this,O,O
proposal,O,O
by,O,O
carrying,O,O
out,O,O
circular,O,O
dichroism,O,O
(,O,O
CD,O,O
),O,O
and,O,O
NMR,O,O
experiments,O,O
on,O,O
the,O,O
Skn,B,B
domain,I,I
and,O,O
five,O,O
truncated,O,O
proteins,O,O
.,O,O
During,O,O
the,O,O
CR,O,O
/,O,O
PP,O,O
diet,O,O
only,O,O
the,O,O
HS,O,O
subjects,O,O
did,O,O
not,O,O
show,O,O
the,O,O
stress,O,O
-,O,O
induced,O,O
rise,O,O
in,O,O
depression,O,O
",",O,O
decline,O,O
in,O,O
vigour,O,O
and,O,O
cortisol,O,O
elevation,O,O
that,O,O
they,O,O
showed,O,O
after,O,O
the,O,O
PR,O,O
/,O,O
CP,O,O
diet,O,O
.,O,O
However,O,O
",",O,O
little,O,O
is,O,O
known,O,O
regarding,O,O
the,O,O
genomic,O,O
organization,O,O
and,O,O
developmental,O,O
expression,O,O
of,O,O
the,O,O
caveolin,B,B
gene,I,I
family,I,O
.,O,O
The,O,O
gene,O,B
was,O,O
uniquely,O,O
mapped,O,O
with,O,O
odds,O,O
>,O,O
1,O,O
",",O,O
000,O,O
:,O,O
1,O,O
on,O,O
chromosome,O,O
3p,O,O
in,O,O
Centre,O,O
d,O,O
',O,O
Etude,O,O
du,O,O
Polymorphisme,O,O
Humain,O,O
pedigrees,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
REP21,O,B
plants,O,O
were,O,O
resistant,O,O
to,O,O
an,O,O
unusually,O,O
broad,O,O
range,O,O
of,O,O
tobamoviruses,O,O
including,O,O
tomato,O,O
mosaic,O,O
virus,O,O
",",O,O
tobacco,O,O
mild,O,O
green,O,O
mosaic,O,O
virus,O,O
",",O,O
TMV,O,O
-,O,O
U5,O,O
",",O,O
green,O,O
tomato,O,O
atypical,O,O
mosaic,O,O
virus,O,O
",",O,O
and,O,O
ribgrass,O,O
mosaic,O,O
virus,O,O
.,O,O
In,O,O
the,O,O
eight,O,O
patients,O,O
with,O,O
persistent,O,O
generalized,O,O
lymph,O,B
-,O,I
adenopathy,O,I
(,O,O
PGL,O,B
),O,O
and,O,O
nontender,O,O
",",O,O
nonenlarging,O,O
nodes,O,O
",",O,O
pathologic,O,O
analysis,O,O
revealed,O,O
lymphoid,O,O
hyperplasia,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
a,O,O
noncanonical,O,O
C,B,B
/,I,I
EBP,I,I
-,I,I
binding,I,I
site,I,I
within,O,O
the,O,O
Gadd45gamma,B,B
promoter,I,O
where,O,O
C,B,B
/,I,I
EBPbeta,I,I
and,O,O
C,B,B
/,I,I
EBPdelta,I,I
could,O,O
bind,O,O
",",O,O
was,O,O
identified,O,O
by,O,O
electrophoretic,O,O
mobility,O,O
shift,O,O
assay,O,O
(,O,O
EMSA,O,O
),O,O
and,O,O
reporter,O,O
gene,O,O
analysis,O,O
.,O,O
I,O,O
.,O,O
The,O,O
effect,O,O
of,O,O
a,O,O
constant,O,O
magnetic,O,O
field,O,O
on,O,O
the,O,O
phagocytic,O,O
activity,O,O
of,O,O
Paramecia,O,B
Genes,O,O
for,O,O
ocs,B,B
element,I,I
binding,I,I
factors,I,I
(,O,O
OBFs,B,B
),O,O
",",O,O
belonging,O,O
to,O,O
a,O,O
specific,O,O
class,O,O
of,O,O
basic,B,O
-,I,O
region,I,O
leucine,I,O
zipper,I,O
(,I,O
bZIP,I,B
),I,O
transcription,I,O
factors,I,O
",",O,O
have,O,O
been,O,O
isolated,O,O
in,O,O
a,O,O
number,O,O
of,O,O
plants,O,O
.,O,O
Hematopoietic,B,O
growth,I,O
factors,I,O
are,O,O
being,O,O
used,O,O
to,O,O
accelerate,O,O
the,O,O
recovery,O,O
of,O,O
myelopoiesis,O,O
following,O,O
high,O,O
-,O,O
dose,O,O
chemotherapy,O,O
in,O,O
cancer,O,O
patients,O,O
.,O,O
The,O,O
remainder,O,O
(,O,O
18,O,O
.,O,O
4,O,O
%,O,O
),O,O
was,O,O
with,O,O
IgA,B,B
nephropathy,O,I
",",O,O
which,O,O
was,O,O
histologically,O,O
mild,O,O
.,O,O
The,O,O
strong,O,O
conservation,O,O
of,O,O
the,O,O
inverted,O,O
terminal,O,O
repeat,O,O
sequence,O,O
may,O,O
reflect,O,O
a,O,O
common,O,O
integration,O,O
mechanism,O,O
for,O,O
VL30,B,B
elements,I,I
and,O,O
MuLV,O,B
proviruses,O,I
.,O,O
In,O,O
addition,O,O
serum,B,O
IgE,I,B
concentrations,O,I
were,O,O
not,O,O
statistically,O,O
different,O,O
.,O,O
The,O,O
comparison,O,O
of,O,O
the,O,O
expression,O,O
patterns,O,O
of,O,O
the,O,O
known,O,O
Kv4,B,B
family,I,I
members,I,I
shows,O,O
subtype,O,O
specificity,O,O
with,O,O
significant,O,O
overlaps,O,O
.,O,O
We,O,O
have,O,O
investigated,O,O
the,O,O
requirements,O,O
of,O,O
the,O,O
CH,B,B
gene,I,I
switch,O,I
by,O,O
characterizing,O,O
two,O,O
rearranged,B,O
gamma,I,B
2b,I,I
genes,I,I
from,O,O
a,O,O
gamma,B,B
2b,I,I
producing,O,I
mouse,O,I
myeloma,O,I
(,O,O
MPC,O,B
-,O,I
11,O,I
),O,O
.,O,O
In,O,O
this,O,O
study,O,O
we,O,O
wanted,O,O
to,O,O
assess,O,O
the,O,O
DR,O,B
using,O,O
the,O,O
',O,O
combined,O,O
test,O,O
',O,O
in,O,O
an,O,O
unselected,O,O
population,O,O
of,O,O
self,O,O
-,O,O
referred,O,O
pregnant,O,O
women,O,O
at,O,O
a,O,O
false,O,O
-,O,O
positive,O,O
rate,O,O
(,O,O
FPR,O,B
),O,O
of,O,O
about,O,O
5,O,O
%,O,O
.,O,O
No,O,O
such,O,O
benefits,O,O
were,O,O
seen,O,O
for,O,O
children,O,O
with,O,O
CD4,B,B
+,I,I
counts,O,O
below,O,O
0,O,O
.,O,O
2,O,O
x,O,O
10,O,O
(,O,O
9,O,O
),O,O
per,O,O
liter,O,O
at,O,O
entry,O,O
.,O,O
Southern,O,O
blot,O,O
analyses,O,O
demonstrated,O,O
a,O,O
low,O,O
",",O,O
if,O,O
not,O,O
single,O,O
",",O,O
copy,O,O
number,O,O
for,O,O
this,O,O
gene,O,B
and,O,O
conservation,O,O
of,O,O
this,O,O
domain,O,O
in,O,O
other,O,O
vertebrates,O,O
.,O,O
We,O,O
cloned,O,O
the,O,O
third,O,O
human,O,B
gene,O,I
for,O,O
the,O,O
LD78,B,B
",",O,O
termed,O,O
LD78,B,B
gamma,I,I
and,O,O
the,O,O
sequence,O,O
analysis,O,O
showed,O,O
that,O,O
it,O,O
is,O,O
a,O,O
5,O,O
',O,O
-,O,O
truncated,O,O
pseudogene,O,O
.,O,O
Two,O,O
mammalian,O,O
enzymes,O,O
",",O,O
the,O,O
haem,B,B
-,I,I
controlled,I,I
repressor,I,I
(,O,O
HCR,B,B
),O,O
and,O,O
the,O,O
double,B,O
-,I,O
stranded,I,O
RNA,I,O
-,I,O
activated,I,O
inhibitor,I,O
(,O,O
dsI,B,B
),O,O
",",O,O
phosphorylate,O,O
Ser,O,O
-,O,O
51,O,O
of,O,O
the,O,O
alpha,O,O
subunit,O,O
",",O,O
thereby,O,O
inhibiting,O,O
the,O,O
exchange,O,O
of,O,O
bound,O,O
nucleotides,O,O
on,O,O
",",O,O
and,O,O
thus,O,O
the,O,O
recycling,O,O
of,O,O
",",O,O
eIF,B,B
-,I,I
2,I,I
.,O,O
Analysis,O,O
of,O,O
the,O,O
5,O,O
',O,O
flanking,O,O
region,O,O
of,O,O
the,O,O
gene,O,O
also,O,O
revealed,O,O
the,O,O
presence,O,O
of,O,O
multiple,O,O
TATA,O,B
and,O,O
CAAT,O,B
sequences,O,O
.,O,O
Analysis,O,O
of,O,O
the,O,O
5,O,O
',O,O
flanking,O,O
region,O,O
of,O,O
the,O,O
gene,O,B
also,O,O
revealed,O,O
the,O,O
presence,O,O
of,O,O
multiple,O,O
TATA,O,B
and,O,O
CAAT,O,B
sequences,O,O
.,O,O
As,O,O
a,O,O
result,O,O
",",O,O
we,O,O
have,O,O
defined,O,O
two,O,O
arginine,O,B
-,O,I
rich,O,I
motifs,O,O
(,O,O
ARM1,O,B
and,O,O
ARM2,O,B
),O,O
that,O,O
mediate,O,O
the,O,O
RNA,O,O
binding,O,O
activity,O,O
of,O,O
SU,B,B
(,I,O
S,I,B
),I,O
.,O,O
Lars,O,O
has,O,O
AIDS,O,B
-,O,I
-,O,I
a,O,O
more,O,O
dignified,O,O
life,O,O
with,O,O
care,O,O
at,O,O
home,O,O
.,O,O
Based,O,O
on,O,O
16S,B,O
rRNA,I,O
gene,I,B
sequence,I,O
analysis,O,O
",",O,O
the,O,O
11,O,O
species,O,O
having,O,O
two,O,O
tuf,B,B
genes,I,O
all,O,O
have,O,O
a,O,O
common,O,O
ancestor,O,O
",",O,O
while,O,O
the,O,O
six,O,O
species,O,O
having,O,O
only,O,O
one,O,O
copy,O,O
diverged,O,O
from,O,O
the,O,O
enterococcal,O,O
lineage,O,O
before,O,O
that,O,O
common,O,O
ancestor,O,O
.,O,O
Gel,O,O
route,O,O
preparation,O,O
of,O,O
low,O,O
fusing,O,O
dental,O,O
porcelain,O,O
frit,O,O
.,O,O
Polypyrimidine,O,B
and,O,O
ssDNA,O,O
binding,O,O
by,O,O
the,O,O
isolated,O,O
VH,B,O
domain,I,O
of,O,O
immunization,O,O
-,O,O
induced,O,O
anti,O,O
-,O,O
Z,O,B
-,O,I
DNA,O,I
Ab,O,O
resembles,O,O
the,O,O
activity,O,O
of,O,O
natural,O,O
autoantibodies,O,O
and,O,O
suggests,O,O
that,O,O
VH,B,O
-,O,O
dependent,O,O
binding,O,O
to,O,O
a,O,O
ligand,O,O
mimicked,O,O
by,O,O
polypyrimidines,O,O
may,O,O
play,O,O
a,O,O
role,O,O
in,O,O
B,O,B
cell,O,I
selection,O,I
before,O,O
immunization,O,O
with,O,O
Z,O,B
-,O,I
DNA,O,I
.,O,O
Many,O,O
human,O,B
viruses,O,O
are,O,O
able,O,O
to,O,O
develop,O,O
suitable,O,O
strategies,O,O
for,O,O
modifying,O,O
apoptosis,O,O
in,O,O
virus,O,O
-,O,O
infected,O,O
cells,O,O
and,O,O
in,O,O
virus,O,O
-,O,O
primed,O,O
T,O,O
cells,O,O
.,O,O
This,O,O
",",O,O
together,O,O
with,O,O
the,O,O
data,O,O
obtained,O,O
with,O,O
haloperidol,O,O
",",O,O
suggests,O,O
that,O,O
a,O,O
minimal,O,O
increase,O,O
in,O,O
the,O,O
firing,O,O
rate,O,O
of,O,O
LC,O,O
cells,O,O
(,O,O
+,O,O
140,O,O
%,O,O
),O,O
is,O,O
required,O,O
before,O,O
it,O,O
could,O,O
influence,O,O
the,O,O
turnover,O,O
of,O,O
",",O,O
as,O,O
measured,O,O
by,O,O
DOPAC,O,O
changes,O,O
.,O,O
We,O,O
have,O,O
been,O,O
studying,O,O
the,O,O
interaction,O,O
of,O,O
the,O,O
oncogenic,O,O
human,O,B
polyomavirus,O,I
BK,O,B
(,O,O
BKV,O,B
),O,O
with,O,O
the,O,O
tumor,B,O
-,I,O
suppressor,I,O
protein,I,O
p53,I,B
to,O,O
understand,O,O
the,O,O
biology,O,O
of,O,O
this,O,O
virus,O,O
as,O,O
well,O,O
as,O,O
to,O,O
understand,O,O
the,O,O
basic,O,O
mechanisms,O,O
of,O,O
p53,B,B
transactivation,O,O
.,O,O
These,O,O
results,O,O
suggest,O,O
that,O,O
",",O,O
for,O,O
the,O,O
HML,B,O
ARS,O,B
cluster,O,O
(,O,O
ARS303,B,B
",",O,O
ARS320,B,B
",",O,O
and,O,O
ARS302,B,B
),O,O
",",O,O
inactivity,O,O
of,O,O
origins,O,O
is,O,O
independent,O,O
of,O,O
local,O,O
transcriptional,O,O
silencing,O,O
",",O,O
even,O,O
though,O,O
origins,O,O
and,O,O
silencers,O,O
share,O,O
key,O,O
cis,O,O
-,O,O
and,O,O
trans,O,O
-,O,O
acting,O,O
components,O,O
.,O,O
Guinea,O,O
pigs,O,O
weighing,O,O
300,O,O
approximately,O,O
350,O,O
g,O,O
were,O,O
used,O,O
.,O,O
The,O,O
pel,B,B
gene,I,O
from,O,O
an,O,O
Amycolata,O,B
sp,O,O
.,O,O
encoding,O,O
a,O,O
pectate,B,B
lyase,I,I
(,O,O
EC,B,O
4,I,O
.,I,O
2,I,O
.,I,O
2,I,O
.,I,O
),O,O
was,O,O
isolated,O,O
by,O,O
activity,O,O
screening,O,O
a,O,O
genomic,O,O
DNA,O,O
library,O,O
in,O,O
Streptomyces,O,B
lividans,O,I
TK24,O,I
.,O,O
Examination,O,O
of,O,O
the,O,O
immediate,O,O
sequence,O,O
5,O,O
',O,O
to,O,O
the,O,O
mRNA,O,O
start,O,O
site,O,O
reveals,O,O
no,O,O
TATA,O,B
box,O,I
and,O,O
multiple,O,O
known,O,O
enhancer,O,O
sequences,O,O
.,O,O
Treatment,O,O
with,O,O
oxyphenylbutazone,O,O
and,O,O
hydrocortisone,O,O
failed,O,O
to,O,O
inhibit,O,O
the,O,O
raised,O,O
serum,B,O
CPN,I,B
levels,O,O
.,O,O
The,O,O
lowest,O,O
detectable,O,O
concentration,O,O
was,O,O
1,O,O
.,O,O
0,O,O
ng,O,O
/,O,O
ml,O,O
in,O,O
the,O,O
serum,O,O
.,O,O
Northern,O,O
blot,O,O
analysis,O,O
with,O,O
one,O,O
of,O,O
the,O,O
PARNAs,B,B
revealed,O,O
a,O,O
highly,O,O
abundant,O,O
signal,O,O
of,O,O
approximately,O,O
2,O,O
.,O,O
0,O,O
kilobases,O,O
(,O,O
kb,O,O
),O,O
present,O,O
in,O,O
all,O,O
cell,O,O
lines,O,O
tested,O,O
.,O,O
Otte,O,O
",",O,O
Mol,O,O
.,O,O
In,O,O
addition,O,O
",",O,O
we,O,O
identified,O,O
two,O,O
mutations,O,O
",",O,O
Delta,O,O
M1281,O,O
and,O,O
IVS51,O,O
+,O,O
5G,O,O
-,O,O
-,O,O
>,O,O
A,O,O
",",O,O
in,O,O
a,O,O
German,O,O
USH1,B,O
patient,O,O
.,O,O
These,O,O
discoloration,O,O
',O,O
s,O,O
can,O,O
be,O,O
treated,O,O
in,O,O
several,O,O
ways,O,O
but,O,O
up,O,O
to,O,O
lately,O,O
tooth,O,O
structure,O,O
had,O,O
to,O,O
be,O,O
removed,O,O
in,O,O
an,O,O
irreversible,O,O
manner,O,O
in,O,O
order,O,O
to,O,O
provide,O,O
sufficient,O,O
bulk,O,O
for,O,O
the,O,O
new,O,O
restorative,O,O
material,O,O
.,O,O
Furthermore,O,O
",",O,O
deletion,O,O
and,O,O
mutation,O,O
analyses,O,O
of,O,O
the,O,O
VCAM,B,B
-,I,I
1,I,I
promoter,I,O
performed,O,O
with,O,O
chloramphenicol,B,O
acetyltransferase,I,O
constructs,I,O
revealed,O,O
that,O,O
Tax,B,O
was,O,O
trans,O,O
activating,O,O
the,O,O
VCAM,B,B
-,I,I
1,I,I
promoter,I,O
via,O,O
two,O,O
NF,B,B
-,I,I
kappaB,I,I
sites,I,O
present,O,O
at,O,O
bp,O,O
-,O,O
72,O,O
and,O,O
-,O,O
57,O,O
in,O,O
the,O,O
VCAM,B,B
-,I,I
1,I,I
gene,I,O
promoter,I,O
",",O,O
with,O,O
both,O,O
of,O,O
them,O,O
being,O,O
required,O,O
for,O,O
the,O,O
Tax,B,O
-,O,O
induced,O,O
expression,O,O
of,O,O
this,O,O
adhesion,O,O
molecule,O,O
.,O,O
In,O,O
this,O,O
study,O,O
we,O,O
provide,O,O
evidence,O,O
that,O,O
B,B,B
-,I,I
Myb,I,I
is,O,O
a,O,O
direct,O,O
physiological,O,O
target,O,O
for,O,O
cyclin,B,O
A,I,B
/,O,O
Cdk2,B,B
.,O,O
The,O,O
geometric,O,O
mean,O,O
hemagglutination,O,O
-,O,O
inhibition,O,O
antibody,O,O
titers,O,O
(,O,O
GMT,O,O
),O,O
of,O,O
non,O,O
-,O,O
immunized,O,O
",",O,O
once,O,O
-,O,O
immunized,O,O
",",O,O
and,O,O
twice,O,O
-,O,O
immunized,O,O
chickens,O,O
were,O,O
compared,O,O
at,O,O
2,O,O
-,O,O
week,O,O
intervals,O,O
following,O,O
primary,O,O
immunization,O,O
",",O,O
secondary,O,O
immunization,O,O
",",O,O
and,O,O
challenge,O,O
.,O,O
Analysis,O,O
of,O,O
an,O,O
autopsy,O,O
population,O,O
.,O,O
Factors,O,O
influencing,O,O
in,O,O
vitro,O,O
skin,B,O
permeability,I,O
factor,I,O
production,O,O
by,O,O
Vibrio,O,B
cholerae,O,I
.,O,O
During,O,O
treatment,O,O
",",O,O
the,O,O
phosphorylation,O,O
state,O,O
of,O,O
Rb,B,B
shifted,O,O
to,O,O
a,O,O
hypophosphorylated,O,O
form,O,O
.,O,O
mRNA,O,O
for,O,O
the,O,O
HPV,O,B
E6,B,I
/,O,I
E7,B,I
genes,O,O
decreased,O,O
;,O,O
however,O,O
",",O,O
significant,O,O
changes,O,O
in,O,O
the,O,O
E7,B,B
protein,I,O
were,O,O
not,O,O
observed,O,O
",",O,O
while,O,O
increased,O,O
levels,O,O
of,O,O
Rb,B,B
immunoprecipitated,O,O
with,O,O
anti,B,O
-,I,O
E7,I,O
antibodies,I,O
were,O,O
observed,O,O
.,O,O
Acquired,O,O
factor,B,B
VIII,I,I
inhibitor,O,O
in,O,O
non,O,O
-,O,O
hemophilic,O,O
patients,O,O
This,O,O
study,O,O
suggests,O,O
that,O,O
BSPMs,O,O
are,O,O
useful,O,O
in,O,O
the,O,O
assessment,O,O
of,O,O
AMI,O,O
in,O,O
terms,O,O
of,O,O
diagnosis,O,O
",",O,O
location,O,O
and,O,O
extent,O,O
of,O,O
myocardial,O,O
infarct,O,O
.,O,O
Mean,O,O
growth,O,O
changes,O,O
in,O,O
this,O,O
Class,O,O
II,O,O
sample,O,O
were,O,O
comparable,O,O
to,O,O
those,O,O
previously,O,O
reported,O,O
for,O,O
male,O,O
subjects,O,O
with,O,O
Class,O,O
I,O,O
malocclusions,O,O
over,O,O
the,O,O
same,O,O
age,O,O
period,O,O
",",O,O
suggesting,O,O
a,O,O
similarity,O,O
in,O,O
postpubertal,O,O
development,O,O
between,O,O
these,O,O
two,O,O
groups,O,O
.,O,O
Oxygen,O,O
tension,O,O
of,O,O
the,O,O
small,O,O
lymph,O,O
vessels,O,O
(,O,O
PLO2,O,B
),O,O
of,O,O
the,O,O
rabbit,O,O
hind,O,O
limb,O,O
was,O,O
measured,O,O
with,O,O
both,O,O
a,O,O
flow,O,O
-,O,O
through,O,O
micro,O,O
chamber,O,O
and,O,O
a,O,O
polarographic,O,O
catheter,O,O
-,O,O
tip,O,O
oxygen,O,O
electrode,O,O
to,O,O
obtain,O,O
experimental,O,O
data,O,O
on,O,O
the,O,O
source,O,O
of,O,O
oxygen,O,O
in,O,O
the,O,O
lymph,O,O
.,O,O
Thus,O,O
",",O,O
we,O,O
have,O,O
identified,O,O
an,O,O
activation,O,O
target,O,O
of,O,O
a,O,O
human,O,B
activator,O,O
",",O,O
Oct,B,B
-,I,I
1,I,I
",",O,O
within,O,O
its,O,O
cognate,O,O
basal,O,O
transcription,O,O
complex,O,O
.,O,O
Southern,O,O
blot,O,O
hybridization,O,O
experiments,O,O
suggest,O,O
the,O,O
presence,O,O
of,O,O
one,O,O
copy,O,O
of,O,O
Atcys1,B,B
",",O,O
Athyp1,B,B
and,O,O
AKin10,B,B
per,O,O
haploid,O,O
genome,O,O
",",O,O
and,O,O
Northern,O,O
blot,O,O
analysis,O,O
demonstrates,O,O
that,O,O
the,O,O
three,O,O
genes,O,O
are,O,O
differentially,O,O
expressed,O,O
in,O,O
roots,O,O
",",O,O
shoots,O,O
and,O,O
leaves,O,O
.,O,O
Transcript,O,O
analysis,O,O
reveals,O,O
that,O,O
lethal,O,O
B,B,B
block,I,I
substitutions,O,I
reduce,O,O
U6,B,B
RNA,I,I
synthesis,O,O
at,O,O
least,O,O
10,O,O
-,O,O
fold,O,O
in,O,O
vivo,O,O
and,O,O
20,O,O
-,O,O
fold,O,O
in,O,O
vitro,O,O
.,O,O
The,O,O
transport,O,O
of,O,O
a,O,O
genetically,O,O
engineered,O,O
chimeric,O,O
transmembrane,O,O
protein,O,O
connected,O,O
to,O,O
this,O,O
ER,O,B
leader,O,I
sequence,O,I
was,O,O
as,O,O
efficient,O,O
as,O,O
that,O,O
of,O,O
the,O,O
original,O,O
protein,O,O
from,O,O
which,O,O
the,O,O
ER,O,B
sequence,O,I
has,O,O
been,O,O
derived,O,O
.,O,O
Kidney,O,O
weight,O,O
and,O,O
kidney,O,O
-,O,O
to,O,O
-,O,O
body,O,O
weight,O,O
ratio,O,O
were,O,O
significantly,O,O
elevated,O,O
at,O,O
the,O,O
highest,O,O
dose,O,O
level,O,O
after,O,O
10,O,O
weeks,O,O
and,O,O
at,O,O
the,O,O
two,O,O
higher,O,O
dose,O,O
levels,O,O
after,O,O
15,O,O
weeks,O,O
of,O,O
exposure,O,O
.,O,O
A,O,O
brief,O,O
account,O,O
of,O,O
the,O,O
1988,O,O
seminar,O,O
in,O,O
Shanghai,O,O
on,O,O
viral,O,O
hepatitis,O,O
A,O,B
The,O,O
two,O,O
-,O,O
hybrid,O,O
assay,O,O
was,O,O
then,O,O
performed,O,O
using,O,O
full,O,O
-,O,O
length,O,O
genes,O,O
of,O,O
CI,B,B
",",O,O
HC,B,B
-,I,I
Pro,I,I
",",O,O
P1,B,B
",",O,O
P3,B,B
",",O,O
and,O,O
CP,B,B
",",O,O
but,O,O
no,O,O
heterologous,O,O
interactions,O,O
were,O,O
detected,O,O
.,O,O
It,O,O
was,O,O
concluded,O,O
that,O,O
patients,O,O
with,O,O
acute,O,O
respiratory,O,O
failure,O,O
requiring,O,O
artificial,O,O
ventilation,O,O
have,O,O
two,O,O
componenents,O,O
of,O,O
the,O,O
pulmonary,O,O
shunt,O,O
",",O,O
one,O,O
parallel,O,O
with,O,O
and,O,O
the,O,O
other,O,O
inversely,O,O
related,O,O
with,O,O
the,O,O
PAO2,O,B
.,O,O
I,O,O
.,O,O
Urine,O,O
specimens,O,O
containing,O,O
either,O,O
phencyclidine,O,B
(,O,O
PCP,O,B
),O,O
or,O,O
11,O,O
-,O,O
nor,O,O
-,O,O
delta,O,O
9,O,O
-,O,O
tetrahydrocannabinol,O,B
-,O,I
acid,O,I
(,O,O
9,O,O
-,O,O
THC,O,B
-,O,I
COOH,O,I
),O,O
were,O,O
adulterated,O,O
with,O,O
sodium,O,O
chloride,O,O
",",O,O
bleach,O,O
",",O,O
vinegar,O,O
",",O,O
potassium,O,O
hydroxide,O,O
",",O,O
liquid,O,O
soap,O,O
",",O,O
2,O,O
-,O,O
propanol,O,O
",",O,O
and,O,O
ammonia,O,O
.,O,O
Personal,O,O
satisfaction,O,O
in,O,O
nursing,O,O
:,O,O
an,O,O
encounter,O,O
with,O,O
extremely,O,O
hostile,O,O
patients,O,O
The,O,O
ventilation,O,O
did,O,O
not,O,O
increase,O,O
when,O,O
PACO2,O,O
was,O,O
increased,O,O
.,O,O
This,O,O
computation,O,O
is,O,O
performed,O,O
by,O,O
a,O,O
parallel,O,O
network,O,O
of,O,O
locally,O,O
connected,O,O
neuron,O,B
-,O,I
like,O,I
elements,O,O
.,O,O
These,O,O
six,O,O
amino,O,O
acids,O,O
are,O,O
part,O,O
of,O,O
an,O,O
amphipathic,O,O
helix,O,O
that,O,O
is,O,O
highly,O,O
conserved,O,O
among,O,O
nuclear,B,O
hormone,I,O
receptors,I,O
and,O,O
contains,O,O
the,O,O
core,O,O
domain,O,O
of,O,O
the,O,O
ligand,O,O
-,O,O
dependent,O,O
transactivation,O,O
function,O,O
",",O,O
AF,O,B
-,O,I
2,O,I
.,O,O
With,O,O
Sair,O,O
and,O,O
So2,O,O
",",O,O
mean,O,O
vital,O,O
capacity,O,O
was,O,O
reduced,O,O
by,O,O
44,O,O
%,O,O
from,O,O
control,O,O
.,O,O
4,O,O
.,O,O
CPDs,O,O
at,O,O
these,O,O
three,O,O
sites,O,O
may,O,O
partially,O,O
displace,O,O
TFIIIA,B,B
",",O,O
thereby,O,O
enabling,O,O
rapid,O,O
repair,O,O
.,O,O
Venkatesan,O,B
",",O,O
and,O,O
D,O,B
.,O,O
This,O,O
generally,O,O
means,O,O
an,O,O
energy,O,O
intake,O,O
of,O,O
1,O,O
.,O,O
4,O,O
to,O,O
1,O,O
.,O,O
6,O,O
times,O,O
the,O,O
energy,O,O
expenditure,O,O
",",O,O
with,O,O
a,O,O
N,O,B
intake,O,O
of,O,O
250,O,O
to,O,O
400,O,O
mg,O,O
/,O,O
kg,O,O
/,O,O
day,O,O
.,O,O
Diazepam,O,B
(,O,O
3,O,O
mg,O,O
/,O,O
kg,O,O
),O,O
generalized,O,O
to,O,O
Ro,O,B
11,O,I
-,O,I
6896,O,I
whereas,O,O
the,O,O
structurally,O,O
related,O,O
Ro,O,B
5,O,I
-,O,I
4864,O,I
(,O,O
3,O,O
mg,O,O
/,O,O
kg,O,O
and,O,O
30,O,O
mg,O,O
/,O,O
kg,O,O
),O,O
did,O,O
not,O,O
.,O,O
axl,O,B
",",O,O
a,O,O
transforming,O,O
gene,O,O
isolated,O,O
from,O,O
primary,O,O
human,O,B
myeloid,O,I
leukemia,O,I
cells,O,O
",",O,O
encodes,O,O
a,O,O
novel,O,O
receptor,B,O
tyrosine,I,O
kinase,I,O
.,O,O
Thyrotropin,B,O
-,I,O
releasing,I,O
hormone,I,O
-,O,O
induced,O,O
contraction,O,O
of,O,O
urethral,O,O
and,O,O
vaginal,O,O
muscle,O,O
.,O,O
NF,B,B
-,I,I
kappaB,I,I
is,O,O
involved,O,O
in,O,O
the,O,O
regulation,O,O
of,O,O
CD154,B,B
(,O,O
CD40,B,I
ligand,I,I
),O,O
expression,O,O
in,O,O
primary,O,O
human,O,B
T,O,I
cells,O,O
.,O,O
Since,O,O
the,O,O
UfAP,B,B
and,O,O
UTMP,B,B
share,O,O
many,O,O
biosynthetic,O,O
and,O,O
structural,O,O
features,O,O
that,O,O
include,O,O
site,O,O
of,O,O
biosynthesis,O,O
in,O,O
the,O,O
endometrium,O,O
",",O,O
P4,O,O
-,O,O
responsiveness,O,O
",",O,O
the,O,O
presence,O,O
of,O,O
the,O,O
mannose,O,O
6,O,O
-,O,O
phosphate,O,O
lysosomal,O,O
recognition,O,O
marker,O,O
",",O,O
and,O,O
considerable,O,O
sequence,O,O
similarity,O,O
",",O,O
the,O,O
UfAP,B,B
and,O,O
the,O,O
UTMP,B,B
may,O,O
have,O,O
homologous,O,O
function,O,O
which,O,O
for,O,O
both,O,O
still,O,O
remains,O,O
obscure,O,O
.,O,O
Although,O,O
both,O,O
transfected,O,O
cell,O,O
lines,O,O
contain,O,O
FGF,B,B
-,I,I
1,I,I
cell,I,O
surface,I,O
receptors,I,O
as,O,O
judged,O,O
by,O,O
crosslinking,O,O
studies,O,O
",",O,O
the,O,O
wild,O,O
-,O,O
type,O,O
transfectants,O,O
are,O,O
refractory,O,O
to,O,O
exogenous,O,O
FGF,B,B
-,I,I
1,I,I
",",O,O
whereas,O,O
the,O,O
mutant,O,O
transfectants,O,O
respond,O,O
normally,O,O
.,O,O
(,O,O
ABSTRACT,O,O
TRUNCATED,O,O
AT,O,O
250,O,O
WORDS,O,O
),O,O
Moreover,O,O
",",O,O
promoters,O,O
containing,O,O
a,O,O
TATA,O,O
box,O,O
in,O,O
the,O,O
absence,O,O
of,O,O
Sp1,B,O
sites,I,O
or,O,O
Sp1,B,O
sites,I,O
in,O,O
the,O,O
absence,O,O
of,O,O
a,O,O
TATA,O,O
box,O,O
were,O,O
equally,O,O
inducible,O,O
in,O,O
vitro,O,O
",",O,O
as,O,O
was,O,O
an,O,O
RNA,B,O
polymerase,I,O
III,I,O
promoter,I,O
.,O,O
As,O,O
expected,O,O
",",O,O
the,O,O
heparin,O,O
did,O,O
produce,O,O
increased,O,O
recalcification,O,O
times,O,O
and,O,O
the,O,O
development,O,O
of,O,O
occasional,O,O
subcutaneous,O,O
hematomas,O,O
.,O,O
NF,B,O
kappa,I,O
B,I,O
was,O,O
activated,O,O
to,O,O
a,O,O
much,O,O
greater,O,O
extent,O,O
by,O,O
roscovitine,O,O
in,O,O
the,O,O
WT,O,O
cells,O,O
than,O,O
in,O,O
Y8,O,O
cells,O,O
.,O,O
The,O,O
total,O,O
number,O,O
of,O,O
specimens,O,O
was,O,O
131,O,O
with,O,O
78,O,O
nonsmokers,O,O
and,O,O
53,O,O
smokers,O,O
.,O,O
We,O,O
obtained,O,O
quantitative,O,O
evidence,O,O
on,O,O
the,O,O
coding,O,O
of,O,O
interaural,O,O
time,O,O
differences,O,O
(,O,O
ITDs,O,B
),O,O
of,O,O
click,O,O
stimuli,O,O
by,O,O
40,O,O
single,O,O
neurons,O,O
in,O,O
the,O,O
auditory,O,O
cortex,O,O
of,O,O
anesthetized,O,O
albino,O,O
rats,O,O
.,O,O
The,O,O
ewes,O,O
were,O,O
returned,O,O
to,O,O
normoxia,O,O
",",O,O
and,O,O
monitoring,O,O
was,O,O
continued,O,O
for,O,O
1,O,O
h,O,O
.,O,O
To,O,O
illustrate,O,O
its,O,O
performance,O,O
",",O,O
measurements,O,O
of,O,O
photoluminescence,O,O
in,O,O
GaAs,O,B
/,O,I
AlGaAs,O,I
heterostructures,O,I
are,O,O
presented,O,O
.,O,O
The,O,O
results,O,O
of,O,O
these,O,O
experiments,O,O
indicate,O,O
that,O,O
at,O,O
least,O,O
two,O,O
upstream,O,O
activator,O,O
sequences,O,O
(,O,O
UAS,O,B
),O,O
mediate,O,O
maximum,O,O
induction,O,O
by,O,O
galactose,O,O
.,O,O
Plasma,B,O
renin,I,O
activity,O,O
does,O,O
not,O,O
predict,O,O
the,O,O
antihypertensive,O,O
efficacy,O,O
of,O,O
chlorthalidone,O,O
.,O,O
INTERVENTIONS,O,O
:,O,O
Study,O,O
patients,O,O
were,O,O
randomly,O,O
divided,O,O
into,O,O
four,O,O
parallel,O,O
groups,O,O
to,O,O
receive,O,O
either,O,O
terbinafine,O,O
250,O,O
mg,O,O
a,O,O
day,O,O
for,O,O
12,O,O
or,O,O
16,O,O
weeks,O,O
(,O,O
groups,O,O
T12,O,O
and,O,O
T16,O,O
),O,O
or,O,O
itraconazole,O,O
400,O,O
mg,O,O
a,O,O
day,O,O
for,O,O
1,O,O
week,O,O
in,O,O
every,O,O
4,O,O
weeks,O,O
for,O,O
12,O,O
or,O,O
16,O,O
weeks,O,O
(,O,O
groups,O,O
I3,O,O
and,O,O
I4,O,O
),O,O
.,O,O
The,O,O
CVA16,B,B
.,I,O
4,I,O
proteolipid,I,O
transcript,I,O
is,O,O
the,O,O
most,O,O
prevalent,O,O
of,O,O
the,O,O
two,O,O
proteolipid,O,O
messages,O,O
in,O,O
expanding,O,O
ovules,O,O
harvested,O,O
10,O,O
d,O,O
post,O,O
-,O,O
anthesis,O,O
.,O,O
Toxicity,O,O
was,O,O
very,O,O
mild,O,O
with,O,O
both,O,O
regimens,O,O
",",O,O
although,O,O
sedation,O,O
was,O,O
significantly,O,O
higher,O,O
in,O,O
arm,O,O
B,O,O
(,O,O
p,O,O
less,O,O
than,O,O
0,O,O
.,O,O
001,O,O
),O,O
.,O,O
The,O,O
yeast,O,O
gene,O,O
that,O,O
encodes,O,O
eIF,B,B
-,I,I
5,I,I
",",O,O
designated,O,O
TIF5,B,O
",",O,O
has,O,O
been,O,O
isolated,O,O
and,O,O
expressed,O,O
in,O,O
Escherichia,O,O
coli,O,O
to,O,O
yield,O,O
a,O,O
catalytically,O,O
active,O,O
eIF,B,B
-,I,I
5,I,I
protein,I,O
.,O,O
We,O,O
have,O,O
cloned,O,O
and,O,O
sequenced,O,O
the,O,O
mouse,B,B
NMO1,I,B
cDNA,I,I
",",O,O
which,O,O
encodes,O,O
the,O,O
NAD,B,B
(,I,O
P,I,I
),I,O
H,I,I
:,I,O
menadione,I,O
oxidoreductase,I,O
[,O,O
also,O,O
called,O,O
NAD,B,B
(,I,O
P,I,I
),I,O
H,I,I
:,I,O
(,I,O
quinone,I,O
acceptor,I,O
),I,O
oxidoreductase,I,O
;,O,O
quinone,B,O
reductase,I,O
;,O,O
azo,B,O
dye,I,O
reductase,I,O
;,O,O
DT,B,O
diaphorase,I,O
;,O,O
EC,B,O
1,I,O
.,I,O
6,I,O
.,I,O
99,I,O
.,I,O
2,I,O
],O,O
.,O,O
In,O,O
conclusion,O,O
",",O,O
IgM,B,B
class,O,I
CIC,O,I
is,O,O
the,O,O
predominant,O,O
CIC,O,O
in,O,O
acute,O,O
hepatitis,O,O
A,O,O
and,O,O
correlated,O,O
with,O,O
disease,O,O
activity,O,O
.,O,O
Ulcer,O,O
appeared,O,O
on,O,O
the,O,O
angulus,O,O
of,O,O
the,O,O
stomach,O,O
at,O,O
the,O,O
28th,O,O
week,O,O
and,O,O
resulted,O,O
in,O,O
ulcer,O,O
scar,O,O
at,O,O
the,O,O
42nd,O,O
week,O,O
.,O,O
As,O,O
expected,O,O
for,O,O
a,O,O
positive,O,O
SpHE,B,O
transcriptional,I,O
regulator,I,O
",",O,O
the,O,O
timing,O,O
of,O,O
SpEts4,B,B
gene,I,I
expression,O,I
precedes,O,O
the,O,O
transient,O,O
expression,O,O
of,O,O
SpHE,B,O
in,O,O
the,O,O
very,O,O
early,O,O
sea,O,O
urchin,O,O
blastula,O,O
.,O,O
A,O,O
secondary,O,O
phosphorylation,O,O
of,O,O
CREB341,B,B
at,O,O
Ser129,O,O
is,O,O
required,O,O
for,O,O
the,O,O
cAMP,O,O
-,O,O
mediated,O,O
control,O,O
of,O,O
gene,O,O
expression,O,O
.,O,O
The,O,O
activity,O,O
of,O,O
the,O,O
coat,B,O
protein,I,O
promoter,I,O
of,O,O
chloris,O,B
striate,O,I
mosaic,O,I
virus,O,I
is,O,O
enhanced,O,O
by,O,O
its,O,O
own,O,O
and,O,O
C1,B,B
-,O,I
C2,B,I
gene,O,I
products,O,I
.,O,O
The,O,O
alterations,O,O
in,O,O
differentiation,O,O
of,O,O
osteoprogenitor,O,O
cells,O,O
",",O,O
together,O,O
with,O,O
the,O,O
failure,O,O
of,O,O
mineralization,O,O
",",O,O
resulted,O,O
in,O,O
significantly,O,O
lower,O,O
rates,O,O
of,O,O
bone,O,O
formation,O,O
(,O,O
as,O,O
measured,O,O
by,O,O
fluorochrome,O,O
labeling,O,O
),O,O
in,O,O
the,O,O
magnesium,O,O
-,O,O
deficient,O,O
rats,O,O
.,O,O
The,O,O
sequence,O,O
of,O,O
the,O,O
HIR1,B,B
gene,I,O
predicts,O,O
an,O,O
88,O,O
-,O,O
kDa,O,O
protein,O,O
with,O,O
three,O,O
repeats,O,O
of,O,O
a,O,O
motif,O,O
found,O,O
in,O,O
the,O,O
G,B,O
beta,I,O
subunit,I,O
of,O,O
retinal,B,O
transducin,I,O
and,O,O
in,O,O
a,O,O
yeast,O,O
transcriptional,O,O
repressor,O,O
",",O,O
Tup1,B,B
.,O,O
Grossly,O,O
",",O,O
the,O,O
experimental,O,O
vulvitis,O,O
was,O,O
identical,O,O
to,O,O
the,O,O
field,O,O
condition,O,O
",",O,O
and,O,O
bacteria,O,O
indistinguishable,O,O
from,O,O
the,O,O
inoculated,O,O
strains,O,O
were,O,O
reisolated,O,O
.,O,O
This,O,O
expression,O,O
assumes,O,O
:,O,O
(,O,O
1,O,O
),O,O
a,O,O
laminar,O,O
flow,O,O
regimen,O,O
during,O,O
expiration,O,O
",",O,O
and,O,O
(,O,O
2,O,O
),O,O
a,O,O
constant,O,O
CT,O,O
value,O,O
over,O,O
the,O,O
range,O,O
of,O,O
VT,O,O
.,O,O
Enhancer,O,O
and,O,O
promoter,O,O
elements,O,O
directing,O,O
activation,O,O
and,O,O
glucocorticoid,O,O
repression,O,O
of,O,O
the,O,O
alpha,B,B
1,I,I
-,I,I
fetoprotein,I,I
gene,I,O
in,O,O
hepatocytes,O,O
.,O,O
A,O,O
prospective,O,O
observational,O,O
study,O,O
was,O,O
conducted,O,O
to,O,O
identify,O,O
early,O,O
indicators,O,O
of,O,O
acute,O,O
dengue,O,B
virus,O,I
infection,O,O
.,O,O
One,O,O
patients,O,O
had,O,O
plasma,B,O
C,I,B
-,I,I
peptide,I,I
greater,O,O
than,O,O
3,O,O
pM,O,O
and,O,O
was,O,O
therefore,O,O
excluded,O,O
from,O,O
analysis,O,O
.,O,O
Measurement,O,O
of,O,O
magnesium,O,O
absorption,O,O
in,O,O
man,O,O
using,O,O
stable,O,O
26Mg,O,B
as,O,O
a,O,O
tracer,O,O
.,O,O
The,O,O
median,O,O
survival,O,O
is,O,O
not,O,O
reached,O,O
with,O,O
a,O,O
median,O,O
follow,O,O
-,O,O
up,O,O
time,O,O
of,O,O
9,O,O
.,O,O
6,O,O
years,O,O
.,O,O
Conformational,O,O
studies,O,O
combining,O,O
secondary,O,O
structure,O,O
predictions,O,O
",",O,O
CD,O,B
and,O,O
NMR,O,B
spectroscopy,O,O
together,O,O
with,O,O
ELISA,O,B
assays,O,O
",",O,O
showed,O,O
that,O,O
the,O,O
greater,O,O
is,O,O
the,O,O
propensity,O,O
of,O,O
the,O,O
epitope,O,O
for,O,O
helix,O,O
formation,O,O
the,O,O
higher,O,O
is,O,O
the,O,O
recognition,O,O
by,O,O
anti,B,O
-,I,O
K159,I,B
.,O,O
Prostate,B,B
specific,I,I
antigen,I,I
shows,O,O
the,O,O
metastatic,O,O
cases,O,O
better,O,O
[,O,O
correction,O,O
of,O,O
worse,O,O
],O,O
than,O,O
prostatic,B,B
acid,I,I
phosphatase,I,I
.,O,O
Simultaneous,O,O
",",O,O
bilateral,O,O
and,O,O
permanent,O,O
ventilation,O,O
with,O,O
a,O,O
diaphragm,O,O
pacing,O,O
in,O,O
childhood,O,O
:,O,O
the,O,O
implantation,O,O
technique,O,O
and,O,O
indications,O,O
The,O,O
first,O,O
follow,O,O
-,O,O
up,O,O
was,O,O
at,O,O
a,O,O
nearly,O,O
constant,O,O
interval,O,O
of,O,O
5,O,O
.,O,O
1,O,O
years,O,O
in,O,O
Caerphilly,O,O
and,O,O
3,O,O
.,O,O
2,O,O
years,O,O
in,O,O
Speedwell,O,O
;,O,O
251,O,O
major,O,O
IHD,O,O
events,O,O
had,O,O
occurred,O,O
.,O,O
Fourteen,O,O
patients,O,O
were,O,O
in,O,O
the,O,O
multifocal,O,O
disease,O,O
group,O,O
;,O,O
13,O,O
were,O,O
detected,O,O
by,O,O
SPECT,O,O
and,O,O
10,O,O
by,O,O
TCT,O,O
.,O,O
U73,B,B
contains,O,O
C,O,B
",",O,O
D,O,B
and,O,O
D,O,B
',O,O
boxes,O,O
and,O,O
a,O,O
12,O,O
-,O,O
nucleotide,O,O
antisense,O,O
complementarity,O,O
to,O,O
the,O,O
28S,B,O
ribosomal,I,O
RNA,I,O
.,O,O
CONCLUSIONS,O,O
:,O,O
XCoe2,B,B
may,O,O
play,O,O
a,O,O
pivotal,O,O
role,O,O
in,O,O
the,O,O
transcriptional,O,O
cascade,O,O
that,O,O
specifies,O,O
primary,O,O
neurons,O,O
in,O,O
Xenopus,O,O
embryos,O,O
:,O,O
by,O,O
maintaining,O,O
Delta,B,O
-,O,O
Notch,B,O
signalling,O,O
",",O,O
XCoe2,B,O
stabilises,O,O
the,O,O
higher,O,O
neural,O,O
potential,O,O
of,O,O
selected,O,O
progenitor,O,O
cells,O,O
that,O,O
express,O,O
X,B,O
-,I,O
ngnr,I,O
-,I,O
1,I,O
",",O,O
ensuring,O,O
the,O,O
transition,O,O
between,O,O
neural,O,O
competence,O,O
and,O,O
irreversible,O,O
commitment,O,O
to,O,O
a,O,O
neural,O,O
fate,O,O
;,O,O
and,O,O
it,O,O
promotes,O,O
neuronal,O,O
differentiation,O,O
by,O,O
activating,O,O
XNeuroD,B,B
expression,O,O
",",O,O
directly,O,O
or,O,O
indirectly,O,O
.,O,O
Negatively,O,O
supercoiled,O,O
plasmid,O,O
pUC19,O,B
did,O,O
not,O,O
compete,O,O
",",O,O
whereas,O,O
an,O,O
otherwise,O,O
identical,O,O
plasmid,O,O
pUC19,O,B
(,O,O
CG,O,B
),O,O
",",O,O
which,O,O
contained,O,O
a,O,O
(,O,O
dG,O,B
-,O,I
dC,O,I
),O,O
7,O,O
segment,O,O
in,O,O
the,O,O
Z,O,O
-,O,O
form,O,O
was,O,O
an,O,O
excellent,O,O
competitor,O,O
.,O,O
In,O,O
contrast,O,O
",",O,O
an,O,O
amino,O,O
-,O,O
terminal,O,O
fragment,O,O
containing,O,O
the,O,O
C,O,O
/,O,O
H1,O,O
domain,O,O
was,O,O
sufficient,O,O
for,O,O
coactivation,O,O
of,O,O
Zta,B,O
transcription,O,O
and,O,O
viral,O,O
reactivation,O,O
function,O,O
.,O,O
Weak,O,O
allergenicity,O,O
of,O,O
recombinant,B,O
hirudin,I,B
CGP,I,I
39393,I,I
(,O,O
REVASC,O,B
),O,O
in,O,O
immunocompetent,O,O
volunteers,O,O
.,O,O
TSA,O,O
treatment,O,O
",",O,O
however,O,O
",",O,O
did,O,O
not,O,O
detectably,O,O
alter,O,O
enhancer,O,O
factor,O,O
binding,O,O
or,O,O
the,O,O
positioning,O,O
of,O,O
nuc,B,O
-,I,O
1,I,O
on,O,O
the,O,O
majority,O,O
of,O,O
the,O,O
chromatin,O,O
templates,O,O
indicating,O,O
that,O,O
protein,O,O
acetylation,O,O
and,O,O
chromatin,O,O
remodeling,O,O
may,O,O
be,O,O
limiting,O,O
steps,O,O
that,O,O
occur,O,O
only,O,O
on,O,O
transcriptionally,O,O
competent,O,O
templates,O,O
",",O,O
or,O,O
that,O,O
remodeling,O,O
of,O,O
nuc,B,O
-,I,O
1,I,O
requires,O,O
additional,O,O
factors,O,O
.,O,O
Twenty,O,O
-,O,O
one,O,O
percent,O,O
of,O,O
these,O,O
patients,O,O
had,O,O
neurologic,O,O
disease,O,O
that,O,O
appeared,O,O
to,O,O
be,O,O
responsible,O,O
for,O,O
the,O,O
tinnitus,O,O
.,O,O
The,O,O
evolution,O,O
of,O,O
the,O,O
CCR5,B,B
cis,I,I
-,I,I
regulatory,I,I
region,I,I
versus,O,O
the,O,O
open,O,O
reading,O,O
frame,O,O
as,O,O
well,O,O
as,O,O
among,O,O
different,O,O
domains,O,O
of,O,O
the,O,O
open,O,O
reading,O,O
frame,O,O
differed,O,O
from,O,O
one,O,O
another,O,O
.,O,O
A,O,O
computer,O,O
program,O,O
",",O,O
ACCESS,O,O
-,O,O
IAQ,O,O
",",O,O
is,O,O
developed,O,O
to,O,O
simulate,O,O
the,O,O
airflow,O,O
pattern,O,O
",",O,O
the,O,O
time,O,O
history,O,O
of,O,O
the,O,O
contaminant,O,O
concentrations,O,O
in,O,O
the,O,O
occupied,O,O
zone,O,O
",",O,O
and,O,O
the,O,O
inhalation,O,O
exposures,O,O
.,O,O
A,O,O
potential,O,O
TATA,O,B
box,O,I
is,O,O
located,O,O
29,O,O
base,O,O
pairs,O,O
upstream,O,O
of,O,O
the,O,O
first,O,O
transcription,O,O
initiation,O,O
site,O,O
.,O,O
The,O,O
cDNA,O,O
encoded,O,O
a,O,O
mature,O,O
protein,O,O
of,O,O
240,O,O
amino,O,O
acids,O,O
",",O,O
including,O,O
a,O,O
29,O,O
-,O,O
amino,O,O
acid,O,O
signal,O,O
sequence,O,O
.,O,O
Using,O,O
a,O,O
MOS,O,O
-,O,O
Hypersil,O,O
reversed,O,O
-,O,O
phase,O,O
column,O,O
with,O,O
a,O,O
phosphate,O,O
buffer,O,O
-,O,O
-,O,O
acetonitrile,O,O
mobile,O,O
phase,O,O
",",O,O
baseline,O,O
separation,O,O
of,O,O
antipyrine,O,O
",",O,O
its,O,O
metabolites,O,O
3,O,O
-,O,O
hydroxymethylantipyrine,O,O
",",O,O
norantipyrine,O,O
and,O,O
4,O,O
-,O,O
hydroxyantipyrine,O,O
",",O,O
and,O,O
the,O,O
internal,O,O
standard,O,O
",",O,O
phenacetin,O,O
",",O,O
was,O,O
achieved,O,O
within,O,O
6,O,O
min,O,O
.,O,O
In,O,O
all,O,O
cases,O,O
",",O,O
high,O,O
-,O,O
level,O,O
expression,O,O
of,O,O
the,O,O
truncated,B,O
avian,I,B
integrins,I,O
was,O,O
obtained,O,O
.,O,O
